PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bransford, KJ; Lai, JA				Bransford, KJ; Lai, JA			Global climate change and air pollution: Common origins with common solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXPOSURE; OZONE		Phys Social Responsibil, Washington, DC USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA	Virginia Commonwealth University	Bransford, KJ (corresponding author), Phys Social Responsibil, Washington, DC USA.							BATES DV, 1995, ENVIRON HEALTH PERSP, V103, P49, DOI 10.2307/3432345; DETELS R, 1991, AM J PUBLIC HEALTH, V81, P350, DOI 10.2105/AJPH.81.3.350; Galizia A, 1999, ENVIRON HEALTH PERSP, V107, P675, DOI 10.2307/3434461; Gong H, 1998, AM J RESP CRIT CARE, V158, P538, DOI 10.1164/ajrccm.158.2.9709034; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; *NAT AC SCI, 2001, CLIM CHANG SCI AN SO; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; SPELLMAN F, 1999, ENV SCI TECHNOLOGY; *US ARM CORPS ENG, 1996, OCC EXP OZ; *US EPA, 2002, AIR TRENDS 1995 SUMM; *US EPA, 1997, HLTH ENV EFF GROUND	12	5	5	3	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2285	2285		10.1001/jama.287.17.2285	http://dx.doi.org/10.1001/jama.287.17.2285			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980533	hybrid			2022-12-24	WOS:000175260600032
J	Rees, J				Rees, J			Complex disease and the new clinical sciences	SCIENCE			English	Editorial Material							MEDICINE; INNOVATION; PSORIASIS; INDUSTRY	Medical research today is dominated by a genocentric point of view. At the same time, clinical discovery and patient-oriented research have become less common. Here, I suggest that these developments are interdependent, each representing the flip side of an inaccurate view of how clinical advance occurs.	Univ Edinburgh, Dept Dermatol, Syst Grp, Edinburgh EH3 9YW, Midlothian, Scotland	University of Edinburgh	Rees, J (corresponding author), Univ Edinburgh, Dept Dermatol, Syst Grp, Lauriston Bldg,Lauriston Pl, Edinburgh EH3 9YW, Midlothian, Scotland.							Altschuler EL, 2000, LANCET, V356, P1360, DOI 10.1016/S0140-6736(05)74277-X; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; Bellamy R, 1998, THORAX, V53, P588, DOI 10.1136/thx.53.7.588; Dill KA, 1999, NATURE, V400, P309, DOI 10.1038/22415; Drews J, 1997, NAT BIOTECHNOL, V15, P1318, DOI 10.1038/nbt1297-1318; Dyson FJ, 1998, SCIENCE, V280, P1014, DOI 10.1126/science.280.5366.1014; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; HOPPER JL, 1998, ENCY BIOSTATISTICS; Horrobin DF, 2000, J ROY SOC MED, V93, P341, DOI 10.1177/014107680009300702; HORROBIN DF, IN PRESS LANCET; JANSSEN P, 1999, PSYCHOPHARMACOLOGIST, V2, pCH3; MARSHALL BJ, 1984, LANCET, V1, P1311; PARRISH JA, 1974, NEW ENGL J MED, V291, P1207, DOI 10.1056/NEJM197412052912301; PECK GL, 1979, NEW ENGL J MED, V300, P329, DOI 10.1056/NEJM197902153000701; Rees J, 2001, CLIN MED, V1, P393, DOI 10.7861/clinmedicine.1-5-393; Rosenberg LE, 1999, SCIENCE, V283, P331, DOI 10.1126/science.283.5400.331; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schechter AN, 1999, NATURE, V401, P424, DOI 10.1038/46672; SHUSTER S, 1984, BRIT J DERMATOL, V111, P235, DOI 10.1111/j.1365-2133.1984.tb04050.x; SHUSTER S, 1987, TRIANGLE, V26, P125; Simon H. A., 1991, MODELS MY LIFE; VANWEELDEN H, 1988, BRIT J DERMATOL, V119, P11; WEATHERALL DJ, 1991, BRIT MED J, V302, P1002, DOI 10.1136/bmj.302.6783.1002; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866	27	105	108	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					698	701		10.1126/science.296.5568.698	http://dx.doi.org/10.1126/science.296.5568.698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976444				2022-12-24	WOS:000175281700043
J	Sanyal, S; Sandstrom, DJ; Hoeffer, CA; Ramaswami, M				Sanyal, S; Sandstrom, DJ; Hoeffer, CA; Ramaswami, M			AP-1 functions upstream of CREB to control synaptic plasticity in Drosophila	NATURE			English	Article							LONG-TERM-MEMORY; TRANSCRIPTION FACTOR; GENETIC DISSECTION; NERVOUS-SYSTEM; DORSAL CLOSURE; C-FOS; EXPRESSION; COMPONENTS; INDUCTION; NEURONS	Activity-regulated gene expression mediates many aspects of neural plasticity, including long-term memory. In the prevailing view, patterned synaptic activity causes kinase-mediated activation of the transcription factor cyclic AMP response-element-binding protein, CREB. Together with appropriate cofactors, CREB then transcriptionally induces a group of 'immediate-early' transcription factors and, eventually, effector proteins that establish or consolidate synaptic change(1). Here, using a Drosophila model synapse, we analyse cellular functions and regulation of the best known immediate-early transcription factor, AP-1; a heterodimer of the basic leucine zipper proteins Fos and Jun(2). We observe that AP-1 positively regulates both synaptic strength and synapse number, thus showing a greater range of influence than CREB3. Observations from genetic epistasis and RNA quantification experiments indicate that AP-1 acts upstream of CREB, regulates levels of CREB messenger RNA, and functions at the top of the hierarchy of transcription factors known to regulate long-term plasticity. A Jun-kinase signalling module provides a CREB-independent route for neuronal AP-1 activation; thus, CREB regulation of AP-1 expression(4) may, in some neurons, constitute a positive feedback loop rather than the primary step in AP-1 activation.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Div Neurobiol, Arizona Res Labs, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Ramaswami, M (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.			Sandstrom, David/0000-0001-6235-7118; Sanyal, Subhabrata/0000-0003-2590-2732; Ramaswami, Mani/0000-0001-7631-0468				BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARTON O, 1979, COMPREHENSIVE ORGANI, V2, P83; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheung US, 1999, J NEUROBIOL, V40, P1, DOI 10.1002/(SICI)1097-4695(199907)40:1<1::AID-NEU1>3.0.CO;2-1; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; DeZazzo J, 2000, NEURON, V27, P145, DOI 10.1016/S0896-6273(00)00016-7; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Schwarzschild MA, 1997, J NEUROSCI, V17, P3455; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zeitlinger J, 1997, EMBO J, V16, P7393, DOI 10.1093/emboj/16.24.7393; ZHONG Y, 1992, J NEUROSCI, V12, P644	28	129	134	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					870	874		10.1038/416870a	http://dx.doi.org/10.1038/416870a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976688				2022-12-24	WOS:000175163800056
J	Royle, NJ; Hartley, IR; Parker, GA				Royle, NJ; Hartley, IR; Parker, GA			Sexual conflict reduces offspring fitness in zebra finches	NATURE			English	Article							MALE PARENTAL CARE; MALE-REMOVAL; EVOLUTION; BIRDS; BEHAVIOR; SIZE	Parental care is often costly(1); hence, in sexually reproducing species where both male and female parents rear their offspring (biparental care), sexual conflict over parental investment can arise(2). Such conflict occurs because each care-giver would benefit from withholding parental investment for use with another partner, leading to a reduction in the amount of care given by one parent at the expense of the other(3-5). Here we report experiments to explore the prediction from theory that parents rearing offspring alone may provide greater parental investment than when rearing offspring together with a partner(3,5). We found that when the number of offspring per parent, and hence the potential workload, were kept constant, offspring received a greater per capita parental investment from single females than from both parents working together, and that males reared by single mothers were more sexually attractive as adults than their biparentally reared siblings. This difference between single- and two-parent families is due to a reduction in care provided by females when they care together with a male, rather than laziness by males or differences in the begging behaviour of chicks, supporting the claim that sexual conflict in biparental care can reduce the quality of offspring raised(3,5).	Univ Lancaster, IENS, Sch Biol Sci, Lancaster LA1 4YQ, England; Univ Liverpool, Sch Biol Sci, Populat & Evolutionary Biol Res Grp, Liverpool L69 3GS, Merseyside, England	Lancaster University; University of Liverpool	Hartley, IR (corresponding author), Univ Lancaster, IENS, Sch Biol Sci, Lancaster LA1 4YQ, England.	i.hartley@lancaster.ac.uk	Royle, Nick J/H-2802-2015; Parker, Geoff/C-4337-2008	Royle, Nick J/0000-0002-1617-3884; Parker, Geoff/0000-0003-4795-6352; Hartley, Ian/0000-0002-7592-3921				BART J, 1989, BEHAV ECOL SOCIOBIOL, V24, P109, DOI 10.1007/BF00299642; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; Birkhead TR, 1998, SPERM COMPETITION SE; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; CHASE ID, 1980, AM NAT, V115, P827, DOI 10.1086/283603; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C, DOI DOI 10.104641420-9101.1992.5040719.X; Gavrilets S, 2000, NATURE, V403, P886, DOI 10.1038/35002564; Godfray HCJ, 1999, MG BEH ECOL, P100; Houston A.I., 1985, P471; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Lessells CM, 1999, MG BEH ECOL, P75; LESSELLS CM, IN PRESS PHIL T R B; Markman S, 1996, ANIM BEHAV, V52, P437, DOI 10.1006/anbe.1996.0188; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; MCNAMARA JM, IN PRESS BEHAV ECOL; Mock D. W., 1997, EVOLUTION SIBLING RI; Moore AJ, 2001, P ROY SOC B-BIOL SCI, V268, P517, DOI 10.1098/rspb.2000.1399; PARKER GA, 1985, ANIM BEHAV, V33, P519, DOI 10.1016/S0003-3472(85)80075-0; Parker GA, 1998, PHILOS T R SOC B, V353, P261, DOI 10.1098/rstb.1998.0208; Partridge L, 1998, SCIENCE, V281, P2003, DOI 10.1126/science.281.5385.2003; Pomiankowski A, 1999, MG BEH ECOL, P121; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; SASVARI L, 1986, J ANIM ECOL, V55, P553, DOI 10.2307/4738; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smith HG, 2000, P ROY SOC B-BIOL SCI, V267, P2163, DOI 10.1098/rspb.2000.1264; Stockley P, 1997, TRENDS ECOL EVOL, V12, P154, DOI 10.1016/S0169-5347(97)01000-8; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Westneat David F., 1996, Trends in Ecology and Evolution, V11, P87, DOI 10.1016/0169-5347(96)81049-4; WHITTINGHAM LA, 1994, ETHOLOGY, V96, P260; WOLF L, 1990, ANIM BEHAV, V39, P125, DOI 10.1016/S0003-3472(05)80732-8	30	119	119	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2002	416	6882					733	736		10.1038/416733a	http://dx.doi.org/10.1038/416733a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961554				2022-12-24	WOS:000175033500041
J	Mandala, S; Hajdu, R; Bergstrom, J; Quackenbush, E; Xie, J; Milligan, J; Thornton, R; Shei, GJ; Card, D; Keohane, C; Rosenbach, M; Hale, J; Lynch, CL; Rupprecht, K; Parsons, W; Rosen, H				Mandala, S; Hajdu, R; Bergstrom, J; Quackenbush, E; Xie, J; Milligan, J; Thornton, R; Shei, GJ; Card, D; Keohane, C; Rosenbach, M; Hale, J; Lynch, CL; Rupprecht, K; Parsons, W; Rosen, H			Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists	SCIENCE			English	Article							SPHINGOSINE 1-PHOSPHATE; FTY720; IMMUNOSUPPRESSANT; PLASMA	Blood lymphocyte numbers, essential for the development of efficient immune responses, are maintained by recirculation through secondary Lymphoid organs. We show that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolite of the immunosuppressive agent FTY720. Both species were high-affinity agonists of at Least four of the five S1P receptors. These agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in lymph nodes, but not spleen. S1P receptor agonists induced emptying of lymphoid sinuses by retention of Lymphocytes on the abluminal side of sinus-lining endothelium and inhibition of egress into lymph. Inhibition of lymphocyte recirculation by activation of S1P receptors may result in therapeutically useful immunosuppression.	Merck Res Labs, Dept Immunol & Rheumatol, Rahway, NJ 07055 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07055 USA; Merck Res Labs, Dept Med Chem, Rahway, NJ 07055 USA	Merck & Company; Merck & Company; Merck & Company	Rosen, H (corresponding author), Merck Res Labs, Dept Immunol & Rheumatol, POB 2000, Rahway, NJ 07055 USA.	hugh_rosen@merck.com						Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Brinkmann V, 2000, TRENDS PHARMACOL SCI, V21, P49, DOI 10.1016/S0165-6147(99)01419-4; Brinkmann V, 2001, TRANSPLANTATION, V72, P764, DOI 10.1097/00007890-200109150-00002; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Chiba K, 1998, J IMMUNOL, V160, P5037; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gowans JL, 1996, IMMUNOL TODAY, V17, P288, DOI 10.1016/0167-5699(96)80547-0; Graler MH, 1999, CURR TOP MICROBIOL, V246, P131; Henning G, 2001, J EXP MED, V194, P1875, DOI 10.1084/jem.194.12.1875; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Ishii I, 2001, J BIOL CHEM, V276, P33697, DOI 10.1074/jbc.M104441200; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Liliom K, 2001, BIOCHEM J, V355, P189, DOI 10.1042/0264-6021:3550189; Luo ZJ, 1999, IMMUNOPHARMACOLOGY, V41, P199, DOI 10.1016/S0162-3109(99)00004-1; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Neumayer HH, 1999, TRANSPLANTATION, V67, pS204, DOI 10.1097/00007890-199904150-00815; Sugiyama A, 2000, JPN J PHARMACOL, V82, P338, DOI 10.1254/jjp.82.338; Sugiyama A, 2000, CARDIOVASC RES, V46, P119, DOI 10.1016/S0008-6363(00)00013-4	23	1343	1439	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					346	349		10.1126/science.1070238	http://dx.doi.org/10.1126/science.1070238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11923495				2022-12-24	WOS:000175000300058
J	Queller, DC; Strassmann, JE				Queller, DC; Strassmann, JE			The many selves of social insects	SCIENCE			English	Article							INTRAGENOMIC CONFLICT; KIN RECOGNITION; HONEY-BEE; HYMENOPTERA; SELECTION; SUPERORGANISM; COLONY; ANT	Social insects show multiple Levels of self identity. Most individuals are sterile workers who selflessly Labor for their colony, which is often viewed as a superorganism. The superorganism protects itself with colony recognition systems based on learned odors, typically cuticular hydrocarbons. Transfer of these odors within the colony obscures separate clan identities. Residual individual interests do appear to cause conflicts within colonies over sex ratio, male production, caste, and reproductive dominance. However, genomic imprinting theory predicts that the individual's maternal and paternal genes will evolve separate infraorganismal identities, perhaps Leaving virtually no coherent individual identity.	Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA	Rice University	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, POB 1892,Mail Stop 170, Houston, TX 77251 USA.			Strassmann, Joan/0000-0003-0638-8440				Alexander R. D., 1979, DARWINISM HUMAN AFFA; AMITH JM, 1995, MAJOR TRANSITIONS EV; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; BOURKE AFG, 1994, J THEOR BIOL, V167, P283, DOI 10.1006/jtbi.1994.1070; Bourke AFG, 1999, BEHAV ECOL SOCIOBIOL, V46, P287, DOI 10.1007/s002650050622; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; Clement Jean-Luc, 1998, P126; COSMIDES LM, 1981, J THEOR BIOL, V89, P83, DOI 10.1016/0022-5193(81)90181-8; Dani FR, 2001, ANIM BEHAV, V62, P165, DOI 10.1006/anbe.2001.1714; GETZ WM, 1982, J THEOR BIOL, V99, P585, DOI 10.1016/0022-5193(82)90212-0; HAIG D, 1995, J EVOLUTION BIOL, V8, P265, DOI 10.1046/j.1420-9101.1995.8030265.x; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; HAIG D, 1992, J THEOR BIOL, V156, P401, DOI 10.1016/S0022-5193(05)80683-6; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hamilton W, 1972, ANNU REV ECOL SYST, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hurst LD, 1996, Q REV BIOL, V71, P317, DOI 10.1086/419442; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Keller L, 1997, TRENDS ECOL EVOL, V12, P99, DOI 10.1016/S0169-5347(96)10065-3; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; Lenoir A, 2001, INSECT SOC, V48, P101, DOI 10.1007/PL00001751; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NONACS P, 1990, P NATL ACAD SCI USA, V87, P9670, DOI 10.1073/pnas.87.24.9670; Passera L, 2001, SCIENCE, V293, P1308, DOI 10.1126/science.1062076; Peters JM, 1999, P ROY SOC B-BIOL SCI, V266, P379, DOI 10.1098/rspb.1999.0648; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; RATNIEKS FLW, 1988, AM NAT, V132, P217, DOI 10.1086/284846; Ratnieks FLW, 2001, BEHAV ECOL SOCIOBIOL, V50, P467, DOI 10.1007/s002650100388; RATNIEKS FLW, 1989, NATURE, V342, P796, DOI 10.1038/342796a0; Rawls J., 1971, THEORY JUSTICE, DOI DOI 10.5860/CHOICE.37-4151; Reeve Hudson Kern, 1998, P118; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; SEELEY TD, 1989, AM SCI, V77, P546; Singer Theresa L., 1998, P104; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; TRIVERS RL, 1998, P R SOC LONDON B, V265, P2393; Vander Meer Robert K., 1998, P79; Wheeler William Morton, 1911, Journal of Morphology Philadelphia, V22, DOI 10.1002/jmor.1050220206; WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9	43	55	57	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					311	313		10.1126/science.1070671	http://dx.doi.org/10.1126/science.1070671			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951035				2022-12-24	WOS:000175000300046
J	Peterson, AT; Ortega-Huerta, MA; Bartley, J; Sanchez-Cordero, V; Soberon, J; Buddemeier, RH; Stockwell, DRB				Peterson, AT; Ortega-Huerta, MA; Bartley, J; Sanchez-Cordero, V; Soberon, J; Buddemeier, RH; Stockwell, DRB			Future projections for Mexican faunas under global climate change scenarios	NATURE			English	Article							SPECIES RANGE; BIODIVERSITY; NICHES	Global climates are changing rapidly, with unexpected consequences(1). Because elements of biodiversity respond intimately to climate as an important driving force of distributional limitation(2), distributional shifts and biodiversity losses are expected(3,4). Nevertheless, in spite of modelling efforts focused on single species(2) or entire ecosystems(5), a few preliminary surveys of fauna-wide effects(6,7), and evidence of climate change-mediated shifts in several species(8,9), the likely effects of climate change on species' distributions remain little known, and fauna-wide or community-level effects are almost completely unexplored(6). Here, using a genetic algorithm and museum specimen occurrence data, we develop ecological niche models for 1,870 species occurring in Mexico and project them onto two climate surfaces modelled for 2055. Although extinctions and drastic range reductions are predicted to be relatively few, species turnover in some local communities is predicted to be high (> 40% of species), suggesting that severe ecological perturbations may result.	Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; Univ Kansas, Dept Geog, Lawrence, KS 66045 USA; Univ Kansas, Kansas Appl Remote Sensing Program, Lawrence, KS 66045 USA; Univ Kansas, Kansas Geol Survey, Lawrence, KS 66045 USA; Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of California System; University of California San Diego	Peterson, AT (corresponding author), Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA.		Soberon, Jorge/ABF-1306-2021; Peterson, A. Townsend/I-5697-2013; Soberon, Jorge/N-7444-2015	Soberon, Jorge/0000-0003-2160-4148; Peterson, A. Townsend/0000-0003-0243-2379; Soberon, Jorge/0000-0003-2160-4148				AUSTIN MP, 1990, ECOL MONOGR, V60, P161, DOI 10.2307/1943043; Carson DJ, 1999, Q J ROY METEOR SOC, V125, P1, DOI 10.1002/qj.49712555303; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; DOBSON A, 1989, TRENDS ECOL EVOL, V4, P64, DOI 10.1016/0169-5347(89)90150-X; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; HOUGHTON JT, 2001, IPCC 3 ASSESSMENT RE; Johnston KM, 1997, GLOB CHANGE BIOL, V3, P531, DOI 10.1046/j.1365-2486.1997.00093.x; KOOPOWITZ H, 1994, CONSERV BIOL, V8, P452; LLORENTEBOUSQUE.J, 1997, PAPILIONIDAE PIERIDA; MacArthur R.H., 1972, pvii; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Peterson AT, 1999, CONSERV BIOL, V13, P427, DOI 10.1046/j.1523-1739.1999.013002427.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 1998, IBIS, V140, P288, DOI 10.1111/j.1474-919X.1998.tb04391.x; Peterson AT, 2002, IBIS, V144, pE27, DOI 10.1046/j.0019-1019.2001.00031.x; Peterson AT, 2001, ECOL MODEL, V144, P21, DOI 10.1016/S0304-3800(01)00345-3; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; PETERSON AT, IN PRESS PREDICTING; Price Jeff, 2000, Bird Observer (Arlington), V28, P224; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Soberon J, 1999, TRENDS ECOL EVOL, V14, P291, DOI 10.1016/S0169-5347(99)01617-1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; TOBLER WR, 1979, J AM STAT ASSOC, V74, P519, DOI 10.2307/2286968; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Woodward FI, 1998, PHILOS T ROY SOC B, V353, P29, DOI 10.1098/rstb.1998.0188	29	606	665	3	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					626	629		10.1038/416626a	http://dx.doi.org/10.1038/416626a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948349				2022-12-24	WOS:000174901900041
J	Flores, ER; Tsai, KY; Crowley, D; Sengupta, S; Yang, A; McKeon, F; Jacks, T				Flores, ER; Tsai, KY; Crowley, D; Sengupta, S; Yang, A; McKeon, F; Jacks, T			p63 and p73 are required for p53-dependent apoptosis in response to DNA damage	NATURE			English	Article							CENTRAL-NERVOUS-SYSTEM; KINASE C-ABL; INDUCE APOPTOSIS; TUMOR-SUPPRESSOR; IN-VIVO; P53; FAMILY; CELLS; PROTEIN; TARGET	The tumour-suppressor gene p53 is frequently mutated in human cancers and is important in the cellular response to DNA damage(1,2). Although the p53 family members p63 and p73 are structurally related to p53, they have not been directly linked to tumour suppression, although they have been implicated in apoptosis(3-9). Given the similarity between this family of genes and the ability of p63 and p73 to transactivate p53 target genes(10,11), we explore here their role in DNA damage-induced apoptosis. Mouse embryo fibroblasts deficient for one or a combination of p53 family members were sensitized to undergo apoptosis through the expression of the adenovirus E1A oncogene(12-14). While using the E1A system facilitated our ability to perform biochemical analyses, we also examined the functions of p63 and p73 using an in vivo system in which apoptosis has been shown to be dependent on p53. Using both systems, we show here that the combined loss of p63 and p73 results in the failure of cells containing functional p53 to undergo apoptosis in response to DNA damage.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Howard Hughes Med Inst, Chevy Chase, MD 20185 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Tsai, Kenneth/0000-0001-5325-212X				Agami R, 1999, NATURE, V399, P809; Attardi LD, 2000, GENE DEV, V14, P704; Chong MJ, 2000, P NATL ACAD SCI USA, V97, P889, DOI 10.1073/pnas.97.2.889; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gong JG, 1999, NATURE, V399, P806; Herzog KH, 1998, SCIENCE, V280, P1089, DOI 10.1126/science.280.5366.1089; Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang ZL, 1999, ACTA GEOL SIN-ENGL, V73, P404; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zaika A, 2001, J BIOL CHEM, V276, P11310, DOI 10.1074/jbc.M005737200	27	689	707	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					560	564		10.1038/416560a	http://dx.doi.org/10.1038/416560a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932750				2022-12-24	WOS:000174756500050
J	Hetherington, S; Hughes, AR; Mosteller, M; Shortino, D; Baker, KL; Spreen, W; Lai, E; Davies, K; Handley, A; Dow, DJ; Fling, ME; Stocum, M; Bowman, C; Thurmond, LM; Roses, AD				Hetherington, S; Hughes, AR; Mosteller, M; Shortino, D; Baker, KL; Spreen, W; Lai, E; Davies, K; Handley, A; Dow, DJ; Fling, ME; Stocum, M; Bowman, C; Thurmond, LM; Roses, AD			Genetic variations in HLA-B region and hypersensitivity reactions to abacavir	LANCET			English	Article								Hypersensitivity to abacavir affects about 4% of patients who receive the drug for HIV-1 infection. We did a retrospective, case-control study to identify multiple markers in the vicinity of HLA-B associated with hypersensitivity reactions. HLA-B57 was present In 39 (46%) of 84 patients versus four (4%) of 113 controls (p<0.0001). However, because of low numbers of women and other ethnic groups enrolled, these findings relate largely to white men. The lower sensitivity of HLA-B57 for predicting hypersensitivity to abacavir identified in this study compared with a previous report highlights that predictive values for markers will vary across populations. Clinical monitoring and management of hypersensitivity reactions among patients receiving abacavir must remain unchanged.	GlaxoSmithKline, HIV Clin Dev & Med Affairs, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Genet Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Clin Stat, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Drug Metab & Pharmacokinet, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Hetherington, S (corresponding author), GlaxoSmithKline, HIV Clin Dev & Med Affairs, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.		Baker-Neblett, Katherine/Y-4823-2019	Baker-Neblett, Katherine/0000-0001-6869-7498				Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Pirmohamed M, 2001, TRENDS PHARMACOL SCI, V22, P298, DOI 10.1016/S0165-6147(00)01717-X; Roses AD, 2000, LANCET, V355, P1358, DOI 10.1016/S0140-6736(00)02126-7	5	593	617	0	18	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1121	1122		10.1016/S0140-6736(02)08158-8	http://dx.doi.org/10.1016/S0140-6736(02)08158-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943262				2022-12-24	WOS:000174729200013
J	Liu, SL; Joseph, KS; Kramer, MS; Allen, JC; Sauve, R; Rusen, I; Wen, SW				Liu, SL; Joseph, KS; Kramer, MS; Allen, JC; Sauve, R; Rusen, I; Wen, SW		Fetal Infant Hlth Study Grp Canadi	Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-TUBE DEFECTS; BIRTH-WEIGHT; CONGENITAL-ANOMALIES; MATERNAL SERUM; UNITED-STATES; RECENT TRENDS; FOLIC-ACID; IMPACT; FETAL; RISK	Context Prenatal diagnosis and termination of affected pregnancies can prevent infant deaths due to congenital anomalies, but an effect at the population level has not been shown. Objective To examine the impact of recent changes in congenital anomaly-related fetal and infant deaths on overall population-based infant mortality. Design, Setting, and Subjects Birth cohort-based study of all live births, stillbirths, and infant deaths in Canada (excluding Ontario) for 1991-1998. Main Outcome Measures Cause-specific infant mortality rates and gestational age-specific fetal death rates. Results The birth cohort-based infant mortality rate fluctuated between 6.4 and 6.1 per 1000 live births between 1991 and 1995, then dropped to 5.4 per 1000 in 1996 and 5.5 per 1000 in 1997. The rate of infant death from congenital anomalies was stable between 1991 and 1995 but declined by 21% (95% confidence interval, 19%-32%) from 1.86 per 1000 in 1995 to 1.47 per 1000 in 1996 and 1997. Fetal deaths due to pregnancy termination at 20 to 23 weeks' gestation increased dramatically in 1994, while fetal deaths due to congenital anomalies at 20 to 21 weeks increased in 1995 and subsequently. Provinces/territories with high rates of fetal death due to pregnancy termination/congenital anomalies at 20 to 23 weeks had fewer infant deaths due to congenital anomalies. Conclusion A large decrease in infant deaths due to congenital anomalies was associated with the most recent decline in infant mortality in Canada, suggesting that increases in prenatal diagnosis and pregnancy termination for congenital anomalies are related to decreases in overall infant mortality at the population level.	Hlth Canada, Ctr Healthy Human Dev, Hlth Surveillance & Epidemiol Div, Ottawa, ON K1A 0L2, Canada; Dalhousie Univ, Dept Obstet & Gynecol, Perinatal Epidemiol Res Unit, Halifax, NS, Canada; Dalhousie Univ, Dept Pediat, Perinatal Epidemiol Res Unit, Halifax, NS, Canada; Dalhousie Univ, IWK Hlth Ctr, Div Neonatal Perinatal Med, Halifax, NS, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Univ Calgary, Dept Paediat, Calgary, AB T2N 1N4, Canada; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	Health Canada; Dalhousie University; Dalhousie University; Dalhousie University; McGill University; McGill University; University of Calgary; University of Calgary	Liu, SL (corresponding author), Hlth Canada, Ctr Healthy Human Dev, Hlth Surveillance & Epidemiol Div, HPB Bldg 7,Tunneys Pasture AL 0701D, Ottawa, ON K1A 0L2, Canada.	shiliang_liu@ch-sc.gc.ca		Joseph, K.S./0000-0003-2317-5607				Carmichael S L, 1998, Matern Child Health J, V2, P67, DOI 10.1023/A:1022916121368; *CDCP CDC, 1989, MMWR-MORBID MORTAL W, V38, P633; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P773; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; Cragan J D, 1995, MMWR CDC Surveill Summ, V44, P1; Daltveit AK, 1997, PAEDIATR PERINAT EP, V11, P214, DOI 10.1046/j.1365-3016.1997.d01-14.x; DOLK H, 1991, J EPIDEMIOL COMMUN H, V45, P52, DOI 10.1136/jech.45.1.52; DUCHESNE D, 1999, 84214XPE STAT CAN; DWYER T, 1995, PEDIATR ANN, V24, P350, DOI 10.3928/0090-4481-19950701-06; Fair M, 1993, Health Rep, V5, P281; Fair M, 2000, Chronic Dis Can, V21, P8; Forman R, 1996, CLIN INVEST MED, V19, P195; Forrester MB, 1998, AM J EPIDEMIOL, V148, P1206; GOLDENBERG RL, 1983, JAMA-J AM MED ASSOC, V250, P513, DOI 10.1001/jama.250.4.513; Haddow JE, 1998, NEW ENGL J MED, V338, P955, DOI 10.1056/NEJM199804023381404; HEIN HA, 1986, AM J DIS CHILD, V140, P989, DOI 10.1001/archpedi.1986.02140240035021; *HLTH STAT DIV, 1999, 84F210XPB STAT CAN H; *HLTH STAT DIV, 1997, 84210XIB STAT CAN HL; *HLTH STAT DIV, 1997, 84F209XPB STAT CAN H; Joseph KS, 1997, CAN MED ASSOC J, V157, P535; Joseph KS, 1999, PAEDIATR PERINAT EP, V13, P278; Joseph KS, 1996, CAN MED ASSOC J, V155, P1047; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Lee K, 2001, OBSTET GYNECOL, V98, P620, DOI 10.1016/S0029-7844(01)01507-1; LIMB CJ, 1994, AM J OBSTET GYNECOL, V170, P1333; Liu SL, 2001, AM J MED GENET, V104, P7, DOI 10.1002/1096-8628(20011115)104:1<7::AID-AJMG10023>3.3.CO;2-2; MORRIS CD, 1991, JAMA-J AM MED ASSOC, V266, P3447, DOI 10.1001/jama.266.24.3447; Permaul-Woods JA, 1999, CAN MED ASSOC J, V161, P381; ROBERTS HE, 1995, PEDIATRICS, V96, P880; SACHS BP, 1995, OBSTET GYNECOL, V85, P941, DOI 10.1016/0029-7844(95)00056-W; SECO A, 1994, J PUBLIC HEALTH MED, V16, P149; SINGH GK, 1995, AM J PUBLIC HEALTH, V85, P957, DOI 10.2105/AJPH.85.7.957; SMITH GD, 1991, ANN NUTR METAB, V35, P53, DOI 10.1159/000177678; Spencer K, 2000, BRIT J OBSTET GYNAEC, V107, P1271, DOI 10.1111/j.1471-0528.2000.tb11619.x; *STAT CAN, 1993, 82549 STAT CAN; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; *TASK FORC PER HLT, 1994, CMAJ, V151, P159; Turner LA, 1998, CAN MED ASSOC J, V158, P773; Velie EM, 1996, AM J EPIDEMIOL, V144, P473; Wen SW, 2000, TERATOLOGY, V61, P342, DOI 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7; Wen SW, 1999, CAN J PUBLIC HEALTH, V90, P316, DOI 10.1007/BF03404519; Wong SL, 1997, J PAEDIATR CHILD H, V33, P226, DOI 10.1111/j.1440-1754.1997.tb01584.x	42	91	96	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2002	287	12					1561	1567		10.1001/jama.287.12.1561	http://dx.doi.org/10.1001/jama.287.12.1561			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533VF	11911759	Bronze			2022-12-24	WOS:000174550400028
J	Steinmetz, LM; Sinha, H; Richards, DR; Spiegelman, JI; Oefner, PJ; McCusker, JH; Davis, RW				Steinmetz, LM; Sinha, H; Richards, DR; Spiegelman, JI; Oefner, PJ; McCusker, JH; Davis, RW			Dissecting the architecture of a quantitative trait locus in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC DISSECTION; COMPLEX TRAITS; LINKAGE	Most phenotypic diversity in natural populations is characterized by differences in degree rather than in kind. Identification of the actual genes underlying these quantitative traits has proved difficult(1-5). As a result, little is known about their genetic architecture. The failures are thought to be due to the different contributions of many underlying genes to the phenotype and the ability of different combinations of genes and environmental factors to produce similar phenotypes(6,7). This study combined genome-wide mapping and a new genetic technique named reciprocal-hemizygosity analysis to achieve the complete dissection of a quantitative trait locus (QTL) in Saccharomyces cerevisiae. A QTL architecture was uncovered that was more complex than expected. Functional linkages both in cis and in trans were found between three tightly linked quantitative trait genes that are neither necessary nor sufficient in isolation. This arrangement of alleles explains heterosis (hybrid vigour), the increased fitness of the heterozygote compared with homozygotes. It also demonstrates a deficiency in current approaches to QTL dissection with implications extending to traits in other organisms, including human genetic diseases.	Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Duke University; Stanford University; Stanford University; Stanford University	McCusker, JH (corresponding author), Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA.		Sinha, Himanshu/AAT-7853-2021	Sinha, Himanshu/0000-0001-7031-0491; McCusker, John/0000-0002-8803-9131; Steinmetz, Lars/0000-0002-3962-2865				BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; CODON AC, 1995, APPL ENVIRON MICROB, V61, P630; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Herskowitz I, 1991, METHOD ENZYMOL, P132; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mauricio R, 2001, NAT REV GENET, V2, P370, DOI 10.1038/35072085; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; MORTIMER RK, 1986, GENETICS, V113, P35; Murphy A, 1999, ENZYME MICROB TECH, V25, P551, DOI 10.1016/S0141-0229(99)00086-1; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schafer AJ, 1998, NAT BIOTECHNOL, V16, P33, DOI 10.1038/nbt0198-33; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Spiegelman JI, 2000, PLANT CELL, V12, P2485, DOI 10.1105/tpc.12.12.2485; Steinmetz LM, 2000, BIOTECHNOL GENET ENG, V17, P109, DOI 10.1080/02648725.2000.10647990; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WICKNER RB, 1987, J BACTERIOL, V169, P4941, DOI 10.1128/jb.169.11.4941-4945.1987; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86	27	403	423	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					326	330		10.1038/416326a	http://dx.doi.org/10.1038/416326a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907579				2022-12-24	WOS:000174482200044
J	Danovaro-Holliday, MC; Wood, AL; LeBaron, CW				Danovaro-Holliday, MC; Wood, AL; LeBaron, CW			Rotavirus vaccine and the news media, 1987-2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUBLIC-HEALTH; MEASLES MUMPS; INTUSSUSCEPTION; IMMUNIZATION; CHILDREN; EFFICACY; INFANTS; SAFETY; TRIAL; PERTUSSIS	Context In August 1998, the US Food and Drug Administration licensed the first vaccine against rotavirus, the most important cause of severe childhood diarrhea. Fourteen months later, amid intense media activity, the vaccine was withdrawn after an association was found with intussusception. Objectives To examine the character of news media stories about rotavirus vaccine before and after intussusception became an issue, to evaluate what prompted the stories, and to assess the extent to which they evoked public reaction, Design and Setting We searched Lexis-Nexis and Video Monitoring Services of America databases for rotavirus vaccine stories from the first US clinical trials (January 1, 1987) until 17 months after withdrawal (March 31, 2001) and examined calls to the National Immunization Hotline during the period in which rotavirus vaccine information was captured (July 1-December 31, 1999). Main Outcome Measures Mention of vaccine benefits and adverse events, classification of stories as positive, negative, or neutral toward the vaccine, story stimuli, and public response. Results We included 280 newspaper (primary subject of analysis), 49 wire service, and 257 television stories. Prior to identification of the intussusception association (January 1, 1987-July 14,1999), 21% of 188 newspaper stories mentioned vaccine adverse events and only 2 stories were negative toward the vaccine. Ninety-nine percent of stories mentioned vaccine benefits. During the period surrounding withdrawal (July 15-December 31, 1999), 93% of 90 stories mentioned adverse events and 77% were negative toward the vaccine. Eighty-four percent mentioned vaccine benefits. The rate of stories per month was 14-fold greater than the preceding period (P < .001); temporal and geographic patterns of media and hotline activity were similar. Thereafter (January 1, 2000-March 31, 2001), only 2 stories focused on rotavirus vaccine. Scientific research or public health actions prompted 80% of stories. Wire service and television stories showed similar patterns. The increase in rotavirus stories in July 1999 was followed by an increase in calls to the National Immunization Hotline regarding rotavirus but not other topics. The number of rotavirus calls that month was 57% higher than for any other childhood vaccine for any month since the hotline began in 1997. Rotavirus calls ceased almost completely after withdrawal of the vaccine in October 1999. Conclusions In response to reports about an adverse event, news media stories about vaccines can change abruptly from positivity to negativity. Since most vaccine stories may be stimulated by research and public health actions, opportunities exist to provide the media with accurate information necessary to avoid the "early idealization-sudden condemnation" pattern seen with rotavirus vaccine.	CDCP, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Danovaro-Holliday, MC (corresponding author), CDCP, Natl Immunizat Program, Mailstop E-61, Atlanta, GA 30333 USA.	carolina.danovaro@lshtm.ac.uk; clebaron@cdc.gov						*AD HOC GROUP, 1998, LANCET, V351, P955; *ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; *AM AC PED PUBL HL, 1999, MMWR-MORBID MORTAL W, V48, P563; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P637; *AUD BUR CIRC, 2001, NAT CIRC DAT BAS REG; BROWN F, 1997, DEV BIOL STANDARIZAT, V89; *CDCP, 1999, M HELD JUN 16 17 ATL; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P780; Chen RT, 1998, LANCET, V352, P63, DOI 10.1016/S0140-6736(05)79543-X; CHEN RT, 1998, VACCINES, P1144; Cohn V, 1996, JAMA-J AM MED ASSOC, V276, P1917; Daneman A, 1998, PEDIATR RADIOL, V28, P913, DOI 10.1007/s002470050497; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; DuVernoy TS, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.4.e52; Estes M.K., 1996, FIELDS VIROLOGY, P1625; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Feudtner C, 2001, PEDIATRICS, V107, P1158, DOI 10.1542/peds.107.5.1158; Freed GL, 1996, JAMA-J AM MED ASSOC, V276, P1869, DOI 10.1001/jama.276.23.1869; Frost K, 1997, AM J PUBLIC HEALTH, V87, P842, DOI 10.2105/AJPH.87.5.842; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; GELLERT GA, 1994, JAMA-J AM MED ASSOC, V271, P1285, DOI 10.1001/jama.271.16.1285; Girardi E, 1998, JAMA-J AM MED ASSOC, V280, P292, DOI 10.1001/jama.280.3.292; GOTHEFORS L, 1989, J INFECT DIS, V159, P753, DOI 10.1093/infdis/159.4.753; Gregorio L, 1997, PEDIATRICS, V99, P738, DOI 10.1542/peds.99.5.738; GRIFFITH AH, 1981, J BIOL STAND, V9, P475, DOI 10.1016/S0092-1157(81)80040-6; Halsey NA, 1999, JAMA-J AM MED ASSOC, V282, P1763, DOI 10.1001/jama.282.18.1763; Halsey NA, 1998, PEDIATRICS, V102, P1483, DOI 10.1542/peds.102.6.1483; HARDING CM, 1985, CHILD CARE HLTH DEV, V11, P21, DOI 10.1111/j.1365-2214.1985.tb00446.x; HIBBS B, 1999, SOC RISK AN ANN M DE; HOWSON CP, 1991, ADV EFFECTS PERTUSSI; *I MED, 1986, NEW VACCINE DEV DIS, V2; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; Izenberg N, 1998, CLIN PEDIATR, V37, P275, DOI 10.1177/000992289803700501; Jefferson T, 2000, J EPIDEMIOL COMMUN H, V54, P402, DOI 10.1136/jech.54.6.402; Joensuu J, 1997, LANCET, V350, P1205, DOI 10.1016/S0140-6736(97)05118-0; Kane MA, 1998, VACCINE, V16, pS73, DOI 10.1016/S0264-410X(98)00302-8; KAPIKIAN AZ, 1996, FIELDS VIROLOGY, V2, P1657; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Leask JA, 1998, AUST NZ J PUBL HEAL, V22, P17, DOI 10.1111/j.1467-842X.1998.tb01140.x; LEBARON CW, 1990, JAMA-J AM MED ASSOC, V264, P983, DOI 10.1001/jama.264.8.983; Mason BW, 2000, J EPIDEMIOL COMMUN H, V54, P473, DOI 10.1136/jech.54.6.473; *MASS MED BUR, 2001, RAD TEL CALL LETT; Miller E, 2001, ARCH DIS CHILD, V84, P227, DOI 10.1136/adc.84.3.227; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Nasir L, 2000, J FAM PRACTICE, V49, P731; *NAT HLTH COUNC, 1997, AM TALK SCI MED NEWS; NELKIN D, 1985, SOC RES, V52, P625; Offit PA, 1998, J CLIN VIROL, V11, P155, DOI 10.1016/S0928-0197(98)00063-4; Parashar UD, 1998, EMERG INFECT DIS, V4, P561, DOI 10.3201/eid0404.980406; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; POKORNY WJ, 1994, PRINCIPLES PRACTICE, P1856; Rennels MB, 1996, PEDIATRICS, V97, P7; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; Rennels MB, 2000, PEDIATRICS, V106, P123, DOI 10.1542/peds.106.1.123; Sansom SL, 2001, AM J EPIDEMIOL, V154, P1077, DOI 10.1093/aje/154.11.1077; SINGER E, 1987, J COMMUN, V37, P10; *US BUR CENS, 2001, WORLD POP PROF 1996; *US FDA, 1997, ROT ROT VACC SPONS P; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; VESIKARI T, 1990, AM J DIS CHILD, V144, P285, DOI 10.1001/archpedi.1990.02150270035021; VESIKARI T, 1986, J INFECT DIS, V153, P832, DOI 10.1093/infdis/153.5.832; Withdrawal of rotavirus vaccine, 1999, MMWR-MORBID MORTAL W, V48, P1007; Zanardi LR, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e97; 1999, AHP NEWS 1998; 2001, AAP NEWS         JAN, P6; 2000, AM JOURNALISM REV NE; 2000, MMWR MORB MORTAL WKL, V49, P585	70	41	41	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2002	287	11					1455	1462		10.1001/jama.287.11.1455	http://dx.doi.org/10.1001/jama.287.11.1455			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532GB	11903035	Green Accepted, Bronze			2022-12-24	WOS:000174465000030
J	Barco, A; Alarcon, JM; Kandel, ER				Barco, A; Alarcon, JM; Kandel, ER			Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture	CELL			English	Article							ELEMENT-BINDING PROTEIN; FAMILY TRANSCRIPTION FACTOR; CAMP-RESPONSIVE ELEMENT; TARGETED MUTATION; GENE-EXPRESSION; CRITICAL PERIOD; MEMORY STORAGE; CA1 REGION; LTP; HIPPOCAMPUS	Restricted and regulated expression in mice of VP16-CREB, a constitutively active form of CRES, in hippocampal CA1 neurons lowers the threshold for eliciting a persistent late phase of long-term potentiation (L-LTP) in the Schaffer collateral pathway. This L-LTP has unusual properties in that its induction is not dependent on transcription. Pharmacological and two-pathway experiments suggest a model in which VP16-CREB activates the transcription of CRE-driven genes and leads to a cell-wide distribution of proteins that prime the synapses for subsequent synapse-specific capture of L-LTP by a weak stimulus. Our analysis indicates that synaptic capture of CRE-driven gene products may be sufficient for consolidation of LTP and provides insight into the molecular mechanisms of synaptic tagging and synapse-specific potentiation.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, 1051 Riverside Dr, New York, NY 10032 USA.		Barco, Angel/C-3062-2008; Barco, Angel/ABF-1864-2021	Barco, Angel/0000-0002-0653-3751; Barco, Angel/0000-0002-0653-3751				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Ausubel F.M., 1999, ANTO LEEUWEN, V34, P253; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; FREY U, 1995, NEUROSCIENCE, V67, P799, DOI 10.1016/0306-4522(95)00117-2; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gass P, 1998, LEARN MEMORY, V5, P274; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Huang Y Y, 1994, Learn Mem, V1, P74; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lu YF, 1999, J NEUROSCI, V19, P10250; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MATTHIES H, 1993, NEUROREPORT, V4, P712, DOI 10.1097/00001756-199306000-00028; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Dell T J, 1994, Learn Mem, V1, P129; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Staubli U, 1996, J NEUROSCI, V16, P853; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	49	412	430	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					689	703		10.1016/S0092-8674(02)00657-8	http://dx.doi.org/10.1016/S0092-8674(02)00657-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893339	Bronze			2022-12-24	WOS:000174314800012
J	Schwetz, BA				Schwetz, BA			Warning on Serzone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-24	WOS:000174186000004
J	Crawford, LM				Crawford, LM			Data bank submissions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2203	2203		10.1001/jama.287.17.2203	http://dx.doi.org/10.1001/jama.287.17.2203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980508				2022-12-24	WOS:000175260600007
J	Shannon, MF; Rao, S				Shannon, MF; Rao, S			Transcription - Of Chips and ChIPs	SCIENCE			English	Editorial Material							GENE-EXPRESSION; CELL-CYCLE; DOMAINS		Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Shannon, MF (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canberra, ACT 2601, Australia.		Rao, Sudha/AAW-5192-2020	Rao, Sudha/0000-0001-9547-947X				Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dillon N, 2000, BIOESSAYS, V22, P657, DOI 10.1002/1521-1878(200007)22:7<657::AID-BIES8>3.3.CO;2-U; Futcher B, 2000, CURR OPIN CELL BIOL, V12, P710, DOI 10.1016/S0955-0674(00)00156-3; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2	19	25	29	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					666	+		10.1126/science.1062936	http://dx.doi.org/10.1126/science.1062936			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976432				2022-12-24	WOS:000175281700032
J	Bicknell, WJ				Bicknell, WJ			Sounding board - The case for voluntary smallpox vaccination.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston University	Bicknell, WJ (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA.							Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Centers for Disease Control and Prevention, 2001, INT SMALLP RESP PLAN; CHIN J, 2000, CONTROL COMMUNICABLE, P457; Cohen J, 2001, SCIENCE, V294, P985, DOI 10.1126/science.294.5544.985; Fenner F., 1988, SMALLPOX ITS ERRADIC, P1; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; *INT COMM RES, 2001, Q946 INT COMM RES; Meltzer MI, 2001, EMERG INFECT DIS, V7, P959, DOI 10.3201/eid0706.010607; MILLAR JD, 2000, PARADOX PREVENTION M; *NAT TRANSP SAF BO, 2001, REP INJ AM; *NAT VACC PROGR OF, 2001, PAND INFL PAND PAND; OTOOLE T, 2001, SHINING LIGHT DARK W; PETERSEN M, 2001, NY TIMES        0824, pC2; PICARD A, 2001, GLOBE MAIL      1106, P1; Rosenthal SR, 2001, EMERG INFECT DIS, V7, P920, DOI 10.3201/eid0706.010602	15	73	74	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2002	346	17					1323	1325						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544GX	11923492				2022-12-24	WOS:000175150800012
J	Reimann, JDR; Jackson, PK				Reimann, JDR; Jackson, PK			Emi1 is required for cytostatic factor arrest in vertebrate eggs	NATURE			English	Article							CLEAVING XENOPUS-EMBRYOS; MOS PROTO-ONCOGENE; OOCYTE MATURATION; METAPHASE ARREST; FROG OOCYTES; MAP KINASE; CYCLIN-B; ACTIVATION; EXTRACTS; FERTILIZATION	Vertebrate eggs are arrested at metaphase of meiosis II with stable cyclin B and high cyclin B/Cdc2 kinase activity. The ability of the anaphase-promoting complex/cyclosome (APC), an E3 ubiquitin ligase, to trigger cyclin B destruction and metaphase exit is blocked in eggs by the activity of cytostatic factor (CSF) (reviewed in ref. 1). CSF was defined as an activity in mature oocytes that caused mitotic arrest when injected into dividing embryos(2). Fertilization causes a transient increase in cytoplasmic calcium concentration leading to CSF inactivation, APC activation, cyclin B destruction and mitotic exit(3). The APC activator Cdc20 is required for APC activation after fertilization(4,5). We show here that the APC(cdc20) inhibitor Emi1 (ref. 6) is necessary and sufficient to inhibit the APC and to prevent mitotic exit in CSF-arrested eggs. CSF extracts immunodepleted of Emi1 degrade cyclin B, and exit from mitosis prematurely in the absence of calcium. Addition of Emi1 to these Emi1-depleted extracts blocks premature inactivation of the CSF-arrested state. Emi1 is required to arrest unfertilized eggs at metaphase of meiosis II and seems to be the long-sought mediator of CSF activity.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Jackson, PK (corresponding author), Stanford Univ, Dept Pathol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA.			Jackson, Peter/0000-0002-1742-2539				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Castro A, 2001, MOL BIOL CELL, V12, P2660, DOI 10.1091/mbc.12.9.2660; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; FURUNO N, 1994, EMBO J, V13, P2399, DOI 10.1002/j.1460-2075.1994.tb06524.x; Gross SD, 2000, CURR BIOL, V10, P430, DOI 10.1016/S0960-9822(00)00425-5; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; HACCARD O, 1993, SCIENCE, V262, P1262, DOI 10.1126/science.8235656; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; LORCA T, 1993, NATURE, V366, P270, DOI 10.1038/366270a0; Masui Y, 2000, NAT REV MOL CELL BIO, V1, P228, DOI 10.1038/35043096; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; Shah JV, 2000, CELL, V103, P997, DOI 10.1016/S0092-8674(00)00202-6; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; SHIBUYA EK, 1993, MOL BIOL CELL, V4, P781, DOI 10.1091/mbc.4.8.781; Sohaskey ML, 1999, MOL BIOL CELL, V10, P3729, DOI 10.1091/mbc.10.11.3729; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; WATANABE N, 1991, NATURE, V352, P247, DOI 10.1038/352247a0; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	31	104	108	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					850	854		10.1038/416850a	http://dx.doi.org/10.1038/416850a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976684				2022-12-24	WOS:000175163800052
J	Finney, BP; Gregory-Eaves, I; Douglas, MSV; Smol, JP				Finney, BP; Gregory-Eaves, I; Douglas, MSV; Smol, JP			Fisheries productivity in the northeastern Pacific Ocean over the past 2,200 years	NATURE			English	Article							SANTA-BARBARA BASIN; SOCKEYE-SALMON; CLIMATE; LAKE; RECONSTRUCTION; COLUMBIA; IMPACTS; HISTORY; TRENDS; GULF	Historical catch records suggest that climatic variability has had basin-wide effects on the northern Pacific and its fish populations, such as salmon, sardines and anchovies(1-7). However, these records are too short to define the nature and frequency of patterns. We reconstructed similar to2,200-year records of sockeye salmon abundance from sediment cores obtained from salmon nursery lakes on Kodiak island, Alaska. Large shifts in abundance, which far exceed the decadal-scale variability recorded during the past 300 years(1-8), occurred over the past two millennia. A marked, multi-centennial decline in Alaskan sockeye salmon was apparent from similar to100 BC to AD 800, but salmon were consistently more abundant from AD 1200 to 1900. Over the past two millennia, the abundances of Pacific sardine and Northern anchovy off the California coast, and of Alaskan salmon, show several synchronous patterns of variability. But sardines and anchovies vary out of phase with Alaskan salmon over low frequency, which differs from the pattern detected in historical records(5,6). The coherent patterns observed across large regions demonstrate the strong role of climatic forcing in regulating northeastern Pacific fish stocks.	Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA; Queens Univ, Dept Biol, PEARL, Kingston, ON K7L 3N6, Canada; Univ Toronto, Dept Geol, PAL, Toronto, ON M5S 3B1, Canada	University of Alaska System; University of Alaska Fairbanks; Queens University - Canada; University of Toronto	Finney, BP (corresponding author), Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK 99775 USA.	finney@ims.uaf.edu	Gregory-Eaves, Irene/U-9325-2019; Smol, John P/A-8838-2015	Gregory-Eaves, Irene/0000-0002-0380-5061; Smol, John/0000-0002-2499-6696				BAUMGARTNER TR, 1992, CAL COOP OCEAN FISH, V33, P24; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; BENNETT J, 1999, THESIS QUEENS U ONTA; Brodeur R.D., 1992, Fisheries Oceanography, V1, P32, DOI 10.1111/j.1365-2419.1992.tb00023.x; Burger CV, 2000, CAN J FISH AQUAT SCI, V57, P2096, DOI 10.1139/cjfas-57-10-2096; Burgner R. L., 1991, PACIFIC SALMON LIFE, P1; Calkin PE, 2001, QUATERNARY SCI REV, V20, P449, DOI 10.1016/S0277-3791(00)00105-0; CLARK DW, 1988, ARCTIC ANTHROPOL, V35, P172; ENNIS GL, 1983, CAN J BOT, V61, P1983, DOI 10.1139/b83-214; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; Francis RC, 1998, FISH OCEANOGR, V7, P1, DOI 10.1046/j.1365-2419.1998.00052.x; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Gargett AE, 1997, FISH OCEANOGR, V6, P109, DOI 10.1046/j.1365-2419.1997.00033.x; GILPIN LM, 1995, THESIS U CALIFORNIA; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JUILLETLECLERC A, 1987, NATURE, V329, P146, DOI 10.1038/329146a0; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; KNECT R, 1995, THESIS BRYN MAWR COL; Lluch-Belda D, 1999, LARGE MARINE ECOSYSTEMS OF THE PACIFIC RIM: ASSESSMENT, SUSTAINABILITY, AND MANAGEMENT, P42; Luckman BH, 1997, HOLOCENE, V7, P375, DOI 10.1177/095968369700700401; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; MILLS RO, 1994, ARCTIC ANTHROPOL, V31, P126; Pienitz R, 2000, HOLOCENE, V10, P673, DOI 10.1191/09596830094935; PISIAS NG, 1978, QUATERNARY RES, V10, P366, DOI 10.1016/0033-5894(78)90027-3; Tunnicliffe V, 2001, MAR GEOL, V174, P197, DOI 10.1016/S0025-3227(00)00150-X; VENRICK EL, 1987, SCIENCE, V238, P70, DOI 10.1126/science.238.4823.70; Welch DW, 1998, CAN J FISH AQUAT SCI, V55, P937, DOI 10.1139/cjfas-55-4-937; Wilson SE, 1996, CAN J FISH AQUAT SCI, V53, P1580, DOI 10.1139/f96-094	30	221	241	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2002	416	6882					729	733		10.1038/416729a	http://dx.doi.org/10.1038/416729a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961553				2022-12-24	WOS:000175033500040
J	Remondes, M; Schuman, EM				Remondes, M; Schuman, EM			Direct cortical input modulates plasticity and spiking in CA1 pyramidal neurons	NATURE			English	Article							ENTORHINAL CORTEX; HIPPOCAMPUS; PLACE; CELLS; RAT; ORGANIZATION; REGION	The hippocampus is necessary for the acquisition and retrieval of declarative memories(1,2). The best-characterized sensory input to the hippocampus is the perforant path projection from layer II of entorhinal cortex (EC) to the dentate gyrus(3,4). Signals are then processed sequentially in the hippocampal CA fields before returning to the cortex via CA1 pyramidal neuron spikes. There is another EC input-the temporoammonic (TA) pathway-consisting of axons from layer III EC neurons that make synaptic contacts on the distal dendrites of CA1 neurons(3,5,6). Here we show that this pathway modulates both the plasticity and the output of the rat hippocampal formation. Bursts of TA activity can, depending on their timing, either increase or decrease the probability of Schaffer-collateral (SC)-evoked CA1 spikes. TA bursts can also significantly reduce the magnitude of synaptic potentiation at SC-CA1 synapses. The TA-CA1 synapse itself exhibits both long-term depression (LTD) and long-term potentiation (LTP). This capacity for bi-directional plasticity can, in turn, regulate the TA modulation of CA1 activity: LTP or LTD of the TA pathway either enhances or diminishes the gating of CA1 spikes and plasticity inhibition, respectively.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-76, Pasadena, CA 91125 USA.		Schuman, Erin M/D-6204-2011	Remondes, Miguel/0000-0001-9321-3985				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BRUN VH, 2001, SOC NEUR ABSTR, P31; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Chrobak JJ, 2000, HIPPOCAMPUS, V10, P457, DOI 10.1002/1098-1063(2000)10:4<457::AID-HIPO12>3.0.CO;2-Z; COLBERT CM, 1992, J NEUROPHYSIOL, V68, P1; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V82, P3213, DOI 10.1152/jn.1999.82.6.3213; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EMPSON RM, 1995, J PHYSIOL-LONDON, V484, P707, DOI 10.1113/jphysiol.1995.sp020697; JARRARD LE, 1984, BEHAV NEUROSCI, V98, P946, DOI 10.1037/0735-7044.98.6.946; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Levy B, 1998, GENET MED, V1, P4; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; Ramon y Cajal S., 2018, BEAUTIFUL BRAIN DRAW; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	19	155	158	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					736	740		10.1038/416736a	http://dx.doi.org/10.1038/416736a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961555				2022-12-24	WOS:000175033500042
J	Smith, R				Smith, R			In search of "non-disease"	BRITISH MEDICAL JOURNAL			English	Review									BMJ, London WC1H 9JR, England		Smith, R (corresponding author), BMJ, BMA House, London WC1H 9JR, England.							BAILEY M, USE ESTEEMED MED J I; CAMPBELL EJM, 1979, BMJ-BRIT MED J, V2, P757, DOI 10.1136/bmj.2.6193.757; Foucault M., 1973, BIRTH CLIN; ILLICH I, 1976, LIMITS MED; MEADOR CK, 1965, NEW ENGL J MED, V272, P92, DOI 10.1056/NEJM196501142720208; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, P59	6	123	132	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					883	885		10.1136/bmj.324.7342.883	http://dx.doi.org/10.1136/bmj.324.7342.883			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950739	Green Published			2022-12-24	WOS:000175052200024
J	Kuruvilla, FG; Shamji, AF; Sternson, SM; Hergenrother, PJ; Schreiber, SL				Kuruvilla, FG; Shamji, AF; Sternson, SM; Hergenrother, PJ; Schreiber, SL			Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; URE2P; TOR; PROTEIN; EXPRESSION; REGULATOR; LIGAND; GLN3P	Small molecules that alter protein function provide a means to modulate biological networks with temporal resolution. Here we demonstrate a potentially general and scalable method of identifying such molecules by application to a particular protein, Ure2p, which represses the transcription factors Gln3p and Nil1p(1-3). By probing a high-density microarray of small molecules generated by diversity-oriented synthesis with fluorescently labelled Ure2p, we performed 3,780 protein-binding assays in parallel and identified several compounds that bind Ure2p. One compound, which we call uretupamine, specifically activates a glucose-sensitive transcriptional pathway downstream of Ure2p. Whole-genome transcription profiling and chemical epistasis demonstrate the remarkable Ure2p specificity of uretupamine and its ability to modulate the glucose-sensitive subset of genes downstream of Ure2p. These results demonstrate that diversity-oriented synthesis and small-molecule microarrays can be used to identify small molecules that bind to a protein of interest, and that these small molecules can regulate specific functions of the protein.	Harvard Univ, Dept Chem & Biol Chem, Bauer Ctr Genom Res, Inst Chem & Cell Biol,Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Biophys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Schreiber, SL (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Bauer Ctr Genom Res, Inst Chem & Cell Biol,Howard Hughes Med Inst, 12 Oxford St, Cambridge, MA 02138 USA.			Sternson, Scott/0000-0002-0835-444X	NIGMS NIH HHS [GM-38627] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Blackwell HE, 2001, CHEM BIOL, V8, P1167, DOI 10.1016/S1074-5521(01)00085-0; Blinder D, 1996, J BACTERIOL, V178, P4734, DOI 10.1128/jb.178.15.4734-4736.1996; BOGONEZ E, 1983, BIOCHIM BIOPHYS ACTA, V733, P234, DOI 10.1016/0005-2736(83)90527-8; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Clemons PA, 2001, CHEM BIOL, V8, P1183, DOI 10.1016/S1074-5521(01)00086-2; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Cunningham TS, 2000, J BIOL CHEM, V275, P14408, DOI 10.1074/jbc.275.19.14408; Edskes HK, 2000, P NATL ACAD SCI USA, V97, P6625, DOI 10.1073/pnas.120168697; Edskes HK, 1999, GENETICS, V153, P585; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Hergenrother PJ, 2000, J AM CHEM SOC, V122, P7849, DOI 10.1021/ja0014032; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Kuruvilla FG, 2001, P NATL ACAD SCI USA, V98, P7283, DOI 10.1073/pnas.121186898; KURUVILLA FG, 2002, GENOME BIOL, V3; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6; Sternson SM, 2001, J AM CHEM SOC, V123, P1740, DOI 10.1021/ja0036108; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; XU SW, 1995, MOL CELL BIOL, V15, P2321	28	319	355	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					653	657		10.1038/416653a	http://dx.doi.org/10.1038/416653a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948353				2022-12-24	WOS:000174901900048
J	Li, MY; Chen, DL; Shiloh, A; Luo, JY; Nikolaev, AY; Qin, J; Gu, W				Li, MY; Chen, DL; Shiloh, A; Luo, JY; Nikolaev, AY; Qin, J; Gu, W			Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization	NATURE			English	Article							UBIQUITIN SYSTEM; MDM2; PHOSPHORYLATION; ONCOPROTEIN; DEGRADATION; STABILITY; PROTEIN; PROTEASOME; LIGASE	The p53 tumour suppressor is a short-lived protein that is maintained at low levels in normal cells by Mdm2-mediated ubiquitination and subsequent proteolysis(1-3). Stabilization of p53 is crucial for its tumour suppressor function(1-5). However, the precise mechanism by which ubiquitinated p53 levels are regulated in vivo is not completely understood. By mass spectrometry of affinity-purified p53-associated factors, we have identified herpesvirus-associated ubiquitin-specific protease(6) (HAUSP) as a novel p53-interacting protein. HAUSP strongly stabilizes p53 even in the presence of excess Mdm2, and also induces p53-dependent cell growth repression and apoptosis. Significantly, HAUSP has an intrinsic enzymatic activity that specifically deubiquitinates p53 both in vitro and in vivo. In contrast, expression of a catalytically inactive point mutant of HAUSP in cells increases the levels of p53 ubiquitination and destabilizes p53. These findings reveal an important mechanism by which p53 can be stabilized by direct deubiquitination and also imply that HAUSP might function as a tumour suppressor in vivo through the stabilization of p53.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Nikolaev, Anatoly/0000-0003-2818-5839				Appella E, 2000, PATHOL BIOL, V48, P227; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Ashcroft M, 1999, ONCOGENE, V18, P7637, DOI 10.1038/sj.onc.1203012; Blattner C, 1999, ONCOGENE, V18, P1723, DOI 10.1038/sj.onc.1202480; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kornitzer D, 2000, J CELL PHYSIOL, V182, P1, DOI 10.1002/(SICI)1097-4652(200001)182:1<1::AID-JCP1>3.0.CO;2-V; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Prives C, 1999, J PATHOL, V187, P112; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Seavey SE, 1999, J VIROL, V73, P7590, DOI 10.1128/JVI.73.9.7590-7598.1999; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Tolbert D, 2002, MOL CELL BIOL, V22, P370, DOI 10.1128/MCB.22.1.370-377.2002; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164	30	758	799	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					648	653		10.1038/nature737	http://dx.doi.org/10.1038/nature737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11923872				2022-12-24	WOS:000174901900047
J	Kalab, P; Weis, K; Heald, R				Kalab, P; Weis, K; Heald, R			Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts	SCIENCE			English	Article							IMPORTIN-ALPHA; NUCLEAR TRANSPORT; PROTEIN IMPORT; BOUND RAN; BINDING; MUTANTS; DOMAIN; BETA	The small guanosine triphosphatase Ran is loaded with guanosine triphosphate (GTP) by the chromatin-bound guanine nucleotide exchange factor RCC1 and releases import cargoes in the nucleus during interphase. In mitosis, Ran-GTP promotes spindle assembly around chromosomes by locally discharging cargoes that regulate microtubule dynamics and organization. We used fluorescence resonance energy transfer-based biosensors to visualize gradients of Ran-GTP and liberated cargoes around chromosomes in mitotic Xenopus egg extracts. Both gradients were required to assemble and maintain spindle structure. During interphase, Ran-GTP was highly enriched in the nucleoplasm, and a steep concentration difference between nuclear and cytoplasmic Ran-GTP was established, providing evidence for a Ran-GTP gradient surrounding chromosomes throughout the cell cycle.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Weis, Karsten/F-5719-2011; Ding, Cheng-Qiang/B-6287-2011; Kalab, Petr/B-2478-2009	Weis, Karsten/0000-0001-7224-925X; Heald, Rebecca/0000-0001-6671-6528				Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; KALAB P, UNPUB; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; SCHLENSTEDT G, 1995, EMBO J, V14, P5367, DOI 10.1002/j.1460-2075.1995.tb00221.x; Tsien RY, 1998, SCIENCE, V280, P1954, DOI 10.1126/science.280.5371.1954; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang CM, 1999, J CELL SCI, V112, P2453	26	412	420	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2452	2456		10.1126/science.1068798	http://dx.doi.org/10.1126/science.1068798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923538				2022-12-24	WOS:000174712600056
J	Shang, YF; Brown, M				Shang, YF; Brown, M			Molecular determinants for the tissue specificity of SERMs	SCIENCE			English	Article							HUMAN ESTROGEN-RECEPTOR; PROMOTER-CONTEXT; C-MYC; ACTIVATION; TRANSCRIPTION; COACTIVATOR; CANCER; GENE; 4-HYDROXYTAMOXIFEN; ANTIESTROGEN	Selective estrogen receptor modulators (SERMs) mimic estrogen action in certain tissues while opposing it in others. The therapeutic effectiveness of SERMS such as tamoxifen and raloxifene in breast cancer depends on their antiestrogenic activity. In the uterus, however, tamoxifen is estrogenic. Here, we show that both tamoxifen and raloxifene induce the recruitment of corepressors to target gene promoters in mammary cells. In endometrial cells, tamoxifen, but not raloxifene, acts like estrogen by stimulating the recruitment of coactivators to a subset of genes. The estrogen-like activity of tamoxifen in the uterus requires a high level of steroid receptor coactivator 1 (SRC-1) expression. Thus cell type- and promoter-specific differences in coregulator recruitment determine the cellular response to SERMs.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Brown, M (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.		Brown, Myles/B-6906-2008; Brown, Myles/AAX-5332-2021	Brown, Myles/0000-0002-8213-1658	NATIONAL CANCER INSTITUTE [R01CA057374] Funding Source: NIH RePORTER; NCI NIH HHS [CA57374] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen HW, 2001, CURR OPIN CELL BIOL, V13, P218, DOI 10.1016/S0955-0674(00)00200-3; DUBIK D, 1992, ONCOGENE, V7, P1587; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Glass CK, 2000, GENE DEV, V14, P121; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; Hu X, 2000, TRENDS ENDOCRIN MET, V11, P6, DOI 10.1016/S1043-2760(99)00215-5; Jackson TA, 1997, MOL ENDOCRINOL, V11, P693, DOI 10.1210/me.11.6.693; Jordan VC, 2001, J NATL CANCER I, V93, P1449, DOI 10.1093/jnci/93.19.1449; Lemon BD, 1999, CURR OPIN GENET DEV, V9, P499, DOI 10.1016/S0959-437X(99)00010-6; METZGER D, 1992, NUCLEIC ACIDS RES, V20, P2813, DOI 10.1093/nar/20.11.2813; Nasi S, 2001, FEBS LETT, V490, P153, DOI 10.1016/S0014-5793(01)02118-4; PHAM TA, 1992, MOL ENDOCRINOL, V6, P1043, DOI 10.1210/me.6.7.1043; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; Tsuchiya F, 2001, BIOCHEM BIOPH RES CO, V284, P2, DOI 10.1006/bbrc.2001.4892; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Watanabe T, 1998, MOL CELL BIOL, V18, P442, DOI 10.1128/MCB.18.1.442; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Williams JA, 1999, EXP MOL PATHOL, V67, P135, DOI 10.1006/exmp.1999.2289; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	28	919	974	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2465	2468		10.1126/science.1068537	http://dx.doi.org/10.1126/science.1068537			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923541				2022-12-24	WOS:000174712600060
J	Fujimoto, Y; Tu, LL; Miller, AS; Bock, C; Fujimoto, M; Doyle, C; Steeber, DA; Tedder, TF				Fujimoto, Y; Tu, LL; Miller, AS; Bock, C; Fujimoto, M; Doyle, C; Steeber, DA; Tedder, TF			CD83 expression influences CD4(+) T cell development in the thymus	CELL			English	Article							BLOOD DENDRITIC CELLS; CLASS-II MHC; POSITIVE SELECTION; ACTIVATED LYMPHOCYTES; LINEAGE COMMITMENT; SURFACE EXPRESSION; ANTIGEN RECEPTOR; LANGERHANS CELLS; DEFICIENT MICE; MURINE CD83	T lymphocyte selection and lineage commitment in the thymus requires multiple signals. Herein, CD4(+) T cell generation required engagement of CD83, a surface molecule expressed by thymic epithelial and dendritic cells. CD83-deficient (CD83(-/-)) mice had a specific block in CD4(+) single-positive thymocyte development without increased CD4(+)CD8(+) double- or CD8(+) single-positive thymocytes. This resulted in a selective 75%-90% reduction in peripheral CD4(+) T cells, predominantly within the naive subset. Wild-type thymocytes and bone marrow stem cells failed to differentiate into mature CD4(+) T cells when transferred into CD83(-/-) mice, while CD83(-/-) thymocytes and stem cells developed normally in wild-type mice. Thereby, CD83 expression represents an additional regulatory component for CD4(+) T cell development in the thymus.	Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Tedder, TF (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.			Fujimoto, Manabu/0000-0002-3062-4872	NCI NIH HHS [CA81776, CA54464] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA054464, R01CA081776, R01CA054464] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; Basson MA, 1998, J EXP MED, V187, P1249; Berchtold S, 1999, FEBS LETT, V461, P211, DOI 10.1016/S0014-5793(99)01465-9; Bommhardt U, 1997, EUR J IMMUNOL, V27, P1152, DOI 10.1002/eji.1830270516; Brocker T, 1997, J EXP MED, V186, P1223, DOI 10.1084/jem.186.8.1223; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; Cibotti R, 1997, IMMUNITY, V6, P245, DOI 10.1016/S1074-7613(00)80327-1; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Cramer SO, 2000, INT IMMUNOL, V12, P1347, DOI 10.1093/intimm/12.9.1347; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; ENGEL P, 1995, LEUKOCYTE TYPING, V5, P693; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; Jameson SC, 1998, CURR OPIN IMMUNOL, V10, P214, DOI 10.1016/S0952-7915(98)80251-3; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KOZLOW EJ, 1993, BLOOD, V81, P454, DOI 10.1182/blood.V81.2.454.454; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; LUNDBERG K, 1995, J EXP MED, V181, P1643, DOI 10.1084/jem.181.5.1643; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; McKinsey TA, 2000, MOL IMMUNOL, V37, P783, DOI 10.1016/S0161-5890(00)00099-7; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; Ohoka Y, 1996, INT IMMUNOL, V8, P297, DOI 10.1093/intimm/8.3.297; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; ROBINSON JH, 1977, CLIN EXP IMMUNOL, V27, P322; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Scholler N, 2001, J IMMUNOL, V166, P3865, DOI 10.4049/jimmunol.166.6.3865; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; Steinman RM, 2000, CELL, V100, P491, DOI 10.1016/S0092-8674(00)80684-4; Suzuki H, 1998, EUR J IMMUNOL, V28, P3252, DOI 10.1002/(SICI)1521-4141(199810)28:10<3252::AID-IMMU3252>3.0.CO;2-G; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; TAKAHAMA Y, 1994, NATURE, V371, P67, DOI 10.1038/371067a0; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Twist CJ, 1998, IMMUNOGENETICS, V48, P383, DOI 10.1007/s002510050449; VANMEERWIJK JPM, 1993, SCIENCE, V261, P911, DOI 10.1126/science.8102208; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826; WILKINSON RW, 1995, J IMMUNOL, V155, P5234; Yasutomo K, 2000, J IMMUNOL, V165, P3015, DOI 10.4049/jimmunol.165.6.3015; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664; ZHOU LJ, 1992, J IMMUNOL, V149, P735; ZHOU LJ, 1995, BLOOD, V86, P3295, DOI 10.1182/blood.V86.9.3295.bloodjournal8693295; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	58	167	184	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					755	767		10.1016/S0092-8674(02)00673-6	http://dx.doi.org/10.1016/S0092-8674(02)00673-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955430	Bronze			2022-12-24	WOS:000174563000006
J	Asfaw, B; Gilbert, WH; Beyene, Y; Hart, WK; Renne, PR; WoldeGabriel, G; Vrba, ES; White, TD				Asfaw, B; Gilbert, WH; Beyene, Y; Hart, WK; Renne, PR; WoldeGabriel, G; Vrba, ES; White, TD			Remains of Homo erectus from bouri, Middle Awash, Ethiopia	NATURE			English	Article							PLEISTOCENE; CLADISTICS; SPECIATION; HOMINIDS; CRANIUM; RECORD	The genesis, evolution and fate of Homo erectus have been explored palaeontologically since the taxon's recognition in the late nineteenth century. Current debate(1) is focused on whether early representatives from Kenya and Georgia should be classified as a separate ancestral species ('H. ergaster')(2-4), and whether H. erectus was an exclusively Asian species lineage that went extinct(5,6). Lack of resolution of these issues has obscured the place of H. erectus in human evolution. A hominid calvaria and postcranial remains recently recovered from the Dakanihylo Member of the Bouri Formation, Middle Awash, Ethiopia, bear directly on these issues. These similar to1.0-million-year (Myr)-old Pleistocene sediments contain abundant early Acheulean stone tools and a diverse vertebrate fauna that indicates a predominantly savannah environment. Here we report that the 'Daka' calvaria's metric and morphological attributes centre it firmly within H. erectus. Daka's resemblance to Asian counterparts indicates that the early African and Eurasian fossil hominids represent demes of a widespread palaeospecies. Daka's anatomical intermediacy between earlier and later African fossils provides evidence of evolutionary change. Its temporal and geographic position indicates that African H. erectus was the ancestor of Homo sapiens.	Rift Valley Res Serv, Addis Ababa, Ethiopia; Univ Calif Berkeley, VLSB, Museum Vertebrate Zool, Lab Human Evolutionary Studies, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Minist Youth Sports & Culture, Dept Anthropol & Archaeol ARCCH, Addis Ababa, Ethiopia; Miami Univ, Dept Geol, Oxford, OH 45056 USA; Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University System of Ohio; Miami University; Berkeley Geochronolgy Center; University of California System; University of California Berkeley; United States Department of Energy (DOE); Los Alamos National Laboratory; Yale University	Asfaw, B (corresponding author), Rift Valley Res Serv, POB 5717, Addis Ababa, Ethiopia.			Renne, Paul/0000-0003-1769-5235				Abbate E, 1998, NATURE, V393, P458, DOI 10.1038/30954; Aguirre E., 2000, Human Evolution, V15, P51, DOI 10.1007/BF02436234; Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Andrews P., 1984, Courier Forschungsinstitut Senckenberg, V69, P167; Bar-Yosef O, 1999, ANTHROPOLOGIE, V37, P51; BRAUER G, 1992, J HUM EVOL, V22, P79, DOI 10.1016/0047-2484(92)90032-5; CLARKE R, 2001, INT J ANTHR, V15, P185; de Heinzelin J, 1999, SCIENCE, V284, P625; DEHEINZELIN J, 2000, ANN SCI GEOL, V104; DELSON E, 1985, NATURE, V316, P762, DOI 10.1038/316762a0; GABUNIA L, 2001, ARCHAEOL ETHNOL ANTH, V2, P128; Groves C., 1989, THEORY HUMAN PRIMATE; Harrison Terry, 1993, P345; Howell FC, 1999, J ANTHROPOL RES, V55, P191, DOI 10.1086/jar.55.2.3631209; KALB JE, 1982, NATURE, V298, P17, DOI 10.1038/298017a0; KENNEDY GE, 1991, J HUM EVOL, V20, P375, DOI 10.1016/0047-2484(91)90006-H; KRAMER A, 1993, AM J PHYS ANTHROPOL, V91, P161, DOI 10.1002/ajpa.1330910203; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Martinez I, 1997, J HUM EVOL, V33, P283, DOI 10.1006/jhev.1997.0155; OLSEN JW, 1999, ANTHROPOLOGIE, V37, P89; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; Rightmire GP, 1996, J HUM EVOL, V31, P21; Rightmire GP, 1998, AM J PHYS ANTHROPOL, V106, P61, DOI 10.1002/(SICI)1096-8644(199805)106:1<61::AID-AJPA5>3.3.CO;2-U; Schwartz JH, 2000, SCIENCE, V289, P55; TRINKAUS E, 1990, AM J PHYS ANTHROPOL, V83, P1, DOI 10.1002/ajpa.1330830102; TURNER A, 1989, J HUM EVOL, V18, P115, DOI 10.1016/0047-2484(89)90066-3; Vrba E. S., 1997, Palaeontologia Africana, V34, P127; Walker A., 1993, NARIOKOTOME HOMO ERE; WOOD BA, 1996, KOOBI FORA RES PROJE, V4	30	187	199	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					317	320		10.1038/416317a	http://dx.doi.org/10.1038/416317a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	532NP	11907576				2022-12-24	WOS:000174482200041
J	Kitagawa, N; Ichihara, S				Kitagawa, N; Ichihara, S			Hearing visual motion in depth	NATURE			English	Article							CORTEX; ADAPTATION; PSYCHOPHYSICS	Auditory spatial perception is strongly affected by visual cues. For example, if auditory and visual stimuli are presented synchronously but from different positions, the auditory event is mislocated towards the locus of the visual stimulus-the ventriloquism effect(1,2). This 'visual capture' also occurs in motion perception in which a static auditory stimulus appears to move with the visual moving object(3,4). We investigated how the human perceptual system coordinates complementary inputs from auditory and visual senses. Here we show that an auditory aftereffect occurs from adaptation to visual motion in depth. After a few minutes of viewing a square moving in depth, a steady sound was perceived as changing loudness in the opposite direction. Adaptation to a combination of auditory and visual stimuli changing in a compatible direction increased the aftereffect and the effect of visual adaptation almost disappeared when the directions were opposite. On the other hand, listening to a sound changing in intensity did not affect the visual changing-size aftereffect. The results provide psychophysical evidence that, for processing of motion in depth, the auditory system responds to both auditory changing intensity and visual motion in depth.	Tokyo Metropolitan Univ, Dept Psychol, Hachioji, Tokyo 1920397, Japan	Tokyo Metropolitan University	Kitagawa, N (corresponding author), Tokyo Metropolitan Univ, Dept Psychol, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.							BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Blauert J, 1997, SPATIAL HEARING PSYC; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CORNSWEET TN, 1962, AM J PSYCHOL, V75, P485, DOI 10.2307/1419876; CUMMING BG, 1994, VISUAL DETECTION MOT, P333; Dong CJ, 2000, PERCEPT PSYCHOPHYS, V62, P1099, DOI 10.3758/BF03212091; Driver J, 2000, CURR BIOL, V10, pR731, DOI 10.1016/S0960-9822(00)00740-5; Ehrenstein WH, 1996, PERCEPT MOTOR SKILL, V82, P23, DOI 10.2466/pms.1996.82.1.23; GRANTHAM DW, 1989, PERCEPT PSYCHOPHYS, V45, P129, DOI 10.3758/BF03208047; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; Kayahara T., 2001, Acoustical Science and Technology, V22, P49, DOI 10.1250/ast.22.49; Kitajima N, 1999, PERCEPT MOTOR SKILL, V89, P1139, DOI 10.2466/PMS.89.7.1139-1158; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; MATEEFF S, 1985, PERCEPTION, V14, P721, DOI 10.1068/p140721; Mather G., 1998, MOTION AFTEREFFECT M; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REGAN D, 1978, VISION RES, V18, P209, DOI 10.1016/0042-6989(78)90188-8; Reinhardt-Rutland AH, 1998, PERCEPTION, V27, P473, DOI 10.1068/p270473; REINHARDTRUTLAND A, 1982, PERCEPT PSYCHOPHYS, V31, P63, DOI 10.3758/BF03206201; SHU ZJ, 1993, NATURE, V364, P721, DOI 10.1038/364721a0; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; WELCH RB, 1986, HDB PERCEPTION HUMAN, V1, pCH25	25	146	152	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					172	174		10.1038/416172a	http://dx.doi.org/10.1038/416172a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894093				2022-12-24	WOS:000174348100036
J	Andreoni, M; Sarmati, L; Nicastri, E; El Sawaf, G; Uccella, I; Bugarini, R; Parisi, SG; Rezza, G				Andreoni, M; Sarmati, L; Nicastri, E; El Sawaf, G; Uccella, I; Bugarini, R; Parisi, SG; Rezza, G			Primary human herpesvirus 8 infection in immunocompetent children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KAPOSIS-SARCOMA; DNA-SEQUENCES; TRANSMISSION; ANTIBODIES; RISK	Context Human herpesvirus 8 (HHV-8) infection causes Kaposi sarcoma and lymphoproliferative disorders in immunosuppresed adults. Its manifestations in immunocompetent hosts are unknown. Objectives To determine whether HHV-8 primary infection is symptomatic in immunocompetent children and to identify the epidemiological and virological correlates of HHV-8 infection. Design and Setting Prospective cohort study conducted in the pediatric emergency department of a hospital in Alexandria, Egypt, between December 1, 1999, and April 30, 2000. Patients Eighty-six children aged 1 to 4 years who were evaluated fora febrile syndrome of undetermined origin. Main Outcome Measures Serological assay and polymerase chain reaction of blood and saliva samples for HHV-8, Information on potential risk factors for HHV-8 infection was also collected. Results Thirty-six children (41.9%) were seropositive; HHV-8 DNA sequences were detected in 14 (38.9%) of these 36 children (detected in saliva in 11 of 14). Significant associations were found between HHV-8 infection and close contact with at least 2 other children in the community (36 of 63 vs 6 of 23 for <2 children; adjusted odds ratio [OR], 3.50; 95% confidence interval [CI], 1.11-12.22) and admission to the emergency department in December or January (28 of 47 vs 14 of 39 for February-April; adjusted OR, 3.15; 95% Cl, 1.23-8.58). Six children had suspected primary HHV-8 infection; all but 1 had a febrile cutaneous craniocaudal maculopapular rash, which was more common among these children (5 of 6 vs 10 of 75; P<.001). For 3 of these 6 children, a second blood sample was obtained after the convalescence phase, and all 3 seroconverted for HHV-8. Conclusions Primary infection with HHV-8 may be associated with a febrile maculopapular skin rash among immunocompetent children. The finding of HHV-8 DNA sequences in saliva supports the hypothesis that transmission through saliva is the main mode of transmission in the pediatric age group.	Univ Roma Tor Vergata, Dept Publ Hlth, Rome, Italy; IRCCS Lazzaro Spallanzani, Ist Nazl Malattie Infett, Rome, Italy; Ist Super Sanita, Epidemiol & Biostat Lab, AIDS & STD Unit, I-00161 Rome, Italy; Univ Alexandria, Med Res Inst, Alexandria, Egypt	University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; Istituto Superiore di Sanita (ISS); Egyptian Knowledge Bank (EKB); Alexandria University	Andreoni, M (corresponding author), Univ Roma Tor Vergata, Dept Publ Hlth & Cellular Biol, Via Montpellier 1, I-00133 Rome, Italy.	andreoni@uniroma2.it	Parisi, Saverio G/C-6088-2009; Andreoni, Masimo/AAL-2214-2020; parisi, saverio/D-3115-2012; nicastri, emanuele/K-7780-2016; rezza, giovanni/D-4393-2016	nicastri, emanuele/0000-0002-5606-8712; rezza, giovanni/0000-0003-0268-6790; Andreoni, Massimo/0000-0002-3205-9758; sarmati, loredana/0000-0003-1452-0333				Andreoni M, 1999, J NATL CANCER I, V91, P465, DOI 10.1093/jnci/91.5.465; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; ASANO Y, 1989, J PEDIATR-US, V114, P535, DOI 10.1016/S0022-3476(89)80689-4; Blauvelt A, 1997, J INFECT DIS, V176, P771, DOI 10.1086/517298; Calabro ML, 2001, J NATL CANCER I, V93, P154, DOI 10.1093/jnci/93.2.154; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Goudsmit J, 2000, P NATL ACAD SCI USA, V97, P4838, DOI 10.1073/pnas.97.9.4838; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Lock MJ, 1997, J VIROL METHODS, V64, P19, DOI 10.1016/S0166-0934(96)02139-8; Luppi M, 2000, BLOOD, V96, P2355; Luppi M, 2000, NEW ENGL J MED, V343, P1378, DOI 10.1056/NEJM200011093431905; Martin JN, 2000, AM J EPIDEMIOL, V151, P225, DOI 10.1093/oxfordjournals.aje.a010196; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Oksenhendler E, 1998, NEW ENGL J MED, V338, P1585, DOI 10.1056/NEJM199805283382204; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; PRUKSANANONDA P, 1992, NEW ENGL J MED, V326, P1445, DOI 10.1056/NEJM199205283262201; Regamey N, 1998, NEW ENGL J MED, V339, P1358, DOI 10.1056/NEJM199811053391903; Rezza G, 1999, J NATL CANCER I, V91, P1468, DOI 10.1093/jnci/91.17.1468; Schatz O, 2001, J MED VIROL, V65, P123, DOI 10.1002/jmv.2011; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276	22	81	85	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 13	2002	287	10					1295	1300		10.1001/jama.287.10.1295	http://dx.doi.org/10.1001/jama.287.10.1295			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YU	11886321	Bronze			2022-12-24	WOS:000174329500028
J	Vilchez, RA; Madden, CR; Kozinetz, CA; Halvorson, SJ; White, ZS; Jorgensen, JL; Finch, CJ; Butel, JS				Vilchez, RA; Madden, CR; Kozinetz, CA; Halvorson, SJ; White, ZS; Jorgensen, JL; Finch, CJ; Butel, JS			Association between simian virus 40 and non-Hodgkin lymphoma	LANCET			English	Article							HUMAN MESOTHELIOMAS; BK-VIRUS; SIMIAN-VIRUS-40; SV40; DISEASE; LYMPHOCYTES; INFECTIONS; SEQUENCES; TUMORS; BRAIN	Background Non-Hodgkin lymphoma has increased in frequency over the past 30 years, and is a common cancer in HIV-1-infected patients. Although no definite risk factors have emerged, a viral cause has been postulated. Polyomaviruses are known to infect human beings and to induce tumours in laboratory animals. We aimed to identify which one of the three polyomaviruses able to infect human beings (simian virus 40 [SV40], JC virus, and BK virus) was associated with non-Hodgkin lymphoma. Methods We analysed systemic non-Hodgkin lymphoma from 76 HIV-1-infected and 78 HIV-1-uninfected patients, and nonmalignant lymphoid samples from 79 HIV-1-positive and 107 HIV-1-negative patients without tumours; 54 colon and breast carcinoma samples served as cancer controls. We used PCR followed by Southern blot hybridisation and DNA sequence analysis to detect DNAs of polyomaviruses and herpesviruses. Findings Polyomavirus T antigen sequences, all of which were SV40-specific, were detected in 64 (42%) of 154 non-Hodgkin lymphomas, none of 186 non-malignant lymphoid samples, and none of 54 control cancers. This difference was similar for HIV-1-infected patients and HIV-1-uninfected patients alike. Few tumours were positive for both SV40 and Epstein-Barr virus. Human herpesvirus, type 8 was not detected. SV40 sequences were found most frequently in diffuse large B-cell and follicular-type lymphomas. Interpretation SV40 is significantly associated with some types of non-Hodgkin lymphoma. These results add lymphomas to the types of human cancers associated with SV40.	Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Baylor Ctr AIDS Res, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Vilchez, RA (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, BCM 286,Room N1319,1 Baylor Plaza, Houston, TX 77030 USA.			Butel, Janet/0000-0002-6876-3245	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NIAID NIH HHS [AI36211] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AM CANC SOC, 2001, CANC FACTS FIG 2001; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Brielmeier M, 1996, J GEN VIROL, V77, P2807, DOI 10.1099/0022-1317-77-11-2807; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Butel JS, 2000, CARCINOGENESIS, V21, P405, DOI 10.1093/carcin/21.3.405; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Chan PKS, 2000, J CLIN MICROBIOL, V38, P2772, DOI 10.1128/JCM.38.7.2772-2773.2000; Chatterjee M, 2000, J MED VIROL, V60, P353, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;353::AID-JMV16&gt;3.0.CO;2-R; CICALA C, 1992, VIROLOGY, V190, P475, DOI 10.1016/0042-6822(92)91237-O; COE JE, 1975, J NATL CANCER I, V54, P269, DOI 10.1093/jnci/54.1.269; David H, 2001, CANCER LETT, V162, P57, DOI 10.1016/S0304-3835(00)00628-5; DIAMANDOPOULOS GT, 1972, SCIENCE, V176, P173, DOI 10.1126/science.176.4031.173; GEARD L, 2001, J ACQ IMMUN DEF SYND, V26, P182; Imperiale MJ, 2000, VIROLOGY, V267, P1, DOI 10.1006/viro.1999.0092; Jafar S, 1998, J MED VIROL, V54, P276, DOI 10.1002/(SICI)1096-9071(199804)54:4<276::AID-JMV7>3.0.CO;2-1; Jaffe ES, 1999, AM J CLIN PATHOL, V111, pS8; Jaffe ES, 2001, WHO CLASSIFICATION T; Lednicky JA, 1998, DEV BIOL STAND, V94, P155; MARKOWITZ RB, 1993, J INFECT DIS, V167, P13, DOI 10.1093/infdis/167.1.13; Martini F, 1998, INT J CANCER, V78, P669, DOI 10.1002/(SICI)1097-0215(19981209)78:6<669::AID-IJC1>3.0.CO;2-B; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; Rizzo P, 1999, CHEST, V116, p470S, DOI 10.1378/chest.116.suppl_3.470S; Rizzo P, 1999, CANCER RES, V59, P6103; ROLLISON DE, 2001, HUMAN POLYOMAVIRUSES, P561; Shiramizu B, 2000, J ACQ IMMUN DEF SYND, V23, pA34; Shivapurkar N, 2002, LANCET, V359, P851, DOI 10.1016/S0140-6736(02)07921-7; Shivapurkar N, 2000, INT J CANCER, V85, P743, DOI 10.1002/(SICI)1097-0215(20000301)85:5<743::AID-IJC24>3.3.CO;2-V; Vilchez RA, 2002, J ACQ IMMUN DEF SYND, V29, P109, DOI 10.1097/00042560-200202010-00001; Waheed I, 1999, CANCER RES, V59, P6068; Zhen HN, 1999, CANCER, V86, P2124, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2124::AID-CNCR34>3.0.CO;2-D	31	163	165	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 9	2002	359	9309					817	823		10.1016/S0140-6736(02)07950-3	http://dx.doi.org/10.1016/S0140-6736(02)07950-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YV	11897278				2022-12-24	WOS:000174329600006
J	Kruger, J; Thomas, CM; Golstein, C; Dixon, MS; Smoker, M; Tang, SK; Mulder, L; Jones, JDG				Kruger, J; Thomas, CM; Golstein, C; Dixon, MS; Smoker, M; Tang, SK; Mulder, L; Jones, JDG			A tomato cysteine protease required for Cf-2-dependent disease resistance and suppression of autonecrosis	SCIENCE			English	Article							CLADOSPORIUM-FULVUM; DEFENSE; PLANTS; ACTIVATION; DROSOPHILA; PROTEINS; GENES; CF-2	Little is known of how plant disease resistance (R) proteins recognize pathogens and activate plant defenses. Rcr3 is specifically required for the function of Cf-2, a Lycopersicon pimpinellifolium gene bred into cultivated tomato (Lycopersicon esculentum) for resistance to Cladosporium fulvum. Rcr3 encodes a secreted papain-like cysteine endoprotease. Genetic analysis shows Rcr3 is allelic to the L. pimpinellifolium Ne gene, which suppresses the Cf-2-dependent autonecrosis conditioned by its L. esculentum allele, ne (necrosis). Rcr3 alleles from these two species encode proteins that differ by only seven amino acids, Possible roles of Rcr3 in Cf-2-dependent defense and autonecrosis are discussed.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Indiana University System; Indiana University Bloomington; University of Southampton; University of North Carolina; University of North Carolina Chapel Hill	Jones, JDG (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.		Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Smoker, Matthew/0000-0002-7003-616X				Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DEWIT PJGM, 1986, PHYSIOL MOL PLANT P, V29, P159, DOI 10.1016/S0048-4059(86)80018-2; Dixon MS, 1998, PLANT CELL, V10, P1915, DOI 10.1105/tpc.10.11.1915; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; Estelle M, 2001, CURR OPIN PLANT BIOL, V4, P254, DOI 10.1016/S1369-5266(00)00169-2; Groves MR, 1996, STRUCTURE, V4, P1193, DOI 10.1016/S0969-2126(96)00127-X; HOLMANS PA, UNPUB; Joosten MHAJ, 1999, ANNU REV PHYTOPATHOL, V37, P335, DOI 10.1146/annurev.phyto.37.1.335; LANGFORD AN, 1948, CAN J RES C, V26, P35, DOI 10.1139/cjr48c-006; LeMosy EK, 2001, P NATL ACAD SCI USA, V98, P5055, DOI 10.1073/pnas.081026598; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; LUDERER R, UNPUB; MICHAUD D, 1993, ELECTROPHORESIS, V14, P94, DOI 10.1002/elps.1150140117; Minami A, 1995, PLANT CELL PHYSIOL, V36, P1599; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; TANG S, 1998, THESIS U E ANGLIA; Vervoort J, 1997, FEBS LETT, V404, P153, DOI 10.1016/S0014-5793(97)00117-8	21	305	316	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					744	747		10.1126/science.1069288	http://dx.doi.org/10.1126/science.1069288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976458				2022-12-24	WOS:000175281700058
J	Nishimura, EK; Jordan, SA; Oshima, H; Yoshida, H; Osawa, M; Moriyama, M; Jackson, IJ; Barrandon, Y; Miyachi, Y; Nishikawa, S				Nishimura, EK; Jordan, SA; Oshima, H; Yoshida, H; Osawa, M; Moriyama, M; Jackson, IJ; Barrandon, Y; Miyachi, Y; Nishikawa, S			Dominant role of the niche in melanocyte stem-cell fate determination	NATURE			English	Article							C-KIT ANTIBODY; EXPRESSION; MIGRATION; SKIN; MICE; DIFFERENTIATION; PROLIFERATION; MELANOGENESIS; EMBRYOS; WAVE	Stem cells-which have the capacity to self-renew and generate differentiated progeny-are thought to be maintained in a specific environment known as a niche(1-3). The localization of the niche, however, remains largely obscure for most stem-cell systems. Melanocytes (pigment cells) in hair follicles proliferate and differentiate closely coupled to the hair regeneration cycle(4). Here we report that stem cells of the melanocyte lineage can be identified, using Dct-lacZ transgenic mice(5,6), in the lower permanent portion of mouse hair follicles throughout the hair cycle. It is only the population in this region that fulfils the criteria for stem cells, being immature, slow cycling, self-maintaining and fully competent in regenerating progeny on activation at early anagen (the growing phase of hair follicles). Induction of the repigmentation process in K14-steel factor transgenic mice(7) demonstrates that a portion of amplifying stem-cell progeny can migrate out from the niche and retain sufficient self-renewing capability to function as stem cells after repopulation into vacant niches. Our data indicate that the niche has a dominant role in the fate determination of melanocyte stem-cell progeny.	Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Ecole Normale Super, F-75230 Paris 05, France; Riken Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; University of Edinburgh; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); RIKEN	Nishikawa, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Sakyo Ku, Shogoin Kawaharacho 53, Kyoto 6068507, Japan.			Osawa, Masatake/0000-0002-5318-9826; Jackson, Ian/0000-0001-6526-0688				Botchkareva NV, 2001, FASEB J, V15, P645, DOI 10.1096/fj.00-0368com; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; COOK AG, 1958, EMBRYOLOGY, V6, P530; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; FITZPATRICK TB, 1987, DERMATOLOGY GEN MED, P810; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Jordan SF, 2000, MECH DEVELOP, V92, P135, DOI 10.1016/S0925-4773(99)00332-9; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; LAVKER RM, 1993, J INVEST DERMATOL, V101, P16; LOEFFLER M, 1997, STEM CELLS, P5; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MANN SJ, 1962, ANAT RECORD, V144, P135, DOI 10.1002/ar.1091440208; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; OGAWA M, 1993, DEVELOPMENT, V117, P1089; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SILVER AF, 1969, EXPERIENTIA, V25, P299, DOI 10.1007/BF02034407; Silvers WK, 1979, COAT COLOURS MICE MO; Slominski A, 1996, J INVEST DERMATOL, V106, P1203, DOI 10.1111/1523-1747.ep12348479; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; SUGIYAMA S, 1979, J ULTRA MOL STRUCT R, V67, P40, DOI 10.1016/S0022-5320(79)80016-7; Tobin DJ, 1998, J INVEST DERMATOL, V111, P941, DOI 10.1046/j.1523-1747.1998.00417.x; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yoshida H, 1996, DEV DYNAM, V207, P222; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	30	620	660	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					854	860		10.1038/416854a	http://dx.doi.org/10.1038/416854a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976685				2022-12-24	WOS:000175163800053
J	Kato, T				Kato, T			Self-assembly of phase-segregated liquid crystal structures	SCIENCE			English	Article							MICRO-SEGREGATION; ANISOTROPIC GELS; LIGHT-SCATTERING; IONIC LIQUIDS; PHYSICAL GELS; AGGREGATION; COMPLEXES; BEHAVIOR; ACID; POLYMERIZATION	Additional functionality can be incorporated into liquid crystalline materials by using phase segregation and self-assembly. Intermolecular interactions such as hydrogen bonding and ionic interactions play key roles in the formation of these complex structures. One-, two-, and three-dimensional phase-segregated structures on various scales of length are formed by self-assembty of a variety of partially incompatible molecules. Such structures can enhance anisotropic properties such as ionic conductivity.	Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo	Kato, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.	kato@chiral.t.u-tokyo.ac.jp	Kato, Takashi/Q-8050-2016	Kato, Takashi/0000-0002-0571-0883				Abdallah DJ, 2000, ADV MATER, V12, P1237; Abetz V, 2000, SUPRAMOLECULAR POLYMERS, P215; ADAM D, 1994, NATURE, V371, P141, DOI 10.1038/371141a0; ALEXANDER C, 1994, MACROMOL SYMP, V77, P283, DOI 10.1002/masy.19940770130; Baars MWPL, 2000, ADV MATER, V12, P715, DOI 10.1002/(SICI)1521-4095(200005)12:10<715::AID-ADMA715>3.0.CO;2-2; BODEN N, 1995, PHYS REV B, V52, P13274, DOI 10.1103/PhysRevB.52.13274; Bonhote P, 1996, INORG CHEM, V35, P1168, DOI 10.1021/ic951325x; Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; CRAWFORD GP, 1996, LIQID CRYSTALS COMPL; Dardel B, 2001, J MATER CHEM, V11, P2814, DOI 10.1039/b103798f; Demus D., 1998, HDB LIQUID CRYSTALS, P3; Elsasser R, 2001, ANGEW CHEM INT EDIT, V40, P2688, DOI 10.1002/1521-3773(20010716)40:14<2688::AID-ANIE2688>3.0.CO;2-S; Evans E, 1996, SCIENCE, V273, P933, DOI 10.1126/science.273.5277.933; FAIRHURST CE, 1998, HDB LIQUID CRYSTALS, V3, pCH7; Furue H, 1999, JPN J APPL PHYS 1, V38, P5660, DOI 10.1143/JJAP.38.5660; Goodby JW, 1999, CURR OPIN SOLID ST M, V4, P361, DOI 10.1016/S1359-0286(99)00035-2; Guymon CA, 1997, SCIENCE, V275, P57, DOI 10.1126/science.275.5296.57; HAAREN JH, 1998, CHEM IND, P1017; HIKMET RAM, 1992, ADV MATER, V4, P679, DOI 10.1002/adma.19920041014; Hillmyer MA, 1996, SCIENCE, V271, P976, DOI 10.1126/science.271.5251.976; KAJIYAMA T, 1989, CHEM LETT, P813, DOI 10.1246/cl.1989.813; Kanie K, 2001, J MATER CHEM, V11, P2875, DOI 10.1039/b103168f; KATO T, 1989, J AM CHEM SOC, V111, P8533, DOI 10.1021/ja00204a044; Kato T, 1998, ADV MATER, V10, P606, DOI 10.1002/(SICI)1521-4095(199805)10:8<606::AID-ADMA606>3.0.CO;2-T; Kato T, 2000, STRUCT BOND, V96, P95; KATO T, 1994, ANGEW CHEM INT EDIT, V33, P1644, DOI 10.1002/anie.199416441; Klok HA, 2002, MACROMOLECULES, V35, P746, DOI 10.1021/ma010907x; Lehn JM, 2000, SUPRAMOLECULAR POLYMERS, P615; Luyten MC, 1998, MACROMOLECULES, V31, P9160, DOI 10.1021/ma9808833; Meeker SP, 2000, PHYS REV E, V61, pR6083, DOI 10.1103/PhysRevE.61.R6083; Mizoshita N, 1999, CHEM COMMUN, P781, DOI 10.1039/a901035a; Mizoshita N, 1999, ADV MATER, V11, P392, DOI 10.1002/(SICI)1521-4095(199903)11:5<392::AID-ADMA392>3.0.CO;2-Q; Mizoshita N, 2002, CHEM COMMUN, P428, DOI 10.1039/b111380c; MIZOSHITA N, UNPUB; Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225; Ohtake T, 2000, CHEM MATER, V12, P782, DOI 10.1021/cm990706w; PERCEC V, 1993, J CHEM SOC PERK T 2, P2381, DOI 10.1039/p29930002381; Percec V, 1998, J AM CHEM SOC, V120, P11061, DOI 10.1021/ja9819007; Radler JO, 1998, LANGMUIR, V14, P4272, DOI 10.1021/la980360o; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Ruokolainen J, 1998, SCIENCE, V280, P557, DOI 10.1126/science.280.5363.557; Sautter A, 2001, ANGEW CHEM INT EDIT, V40, P4425, DOI 10.1002/1521-3773(20011203)40:23<4425::AID-ANIE4425>3.0.CO;2-Z; Slack NL, 1998, MACROMOLECULES, V31, P8503, DOI 10.1021/ma980901g; Smith RC, 1997, J AM CHEM SOC, V119, P4092, DOI 10.1021/ja963837w; Tschierske C, 2001, J MATER CHEM, V11, P2647, DOI 10.1039/b102914m; Tschierske C, 1998, J MATER CHEM, V8, P1485, DOI 10.1039/a800946e; van Boxtel MCW, 2000, ADV MATER, V12, P753, DOI 10.1002/(SICI)1521-4095(200005)12:10<753::AID-ADMA753>3.0.CO;2-V; Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; YAMADA M, 1995, MACROMOLECULES, V28, P50, DOI 10.1021/ma00105a006; Yamamoto J, 2001, NATURE, V409, P321, DOI 10.1038/35053035; YANG DK, 1992, APPL PHYS LETT, V60, P3102, DOI 10.1063/1.106765; Yoshio M, 2002, ADV MATER, V14, P351, DOI 10.1002/1521-4095(20020304)14:5<351::AID-ADMA351>3.0.CO;2-D; Yu SJM, 1997, NATURE, V389, P167, DOI 10.1038/38254; Zhang LF, 1996, SCIENCE, V272, P1777, DOI 10.1126/science.272.5269.1777; Zheng YG, 2000, J MATER CHEM, V10, P69, DOI 10.1039/a903000j; Zimmerman N, 1998, CHEM IND-LONDON, P604	57	814	833	4	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2002	295	5564					2414	2418		10.1126/science.1070967	http://dx.doi.org/10.1126/science.1070967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923528				2022-12-24	WOS:000174712600044
J	Krojer, T; Garrido-Franco, M; Huber, R; Ehrmann, M; Clausen, T				Krojer, T; Garrido-Franco, M; Huber, R; Ehrmann, M; Clausen, T			Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine	NATURE			English	Article							ESCHERICHIA-COLI; SERINE-PROTEASE; QUALITY-CONTROL; PROTEINS; PDZ; RECOGNITION; TEMPERATURE; PROTEOLYSIS; RESOLUTION; DOMAIN	Molecular chaperones and proteases monitor the folded state of other proteins. In addition to recognizing non-native conformations, these quality control factors distinguish substrates that can be refolded from those that need to be degraded(1). To investigate the molecular basis of this process, we have solved the crystal structure of DegP (also known as HtrA), a widely conserved heat shock protein that combines refolding and proteolytic activities(2). The DegP hexamer is formed by staggered association of trimeric rings. The proteolytic sites are located in a central cavity that is only accessible laterally. The mobile side-walls are constructed by twelve PDZ domains, which mediate the opening and closing of the particle and probably the initial binding of substrate. The inner cavity is lined by several hydrophobic patches that may act as docking sites for unfolded polypeptides. In the chaperone conformation, the protease domain of DegP exists in an inactive state, in which substrate binding in addition to catalysis is abolished.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Max Planck Society; Cardiff University	Clausen, T (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.		Krojer, Tobias/ABE-3829-2021; Ehrmann, Michael/A-7307-2012	Ehrmann, Michael/0000-0002-1927-260X; Krojer, Tobias/0000-0003-0661-0814; Clausen, Tim/0000-0003-1582-6924				Bochtler M, 1997, P NATL ACAD SCI USA, V94, P6070, DOI 10.1073/pnas.94.12.6070; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; SWAMY KHS, 1983, ARCH BIOCHEM BIOPHYS, V224, P543, DOI 10.1016/0003-9861(83)90242-4; Wang JM, 1997, CELL, V91, P447, DOI 10.1016/S0092-8674(00)80431-6; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X; [No title captured]	30	331	341	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					455	459		10.1038/416455a	http://dx.doi.org/10.1038/416455a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919638				2022-12-24	WOS:000174607800053
J	Brunner, HR; Gavras, H				Brunner, HR; Gavras, H			Angiotensin blockade for hypertension: a promise fulfilled	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; FAILURE; RENIN; ALDOSTERONE; INHIBITION; MORTALITY; CAPTOPRIL; SURVIVAL; LOSARTAN		CHU Vaudois, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland; Boston Univ, Med Ctr, Boston, MA USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Boston University	Brunner, HR (corresponding author), CHU Vaudois, Div Hypertens & Vasc Med, CH-1011 Lausanne, Switzerland.	Hans-R.Brunner@chuv.hospvd.ch						[Anonymous], 1997, ARCH INTERN MED, V157, P2413; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BRUNNER HR, 1973, LANCET, V2, P1045; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; GAVRAS H, 1971, LANCET, V2, P19; GAVRAS H, 1977, JAMA-J AM MED ASSOC, V238, P880, DOI 10.1001/jama.238.8.880; GAVRAS H, 1974, PROG CARDIOVASC DIS, V17, P39, DOI 10.1016/0033-0620(74)90037-1; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; *MCR WORK PART, 1985, BMJ-BRIT MED J, V291, P97; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Yusuf S, 2000, NEW ENGL J MED, V342, P145	17	36	38	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2002	359	9311					990	992		10.1016/S0140-6736(02)08062-5	http://dx.doi.org/10.1016/S0140-6736(02)08062-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937175				2022-12-24	WOS:000174585800002
J	Simonson, AB; Lake, JA				Simonson, AB; Lake, JA			The transorientation hypothesis for codon recognition during protein synthesis	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; PHENYLALANINE TRANSFER-RNA; AMINOACYL-TRANSFER-RNA; ELONGATION-FACTOR TU; EF-TU; ANGSTROM RESOLUTION; A-SITE; SUBUNIT; MECHANISM; BINDING	During decoding, a codon of messenger RNA is matched with its cognate aminoacyl-transfer RNA and the amino acid carried by the tRNA is added to the growing protein chain. Here we propose a molecular mechanism for the decoding phase of translation: the transorientation hypothesis. The model incorporates a newly identified tRNA binding site and utilizes a flip between two tRNA anticodon loop structures, the 5'-stacked and the 3'-stacked conformations. The anticodon loop acts as a three-dimensional hinge permitting rotation of the tRNA about a relatively fixed codon-anticodon pair. This rotation, driven by a conformational change in elongation factor Tu involving GTP hydrolysis, transorients the incoming tRNA into the A site from the D site of initial binding and decoding, where it can be proofread and accommodated. The proposed mechanisms are compatible with the known structures, conformations and functions of the ribosome and its component parts including tRNAs and EF-Tu, in both the GTP and GDP states.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.							ABDULKARIM F, 1994, FEBS LETT, V352, P118, DOI 10.1016/0014-5793(94)00937-6; Abel K, 1996, STRUCTURE, V4, P1153, DOI 10.1016/S0969-2126(96)00123-2; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Briones E, 1998, J BIOL CHEM, V273, P31956, DOI 10.1074/jbc.273.48.31956; CARBON J, 1974, J MOL BIOL, V85, P371, DOI 10.1016/0022-2836(74)90439-2; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; CRICK FHC, 1976, ORIGINS LIFE EVOL B, V7, P389, DOI 10.1007/BF00927934; CUNDLIFFE E, 1906, STRUCTURE FUNCTION G, P586; Dickerson RE, 1997, BIOPOLYMERS, V44, P361, DOI 10.1002/(SICI)1097-0282(1997)44:4<361::AID-BIP4>3.0.CO;2-X; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; FULLER W, 1967, NATURE, V215, P817, DOI 10.1038/215817a0; Garrett R. A., 2000, RIBOSOME STRUCTURE F; GEFTER ML, 1969, J MOL BIOL, V39, P145, DOI 10.1016/0022-2836(69)90339-8; GUPTA SL, 1971, BIOCHEMISTRY-US, V10, P4410, DOI 10.1021/bi00800a010; HARADA F, 1975, NUCLEIC ACIDS RES, V2, P865, DOI 10.1093/nar/2.6.865; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLUG A, 1979, J MOL BIOL, V131, P669, DOI 10.1016/0022-2836(79)90196-7; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; LADNER JE, 1975, P NATL ACAD SCI USA, V72, P4414, DOI 10.1073/pnas.72.11.4414; LAKE JA, 1977, P NATL ACAD SCI USA, V74, P1903, DOI 10.1073/pnas.74.5.1903; Markus MA, 1997, NAT STRUCT BIOL, V4, P70, DOI 10.1038/nsb0197-70; NIERHAUS KH, 1990, BIOCHEMISTRY-US, V29, P4997, DOI 10.1021/bi00473a001; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; QUIGLEY GJ, 1975, NUCLEIC ACIDS RES, V2, P2329, DOI 10.1093/nar/2.12.2329; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Schweisguth DC, 1997, J MOL BIOL, V267, P505, DOI 10.1006/jmbi.1996.0903; Song HW, 1999, J MOL BIOL, V285, P1245, DOI 10.1006/jmbi.1998.2387; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STOEFFLER G, 1980, Journal of Biological Chemistry, V255, P10517; STRYCHARZ WA, 1978, J MOL BIOL, V126, P123, DOI 10.1016/0022-2836(78)90355-8; TAL J, 1975, NUCLEIC ACIDS RES, V2, P1073, DOI 10.1093/nar/2.7.1073; THACH SS, 1971, P NATL ACAD SCI USA, V68, P1791, DOI 10.1073/pnas.68.8.1791; Vogeley L, 2001, J BIOL CHEM, V276, P17149, DOI 10.1074/jbc.M100017200; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WOESE C, 1970, NATURE, V226, P817, DOI 10.1038/226817a0; WREDE P, 1979, P NATL ACAD SCI USA, V76, P3289, DOI 10.1073/pnas.76.7.3289; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911	45	14	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					281	285		10.1038/416281a	http://dx.doi.org/10.1038/416281a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907568				2022-12-24	WOS:000174482200032
J	Nelson, G; Chandrashekar, J; Hoon, MA; Feng, LX; Zhao, G; Ryba, NJP; Zuker, CS				Nelson, G; Chandrashekar, J; Hoon, MA; Feng, LX; Zhao, G; Ryba, NJP; Zuker, CS			An amino-acid taste receptor	NATURE			English	Article							GLUTAMATE RECEPTORS; MICE; G-ALPHA(16); RESPONSES; SACCHARIN; FAMILY	The sense of taste provides animals with valuable information about the nature and quality of food. Mammals can recognize and respond to a diverse repertoire of chemical entities, including sugars, salts, acids and a wide range of toxic substances(1). Several amino acids taste sweet or delicious (umami) to humans, and are attractive to rodents and other animals(2). This is noteworthy because L-amino acids function as the building blocks of proteins, as biosynthetic precursors of many biologically relevant small molecules, and as metabolic fuel. Thus, having a taste pathway dedicated to their detection probably had significant evolutionary implications. Here we identify and characterize a mammalian amino-acid taste receptor. This receptor, T1R1+3, is a heteromer of the taste-specific T1R1 and T1R3 G-protein-coupled receptors. We demonstrate that T1R1 and T1R3 combine to function as a broadly tuned L-amino-acid sensor responding to most of the 20 standard amino acids, but not to their D-enantiomers or other compounds. We also show that sequence differences in T1R receptors within and between species (human and mouse) can significantly influence the selectivity and specificity of taste responses.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bachmanov AA, 2000, J NUTR, V130, p935S, DOI 10.1093/jn/130.4.935S; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Dahl M, 1997, BRAIN RES, V756, P22, DOI 10.1016/S0006-8993(97)00131-5; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ikeda Kikunae, 1909, J TOKYO CHEM SOC JAP, V30, P820, DOI DOI 10.1093/CHEMSE/27.9.847; IWASAKI K, 1985, PHYSIOL BEHAV, V34, P531, DOI 10.1016/0031-9384(85)90045-9; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Mody SM, 2000, MOL PHARMACOL, V57, P13; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5	27	1030	1095	8	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					199	202		10.1038/nature726	http://dx.doi.org/10.1038/nature726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894099				2022-12-24	WOS:000174348100043
J	Paine, RT				Paine, RT			Trophic controt of production in a rocky intertidal community	SCIENCE			English	Article							ECOSYSTEM PROCESSES; BIODIVERSITY; COMPETITION; DIVERSITY	In the low intertidal zone at Tatoosh Island, Washington, United States, minimal estimates of primary production can vary from 0 to an average of 86 kilograms of wet mass per square meter per year when the grazing assemblage is manipulated. Highly productive annual kelps (Laminariales) replace less productive perennial species when macroscopic grazers are reduced or absent, resulting in monodominant assemblages of Alaria marginata. Experiments were repeated in seven consecutive years. Increased species richness makes no significant additional contribution to annual production. Rather, a competitively superior species is favored when its enemies are reduced, suggesting that terrestrial perspectives on the rote of biodiversity that are developed without considering consumers may not be general.	Univ Washington, Dept Zool, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Paine, RT (corresponding author), Univ Washington, Dept Zool, Seattle, WA 98195 USA.							[Anonymous], 1997, NATURES SERVICES; DAYTON PK, 1975, ECOL MONOGR, V45, P137, DOI 10.2307/1942404; Druehl L. P., 1981, BIOL SEAWEEDS, V17, P306; DUGGINS DO, 1985, OECOLOGIA, V67, P183, DOI 10.1007/BF00384282; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; EWEL JJ, 1991, ECOL APPL, V1, P289, DOI 10.2307/1941758; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; HART TB, 1989, AM NAT, V133, P613, DOI 10.1086/284941; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUBBLE SP, 2001, UNIFIED THEORY BIODI; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KINZIE AP, 2001, FUNCTIONAL COSNEQUEN, P1; KVITEK RG, 1989, MAR MAMMAL SCI, V5, P266, DOI 10.1111/j.1748-7692.1989.tb00340.x; LEIGH EG, 1987, P NATL ACAD SCI USA, V84, P1314, DOI 10.1073/pnas.84.5.1314; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MACARTHUR R, 1962, AM NAT, V96, P167, DOI 10.1086/282219; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Markel RW, 1998, MAR ECOL PROG SER, V166, P151, DOI 10.3354/meps166151; Mulder CPH, 1999, ECOL LETT, V2, P237; PAINE R T, 1977, Special Publication Academy of Natural Sciences Philadelphia, V12, P245; PAINE RT, 1984, ECOLOGY, V65, P1339, DOI 10.2307/1939114; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Sundene O., 1962, NYTT MAG BOT, V9, P155; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Torti SD, 2001, AM NAT, V157, P141, DOI 10.1086/318629	30	166	176	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					736	739		10.1126/science.1069811	http://dx.doi.org/10.1126/science.1069811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976455				2022-12-24	WOS:000175281700055
J	Mintzes, B				Mintzes, B			Direct to consumer advertising is medicalising normal human experience	BRITISH MEDICAL JOURNAL			English	Article									Univ British Columbia, Ctr Hlth Serv & Policy Res, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Mintzes, B (corresponding author), Univ British Columbia, Ctr Hlth Serv & Policy Res, 429-2194 Hlth Serv Mall, Vancouver, BC V6T 1Z3, Canada.							Bell RA, 2000, J FAM PRACTICE, V49, P1092; GREEN CJ, 1997, 972T BCOHTA; *IMS HLTH, 2002, IMS HLTH REP PHARM D; Kawachi I., 1996, CONTESTED GROUND PUB; Mintzes B, 2002, BRIT MED J, V324, P278, DOI 10.1136/bmj.324.7332.278; MORAIS RJ, 1998, PHARM EXECUTIVE  OCT, P63; Pfizer and Canadian Lipid Nurses' Network, 2001, CHATELAINE, V74, P74; Pignone M, 2000, BRIT MED J, V321, P983, DOI 10.1136/bmj.321.7267.983; Pressman A, 2001, OSTEOPOROSIS INT, V12, P337, DOI 10.1007/s001980170099; *RES MED IND ASS N, 2000, DTC ADV CAN ENH PUBL; *REUT MED NEWS, 2002, EUR DIR TO CONS DRUG; SHERWOOD LM, 1996, COMMUNICATION   0315; *THER IN, 2001, THERAPEUTICS LETT, P43; THOMAS L, 1980, MEDUSA SNAIL; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; *WHO, 1993, 173 EURICPDSE WHO	16	96	98	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					908	909		10.1136/bmj.324.7342.908	http://dx.doi.org/10.1136/bmj.324.7342.908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950745	Green Published			2022-12-24	WOS:000175052200031
J	Sen Gupta, S; Stadler, M; Noser, CA; Ghosh, A; Steinhoff, B; Lenoir, D; Horwitz, CP; Schramm, KW; Collins, TJ				Sen Gupta, S; Stadler, M; Noser, CA; Ghosh, A; Steinhoff, B; Lenoir, D; Horwitz, CP; Schramm, KW; Collins, TJ			Rapid total destruction of chlorophenols by activated hydrogen peroxide	SCIENCE			English	Article							PHOSPHOREUM TOXICITY BIOASSAY; ROBUST OXIDATION CATALYSTS; IRON TETRASULFOPHTHALOCYANINE; DESIGNING LIGANDS; DEGRADATION; 2,4,6-TRICHLOROPHENOL; PENTACHLOROPHENOL; PRODUCT; H2O2	A practical, inexpensive, green chemical process for degrading environmental pollutants is greatly needed, especially for persistent chlorinated pollutants. Here we describe the activation of hydrogen peroxide by tetraamidomacrocylic ligand (TAML) iron catalysts, to destroy the priority pollutants pentachlorophenol (PCP) and 2,4,6-trichlorophenol (TCP). In water, in minutes, under ambient conditions of temperature and pressure, PCP and TCP are completely destroyed at catalyst:substrate ratios of 1:715 and 1:2000, respectively. The fate of about 90% of the carbon and about 99% of the chlorine has been determined in each case. Neither dioxins nor any other toxic compounds are detectable products, and the catalysts themselves show Low toxicity.	Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; GSF Forschungszentrum Umwelt & Gesundheit, Inst Okol Chem, D-85758 Neuherberg, Germany	Carnegie Mellon University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Collins, TJ (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.		Collins, Terrence J/A-9807-2017; Schramm, Karl-Werner/C-7438-2013; Lenoir, Dieter/A-2996-2011; Lenoir, Dieter/AAF-9217-2019	Collins, Terrence J/0000-0003-2611-9184; Schramm, Karl-Werner/0000-0002-8945-4062; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044867] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44867-05] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartos MJ, 1998, COORDIN CHEM REV, V174, P361, DOI 10.1016/S0010-8545(98)00142-8; Benitez FJ, 1999, IND ENG CHEM RES, V38, P1341, DOI 10.1021/ie980441f; COLLINS TJ, 1994, ACCOUNTS CHEM RES, V27, P279, DOI 10.1021/ar00045a004; Fukushima M, 2001, ENVIRON SCI TECHNOL, V35, P1771, DOI 10.1021/es001088j; Hadasch A, 1998, NEW J CHEM, V22, P45, DOI 10.1039/a706741k; HALL JA, 1999, P 53 APPITA ANN C 19, V2, P455; Hatta T, 1999, J BIOSCI BIOENG, V87, P267, DOI 10.1016/S1389-1723(99)80030-9; Hemmert C, 1999, J MOL CATAL A-CHEM, V137, P205, DOI 10.1016/S1381-1169(98)00131-9; Horwitz CP, 1998, J AM CHEM SOC, V120, P4867, DOI 10.1021/ja972891p; KAISER KLE, 1988, TOXIC ASSESS, V3, P195, DOI 10.1002/tox.2540030209; McAllister KA, 1996, BIODEGRADATION, V7, P1, DOI 10.1007/BF00056556; MILLS G, 1993, ENVIRON SCI TECHNOL, V27, P1681, DOI 10.1021/es00045a027; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; OEBERG LG, 1992, CHEMOSPHERE, V25, P49; PAL N, 1995, BIOTECHNOL BIOENG, V46, P599, DOI 10.1002/bit.260460613; Pifer A, 1999, J AM CHEM SOC, V121, P7485, DOI 10.1021/ja990244n; Ramamoorthy S., 1997, CHLORINATED ORGANIC; RIBO JM, 1987, TOXIC ASSESS, V2, P305; SIMANDI LI, 1977, J CHEM SOC PERK T 2, P1794, DOI 10.1039/p29770001794; SOROKIN A, 1995, SCIENCE, V268, P1163, DOI 10.1126/science.268.5214.1163; Sorokin A, 1996, CHEM-EUR J, V2, P1308, DOI 10.1002/chem.19960021019; Sorokin A, 1996, J AM CHEM SOC, V118, P7410, DOI 10.1021/ja960177m; VUOCOLO LD, 2000, THESIS CARNEGIE MELL; [No title captured]	24	334	365	7	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					326	328		10.1126/science.1069297	http://dx.doi.org/10.1126/science.1069297			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951040				2022-12-24	WOS:000175000300051
J	de Vries, N; van Riel, PLCM; van de Putte, LBA				de Vries, N; van Riel, PLCM; van de Putte, LBA			Research in complex diseases	LANCET			English	Editorial Material							CHIMERIC MONOCLONAL-ANTIBODY; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; CA2		Univ Amsterdam, Acad Med Ctr Amsterdam FL1 218, Div Clin Immunol & Rheumatol, NL-1100 DE Amsterdam, Netherlands; Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; Univ Med Ctr St Radboud, Dept Rheumatol, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	de Vries, N (corresponding author), Univ Amsterdam, Acad Med Ctr Amsterdam FL1 218, Div Clin Immunol & Rheumatol, POB 22700, NL-1100 DE Amsterdam, Netherlands.		van Riel, P.L.C.M./H-8082-2014; de Vries, Niek/J-9348-2013	de Vries, Niek/0000-0002-6257-8604				ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Fox DA, 1997, PERSPECT BIOL MED, V40, P479; LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357, DOI 10.1136/ard.29.4.357; MCKUSICK VA, 1998, MENDELIAN INHERITANC, P28; ROTHMAN KJ, 1997, OXFORD TXB PUBLIC HL, P617; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502	6	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 6	2002	359	9313					1243	1245		10.1016/S0140-6736(02)08223-5	http://dx.doi.org/10.1016/S0140-6736(02)08223-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AB	11955559				2022-12-24	WOS:000174846300031
J	Gross, C; Zhuang, XX; Stark, K; Ramboz, S; Oosting, R; Kirby, L; Santarelli, L; Beck, S; Hen, R				Gross, C; Zhuang, XX; Stark, K; Ramboz, S; Oosting, R; Kirby, L; Santarelli, L; Beck, S; Hen, R			Serotonin(1A) receptor acts during development to establish normal anxiety-like behaviour in the adult	NATURE			English	Article							MONOAMINE-OXIDASE; MICE; EXPRESSION; RAT; BINDING; DEPLETION; MEDIATE; MODELS; EXCESS	Serotonin is implicated in mood regulation, and drugs acting via the serotonergic system are effective in treating anxiety and depression. Specifically, agonists of the serotonin(1A) receptor have anxiolytic properties, and knockout mice lacking this receptor show increased anxiety-like behaviour. Here we use a tissue-specific, conditional rescue strategy to show that expression of the serotonin(1A) receptor primarily in the hippocampus and cortex, but not in the raphe nuclei, is sufficient to rescue the behavioural phenotype of the knockout mice. Furthermore, using the conditional nature of these transgenic mice, we suggest that receptor expression during the early postnatal period, but not in the adult, is necessary for this behavioural rescue. These findings show that postnatal developmental processes help to establish adult anxiety-like behaviour. In addition, the normal role of the serotonin(1A) receptor during development may be different from its function when this receptor is activated by therapeutic intervention in adulthood.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	Columbia University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	rh95@columbia.edu			NIMH NIH HHS [R21 MH099488, RC1 MH089800, P01 MH048125] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH048125, R21MH099488, RC1MH089800] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cao BJ, 1997, PHARMACOL BIOCHEM BE, V58, P593, DOI 10.1016/S0091-3057(97)00279-7; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Coplan JD, 1995, PSYCHIAT CLIN N AM, V18, P727, DOI 10.1016/S0193-953X(18)30020-0; Durig J, 2000, NEUROREPORT, V11, P833, DOI 10.1097/00001756-200003200-00035; FEIGHNER JP, 1989, PSYCHOPATHOLOGY, V22, P21, DOI 10.1159/000284623; Fletcher A, 1996, BEHAV BRAIN RES, V73, P337; Gross C, 2000, BIOL PSYCHIAT, V48, P1157, DOI 10.1016/S0006-3223(00)01041-6; Haring JH, 1999, DEV BRAIN RES, V114, P269, DOI 10.1016/S0165-3806(99)00032-2; Heisler LK, 1998, P NATL ACAD SCI USA, V95, P15049, DOI 10.1073/pnas.95.25.15049; HOHMANN CF, 1988, DEV BRAIN RES, V43, P163, DOI 10.1016/0165-3806(88)90163-0; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KUNG MP, 1995, J PHARMACOL EXP THER, V272, P429; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MARTIN KF, 1992, BRIT J PHARMACOL, V107, P15, DOI 10.1111/j.1476-5381.1992.tb14457.x; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Menard J, 1999, NEUROSCI BIOBEHAV R, V23, P591, DOI 10.1016/S0149-7634(98)00056-6; MITCHELL JB, 1990, DEV BRAIN RES, V55, P231, DOI 10.1016/0165-3806(90)90204-C; Parks CL, 1998, P NATL ACAD SCI USA, V95, P10734, DOI 10.1073/pnas.95.18.10734; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Sibille E, 2000, J NEUROSCI, V20, P2758; TWEED JL, 1989, BRIT J PSYCHIAT, V154, P823, DOI 10.1192/bjp.154.6.823; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; Yan W, 1997, DEV BRAIN RES, V98, P185, DOI 10.1016/S0165-3806(96)00175-7; Yan W, 1997, DEV BRAIN RES, V98, P177, DOI 10.1016/S0165-3806(96)00176-9	28	696	719	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					396	400		10.1038/416396a	http://dx.doi.org/10.1038/416396a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919622				2022-12-24	WOS:000174607800037
J	Wiesen, AR; Littell, CT				Wiesen, AR; Littell, CT			Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US army women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIOLOGICAL WARFARE; HEALTH; SAFETY	Context Substantial concern surrounds the potential health effects of the anthrax vaccine, particularly the-potential adverse effects on reproductive processes. Objective To determine whether receipt of anthrax vaccination by reproductive-aged women has an effect on pregnancy rates. Design, Setting, and Patients Cohort study, based on information from a computer database, of women aged 17 to 44 years who were stationed at Fort Stewart, Ga, or Hunter Army Airfield, Ga, from January 1999 through March 2000. Main Outcome Measures Pregnancy and birth rates and adverse birth outcomes. Results Of a total of 4092 women, 3136 received at least 1 dose of the anthrax vaccine. There was a total of 513 pregnancies, with 385 following at least 1 dose of anthrax vaccine. The pregnancy rate ratio (before and after adjustment for marital status, race, and age) comparing vaccinated with unvaccinated women was 0.94 (95% confidence interval [CI], 0.8-1.2; P=.60). There were 353 live births and 25 pregnancies lost to follow-up. The birth odds ratio after anthrax vaccination (before and after adjustment for marital status and age) was 0.9 (95% CI, 0.5-1.4; P=.55). After adjusting for age, the odds ratio for adverse birth outcome after receiving at least 1 dose of anthrax vaccination was 0.9 (95% CI, 0.4-2.4; P=.88). However, this study did not have sufficient power to detect adverse birth outcomes. Conclusion Anthrax vaccination had no effect on pregnancy and birth rates or adverse birth outcomes.	Madigan Army Med Ctr, Dept Prevent Med, MCHJ PV, Tacoma, WA 98431 USA	Madigan Army Medical Center	Wiesen, AR (corresponding author), Madigan Army Med Ctr, Dept Prevent Med, MCHJ PV, Tacoma, WA 98431 USA.	andrew.wiesen@amedd.army.mil						*ADV COMM IMM PRAC, 1994, MMWR-MORBID MORTAL W, V43, P20; American College of obstetricians and gynecologists, 1993, INT J GYNECOL OBSTET, V40, P69; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Biological products, 1985, FED REGISTER, V50, P51002; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P341; Chin J., 2000, CONTROL COMMUNICABLE, V17th, P20; Christopher GW, 1997, JAMA-J AM MED ASSOC, V278, P412, DOI 10.1001/jama.278.5.412; Demicheli V, 1998, VACCINE, V16, P880, DOI 10.1016/S0264-410X(98)00023-1; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; GRABENSTEIN JD, 1999, HOSP PHARM, V34, P949; GRABENSTEIN JD, 1999, HOSP PHARM, V34, P959; GRABENSTEIN JD, 1999, HOSP PHARM, V34, P955; HOLMES LB, 1999, OSKIS PEDIAT PRINCIP, P136; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; Mazzuchi JF, 2000, AVIAT SPACE ENVIR MD, V71, P260; MCNEIL D, 1996, EPIDEMIOLOGICAL RES, P170; *MI BIOL PROD I, 1999, ANTHR VACC ADS PACK; Pile JC, 1998, ARCH INTERN MED, V158, P429, DOI 10.1001/archinte.158.5.429; Sohl B, 1998, AVERYS DIS NEWBORN, P90; Stoll B. J., 2000, NELSON TXB PEDIAT, P477; VENTURA SJ, 1996, MONTHLY VITAL STAT R, V44; Walker M, 1998, AVERYS DIS NEWBORN, P144; WHITE CS, 1974, ANN INTERN MED, V81, P594, DOI 10.7326/0003-4819-81-5-594; 1989, MODEL BUILDING STRAT, P82	28	33	37	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2002	287	12					1556	1560		10.1001/jama.287.12.1556	http://dx.doi.org/10.1001/jama.287.12.1556			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533VF	11911758				2022-12-24	WOS:000174550400027
J	Cho, NK; Keyes, L; Johnson, E; Heller, J; Ryner, L; Karim, F; Krasnow, MA				Cho, NK; Keyes, L; Johnson, E; Heller, J; Ryner, L; Karim, F; Krasnow, MA			Developmental control of blood cell migration by the Drosophila VEGF pathway	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR-PERMEABILITY FACTOR; HEMATOPOIETIC STEM-CELLS; APOPTOTIC CELLS; RECEPTOR FLT-1; PROTEIN; DEATH; CROQUEMORT; DISTINCT; LINEAGE	We show that a vascular endothelial growth factor (VEGF) pathway controls embryonic migrations of blood cells (hemocytes) in Drosophila. The VEGF receptor homolog is expressed in hemocytes, and three VEGF homologs are expressed along hemocyte migration routes. A receptor mutation arrests progression of blood cell movement. Mutations in Vegf17E or Vegf27Cb have no effect, but simultaneous inactivation of all three Vegf genes phenocopied the receptor mutant, and ectopic expression of Vegf27Cb redirected migration. Genetic experiments indicate that the VEGF pathway functions independently of pathways governing hemocyte homing on apoptotic cells. The results suggest that the Drosophila VEGF pathway guides developmental migrations of blood cells, and we speculate that the ancestral function of VEGF pathways was to guide blood cell movement.	Stanford Univ, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA; Exelixis Inc, Dept Genet, San Francisco, CA USA	Howard Hughes Medical Institute; Stanford University; Exelixis, Inc.	Krasnow, MA (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA.							ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bernardoni R, 1997, DEV BIOL, V191, P118; BRAND AH, 1993, DEVELOPMENT, V118, P401; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; CHAMPION S, 1986, CELL, V44, P781, DOI 10.1016/0092-8674(86)90844-5; Choi K, 1998, DEVELOPMENT, V125, P725; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Clauss M, 2000, SEMIN THROMB HEMOST, V26, P561, DOI 10.1055/s-2000-13213; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Lee T, 1996, DEVELOPMENT, V122, P409; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; NELSON RE, 1994, EMBO J, V13, P3438, DOI 10.1002/j.1460-2075.1994.tb06649.x; ONEILL JW, 1994, BIOTECHNIQUES, V17, P870; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHEN H, 1993, BLOOD, V81, P2767; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; TEPASS U, 1994, DEVELOPMENT, V120, P1829; ZHOU L, 1995, CURR BIOL, V5, P784, DOI 10.1016/S0960-9822(95)00155-2	40	223	226	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					865	876		10.1016/S0092-8674(02)00676-1	http://dx.doi.org/10.1016/S0092-8674(02)00676-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955438	Bronze			2022-12-24	WOS:000174563000014
J	Haj, FG; Verveer, PJ; Squire, A; Neel, BG; Bastiaens, PIH				Haj, FG; Verveer, PJ; Squire, A; Neel, BG; Bastiaens, PIH			Imaging sites of receptor dephosphorylation by PTP1B on the surface of the endoplasmic reticulum	SCIENCE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; CLATHRIN-MEDIATED ENDOCYTOSIS; INSULIN SENSITIVITY; SPATIAL-RESOLUTION; SUBSTRATE; SPECIFICITY; MICROSCOPY; LIGASE; CELL; MICE	When bound by extracellular ligands, receptor tyrosine kinases (RTKs) on the cell surface transmit critical signals to the cell interior. Although signal termination is less well understood, protein tyrosine phosphatase-1B (PTP1B) is implicated in the dephosphorytation and inactivation of several RTKs. However, PTP1B resides on the cytoplasmic surface of the endoplasmic reticulum (ER), so how and when it accesses RTKs has been unclear. Using fluorescence resonance energy transfer (FRET) methods, we monitored interactions between the epidermal- and platelet-derived growth factor receptors and PTP1B. PTP1B-catatyzed dephosphorylation required endocytosis of the receptors and occurred at specific sites on the surface of the ER. Most of the RTKs activated at the cell surface showed interaction with PTP1B after internalization, establishing that RTK activation and inactivation are spatially and temporally partitioned within cells.	Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	Harvard University; Beth Israel Deaconess Medical Center; European Molecular Biology Laboratory (EMBL)	Neel, BG (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Canc Biol Program, Boston, MA 02115 USA.				NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA49152] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastiaens PIH, 1999, TRENDS CELL BIOL, V9, P48, DOI 10.1016/S0962-8924(98)01410-X; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BLISKA JB, 1992, J EXP MED, V176, P1625, DOI 10.1084/jem.176.6.1625; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; GADELLA TWJ, 1993, BIOPHYS CHEM, V48, P221, DOI 10.1016/0301-4622(93)85012-7; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; GOLD T, 1982, ENERG EXPLOR EXPLOIT, V1, P1; HAJ FG, UNPUB; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; LAKOWICZ JR, 1991, REV SCI INSTRUM, V62, P1727, DOI 10.1063/1.1142413; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Squire A, 1999, J MICROSC-OXFORD, V193, P36, DOI 10.1046/j.1365-2818.1999.00427.x; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040	26	342	354	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1708	1711		10.1126/science.1067566	http://dx.doi.org/10.1126/science.1067566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872838				2022-12-24	WOS:000174212900045
J	del Hoyo, GM; Martin, P; Vargas, HH; Ruiz, S; Arias, CF; Ardavin, C				del Hoyo, GM; Martin, P; Vargas, HH; Ruiz, S; Arias, CF; Ardavin, C			Characterization of a common precursor population for dendritic cells	NATURE			English	Article							MURINE BONE-MARROW; MYELOID PROGENITOR; LYMPH-NODES; MATURATION; INTERFERON; LINEAGES; MOUSE	Dendritic cells (DCs) are essential for the establishment of immune responses against pathogens and tumour cells, and thus have great potential as tools for vaccination and cancer immunotherapy trials. Experimental evidence has led to a dual DC differentiation model, which involves the existence of both myeloid- and lymphoid-derived DCs1. But this concept has been challenged by recent reports demonstrating that both CD8(-) and CD8(+) DCs, considered in mice as archetypes of myeloid and lymphoid DCs respectively, can be generated from either lymphoid(2-4) or myeloid progenitors(3,4). The issue of DC physiological derivation therefore remains an open question. Here we report the characterization of a DC-committed precursor population, which has the capacity to generate all the DC subpopulations present in mouse lymphoid organs-including CD8(-) and CD8(+) DCs, as well as the B220(+) DC subset-but which is devoid of myeloid or lymphoid differentiation potential. These data support an alternative model of DC development, in which there is an independent, common DC differentiation pathway.	Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain	Complutense University of Madrid	Ardavin, C (corresponding author), Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain.		Martin, Pilar/F-8193-2014; Martinez del Hoyo, Gloria/K-4750-2015; Fernandez-Arias, Cristina/D-1618-2018	Martin, Pilar/0000-0002-2392-1764; Martinez del Hoyo, Gloria/0000-0003-2588-2575; Hernandez-Vargas, Hector/0000-0001-6045-2103				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anjuere F, 2000, J LEUKOCYTE BIOL, V67, P206, DOI 10.1002/jlb.67.2.206; Anjuere F, 1999, BLOOD, V93, P590, DOI 10.1182/blood.V93.2.590.402k11_590_598; ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; Ardavin C, 1999, J IMMUNOL, V162, P2538; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; del Hoyo GM, 2002, BLOOD, V99, P999, DOI 10.1182/blood.V99.3.999; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lyman SD, 1998, BLOOD, V91, P1101, DOI 10.1182/blood.V91.4.1101; Manz MG, 2001, BLOOD, V97, P3333, DOI 10.1182/blood.V97.11.3333; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; MARTIN P, UNPUB BLOOD; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Mojica MP, 2001, J IMMUNOL, V166, P3042, DOI 10.4049/jimmunol.166.5.3042; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sozzani S, 1998, J IMMUNOL, V161, P1083; Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152; Tudor KSRS, 2000, IMMUNITY, V12, P335, DOI 10.1016/S1074-7613(00)80186-7	21	173	179	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1043	1047		10.1038/4151043a	http://dx.doi.org/10.1038/4151043a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875574				2022-12-24	WOS:000174075000050
J	Wang, JX; Knottnerus, AM; Schuit, G; Norman, RJ; Chan, A; Dekker, GA				Wang, JX; Knottnerus, AM; Schuit, G; Norman, RJ; Chan, A; Dekker, GA			Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia	LANCET			English	Article							PREECLAMPSIA; PREGNANCY	The cause of pre-eclampsia is unknown, although a partner-specific immune maladaptation might be Involved. We compared rates of pre-eclampsia and gestational hypertension in women whose genital tracts had and had not been exposed to their partner's sperm cells. Our aim was to ascertain whether or not protective partner-specific immune-tolerance is conveyed by sperm cells, rather than seminal fluid. Our findings Indicate that, compared with women exposed to their partner's sperm cells and seminal fluid-ie, those treated with in-vitro fertilisation (IVF) or intracytoplasmic sperm Injection (ICSI) with ejaculated sperm-the risk of hypertension was doubled and the risk of pre-eclampsia tripled In those never exposed to their partner's sperm-ie, those treated with ICSI done with surgically obtained sperm.	Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia; Univ Adelaide, N Western Adelaide Hlth Serv, Dept Obstet & Gynaecol, Woodville, SA, Australia; Dept Human Serv, Pregnancy Outcome Unit, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Wang, JX (corresponding author), Univ Adelaide, Queen Elizabeth Hosp, Dept Obstet & Gynaecol, Reprod Med Unit, Woodville, SA 5011, Australia.		Knottnerus, Andre/F-4866-2013; Norman, Robert J/A-1155-2007	Norman, Robert J/0000-0002-3118-3896				Dekker G A, 1998, Obstet Gynecol Surv, V53, P377, DOI 10.1097/00006254-199806000-00023; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; ROBILLARD PY, 1994, LANCET, V344, P973, DOI 10.1016/S0140-6736(94)91638-1; Salha O, 1999, HUM REPROD, V14, P2268, DOI 10.1093/humrep/14.9.2268; Smith GN, 1997, AM J OBSTET GYNECOL, V177, P455, DOI 10.1016/S0002-9378(97)70215-1	5	115	122	1	13	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					673	674		10.1016/S0140-6736(02)07804-2	http://dx.doi.org/10.1016/S0140-6736(02)07804-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879865				2022-12-24	WOS:000174107400013
J	Lendlein, A; Langer, R				Lendlein, A; Langer, R			Biodegradable, elastic shape-memory polymers for potential biomedical applications	SCIENCE			English	Article							POLYETHER-BASED POLYURETHANES; THERMOMECHANICAL PROPERTIES; BEHAVIOR; POLYNORBORNENE; COPOLYMERS; SERIES	The introduction of biodegradable implant materials as well as minimally invasive surgical procedures in medicine has substantially improved health care within the past few decades. This report describes a group of degradable thermoplastic polymers that are able to change their shape after an increase in temperature. Their shape-memory capability enables bulky implants to be placed in the body through small incisions or to perform complex mechanical deformations automatically. A smart degradable suture was created to illustrate the potential of these shape-memory thermoplastics in biomedical applications.	mnemoSci GmbH, D-52074 Aachen, Germany; Rhein Westfal TH Aachen, Inst Tech & Macromol Chem, Aachen, Germany; MIT, Dept Chem Engn, Cambridge, MA 02139 USA	RWTH Aachen University; Massachusetts Institute of Technology (MIT)	Lendlein, A (corresponding author), mnemoSci GmbH, Pauwelsstr 19, D-52074 Aachen, Germany.	a.lendlein@mnemoscience.de	Lendlein, Andreas/K-9553-2013	Lendlein, Andreas/0000-0003-4126-4670				CHARLESBY A, 1960, ATOMIC RAD POLYM, P198; CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056; Fu K, 2000, PHARM RES-DORDR, V17, P100, DOI 10.1023/A:1007582911958; GRABLOWITZ HG, UNPUB; Hodgson NCF, 2000, ANN SURG, V231, P436, DOI 10.1097/00000658-200003000-00018; Hoer J, 2001, LANGENBECK ARCH SURG, V386, P218, DOI 10.1007/s004230000196; Hooper KA, 1998, J BIOMED MATER RES, V41, P443, DOI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J; HU ZB, 1995, SCIENCE, V269, P525, DOI 10.1126/science.269.5223.525; Hunter J. G., 1993, MINIMALLY INVASIVE S; Kagami Y, 1996, MACROMOL RAPID COMM, V17, P539, DOI 10.1002/marc.1996.030170806; Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9; Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398; Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505; Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067; Lin JR, 1998, J APPL POLYM SCI, V69, P1563, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1563::AID-APP11>3.0.CO;2-W; Lin JR, 1998, J APPL POLYM SCI, V69, P1575, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1575::AID-APP12>3.0.CO;2-U; MAK AFT, 1998, HDB BIOMATERIAL PROP, P66; OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0; SAKURAI K, 1993, J APPL POLYM SCI, V47, P937, DOI 10.1002/app.1993.070470521; SAKURAI K, 1994, POLYMER, V35, P4238, DOI 10.1016/0032-3861(94)90602-5; SAKURAI K, 1989, J APPL POLYM SCI, V38, P1191, DOI 10.1002/app.1989.070380616; SCHETKY LM, 1979, SCI AM, V241, P74, DOI 10.1038/scientificamerican1179-74; SPANELBOROWSKI K, 1989, RES EXP MED, V189, P69, DOI 10.1007/BF01856032; SWAIN MV, 1986, NATURE, V322, P234, DOI 10.1038/322234a0; Takahashi T, 1996, J APPL POLYM SCI, V60, P1061; Tobushi H, 1996, P SOC PHOTO-OPT INS, V2716, P46, DOI 10.1117/12.232168; Tobushi H, 1996, J PHYS IV, V6, P377, DOI 10.1051/jp4:1996136; Van Humbeeck J, 1999, MAT SCI ENG A-STRUCT, V273, P134, DOI 10.1016/S0921-5093(99)00293-2	28	1746	2026	72	1738	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1673	1676		10.1126/science.1066102	http://dx.doi.org/10.1126/science.1066102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	11976407				2022-12-24	WOS:000175976200053
J	Soderblom, LA; Becker, TL; Bennett, G; Boice, DC; Britt, DT; Brown, RH; Buratti, BJ; Isbell, C; Giese, B; Hare, T; Hicks, MD; Howington-Kraus, E; Kirk, RL; Lee, M; Nelson, RM; Oberst, J; Owen, TC; Rayman, MD; Sandel, BR; Stern, SA; Thomas, N; Yelle, RV				Soderblom, LA; Becker, TL; Bennett, G; Boice, DC; Britt, DT; Brown, RH; Buratti, BJ; Isbell, C; Giese, B; Hare, T; Hicks, MD; Howington-Kraus, E; Kirk, RL; Lee, M; Nelson, RM; Oberst, J; Owen, TC; Rayman, MD; Sandel, BR; Stern, SA; Thomas, N; Yelle, RV			Observations of comet 19P/Borrelly by the Miniature Integrated Camera and Spectrometer Aboard Deep Space 1	SCIENCE			English	Article							NUCLEUS; PHOTOMETRY; 253-MATHILDE; HALLEY; IMAGES	The nucleus of the Jupiter-family comet 19P/Borrelly was closely observed by the Miniature Integrated Camera and Spectrometer aboard the Deep Space I spacecraft on 22 September 2001. The 8-kilometer-long body is highly variegated on a scale of 200 meters, exhibiting large albedo variations (0.01 to 0.03) and complex geologic relationships. Short-wavelength infrared spectra (1.3 to 2.6 micrometers) show a slope toward the red and a hot, dry surface (less than or equal to345 kelvin, with no trace of water ice or hydrated minerals), consistent with similar to10% or less of the surface actively sublimating. Borrelly's coma exhibits two types of dust features: fans and highly collimated jets. At encounter, the near-nucleus coma was dominated by a prominent dust jet that resolved into at least three smaller jets emanating from a broad basin in the middle of the nucleus. Because the major dust jet remained fixed in orientation, it is evidently aligned near the rotation axis of the nucleus.	US Geol Survey, Flagstaff, AZ 86001 USA; SW Res Inst, San Antonio, TX 78238 USA; Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA; Univ Arizona, Lunar & Planetary Lab, Dept Planetary Sci, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; DLR, Inst Space Sensor Technol & Planetary Explorat, D-12489 Berlin, Germany; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany	United States Department of the Interior; United States Geological Survey; Southwest Research Institute; University of Tennessee System; University of Tennessee Knoxville; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Helmholtz Association; German Aerospace Centre (DLR); University of Hawaii System; Max Planck Society	Soderblom, LA (corresponding author), US Geol Survey, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA.		; Thomas, Nicolas/G-4693-2015; Boice, Daniel/C-4831-2018	Hare, Trent/0000-0001-8842-389X; Thomas, Nicolas/0000-0002-0146-0071; Boice, Daniel/0000-0001-6423-3768				AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; BEAUCHAMP PM, 1994, P 8 ANN AIAA UT STAT; BORRELLY ALN, COMET 19P BORRELLY D; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Clark BE, 1999, ICARUS, V140, P53, DOI 10.1006/icar.1999.6124; Cruikshank DP, 1998, ICARUS, V135, P389, DOI 10.1006/icar.1998.5997; Farinella P., 2000, Protostars and planets 4, P1255; HANNER MS, 1985, ICARUS, V62, P97, DOI 10.1016/0019-1035(85)90174-5; HUEBNER WF, 1987, SCIENCE, V237, P628, DOI 10.1126/science.237.4815.628; *IAU, 1998, 31664 IAU; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; Knollenberg J, 1996, EARTH MOON PLANETS, V72, P103, DOI 10.1007/BF00117509; KONNO I, 1995, ICARUS, V116, P77; Lamy PL, 1998, ASTRON ASTROPHYS, V337, P945; MARSDEN BG, 2001, 7771 IAU; MITCHELL DL, 1987, SCIENCE, V237, P626, DOI 10.1126/science.237.4815.626; MUELLER B, 2001, B AM ASTRON SOC, V33, P1090; OCKERT ME, 1987, J GEOPHYS RES, V92, P14969, DOI 10.1029/JA092iA13p14969; RAUER H, 1999, B AM ASTRON SOC, V31, P1131; Rayman MD, 2001, ACTA ASTRONAUT, V48, P693, DOI 10.1016/S0094-5765(01)00044-3; Rayman MD, 2000, ACTA ASTRONAUT, V47, P475, DOI 10.1016/S0094-5765(00)00087-4; SODERBLOM LA, 2000, P DS1 TECHN VAL S PA; TEDESCO EF, 1989, ASTRON J, V97, P580, DOI 10.1086/115007; VEEDER GJ, 1987, ASTRON J, V94, P169, DOI 10.1086/114460; Veverka J, 1997, SCIENCE, V278, P2109, DOI 10.1126/science.278.5346.2109; WEISSMAN PR, 1986, NATURE, V320, P242, DOI 10.1038/320242a0	26	170	171	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1087	1091		10.1126/science.1069527	http://dx.doi.org/10.1126/science.1069527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	11934989				2022-12-24	WOS:000175565000044
J	Crawford, LM				Crawford, LM			Patient safety news	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2203	2203		10.1001/jama.287.17.2203	http://dx.doi.org/10.1001/jama.287.17.2203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980508				2022-12-24	WOS:000175260600008
J	Downing, AL; Leibold, MA				Downing, AL; Leibold, MA			Ecosystem consequences of species richness and composition in pond food webs	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; PRODUCTIVITY	Resolving current concerns about the role of biodiversity on ecosystems calls for understanding the separate roles of changes in species numbers and of composition. Recent work shows that primary productivity often, but not always, saturates with species richness within single trophic levels(1-8). However, any interpretation of such patterns must consider that variation in biodiversity is necessarily associated with changes in species composition (identity)(9-12), and that changes in biodiversity often occur across multiple trophic levels(13,14). Here we present results from a mesocosm experiment in which we independently manipulated species richness and species composition across multiple trophic levels in pond food webs. In contrast to previous studies that focused on single trophic levels, we found that productivity is either idiosyncratic or increases with respect to species richness, and that richness influences trophic structure. However, the composition of species within richness levels can have equally or more marked effects on ecosystems than average effects of richness per se. Indirect evidence suggests that richness and associated changes in species composition affect ecosystem attributes through indirect effects and trophic interactions among species, features that are highly characteristic of natural, complex ecosystems.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Downing, AL (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	aldownin@owu.edu						Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Lund OT, 1979, HDB COMMON METHODS L; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; McCollum EW, 1998, ECOLOGY, V79, P1980; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Mikola J, 1998, OECOLOGIA, V117, P396, DOI 10.1007/s004420050673; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Norberg J, 2000, OECOLOGIA, V122, P264, DOI 10.1007/PL00008855; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Schlapfer F, 1999, OIKOS, V84, P346, DOI 10.2307/3546733; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wetzel R.G., 1983, LIMNOLOGY, V2nd; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yodzis Peter, 1996, P192	30	169	174	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2002	416	6883					837	841		10.1038/416837a	http://dx.doi.org/10.1038/416837a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976680				2022-12-24	WOS:000175163800048
J	Fleisher, LA				Fleisher, LA			Preoperative evaluation of the patient with hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTOPERATIVE MYOCARDIAL-ISCHEMIA; MAJOR VASCULAR-SURGERY; CARDIAC MORBIDITY; RISK; PREDICTORS; INFARCTION; ANESTHESIA; MORTALITY; UPDATE; INDEX		Johns Hopkins Univ, Sch Med, Dept Anesthesiol, Baltimore, MD 21287 USA	Johns Hopkins University	Fleisher, LA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol, 600 N Wolfe St,Carnegie 280, Baltimore, MD 21287 USA.	lfleishe@jhmi.edu	Lee A, Fleisher/Q-9894-2019					American Heart Association, 2002, HEART STROK STAT UPD; Ang-Lee MK, 2001, JAMA-J AM MED ASSOC, V286, P208, DOI 10.1001/jama.286.2.208; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; ARONSON S, 2001, ANESTH ANALG, V92, pS45; Bertrand M, 2001, ANESTH ANALG, V92, P26; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; CORIAT P, 1994, ANESTHESIOLOGY, V81, P299, DOI 10.1097/00000542-199408000-00006; Eagle KA, 2002, J AM COLL CARDIOL, V39, P542, DOI 10.1016/S0735-1097(01)01788-0; FLEISHER LA, 1995, J CLIN ANESTH, V7, P97, DOI 10.1016/0952-8180(94)00030-8; GOLDMAN L, 1979, ANESTHESIOLOGY, V50, P285, DOI 10.1097/00000542-197904000-00002; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HOLLENBERG M, 1992, JAMA-J AM MED ASSOC, V268, P205, DOI 10.1001/jama.268.2.205; JONAS WB, 1999, ESSENTIALS COMPLEMEN, P118; KANNEL WB, 1984, NEW ENGL J MED, V311, P1144, DOI 10.1056/NEJM198411013111802; LANDESBERG G, 1993, LANCET, V341, P715, DOI 10.1016/0140-6736(93)90486-Z; Landesberg G, 1997, J VASC SURG, V26, P570, DOI 10.1016/S0741-5214(97)70054-5; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; LEUNG JM, 1990, ANESTHESIOLOGY, V73, P802, DOI 10.1097/00000542-199011000-00002; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; PROBSTFIELD JL, 1991, JAMA-J AM MED ASSOC, V265, P3255; Prys-Roberts C, 2001, ANAESTHESIA, V56, P505, DOI 10.1046/j.1365-2044.2001.02136.x; PRYSROBERTS C, 1973, BRIT J ANAESTH, V45, P671, DOI 10.1093/bja/45.7.671; PRYSROBERTS C, 1971, BRIT J ANAESTH, V43, P122, DOI 10.1093/bja/43.2.122; STONE JG, 1988, ANESTHESIOLOGY, V68, P495, DOI 10.1097/00000542-198804000-00004; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005	27	38	39	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2002	287	16					2043	2046		10.1001/jama.287.16.2043	http://dx.doi.org/10.1001/jama.287.16.2043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZK	11966361				2022-12-24	WOS:000175075700001
J	Pinkney, J; Williams, G				Pinkney, J; Williams, G			Ghrelin gets hungry	LANCET			English	Editorial Material							GROWTH-HORMONE DEFICIENCY; QUALITY-OF-LIFE		Univ Liverpool, Univ Hosp Aintree,Ctr Clin Sci, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AL, Merseyside, England	University of Liverpool	Pinkney, J (corresponding author), Univ Liverpool, Univ Hosp Aintree,Ctr Clin Sci, Dept Med, Diabet & Endocrinol Res Grp, Liverpool L9 7AL, Merseyside, England.							Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Bing C, 2000, CANCER RES, V60, P2405; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, DIABETES, V51, P124, DOI 10.2337/diabetes.51.1.124; Kamegai J, 2001, DIABETES, V50, P2438, DOI 10.2337/diabetes.50.11.2438; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Palmiter RD, 1998, RECENT PROG HORM RES, V53, P163; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Wallymahmed ME, 1997, CLIN ENDOCRINOL, V47, P439, DOI 10.1046/j.1365-2265.1997.2801076.x; Wallymahmed ME, 1999, CLIN ENDOCRINOL, V51, P333; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wisse BE, 2001, ENDOCRINOLOGY, V142, P3292, DOI 10.1210/en.142.8.3292; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540	19	23	26	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1360	1361		10.1016/S0140-6736(02)08387-3	http://dx.doi.org/10.1016/S0140-6736(02)08387-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978327				2022-12-24	WOS:000175076200002
J	Serghides, L; Kain, KC				Serghides, L; Kain, KC			Mechanism of protection induced by vitamin A in falciparum malaria	LANCET			English	Article							PLASMODIUM-FALCIPARUM	Supplementation with vitamin A potentiates host resistance to malaria, however, the underlying mechanism is unknown. We tested the effects of 9-cis-retinolc acid, a metabolite of vitamin A, on CD36 expression, non-opsonic phagocytic clearance of parasitised erythrocytes, and TNFalpha production in human monocytes and macrophages. We found reduced secretion of TNFalpha, upregulated CD36 expression, and increased phagocytosis of Plasmodium falciparum-parasitised erythrocytes. Increased parasite clearance and reduced proinflammatory cytokine responses to Infection might partly explain the beneficial effects of supplementation with vitamin A in malaria.	Toronto Gen Hosp, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Kain, KC (corresponding author), Toronto Gen Hosp, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON M5G 2C4, Canada.		Serghides, Lena/C-7968-2018	Serghides, Lena/0000-0002-2817-6134; Kain, Kevin/0000-0001-6068-1272				McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Shankar AH, 2000, J INFECT DIS, V182, pS37, DOI 10.1086/315906; Shankar AH, 1999, LANCET, V354, P203, DOI 10.1016/S0140-6736(98)08293-2	5	47	49	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1404	1406		10.1016/S0140-6736(02)08360-5	http://dx.doi.org/10.1016/S0140-6736(02)08360-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978340				2022-12-24	WOS:000175076200015
J	Brummelkamp, TR; Bernards, R; Agami, R				Brummelkamp, TR; Bernards, R; Agami, R			A system for stable expression of short interfering RNAs in mammalian cells	SCIENCE			English	Article							GENE	Mammalian genetic approaches to study gene function have been hampered by the lack of toots to generate stable loss-of-function phenotypes efficiently. We report here a new vector system, named pSUPER, which directs the synthesis of small interfering RNAs (siRNAs) in mammalian cells. We show that siRNA expression mediated by this vector causes efficient and specific down-regulation of gene expression, resulting in functional inactivation of the targeted genes. Stable expression of siRNAs using this vector mediates persistent suppression of gene expression, allowing the analysis of loss-of-function phenotypes that develop over longer periods of time. Therefore, the pSUPER vector constitutes a new and powerful system to analyze gene function in a variety of mammalian cell types.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Ctr Biomed Genet, Utrecht, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Agami, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.		agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; BRUMMELKAMP TR, UNPUB; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; HUNTER T, 1975, J BIOL CHEM, V250, P409; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139	7	3652	4893	8	353	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					550	553		10.1126/science.1068999	http://dx.doi.org/10.1126/science.1068999			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11910072	Green Published			2022-12-24	WOS:000175179400052
J	Spero, HJ; Lea, DW				Spero, HJ; Lea, DW			The cause of carbon isotope minimum events on glacial terminations	SCIENCE			English	Article							ANTARCTIC INTERMEDIATE WATER; PLANKTONIC-FORAMINIFERA; ATMOSPHERIC CO2; SURFACE-WATER; PACIFIC DEEP; SEA-ICE; OCEAN; CIRCULATION; CLIMATE; AGE	The occurrence of carbon isotope minima at the beginning of glacial terminations is a common feature of planktic foraminifera carbon isotopic records from the Indo-Pacific, sub-Antarctic, and South Atlantic. We use the delta(13)C record of a thermocline-dwelling foraminifera, Neogloboquadrina dutertrei, and surface temperature estimates from the eastern equatorial Pacific to demonstrate that the onset of delta(13)C minimum events and the initiation of Southern Ocean warming occurred simultaneously. Timing agreement between the marine record and the delta(13)C minimum in an Antarctic atmospheric record suggests that the deglacial events were a response to the breakdown of surface water stratification, renewed Circumpolar Deep Water upwelling, and advection of low delta(13)C waters to the convergence zone at the sub-Antarctic front. On the basis of age agreement between the absolute delta(13)C minimum in surface records and the shift from low to high delta(13)C in the deep South Atlantic, we suggest that the delta(13)C rise that marks the end of the carbon isotope minima was due to the resumption of North Atlantic Deep Water influence in the Southern Ocean.	Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Davis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Spero, HJ (corresponding author), Univ Calif Davis, Dept Geol, Davis, CA 95616 USA.	spero@geology.ucdavis.edu		Spero, Howard/0000-0001-5465-8607				Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; BROECKER WS, 1990, RADIOCARBON, V32, P119, DOI 10.1017/S003382220004011X; CHARLES CD, 1992, NATURE, V355, P416, DOI 10.1038/355416a0; CHARLES CD, 1990, NATO ADV SCI I C-MAT, V308, P519; Curry WB, 1987, PALEOCEANOGRAPHY, V2, P489, DOI 10.1029/PA002i005p00489; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Gildor H, 2000, PALEOCEANOGRAPHY, V15, P605, DOI 10.1029/1999PA000461; Hanawa K., 2001, INT GEOPHYS, Vpp, P373, DOI [DOI 10.1016/S0074-6142(01)80129-7, 10.1016/S0074-6142(01)80129-7]; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LUKAS R, 1986, PROG OCEANOGR, V16, P63, DOI 10.1016/0079-6611(86)90007-8; LYNCHSTIEGLITZ J, 1994, PALEOCEANOGRAPHY, V9, P7, DOI 10.1029/93PA02446; Mackensen A, 2001, GLOBAL PLANET CHANGE, V30, P197, DOI 10.1016/S0921-8181(01)00102-3; MAQUEDA MAM, 2002, GEOPHYS RES LETT, V29, DOI DOI 10.1029/2001G6013240; MARINO BD, 1992, NATURE, V357, P461, DOI 10.1038/357461a0; Millero FJ, 1998, DEEP-SEA RES PT II, V45, P1115, DOI 10.1016/S0967-0645(98)00016-2; Mix AC, 1991, PALEOCEANOGRAPHY, V6, P205, DOI 10.1029/90PA02303; Ninnemann US, 1997, PALEOCEANOGRAPHY, V12, P560, DOI 10.1029/97PA01032; Oppo DW, 1989, PALEOCEANOGRAPHY, V4, P333, DOI 10.1029/PA004i004p00333; OPPO DW, 1987, EARTH PLANET SC LETT, V86, P1, DOI 10.1016/0012-821X(87)90183-X; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SCHNEIDER RR, 1992, UPWELLING SYSTEMS EV, P285; SHACKLETON NJ, 1983, NATURE, V306, P319, DOI 10.1038/306319a0; SHACKLETON NJ, 1977, FATE FOSSIL FUEL OCE; SHACKLETON NJ, 1988, NATURE, V335, P708, DOI 10.1038/335708a0; SHACKLETON NJ, TR16331B; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; SOWERS T, 1993, PALEOCEANOGRAPHY, V8, P737, DOI 10.1029/93PA02328; SPERO HJ, UNPUB; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; TAYLOR KC, 1993, NATURE, V366, P549, DOI 10.1038/366549a0; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; TSUCHIYA M, 1991, DEEP-SEA RES, V38, pS273, DOI 10.1016/S0198-0149(12)80013-6; TSUCHIYA M, 1989, PROG OCEANOGR, V23, P101, DOI 10.1016/0079-6611(89)90012-8	36	183	198	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					522	525		10.1126/science.1069401	http://dx.doi.org/10.1126/science.1069401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964477				2022-12-24	WOS:000175179400044
J	Tajkhorshid, E; Nollert, P; Jensen, MO; Miercke, LJW; O'Connell, J; Stroud, RM; Schulten, K				Tajkhorshid, E; Nollert, P; Jensen, MO; Miercke, LJW; O'Connell, J; Stroud, RM; Schulten, K			Control of the selectivity of the aquaporin water channel family by global orientational tuning	SCIENCE			English	Article							MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; PROTEIN; TRANSPORT	Aquaporins are transmembrane channels found in cell membranes of all life forms. We examine their apparently paradoxical property, facilitation of efficient permeation of water while excluding protons, which is of critical importance to preserving the electrochemical potential across the cell membrane. We have determined the structure of the Escherichia coli aquaglyceroporin GlpF with bound water, in native (2.7 angstroms) and in W48F/F200T mutant (2.1 angstroms) forms, and carried out 12-nanosecond molecular dynamics simulations that define the spatial and temporal probability distribution and orientation of a single file of seven to nine water molecules inside the channel. Two conserved asparagines force a central water molecule to serve strictly as a hydrogen bond donor to its neighboring water molecules. Assisted by the electrostatic potential generated by two half-membrane spanning loops, this dictates opposite orientations of water molecules in the two halves of the channel, and thus prevents the formation of a "proton wire," while permitting rapid water diffusion. Both simulations and observations revealed a more regular distribution of channel water and an increased water permeability for the W48F/F200T mutant.	Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Illinois, Beckman Inst, Theoret Biophys Grp, Urbana, IL 61801 USA	University of California System; University of California San Francisco; University of Illinois System; University of Illinois Urbana-Champaign	Stroud, RM (corresponding author), Univ Calif San Francisco, Sch Med, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu; schulte@ks.uiuc.edu	Stroud, Rhonda/GQZ-0151-2022; Tajkhorshid, Emad/A-1249-2010; Tajkhorshid, Emad/AAN-8323-2021; Schulten, Klaus/D-5561-2009	Stroud, Rhonda/0000-0001-5242-8015; Tajkhorshid, Emad/0000-0001-8434-1010				Agre P, 1998, J BIOL CHEM, V273, P14659, DOI 10.1074/jbc.273.24.14659; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Borgnia MJ, 2001, P NATL ACAD SCI USA, V98, P2888, DOI 10.1073/pnas.051628098; BRUNGER A, 1996, CNS PROGRAM; Cowin JP, 1999, NATURE, V398, P405, DOI 10.1038/18848; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; de Grotthuss C, 1806, ANN CHIM, V58, P54; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2001, STRUCTURE, V9, P1083, DOI 10.1016/S0969-2126(01)00668-2; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; KURINOV IV, 1995, ACTA CRYSTALLOGR D, V51, P98, DOI 10.1107/S0907444994009261; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nollert P, 2001, FEBS LETT, V504, P112, DOI 10.1016/S0014-5793(01)02710-7; Pomes R, 1996, BIOPHYS J, V71, P19, DOI 10.1016/S0006-3495(96)79211-1; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; SCHULTEN Z, 1986, METHOD ENZYMOL, V127, P419; SMART O, HOLE2 PROGRAM; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Vitkup D, 2000, NAT STRUCT BIOL, V7, P34; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042	27	711	750	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					525	530		10.1126/science.1067778	http://dx.doi.org/10.1126/science.1067778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964478				2022-12-24	WOS:000175179400045
J	Childers, SE; Ciufo, S; Lovley, DR				Childers, SE; Ciufo, S; Lovley, DR			Geobacter metallireducens accesses insoluble Fe(III) oxide by chemotaxis	NATURE			English	Article							IRON REDUCTION; IV PILI; OXIDATION; MICROORGANISM; BIOGENESIS; MANGANESE; SEDIMENTS; MOTILITY; BENZENE; AQUIFER	Microorganisms that use insoluble Fe(III) oxide as an electron acceptor can have an important function in the carbon and nutrient cycles of aquatic sediments and in the bioremediation of organic and metal contaminants in groundwater(1,2). Although Fe(III) oxides are often abundant, Fe(III)-reducing microbes are faced with the problem of how to access effectively an electron acceptor that can not diffuse to the cell. Fe(III)-reducing microorganisms in the genus Shewanella have resolved this problem by releasing soluble quinones that can carry electrons from the cell surface to Fe(III) oxide that is at a distance from the cell(3,4). Here we report that another Fe(III)-reducer, Geobacter metallireducens, has an alternative strategy for accessing Fe( III) oxides. Geobacter metallireducens specifically expresses flagella and pili only when grown on insoluble Fe(III) or Mn(IV) oxide, and is chemotactic towards Fe(II) and Mn( II) under these conditions. These results suggest that G. metallireducens senses when soluble electron acceptors are depleted and then synthesizes the appropriate appendages to permit it to search for, and establish contact with, insoluble Fe( III) or Mn( IV) oxide. This approach to the use of an insoluble electron acceptor may explain why Geobacter species predominate over other Fe( III) oxide-reducing microorganisms in a wide variety of sedimentary environments(5-8).	Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Lovley, DR (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.							Alm RA, 1997, GENE, V192, P89, DOI 10.1016/S0378-1119(96)00805-0; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Lovley D. R., 2000, FE 3 MN4 REDUCTION E, P3; LOVLEY DR, 1987, NATURE, V330, P252, DOI 10.1038/330252a0; LOVLEY DR, 1989, NATURE, V339, P297, DOI 10.1038/339297a0; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Macnab RM, 1996, ESCHERICHIA COLI SAL, V1, P123; NEALSON KH, 1995, APPL ENVIRON MICROB, V61, P1551, DOI 10.1128/AEM.61.4.1551-1554.1995; NEVIN KP, 2000, ASM 100 GEN M ASM WA, P598; NEVIN KP, 2001, ASM 101 GEN M ASM WA, P588; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Parales RE, 2000, APPL ENVIRON MICROB, V66, P4098, DOI 10.1128/AEM.66.9.4098-4104.2000; PHILLIPS EJP, 1987, SOIL SCI SOC AM J, V51, P938, DOI 10.2136/sssaj1987.03615995005100040021x; Roling WFM, 2001, APPL ENVIRON MICROB, V67, P4619, DOI 10.1128/AEM.67.10.4619-4629.2001; Rooney-Varga JN, 1999, APPL ENVIRON MICROB, V65, P3056; Snoeyenbos-West OL, 2000, MICROBIAL ECOL, V39, P153, DOI 10.1007/s002480000018; Stein LY, 2001, ENVIRON MICROBIOL, V3, P10, DOI 10.1046/j.1462-2920.2001.00154.x; STROM MS, 1993, ANNU REV MICROBIOL, V47, P565, DOI 10.1146/annurev.micro.47.1.565; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997	22	306	331	20	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					767	769		10.1038/416767a	http://dx.doi.org/10.1038/416767a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961561				2022-12-24	WOS:000175033500049
J	Drenkard, E; Ausubel, FM				Drenkard, E; Ausubel, FM			Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation	NATURE			English	Article							SMALL-COLONY VARIANTS; BROWN BLOTCH DISEASE; CYSTIC-FIBROSIS; ESCHERICHIA-COLI; SURFACE HYDROPHOBICITY; PERSISTENT INFECTIONS; BACTERIAL BIOFILMS; AERUGINOSA; STRAINS; MULTIPLE	Colonization of the lungs of cystic fibrosis (CF) patients by the opportunistic bacterial pathogen Pseudomonas aeruginosa is the principal cause of mortality in CF populations(1,2). Pseudomonas aeruginosa infections generally persist despite the use of long-term antibiotic therapy(1,3). This has been explained by postulating that P. aeruginosa forms an antibiotic-resistant biofilm(4,5) consisting of bacterial communities embedded in an exopolysaccharide matrix. Alternatively, it has been proposed that resistant P. aeruginosa variants may be selected in the CF respiratory tract by antimicrobial therapy itself(1,6). Here we report that both explanations are correct, and are interrelated. We found that antibiotic-resistant phenotypic variants of P. aeruginosa with enhanced ability to form biofilms arise at high frequency both in vitro and in the lungs of CF patients. We also identified a regulatory protein (PvrR) that controls the conversion between antibiotic-resistant and antibiotic-susceptible forms. Compounds that affect PvrR function could have an important role in the treatment of CF infections.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ausubel, FM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.							Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Ausubel F.M., 1992, SHORT PROTOCOLS MOL; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DRUMM B, 1989, J CLIN INVEST, V84, P1588, DOI 10.1172/JCI114336; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GREWAL SIS, 1995, J BACTERIOL, V177, P4658, DOI 10.1128/jb.177.16.4658-4668.1995; Han B, 1997, MOL MICROBIOL, V25, P211, DOI 10.1046/j.1365-2958.1997.4411811.x; Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McNamara PJ, 2000, INT J ANTIMICROB AG, V14, P117, DOI 10.1016/S0924-8579(99)00170-3; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SAMADPOUR M, 1988, J CLIN MICROBIOL, V26, P2319, DOI 10.1128/JCM.26.11.2319-2323.1988; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SHERMAN PM, 1985, INFECT IMMUN, V49, P797, DOI 10.1128/IAI.49.3.797-804.1985; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; SPEERT DP, 1990, J CLIN MICROBIOL, V28, P188, DOI 10.1128/JCM.28.2.188-194.1990	28	715	756	6	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					740	743		10.1038/416740a	http://dx.doi.org/10.1038/416740a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961556				2022-12-24	WOS:000175033500043
J	Suzuki, N; Suzuki, S; Duncan, GS; Millar, DG; Wada, T; Mirtsos, C; Takada, H; Wakeham, A; Itie, A; Li, SY; Penninger, JM; Wesche, H; Ohashi, PS; Mak, TW; Yeh, WC				Suzuki, N; Suzuki, S; Duncan, GS; Millar, DG; Wada, T; Mirtsos, C; Takada, H; Wakeham, A; Itie, A; Li, SY; Penninger, JM; Wesche, H; Ohashi, PS; Mak, TW; Yeh, WC			Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4	NATURE			English	Article							SIGNALING PATHWAYS; KINASE; MYD88; DEFICIENCY; PROTEIN; FAMILY; GENE; RESPONSES; ADAPTER; MEMBER	Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns, and members of the pro-inflammatory interleukin-1 receptor (IL-1R) family, share homologies in their cytoplasmic domains called Toll/IL-1R/plant R gene homology (TIR) domains(1-3). Intracellular signalling mechanisms mediated by TIRs are similar(4), with MyD88 (refs 5-8) and TRAF6 (refs 9, 10) having critical roles. Signal transduction between MyD88 and TRAF6 is known to involve the serine-threonine kinase IL-1 receptor-associated kinase 1 (IRAK-1)(11) and two homologous proteins, IRAK-2 (ref. 12) and IRAK-M-13. However, the physiological functions of the IRAK molecules remain unclear, and gene-targeting studies have shown that IRAK-1 is only partially required for IL-1R and TLR signalling(14,15). Here we show by gene-targeting that IRAK-4, an IRAK molecule closely related to the Drosophila Pelle protein 16, is indispensable for the responses of animals and cultured cells to IL-1 and ligands that stimulate various TLRs. IRAK-4-deficient animals are completely resistant to a lethal dose of lipopolysaccharide (LPS). In addition, animals lacking IRAK-4 are severely impaired in their responses to viral and bacterial challenges. Our results indicate that IRAK-4 has an essential role in innate immunity.	Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Tularik Inc, San Francisco, CA 94080 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Yeh, WC (corresponding author), Univ Toronto, Ontario Canc Inst, Amgen Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.		Duncan, Gordon/AIE-7011-2022; Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Ohashi, Pamela S./0000-0003-2915-9317; Millar, Douglas/0000-0002-8640-7148				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; LI S, IN PRESS P NATL ACAD; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; ONEILL HJ, 1963, J GAS CHROMATOGR, V1, P28, DOI 10.1093/chromsci/1.2.28; Orange JS, 1996, J IMMUNOL, V156, P4746; Parnet P, 1996, J BIOL CHEM, V271, P3967; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thomas JA, 1999, J IMMUNOL, V163, P978; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wasserman SA, 2000, CURR OPIN GENET DEV, V10, P497, DOI 10.1016/S0959-437X(00)00118-0; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403	30	613	707	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					750	754		10.1038/nature736	http://dx.doi.org/10.1038/nature736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11923871				2022-12-24	WOS:000175033500045
J	Stern, MP; Williams, K; Haffner, SA				Stern, MP; Williams, K; Haffner, SA			Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test?	ANNALS OF INTERNAL MEDICINE			English	Article							OPERATING CHARACTERISTIC CURVES; AREAS	Background: The standard method of identifying persons at high risk for type 2 diabetes mellitus involves detection of impaired glucose tolerance, which requires a costly and inconvenient 2-hour oral glucose tolerance test. Because clinical trials have indicated that diabetes is preventable by using behavioral or pharmacologic interventions, less expensive methods of identifying high-risk persons are needed. Objective: To determine whether multivariable models are superior to glucose tolerance tests for identifying persons at high risk for diabetes mellitus. Design: Prospective cohort study. Setting: San Antonio, Texas. Participants: 1791 Mexican Americans and 1112 non-Hispanic whites without diabetes at baseline who were randomly selected from census tracts. Measurements: Medical history; body mass index; blood pressure; fasting and 2-hour plasma glucose levels; fasting serum total, low-density lipoprotein, and high-density lipoprotein cholesterol levels; and triglyceride level. Results: For prediction of 7.5-year incidence of type 2 diabetes, the area under the receiver-operating characteristic (ROC) curve for a multivariable model involving readily available clinical variables was significantly (P < 0.001) greater than the area under the ROC curve for the 2-hour glucose value alone (84.3% vs. 77.5%). Impaired glucose tolerance represents a single point on the latter curve. Adding the 2-hour glucose measurement to the multivariable model increased the area under its ROC curve, but only from 84.3% to 85.7%. Conclusion: Persons at high risk for diabetes mellitus are better identified by using a simple prediction model than by relying exclusively on the results of a 2-hour oral glucose tolerance test. Although adding the 2-hour glucose variable to the model enhanced prediction, the resulting slight improvement entails greater cost and inconvenience.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Stern, MP (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	stern@uthscsa.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036820, R01HL024799] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL24799, R01 HL36820] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Burke JP, 1998, DIABETES CARE, V21, P1266, DOI 10.2337/diacare.21.8.1266; CHIASSON JL, IN PRESS LANCET; CLEVES M, 1999, STATA TECHNICAL B, V52, P19; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gavin JR, 1997, DIABETES CARE, V20, P1183; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harrell FE, 2001, REGRESSION MODELING, P87, DOI 10.1007/978-1-4757-3462-1; HARRIS M, 1979, DIABETES, V28, P1039; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LITTLE RR, 1988, DIABETES, V37, P60, DOI 10.2337/diabetes.37.1.60; REAVEN GM, 1972, LANCET, V1, P1247; *SAS I, 2001, SAS VERS 8 0; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; STERN MP, 1989, JAMA-J AM MED ASSOC, V262, P360, DOI 10.1001/jama.262.3.360; STOLK RP, 1995, DIABETES CARE, V18, P1045, DOI 10.2337/diacare.18.7.1045; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; *WHO DEP NONC DIS, 1999, DEF DIAGN CLASS DIAB; *WHO EXP COMM DIAB, 1980, WHO TECH REP SER, V646, P9	19	396	411	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2002	136	8					575	581		10.7326/0003-4819-136-8-200204160-00006	http://dx.doi.org/10.7326/0003-4819-136-8-200204160-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543WY	11955025				2022-12-24	WOS:000175125800002
J	Clark, TG; Altman, DG; De Stavola, BL				Clark, TG; Altman, DG; De Stavola, BL			Quantification of the completeness of follow-up	LANCET			English	Article								Completeness of follow-up is important, especially In clinical trials, since unequal follow-up In the treatment groups can bias the analysis of results. In survival studies, information on participants who do not complete the study is often omitted because their data can be Included up to the time at which they were lost to follow-up. We propose a simple measure of completeness that Is the ratio of the total observed person-time and the potential person-time of follow-up in a study. Our measure is easy to calculate, can be Illustrated pictorially, and can be used to Identify subgroups with especially poor follow-up.	Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Med Stat Unit, London W1CE 7HT, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Clark, TG (corresponding author), Inst Hlth Sci, Ctr Stat Med, Oxford OX3 7LF, England.	taane.clark@cancer.org.uk	Clark, Taane G./AAM-2570-2020	Clark, Taane G./0000-0001-8985-9265; De Stavola, Bianca Lucia/0000-0001-7853-0528				CHRISTENSEN E, 1985, GASTROENTEROLOGY, V89, P1084, DOI 10.1016/0016-5085(85)90213-6; Clark TG, 2001, BRIT J CANCER, V85, P944, DOI 10.1054/bjoc.2001.2030; CUZICK J, 1990, BRIT J HAEMATOL, V75, P506, DOI 10.1111/j.1365-2141.1990.tb07790.x; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X	5	307	308	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2002	359	9314					1309	1310		10.1016/S0140-6736(02)08272-7	http://dx.doi.org/10.1016/S0140-6736(02)08272-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965278				2022-12-24	WOS:000174989700015
J	Matzinger, P				Matzinger, P			The danger model: A renewed sense of self	SCIENCE			English	Article							VERSUS-HOST-DISEASE; TOLL-LIKE RECEPTORS; T-CELLS; NETWORK THEORY; INNATE; RECOGNITION; INDUCTION; TOLERANCE; EVOLUTION; REJECTION		NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Matzinger, P (corresponding author), NIAID, Cellular & Mol Immunol Lab, NIH, Bethesda, MD 20892 USA.	pcm@helix.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000581, Z01AI000581] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Benlagha K, 2000, SEMIN IMMUNOL, V12, P537, DOI 10.1006/smim.2000.0276; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Boismenu R, 1997, CURR OPIN IMMUNOL, V9, P57, DOI 10.1016/S0952-7915(97)80159-8; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Coley W.B., 1898, J AM MED ASS, VXXXI, P389; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; COUTINHO A, 1995, SCAND J IMMUNOL, V42, P3, DOI 10.1111/j.1365-3083.1995.tb03619.x; D'Alessandro AM, 1998, SURGERY, V124, P604, DOI 10.1067/msy.1998.91482; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; HALL SS, 1998, COMMOTION BLOOD, P198; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; HEIDT PJ, 1992, J MED, V23, P161; Hill GR, 1997, BLOOD, V90, P3204, DOI 10.1182/blood.V90.8.3204; Iciek LA, 1997, J IMMUNOL, V158, P4769; Inohara N, 2001, ONCOGENE, V20, P6473, DOI 10.1038/sj.onc.1204787; Ishii KJ, 2001, J IMMUNOL, V167, P2602, DOI 10.4049/jimmunol.167.5.2602; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; JANEWAY CA, 1989, COLD SH Q B, V54, P1; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KIMATA H, 1994, EUR J IMMUNOL, V24, P2262, DOI 10.1002/eji.1830240950; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Kirk AD, 1997, P NATL ACAD SCI USA, V94, P8789, DOI 10.1073/pnas.94.16.8789; KOSHLAND DE, 1990, SCIENCE, V248, P1273, DOI 10.1126/science.2356462; LAFFERTY KJ, 1975, AUST J EXP BIOL MED, V53, P27, DOI 10.1038/icb.1975.3; Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LENSCHOW DJ, 1995, TRANSPLANTATION, V60, P1171, DOI 10.1097/00007890-199511270-00019; LINDENMANN J, 1967, J EXP MED, V126, P93, DOI 10.1084/jem.126.1.93; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2001, SCAND J IMMUNOL, V54, P4, DOI 10.1046/j.1365-3083.2001.00974.x; MATZINGER P, 1996, J NIH RES, V8, P35; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morita CT, 1996, RES IMMUNOL, V147, P347, DOI 10.1016/0923-2494(96)89649-0; OWEN RD, 1945, SCIENCE, V102, P400, DOI 10.1126/science.102.2651.400; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Schwartz M, 2001, J MOL MED-JMM, V78, P594, DOI 10.1007/s001090000172; SEONG SY, COMMUNICATION; Thomas JM, 1999, TRANSPLANTATION, V68, P1660, DOI 10.1097/00007890-199912150-00009	51	2966	3169	4	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					301	305		10.1126/science.1071059	http://dx.doi.org/10.1126/science.1071059			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951032	Green Submitted			2022-12-24	WOS:000175000300043
J	Albert, CM; Campos, H; Stampfer, MJ; Ridker, PM; Manson, JE; Willett, WC; Ma, J				Albert, CM; Campos, H; Stampfer, MJ; Ridker, PM; Manson, JE; Willett, WC; Ma, J			Blood levels of long-chain n-3 fatty acids and the risk of sudden death.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-RATE-VARIABILITY; VENTRICULAR-FIBRILLATION; MYOCARDIAL-INFARCTION; FISH CONSUMPTION; DIETARY-INTAKE; PREVENTION; CURRENTS	Background: Experimental data suggest that long-chain n-3 polyunsaturated fatty acids found in fish have antiarrhythmic properties, and a randomized trial suggested that dietary supplements of n-3 fatty acids may reduce the risk of sudden death among survivors of myocardial infarction. Whether long-chain n-3 fatty acids are also associated with the risk of sudden death in those without a history of cardiovascular disease is unknown. Methods: We conducted a prospective, nested case-control analysis among apparently healthy men who were followed for up to 17 years in the Physicians' Health Study. The fatty-acid composition of previously collected blood was analyzed by gas-liquid chromatography for 94 men in whom sudden death occurred as the first manifestation of cardiovascular disease and for 184 controls matched with them for age and smoking status. Results: Base-line blood levels of long-chain n-3 fatty acids were inversely related to the risk of sudden death both before adjustment for potential confounders (P for trend = 0.004) and after such adjustment (P for trend = 0.007). As compared with men whose blood levels of long-chain n-3 fatty acids were in the lowest quartile, the relative risk of sudden death was significantly lower among men with levels in the third quartile (adjusted relative risk, 0.28; 95 percent confidence interval, 0.09 to 0.87) and the fourth quartile (adjusted relative risk, 0.19; 95 percent confidence interval, 0.05 to 0.71). Conclusions: The n-3 fatty acids found in fish are strongly associated with a reduced risk of sudden death among men without evidence of prior cardiovascular disease.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02215 USA; Massachusetts Gen Hosp, Dept Med, Div Cardiovasc, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Albert, CM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	calbert@partners.org		Albert, Christine/0000-0002-2081-1121	NCI NIH HHS [CA-34944, CA-40360] Funding Source: Medline; NHLBI NIH HHS [HL-34595, 1-K08-HL-03783, HL-26490] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595, K08HL003783] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; [Anonymous], 1988, NEW ENGL J MED, V318, P262; BILLMAN GE, 1994, P NATL ACAD SCI USA, V91, P4427, DOI 10.1073/pnas.91.10.4427; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Christensen JH, 1997, AM J CARDIOL, V79, P1670, DOI 10.1016/S0002-9149(97)00220-8; Christensen JH, 2001, CIRCULATION, V103, P651, DOI 10.1161/01.CIR.103.5.651; Cunnane SC, 1997, J NUTR, V127, P146, DOI 10.1093/jn/127.1.146; *GISSI PREV INV, 2000, LANCET, V357, P642; GUALLAR E, 1995, J AM COLL CARDIOL, V25, P387, DOI 10.1016/0735-1097(94)00370-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Jouven X, 2001, CIRCULATION, V104, P756, DOI 10.1161/hc3201.094151; Kang JX, 1996, CIRCULATION, V94, P1774, DOI 10.1161/01.CIR.94.7.1774; KANNEL WB, 1985, J AM COLL CARDIOL, V5, pB141, DOI 10.1016/S0735-1097(85)80545-3; Li YY, 1997, PROSTAGLANDINS, V54, P511, DOI 10.1016/S0090-6980(97)00122-6; MCLENNAN PL, 1992, AM HEART J, V123, P1555, DOI 10.1016/0002-8703(92)90809-A; Nair SSD, 1997, J NUTR, V127, P383, DOI 10.1093/jn/127.3.383; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Zeleniuch-Jacquotte A, 2000, EUR J CLIN NUTR, V54, P367, DOI 10.1038/sj.ejcn.1600964; Zock PL, 1997, AM J EPIDEMIOL, V145, P1114, DOI 10.1093/oxfordjournals.aje.a009074; Zock PL, 1996, EUR J CLIN INVEST, V26, P141, DOI 10.1046/j.1365-2362.1996.t01-1-105263.x	25	870	936	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2002	346	15					1113	1118		10.1056/NEJMoa012918	http://dx.doi.org/10.1056/NEJMoa012918			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539PX	11948270				2022-12-24	WOS:000174880600003
J	Musser, RO; Hum-Musser, SM; Eichenseer, H; Peiffer, M; Ervin, G; Murphy, JB; Felton, GW				Musser, RO; Hum-Musser, SM; Eichenseer, H; Peiffer, M; Ervin, G; Murphy, JB; Felton, GW			Herbivory: Caterpillar saliva beats plant defences - A new weapon emerges in the evolutionary arms race between plants and herbivores.	NATURE			English	Article									Univ Arkansas, Dept Entomol, Fayetteville, AR 72701 USA; Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Musser, RO (corresponding author), Univ Arkansas, Dept Entomol, Fayetteville, AR 72701 USA.		Felton, Gary W./E-8575-2013	Musser, Richard/0000-0002-9331-4249				Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; FELTON GW, 1999, INDUCED PLANT DEFENC; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; MATTIACCI L, 1995, P NATL ACAD SCI USA, V92, P2036, DOI 10.1073/pnas.92.6.2036; Ribeiro J.M., 1995, REGULATORY MECH INSE; SAUNDERS JA, 1981, J CHROMATOGR, V205, P147, DOI 10.1016/S0021-9673(00)81822-1	7	367	412	3	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					599	600		10.1038/416599a	http://dx.doi.org/10.1038/416599a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948341				2022-12-24	WOS:000174901900029
J	Verstreken, P; Kjaerulff, O; Lloyd, TE; Atkinson, R; Zhou, Y; Meinertzhagen, IA; Bellen, HJ				Verstreken, P; Kjaerulff, O; Lloyd, TE; Atkinson, R; Zhou, Y; Meinertzhagen, IA; Bellen, HJ			Endophilin mutations block clathrin-mediated endocytosis but not neurotransmitter release	CELL			English	Article							TUMOR-SUPPRESSOR GENE; SYNAPTIC VESICLES; TRANSMITTER RELEASE; DROSOPHILA MUTANT; RAPID ENDOCYTOSIS; BINDING PARTNERS; ACTIVE ZONE; DYNAMIN; EXOCYTOSIS; PROTEINS	We have identified mutations in Drosophila endophilin to study its function in vivo. Endophilin is required presynaptically at the neuromuscular junction, and absence of Endophilin dramatically impairs endocytosis in vivo. Mutant larvae that lack Endophilin fail to take up FM1-43 dye in synaptic boutons, indicating an inability to retrieve synaptic membrane. This defect is accompanied by an expansion of the presynaptic membrane, and a depletion of vesicles from the bouton lumen. Interestingly, mutant larvae are still able to sustain release at 15%-20% of the normal rate during high-frequency stimulation. We propose that kiss-and-run maintains neurotransmission at active zones of the larval NMJ in endophilin animals.	Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Dalhousie Univ, Ctr Life Sci, Inst Neurosci, Halifax, NS, Canada	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Dalhousie University	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Verstreken, Patrik/AAC-7591-2022; Kjaerulff, Ole/Q-6996-2018	Verstreken, Patrik/0000-0002-5073-5393; Kjaerulff, Ole/0000-0002-8654-1435; Lloyd, Thomas/0000-0003-4756-3700; Bellen, Hugo/0000-0001-5992-5989				AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALMERS W, 1990, NEURON, V4, P813, DOI 10.1016/0896-6273(90)90134-2; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; BETZ WJ, 1995, CURR BIOL, V5, P1098, DOI 10.1016/S0960-9822(95)00220-X; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dornan S, 1997, MOL BIOL CELL, V8, P1391, DOI 10.1091/mbc.8.8.1391; Estes PS, 1996, J NEUROSCI, V16, P5443; Fergestad T, 2001, J NEUROSCI, V21, P1218; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GUICHET, IN PRESS EMBO J; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Henkel AW, 1995, J NEUROSCI, V15, P8246; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; IKEDA K, 1988, J PHYSIOL-LONDON, V406, P215, DOI 10.1113/jphysiol.1988.sp017377; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Jarousse N, 2001, CURR OPIN CELL BIOL, V13, P461, DOI 10.1016/S0955-0674(00)00237-4; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; Koenig JH, 1998, P NATL ACAD SCI USA, V95, P12677, DOI 10.1073/pnas.95.21.12677; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; Loewen CA, 2001, GENESIS, V31, P30, DOI 10.1002/gene.10002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; ROBINSON MS, 1994, CURR OPIN CELL BIOL, V6, P538, DOI 10.1016/0955-0674(94)90074-4; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	59	251	256	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2002	109	1					101	112		10.1016/S0092-8674(02)00688-8	http://dx.doi.org/10.1016/S0092-8674(02)00688-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955450	Bronze			2022-12-24	WOS:000174888300012
J	Coopersmith, CM; Stromberg, PE; Dunne, WM; Davis, CG; Amiot, DM; Buchman, TG; Karl, IE; Hotchkiss, RS				Coopersmith, CM; Stromberg, PE; Dunne, WM; Davis, CG; Amiot, DM; Buchman, TG; Karl, IE; Hotchkiss, RS			Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCREASED GUT PERMEABILITY; MULTIPLE-ORGAN-FAILURE; BACTERIAL TRANSLOCATION; CELL-DEATH; HEMORRHAGIC-SHOCK; IMPROVES SURVIVAL; MESENTERIC LYMPH; BCL-2; ISCHEMIA; LUNG	Context Increased intestinal epithelial apoptosis is present in both human autopsy studies and animal models of sepsis. Whether altering gut apoptosis decreases mortality in sepsis induced by pathogenic bacteria outside the gut is unknown. Objective To determine if decreasing levels of intestinal cell death improves survival in a murine model of Pseudomonas aeruginosa pneumonia-induced sepsis. Design and Materials Prospective study in which transgenic mice that overexpress the antiapoptotic protein Bcl-2 in their intestinal epithelium (n=25) and control littermates (n=26) were subjected to intratracheal injection of P aeruginosa. Main Outcome Measures Survival at:7 postoperative days, compared between the 2 groups. Secondary outcomes included quantification of gut epithelial apoptosis. Results Survival in transgenic mice that overexpress Bcl-2 in the intestinal epithelium was 40% (10/25) compared with 4% (1/26) in control littermates 7 days after intratracheal injection of P aeruginosa (P=.001), with differences in survival noted within 24 hours of surgery. Overexpression of Bcl-2 was associated with a decrease in gut epithelial apoptosis demonstrated by active caspase 3 staining, the terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling assay, and hematoxylin-eosin staining. Conclusions In this murine model, inhibiting gut epithelial apoptosis by overexpression of Bcl-2 was associated with a survival advantage in P aeruginosa pneumonia-induced sepsis. These results suggest that intestinal epithelial apoptosis may play a role in sepsis-related mortality.	Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Coopersmith, CM (corresponding author), Washington Univ, Sch Med, Dept Surg, 660 S Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA.	coopersmithc@msnotes.wustl.edu		Buchman, Timothy/0000-0001-7350-5921	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055194, R01GM048095, R37GM044118, R01GM044118, R55GM048095] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK52574] Funding Source: Medline; NIGMS NIH HHS [GM48095, GM55194, GM44118] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu MT, 2000, GASTROENTEROLOGY, V119, P1524, DOI 10.1053/gast.2000.20232; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; Baue AE, 1996, SHOCK, V6, pS1, DOI 10.1097/00024382-199610001-00002; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Coopersmith CM, 1999, AM J PHYSIOL-GASTR L, V276, pG677, DOI 10.1152/ajpgi.1999.276.3.G677; Doig CJ, 1998, AM J RESP CRIT CARE, V158, P444, DOI 10.1164/ajrccm.158.2.9710092; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hiramatsu M, 1997, SHOCK, V7, P247, DOI 10.1097/00024382-199704000-00002; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; HOTCHKISS RS, 2002, SCIENCE, V294, P1783; JIANG JX, 1995, ANN SURG, V221, P100, DOI 10.1097/00000658-199501000-00012; Koo DJ, 1999, BBA-MOL BASIS DIS, V1454, P289, DOI 10.1016/S0925-4439(99)00045-9; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; MAINOUS MR, 1995, SHOCK, V4, P193, DOI 10.1097/00024382-199509000-00007; Maloney JP, 2000, NEW ENGL J MED, V343, P1047, DOI 10.1056/NEJM200010053431416; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; Murphy S L, 2000, Natl Vital Stat Rep, V48, P1; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017; Sun Z, 1998, SCAND J GASTROENTERO, V33, P415; Sun ZW, 1998, SHOCK, V10, P203, DOI 10.1097/00024382-199809000-00009; Unno N, 1998, GASTROENTEROL CLIN N, V27, P289, DOI 10.1016/S0889-8553(05)70004-2; Wang WY, 1998, J SURG RES, V79, P39, DOI 10.1006/jsre.1998.5385; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; WILMORE DW, 1988, SURGERY, V104, P917; Yu P, 2000, CRIT CARE MED, V28, P2573, DOI 10.1097/00003246-200007000-00065	38	212	232	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1716	1721		10.1001/jama.287.13.1716	http://dx.doi.org/10.1001/jama.287.13.1716			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926897	Bronze			2022-12-24	WOS:000174730300027
J	Manfredini, R; Gallerani, M; la Cecilia, O; Boari, B; Fersini, C; Portaluppi, F				Manfredini, R; Gallerani, M; la Cecilia, O; Boari, B; Fersini, C; Portaluppi, F			Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes	BRITISH MEDICAL JOURNAL			English	Article							RHYTHM; RISK		Univ Ferrara, Sch Med, Dept Clin & Expt Med, I-44100 Ferrara, Italy; Univ Ferrara, Sch Specialisat Nephrol, I-44100 Ferrara, Italy; Univ Ferrara, Sch Specialisat Internal Med, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara	Manfredini, R (corresponding author), Univ Ferrara, Sch Med, Dept Clin & Expt Med, Via Savonarola 9, I-44100 Ferrara, Italy.		Manfredini, Roberto/N-3859-2019; Portaluppi, Francesco/H-2206-2012; Manfredini, Roberto/AAJ-5442-2020; Boari, Benedetta/AAB-4792-2022; Manfredini, Roberto/A-3471-2008	Manfredini, Roberto/0000-0002-8364-2601; Portaluppi, Francesco/0000-0002-2948-1579; Boari, Benedetta/0000-0002-9015-7858; Manfredini, Roberto/0000-0002-8364-2601				KOOPMAN MG, 1989, CLIN SCI, V77, P105, DOI 10.1042/cs0770105; Portaluppi F, 1999, CHRONOBIOL INT, V16, P33, DOI 10.3109/07420529908998710; RIGAS B, 1990, J CLIN GASTROENTEROL, V12, P409, DOI 10.1097/00004836-199008000-00011; ROBERT M, 1994, BRIT J UROL, V74, P294, DOI 10.1111/j.1464-410X.1994.tb16613.x; SINGH RK, 1993, EUR UROL, V24, P387	5	13	13	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2002	324	7340					767	767		10.1136/bmj.324.7340.767	http://dx.doi.org/10.1136/bmj.324.7340.767			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538KY	11923160	Green Published, Bronze			2022-12-24	WOS:000174816200017
J	Whitesides, GM; Grzybowski, B				Whitesides, GM; Grzybowski, B			Self-assembly at all scales	SCIENCE			English	Article							CAPILLARY FORCES; PATTERNS; MILLIMETER; OBJECTS	Self-assembty is the autonomous organization of components into patterns or structures without human intervention. Self-assembling processes are common throughout nature and technology. They involve components from the molecular (crystals) to the planetary (weather systems) scale and many different kinds of interactions. The concept of self-assembly is used increasingly in many disciplines, with a different flavor and emphasis in each.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Grzybowski, Bartosz/B-7644-2009; Grzybowski, Bartosz A/H-5741-2017	Grzybowski, Bartosz/0000-0001-6613-4261				Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Ball P., 1999, SELF MADE TAPESTRY P; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; Bowden N, 1999, J AM CHEM SOC, V121, P5373, DOI 10.1021/ja983882z; BURNS MM, 1991, SCIENCE, V252, P1049, DOI 10.1126/science.252.5009.1049-a; Clark TD, 2001, J AM CHEM SOC, V123, P7677, DOI 10.1021/ja010634l; De Rosa C, 2000, NATURE, V405, P433, DOI 10.1038/35013018; Desiraju G. R., 1989, CRYSTAL ENG DESIGN O; Gates B, 2001, ADV MATER, V13, P1605, DOI 10.1002/1521-4095(200111)13:21<1605::AID-ADMA1605>3.0.CO;2-9; Gracias DH, 2000, SCIENCE, V289, P1170, DOI 10.1126/science.289.5482.1170; Gracias DH, 2002, ADV MATER, V14, P235, DOI 10.1002/1521-4095(20020205)14:3<235::AID-ADMA235>3.0.CO;2-B; GRZYBOWSKI B, UNPUB; Grzybowski BA, 2000, NATURE, V405, P1033, DOI 10.1038/35016528; Grzybowski BA, 2001, J PHYS CHEM B, V105, P404, DOI 10.1021/jp0026383; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Isaacs L, 1999, PER SUPRAMOL CHEM, V4, P1, DOI 10.1002/9780470511497.ch1; Ismagilov RF, 2001, APPL PHYS LETT, V79, P439, DOI 10.1063/1.1384473; JAKUBITH S, 1990, PHYS REV LETT, V65, P3013, DOI 10.1103/PhysRevLett.65.3013; Jones M. N., 1995, MICELLES MONOLAYERS; Loudet JC, 2000, NATURE, V407, P611, DOI 10.1038/35036539; Philp D, 1996, ANGEW CHEM INT EDIT, V35, P1154, DOI 10.1002/anie.199611541; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Shimoyama N, 1996, PHYS REV LETT, V76, P3870, DOI 10.1103/PhysRevLett.76.3870; SIMPSON AW, 1972, NATURE, V237, P320, DOI 10.1038/237320a0; Singh R, 1998, J NONLINEAR SCI, V8, P235, DOI 10.1007/s003329900051; Srinivasan U, 2001, J MICROELECTROMECH S, V10, P17, DOI 10.1109/84.911087; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Whitesides GM, 1999, SCIENCE, V284, P89, DOI 10.1126/science.284.5411.89; Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J	32	5544	5696	72	3250	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2002	295	5564					2418	2421		10.1126/science.1070821	http://dx.doi.org/10.1126/science.1070821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923529				2022-12-24	WOS:000174712600045
J	Chase, JM; Leibold, MA				Chase, JM; Leibold, MA			Spatial scale dictates the productivity-biodiversity relationship	NATURE			English	Article							SPECIES RICHNESS; PATTERNS; COMMUNITIES	The diversity of life is heterogeneously distributed across the Earth. A primary cause for this pattern is the heterogeneity in the amount of energy, or primary productivity (the rate of carbon fixed through photosynthesis), available to the biota in a given location(1-12). But the shape of the relationship between productivity and species diversity is highly variable(10-14). In many cases, the relationship is 'hump-shaped', where diversity peaks at intermediate productivity(7,9,10,12,10,15-18). In other cases, diversity increases linearly with productivity(4-6,10-12). A possible reason for this discrepancy is that data are often collected at different spatial scales(10,12,14). If the mechanisms that determine species diversity vary with spatial scale, then so would the shape of the productivity-diversity relationship. Here, we present evidence for scale-dependent productivity-diversity patterns in ponds. When the data were viewed at a local scale (among ponds), the relationship was hump-shaped, whereas when the same data were viewed at a regional scale (among watersheds), the relationship was positively linear. This dependence on scale results because dissimilarity in local species composition within regions increased with productivity.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago	Chase, JM (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jchase@pitt.edu	Bond, Alexander L/A-3786-2010; B, A/AHB-5155-2022	Chase, Jonathan/0000-0001-5580-4303				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; ABRAMSKY Z, 1984, NATURE, V309, P150, DOI 10.1038/309150a0; BROWN JH, 1981, AM ZOOL, V21, P877; CARPENTER S, 1998, ECOLOGY, V3; CONNELL JH, 1964, AM NAT, V98, P399, DOI 10.1086/282335; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Dodson SI, 2000, ECOLOGY, V81, P2662, DOI 10.1890/0012-9658(2000)081[2662:TRILCB]2.0.CO;2; Eaton A.D., 1998, STANDARD METHODS EXA, V20th; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; LANDE R, 1996, OIKOS, V76, P393; Law R., 1999, ADV ECOLOGICAL THEOR, P141; Leibold MA, 1999, EVOL ECOL RES, V1, P73; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; Lotka A. J., 1956, ELEMENTS MATH BIOL, DOI DOI 10.2307/1909476; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Tilman D., 1993, SPECIES DIVERSITY EC, P12; VITOUSEK PM, 1997, ECOLOGY, V1; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wright David H., 1993, P66	26	582	623	15	353	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					427	430		10.1038/416427a	http://dx.doi.org/10.1038/416427a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919631				2022-12-24	WOS:000174607800046
J	Beattie, EC; Stellwagen, D; Morishita, W; Bresnahan, JC; Ha, BK; Von Zastrow, M; Beattie, MS; Malenka, RC				Beattie, EC; Stellwagen, D; Morishita, W; Bresnahan, JC; Ha, BK; Von Zastrow, M; Beattie, MS; Malenka, RC			Control of synaptic strength by glial TNF alpha	SCIENCE			English	Article							AMPA RECEPTOR ENDOCYTOSIS; NEURONS; TRANSMISSION	Activity-dependent modulation of synaptic efficacy in the brain contributes to neural circuit development and experience-dependent plasticity. Although glia are affected by activity and ensheathe synapses, their influence on synaptic strength has largely been ignored. Here, we show that a protein produced by glia, tumor necrosis factor alpha (TNFalpha), enhances synaptic efficacy by increasing surface expression of AMPA receptors. Preventing the actions of endogenous TNFalpha has the opposite effects. Thus, the continual presence of TNFalpha is required for preservation of synaptic strength at excitatory synapses. Through its effects on AMPA receptor trafficking, TNFalpha may play roles in synaptic plasticity and modulating responses to neural injury.	Ohio State Univ, Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Beattie, MS (corresponding author), Ohio State Univ, Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.	beattie.2@osu.edu; malenka@stanford.edu	Beattie, Michael S/A-8953-2009		NIDA NIH HHS [DA00439] Funding Source: Medline; NIMH NIH HHS [MH063394] Funding Source: Medline; NINDS NIH HHS [NS 31193, NS38079] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031193] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albensi BC, 2000, SYNAPSE, V35, P151; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Allison DW, 1998, J NEUROSCI, V18, P2423; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Cunningham AJ, 1996, NEUROSCI LETT, V203, P17, DOI 10.1016/0304-3940(95)12252-4; Emch GS, 2000, AM J PHYSIOL-GASTR L, V279, pG582, DOI 10.1152/ajpgi.2000.279.3.G582; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; NOBLE M, 1998, CULTURING NERVE CELL, P526; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Solorzano CC, 1997, SHOCK, V7, P427, DOI 10.1097/00024382-199706000-00007; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	23	995	1032	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2282	2285		10.1126/science.1067859	http://dx.doi.org/10.1126/science.1067859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910117				2022-12-24	WOS:000174561700051
J	DeMattos, RB; Bales, KR; Cummins, DJ; Paul, SM; Holtzman, DM				DeMattos, RB; Bales, KR; Cummins, DJ; Paul, SM; Holtzman, DM			Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease	SCIENCE			English	Article							DEPOSITION; PEPTIDE; PLAQUES	The deposition of amyloid-beta (Abeta) peptides into amyloid plaques precedes the cognitive dysfunction of Alzheimer's disease (AD) by years. Biomarkers indicative of brain amyloid burden could be useful for identifying individuals at high risk for developing AD. As in AD in humans, baseline plasma Abeta levels in a transgenic mouse model of AD did not correlate with brain amyloid burden. However, after peripheral administration of a monoclonal antibody to Abeta (m266), we observed a rapid increase in plasma Abeta and the magnitude of this increase was highly correlated with amyloid burden in the hippocampus and cortex. This method may be useful for quantifying brain amyloid burden in patients at risk for or those who have been diagnosed with AD.	Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Indiana Univ, Sch Med, Dept Pharmacol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Toxicol, Indianapolis, IN 46285 USA; Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46285 USA	Eli Lilly; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Paul, SM (corresponding author), Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA.		Paul, Steve/ABE-5400-2020		NATIONAL INSTITUTE ON AGING [R01AG020222] Funding Source: NIH RePORTER; NIA NIH HHS [AG20222] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Breiman L, 1983, CLASSIFICATION REGRE; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Fishman CE, 2001, J NEUROSCI METH, V108, P145, DOI 10.1016/S0165-0270(01)00381-8; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Ji Y, 2001, J ALZHEIMERS DIS, V3, P23, DOI 10.3233/JAD-2001-3105; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Yamaguchi H, 2001, J NEUROPATH EXP NEUR, V60, P731, DOI 10.1093/jnen/60.7.731	17	477	532	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2264	2267		10.1126/science.1067568	http://dx.doi.org/10.1126/science.1067568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910111				2022-12-24	WOS:000174561700045
J	Esper, J; Cook, ER; Schweingruber, FH				Esper, J; Cook, ER; Schweingruber, FH			Low-frequency signals in long tree-ring chronologies for reconstructing past temperature variability	SCIENCE			English	Article							MEDIEVAL WARM PERIOD; SUMMER TEMPERATURES; CLIMATE; HOLOCENE; INFERENCES; CANADA	Preserving multicentennial climate variability in long tree-ring records is critically important for reconstructing the full range of temperature variability over the past 1000 years. This allows the putative "Medieval Warm Period" (MWP) to be described and to be compared with 20th-century warming in modeling and attribution studies. We demonstrate that carefully selected tree-ring chronologies from 14 sites in the Northern Hemisphere (NH) extratropics can preserve such coherent large-scale, multicentennial temperature trends if proper methods of analysis are used. In addition, we show that the average of these chronologies supports the large-scale occurrence of the MWP over the NH extratropics.	Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland	Columbia University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Cook, ER (corresponding author), Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	drdendro@ldeo.columbia.edu	Esper, Jan/O-3127-2018	Esper, Jan/0000-0003-3919-014X				Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bond G, 1997, SCIENCE, V278, P1257, DOI 10.1126/science.278.5341.1257; BRIFFA KR, 1992, CLIM DYNAM, V7, P111, DOI 10.1007/BF00211153; Briffa KR, 2001, J GEOPHYS RES-ATMOS, V106, P2929, DOI 10.1029/2000JD900617; Briffa KR, 2000, QUATERNARY SCI REV, V19, P87, DOI 10.1016/S0277-3791(99)00056-6; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; BRIFFA KR, 1995, NATURE, V376, P156, DOI 10.1038/376156a0; Broecker WS, 2001, SCIENCE, V291, P1497, DOI 10.1126/science.291.5508.1497; Cook E.R., 2013, METHODS DENDROCHRONO; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; Crowley TJ, 2000, AMBIO, V29, P51, DOI 10.1579/0044-7447-29.1.51; D'Arrigo R, 2001, GEOPHYS RES LETT, V28, P543, DOI 10.1029/2000GL011845; Esper J, 2002, HOLOCENE, V12, P267, DOI 10.1191/0959683602hl543rp; ESPER J, IN PRESS TREE RING R; HUGHES MK, 1994, CLIMATIC CHANGE, V26, P109, DOI 10.1007/BF01092410; Jacoby GC, 1996, SCIENCE, V273, P771, DOI 10.1126/science.273.5276.771; Jones PD, 2001, SCIENCE, V292, P662, DOI 10.1126/science.1059126; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Jones PD, 1999, REV GEOPHYS, V37, P173, DOI 10.1029/1999RG900002; LAMARCHE VC, 1974, SCIENCE, V183, P1043, DOI 10.1126/science.183.4129.1043; Lamb H. H., 1965, PALAEOGEOGR PALAEOCL, V1, P13, DOI [DOI 10.1016/0031-0182(65)90004-0, 10.1016/0031-0182(65)90004-0]; Lloyd AH, 1997, ECOLOGY, V78, P1199, DOI 10.1890/0012-9658(1997)078[1199:HDOTFI]2.0.CO;2; Luckman BH, 1997, HOLOCENE, V7, P375, DOI 10.1177/095968369700700401; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; SZEICZ JM, 1995, QUATERNARY RES, V44, P257, DOI 10.1006/qres.1995.1070; [No title captured]	27	1024	1161	8	295	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2250	2253		10.1126/science.1066208	http://dx.doi.org/10.1126/science.1066208			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910106				2022-12-24	WOS:000174561700040
J	Lambert, DM; Ritchie, PA; Millar, CD; Holland, B; Drummond, AJ; Baroni, C				Lambert, DM; Ritchie, PA; Millar, CD; Holland, B; Drummond, AJ; Baroni, C			Rates of evolution in ancient DNA from Adelie penguins	SCIENCE			English	Article							MITOCHONDRIAL-DNA; ANTARCTICA	Well-preserved subfossil bones of Adelie penguins, Pygoscelis adeliae, underlie existing and abandoned nesting colonies in Antarctica. These bones, dating back to more than 7000 years before the present, harbor some of the best-preserved ancient DNA yet discovered. From 96 radiocarbon-aged bones, we report large numbers of mitochondrial haplotypes, some of which appear to be extinct, given the 380 living birds sampled. We demonstrate DNA sequence evolution through time and estimate the rate of evolution of the hypervariable region I using a Markov chain Monte Carlo integration and a least-squares regression analysis. our calculated rates of evolution are approximately two to seven times higher than previous indirect phylogenetic estimates.	Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Pisa, Dipartimento Sci Terra, I-56126 Pisa, Italy; CNR, Ctr Studio Geol Strutturale, I-56126 Pisa, Italy	Massey University; Massey University; University of Auckland; University of Pisa; Consiglio Nazionale delle Ricerche (CNR)			Drummond, Alexei J/A-3209-2010; Holland, Barbara/G-1646-2013; Baroni, Carlo/D-8184-2012; Millar, Craig/B-5168-2009	Drummond, Alexei J/0000-0003-4454-2576; Holland, Barbara/0000-0002-4628-7938; Baroni, Carlo/0000-0001-5905-4650; Ritchie, Peter/0000-0002-8351-7931; Lambert, David/0000-0002-5821-3637				Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BARONI C, 1991, QUATERNARY RES, V36, P157, DOI 10.1016/0033-5894(91)90023-X; BARONI C, 1994, GEOLOGY, V22, P23, DOI 10.1130/0091-7613(1994)022<0023:APRAHP>2.3.CO;2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; SHIELDS GF, 1987, J MOL EVOL, V24, P212, DOI 10.1007/BF02111234	12	232	239	0	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2270	2273		10.1126/science.1068105	http://dx.doi.org/10.1126/science.1068105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910113				2022-12-24	WOS:000174561700047
J	Mackey, D; Holt, BF; Wiig, A; Dangl, JL				Mackey, D; Holt, BF; Wiig, A; Dangl, JL			RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1-mediated resistance in Arabidopsis	CELL			English	Article							PLANT-DISEASE-RESISTANCE; HYPERSENSITIVE CELL-DEATH; LEUCINE-RICH REPEATS; FOR-GENE CONCEPT; SIGNAL-TRANSDUCTION; AVIRULENCE GENES; PROTEINS; RPM1; SPECIFICITY; VIRULENCE	In Arabidopsis, RPM1 confers resistance against Pseudomonas syringae expressing either of two sequence unrelated type III effectors, AvrRpm1 or AvrB. An RPM1-interacting protein (RIN4) coimmunoprecipitates from plant cell extracts with AvrB, AvrRpm1, or RPM1. Reduction of RIN4 protein levels inhibits both the hypersensitive response and the restriction of pathogen growth controlled by RPM1. RIN4 reduction causes diminution of RPM1. RIN4 reduction results in heightened resistance to virulent Peronospora parasitica and P. syringae, and ectopic defense gene expression. Thus, RIN4 positively regulates RPM1-mediated resistance yet is, formally, a negative regulator of basal defense responses. AvrRpm1 and AvrB induce RIN4 phosphorylation. This may enhance RIN4 activity as a negative regulator of plant defense, facilitating pathogen growth. RPM1 may "guard" against pathogens that use AvrRpm1 and AvrB to manipulate RIN4 activity.	Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Cooker Hall CB 3280, Chapel Hill, NC 27599 USA.		Holt, Ben F/D-1513-2011					Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; ASHFIELD T, 1995, GENETICS, V141, P1597; BAKER CJ, 1991, PHYTOPATHOLOGY, V81, P1504, DOI 10.1094/Phyto-81-1504; Banerjee D, 2001, GENETICS, V158, P439; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chen ZY, 2000, MOL PLANT MICROBE IN, V13, P1312, DOI 10.1094/MPMI.2000.13.12.1312; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dangl J. L., 1992, Methods in Arabidopsis research., P393; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dangl JL, 1996, PLANT CELL, V8, P1793, DOI 10.1105/tpc.8.10.1793; DIETRICH A, 1990, J BIOL CHEM, V265, P6360; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Ellis J, 2000, TRENDS PLANT SCI, V5, P373, DOI 10.1016/S1360-1385(00)01694-0; Feys BJ, 2000, TRENDS GENET, V16, P449, DOI 10.1016/S0168-9525(00)02107-7; FINLEY RL, 1996, GENE PROBES PRACTICA; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; GYURIUS J, 1996, CELL, V75, P791; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones DA, 1996, ADV BOT RES ADV PLAN, V24, P90; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Leister RT, 2000, PLANT J, V22, P345, DOI 10.1046/j.1365-313x.2000.00744.x; Leister RT, 1996, P NATL ACAD SCI USA, V93, P15497, DOI 10.1073/pnas.93.26.15497; Luck JE, 2000, PLANT CELL, V12, P1367, DOI 10.1105/tpc.12.8.1367; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; McDowell JM, 1998, PLANT CELL, V10, P1861, DOI 10.1105/tpc.10.11.1861; MOREL JB, 1997, CELL DEATH DIFFER, V19, P17; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2001, CURR OPIN PLANT BIOL, V4, P288, DOI 10.1016/S1369-5266(00)00175-8; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; TOMERO P, 2001, PLANT J, V28, P475; TOMERO P, 2002, IN PRESS PLANT CELL; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; van der Biezen EA, 2000, P NATL ACAD SCI USA, V97, P3747, DOI 10.1073/pnas.060392397; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997	50	835	876	8	169	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					743	754		10.1016/S0092-8674(02)00661-X	http://dx.doi.org/10.1016/S0092-8674(02)00661-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955429	Green Published, Bronze			2022-12-24	WOS:000174563000005
J	van Hoof, A; Frischmeyer, PA; Dietz, HC; Parker, R				van Hoof, A; Frischmeyer, PA; Dietz, HC; Parker, R			Exosome-mediated recognition and degradation of mRNAs lacking a termination codon	SCIENCE			English	Article							3 END; PROTEIN; SURVEILLANCE; MECHANISM; INTERACTS; TURNOVER; COMPLEX; SYSTEM	One role of messenger RNA (mRNA) degradation is to maintain the fidelity of gene expression by degrading aberrant transcripts. Recent results show that mRNAs without translation termination codons are unstable in eukaryotic cells. We used yeast mutants to demonstrate that these "nonstop" mRNAs; are degraded by the exosome in a 3'-to-5' direction. The degradation of nonstop transcripts requires the exosome-associated protein Ski7p. Ski7p is closely related to the translation elongation factor EF1A and the translation termination factor eRF3. This suggests that the recognition of nonstop mRNAs involves the binding of Ski7p to an empty aminoacyl-(RNA-binding) site (A site) on the ribosome, thereby bringing the exosome to a mRNA with a ribosome stalled near the 3' end. This system efficiently degrades mRNAs that are prematurely polyadenylated within the coding region and prevents their expression.	Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; University of Arizona; Johns Hopkins University	van Hoof, A (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	ambro@u.arizona.edu; rrparker@u.arizona.edu	Guerrerio, Pamela/S-9360-2019	van Hoof, Ambro/0000-0002-7800-9764				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; BEELMAN C, 1996, NATURE, V382, P577; Benard L, 1999, J VIROL, V73, P2893, DOI 10.1128/JVI.73.4.2893-2900.1999; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Mahadevan S, 1997, GENE, V190, P69, DOI 10.1016/S0378-1119(96)00708-1; Mitchell P, 2000, NAT STRUCT BIOL, V7, P843, DOI 10.1038/82817; Mitchell P, 1996, GENE DEV, V10, P502, DOI 10.1101/gad.10.4.502; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; SIKORSKI RS, 1989, GENETICS, V122, P19; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2	23	402	413	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2262	2264		10.1126/science.1067272	http://dx.doi.org/10.1126/science.1067272			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910110				2022-12-24	WOS:000174561700044
J	Saether, BE; Engen, S; Matthysen, E				Saether, BE; Engen, S; Matthysen, E			Demographic characteristics and population dynamical patterns of solitary birds	SCIENCE			English	Article							LIFE-HISTORY VARIATION; ENVIRONMENTAL STOCHASTICITY; STRATEGIES; EXTINCTION; ABUNDANCE; DENSITY; GROWTH; TIME	In birds and many other animals, there are large interspecific differences in the magnitude of annual variation in population size, Using time-series data on populations of solitary bird species, we found that fluctuations in population size of solitary birds were affected by the deterministic characteristics of the population dynamics as well as the stochastic factors. In species with highly variable populations, annual variation in recruitment was positively related to the return rate of adults between successive breeding seasons. In stable populations, more recruits were found in years with low return rates of breeding adults. This identifies a gradient, associated with the position of the species along a "slow-fast" continuum of life history variation, from highly variable populations with a recruitment-driven demography to stable, strongly density-regulated populations with a survival-restricted demography. These results suggest that patterns in avian population fluctuations can be predicted from a knowledge of life-history characteristics and/or temporal variation in certain demographic traits.	Norwegian Univ Sci & Technol, Dept Zool, N-7491 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Math Sci, N-7491 Trondheim, Norway; Univ Instelling Antwerp, Dept Biol, Lab Anim Ecol, B-2610 Antwerp, Belgium	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Antwerp	Saether, BE (corresponding author), Norwegian Univ Sci & Technol, Dept Zool, N-7491 Trondheim, Norway.	bernt-erik.sather@chembio.ntnu.no						Aanes S, 2002, ECOL APPL, V12, P281, DOI 10.1890/1051-0761(2002)012[0281:SHSOWP]2.0.CO;2; ARCESE P, 1992, ECOLOGY, V73, P805, DOI 10.2307/1940159; ARINO A, 1995, EVOL ECOL, V9, P429, DOI 10.1007/BF01237765; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Charnov Eric L., 1993, P1; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Diserud OH, 2000, AM NAT, V155, P497, DOI 10.1086/303339; Engen S, 1998, BIOMETRICS, V54, P840, DOI 10.2307/2533838; ENGEN S, UNPUB; Fowler C.W., 1987, Current Mammalogy, V1, P401; FOWLER CW, 1988, EVOL ECOL, V2, P197, DOI 10.1007/BF02214283; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; GILPIN ME, 1973, P NATL ACAD SCI USA, V70, P3590, DOI 10.1073/pnas.70.12.3590; LANDE R, IN PRESS AM NAT; Lewontin R. C., 1965, P77; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; Newton I., 1998, POPULATION LIMITATIO; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pimm S.L., 1991, BALANCE NATURE; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; Royama T., 1992, Analytical population dynamics.; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saether BE, 2000, P ROY SOC B-BIOL SCI, V267, P621, DOI 10.1098/rspb.2000.1047; Saether BE, 1998, AM NAT, V151, P441, DOI 10.1086/286131; SOUTHWOOD TRE, 1977, J ANIM ECOL, V46, P337	25	128	129	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2070	2073						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896278				2022-12-24	WOS:000174450500048
J	Rauhut, OWM; Martin, T; Ortiz-Jaureguizar, E; Puerta, P				Rauhut, OWM; Martin, T; Ortiz-Jaureguizar, E; Puerta, P			A jurassic mammal from South America	NATURE			English	Article							AUSTRALIA	The Jurassic period is an important stage in early mammalian evolution, as it saw the first diversification of this group, leading to the stem lineages of monotremes and modern therian mammals(1). However, the fossil record of Jurassic mammals is extremely poor, particularly in the southern continents. Jurassic mammals from Gondwanaland are so far only known from Tanzania(2,3) and Madagascar(4), and from trackway evidence from Argentina(5). Here we report a Jurassic mammal represented by a dentary, which is the first, to our knowledge, from South America. The tiny fossil from the Middle to Late Jurassic of Patagonia is a representative of the recently termed Australosphenida, a group of mammals from Gondwanaland that evolved tribosphenic molars convergently to the Northern Hemisphere Tribosphenida, and probably gave rise to the monotremes(1). Together with other mammalian evidence from the Southern Hemisphere(2-4,6-8), the discovery of this new mammal indicates that the Australosphenida had diversified and were widespread in Gondwanaland well before the end of the Jurassic, and that mammalian faunas from the Southern Hemisphere already showed a marked distinction from their northern counterparts by the Middle to Late Jurassic.	Free Univ Berlin, Inst Geol Wissensch, Fachrichtung Palaontol, D-12249 Berlin, Germany; Museo Paleontol Egidio Feruglio, RA-9100 Trelew, Argentina	Free University of Berlin	Martin, T (corresponding author), Free Univ Berlin, Inst Geol Wissensch, Fachrichtung Palaontol, Malteserstr 74-100, D-12249 Berlin, Germany.	tmartin@zedat.fu-berlin.de	Rauhut, Oliver/AAG-1029-2020; Ortiz-Jaureguizar, Edgardo/F-8193-2010	Ortiz-Jaureguizar, Edgardo/0000-0002-4333-1606; Rauhut, Oliver/0000-0003-3958-603X				ARCHER M, 1985, NATURE, V318, P363, DOI 10.1038/318363a0; Bonaparte J.F., 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P31; Bonaparte Jose F., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P73; Casamicjuela R. M., 1961, Physis, V22, P225; CLEMENS W A, 1971, Bulletin of the British Museum (Natural History) Geology, V20, P89; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Hahn G, 1969, PALAEONTOGRAPHICA A, V133, P1; Heinrich Wolf-Dieter, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P159; Heinrich Wolf-Dieter, 1998, Journal of Mammalian Evolution, V5, P269, DOI 10.1023/A:1020548010203; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, LETHAIA, V31, P267; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; Martin T, 2000, GUIMAROTA JURASSIC E; MARTIN T, ABH SENCKENBERG NATU, V550, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; MUSACCHIO EA, 1986, BIOESTRATIGRAFIA SIS, V1, P355; Pascual R., 1992, P1; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual R, 1999, J VERTEBR PALEONTOL, V19, P373, DOI 10.1080/02724634.1999.10011148; Pascual Rosendo, 2000, Geodiversitas, V22, P395; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; RICH TH, 2001, REC QUEEN VICT MUS, V101, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Tasch P., 1970, 50 U KANS PAL CONTR, V50, P1; Wible John R., 1995, American Museum Novitates, V3149, P1	30	96	110	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					165	168		10.1038/416165a	http://dx.doi.org/10.1038/416165a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894091				2022-12-24	WOS:000174348100034
J	Richardson, D; Sawers, G				Richardson, D; Sawers, G			PMF through the redox loop	SCIENCE			English	Editorial Material							CYTOCHROME-C-OXIDASE; FORMATE DEHYDROGENASE; CRYSTAL-STRUCTURE; PROTEIN; NITRATE; SITES		Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Richardson, D (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	d.richardson@uea.ac.uk; gary.sawers@bbsrc.ac.uk	Richardson, David J/E-2275-2011					BERKS BC, 1995, MOL MICROBIOL, V15, P319, DOI 10.1111/j.1365-2958.1995.tb02246.x; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Fisher N, 2000, J MOL BIOL, V296, P1153, DOI 10.1006/jmbi.2000.3509; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; JONES RW, 1980, FEMS MICROBIOL LETT, V8, P167, DOI 10.1111/j.1574-6968.1980.tb05072.x; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Ordal EJ, 1939, J BACTERIOL, V38, P199, DOI 10.1128/JB.38.2.199-220.1939; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; SAWERS G, 1994, ANTON LEEUW INT J G, V66, P57, DOI 10.1007/BF00871633; SUPPMANN B, 1994, MOL MICROBIOL, V11, P965, DOI 10.1111/j.1365-2958.1994.tb00375.x; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60	19	55	56	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1842	1843		10.1126/science.1070366	http://dx.doi.org/10.1126/science.1070366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884738				2022-12-24	WOS:000174299500021
J	Le Maho, Y				Le Maho, Y			Ecophysiology: Nature and function	NATURE			English	Editorial Material									CNRS, Ctr Ecol & Physiol Energet, F-67087 Strasbourg 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Le Maho, Y (corresponding author), CNRS, Ctr Ecol & Physiol Energet, 23 Rue Becquerel, F-67087 Strasbourg 2, France.							Feder ME, 2000, ANNU REV ECOL SYST, V31, P315, DOI 10.1146/annurev.ecolsys.31.1.315; Harvey J, 2001, NATURE, V413, P463, DOI 10.1038/35097209; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Schmidt-Nielsen K., 1972, ANIMALS WORK; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0	5	15	15	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					21	21		10.1038/416021a	http://dx.doi.org/10.1038/416021a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882871	Bronze			2022-12-24	WOS:000174211600019
J	Norell, M; Ji, Q; Gao, KQ; Yuan, CX; Zhao, YB; Wang, LX				Norell, M; Ji, Q; Gao, KQ; Yuan, CX; Zhao, YB; Wang, LX			Palaeontology - 'Modern' feathers on a non-avian dinosaur	NATURE			English	Article							THEROPOD DINOSAUR; ORIGIN; CHINA		Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; Liaoning Prov Bur Land & Resources, Shenyang 110032, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Geological Sciences	Norell, M (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org						Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Jin F, 1996, VERTEBRATA PALASIATI, V34, P102; Jones TD, 2000, NATURE, V406, P716, DOI 10.1038/35021041; Norell MA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P49; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Ostrom J.H., 1990, P269; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589	13	78	90	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					36	37		10.1038/416036a	http://dx.doi.org/10.1038/416036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882883				2022-12-24	WOS:000174211600029
J	Schwetz, BA				Schwetz, BA			Treatment for psoriatic arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-24	WOS:000174186000007
J	Gillet, Y; Issartel, B; Vanhems, P; Fournet, JC; Lina, G; Bes, M; Vandenesch, F; Piemont, Y; Brousse, N; Floret, D; Etienne, J				Gillet, Y; Issartel, B; Vanhems, P; Fournet, JC; Lina, G; Bes, M; Vandenesch, F; Piemont, Y; Brousse, N; Floret, D; Etienne, J			Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients	LANCET			English	Article							GAMMA-HEMOLYSIN; IDENTIFICATION; LEUCOCIDINS; INVOLVEMENT; INFECTIONS; MEMBRANE; SPECTRUM	Background Between 1986 and 1998, eight cases of community-acquired pneumonia due to Staphylococcus aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. We aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains. Methods We compared eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia with 36 cases of PVL-negative S aureus pneumonia. For all patients, we recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings. Findings Median age was 14.8 years (IQR 5.4-24.0) for the PVL-positive patients and 70.1 years (59.2-81.4) for the others (p=0.001). Influenza-like illness had occurred during the 2 days before admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients (p<0.0001). PVL-positive infections were more often marked by: temperature greater than 39 degrees C (p=0.01), heart rate above 140 beats per min (p=0.02), haemoptysis (p=0.005), onset of pleural effusion during hospital stay (p=0.004), and leucopenia (p=0.001). The survival rate 48 h after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals (p=0.007). Histopathological examination of lungs at necropsy from three cases of necrotising pneumonia associated with PVL-positive S aureus showed extensive necrotic ulcerations of the tracheal and bronchial mucosa and massive haemorrhagic necrosis of interalveolar septa. Interpretation PVL-producing S aureus strains cause rapidly progressive, haemorrhagic, necrotising pneumonia, mainly in otherwise healthy children and young adults. The pneumonia is often preceded by influenza-like symptoms and has a high lethality rate.	Fac Med Laennec, Natl Reference Ctr Staphylococcal Toxaemia, EA 1655, F-69372 Lyon 08, France; Hop Edouard Herriot, INSERM, U271, Hyg & Epidemiol Unit, Lyon, France; Hop Edouard Herriot, Div Paediat Intens Care, Lyon, France; Univ Paris 05, Hop Necker Enfants Malad, Dept Pathol, EA 219, Paris, France; Univ Strasbourg, Inst Bacteriol, Strasbourg, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Etienne, J (corresponding author), Fac Med Laennec, Natl Reference Ctr Staphylococcal Toxaemia, EA 1655, Rue Guillaume Paradin, F-69372 Lyon 08, France.	jetienne@univ-lyon1.fr	Vandenesch, Francois/C-7209-2014; Lina, Gerard J/L-9352-2014; gillet, yves/C-6307-2012; ETIENNE, Jerome/C-5471-2014	Vandenesch, Francois/0000-0001-9412-7106; gillet, yves/0000-0003-1791-1639; ETIENNE, Jerome/0000-0002-3348-3315; ISSARTEL, Bertrand/0000-0002-2559-8534; Lina, Gerard/0000-0002-9236-7998				Buwalda M, 1995, NETH J MED, V47, P291, DOI 10.1016/0300-2977(95)00042-9; Chandler FW, 1994, PULMONARY PATHOLOGY, P255; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FINE MJ, 1993, AM J MED, V94, P153, DOI 10.1016/0002-9343(93)90177-Q; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; GOERING RV, 1992, J CLIN MICROBIOL, V30, P577, DOI 10.1128/JCM.30.3.577-580.1992; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Jarraud S, 1999, J CLIN MICROBIOL, V37, P2446, DOI 10.1128/JCM.37.8.2446-2449.1999; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KAYE MG, 1990, CHEST, V97, P788, DOI 10.1378/chest.97.4.788; KONIG B, 1995, J INFECT DIS, V171, P607, DOI 10.1093/infdis/171.3.607; Le Thomas I, 2001, J CLIN MICROBIOL, V39, P728, DOI 10.1128/JCM.39.2.728-729.2001; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Melish ME, 1998, TXB PEDIAT INFECT DI, P1039; Mongodin E, 2000, J HISTOCHEM CYTOCHEM, V48, P523, DOI 10.1177/002215540004800410; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; MUSHER DM, 1994, MEDICINE, V73, P186, DOI 10.1097/00005792-199407000-00002; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; OLCAY L, 1995, ARCH PEDIAT ADOL MED, V149, P925, DOI 10.1001/archpedi.1995.02170210099019; Pedelacq JD, 2000, INT J MED MICROBIOL, V290, P395; Petros S, 1998, INTENS CARE MED, V24, P189, DOI 10.1007/s001340050544; PLOTKOWSKI MC, 1986, AM REV RESPIR DIS, V134, P1040, DOI 10.1164/arrd.1986.134.5.1040; PREVOST G, 1995, J MED MICROBIOL, V42, P237, DOI 10.1099/00222615-42-4-237; PREVOST G, 1995, INFECT IMMUN, V63, P4121; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; Staali L, 1998, J MEMBRANE BIOL, V162, P209, DOI 10.1007/s002329900358; SUPERSAC G, 1993, INFECT IMMUN, V61, P580, DOI 10.1128/IAI.61.2.580-587.1993; Touchie C, 1997, STAPHYLOCOCCI HUMAN, P475; WARD PD, 1980, INFECT IMMUN, V28, P393; WATANAKUNAKORN C, 1987, SCAND J INFECT DIS, V19, P623, DOI 10.3109/00365548709117196; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	35	1116	1182	0	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					753	759		10.1016/S0140-6736(02)07877-7	http://dx.doi.org/10.1016/S0140-6736(02)07877-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888586				2022-12-24	WOS:000174115200010
J	Kovalchuk, Y; Hanse, E; Kafitz, KW; Konnerth, A				Kovalchuk, Y; Hanse, E; Kafitz, KW; Konnerth, A			Postsynaptic induction of BDNF-mediated long-term potentiation	SCIENCE			English	Article							NEUROTROPHIC FACTOR BDNF; SYNAPTIC TRANSMISSION; RAT HIPPOCAMPUS; LASTING POTENTIATION; TRKB RECEPTORS; DENTATE GYRUS; KNOCKOUT MICE; CA1 REGION; ADULT-RAT; PLASTICITY	Brain-derived neurotrophic factor (BDNF) and other neurotrophins are critically involved in long-term potentiation (LTP). Previous reports point to a presynaptic site of neurotrophin action. By imaging dentate granule cells in mouse hippocampal slices, we identified BDNF-evoked Ca2+ transients in dendrites and spines, but not at presynaptic sites. Pairing a weak burst of synaptic stimulation with a brief dendritic BDNF application caused an immediate and robust induction of LTP. LTP induction required activation of postsynaptic Ca2+ channels and N-methyl-D-aspartate receptors and was prevented by the blockage of postsynaptic Call transients. Thus, our results suggest that BDNF-mediated LTP is induced postsynaptically. Our finding that dendritic spines are the exclusive synaptic sites for rapid BDNF-evoked Ca2+ signaling supports this conclusion.	Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Munich	Konnerth, A (corresponding author), Univ Munich, Inst Physiol, D-80336 Munich, Germany.		Hanse, Eric/B-4935-2009					ANDERSEN P, 1966, ACTA PHYSIOL SCAND, V66, P448, DOI 10.1111/j.1748-1716.1966.tb03223.x; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Chen GQ, 1999, J NEUROSCI, V19, P7983; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frerking M, 1998, J NEUROPHYSIOL, V80, P3383, DOI 10.1152/jn.1998.80.6.3383; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GUSTAFSSON B, 1988, TRENDS NEUROSCI, V11, P156, DOI 10.1016/0166-2236(88)90142-7; HANSE E, 1992, J NEUROSCI, V12, P3226, DOI 10.1523/JNEUROSCI.12-08-03226.1992; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 2000, NEUROSCI LETT, V282, P141, DOI 10.1016/S0304-3940(00)00893-4; KELLER BU, 1991, J PHYSIOL-LONDON, V435, P275, DOI 10.1113/jphysiol.1991.sp018510; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1996, P NATL ACAD SCI USA, V93, P12547, DOI 10.1073/pnas.93.22.12547; Kossel AH, 2001, P NATL ACAD SCI USA, V98, P14702, DOI 10.1073/pnas.251326998; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; REGEHR WG, 1991, J NEUROSCI METH, V37, P111, DOI 10.1016/0165-0270(91)90121-F; Scharfman HE, 1997, J NEUROPHYSIOL, V78, P1082, DOI 10.1152/jn.1997.78.2.1082; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schinder AF, 2000, NEURON, V25, P151, DOI 10.1016/S0896-6273(00)80879-X; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Sherwood NT, 1999, J NEUROSCI, V19, P7025, DOI 10.1523/JNEUROSCI.19-16-07025.1999; Tanaka T, 1997, J NEUROSCI, V17, P2959; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; WU LG, 1994, J NEUROSCI, V14, P645; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000	37	360	378	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1729	1734		10.1126/science.1067766	http://dx.doi.org/10.1126/science.1067766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872844				2022-12-24	WOS:000174212900051
J	Grant, PR; Grant, BR				Grant, PR; Grant, BR			Unpredictable evolution in a 30-year study of Darwin's finches	SCIENCE			English	Article							NATURAL-SELECTION; 2 POPULATIONS; BODY-SIZE; EL-NINO; HYBRIDIZATION; GALAPAGOS; BIRD	Evolution can be predicted in the short term from a knowledge of selection and inheritance. However, in the long term evolution is unpredictable because environments, which determine the directions and magnitudes of selection coefficients, fluctuate unpredictably. These two features of evolution, the predictable and unpredictable, are demonstrated in a study of two populations of Darwin's finches on the Galapagos island of Daphne Major. From 1972 to 2001, Geospiza fortis (medium ground finch) and Geospiza scandens (cactus finch) changed several times in body size and two beak traits. Natural selection occurred frequently in both species and varied from unidirectional to oscillating, episodic to gradual. Hybridization occurred repeatedly though rarely, resulting in elevated phenotypic variances in G. scandens and a change in beak shape. The phenotypic states of both species at the end of the 30-year study could not have been predicted at the beginning. Continuous, long-term studies are needed to detect and interpret rare but important events and nonuniform evolutionary change.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Grant, PR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Washington Rd, Princeton, NJ 08544 USA.							ANDERSON WW, 1991, P NATL ACAD SCI USA, V88, P10367, DOI 10.1073/pnas.88.22.10367; Arnold ML, 1997, NATURAL HYBRIDIZATIO; Barbraud C, 2000, J EVOLUTION BIOL, V13, P81; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; CARLSON HL, 1968, POPULATION BIOL EVOL, P123; Carney SE, 2000, EVOLUTION, V54, P462, DOI 10.1111/j.0014-3820.2000.tb00049.x; Cowie RH, 1998, BIOL J LINN SOC, V65, P233, DOI 10.1006/bijl.1998.0250; EHRLICH PR, 1965, EVOLUTION, V20, P165; Endler J. A., 1986, NATURAL SELECTION WI; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; FORD H. D., 1930, TRANS ENT SOC LONDON, V78, P345; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; Grant B. R., 1989, EVOLUTIONARY DYNAMIC; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant Peter R., 1996, P343, DOI 10.1016/B978-012178075-3/50013-1; GRANT PR, 1994, EVOLUTION, V48, P297, DOI 10.1111/j.1558-5646.1994.tb01313.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; GRANT PR, 1993, PHILOS T R SOC B, V340, P127, DOI 10.1098/rstb.1993.0052; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; GRANT PR, 1992, ECOLOGY, V73, P766, DOI 10.2307/1940156; Grant PR, 2000, P ROY SOC B-BIOL SCI, V267, P131, DOI 10.1098/rspb.2000.0977; Grant PR, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P3; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GRANT PR, 1998, ENDLESS FORMS SPECIE, P404; Guilderson TP, 1998, SCIENCE, V281, P240, DOI 10.1126/science.281.5374.240; Halkka O, 2001, BIOL J LINN SOC, V74, P571, DOI 10.1111/j.1095-8312.2001.tb01414.x; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; JONES DA, 1989, TRENDS ECOL EVOL, V4, P298, DOI 10.1016/0169-5347(89)90025-6; Kareiva P.M., 1993, BIOTIC INTERACTIONS; Keller LF, 1998, EVOLUTION, V52, P240, DOI 10.1111/j.1558-5646.1998.tb05157.x; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kruuk LEB, 2001, AM NAT, V158, P557, DOI 10.1086/323585; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6608; Likens G.E., 1989, SPACE FOR TIME SUBST, DOI DOI 10.1007/978-1-4615-7358-6; MAJERUS MEN, 1998, MELANISMS EVOLUTION; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; PRICE TD, 1984, EVOLUTION, V38, P327, DOI 10.1111/j.1558-5646.1984.tb00291.x; PRICE TD, 1984, NATURE, V309, P787, DOI 10.1038/309787a0; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; SOKAL R, 1996, BIOMETRY PRINCIPLES; Teotonio H, 2001, EVOLUTION, V55, P653, DOI 10.1554/0014-3820(2001)055[0653:PRE]2.0.CO;2; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Zhang RH, 1998, NATURE, V391, P879, DOI 10.1038/36081	48	890	912	28	861	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					707	711		10.1126/science.1070315	http://dx.doi.org/10.1126/science.1070315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976447				2022-12-24	WOS:000175281700046
J	Sharpe, J; Ahlgren, U; Perry, P; Hill, B; Ross, A; Hecksher-Sorensen, J; Baldock, R; Davidson, D				Sharpe, J; Ahlgren, U; Perry, P; Hill, B; Ross, A; Hecksher-Sorensen, J; Baldock, R; Davidson, D			Optical projection tomography as a tool for 3D microscopy and gene expression studies	SCIENCE			English	Article							AXIAL SKELETON; VISUALIZATION	Current techniques for three-dimensional (3D) optical microscopy (deconvolution, confocal. microscopy, and optical coherence tomography) generate 3D data by "optically sectioning" the specimen. This places severe constraints on the maximum thickness of a specimen that can be imaged. We have developed a microscopy technique that uses optical projection tomography (OPT) to produce high-resolution 3D images of both fluorescent and nonfluorescent biological specimens with a thickness of up to 15 millimeters. OPT microscopy allows the rapid mapping of the tissue distribution of RNA and protein expression in intact embryos or organ systems and can therefore be instrumental in studies of developmental biology or gene function.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sharpe, J (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	james.sharpe@hgu.mrc.ac.uk	Hecksher-Sørensen, Jacob/AAB-3424-2021; Sharpe, James/L-1150-2014; Sharpe, James/AAB-7948-2019	Sharpe, James/0000-0002-1434-9743; Ahlgren, Ulf/0000-0001-5923-8572; Baldock, Richard/0000-0003-0332-6877	MRC [MC_U127527203] Funding Source: UKRI; Medical Research Council [MC_U127527203] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahlgren U, 1996, DEVELOPMENT, V122, P1409; AHLGREN U, UNPUB; Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; ALTABA ARI, 1993, MECH DEVELOP, V44, P91, DOI 10.1016/0925-4773(93)90060-B; Boppart SA, 1996, DEV BIOL, V177, P54, DOI 10.1006/dbio.1996.0144; Chen K, 2000, J BIOMED OPT, V5, P144, DOI 10.1117/1.429981; Davidson D, 2001, NAT REV GENET, V2, P409, DOI 10.1038/35076500; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; JACOBS RE, 1994, SCIENCE, V263, P681, DOI 10.1126/science.7508143; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; POTTER SM, 1996, SCANNING, V18, P147; Streicher J, 2000, NAT GENET, V25, P147, DOI 10.1038/75989; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15	17	893	936	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					541	545		10.1126/science.1068206	http://dx.doi.org/10.1126/science.1068206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964482				2022-12-24	WOS:000175179400049
J	Luise, C; Jermy, K; May, C; Costello, G; Collins, WP; Bourne, TH				Luise, C; Jermy, K; May, C; Costello, G; Collins, WP; Bourne, TH			Outcome of expectant management of spontaneous first trimester miscarriage: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To evaluate the uptake and outcome of expectant management of spontaneous first trimester miscarriage in an early pregnancy assessment unit. Participants 1096 consecutive patients with a diagnosis of spontaneous first trimester miscarriage. Methods Each miscarriage was classified as complete, incomplete, missed, or anembryonic on the basis of ultrasonography. Women who needed treatment were given the choice of expectant management or surgical evacuation of retained products of conception under general anaesthesia. Women undergoing expectant management were checked a few days after transvaginal bleeding had stopped, or they were monitored at weekly intervals for four weeks. Main outcome measures A complete miscarriage (absence of transvaginal bleeding and endometrial thickness < 15 min), the number of women completing their miscarriage within each week of management, and complications (excessive pain or transvaginal bleeding necessitating hospital admission or clinical evidence of infection). Results Two patients with molar pregnancies were excluded, and 37% of the remainder (408/1094) were classified as leaving had a complete miscarriage. 70% (478/686) of women with retained products of conception chose expect ant management; of these, 27 (6%) were lost to follow up. A successful outcome without surgical intervention was seen in 81% of cases (367/451). The rate of spontaneous completion was 91% (201/221) for those cases classified as incomplete miscarriage, 76% (105/138) for missed miscarriage, and 66% (61/92) for anembryonic pregnancy. 70% of women completed their miscarriage within 14 days of classification (84% for incomplete miscarriage and 52% for missed miscarriage and anembryonic pregnancy). Conclusions Most women with retained products of conception chose expectant management. Ultrasonography can be used to advise patients on the likelihood that their miscarriage will complete spontaneously within a given time.	St George Hosp, Early Pregnancy Gynaecol Ultrasound & Minimal Acc, London SW17 0RE, England; Kings Coll Hosp London, Gys Kings & St Thomas Sch Med, Acad Dept Obstet & Gynaecol, London SE5 9PJ, England	St Georges University London; King's College Hospital NHS Foundation Trust; King's College Hospital	Bourne, TH (corresponding author), St George Hosp, Early Pregnancy Gynaecol Ultrasound & Minimal Acc, London SW17 0RE, England.	tbourne@gynae-scanning.com	Bourne, Tom/I-6478-2012	Bourne, Tom/0000-0003-1421-6059				Jurkovic D, 1998, BRIT J OBSTET GYNAEC, V105, P670, DOI 10.1111/j.1471-0528.1998.tb10184.x; MACKENZIE IZ, 1978, LANCET, V2, P566; Nielsen S, 1999, BRIT J OBSTET GYNAEC, V106, P804, DOI 10.1111/j.1471-0528.1999.tb08401.x; *RCR RCOG WORK PAR, 1996, EARL PREGN ASS; Schwarzler P, 1999, HUM REPROD, V14, P1341, DOI 10.1093/humrep/14.5.1341; STEER C, 1989, BRIT MED J, V299, P1317, DOI 10.1136/bmj.299.6711.1317	6	111	115	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2002	324	7342					873	875		10.1136/bmj.324.7342.873	http://dx.doi.org/10.1136/bmj.324.7342.873			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950733	Green Published, Bronze			2022-12-24	WOS:000175052200017
J	Castellsague, X; Bosch, FX; Munoz, N; Meijer, CJLM; Shah, KV; de Sanjose, S; Eluf-Neto, J; Ngelangel, CA; Chichareon, S; Smith, JS; Herrero, R; Moreno, V; Franceschi, S				Castellsague, X; Bosch, FX; Munoz, N; Meijer, CJLM; Shah, KV; de Sanjose, S; Eluf-Neto, J; Ngelangel, CA; Chichareon, S; Smith, JS; Herrero, R; Moreno, V; Franceschi, S		Int Agency Res Canc Multicenter Ce	Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CARCINOMA IN-SITU; RISK-FACTORS; HIV-INFECTION; NEOPLASIA; POPULATION; COLOMBIA; DISEASES; SPAIN; MEN	Background: It is uncertain whether male circumcision reduces the risks of penile human papillomavirus (HPV) infection in the man and of cervical cancer in his female partner. Methods: We pooled data on 1913 couples enrolled in one of seven case-control studies of cervical carcinoma in situ and cervical cancer in five countries. Circumcision status was self-reported, and the accuracy of the data was confirmed by physical examination at three study sites. The presence or absence of penile HPV DNA was assessed by a polymerase-chain-reaction assay in 1520 men and yielded a valid result in the case of 1139 men (74.9 percent). Results: Penile HPV was detected in 166 of the 847 uncircumcised men (19.6 percent) and in 16 of the 292 circumcised men (5.5 percent). After adjustment for age at first intercourse, lifetime number of sexual partners, and other potential confounders, circumcised men were less likely than uncircumcised men to have HPV infection (odds ratio, 0.37; 95 percent confidence interval, 0.16 to 0.85). Monogamous women whose male partners had six or more sexual partners and were circumcised had a lower risk of cervical cancer than women whose partners were uncircumcised (adjusted odds ratio, 0.42; 95 percent confidence interval, 0.23 to 0.79). Results were similar in the subgroup of men in whom circumcision was confirmed by medical examination. Conclusions: Male circumcision is associated with a reduced risk of penile HPV infection and, in the case of men with a history of multiple sexual partners, a reduced risk of cervical cancer in their current female partners.	Inst Catala Oncol, Serv Epidemiol, Barcelona 08907, Spain; Inst Catala Oncol, Registre Canc, Barcelona 08907, Spain; Int Agcy Res Canc, F-69372 Lyon, France; Free Univ Amsterdam Hosp, Amsterdam, Netherlands; Johns Hopkins Univ, Baltimore, MD USA; Univ Sao Paulo, Sao Paulo, Brazil; Univ Philippines, Philippine Gen Hosp, Manila, Philippines; Prince Songkla Univ, Fac Med, Hat Yai, Thailand; Proyecto Epidemiol Guanacaste, San Jose, Costa Rica	Catalan Institute of Oncology; Catalan Institute of Oncology; World Health Organization; International Agency for Research on Cancer (IARC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University; Universidade de Sao Paulo; University of the Philippines System; University of the Philippines Manila; Prince of Songkla University	Castellsague, X (corresponding author), Inst Catala Oncol, Serv Epidemiol, Gran Via S-N,Km 2-7, Barcelona 08907, Spain.	xcastellsague@ico.scs.es	JOSÉ, FRANCESC XAVIER BOSCH/J-6339-2012; franceschi, silvia/M-2452-2014; Pique, Xavier Castellsagué/N-5795-2014; Moreno, Victor/A-1697-2010; Eluf-Neto, Jose/B-2522-2009; de Sanjosé Llongueras, Silvia/H-6339-2014	JOSÉ, FRANCESC XAVIER BOSCH/0000-0002-7172-3412; franceschi, silvia/0000-0003-4181-8071; Pique, Xavier Castellsagué/0000-0002-0802-3595; Moreno, Victor/0000-0002-2818-5487; Eluf-Neto, Jose/0000-0001-7504-2115; 				Aynaud O, 1999, BJU INT, V84, P57; BOON ME, 1989, CANCER, V64, P559, DOI 10.1002/1097-0142(19890715)64:2<559::AID-CNCR2820640234>3.0.CO;2-A; Bosch FX, 1996, JNCI-J NATL CANCER I, V88, P1060, DOI 10.1093/jnci/88.15.1060; BOSCH FX, 1993, CANCER EPIDEM BIOMAR, V2, P415; BOSCH FX, 1992, INT J CANCER, V52, P750, DOI 10.1002/ijc.2910520514; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BRINTON LA, 1989, INT J CANCER, V44, P199, DOI 10.1002/ijc.2910440202; BRINTON LA, 1991, INT J CANCER, V47, P504, DOI 10.1002/ijc.2910470406; CAMERON DW, 1989, LANCET, V2, P403; Castellsague X, 1997, J INFECT DIS, V176, P353, DOI 10.1086/514052; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; COOK LS, 1994, AM J PUBLIC HEALTH, V84, P197, DOI 10.2105/AJPH.84.2.197; COOK LS, 1993, GENITOURIN MED, V69, P262; DONOVAN B, 1994, GENITOURIN MED, V70, P317; ELUFNETO J, 1994, BRIT J CANCER, V69, P114, DOI 10.1038/bjc.1994.18; HILDESHEIM A, 1994, J INFECT DIS, V169, P235, DOI 10.1093/infdis/169.2.235; HOLLY EA, 1993, J NATL CANCER I, V85, P2, DOI 10.1093/jnci/85.1.2; HUSMAN AMD, 1994, INT J CANCER, V56, P802, DOI 10.1002/ijc.2910560607; HUSSAIN LA, 1995, IMMUNOLOGY, V85, P475; Hutchinson J., 1855, MED TIMES GAZETTE, VII, P542, DOI DOI 10.1056/NEJM185608280550404; *IARC, 1995, IARC MON EV CARC RIS, V64; JACOBS MV, 1995, J CLIN MICROBIOL, V33, P901, DOI 10.1128/JCM.33.4.901-905.1995; KJAER SK, 1991, INT J CANCER, V48, P39; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; MADEN C, 1993, JNCI-J NATL CANCER I, V85, P19, DOI 10.1093/jnci/85.1.19; Melbye M, 1998, SEMIN CANCER BIOL, V8, P307, DOI 10.1006/scbi.1998.0081; MORENO V, 1995, CANCER EPIDEM BIOMAR, V4, P459; Munoz N, 1996, JNCI-J NATL CANCER I, V88, P1068, DOI 10.1093/jnci/88.15.1068; MUNOZ N, 1992, INT J CANCER, V52, P743, DOI 10.1002/ijc.2910520513; MUNOZ N, 1993, CANCER EPIDEM BIOMAR, V2, P423; Ngelangel C, 1998, JNCI-J NATL CANCER I, V90, P43, DOI 10.1093/jnci/90.1.43; O'Farrell N, 2000, INT J STD AIDS, V11, P137, DOI 10.1258/0956462001915480; ORIEL JD, 1971, BRIT J VENER DIS, V47, P1; PARKER SW, 1983, MED J AUSTRALIA, V2, P288, DOI 10.5694/j.1326-5377.1983.tb122467.x; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SCHOEN EJ, 1990, NEW ENGL J MED, V322, P1308, DOI 10.1056/NEJM199005033221810; Szabo R, 2000, BRIT MED J, V320, P1592, DOI 10.1136/bmj.320.7249.1592; Tseng HF, 2001, CANCER CAUSE CONTROL, V12, P267, DOI 10.1023/A:1011266405062; Urassa M, 1997, AIDS, V11, P73, DOI 10.1097/00002030-199701000-00011; Van Howe RS, 1998, PEDIATR INFECT DIS J, V17, P1, DOI 10.1097/00006454-199801000-00002; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Weiss GN, 1997, PEDIATR INFECT DIS J, V16, P727, DOI 10.1097/00006454-199708000-00002; WILSON RA, 1947, CAN MED ASSOC J, V56, P54; 1966, LANCET, V1, P137	44	480	512	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 11	2002	346	15					1105	1112		10.1056/NEJMoa011688	http://dx.doi.org/10.1056/NEJMoa011688			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539PX	11948269	Green Published			2022-12-24	WOS:000174880600002
J	Leadbetter, EA; Rifkin, IR; Hohlbaum, AM; Beaudette, BC; Shlomchik, MJ; Marshak-Rothstein, A				Leadbetter, EA; Rifkin, IR; Hohlbaum, AM; Beaudette, BC; Shlomchik, MJ; Marshak-Rothstein, A			Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors	NATURE			English	Article							CUTTING EDGE; CPG-DNA; GENE; AUTOANTIBODY; DISRUPTION; EXPRESSION; LUPUS; MICE	Autoreactive B cells are present in the lymphoid tissues of healthy individuals, but typically remain quiescent. When this homeostasis is perturbed, the formation of self-reactive antibodies can have serious pathological consequences. B cells expressing an antigen receptor specific for self-immunoglobulin-g (IgG) make a class of autoantibodies known as rheumatoid factor (RF). Here we show that effective activation of RF+ B cells is mediated by IgG2a-chromatin immune complexes and requires the synergistic engagement of the antigen receptor and a member of the MyD88-dependent Toll-like receptor (TLR) family. Inhibitor studies implicate TLR9. These data establish a critical link between the innate and adaptive immune systems in the development of systemic autoimmune disease and explain the preponderance of autoantibodies reactive with nucleic acid-protein particles. The unique features of this dual-engagement pathway should facilitate the development of therapies that specifically target autoreactive B cells.	Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Boston University; Boston University; Yale University; Yale University	Marshak-Rothstein, A (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	amrothst@bu.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Beaudette-Zlatanova, Britte/0000-0002-1585-0409; Rifkin, Ian/0000-0002-2674-3991				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; BELL DA, 1991, CLIN IMMUNOL IMMUNOP, V60, P13, DOI 10.1016/0090-1229(91)90108-M; BELL DA, 1990, J CLIN INVEST, V85, P1487, DOI 10.1172/JCI114595; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Bickerstaff MCM, 1999, NAT MED, V5, P694, DOI 10.1038/9544; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CARTER RH, 1988, J IMMUNOL, V141, P457; EMLEN W, 1992, J IMMUNOL, V148, P3042; ESDAILE J, 1991, NEW ENGL J MED, V324, P150; Furst DE, 1999, ARTHRITIS RHEUM, V42, P357, DOI 10.1002/1529-0131(199902)42:2<357::AID-ANR19>3.0.CO;2-J; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; JACOBSON BA, 1994, J IMMUNOL, V152, P4489; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LENART P, 2001, ANTISENSE NUCLEIC A, V4, P247; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOLLER G, 1972, CELL IMMUNOL, V4, P416, DOI 10.1016/0008-8749(72)90043-3; Monestier M, 1996, MOL IMMUNOL, V33, P89, DOI 10.1016/0161-5890(95)00115-8; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Rifkin IR, 2000, J IMMUNOL, V165, P1626, DOI 10.4049/jimmunol.165.3.1626; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; SHLOMCHIK MJ, 1993, INT IMMUNOL, V5, P1329, DOI 10.1093/intimm/5.10.1329; SHLOMCHIK MJ, 1987, NATURE, V328, P805, DOI 10.1038/328805a0; Singal R, 1999, BLOOD, V93, P4059, DOI 10.1182/blood.V93.12.4059; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; THEOFILOPOULOS AN, 1985, J EXP MED, V162, P1, DOI 10.1084/jem.162.1.1; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; WILLIAM J, UNPUB EVOLUTION AUTO; WOLFOWICZ CB, 1988, CLIN IMMUNOL IMMUNOP, V46, P382, DOI 10.1016/0090-1229(88)90057-8; Yi AK, 1998, J IMMUNOL, V160, P4755; Zeng D, 2000, J IMMUNOL, V164, P5000, DOI 10.4049/jimmunol.164.10.5000	39	1483	1563	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					603	607		10.1038/416603a	http://dx.doi.org/10.1038/416603a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948342				2022-12-24	WOS:000174901900034
J	Kosak, ST; Skok, JA; Medina, KL; Riblet, R; Le Beau, MM; Fisher, AG; Singh, H				Kosak, ST; Skok, JA; Medina, KL; Riblet, R; Le Beau, MM; Fisher, AG; Singh, H			Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development	SCIENCE			English	Article							V(D)J RECOMBINATION; CENTROMERIC HETEROCHROMATIN; HISTONE ACETYLATION; CHROMATIN; LOCALIZATION; RECEPTOR; ORGANIZATION; ASSOCIATION; NUCLEUS; MICE	Immunoglobulin (Ig) loci are selectively activated for transcription and rearrangement during B lymphocyte development. Using fluorescence in situ hybridization, we show that Ig heavy (H) and Igkappa Loci are preferentially positioned at the nuclear periphery in hematopoietic progenitors and pro-T cells but are centrally configured in pro-B nuclei. The inactive loci at the periphery do not associate with centromeric heterochromatin. Upon localization away from the nuclear periphery in pro-B cells, the IgH locus appears to undergo large-scale compaction. We suggest that subnuclear positioning represents a novel means of regulating transcription and recombination of IgH and Igkappa loci during lymphocyte development.	Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Hammersmith Hosp, Imperial Coll Sch Med, MRC, Clin Sci Ctr,Lymphocyte Dev Grp, London W12 0NN, England; Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; Imperial College London; Torrey Pines Institute for Molecular Studies, California	Singh, H (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, 920 E 58th St, Chicago, IL 60637 USA.		Skok, Jane/ABF-7249-2020	Skok, Jane/0000-0002-4145-1516	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM07183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Csink AK, 1996, NATURE, V381, P529, DOI 10.1038/381529a0; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gotzmann J, 1999, CRIT REV EUKAR GENE, V9, P257, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.100; KOSAK ST, UNPUB; McBlane F, 2000, CURR BIOL, V10, P483, DOI 10.1016/S0960-9822(00)00449-8; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Roth DB, 2000, CELL, V103, P699, DOI 10.1016/S0092-8674(00)00173-2; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; StanhopeBaker P, 1996, CELL, V85, P887, DOI 10.1016/S0092-8674(00)81272-6; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2	20	556	568	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					158	162		10.1126/science.1068768	http://dx.doi.org/10.1126/science.1068768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935030				2022-12-24	WOS:000174858800053
J	Ma, YM; Pannicke, U; Schwarz, K; Lieber, MR				Ma, YM; Pannicke, U; Schwarz, K; Lieber, MR			Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination	CELL			English	Article							DNA-LIGASE-IV; STRAND BREAK REPAIR; SEVERE COMBINED IMMUNODEFICIENCY; COMBINED IMMUNE-DEFICIENCY; SACCHAROMYCES-CEREVISIAE; INCREASED SENSITIVITY; GENE REARRANGEMENT; CODING SEGMENTS; XRCC4 PROTEIN; SCID MUTATION	Mutations in the Artemis protein in humans result in hypersensitivity to DNA double-strand break-inducing agents and absence of B and T lymphocytes (radiosensitive severe combined immune deficiency [RS-SCID]). Here, we report that Artemis forms a complex with the 469 kDa DNA-dependent protein kinase (DNA-PKcs) in the absence of DNA. The purified Artemis protein alone possesses single-strand-specific 5' to 3' exonuclease activity. Upon complex formation, DNA-PKcs phosphorylates Artemis, and Artemis acquires endonucleolytic activity on 5' and 3' overhangs, as well as hairpins. Finally, the Artemis:DNA-PKcs complex can open hairpins generated by the RAG complex. Thus, DNA-PKcs regulates Artemis by both phosphorylation and complex formation to permit enzymatic activities that are critical for the hairpin-opening step of V(D)J recombination and for the 5' and 3' overhang processing in nonhomologous DNA end joining.	Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90033 USA; Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; Univ Ulm, Dept Transfus Med, German Red Cross Blood Donat Serv Baden Wuertt, Inst Ulm, D-89081 Ulm, Germany	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Ulm University	Lieber, MR (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Rm 5428,1441 Eastlake Ave, Los Angeles, CA 90033 USA.		Pannicke, Ulrich/D-7348-2014	Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; ANDERSON CW, 1996, MOL ANAL DNA REARRAN, P91; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; BLOMMERS MJJ, 1989, BIOCHEMISTRY-US, V28, P7491, DOI 10.1021/bi00444a049; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Grawunder U, 1998, CURR OPIN IMMUNOL, V10, P172, DOI 10.1016/S0952-7915(98)80246-X; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Harfst E, 2000, MOL IMMUNOL, V37, P915, DOI 10.1016/S0161-5890(01)00008-6; HARRINGTON J, 1992, MOL CELL BIOL, V12, P4758, DOI 10.1128/MCB.12.10.4758; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HENRIQUES JAP, 1980, GENETICS, V95, P273; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; HOWARD FB, 1991, BIOCHEMISTRY-US, V30, P779, DOI 10.1021/bi00217a030; KOWALCZYKOWSKI SC, 1994, ANNU REV BIOCHEM, V63, P991, DOI 10.1146/annurev.biochem.63.1.991; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; Lieber MR, 1998, AM J PATHOL, V153, P1323, DOI 10.1016/S0002-9440(10)65716-1; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; MA Y, 2002, IN PRESS J BIOL CHEM, V277; Ma YM, 2001, BIOCHEMISTRY-US, V40, P9638, DOI 10.1021/bi010932v; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; Modesti M, 1999, EMBO J, V18, P2008, DOI 10.1093/emboj/18.7.2008; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Moshous D, 2000, HUM MOL GENET, V9, P583, DOI 10.1093/hmg/9.4.583; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Paul W., 1999, FUNDAMENTAL IMMUNOLO; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; RAGHUNATHAN G, 1991, BIOCHEMISTRY-US, V30, P782, DOI 10.1021/bi00217a031; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Schlissel MS, 1998, MOL CELL BIOL, V18, P2029, DOI 10.1128/MCB.18.4.2029; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; SCHWARZ K, 1991, J EXP MED, V174, P1039, DOI 10.1084/jem.174.5.1039; Shen BH, 1996, J BIOL CHEM, V271, P9173, DOI 10.1074/jbc.271.16.9173; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vanasse GJ, 1999, BLOOD, V94, P3997, DOI 10.1182/blood.V94.12.3997.424k44_3997_4010; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; West CE, 2000, PLANT J, V24, P67, DOI 10.1046/j.1365-313x.2000.00856.x; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Xie YL, 2001, MOL CELL BIOL, V21, P4889, DOI 10.1128/MCB.21.15.4889-4899.2001; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yeo TC, 2000, MOL IMMUNOL, V37, P1131, DOI 10.1016/S0161-5890(01)00026-8; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	65	788	810	1	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					781	794		10.1016/S0092-8674(02)00671-2	http://dx.doi.org/10.1016/S0092-8674(02)00671-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955432	Bronze			2022-12-24	WOS:000174563000008
J	Stuhlinger, MC; Abbasi, F; Chu, JW; Lamendola, C; McLaughlin, TL; Cooke, JP; Reaven, GM; Tsao, PS				Stuhlinger, MC; Abbasi, F; Chu, JW; Lamendola, C; McLaughlin, TL; Cooke, JP; Reaven, GM; Tsao, PS			Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDIATED GLUCOSE DISPOSAL; STAGE RENAL-DISEASE; ASYMMETRIC DIMETHYLARGININE; ENDOTHELIAL DYSFUNCTION; PLASMA-CONCENTRATIONS; HYPERTENSION; PREDICTOR; ADHERENCE; CELLS; ADMA	Context Increased levels of asymmetric dimethylarginine (ADMA) are associated with endothelial dysfunction and increased risk of cardiovascular disease. Several cardiovascular risk factors are associated with reduced sensitivity to insulin, but elevated ADMA concentrations have not been fully linked to the metabolic syndrome. Objective To evaluate the relationship between insulin sensitivity and plasma ADMA concentrations, and to determine whether a pharmacological treatment that increases insulin sensitivity would also modulate ADMA concentrations. Design, Setting, and Subjects Cross-sectional study, containing a nonrandomized controlled trial component, of 64 healthy volunteers without diabetes (42 women, 22 men; 48 with normal blood pressure and 16 with hypertension), which was conducted at a university medical center between October 2000 and July 2001. Intervention Rosiglitazone (4 mg/d for 4 weeks and then 4 mg twice daily for 8 weeks), an insulin-sensitizing agent, was given to 7 insulin-resistant subjects with hypertension. These subjects were studied before and after 12-week treatment. Main Outcome Measures Insulin sensitivity measured by the insulin suppression test, and fasting plasma levels of low-density lipoprotein cholesterol, triglycerides, high-density lipoprotein cholesterol, glucose, insulin, and ADMA concentrations. Results Plasma ADMA concentrations were positively correlated with impairment of insulin-mediated glucose disposal in nondiabetic, normotensive subjects (r = 0.73; P < .001). Consistent with the metabolic syndrome, ADMA levels were also positively correlated with fasting triglyceride levels (r = 0.52; P < .001) but not with low-density lipoprotein cholesterol levels (r = 0.19; P = .20). Plasma ADMA concentrations increased in insulin-resistant subjects independent of hypertension. Pharmacological treatment improved insulin sensitivity and reduced mean (SD) plasma ADMA concentrations from 1.50 (0.30) to 1.05 (0.33) pmol/L (P = .001). Conclusion A significant relationship exists between insulin resistance and plasma concentrations of ADMA. Pharmacological intervention with rosiglitazone enhanced insulin sensitivity and reduced ADMA levels. Increases in plasma ADMA concentrations may contribute to the endothelial dysfunction observed in insulin-resistant patients.	Stanford Univ, Div Cardiovasc Med, Sch Med, Falk Cardiovasc Res Ctr, Stanford, CA 94305 USA	Stanford University	Tsao, PS (corresponding author), Stanford Univ, Div Cardiovasc Med, Sch Med, Falk Cardiovasc Res Ctr, 300 Pasteur Dr, Stanford, CA 94305 USA.	ptsao@stanford.edu		Cooke, John/0000-0003-0033-9138	NCRR NIH HHS [M01-RR00070] Funding Source: Medline; NHLBI NIH HHS [R01 HL08506, R01 HL62889, R01 HL-58638] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062889, R01HL008506] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Abbasi F, 1999, ARTERIOSCL THROM VAS, V19, P2818, DOI 10.1161/01.ATV.19.11.2818; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Boger RH, 2000, CIRC RES, V87, P99, DOI 10.1161/01.RES.87.2.99; Boger RH, 2001, CLIN SCI, V100, P161, DOI 10.1042/CS20000173; Carantoni M, 1997, DIABETES CARE, V20, P1462, DOI 10.2337/diacare.20.9.1462; Chan JR, 2000, ARTERIOSCL THROM VAS, V20, P1040, DOI 10.1161/01.ATV.20.4.1040; Chen NG, 1999, J CLIN ENDOCR METAB, V84, P3485, DOI 10.1210/jc.84.10.3485; Chen NG, 1999, CIRCULATION, V100, P940, DOI 10.1161/01.CIR.100.9.940; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Fard A, 2000, ARTERIOSCL THROM VAS, V20, P2039, DOI 10.1161/01.ATV.20.9.2039; Ferri C, 1997, EXP CLIN ENDOCR DIAB, V105, P38, DOI 10.1055/s-0029-1211794; Fleck C, 2001, KIDNEY INT, V59, pS14, DOI 10.1046/j.1523-1755.2001.59780014.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; GINSBERG H, 1975, J CLIN INVEST, V55, P454, DOI 10.1172/JCI107951; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; HAGER SR, 1989, AM J KIDNEY DIS, V14, P272, DOI 10.1016/S0272-6386(89)80201-X; HARRISON DG, 1993, J CLIN INVEST, V91, P1, DOI 10.1172/JCI116156; Higashi Y, 1997, HYPERTENSION, V29, P280, DOI 10.1161/01.HYP.29.1.280; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Leiper J, 1999, CARDIOVASC RES, V43, P542, DOI 10.1016/S0008-6363(99)00162-5; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; MacAllister RJ, 1996, NEPHROL DIAL TRANSPL, V11, P2449, DOI 10.1093/oxfordjournals.ndt.a027213; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; Petrie JR, 1996, CIRCULATION, V93, P1331, DOI 10.1161/01.CIR.93.7.1331; Pettersson A, 1997, J CHROMATOGR B, V692, P257, DOI 10.1016/S0378-4347(96)00525-7; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schroder M, 2001, KIDNEY INT, V59, pS19, DOI 10.1046/j.1523-1755.2001.59780019.x; Segarra G, 1999, STROKE, V30, P2206, DOI 10.1161/01.STR.30.10.2206; SHEN DC, 1988, J CLIN ENDOCR METAB, V66, P580, DOI 10.1210/jcem-66-3-580; Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, J CARDIOVASC PHARM, V20, pS60, DOI 10.1097/00005344-199204002-00018; VALLANCE P, 1992, LANCET, V339, P572; Vallance P, 2001, LANCET, V358, P2096, DOI 10.1016/S0140-6736(01)07229-4; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773; Zavaroni I, 1999, METABOLISM, V48, P989, DOI 10.1016/S0026-0495(99)90195-6; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	44	480	509	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 20	2002	287	11					1420	1426		10.1001/jama.287.11.1420	http://dx.doi.org/10.1001/jama.287.11.1420			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532GB	11903029	Bronze			2022-12-24	WOS:000174465000024
J	Petrelli, A; Gilestro, GF; Lanzardo, S; Comoglio, PM; Migone, N; Giordano, S				Petrelli, A; Gilestro, GF; Lanzardo, S; Comoglio, PM; Migone, N; Giordano, S			The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met	NATURE			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; TYROSINE KINASE RECEPTOR; ADAPTER PROTEIN; FAMILY; CBL; PHOSPHORYLATION; TRANSFORMATION; CIN85; SITE; GAB1	Ligand-dependent downregulation of tyrosine kinase receptors is a critical step for modulating their activity. Upon ligand binding, hepatocyte growth factor (HGF) receptor (Met) is polyubiquitinated(1) and degraded(2); however, the mechanisms underlying HGF receptor endocytosis are not yet known. Here we demonstrate that a complex involving endophilins, CIN85 and Cbl controls this process. Endophilins(3) are regulatory components of clathrin-coated vesicle formation. Through their acyltransferase activity they are thought to modify the membrane phospholipids and induce negative curvature and invagination of the plasma membrane during the early steps of endocytosis(4). Furthermore, by means of their Src-homology 3 domains, endophilins are able to bind CIN85, a recently identified protein that interacts with the Cbl proto-oncogene(5). Cbl, in turn, binds and ubiquitinates activated HGF receptor, and by recruiting the endophilin-CIN85 complex, it regulates receptor internalization. Inhibition of complex formation is sufficient to block HGF receptor internalization and to enhance HGF-induced signal transduction and biological responses. These data provide further evidence of a relationship between receptor-mediated signalling and endocytosis, and disclose a novel functional role for Cbl in HGF receptor signalling.	Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy; Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; CNR, CIOS, I-10126 Turin, Italy	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR)	Giordano, S (corresponding author), Univ Turin, Sch Med, Inst Canc Res & Treatment, Div Mol Oncol, I-10060 Turin, Italy.		Giordano, Silvia/J-9858-2018; Gilestro, Giorgio/A-8721-2010	Giordano, Silvia/0000-0003-1854-1086; Gilestro, Giorgio/0000-0001-7512-8541; Comoglio, Paolo/0000-0002-7056-5328				Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Garcia-Guzman M, 2000, ONCOGENE, V19, P4058, DOI 10.1038/sj.onc.1203750; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Hammond DE, 2001, ONCOGENE, V20, P2761, DOI 10.1038/sj.onc.1204475; Hill E, 2001, J CELL BIOL, V152, P309, DOI 10.1083/jcb.152.2.309; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Jeffers M, 1997, MOL CELL BIOL, V17, P799, DOI 10.1128/MCB.17.2.799; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Prat M, 1998, J CELL SCI, V111, P237; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0	25	354	372	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					187	190		10.1038/416187a	http://dx.doi.org/10.1038/416187a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894096				2022-12-24	WOS:000174348100040
J	Yokouchi, Y; Ikeda, M; Inuzuka, Y; Yukawa, T				Yokouchi, Y; Ikeda, M; Inuzuka, Y; Yukawa, T			Strong emission of methyl chloride from tropical plants	NATURE			English	Article							DIMETHYL SULFIDE; ATMOSPHERE; BROMIDE; PACIFIC; BIOMASS; BUDGETS; OCEAN	Methyl chloride is the largest natural source of ozone-depleting chlorine compounds, and accounts for about 15 per cent of the present atmospheric chlorine content(1). This contribution was likely to have been relatively greater in pre-industrial times 2, when additional anthropogenic sources-such as chlorofluoro-carbons-were absent. Although it has been shown that there are large emissions of methyl chloride from coastal lands in the tropics 3,4, there remains a substantial shortfall in the overall methyl chloride budget. Here we present observations of large emissions of methyl chloride from some common tropical plants (certain types of ferns and Dipterocarpaceae), ranging from 0.1 to 3.7 mug per gram of dry leaf per hour. On the basis of these preliminary measurements, the methyl chloride flux from Dipterocarpaceae in southeast Asia alone is estimated at 0.91 Tg yr(-1), which could explain a large portion of missing methyl chloride sources. With continuing tropical deforestation, natural sources of chlorine compounds may accordingly decrease in the future. Conversely, the abundance of massive ferns in the Carboniferous period(5) may have created an atmosphere rich in methyl chloride.	Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; Meisei Univ, Tokyo 1918506, Japan; Museum Nat Sci, Tsukuba Bot Garden, Tsukuba, Ibaraki 3050005, Japan	National Institute for Environmental Studies - Japan; Meisei University	Yokouchi, Y (corresponding author), Natl Inst Environm Studies, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	yokouchi@nies.go.jp	陽子, 横内/E-8041-2010					Aiba S, 1999, PLANT ECOL, V140, P139, DOI 10.1023/A:1009710618040; BERG LR, 1997, INTRO BOT; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; Butler JH, 2000, NATURE, V403, P260, DOI 10.1038/35002232; FAO, 1997, STAT WORLDS FOR 1997; Khalil MAK, 1999, ATMOS ENVIRON, V33, P1305, DOI 10.1016/S1352-2310(98)00234-9; Li HJ, 2001, GEOCHEM J, V35, P137, DOI 10.2343/geochemj.35.137; Li HJ, 1999, ATMOS ENVIRON, V33, P1881, DOI 10.1016/S1352-2310(98)00303-3; Lobert JM, 1999, J GEOPHYS RES-ATMOS, V104, P8373, DOI 10.1029/1998JD100077; Manokaran N., 1998, CONSERVATION MANAGEM, P41; Moore RM, 1996, J GEOPHYS RES-OCEANS, V101, P28529, DOI 10.1029/96JC02915; Redeker KR, 2000, SCIENCE, V290, P966, DOI 10.1126/science.290.5493.966; Rhew RC, 2000, NATURE, V403, P292, DOI 10.1038/35002043; Takhtajan A. L., 1986, FLORISTIC REGIONS WO; Watling R, 1998, MYCOL RES, V102, P769, DOI 10.1017/S0953756298006157; Watts SF, 2000, ATMOS ENVIRON, V34, P761, DOI 10.1016/S1352-2310(99)00342-8; YAMAKURA T, 1986, VEGETATIO, V68, P71; Yokouchi Y, 2000, NATURE, V403, P295, DOI 10.1038/35002049; Yokouchi Y, 1999, J GEOPHYS RES-ATMOS, V104, P8067, DOI 10.1029/1998JD100013	19	106	108	6	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					163	165		10.1038/416163a	http://dx.doi.org/10.1038/416163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894090				2022-12-24	WOS:000174348100033
J	Swenson, ER; Maggiorini, M; Mongovin, S; Gibbs, JSR; Greve, I; Mairbaurl, HH; Bartsch, P				Swenson, ER; Maggiorini, M; Mongovin, S; Gibbs, JSR; Greve, I; Mairbaurl, HH; Bartsch, P			Pathogenesis of high-altitude pulmonary edema - Inflammation is not an etiologic factor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MOUNTAIN-SICKNESS; EXHALED NITRIC-OXIDE; BRONCHOALVEOLAR LAVAGE; STRESS FAILURE; BLOOD-FLOW; HYPOXIA; LUNG; REDISTRIBUTION; FLUID; HEMODYNAMICS	Context The pathogenesis of high-altitude pulmonary edema (HAPE) is considered an altered permeability of the alveolar-capillary barrier secondary to intense pulmonary vasoconstriction and high capillary pressure, but previous bronchoalveolar lavage (BAL) findings in well-established HAPE are also consistent with inflammatory etiologic characteristics. Objectives To determine whether inflammation is a primary event in HAPE and to define the temporal sequence of events in HAPE. Design, Setting, and Participants Case study from July through August 1999 of 10 subjects with susceptibility to HAPE and 6 subjects resistant to HAPE, all of whom are nonprofessional alpinists with previous mountaineering experience above 3000 m. Main Outcome Measures Pulmonary artery pressure measurements and BAL findings at low altitude (490 m) and shortly before or at the onset of HAPE at an altitude of 4559 m. Results Subjects who were HAPE susceptible had higher mean (SD) pulmonary artery systolic blood pressures at 4559 m compared with HAPE-resistant subjects (66 vs 37 mm Hg; P=.004). Despite development of HAPE in the majority of HAPE-susceptible subjects, there were no differences in BAL fluid total leukocyte counts between resistant and susceptible subjects or between counts taken at low and high altitudes. Subjects who developed HAPE had BAL fluid with high concentrations of plasma-derived proteins and erythrocytes, but there was no increase in plasma concentrations of surfactant protein A and Clara cell protein. The chest radiograph score was 12.7 for the 3 HAPE-susceptible subjects who developed HAPE before BAL was performed; they were lavaged within 3 to 5 hours. The remainder of the HAPE-susceptible group was lavaged before edema was apparent on radiographs. However, 6 subjects from the HAPE-susceptible group who developed HAPE on the following day had a score on bronchoscopy of 1.5, which increased to 4.6, reflective of mild pulmonary edema. In HAPE cases, there were no elevations in a number of proinflammatory cytokines and eicosanoid and nitric oxide metabolites. Conclusions Early HAPE is characterized by high pulmonary artery pressures that lead to a protein-rich and mildly hemorrhagic edema, with normal levels of leukocytes, cytokines, and eicosanoids. HAPE is a form of hydrostatic pulmonary edema with altered alveolar-capillary permeability.	Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Med Serv, Seattle, WA 98195 USA; Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Res Serv, Seattle, WA 98195 USA; Univ Zurich Hosp, Dept Internal Med, Med Intens Care Unit, Zurich, Switzerland; Univ London Imperial Coll Sci Technol & Med, Sch Sci Technol & Med, Natl Heart & Lung Inst, London, England; Univ Clin Heidelberg, Dept Med, Div Sports Med, Heidelberg, Germany	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Zurich; University Zurich Hospital; Imperial College London; Ruprecht Karls University Heidelberg	Swenson, ER (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Pulm & Crit Care Sect, S-111-Pulm,1660 S Columbian Way, Seattle, WA 98108 USA.	eswenson@u.washington.edu		Maggiorini, Marco/0000-0001-8180-2117				Ali MH, 1999, AM J PHYSIOL-LUNG C, V277, pL1057, DOI 10.1152/ajplung.1999.277.5.L1057; Anand IS, 1998, CIRCULATION, V98, P2441, DOI 10.1161/01.CIR.98.22.2441; AUDI SH, 1991, J APPL PHYSIOL, V70, P2126, DOI 10.1152/jappl.1991.70.5.2126; BACHOFEN H, 1993, AM REV RESPIR DIS, V147, P989, DOI 10.1164/ajrccm/147.4.989; Bartsch P, 2000, CHEST, V117, P1393, DOI 10.1378/chest.117.5.1393; BARTSCH P, 1989, J APPL PHYSIOL, V66, P2136, DOI 10.1152/jappl.1989.66.5.2136; BARTSCH P, 1991, NEW ENGL J MED, V325, P1284, DOI 10.1056/NEJM199110313251805; Bartsch P, 1997, RESPIRATION, V64, P435; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Carpenter TC, 1998, J APPL PHYSIOL, V84, P1048, DOI 10.1152/jappl.1998.84.3.1048; CRAPO JD, 1993, AM REV RESPIR DIS, V147, P790, DOI 10.1164/ajrccm/147.4.790; Droma Y, 1996, EUR RESPIR J, V9, P1947, DOI 10.1183/09031936.96.09091947; Duplain H, 2000, AM J RESP CRIT CARE, V162, P221, DOI 10.1164/ajrccm.162.1.9908039; Durmowicz AG, 1997, J PEDIATR-US, V130, P838, DOI 10.1016/S0022-3476(97)80033-9; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; HACKETT PH, 1992, INT J SPORTS MED, V13, pS68, DOI 10.1055/s-2007-1024599; Hanaoka M, 1998, CIRCULATION, V97, P1124, DOI 10.1161/01.CIR.97.12.1124; Hanaoka M, 2000, CIRCULATION, V101, P1418, DOI 10.1161/01.CIR.101.12.1418; Hermans C, 1999, EUR RESPIR J, V13, P1014, DOI 10.1034/j.1399-3003.1999.13e14.x; HOMIK LA, 1988, J APPL PHYSIOL, V63, P521; HULTGREN HN, 1971, CIRCULATION, V44, P759, DOI 10.1161/01.CIR.44.5.759; HULTGREN HN, 1964, CIRCULATION, V29, P393, DOI 10.1161/01.CIR.29.3.393; Irwin DC, 2001, HIGH ALT MED BIOL, V2, P349, DOI 10.1089/15270290152608525; Kaminsky DA, 1996, CHEST, V110, P939, DOI 10.1378/chest.110.4.939; Kleger GR, 1996, J APPL PHYSIOL, V81, P1917, DOI 10.1152/jappl.1996.81.5.1917; KOBAYASHI T, 1987, CHEST, V92, P814, DOI 10.1378/chest.92.5.814; Kubo K, 1998, RESP PHYSIOL, V111, P301, DOI 10.1016/S0034-5687(98)00006-1; Kubo K, 1996, THORAX, V51, P739, DOI 10.1136/thx.51.7.739; Kuwahira I, 2001, INT J SPORTS MED, V22, P393, DOI 10.1055/s-2001-16239; Leeper-Woodford SK, 1999, AM J PHYSIOL-LUNG C, V276, pL909, DOI 10.1152/ajplung.1999.276.6.L909; Maggiorini M, 2001, CIRCULATION, V103, P2078; Mann CM, 1998, J APPL PHYSIOL, V84, P2010, DOI 10.1152/jappl.1998.84.6.2010; MARON MB, 1987, J APPL PHYSIOL, V62, P470, DOI 10.1152/jappl.1987.62.2.470; MAYATEPEK E, 1993, J CLIN INVEST, V91, P881, DOI 10.1172/JCI116309; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Mundy AL, 2000, BRIT J ANAESTH, V85, P570, DOI 10.1093/bja/85.4.570; Naldini A, 1997, J CELL PHYSIOL, V173, P335, DOI 10.1002/(SICI)1097-4652(199712)173:3<335::AID-JCP5>3.3.CO;2-T; Neal CR, 1996, J PHYSIOL-LONDON, V492, P39, DOI 10.1113/jphysiol.1996.sp021287; OELZ O, 1989, LANCET, V2, P1241; ONO S, 1993, J APPL PHYSIOL, V74, P1534, DOI 10.1152/jappl.1993.74.4.1534; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; Schoene RB, 2001, LUNG BIOL HEALTH DIS, V161, P777; SCHOENE RB, 1986, JAMA-J AM MED ASSOC, V256, P63, DOI 10.1001/jama.256.1.63; SCHOENE RB, 1988, J APPL PHYSIOL, V64, P2605, DOI 10.1152/jappl.1988.64.6.2605; Schutte H, 1996, EUR RESPIR J, V9, P1858, DOI 10.1183/09031936.96.09091858; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; TSUKIMOTO K, 1994, J APPL PHYSIOL, V76, P321, DOI 10.1152/jappl.1994.76.1.321; VISWANATHAN R, 1979, RESPIRATION, V37, P142, DOI 10.1159/000194023; VOCK P, 1989, RADIOLOGY, V170, P661, DOI 10.1148/radiology.170.3.2916019; WEST JB, 1995, EUR RESPIR J, V8, P523; WEST JB, 1991, J APPL PHYSIOL, V70, P1731, DOI 10.1152/jappl.1991.70.4.1731; YAN SF, 1995, J BIOL CHEM, V270, P11463, DOI 10.1074/jbc.270.19.11463; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657	55	233	248	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2228	2235		10.1001/jama.287.17.2228	http://dx.doi.org/10.1001/jama.287.17.2228			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980523	Bronze			2022-12-24	WOS:000175260600023
J	Keriel, A; Stary, A; Sarasin, A; Rochette-Egly, C; Egly, JM				Keriel, A; Stary, A; Sarasin, A; Rochette-Egly, C; Egly, JM			XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RAR alpha	CELL			English	Article							TRANSCRIPTION FACTOR TFIIH; RNA-POLYMERASE-II; NUCLEOTIDE EXCISION-REPAIR; ACTIVATION FUNCTION AF-1; C-TERMINAL DOMAIN; XERODERMA-PIGMENTOSUM; DNA-REPAIR; ESTROGEN-RECEPTOR; PROTEIN-KINASE; SKIN-CANCER	Inherited mutations in the XPD subunit of the general transcription/repair factor TFIIH yield the rare genetic disorder Xeroderma pigmentosum (XP), the phenotypes of which cannot be explained solely on the basis of a DNA repair defect. In cells derived from XP-D patients, we observed a reduction of the ligand-dependent transactivation mediated by several nuclear receptors (RARalpha, ERalpha, and AR). We demonstrate that the XPD mutation alters cdk7 function in RARalpha phosphorylation. Transactivation is restored upon overexpression of either the wild-type XPD or the RARalphaS77E (a mutation which mimics phosphorylated RARalpha). Thus, we demonstrate that the cdk7 kinase of TFIIH phosphorylates the nuclear receptor, then allowing ligand-dependent control of the activation of the hormone-responsive genes.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; CNRS, UPR 2169, Lab Genet Instabil & Canc, F-94801 Villejuif, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS)	Egly, JM (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.		stary, anne/GRY-3781-2022; Keriel, Anne/N-3753-2017	Keriel, Anne/0000-0003-3340-299X				Bastien J, 2000, J BIOL CHEM, V275, P21896, DOI 10.1074/jbc.M001985200; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; de Boer J, 1998, CANCER RES, V58, P89; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Delmotte MH, 1999, J BIOL CHEM, V274, P38225, DOI 10.1074/jbc.274.53.38225; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dilworth FJ, 2001, ONCOGENE, V20, P3047, DOI 10.1038/sj.onc.1204329; Drapkin R, 1996, P NATL ACAD SCI USA, V93, P6488, DOI 10.1073/pnas.93.13.6488; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; GERARD M, 1991, J BIOL CHEM, V266, P20940; Glass CK, 2000, GENE DEV, V14, P121; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JOHNSON RT, 1985, J CELL SCI, V76, P115; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KERIEL A, 2001, CDK ACTIVATING KINAS, pCH8; Kopf E, 2000, J BIOL CHEM, V275, P33280, DOI 10.1074/jbc.M002840200; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; Larochelle S, 1998, GENE DEV, V12, P370, DOI 10.1101/gad.12.3.370; Leclerc V, 2000, EMBO J, V19, P1567, DOI 10.1093/emboj/19.7.1567; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Niles RM, 2000, NUTRITION, V16, P1084, DOI 10.1016/S0899-9007(00)00436-6; Reardon JT, 1996, P NATL ACAD SCI USA, V93, P6482, DOI 10.1073/pnas.93.13.6482; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; ROCHETTEEGLY C, 1995, MOL ENDOCRINOL, V9, P860, DOI 10.1210/me.9.7.860; Rossignol M, 1997, EMBO J, V16, P1628, DOI 10.1093/emboj/16.7.1628; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SERIZAWA H, 1995, NATURE, V374, P280, DOI 10.1038/374280a0; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; STARY A, 1992, MUTAT RES, V272, P101, DOI 10.1016/0165-1161(92)90038-N; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Takayama K, 1996, AM J HUM GENET, V58, P263; Taylor EM, 1997, P NATL ACAD SCI USA, V94, P8658, DOI 10.1073/pnas.94.16.8658; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Tremblay A, 1999, MOL CELL, V3, P513, DOI 10.1016/S1097-2765(00)80479-7; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; van Steeg H, 1999, MOL MED TODAY, V5, P86, DOI 10.1016/S1357-4310(98)01394-X; Vermeulen W, 2000, NAT GENET, V26, P307, DOI 10.1038/81603; Winkler GS, 1998, J BIOL CHEM, V273, P1092, DOI 10.1074/jbc.273.2.1092; Winkler GS, 2000, J BIOL CHEM, V275, P4258, DOI 10.1074/jbc.275.6.4258	56	157	158	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					125	135		10.1016/S0092-8674(02)00692-X	http://dx.doi.org/10.1016/S0092-8674(02)00692-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955452	Bronze			2022-12-24	WOS:000174888300014
J	Ely, JW; Osheroff, JA; Ebell, MH; Chambliss, ML; Vinson, DC; Stevermer, JJ; Pifer, EA				Ely, JW; Osheroff, JA; Ebell, MH; Chambliss, ML; Vinson, DC; Stevermer, JJ; Pifer, EA			Obstacles to answering doctors' questions about patient care with evidence: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							CLINICAL QUESTIONS; INFORMATION NEEDS; PHYSICIANS; PRACTITIONERS; LANSOPRAZOLE; ESOPHAGITIS; MULTICENTER; OMEPRAZOLE	Objective To describe the obstacles encountered when attempting to answer doctors' questions with evidence. Design Qualitative study. Setting General practices in Iowa. Participants 9 academic generalist doctors, 14 family doctors, and 2 medical librarians. Main outcome measure A taxonomy of obstacles encountered while searching for evidence based answers to doctors' questions. Results 59 obstacles were encountered and organised according to the five steps in asking and answering questions: recognise a gap in knowledge, formulate a question, search for relevant information, formulate an answer, and use the answer to direct patient care. Six obstacles were considered particularly salient by the investigators and practising doctors: the excessive time required to find information; difficulty modifying the original question, which was often vague and open to interpretation; difficulty selecting an optimal strategy to search for information; failure of a seemingly appropriate resource to cover die topic; uncertainty about how to know when all the relevant evidence has been found so that the search can stop; and inadequate synthesis of multiple bits of evidence into a clinically useful statement. Conclusions Many obstacles are encountered when asking and answering questions about how to care for patients. Addressing these obstacles could lead to better patient care by improving clinically oriented information resources.	Univ Iowa, Coll Med, Dept Family Med, Iowa City, IA 52242 USA; Praxis Press, New York, NY 10010 USA; Michigan State Univ, Dept Family Practice, E Lansing, MI 48824 USA; Moses Cone Hosp Family Med Residency, Greensboro, NC 27401 USA; Univ Missouri, Sch Med, Columbia, MO 65212 USA; Univ Penn, Div Gen Internal Med, Philadelphia, PA 19104 USA	University of Iowa; Michigan State University; Moses Cone Memorial Hospital; University of Missouri System; University of Missouri Columbia; University of Pennsylvania	Ely, JW (corresponding author), Univ Iowa, Coll Med, Dept Family Med, Iowa City, IA 52242 USA.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285	NLM NIH HHS [R01 LM007179, 1R01LM07179-01] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [R01LM007179] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Armstrong E C, 1999, WMJ, V98, P25; Bergus GR, 2000, ARCH FAM MED, V9, P541, DOI 10.1001/archfami.9.6.541; Chambliss ML, 1996, J FAM PRACTICE, V43, P140; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Davidoff F, 2000, ANN INTERN MED, V132, P996, DOI 10.7326/0003-4819-132-12-200006200-00012; Davison GC, 1997, J CONSULT CLIN PSYCH, V65, P950, DOI 10.1037/0022-006X.65.6.950; Ebell M, 1999, J Am Board Fam Pract, V12, P225; Ely JW, 2000, BRIT MED J, V321, P429, DOI 10.1136/bmj.321.7258.429; Ely JW, 1999, BRIT MED J, V319, P358, DOI 10.1136/bmj.319.7206.358; Ericsson K.A., 1993, PROTOCOL ANAL VERBAL; Feinstein AR, 1997, AM J MED, V103, P529, DOI 10.1016/S0002-9343(97)00244-1; Fozi K, 2000, Med J Malaysia, V55, P486; Freeman AC, 2001, BRIT MED J, V323, P1100, DOI 10.1136/bmj.323.7321.1100; GORMAN PN, 1995, J AM SOC INFORM SCI, V46, P729, DOI 10.1002/(SICI)1097-4571(199512)46:10<729::AID-ASI3>3.0.CO;2-2; GORMAN PN, 1995, MED DECIS MAKING, V15, P113, DOI 10.1177/0272989X9501500203; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; HATLEBAKK JG, 1993, SCAND J GASTROENTERO, V28, P224, DOI 10.3109/00365529309096076; Hersh WR, 1998, JAMA-J AM MED ASSOC, V280, P1307, DOI 10.1001/jama.280.15.1307; OSHEROFF JA, 1993, B MED LIBR ASSOC, V81, P11; OSHEROFF JA, 1991, ANN INTERN MED, V114, P576, DOI 10.7326/0003-4819-114-7-576; Richter JE, 2000, ARCH INTERN MED, V160, P1803, DOI 10.1001/archinte.160.12.1803; Sackett DL, 1997, EVIDENCE BASED MED P; SONTAG SJ, 1992, GASTROENTEROLOGY, V102, P109, DOI 10.1016/0016-5085(92)91790-B; WILLIAMSON JW, 1989, ANN INTERN MED, V110, P151, DOI 10.7326/0003-4819-110-2-151; WILSON SR, 1989, UNPUB USE CRITICAL I	26	236	245	0	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2002	324	7339					710	713		10.1136/bmj.324.7339.710	http://dx.doi.org/10.1136/bmj.324.7339.710			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535ML	11909789	Green Published, Bronze			2022-12-24	WOS:000174648200020
J	Mekler, V; Kortkhonjia, E; Mukhopadhyay, J; Knight, J; Revyakin, A; Kapanidis, AN; Niu, W; Ebright, YW; Levy, R; Ebright, RH				Mekler, V; Kortkhonjia, E; Mukhopadhyay, J; Knight, J; Revyakin, A; Kapanidis, AN; Niu, W; Ebright, YW; Levy, R; Ebright, RH			Structural organization of bacterial RNA polymerase holoenzyme and the RNA polymerase-promoter open complex	CELL			English	Article							RESONANCE ENERGY-TRANSFER; SIGMA(70) BINDING-SITE; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; LARGE SUBUNITS; BETA-SUBUNIT; AMINO-ACIDS; TRANSCRIPTION	We have used systematic fluorescence resonance energy transfer and distance-constrained docking to define the three-dimensional structures of bacterial RNA polymerase holoenzyme and the bacterial RNA polymerase-promoter open complex in solution. The structures provide a framework for understanding sigma(70)-(RNA polymerase core), sigma(70)-DNA, and sigma(70)-RNA interactions. The positions of sigma(70) regions 1.2, 2, 3, and 4 are similar in holoenzyme and open complex. In contrast, the position of sigma(70) region 1.1 differs dramatically in holoenzyme and open complex. In holoenzyme, region 1.1 is located within the active-center cleft, apparently serving as a "molecular mimic" of DNA, but, in open complex, region 1.1 is located outside the active center cleft. The approach described here should be applicable to the analysis of other nanometer-scale complexes.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Chem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, POB 759, Piscataway, NJ 08854 USA.	ebright@mbcl.rutges.edu	Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376, P20GM064375] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64375, GM41376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIYAR SE, 1994, BIOCHEMISTRY-US, V33, P11501, DOI 10.1021/bi00204a012; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Ayers B, 1999, BIOPOLYMERS, V51, P343, DOI 10.1002/(SICI)1097-0282(1999)51:5<343::AID-BIP4>3.0.CO;2-W; Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Burley SK, 1998, CELL, V94, P551, DOI 10.1016/S0092-8674(00)81596-2; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; CHEN RF, 1965, SCIENCE, V147, P729, DOI 10.1126/science.147.3659.729; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Christie GE, 1996, J BACTERIOL, V178, P6991, DOI 10.1128/jb.178.23.6991-6993.1996; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DANIELS D, 1990, P NATL ACAD SCI USA, V87, P8075, DOI 10.1073/pnas.87.20.8075; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; FISHER R, 1953, PROC R SOC LON SER-A, V217, P295, DOI 10.1098/rspa.1953.0064; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Ghosh A, 1998, J PHYS CHEM B, V102, P10983, DOI 10.1021/jp982533o; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2001, MOL CELL, V8, P21, DOI 10.1016/S1097-2765(01)00292-1; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JUANG YL, 1994, J MOL BIOL, V239, P1, DOI 10.1006/jmbi.1994.1346; Kapanidis AN, 2001, J MOL BIOL, V312, P453, DOI 10.1006/jmbi.2001.4976; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; LAKOWICZ J, 1999, PRINCIPLES FLUORESCE, V27; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Lilley DMJ, 2000, CURR OPIN CHEM BIOL, V4, P507, DOI 10.1016/S1367-5931(00)00124-1; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Marr MT, 2001, P NATL ACAD SCI USA, V98, P8972, DOI 10.1073/pnas.161253298; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Naryshkin N, 2000, METH MOL B, V148, P337; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NIU W, 1999, THESIS RUTGERS U NEW; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Severinov K, 1997, J BIOL CHEM, V272, P24137, DOI 10.1074/jbc.272.39.24137; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SUH WC, 1992, BIOCHEMISTRY-US, V31, P7815, DOI 10.1021/bi00149a011; TANG H, 1994, GENE DEV, V8, P3058, DOI 10.1101/gad.8.24.3058; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; Traviglia SL, 1999, BIOCHEMISTRY-US, V38, P4259, DOI 10.1021/bi983016z; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Waldspurger J.-L., 1990, ISRAEL MATH C P, V2, P267; Wilson C, 1997, J MOL BIOL, V267, P60, DOI 10.1006/jmbi.1997.0875; WU PG, 1992, BIOCHEMISTRY-US, V31, P7939, DOI 10.1021/bi00149a027; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	72	229	236	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					599	614		10.1016/S0092-8674(02)00667-0	http://dx.doi.org/10.1016/S0092-8674(02)00667-0			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893332	Bronze			2022-12-24	WOS:000174314800005
J	Solowij, N; Stephens, RS; Roffman, RA; Babor, T; Kadden, R; Miller, M; Christiansen, K; McRee, B; Vendetti, J				Solowij, N; Stephens, RS; Roffman, RA; Babor, T; Kadden, R; Miller, M; Christiansen, K; McRee, B; Vendetti, J		Marijuana Treatment Project Res	Cognitive functioning of long-term heavy cannabis users seeking treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SELECTIVE ATTENTION; MARIJUANA USE; MEMORY; IMPAIRMENTS; ABSTINENCE; CEREBELLAR; EDUCATION; ADDICTION; SMOKING; INJURY	Context Cognitive impairments are associated with long-term cannabis use, but the parameters of use that contribute to impairments and the nature and endurance of cognitive dysfunction remain uncertain. Objective To examine the effects of duration of cannabis use on specific areas of cognitive functioning among users seeking treatment for cannabis dependence. Design, Setting, and Participants Multisite retrospective cross-sectional neuropsychological study conducted in the United States (Seattle, Wash; Farmington, Conn; and Miami, Fla) between 1997 and 2000 among 102 near-daily cannabis users (51 long-term users: mean, 23.9 years of use; 51 shorter-term users: mean, 10.2 years of use) compared with 33 nonuser controls. Main Outcome Measures Measures from 9 standard neuropsychological tests that assessed attention, memory, and executive functioning, and were administered prior to entry to a treatment program and following a median 17-hour abstinence. Results Long-term cannabis users performed significantly less well than shorter-term users and controls on tests of memory and attention. On the Rey Auditory Verbal Learning Test, long-term users recalled significantly fewer words than either shorter-term users (P=.001) or controls (P=.005); there was no difference between shorter-term users and controls. Long-term users showed impaired learning (P=.007), retention (P=.003), and retrieval (P=.002) compared with controls. Both user groups performed poorly on a time estimation task (P<.001 vs controls). Performance measures often correlated significantly with the duration of cannabis use, being worse with increasing years of use, but were unrelated to withdrawal symptoms and persisted after controlling for recent cannabis use and other drug use. Conclusions These results confirm that long-term heavy cannabis users show impairments in memory and attention that endure beyond the period of intoxication and worsen with increasing years of regular cannabis use.	Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Wollongong, Dept Psychol, Wollongong, NSW 2500, Australia; Virginia Polytech Inst & State Univ, Dept Psychol, Blacksburg, VA 24061 USA; Univ Washington, Sch Social Work, Innovat Programs Res Grp, Seattle, WA 98195 USA; Univ Connecticut, Ctr Hlth, Dept Psychiat, Farmington, CT 06032 USA; Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT USA; Village S Inc, Miami, FL USA	University of New South Wales Sydney; University of Wollongong; Virginia Polytechnic Institute & State University; University of Washington; University of Washington Seattle; University of Connecticut; University of Connecticut	Solowij, N (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.		Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Solowij, Nadia/0000-0002-5222-5637; Babor, Thomas/0000-0002-2580-0835	CSAT SAMHSA HHS [UR4 TI11273, UR4TI11274, UR4TI11310, UR4 TI11270] Funding Source: Medline	CSAT SAMHSA HHS		Baddeley AD, 1992, SPEED CAPACITY LANGU; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BELL R, 1989, J TOXICOL-CLIN TOXIC, V27, P109, DOI 10.3109/15563658909038574; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Block RI, 2000, NEUROREPORT, V11, P749, DOI 10.1097/00001756-200003200-00019; BLOCK RI, 2000, ABSTR SOC NEUROSCI, V26, P2080; BLOCK RI, IN PRESS PHARM BIOCH; Bohme GA, 2000, NEUROSCIENCE, V95, P5; Bohnen N, 1992, Clin Neuropsychol, V6, P178, DOI 10.1080/13854049208401854; Brittain J.L., 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; DACKIS CA, 1982, AM J PSYCHIAT, V139, P1196; ELLIS GM, 1985, CLIN PHARMACOL THER, V38, P572, DOI 10.1038/clpt.1985.226; Elwan O, 1997, J NEUROL SCI, V148, P79, DOI 10.1016/S0022-510X(96)05336-1; First M. D., 1996, USERS GUIDE STRUCTUR; Fletcher JM, 1996, ARCH GEN PSYCHIAT, V53, P1051; Fraser AD, 1999, J ANAL TOXICOL, V23, P531, DOI 10.1093/jat/23.6.531; Fried PA, 1998, NEUROTOXICOL TERATOL, V20, P293, DOI 10.1016/S0892-0362(97)00091-3; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Golden C.J., 1978, STROOP COLOR WORD TE; Hall W, 2000, ADDICTION, V95, P485, DOI 10.1046/j.1360-0443.2000.9544851.x; Hampson RE, 1999, LIFE SCI, V65, P715, DOI 10.1016/S0024-3205(99)00294-5; Hampson RE, 2000, J NEUROSCI, V20, P8932; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Hermann BP, 1996, CORTEX, V32, P323, DOI 10.1016/S0010-9452(96)80054-2; Jastak J.J., 1984, MANUAL WIDE RANGE AC; KAREKEN DA, 1995, ARCH CLIN NEUROPSYCH, V10, P147, DOI 10.1016/0887-6177(94)E0012-E; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levy R, 2000, EXP BRAIN RES, V133, P23, DOI 10.1007/s002210000397; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Loeber RT, 1999, HUM PSYCHOPHARM CLIN, V14, P291, DOI 10.1002/(SICI)1099-1077(199907)14:5<291::AID-HUP100>3.0.CO;2-H; Lyketsos CG, 1999, AM J EPIDEMIOL, V149, P794; *MAR TREATM PROJ R, IN PRESS ARCH GEN PS; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Miller W. R., 1996, PROJECT MATCH MONOGR, V5; Pope HG, 1997, PSYCHOTHER PSYCHOSOM, V66, P179; POPE HG, 1995, DRUG ALCOHOL DEPEN, V38, P25, DOI 10.1016/0376-8716(95)01097-I; Pope HG, 1996, JAMA-J AM MED ASSOC, V275, P521, DOI 10.1001/jama.275.7.521; *PSYCH ASS RES INC, 1989, WISC CARD SORT TEST; Reibaud M, 1999, EUR J PHARMACOL, V379, pR1, DOI 10.1016/S0014-2999(99)00496-3; Rey A, 1964, LEXAMEN CLINIQUE PSY; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33, DOI DOI 10.1080/13854049108401840; Schacter DL, 1998, SCIENCE, V280, P59, DOI 10.1126/science.280.5360.59; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Sobell L. C, 1992, MEASURING ALCOHOL CO; SOLOWIJ N, 1995, BIOL PSYCHIAT, V37, P731, DOI 10.1016/0006-3223(94)00178-6; SOLOWIJ N, 1991, PHARMACOL BIOCHEM BE, V40, P683, DOI 10.1016/0091-3057(91)90382-C; SOLOWIJ N, 1995, LIFE SCI, V56, P2119, DOI 10.1016/0024-3205(95)00197-E; Solowij N., 1998, CANNABIS COGNITIVE F; SOLOWIJ N, 1997, 1997 S CANN BURL VT, P84; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stuss D, 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [10.1080/13854048708520046, DOI 10.1080/13854048708520046]; Stuss D.T., 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [10.1080/13854048808520107, DOI 10.1080/13854048808520107]; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG H, V6; Voelker R, 1997, JAMA-J AM MED ASSOC, V278, P802, DOI 10.1001/jama.278.10.802; Watson SJ, 2000, ARCH GEN PSYCHIAT, V57, P547, DOI 10.1001/archpsyc.57.6.547	56	547	562	1	97	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1123	1131		10.1001/jama.287.9.1123	http://dx.doi.org/10.1001/jama.287.9.1123			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	11879109	Bronze			2022-12-24	WOS:000174186000027
J	Klein-Seetharaman, J; Oikawa, M; Grimshaw, SB; Wirmer, J; Duchardt, E; Ueda, T; Imoto, T; Smith, LJ; Dobson, CM; Schwalbe, H				Klein-Seetharaman, J; Oikawa, M; Grimshaw, SB; Wirmer, J; Duchardt, E; Ueda, T; Imoto, T; Smith, LJ; Dobson, CM; Schwalbe, H			Long-range interactions within a nonnative protein	SCIENCE			English	Article							FREE-ENERGY FUNCTIONALS; ACID-BINDING PROTEIN; RESIDUAL STRUCTURE; EXPLORING STRUCTURES; DENATURED PROTEIN; FOLDING FUNNELS; CHEMICAL-SHIFTS; PHOTO-CIDNP; MAIN-CHAIN; NMR	Protein folding and unfolding are coupled to a range of biological phenomena, from the regulation of cellular activity to the onset of neurodegenerative diseases. Defining the nature of the conformations sampled in nonnative proteins is crucial for understanding the origins of such phenomena. We have used a combination of nuclear magnetic resonance (NMR) spectroscopy and site-directed mutagenesis to study unfolded states of the protein lysozyme. Extensive clusters of hydrophobic structure exist within the wild-type protein even under strongly denaturing conditions. These clusters involve distinct regions of the sequence but are all disrupted by a single point mutation that replaced residue Trp(62) with Gly located at the interface of the two major structural domains in the native state. Thus, nativelike structure in the denatured protein is stabilized by the involvement of Trp(62) in nonnative and long-range interactions.	MIT, Dept Chem, Francis Bitter Magnet Lab, Cambridge, MA 02139 USA; Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; Univ Oxford, Oxford Ctr Mol Sci, New Chem Lab, Oxford OX1 3QH, England	Massachusetts Institute of Technology (MIT); Kyushu University; University of Oxford	Klein-Seetharaman, J (corresponding author), Goethe Univ Frankfurt, Ctr Biol Magnet Resonance, Inst Organ Chem, Marie Curie Str 11, D-60439 Frankfurt, Germany.	schwalbe@nmr.uni-frankfurt.de	Schwalbe, Harald/AAB-3143-2020; Schwalbe, Harald J/F-9023-2010	Schwalbe, Harald/0000-0001-5693-7909; Schwalbe, Harald J/0000-0001-5693-7909				BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blanco FJ, 1998, J MOL BIOL, V284, P1153, DOI 10.1006/jmbi.1998.2229; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BUCK M, 1995, BIOCHEMISTRY-US, V34, P4041, DOI 10.1021/bi00012a023; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Dyson HJ, 1998, NAT STRUCT BIOL, V5, P499, DOI 10.1038/739; Fiebig KM, 1996, J PHYS CHEM-US, V100, P2661, DOI 10.1021/jp952747v; Hodsdon ME, 2001, BIOCHEMISTRY-US, V40, P732, DOI 10.1021/bi001518i; Hore PJ, 1997, J AM CHEM SOC, V119, P5049, DOI 10.1021/ja9644135; Lyon CE, 1999, J AM CHEM SOC, V121, P6505, DOI 10.1021/ja9907663; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410; Radford SE, 1999, CELL, V97, P291, DOI 10.1016/S0092-8674(00)80739-4; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; ROMERO P, 1998, PAC S BIOCOMPUT, V3; ROPSON IJ, 1992, P NATL ACAD SCI USA, V89, P7222, DOI 10.1073/pnas.89.15.7222; Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119; SaabRincon G, 1996, BIOCHEMISTRY-US, V35, P1988, DOI 10.1021/bi951726o; Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q; Schwalbe H, 2001, PROTEIN SCI, V10, P677, DOI 10.1110/ps.43301; Shoemaker BA, 1999, J MOL BIOL, V287, P675, DOI 10.1006/jmbi.1999.2613; Shoemaker BA, 1999, J MOL BIOL, V287, P657, DOI 10.1006/jmbi.1999.2612; SHORTLE D, 1993, STRUCTURE, V1, P121, DOI 10.1016/0969-2126(93)90027-E; Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438; Shortle DR, 1996, CURR OPIN STRUC BIOL, V6, P24, DOI 10.1016/S0959-440X(96)80091-1; Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041; Sober H. A., 1970, HDB BIOCH SELECTED D; UEDA T, 1990, J BIOCHEM-TOKYO, V108, P886, DOI 10.1093/oxfordjournals.jbchem.a123297; UEDA T, 1994, J MOL BIOL, V235, P1312, DOI 10.1006/jmbi.1994.1084; Ueda T, 1996, BIOCHEM BIOPH RES CO, V228, P203, DOI 10.1006/bbrc.1996.1640; van Gunsteren WF, 2001, ANGEW CHEM INT EDIT, V40, P351, DOI 10.1002/1521-3773(20010119)40:2<351::AID-ANIE351>3.0.CO;2-6; Vaney MC, 1996, ACTA CRYSTALLOGR D, V52, P505, DOI 10.1107/S090744499501674X; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wong KB, 1996, J MOL BIOL, V259, P805, DOI 10.1006/jmbi.1996.0359; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	38	543	547	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1719	1722		10.1126/science.1067680	http://dx.doi.org/10.1126/science.1067680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872841				2022-12-24	WOS:000174212900048
J	Shapiro, B; Sibthorpe, D; Rambaut, A; Austin, J; Wragg, GM; Bininda-Emonds, ORP; Lee, PLM; Cooper, A				Shapiro, B; Sibthorpe, D; Rambaut, A; Austin, J; Wragg, GM; Bininda-Emonds, ORP; Lee, PLM; Cooper, A			Flight of the dodo	SCIENCE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Oxford; University of Oxford; Natural History Museum London	Cooper, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Rambaut, Andrew/B-2481-2009; Bininda-Emonds, Olaf/P-6718-2019; Austin, Jeremy J/F-8729-2010; Lee, Patricia/N-4157-2013; Cooper, Alan/E-8171-2012; Bininda-Emonds, Olaf R.P:/C-5405-2008	Rambaut, Andrew/0000-0003-4337-3707; Austin, Jeremy J/0000-0003-4244-2942; Lee, Patricia/0000-0002-8489-9206; Cooper, Alan/0000-0002-7738-7851; Bininda-Emonds, Olaf R.P:/0000-0003-4432-224X				Cooper A, 2000, SCIENCE, V289, P1139; Gibbs D., 2001, PIGEONS DOVES GUIDE; Janoo Anwar, 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P57; MCDOUGAL.I, 1969, GEOL SOC AM BULL, V80, P1419, DOI 10.1130/0016-7606(1969)80[1419:IDAGPS]2.0.CO;2	4	123	133	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1683	1683		10.1126/science.295.5560.1683	http://dx.doi.org/10.1126/science.295.5560.1683			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872833				2022-12-24	WOS:000174212900037
J	Zaccolo, M; Pozzan, T				Zaccolo, M; Pozzan, T			Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; HEART; COMPARTMENTATION; PROSTAGLANDIN-E1; ISOPROTERENOL; ACTIVATION; BETA	The second messenger cyclic adenosine monophosphate (cAMP) is the most important modulator of sympathetic control over cardiac contractility. In cardiac myocytes and many other cell types, however, cAMP transduces the signal generated upon stimulation of various receptors and activates different cellular functions, raising the issue of how specificity can be achieved. In the general field of signal transduction, the view is emerging that specificity is guaranteed by tight localization of signaling events. Here, we show that in neonatal rat cardiac myocytes, P-adrenergic stimulation generates multiple microdomains with increased concentration of cAMP in correspondence with the region of the transverse tubule/junctional sarcoplasmic reticulum membrane. The restricted pools of cAMP show a range of action as small as approximately 1 micrometer, and free diffusion of the second messenger is limited by the activity of phosphodiesterases. Furthermore, we demonstrate that such gradients of cAMP specifically activate a subset of protein kinase A molecules anchored in proximity to the T tubule.	Univ Padua, Dept Biomed Sci, I-35129 Padua, Italy; Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Zaccolo, M (corresponding author), Univ Padua, Dept Biomed Sci, Via Orus 2, I-35129 Padua, Italy.		Zaccolo, Manuela/B-3802-2011; Zaccolo, Manuela/AAP-6706-2020	Zaccolo, Manuela/0000-0002-0934-3662	Telethon [TCP00089] Funding Source: Medline	Telethon(Fondazione Telethon)		BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; BRUNTON LL, 1981, ADV CYCL NUCL RES<D>, V14, P391; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; CARR DW, 1992, J BIOL CHEM, V267, P13376; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC838, DOI 10.1152/ajpcell.1992.263.4.C838; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; HAYES JS, 1982, BIOCHIM BIOPHYS ACTA, V714, P136, DOI 10.1016/0304-4165(82)90135-0; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jurevicius J, 1996, P NATL ACAD SCI USA, V93, P295, DOI 10.1073/pnas.93.1.295; Laflamme MA, 1999, AM J PHYSIOL-HEART C, V277, pH1841, DOI 10.1152/ajpheart.1999.277.5.H1841; LI Y, 1995, J BIOL CHEM, V270, P1935, DOI 10.1074/jbc.270.4.1935; Schillace RV, 1999, J CLIN INVEST, V103, P761, DOI 10.1172/JCI6491; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; ZACCOLO M, UNPUB	19	651	681	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1711	1715		10.1126/science.1069982	http://dx.doi.org/10.1126/science.1069982			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872839				2022-12-24	WOS:000174212900046
J	van Praag, H; Schinder, AF; Christie, BR; Toni, N; Palmer, TD; Gage, FH				van Praag, H; Schinder, AF; Christie, BR; Toni, N; Palmer, TD; Gage, FH			Functional neurogenesis in the adult hippocampus	NATURE			English	Article							LONG-TERM POTENTIATION; DENTATE GYRUS; STEM-CELLS; IN-VITRO; RAT; NEURONS; MICE; PROLIFERATION; VIRUS	There is extensive evidence indicating that new neurons are generated in the dentate gyrus of the adult mammalian hippocampus, a region of the brain that is important for learning and memory(1-5). However, it is not known whether these new neurons become functional, as the methods used to study adult neurogenesis are limited to fixed tissue. We use here a retroviral vector expressing green fluorescent protein that only labels dividing cells, and that can be visualized in live hippocampal slices. We report that newly generated cells in the adult mouse hippocampus have neuronal morphology and can display passive membrane properties, action potentials and functional synaptic inputs similar to those found in mature dentate granule cells. Our findings demonstrate that newly generated cells mature into functional neurons in the adult mammalian brain.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	van Praag, H (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vanpraag@salk.edu	Christie, Brian Ross/AAF-3766-2019; Palmer, Theo/GSI-6635-2022; Toni, Nicolas/M-2057-2014; van Praag, Henriette/F-3939-2015	Christie, Brian Ross/0000-0002-6830-0160; Toni, Nicolas/0000-0001-5585-268X; van Praag, Henriette/0000-0002-5727-434X; Palmer, Theo/0000-0002-6266-1862; Schinder, Alejandro/0000-0003-4863-8348	NIMH NIH HHS [R01 MH090258] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; COLEMAN LA, 1992, J NEUROSCI METH, V44, P167, DOI 10.1016/0165-0270(92)90009-3; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; CRAIN B, 1973, BRAIN RES, V63, P195, DOI 10.1016/0006-8993(73)90088-7; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GOULD E, 1992, J NEUROSCI, V12, P3642; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Liu JL, 1998, J NEUROSCI, V18, P7768; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Markakis EA, 1999, J COMP NEUROL, V406, P449; Palmer TD, 1999, J NEUROSCI, V19, P8487; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parent JM, 1997, J NEUROSCI, V17, P3727; Roy NS, 2000, NAT MED, V6, P271; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Suzuki F, 1997, EXP NEUROL, V145, P203, DOI 10.1006/exnr.1997.6469; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; XU L, 1989, VIROLOGY, V171, P331, DOI 10.1016/0042-6822(89)90600-4	30	2203	2265	3	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1030	1034		10.1038/4151030a	http://dx.doi.org/10.1038/4151030a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875571	Green Accepted			2022-12-24	WOS:000174075000047
J	Klass, KD; Zompro, O; Kristensen, NP; Adis, J				Klass, KD; Zompro, O; Kristensen, NP; Adis, J			Mantophasmatodea: A new insect order with extant members in the afrotropics	SCIENCE			English	Article							PHYLOGENY; ABDOMEN; DICTYOPTERA; MORPHOLOGY	A new insect order, Mantophasmatodea, is described on the basis of museum specimens of a new genus with two species: Mantophasma zephyra gen. et sp. nov. (one female from Namibia) and M. subsolana sp. nov. (one male from Tanzania). This is the first time since 1914 that a newly described extant insect taxon has proved unplaceable within a recognized order. Mantophasmatodeans are apterous carnivores. Their closest phylogenetic relationships may be to Grylloblattodea (ice-crawlers) and/or Phasmatodea (stick insects), but the morphological evidence is ambiguous. Raptophasma Zompro from Baltic amber is assigned to the Mantophasmatodea, revealing a wider previous range for the lineage.	Univ Copenhagen, Zool Museum, DK-2100 Copenhagen, Denmark; AG Tropenokol, Max Planck Inst Limnol, D-24306 Plon, Germany; Staatliche Nat Hist Sammlungen Dresden, Museum Tierkunde, D-01109 Dresden, Germany	University of Copenhagen; Max Planck Society	Klass, KD (corresponding author), Univ Copenhagen, Zool Museum, Univ Pk 15, DK-2100 Copenhagen, Denmark.	klass@snsd.de; zompro@mpil.ploen.mpg.de	Kristensen, Niels/A-8795-2013					Arillo Antonio, 1997, Bulletin de la Societe Entomologique de France, V102, P11; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; CHOPARD L, 1938, BIOL ORTHOPTERES; GUNTHER K, 1933, Z NATURWISS, V68, P403; Hinton H. E., 1981, BIOL INSECT EGGS; Klass KD, 1998, ZOOL ANZ, V237, P15; Klass KD, 1999, DEUT ENTOMOL Z, V46, P3; Klass KD, 2000, ZOOL ANZ, V239, P231; Klass KD, 2001, ZOOL J LINN SOC-LOND, V131, P251, DOI 10.1111/j.1096-3642.2001.tb02239.x; KRISTENSEN NP, 1989, INT CONGR SER, V824, P295; KRISTENSEN NP, 1991, INSECTS AUSTR, V1, pCH5; Sellick J, 1997, ITAL J ZOOL, V64, P97, DOI 10.1080/11250009709356178; Staniczek AH, 2000, ZOOL ANZ, V239, P147; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; Walker E. M., 1943, ANN ENT SOC AMERICA, V36, P681; WALKER E. M., 1949, CANADIAN JOUR RES SECT D ZOOL SCI, V27, P309; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	18	124	148	5	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1456	1459		10.1126/science.1069397	http://dx.doi.org/10.1126/science.1069397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	11964441				2022-12-24	WOS:000175910300045
J	Benlagha, K; Kyin, T; Beavis, A; Teyton, L; Bendelac, A				Benlagha, K; Kyin, T; Beavis, A; Teyton, L; Bendelac, A			A thymic precursor to the NK T cell lineage	SCIENCE			English	Article							CLASS-I MOLECULES; CD1D TETRAMERS; THYMOCYTES; SELECTION; RECOGNITION	CD1d-restricted autoreactive natural killer (NK1.1(+)) T cells function as regulatory cells in various disease conditions. Using improved tetramer tracking methodology, we identified a NK1.1(-) thymic precursor and followed its differentiation and emigration to tissues by direct cell transfer and in situ cell labeling studies. A major lineage expansion occurred within the thymus after positive selection and before NK receptor expression. Surprisingly, cytokine analysis of the developmental intermediates between NK- and NK+ stages showed a T helper cell T(H)2 to T(H)1 conversion, suggesting that the regulatory functions of NK T cells may be developmentally controlled. These findings characterize novel thymic and postthymic developmental pathways that expand autoreactive cells and differentiate them into regulatory cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Princeton University; Scripps Research Institute	Bendelac, A (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.		Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022	benlagha, kamel/0000-0002-3251-9195	NATIONAL CANCER INSTITUTE [R01CA087060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038339, R01AI038339] Funding Source: NIH RePORTER; NCI NIH HHS [CA87060] Funding Source: Medline; NIAID NIH HHS [AI38339, AI62267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; BENLAGHA K, UNPUB; Coles MC, 2000, J IMMUNOL, V164, P2412, DOI 10.4049/jimmunol.164.5.2412; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Ikarashi Y, 2001, J EXP MED, V194, P1179, DOI 10.1084/jem.194.8.1179; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; MacDonald HR, 1998, J EXP MED, V187, P2109, DOI 10.1084/jem.187.12.2109; MAKINO Y, 1993, J EXP MED, V177, P1399, DOI 10.1084/jem.177.5.1399; Makino Y, 1996, P NATL ACAD SCI USA, V93, P6516, DOI 10.1073/pnas.93.13.6516; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Park SH, 1998, J IMMUNOL, V160, P3128; Sato H, 1999, P NATL ACAD SCI USA, V96, P7439, DOI 10.1073/pnas.96.13.7439; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shimamura M, 1997, EUR J IMMUNOL, V27, P1576, DOI 10.1002/eji.1830270638; Shimamura M, 1997, J IMMUNOL, V158, P3682; TAKAHAMA Y, 1991, J IMMUNOL, V146, P1134; Tilloy F, 1999, EUR J IMMUNOL, V29, P3313, DOI 10.1002/(SICI)1521-4141(199910)29:10<3313::AID-IMMU3313>3.3.CO;2-#	27	410	416	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					553	555		10.1126/science.1069017	http://dx.doi.org/10.1126/science.1069017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11968185				2022-12-24	WOS:000175179400053
J	Sasaki, A; Ashikari, M; Ueguchi-Tanaka, M; Itoh, H; Nishimura, A; Swapan, D; Ishiyama, K; Saito, T; Kobayashi, M; Khush, GS; Kitano, H; Matsuoka, M				Sasaki, A; Ashikari, M; Ueguchi-Tanaka, M; Itoh, H; Nishimura, A; Swapan, D; Ishiyama, K; Saito, T; Kobayashi, M; Khush, GS; Kitano, H; Matsuoka, M			Green revolution: A mutant gibberellin-synthesis gene in rice - New insight into the rice variant that helped to avert famine over thirty years ago.	NATURE			English	Editorial Material							20-OXIDASE; CLONING		Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Sasaki, A (corresponding author), Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan.		Khush, Gurdev Singh/C-5109-2009; Kobayashi, Masatomo/A-5945-2016					Dalrymple DG, 1986, Development and spread of high -yielding wheat varieties in developing countries, V7th; HARGROVE TR, 1979, BIOSCIENCE, V29, P731, DOI 10.2307/1307667; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; HOOLEY R, 1994, PLANT MOL BIOL, V26, P1529, DOI 10.1007/BF00016489; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Maeda H, 1997, BREEDING SCI, V47, P317; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Ross JJ, 1997, PHYSIOL PLANTARUM, V100, P550, DOI 10.1034/j.1399-3054.1997.1000317.x; Toyomasu T, 1997, PHYSIOL PLANTARUM, V99, P111, DOI 10.1034/j.1399-3054.1997.990116.x; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; ZHANG WG, 1991, PLANT CELL, V3, P1155, DOI 10.1105/tpc.3.11.1155	11	805	940	31	359	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					701	702		10.1038/416701a	http://dx.doi.org/10.1038/416701a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961544				2022-12-24	WOS:000175033500031
J	Choe, KM; Werner, T; Stoven, S; Hultmark, D; Anderson, KV				Choe, KM; Werner, T; Stoven, S; Hultmark, D; Anderson, KV			Requirement for a peptidoglycan recognition protein (PGRP) in relish activation and antibacterial immune responses in Drosophila	SCIENCE			English	Article							GENE; ANTIFUNGAL; DEFENSE	Components of microbial cell walls are potent activators of innate immune responses in animals. For example, the mammalian TLR4 signaling pathway is activated by bacterial lipopolysaccharide and is required for resistance to infection by Gram-negative bacteria. Other components of microbial surfaces, such as peptidoglycan, are also potent activators of innate immune responses, but less is known about how those components activate host defense. Here we show that a peptidoglycan recognition protein, PGRP-LC, is absolutely required for the induction of antibacterial peptide genes in response to infection in Drosophila and acts by controlling activation of the NF-kappaB family transcription factor Relish.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Mol & Cell Biol Program, New York, NY 10021 USA; Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden	Memorial Sloan Kettering Cancer Center; Cornell University; Umea University	Anderson, KV (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Hultmark, Dan/C-5058-2013	Hultmark, Dan/0000-0002-6506-5855; Anderson, Kathryn/0000-0003-1657-2161				BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen B, 1998, GENETICS, V149, P157; CHOE KH, UNPUB; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; HATTON LS, 1999, ELSEVIER TRENDS J TE; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; JANEWAY CA, 1989, COLD SH Q B, V54, P1; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Khush RS, 2001, TRENDS IMMUNOL, V22, P260, DOI 10.1016/S1471-4906(01)01887-7; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Spradling A. C, 1986, DROSOPHILA PRACTICAL; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu LP, 1998, NATURE, V392, P93, DOI 10.1038/32195; Wu LP, 2001, GENETICS, V159, P189; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	29	466	499	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					359	362		10.1126/science.1070216	http://dx.doi.org/10.1126/science.1070216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11872802				2022-12-24	WOS:000175000300062
J	Kew, O; Morris-Glasgow, V; Landaverde, M; Burns, C; Shaw, J; Garib, Z; Andre, J; Blackman, E; Freeman, CJ; Jorba, J; Sutter, R; Tambini, G; Venczel, L; Pedreira, C; Laender, F; Shimizu, H; Yoneyama, T; Miyamura, T; van der Avoort, H; Oberste, MS; Kilpatrick, D; Cochi, S; Pallansch, M; de Quadros, C				Kew, O; Morris-Glasgow, V; Landaverde, M; Burns, C; Shaw, J; Garib, Z; Andre, J; Blackman, E; Freeman, CJ; Jorba, J; Sutter, R; Tambini, G; Venczel, L; Pedreira, C; Laender, F; Shimizu, H; Yoneyama, T; Miyamura, T; van der Avoort, H; Oberste, MS; Kilpatrick, D; Cochi, S; Pallansch, M; de Quadros, C			Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus	SCIENCE			English	Article							WILD POLIOVIRUS; PARALYTIC POLIOMYELITIS; MOLECULAR EVOLUTION; EPIDEMIOLOGY; ERADICATION; REGION; DETERMINANTS; TRANSMISSION; ATTENUATION; AMERICA	An outbreak of paralytic poliomyelitis occurred in the Dominican Republic (13 confirmed cases) and Haiti (8 confirmed cases, including 2 fatal cases) during 2000-2001. All but one of the patients were either unvaccinated or incompletely vaccinated children, and cases occurred in communities with very Low (7 to 40%) rates of coverage with oral poliovirus vaccine (OPV). The outbreak was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998-1999. The vaccine-derived poliovirus associated with the outbreak had biological properties indistinguishable from those of wild poliovirus.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Pan Amer Hlth Org, Caribbean Epidemiol Ctr Lab, Port of Spain, Trinidad Tobago; PAHO, Div Vaccines & Immunizat, Washington, DC 20037 USA; Minist Hlth, Santo Domingo, Dominican Rep; Minist Publ Hlth, Port au Prince, Haiti; Ctr Dis Control & Prevent, Vaccine Preventable Dis Eradicat Div, Natl Immunizat Program, Atlanta, GA 30333 USA; PAHO, Santo Domingo, Dominican Rep; PAHO, Port au Prince, Haiti; Natl Inst Infect Dis, Dept Virol 2, Shinjuku Ku, Tokyo 162, Japan; Natl Inst Publ Hlth & Environm, Polio Lab, RIVM, NL-3720 BA Bilthoven, Netherlands	Centers for Disease Control & Prevention - USA; Pan American Health Organization; Pan American Health Organization; Centers for Disease Control & Prevention - USA; National Institute of Infectious Diseases (NIID); Netherlands National Institute for Public Health & the Environment	Kew, O (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.	okew@cdc.gov	Shimizu, Hiroyuki/AAU-9621-2020	Shimizu, Hiroyuki/0000-0002-2987-2377				ANDRUS JK, 1995, B WORLD HEALTH ORGAN, V73, P33; BOUCHARD MJ, 1995, J VIROL, V69, P4972, DOI 10.1128/JVI.69.8.4972-4978.1995; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P874; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P41; DE L, 1995, J CLIN MICROBIOL, V33, P562, DOI 10.1128/JCM.33.3.562-571.1995; deQuadros CA, 1997, J INFECT DIS, V175, pS37, DOI 10.1093/infdis/175.Supplement_1.S37; Drebot MA, 1997, APPL ENVIRON MICROB, V63, P519, DOI 10.1128/AEM.63.2.519-523.1997; Gromeier M, 1999, J VIROL, V73, P958, DOI 10.1128/JVI.73.2.958-964.1999; KAWAMURA N, 1989, J VIROL, V63, P1302, DOI 10.1128/JVI.63.3.1302-1309.1989; Kew OM, 1995, SEMIN VIROL, V6, P401, DOI 10.1016/S1044-5773(05)80017-4; Liu HM, 2000, J VIROL, V74, P11153, DOI 10.1128/JVI.74.23.11153-11161.2000; MINOR PD, 1988, J GEN VIROL, V69, P1091, DOI 10.1099/0022-1317-69-5-1091; MINOR PD, 1990, CURR TOP MICROBIOL, V161, P121; MUZYCHENKO AR, 1991, VIRUS RES, V21, P111, DOI 10.1016/0168-1702(91)90002-D; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; *PAN AM HLTH ORG, 1996, EPI NEWSL, V18, P4; Patriarca PA, 1997, J INFECT DIS, V175, pS165, DOI 10.1093/infdis/175.Supplement_1.S165; Robbins FC, 1997, J INFECT DIS, V175, pS281, DOI 10.1093/infdis/175.Supplement_1.S281; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; STREBEL PM, 1992, CLIN INFECT DIS, V14, P568, DOI 10.1093/clinids/14.2.568; VANDERAVOORT HGAM, 1995, J CLIN MICROBIOL, V33, P2562, DOI 10.1128/JCM.33.10.2562-2566.1995; Wood DJ, 2000, B WORLD HEALTH ORGAN, V78, P347; World Health Organ, 2001, WKLY EPIDEMIOL REC, V76, P126	24	418	455	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					356	359		10.1126/science.1068284	http://dx.doi.org/10.1126/science.1068284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11896235	Green Submitted			2022-12-24	WOS:000175000300061
J	Bradbury, EJ; Moon, LDF; Popat, RJ; King, VR; Bennett, GS; Patel, PN; Fawcett, JW; McMahon, SB				Bradbury, EJ; Moon, LDF; Popat, RJ; King, VR; Bennett, GS; Patel, PN; Fawcett, JW; McMahon, SB			Chondroitinase ABC promotes functional recovery after spinal cord injury	NATURE			English	Article							NEURITE GROWTH-INHIBITORS; SULFATE PROTEOGLYCANS; REACTIVE ASTROCYTES; SENSORY AXONS; GLIAL SCAR; CNS; REGENERATION; EXPRESSION; OUTGROWTH; NEUROCAN	The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)(1,2). CSPGs are inhibitory to axon growth in vitro(3-5), and regenerating axons stop at CSPG-rich regions in vivo(6). Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity(7-10). To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.	Kings Coll London, Ctr Res Neurosci, Sensory Funct Grp, London SE1 1UL, England; Univ Cambridge, Dept Physiol, Cambridge CB2 2PY, England; Univ Cambridge, Ctr Brain Repair, Cambridge CB2 2PY, England; Queen Mary Univ London, St Bartholomews & Royal London Sch Med & Dent, Dept Neurosci, London E1 4NS, England	University of London; King's College London; University of Cambridge; University of Cambridge; University of London; Queen Mary University London	Bradbury, EJ (corresponding author), Kings Coll London, Ctr Res Neurosci, Sensory Funct Grp, Hodgkin Bldg,Guys Campus,London Bridge, London SE1 1UL, England.	elizabeth.bradbury@kcl.ac.uk	Moon, Lawrence/C-4906-2008	Moon, Lawrence/0000-0001-9622-0312; Fawcett, James/0000-0002-7990-4568; McMahon, Stephen/0000-0003-4656-5536; Bradbury, Elizabeth/0000-0003-4252-0234				Asher RA, 2000, J NEUROSCI, V20, P2427; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; Bradbury EJ, 2000, TRENDS PHARMACOL SCI, V21, P389, DOI 10.1016/S0165-6147(00)01536-4; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; CHONG MS, 1994, J NEUROSCI, V14, P4375; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Fitch MT, 1999, CNS REGENERATION BAS, P55; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Karim F, 2001, BRAIN RES REV, V36, P204, DOI 10.1016/S0165-0173(01)00096-0; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; LEVINE JM, 1994, J NEUROSCI, V14, P4716; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Murray M, 1997, Adv Neurol, V72, P219; Murray M, 2001, NEUROSCIENTIST, V7, P28, DOI 10.1177/107385840100700107; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Pasterkamp RJ, 2001, EUR J NEUROSCI, V13, P457, DOI 10.1046/j.0953-816X.2000.01398.x; Plant GW, 2001, MOL CELL NEUROSCI, V17, P471, DOI 10.1006/mcne.2000.0948; Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084; Ramer MS, 2000, SPINAL CORD, V38, P449, DOI 10.1038/sj.sc.3101055; SMITHTHOMAS LC, 1994, J CELL SCI, V107, P1687; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Wall PD, 1997, J NEUROPHYSIOL, V78, P860, DOI 10.1152/jn.1997.78.2.860; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	30	1768	1883	6	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					636	640		10.1038/416636a	http://dx.doi.org/10.1038/416636a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948352				2022-12-24	WOS:000174901900044
J	Zhou, Q; Anderson, DJ				Zhou, Q; Anderson, DJ			The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD OLIGODENDROCYTES; VENTRAL NEURAL-TUBE; LIM HOMEOBOX GENES; MOTOR-NEURONS; PROGENITOR CELLS; MAMMALIAN-CELLS; ACHAETE-SCUTE; EXPRESSION; LINEAGE	OLIG1 and OLIG2 are basic-helix-loop-helix (bHLH) transcription factors expressed in the pMN domain of the spinal cord, which sequentially generates motoneurons and oligodendrocytes. In Olig1/2 double-mutant mice, motoneurons are largely eliminated, and oligodendrocyte differentiation is abolished. Lineage tracing data suggest that Olig1(-/-)2(-/-) pMN progenitors instead generate V2 interneurons and then astrocytes. This apparent conversion likely reflects independent roles for OLIG1/2 in specifying motoneuron and oligodendrocyte fates. Olig genes therefore couple neuronal and glial subtype specification, unlike proneural bHLH factors that control the neuron versus glia decision. Our results suggest that in the spinal cord, Olig and proneural genes comprise a combinatorial code for the specification of neurons, astrocytes, and oligodendrocytes, the three fundamental cell types of the central nervous system.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.			Zhou, Qiao/0000-0002-0099-3909	NINDS NIH HHS [R01-NS23476] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Farah MH, 2000, DEVELOPMENT, V127, P693; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Hall A, 1996, DEVELOPMENT, V122, P4085; Hardy RJ, 1997, J NEUROSCI RES, V50, P139, DOI 10.1002/(SICI)1097-4547(19971015)50:2<139::AID-JNR3>3.0.CO;2-G; Hojo M, 2000, DEVELOPMENT, V127, P2515; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; LEBER SM, 1990, J NEUROSCI, V10, P2451; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LO L, 2002, IN PRESS DEVELOPMENT; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; LU QR, 2002, IN PRESS CELL, V109, P61; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Satow T, 2001, J NEUROSCI, V21, P1265; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sun T, 2001, CURR BIOL, V11, P1413, DOI 10.1016/S0960-9822(01)00441-9; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; TAEBAYASHI H, 2000, MECH DEVELOP, V99, P143; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Vetter M, 2001, NEURON, V29, P559, DOI 10.1016/S0896-6273(01)00231-8; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	53	785	816	1	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					61	73		10.1016/S0092-8674(02)00677-3	http://dx.doi.org/10.1016/S0092-8674(02)00677-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955447	Bronze			2022-12-24	WOS:000174888300009
J	Psaty, BM; Smith, NL; Heekbert, SR; Vos, HL; Lemaitre, RN; Reiner, AP; Siscovick, DS; Bis, J; Lumley, T; Longstreth, WT; Rosendaal, FR				Psaty, BM; Smith, NL; Heekbert, SR; Vos, HL; Lemaitre, RN; Reiner, AP; Siscovick, DS; Bis, J; Lumley, T; Longstreth, WT; Rosendaal, FR			Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; ENVIRONMENT INTERACTION; JAPANESE POPULATION; MOLECULAR-GENETICS; LINKAGE ANALYSIS; CANDIDATE GENES; HEALTH OUTCOMES; ASSOCIATION; POLYMORPHISM; PHARMACOGENOMICS	Context A genetic variant in alpha-adducin has been associated with renal sodium reabsorption and salt-sensitive hypertension, Whether this genetic variant modifies the effect of diuretic therapy on the incidence of myocardial infarction (MI) and stroke is unknown. Objectives To estimate the interaction between alpha-adducin and diuretic therapy on the risk of MI or stroke. Specifically, we hypothesized that in participants with treated hypertension, the risk of MI or stroke associated with diuretic use would be lower in carriers of the adducin variant than in carriers of the adducin wild-type genotype. Design, Setting, and Participants Population-based case-control study of patients enrolled in a health maintenance organization, treated pharmacologically for hypertension, and genotyped as homozygous carriers of the adducin wild-type genotype or carriers of 1 or 2 copies of the Trp460 variant allele. Cases had a first nonfatal MI (n = 206) or stroke (n = 117) between January 1995 and December 1998. Controls (n=715) were a stratified random sample of pharmacologically treated hypertensive patients who were matched to MI cases by age, sex, and calendar year. Main Outcome Measure Risk of the combined outcome of first nonfatal MI or stroke. Results The adducin variant was present in more than one third of the participants. Among the 653 carriers of the adducin wild-type genotype, diuretic therapy was not associated with the risk of MI or stroke (odds ratio [OR], 1.09; 95% confidence interval [CI], 0.78-1.52). Among the 385 carriers of the adducin variant allele, diuretic therapy was associated with a lower risk of the combined outcome of MI and stroke than other anti hypertensive therapies (OR, 0.49; 95% Cl, 0.32-0.77). The OR in carriers of the adducin variant was less than half of the OR in carriers of the wild-type genotype (P=.005). The case-control synergy index (SI) was 0.45 (95% Cl, 0.26-0.79) for the combined outcome of MI and stroke. The point estimates of the diuretic-adducin interaction were similar in separate analyses of MI (SI, 0.41; 95% Cl, 0.21-0.80) and stroke (SI, 0.53; 95% Cl, 0.24-1.19). The diuretic-adducin interaction was not confounded by traditional cardiovascular risk factors, was specific to diuretic therapy but not present for other major anti hypertensive drug classes, and did not differ substantially between subgroups defined by age, sex, race, diabetes, and history of cardiovascular disease. Conclusions In carriers of the adducin variant, diuretic therapy was associated with a lower risk of combined MI or stroke than other antihypertensive therapies. If these findings are confirmed in other studies, this large subgroup of the hypertensive population may be especially likely to benefit from low-dose diuretic therapy.	Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; Univ Washington, Dept Med, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98101 USA; Univ Washington, Dept Biostat, Seattle, WA 98101 USA; Univ Washington, Dept Neurol, Seattle, WA 98101 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98101 USA; Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Psaty, BM (corresponding author), Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Suite 1360, Seattle, WA 98101 USA.		Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496	NHLBI NIH HHS [HL40628, HL60739, HL43201] Funding Source: Medline; NIA NIH HHS [AG09556] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040628, R01HL043201, R01HL060739, R29HL040628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009556] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bianchi G, 2000, AM J HYPERTENS, V13, P739, DOI 10.1016/S0895-7061(00)00241-7; Black HR, 1997, ARCH INTERN MED, V157, P2413; Boerwinkle E, 2000, AM J HYPERTENS, V13, P734, DOI 10.1016/S0895-7061(00)00243-0; Bray MS, 2000, AM J HYPERTENS, V13, P699, DOI 10.1016/S0895-7061(00)00242-9; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Corvol P, 1999, HYPERTENSION, V33, P1324, DOI 10.1161/01.HYP.33.6.1324; Cusi D, 1998, KIDNEY INT, V54, P328, DOI 10.1046/j.1523-1755.1998.00007.x; Cusi D, 1997, LANCET, V349, P1353, DOI 10.1016/S0140-6736(97)01029-5; Ferrandi M, 2000, ACTA PHYSIOL SCAND, V168, P187; Ferrari P, 1998, CURR OPIN NEPHROL HY, V7, P217, DOI 10.1097/00041552-199803000-00012; Ferrari Patrizia, 1995, P1261; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Glorioso N, 1999, HYPERTENSION, V34, P649, DOI 10.1161/01.HYP.34.4.649; Green SA, 1995, PULM PHARMACOL, V8, P1, DOI 10.1006/pulp.1995.1001; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Housman D, 1998, NAT BIOTECHNOL, V16, P492, DOI 10.1038/nbt0698-492; Ishikawa K, 1998, AM J HYPERTENS, V11, P502, DOI 10.1016/S0895-7061(97)00486-X; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kamitani A, 1998, HYPERTENSION, V32, P138, DOI 10.1161/01.HYP.32.1.138; Kato N, 1998, HYPERTENSION, V31, P730, DOI 10.1161/01.HYP.31.3.730; Khoury M, 1993, FUNDAMENTALS GENETIC; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Luft FC, 1998, J HYPERTENS, V16, P1871, DOI 10.1097/00004872-199816121-00004; Manunta P, 1998, KIDNEY INT, V53, P1471, DOI 10.1046/j.1523-1755.1998.00931.x; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; MAY DG, 1994, J CLIN PHARMACOL, V34, P881, DOI 10.1002/j.1552-4604.1994.tb04001.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Perna A, 2000, KIDNEY INT, V57, P274, DOI 10.1046/j.1523-1755.2000.00818.x; Price T R, 1993, Ann Epidemiol, V3, P504; Province MA, 2000, AM J HYPERTENS, V13, P710, DOI 10.1016/S0895-7061(99)00282-4; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Psaty BM, 2000, J HUM HYPERTENS, V14, P95, DOI 10.1038/sj.jhh.1000943; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BM, 2001, JAMA-J AM MED ASSOC, V285, P906, DOI 10.1001/jama.285.7.906; Rieder M J, 2000, Curr Hypertens Rep, V2, P44, DOI 10.1007/s11906-000-0057-4; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SMITH PG, 1984, INT J EPIDEMIOL, V13, P356, DOI 10.1093/ije/13.3.356; SMITH RL, 1986, XENOBIOTICA, V16, P361, DOI 10.3109/00498258609050244; Tamaki S, 1998, HYPERTENS RES-CLIN E, V21, P29, DOI 10.1291/hypres.21.29; Turner ST, 2000, CIRCULATION, V102, P40; Yang QH, 1997, AM J EPIDEMIOL, V146, P713	48	169	180	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1680	1689		10.1001/jama.287.13.1680	http://dx.doi.org/10.1001/jama.287.13.1680			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926892	Bronze			2022-12-24	WOS:000174730300022
J	Caro, GMM; Meierhenrich, UJ; Schutte, WA; Barbier, B; Segovia, AA; Rosenbauer, H; Thiemann, WHP; Brack, A; Greenberg, JM				Caro, GMM; Meierhenrich, UJ; Schutte, WA; Barbier, B; Segovia, AA; Rosenbauer, H; Thiemann, WHP; Brack, A; Greenberg, JM			Amino acids from ultraviolet irradiation of interstellar ice analogues	NATURE			English	Article							COMET HALLEY; DUST; HYDROCARBONS; MIXTURES; SPACE; LIFE	Amino acids are the essential molecular components of living organisms on Earth, but the proposed mechanisms for their spontaneous generation have been unable to account for their presence in Earth's early history(1). The delivery of extraterrestrial organic compounds has been proposed as an alternative to generation on Earth(2-5), and some amino acids have been found in several meteorites(6-9). Here we report the detection of amino acids in the room-temperature residue of an interstellar ice analogue that was ultraviolet-irradiated in a high vacuum at 12 K. We identified 16 amino acids; the chiral ones showed enantiomeric separation. Some of the identified amino acids are also found in meteorites. Our results demonstrate that the spontaneous generation of amino acids in the interstellar medium is possible, supporting the suggestion that prebiotic molecules could have been delivered to the early Earth by cometary dust, meteorites or interplanetary dust particles.	Ctr Biophys Mol, F-45160 Olivet, France; Leiden Observ, Raymond & Beverly Sackler Lab Astrophys, NL-2300 RA Leiden, Netherlands; Univ Bremen, Dept Phys Chem, D-28359 Bremen, Germany; Max Planck Inst Aeron, D-37189 Katlenburg Lindau, Germany	Leiden University; Leiden University - Excl LUMC; University of Bremen; Max Planck Society	Meierhenrich, UJ (corresponding author), Ctr Biophys Mol, Rue Charles Sadron, F-45160 Olivet, France.		Muñoz, Guillermo M/L-6370-2014; Meierhenrich, Uwe J/A-1643-2008	Muñoz, Guillermo M/0000-0001-7003-7368; Meierhenrich, Uwe J/0000-0001-6422-3930; Arcones, Almudena/0000-0002-6995-3032				Abe I, 1996, J CHROMATOGR A, V722, P221, DOI 10.1016/0021-9673(95)00506-4; BARNUN A, 1983, J GEOPHYS RES-OCEANS, V88, P6662, DOI 10.1029/JC088iC11p06662; Bernstein MP, 1999, SCIENCE, V283, P1135, DOI 10.1126/science.283.5405.1135; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Brack A, 1999, ADV SPACE RES-SERIES, V24, P417, DOI 10.1016/S0273-1177(99)00457-3; BRIGGS R, 1992, ORIGINS LIFE EVOL B, V22, P287, DOI 10.1007/BF01810858; Caro GMM, 2001, ASTRON ASTROPHYS, V367, P347, DOI 10.1051/0004-6361:20000341; CARO GMM, UNPUB ASTRON ASTROPH; CHYBA C, 1992, NATURE, V355, P125, DOI 10.1038/355125a0; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; Ehrenfreund P, 1999, ASTRON ASTROPHYS, V350, P240; Ehrenfreund P, 2001, P NATL ACAD SCI USA, V98, P2138, DOI 10.1073/pnas.051502898; Engel MH, 2001, PRECAMBRIAN RES, V106, P35, DOI 10.1016/S0301-9268(00)00123-6; GERAKINES PA, 1995, ASTRON ASTROPHYS, V296, P810; Gerakines PA, 1999, ASTROPHYS J, V522, P357, DOI 10.1086/307611; Gibb EL, 2001, ASTROPHYS J, V558, P702, DOI 10.1086/322291; Greenberg J., 1982, COMETS, P131; GREENBERG JM, 1972, EXTRAIT MEMOIRES SOC, P425; GREENBERG JM, 1986, GALAXY SOLAR SYSTEM, P103; HUANG ZH, 1993, J CHROMATOGR, V635, P271, DOI 10.1016/0021-9673(93)80370-N; Irvine W. M., 2000, Protostars and planets 4, P1159; JENNISKENS P, 1993, ASTRON ASTROPHYS, V273, P583; JOHNS RB, 1970, PHOTOCHEM PHOTOBIOL, V12, P405, DOI 10.1111/j.1751-1097.1970.tb06071.x; KISSEL J, 1987, NATURE, V326, P755, DOI 10.1038/326755a0; Kobayashi K, 1999, ADV SPACE RES, V23, P401, DOI 10.1016/S0273-1177(99)00065-4; KVENVOLDEN K, 1970, NATURE, V228, P923, DOI 10.1038/228923a0; Meierhenrich U, 1999, CHIRALITY, V11, P575, DOI 10.1002/(SICI)1520-636X(1999)11:7<575::AID-CHIR10>3.0.CO;2-P; Mennella V, 2001, ASTRON ASTROPHYS, V367, P355, DOI 10.1051/0004-6361:20000340; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; WEBER P, 1985, NATURE, V316, P403, DOI 10.1038/316403a0	31	617	623	4	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					403	406		10.1038/416403a	http://dx.doi.org/10.1038/416403a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919624				2022-12-24	WOS:000174607800039
J	Price, MA; Kalderon, D				Price, MA; Kalderon, D			Proteolysis of the Hedgehog signaling effector Cubitus interruptus requires phosphorylation by glycogen synthase kinase 3 and casein kinase 1	CELL			English	Article							DEPENDENT PROTEIN-KINASE; KAPPA-B-ALPHA; BETA-CATENIN; TRANSCRIPTIONAL ACTIVATOR; LIMB DEVELOPMENT; REPRESSOR FORMS; IMAGINAL DISCS; GLI PROTEINS; DOUBLE-TIME; I-EPSILON	The secreted signaling molecule Hedgehog regulates gene expression in target cells in part by preventing proteolysis of the full-length Cubitus interruptus (Ci-155) transcriptional activator to the Ci-75 repressor form. Ci-155 proteolysis depends on phosphorylation at three sites by Protein Kinase A (PKA). We show that these phosphoserines prime further phosphorylation at adjacent Glycogen Synthase Kinase 3 (GSK3) and Casein Kinase I (CK1) sites. Alteration of the GSK3 or CK1 sites prevents Ci-155 proteolysis and activates Ci in the absence of Hedgehog. Ci-155 proteolysis is also inhibited if cells lack activity of the Drosophila GSK3, Shaggy, previously implicated in Wingless signaling. Conversely, Ci-155 levels are reduced in Hedgehog-responding cells by overexpression of PKA and the Drosophila CK1, Double-time, a regulator of circadian rhythms.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Kalderon, D (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041815] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41815] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLAIR SS, 1994, DEV BIOL, V162, P229, DOI 10.1006/dbio.1994.1081; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, P NATL ACAD SCI USA, V95, P2349, DOI 10.1073/pnas.95.5.2349; Chen Y, 1999, DEVELOPMENT, V126, P3607; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; DENT P, 1989, FEBS LETT, V248, P67, DOI 10.1016/0014-5793(89)80433-8; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Harlow E, 1988, ANTIBODIES LAB MANUA; Hepker J, 1999, DEVELOPMENT, V126, P3669; Heslip TR, 1997, DEVELOPMENT, V124, P1069; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2000, DEVELOPMENT, V127, P4001; Methot N, 2001, DEVELOPMENT, V128, P733; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Pai LM, 1997, DEVELOPMENT, V124, P2255; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Price MA, 1999, DEVELOPMENT, V126, P4331; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; von Mering C, 1999, CURR BIOL, V9, P1319, DOI 10.1016/S0960-9822(00)80054-8; Von Ohlen T, 1997, MECH DEVELOP, V68, P149, DOI 10.1016/S0925-4773(97)00150-0; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wang QT, 1999, DEVELOPMENT, V126, P5097; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Zilian O, 1999, DEVELOPMENT, V126, P5409	54	309	321	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					823	835		10.1016/S0092-8674(02)00664-5	http://dx.doi.org/10.1016/S0092-8674(02)00664-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955435	Bronze			2022-12-24	WOS:000174563000011
J	Smith, BO; Mallin, RL; Krych-Goldberg, M; Wang, XF; Hauhart, RE; Bromek, K; Uhrin, D; Atkinson, JP; Barlow, PN				Smith, BO; Mallin, RL; Krych-Goldberg, M; Wang, XF; Hauhart, RE; Bromek, K; Uhrin, D; Atkinson, JP; Barlow, PN			Structure of the C3b binding site of CR1 (CD35), the immune adherence receptor	CELL			English	Article							TRIPLE-RESONANCE EXPERIMENTS; COMPLEMENT RECEPTOR-TYPE-1; C3B/C4B RECEPTOR; CRYSTAL-STRUCTURE; C-13-LABELED PROTEINS; IMPROVED SENSITIVITY; DIPOLAR COUPLINGS; NMR-SPECTROSCOPY; LIGAND-BINDING; ACTIVE-SITES	Complement receptor type 1 (CR1 or CD35) is a multiple modular protein that mediates the immune adherence phenomenon, a fundamental event for destroying microbes and initiating an immunological response. It fulfills this role through binding C3b/C4b-opsonized foreign antigens. The structure of the principal C3b/C4b binding site (residues 901-1095) of CR1 is reported, revealing three complement control protein modules (modules 15-17) in an extended head-to-tail arrangement with flexibility at the 16-17 junction. Structure-guided mutagenesis identified a positively charged surface region on module 15 that is critical for C4b binding. This patch, together with basic side chains of module 16 exposed on the same face of CR1 is required for C3b binding. These studies reveal the initial structural details of one of the first receptor-ligand interactions to be identified in immunobiology.	Univ Edinburgh, Edinburgh Prot Interact Ctr, Edinburgh EH9 3JR, Midlothian, Scotland; Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA	University of Edinburgh; Washington University (WUSTL)	Barlow, PN (corresponding author), Univ Edinburgh, Edinburgh Prot Interact Ctr, Joseph Black Chem Bldg,W Mains Rd, Edinburgh EH9 3JR, Midlothian, Scotland.		Barlow, Paul N/G-2853-2011; Smith, Brian/AAJ-9393-2020; Smith, Brian O/J-1899-2015	Smith, Brian/0000-0003-3363-4168; Smith, Brian O/0000-0003-3363-4168; Atkinson, John/0000-0002-2514-3441	PHS HHS [R01 A141592] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aitio H, 2000, J MAGN RESON, V143, P391, DOI 10.1006/jmre.1999.2010; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; Blom AM, 2000, MOL IMMUNOL, V37, P445, DOI 10.1016/S0161-5890(00)00059-6; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clark NS, 1996, PROTEIN ENG, V9, P877, DOI 10.1093/protein/9.10.877; COLE JL, 1985, P NATL ACAD SCI USA, V82, P859, DOI 10.1073/pnas.82.3.859; Copie V, 1998, J MOL BIOL, V277, P663; Engelke J, 1995, J MAGN RESON SER B, V109, P318, DOI 10.1006/jmrb.1995.9988; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; Henderson CE, 2001, J MOL BIOL, V307, P323, DOI 10.1006/jmbi.2000.4477; HOURCADE D, 1988, J EXP MED, V168, P1255, DOI 10.1084/jem.168.4.1255; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kirkitadze MD, 1999, BIOCHEMISTRY-US, V38, P7019, DOI 10.1021/bi982453a; Kirkitadze MD, 1999, FEBS LETT, V459, P133, DOI 10.1016/S0014-5793(99)01205-3; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kirkitadze MD, 1999, PROG COLL POL SCI S, V113, P164; KLICKSTEIN LB, 1988, J EXP MED, V168, P1699, DOI 10.1084/jem.168.5.1699; KLICKSTEIN LB, 1987, J EXP MED, V165, P1095, DOI 10.1084/jem.165.4.1095; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P9446; KRYCH M, 1991, P NATL ACAD SCI USA, V88, P4353, DOI 10.1073/pnas.88.10.4353; Krych M, 1998, J BIOL CHEM, V273, P8623, DOI 10.1074/jbc.273.15.8623; KRYCH M, 1994, J BIOL CHEM, V269, P13273; Krych-Goldberg M, 1999, J BIOL CHEM, V274, P31160, DOI 10.1074/jbc.274.44.31160; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Kuttner-Kondo LA, 2001, J IMMUNOL, V167, P2164, DOI 10.4049/jimmunol.167.4.2164; KuttnerKondo L, 1996, PROTEIN ENG, V9, P1143, DOI 10.1093/protein/9.12.1143; Liszewski M.K., 1998, HUMAN COMPLEMENT SYS, P149; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Mori S, 1997, J AM CHEM SOC, V119, P6844, DOI 10.1021/ja963351f; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Murthy KHM, 2001, CELL, V104, P301, DOI 10.1016/S0092-8674(01)00214-8; NELSON DS, 1963, ADV IMMUNOL, V3, P131, DOI 10.1016/S0065-2776(08)60812-3; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Oran AE, 1999, J BIOL CHEM, V274, P5120, DOI 10.1074/jbc.274.8.5120; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Reilly BD, 1997, CLIN EXP IMMUNOL, V110, P310; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Subramanian VB, 1996, J IMMUNOL, V157, P1242; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Uhrin D, 2000, J MAGN RESON, V142, P288, DOI 10.1006/jmre.1999.1951; Villoutreix BO, 1998, PROTEINS, V31, P391, DOI 10.1002/(SICI)1097-0134(19980601)31:4<391::AID-PROT6>3.0.CO;2-L; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241; WONG WW, 1991, J IMMUNOL, V146, P656; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; [No title captured]	64	88	92	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					769	780		10.1016/S0092-8674(02)00672-4	http://dx.doi.org/10.1016/S0092-8674(02)00672-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955431	Bronze			2022-12-24	WOS:000174563000007
J	Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Tielsch, JM; Klein, BEK; Hubbard, LD				Wong, TY; Klein, R; Sharrett, AR; Duncan, BB; Couper, DJ; Tielsch, JM; Klein, BEK; Hubbard, LD			Retinal arteriolar narrowing and risk of coronary heart disease in men and women - The atherosclerosis risk in communities study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; ANGINA-PECTORIS; ARTERY DISEASE; CHEST PAIN; ANGIOGRAMS; MORTALITY; SEX	Context Microvascular processes have been hypothesized to play a greater role in the development of coronary heart disease (CHD) in women than in men; however, prospective clinical data are limited. Objective To examine the association between retinal arteriolar narrowing, a marker of microvascular damage from hypertension and inflammation, and incident CHD in healthy middle-aged women and men. Design, Setting, and Participants The Atherosclerosis Risk in Communities Study, an ongoing prospective, population-based cohort study in 4 US communities initiated in 1987-1989. Retinal photographs were taken in 9648 women and men aged 51 to 72 years without CHD at the third examination (1993-1995). To quantify retinal arteriolar narrowing, the photographs were digitized, individual arteriolar and venular diameters were measured, and a summary arteriole-to-venule ratio (AVR) was calculated. Main Outcome Measure Risk of CHD associated with retinal arteriolar narrowing. Results During an average 3.5 years of follow-up, 84 women and 187 men experienced incident CHD events. In women, after controlling for mean arterial blood pressure averaged over the previous 6 years, diabetes, cigarette smoking, plasma lipid levels, and other risk factors, each SD decrease in the AVR was associated with an increased risk of any incident CHD (relative risk [RR], 1.37; 95% confidence interval [CI], 1.08-1.72) and of acute myocardial infarction (RR, 1.50; 95% CI, 1.10-2.04). In contrast, AVR was unrelated to any incident CHD in men (RR, 1,00; 95% CI, 0.84-1.18) or to acute myocardial infarction (RR, 1.08; 95% CI, 0.85-1.38). Conclusion Retinal arteriolar narrowing is related to risk of CHD in women but not in men, supporting a more prominent microvascular role in the development of CHD in women than in men. Future work is needed to confirm these findings.	Natl Univ Singapore, Dept Ophthalmol, Singapore 119260, Singapore; Univ Wisconsin, Dept Ophthalmol, Madison, WI USA; NHLBI, Bethesda, MD 20892 USA; Univ Fed Rio Grande Sul, Sch Med, Dept Social Med, Porto Alegre, RS, Brazil; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA	National University of Singapore; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Wong, TY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Duncan, Bruce B/L-4140-2016; Wong, Tien Yin/AAC-9724-2020	Duncan, Bruce B/0000-0002-7491-2630; Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Couper, David/0000-0002-4313-9235; Tielsch, James/0000-0002-1151-060X	NHLBI NIH HHS [N01-HC-55021, N01-HC-55016, N01-HC-55015, N01-HC-35126, N01-HC-35125, N01-HC-55022, N01-HC-55018, N01-HC-55019, N01-HC-55020] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055019, N01HC055020, N01HC035126, N01HC055016, N01HC055018, N01HC055015, N01HC055021, N01HC035125, N01HC055022] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; BRUSH JE, 1988, NEW ENGL J MED, V319, P1302, DOI 10.1056/NEJM198811173192002; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Cannon RO, 2000, NEW ENGL J MED, V342, P885, DOI 10.1056/NEJM200003233421209; CANNON RO, 1992, CIRCULATION, V85, P883, DOI 10.1161/01.CIR.85.3.883; CANNON RO, 1985, AM J CARDIOL, V55, P50; Chilian WM, 1997, CIRCULATION, V95, P522; EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302; EYSMANN SB, 1992, JAMA-J AM MED ASSOC, V268, P1903, DOI 10.1001/jama.268.14.1903; GILLUM RF, 1991, AM HEART J, V122, P262, DOI 10.1016/0002-8703(91)90796-K; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; KARLSON BW, 1994, AM HEART J, V128, P477, DOI 10.1016/0002-8703(94)90620-3; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; Lekakis JP, 1998, J AM COLL CARDIOL, V31, P541, DOI 10.1016/S0735-1097(97)00542-1; LIKOFF W, 1967, NEW ENGL J MED, V276, P1063, DOI 10.1056/NEJM196705112761904; Liu PP, 1999, AM J CARDIOL, V84, p23L; MARCUS ML, 1990, CIRCULATION, V82, P1, DOI 10.1161/01.CIR.82.1.1; Mehilli J, 2000, JAMA-J AM MED ASSOC, V284, P1799, DOI 10.1001/jama.284.14.1799; MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964; *NAT HEART LUNG BL, 1988, ATH RISK COMM STUD O; Prineas R., 1982, MINNESOTA CODE MANUA; SAX FL, 1987, NEW ENGL J MED, V317, P1366, DOI 10.1056/NEJM198711263172202; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; TANAKA M, 1987, CIRCULATION, V75, P1130, DOI 10.1161/01.CIR.75.6.1130; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Wexler LF, 1999, NEW ENGL J MED, V341, P275, DOI 10.1056/NEJM199907223410409; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wu KC, 1998, CIRCULATION, V97, P765, DOI 10.1161/01.CIR.97.8.765	37	590	610	2	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1153	1159		10.1001/jama.287.9.1153	http://dx.doi.org/10.1001/jama.287.9.1153			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879113	Bronze			2022-12-24	WOS:000174186000031
J	Braddock, DT; Louis, JM; Baber, JL; Levens, D; Clore, GM				Braddock, DT; Louis, JM; Baber, JL; Levens, D; Clore, GM			Structure and dynamics of KH domains from FBP bound to single-stranded DNA	NATURE			English	Article							RESIDUAL DIPOLAR COUPLINGS; FAR UPSTREAM ELEMENT; C-MYC; STRUCTURE REFINEMENT; INTERDOMAIN MOTION; RNA-BINDING; RELAXATION; COMPLEXES; PROTEINS; TFIIH	Gene regulation can be tightly controlled by recognition of DNA deformations that are induced by stress generated during transcription(1-3). The KH domains of the FUSE-binding protein (FBP), a regulator of c-myc expression(1,4), bind in vivo and in vitro to the single-stranded far-upstream element (FUSE), 1,500 base pairs upstream from the c-myc promoter(4-6). FBP bound to FUSE acts through TFIIH at the promoter(4). Here we report the solution structure of a complex between the KH3 and KH4 domains of FBP and a 29-base single-stranded DNA from FUSE. The KH domains recognize two sites, 9-10 bases in length, separated by 5 bases, with KH4 bound to the 5' site and KH3 to the 3' site. The central portion of each site comprises a tetrad of sequence 5'd-ATTC for KH4 and 5'd-TTTT for KH3. Dynamics measurements show that the two KH domains bind as articulated modules to single-stranded DNA, providing a flexible framework with which to recognize transient, moving targets.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	clore@speck.niddk.nih.gov	Clore, G. Marius/A-3511-2008; Levens, David/C-9216-2009; Clore, G Marius/L-2546-2018	Clore, G. Marius/0000-0003-3809-1027; Levens, David/0000-0002-7616-922X; Clore, G Marius/0000-0003-3809-1027; Louis, John M/0000-0002-0052-1899	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029023, Z01DK029023] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVIGAN MI, 1990, J BIOL CHEM, V265, P18538; Baber JL, 2001, J AM CHEM SOC, V123, P3953, DOI 10.1021/ja0041876; Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Braddock DT, 2001, J AM CHEM SOC, V123, P8634, DOI 10.1021/ja016234f; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P564; CANTOR CR, 1980, BIOPHYSICAL CHEM 3, P1008; Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; GORENSTEIN DG, 1994, CHEM REV, V94, P1315, DOI 10.1021/cr00029a007; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; He LS, 2000, EMBO J, V19, P1034, DOI 10.1093/emboj/19.5.1034; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JH, 2000, MOL CELL, V5, P331, DOI 10.1016/S1097-2765(00)80428-1; Liu JH, 2001, CELL, V104, P353, DOI 10.1016/S0092-8674(01)00223-9; Michelotti EF, 1997, NATURE, V388, P895, DOI 10.1038/42282; Michelotti GA, 1996, MOL CELL BIOL, V16, P2656, DOI 10.1128/mcb.16.6.2656; Musco G, 1996, CELL, V85, P237, DOI 10.1016/S0092-8674(00)81100-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rothman-Denes LB, 1998, COLD SPRING HARB SYM, V63, P63, DOI 10.1101/sqb.1998.63.63; Saenger W., 1984, PRINCIPLES NUCL ACID; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300	31	143	148	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1051	1056		10.1038/4151051a	http://dx.doi.org/10.1038/4151051a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875576	Green Published			2022-12-24	WOS:000174075000052
J	Crawford, LM				Crawford, LM			FDA-PPTA workshop	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2203	2203		10.1001/jama.287.17.2203	http://dx.doi.org/10.1001/jama.287.17.2203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980508				2022-12-24	WOS:000175260600006
J	Lam, YA; Lawson, TG; Velayutham, M; Zweier, JL; Pickart, CM				Lam, YA; Lawson, TG; Velayutham, M; Zweier, JL; Pickart, CM			A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal	NATURE			English	Article							MULTIUBIQUITIN-CHAIN-BINDING; UBIQUITIN; PROTEIN; IDENTIFICATION; PROTEOLYSIS; INHIBITION; SUBCOMPLEX; MCB1	The 26S proteasome is the chief site of regulatory protein turnover in eukaryotic cells(1). It comprises one 20S catalytic complex (composed of four stacked rings of seven members) and two axially positioned 19S regulatory complexes (each containing about 18 subunits) that control substrate access to the catalytic chamber(2). In most cases, targeting to the 26S proteasome depends on tagging of the substrate with a specific type of polyubiquitin chain(3-6). Recognition of this signal is followed by substrate unfolding and translocation, which are presumably catalysed by one or more of six distinct AAA ATPases located in the base-a ring-like 19S subdomain that abuts the axial pore of the 20S complex and exhibits chaperone activity in vitro(7-9). Despite the importance of polyubiquitin chain recognition in proteasome function, the site of this signal's interaction with the 19S complex has not been identified previously. Here we use crosslinking to a reactive polyubiquitin chain to show that a specific ATPase subunit, S6' (also known as Rpt5), contacts the bound chain. The interaction of this signal with 26S proteasomes is modulated by ATP hydrolysis. Our results suggest that productive recognition of the proteolytic signal, as well as proteasome assembly and substrate unfolding, are ATP-dependent events.	Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, EPR Ctr, Baltimore, MD 21205 USA; Bates Coll, Dept Chem, Lewiston, ME 04240 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pickart, CM (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.							Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; DeMartino GN, 1996, J BIOL CHEM, V271, P3112, DOI 10.1074/jbc.271.6.3112; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fu HY, 1998, J BIOL CHEM, V273, P1970, DOI 10.1074/jbc.273.4.1970; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Qin PZ, 2001, BIOCHEMISTRY-US, V40, P6929, DOI 10.1021/bi010294g; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Sankarapandi S, 1999, J BIOL CHEM, V274, P1226, DOI 10.1074/jbc.274.3.1226; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015	28	344	350	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					763	767		10.1038/416763a	http://dx.doi.org/10.1038/416763a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961560				2022-12-24	WOS:000175033500048
J	Martin, JM; Green, M; Barbadora, KA; Wald, ER				Martin, JM; Green, M; Barbadora, KA; Wald, ER			Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROUP-A STREPTOCOCCI; MACROLIDE RESISTANCE; GEL-ELECTROPHORESIS; RHEUMATIC-FEVER; PYOGENES; ANTIBIOTICS; SUSCEPTIBILITY; PHARYNGITIS; CLINDAMYCIN; INFECTIONS	Background: Resistance to erythromycin has been very uncommon among group A streptococci in the United States. Methods: As part of a longitudinal study, we obtained surveillance throat cultures twice monthly and with each new respiratory tract illness from children in kindergarten through grade 8 at one school in Pittsburgh. Screening for resistance to erythromycin and clindamycin was initially accomplished with use of the Kirby-Bauer disk-diffusion test. The minimal inhibitory concentration of resistant isolates was determined by the E test. A double disk-diffusion test was used to characterize the resistance phenotype, and the polymerase-chain-reaction assay was used to identify the resistance gene. The molecular relatedness of strains was determined by field-inversion gel electrophoresis. Results: A total of 1794 throat cultures were obtained from 100 children between October 2000 and May 2001, of which 318 cultures (18 percent) from 60 of the children were positive for group A streptococci. Forty-eight percent of these isolates (153 of 318) were resistant to erythromycin. None were resistant to clindamycin. Results of the double disk-diffusion test indicated the presence of the M phenotype of erythromycin resistance. Molecular typing indicated that the outbreak was due to a single strain of group A streptococci. Of 100 randomly selected isolates of group A streptococci obtained from the community between April and June 2001, 38 were resistant to erythromycin. Conclusions: In January 2001, during a longitudinal study of schoolchildren, we detected the emergence of erythromycin resistance in pharyngeal isolates of group A streptococci. This clonal outbreak also affected the wider community.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Allergy Immunol & Infect Dis, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Martin, JM (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat,Div Allergy Immunol & Infect Dis, 3705 5th Ave, Pittsburgh, PA 15213 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI001713] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR000084] Funding Source: Medline; NIAID NIH HHS [K23 AI001713, 5K23 AI01713-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Avanzini C, 2000, MICROB DRUG RESIST, V6, P289, DOI 10.1089/mdr.2000.6.289; Bassetti M, 2000, EMERG INFECT DIS, V6, P180, DOI 10.3201/eid0602.000212; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Betriu C, 1999, DIAGN MICR INFEC DIS, V33, P255, DOI 10.1016/S0732-8893(98)00155-2; Bingen E, 2000, ANTIMICROB AGENTS CH, V44, P1453, DOI 10.1128/AAC.44.6.1453-1457.2000; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; Cha S, 2001, J Infect Chemother, V7, P81, DOI 10.1007/s101560100013; CHERRY D, 2001, ADV DATA VITAL HLTH, V322; Cizman M, 2001, J ANTIMICROB CHEMOTH, V47, P475, DOI 10.1093/jac/47.4.475; Cocuzza CE, 1997, MICROB DRUG RESIST, V3, P371, DOI 10.1089/mdr.1997.3.371; COONAN KM, 1994, PEDIATR INFECT DIS J, V13, P630, DOI 10.1097/00006454-199407000-00009; Descheemaeker P, 2000, J ANTIMICROB CHEMOTH, V45, P167, DOI 10.1093/jac/45.2.167; Facinelli B, 2001, LANCET, V358, P30, DOI 10.1016/S0140-6736(00)05253-3; FUJITA K, 1994, PEDIATR INFECT DIS J, V13, P1075, DOI 10.1097/00006454-199412000-00001; Garcia-Bermejo I, 1998, ANTIMICROB AGENTS CH, V42, P989, DOI 10.1128/AAC.42.4.989; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KAPLAN EL, 1994, CIRCULATION, V89, pA98; Kaplan EL, 1997, CLIN INFECT DIS, V24, pS89, DOI 10.1093/clinids/24.Supplement_1.S89; KAPLAN EL, 1993, CIRCULATION, V88, P1964, DOI 10.1161/01.CIR.88.4.1964; Linder JA, 2001, JAMA-J AM MED ASSOC, V286, P1181, DOI 10.1001/jama.286.10.1181; Martin JM, 2000, CLIN INFECT DIS, V31, P233; Martin JM, 1998, J INFECT DIS, V177, P504, DOI 10.1086/517387; MARTIN JM, 1999, CLIN INFECT DIS, V29, P984; *NAT COMM CLIN LAB, 2001, M100S11 NCCLS; PICKERING LK, 2000, 2000 RED BOOK REPORT, P526; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; SEPPALA H, 1992, NEW ENGL J MED, V326, P292, DOI 10.1056/NEJM199201303260503; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Syrogiannopoulos GA, 2001, PEDIATR INFECT DIS J, V20, P863, DOI 10.1097/00006454-200109000-00008; Syrogiannopoulos George A., 2001, Pediatric Infectious Disease Journal, V20, P1131; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Valisena S, 1999, EUR J CLIN MICROBIOL, V18, P260, DOI 10.1007/s100960050274; Varaldo PE, 1999, CLIN INFECT DIS, V29, P869, DOI 10.1086/520451	38	183	189	1	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 18	2002	346	16					1200	1206		10.1056/NEJMoa013169	http://dx.doi.org/10.1056/NEJMoa013169			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542FT	11961148				2022-12-24	WOS:000175033400004
J	Li, QL; Ito, K; Sakakura, C; Fukamachi, H; Inoue, K; Chi, XZ; Lee, KY; Nomura, S; Lee, CW; Han, SB; Kim, HM; Kim, WJ; Yamamoto, H; Yamashita, N; Yano, T; Ikeda, T; Itohara, S; Inazawa, J; Abe, T; Hagiwara, A; Yamagishi, H; Ooe, A; Kaneda, A; Sugimura, T; Ushijima, T; Bae, SC; Ito, Y				Li, QL; Ito, K; Sakakura, C; Fukamachi, H; Inoue, K; Chi, XZ; Lee, KY; Nomura, S; Lee, CW; Han, SB; Kim, HM; Kim, WJ; Yamamoto, H; Yamashita, N; Yano, T; Ikeda, T; Itohara, S; Inazawa, J; Abe, T; Hagiwara, A; Yamagishi, H; Ooe, A; Kaneda, A; Sugimura, T; Ushijima, T; Bae, SC; Ito, Y			Causal relationship between the loss of RUNX3 expression and gastric cancer	CELL			English	Article							CONFORMATION POLYMORPHISM ANALYSIS; CLEIDOCRANIAL DYSPLASIA; FREQUENT LOSS; EPITHELIAL-CELLS; GENE; MUTATIONS; DOMAIN; HETEROZYGOSITY; DIFFERENTIATION; AMPLIFICATION	Runx3/Pebp2alphaC null mouse gastric mucosa exhibits hyperplasias due to stimulated proliferation and suppressed apoptosis in epithelial cells, and the cells are resistant to growth-inhibitory and apoptosis-inducing action of TGF-beta, indicating that Runx3 is a major growth regulator of gastric epithelial cells. Between 45% and 60% of human gastric cancer cells do not significantly express RUNX3 due to hemizygous deletion and hypermethylation of the RUNX3 promoter region. Tumorigenicity of human gastric cancer cell lines in nude mice was inversely related to their level of RUNX3 expression, and a mutation (R122C) occurring within the conserved Runt domain abolished the tumor-suppressive effect of RUNX3, suggesting that a lack of RUNX3 function is causally related to the genesis and progression of human gastric cancer.	Chungbuk Natl Univ, Coll Med, Dept Biochem, Inst Med Res, Cheongju 361763, South Korea; Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Prefectural Univ Med, Dept Digest Surg, Kamigyo Ku, Kyoto 6020841, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; Korea Res Inst Biosci & Biotechnol, Taejon 305600, South Korea; Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju 361763, South Korea; Kyoto Univ, Inst Virus Res, Lab Adv Biol Informat, Sakyo Ku, Kyoto 6068507, Japan; Natl Canc Ctr, Res Inst, Chuo Ku, Tokyo 1040045, Japan; Tokyo Med & Dent Univ, Med Res Inst, Bunkyo Ku, Tokyo 1138510, Japan	Chungbuk National University; Kyoto University; Kyoto Prefectural University of Medicine; University of Tokyo; Osaka University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Kyoto University; National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU)	Bae, SC (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Biochem, Inst Med Res, Cheongju 361763, South Korea.		Itohara, Shigeyoshi/I-8769-2012; Li, Qinglin/K-2570-2015; Ushijima, Toshikazu/AAP-5742-2021	Itohara, Shigeyoshi/0000-0002-2410-9989; Li, Qinglin/0000-0002-4125-1944; Ushijima, Toshikazu/0000-0003-3405-7817				BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Baylin SB, 2001, HUM MOL GENET, V10, P687, DOI 10.1093/hmg/10.7.687; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cleary ML, 1999, NAT GENET, V23, P134, DOI 10.1038/13761; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Ezaki T, 1996, BRIT J CANCER, V73, P424, DOI 10.1038/bjc.1996.76; FUKAMACHI H, 1992, J CELL SCI, V103, P511; FUKAMACHI H, 1994, DIFFERENTIATION, V56, P83, DOI 10.1046/j.1432-0436.1994.56120083.x; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang D, 1998, DEVELOPMENT, V125, P3235; Ishino S, 1998, CANCER, V83, P360, DOI 10.1002/(SICI)1097-0142(19980715)83:2<360::AID-CNCR21>3.0.CO;2-Q; Ito Y, 1999, GENES CELLS, V4, P685, DOI 10.1046/j.1365-2443.1999.00298.x; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; KIM JH, 1991, J NATL CANCER I, V83, P938, DOI 10.1093/jnci/83.13.938; KUNIYASU H, 1994, INT J CANCER, V59, P597, DOI 10.1002/ijc.2910590504; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Matsubara Y, 1998, BIOCHEM BIOPH RES CO, V253, P477, DOI 10.1006/bbrc.1998.9808; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nam S, 2002, MOL CELL BIOL, V22, P547, DOI 10.1128/MCB.22.2.547-554.2002; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; PARK KC, 1994, P NATL ACAD SCI USA, V91, P8772, DOI 10.1073/pnas.91.19.8772; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; SANO T, 1991, CANCER RES, V51, P2926; SATAKE M, 1995, MOL CELL BIOL, V15, P1662; SOBIN IH, 1997, TNM CLASSIFICATION M; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; TAMURA G, 1991, CANCER RES, V51, P3056; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; UCHINO S, 1992, CANCER RES, V52, P3099; USHIJIMA T, 1995, MUTAT RES-ENVIR MUTA, V334, P283, DOI 10.1016/0165-1161(95)90065-9; Yamada K, 1997, HUM MOL GENET, V6, P2223, DOI 10.1093/hmg/6.13.2223; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	40	885	981	0	43	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					113	124		10.1016/S0092-8674(02)00690-6	http://dx.doi.org/10.1016/S0092-8674(02)00690-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955451	Bronze			2022-12-24	WOS:000174888300013
J	Ying, QL; Nichols, J; Evans, EP; Smith, AG				Ying, QL; Nichols, J; Evans, EP; Smith, AG			Changing potency by spontaneous fusion	NATURE			English	Article							EMBRYONIC STEM-CELLS; MARROW; BRAIN; BLOOD; HYBRIDIZATION; EXPRESSION	Recent reports have suggested that mammalian stem cells residing in one tissue may have the capacity to produce differentiated cell types for other tissues and organs(1-9). Here we define a mechanism by which progenitor cells of the central nervous system can give rise to non-neural derivatives. Cells taken from mouse brain were co-cultured with pluripotent embryonic stem cells. Following selection for a transgenic marker carried only by the brain cells, undifferentiated stem cells are recovered in which the brain cell genome has undergone epigenetic reprogramming. However, these cells also carry a transgenic marker and chromosomes derived from the embryonic stem cells. Therefore the altered phenotype does not arise by direct conversion of brain to embryonic stem cell but rather through spontaneous generation of hybrid cells. The tetraploid hybrids exhibit full pluripotent character, including multilineage contribution to chimaeras. We propose that transdetermination consequent to cell fusion 10 could underlie many observations otherwise attributed to an intrinsic plasticity of tissue stem cells(9).	Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Edinburgh; University of Oxford	Smith, AG (corresponding author), Univ Edinburgh, Ctr Genome Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	austin.smith@ed.ac.uk		Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682				AKESON EC, 1996, GENETIC VARIANTS STR, P1506; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BARSKI G, 1961, J NATL CANCER I, V26, P1269; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Ephrussi Boris, 1972, HYBRIDIZATION SOMATI; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Galli R, 2000, NAT NEUROSCI, V3, P986, DOI 10.1038/79924; GARDNER RL, 1988, J CELL SCI, P11; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; ROBERTSON E, 1987, TERATOCARCINOMA EMBR; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/bf01666137, DOI 10.1007/BF01666137, 10.1007/BF01666137]; SORIEUL S, 1961, NATURE, V190, P653, DOI 10.1038/190653b0; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Yeom YI, 1996, DEVELOPMENT, V122, P881	29	1193	1321	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2002	416	6880					545	548		10.1038/nature729	http://dx.doi.org/10.1038/nature729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932748	Green Published			2022-12-24	WOS:000174756500046
J	Krajinovic, M; Costea, I; Chiasson, S				Krajinovic, M; Costea, I; Chiasson, S			Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia	LANCET			English	Article								Interindividual variability In response to methotrexate could be caused by variable concentrations of thymidylate synthase. We Investigated the possible association between a tandem-repeat polymorphism in the thymidylate synthase promoter, of which a triple repeat Is associated with Increased expression of thymidylate synthase, and outcome of acute lymphoblastic leukaemia in 205 children treated with methotrexate. We obtained DNA samples from buccal epithelial cells, peripheral blood, or bone marrow In remission, and analysed them for the polymorphism by PCR amplification. Individuals who were homozygous for the triple repeat had a poorer outlook than those with other genotypes (odds ratio 4.1, 95% CI 1.9-9.0, p = 0.001). Genotyping of thymidylate synthase might make It possible to Individualise treatment for patients with acute lymphoblastic leukaemia.	Hop St Justine, Ctr Rech, Serv Hematol Oncol, Montreal, PQ H3T 1C5, Canada; Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Krajinovic, M (corresponding author), Hop St Justine, Ctr Rech, Serv Hematol Oncol, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.							HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191; Iacopetta B, 2001, BRIT J CANCER, V85, P827, DOI 10.1054/bjoc.2001.2007; Kawakami K, 1999, ANTICANCER RES, V19, P3249; Rots MG, 2000, LEUKEMIA, V14, P2166, DOI 10.1038/sj.leu.2401943; Welsh SJ, 2000, CLIN CANCER RES, V6, P2538	5	135	143	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 23	2002	359	9311					1033	1034		10.1016/S0140-6736(02)08065-0	http://dx.doi.org/10.1016/S0140-6736(02)08065-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937185				2022-12-24	WOS:000174585800012
J	Yang, QH; Rasmussen, SA; Friedman, JM				Yang, QH; Rasmussen, SA; Friedman, JM			Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study	LANCET			English	Article							DEATH; SURVIVAL; INDIVIDUALS; LEUKEMIA	Background Down's syndrome is the most frequently identified cause of mental retardation, but information about mortality and comorbidity in people with Down's syndrome is limited. Methods We used data from US death certificates from 1983 to 1997 to calculate median age at death and standardised mortality odds ratios (SMORs) for common medical disorders in people with Down's syndrome. Findings Of 17 897 people reported to have Down's syndrome, median age at death increased from 25 years in 1983 to 49 years in 1997, an average increase of 1.7 years per year studied (p < 0.0001). Median age at death was significantly lower in black people and people of other races than in white people with Down's syndrome. As expected, death certificates with a diagnosis of Down's syndrome were more likely to list congenital heart defects (SMOR 29.1, 95% CI 27.8-30.4), dementia (21.2, 19.6-22.7), hypothyroidism (20.3, 18.5-22.3), or leukaemia (1.6, 1.4-1.8) than were those that did not report Down's syndrome. By contrast, malignant neoplasms other than leukaemia were listed on death certificates of people with Down's syndrome less than one-tenth as often as expected (0.07, 0.06-0.08). A strikingly low SMOR for malignancy was associated with Down's syndrome at all ages, in both sexes, and for all common tumour types except leukaemia and testicular cancer. Interpretation Identification of factors responsible for the racial differences recorded could facilitate further improvement in survival of people with Down's syndrome. Reduced exposure to environmental factors that contribute to cancer risk, tumour-suppressor genes on chromosome 21, or a slower rate of replication or higher likelihood of apoptosis in Down's syndrome cells, could be possible reasons for paucity of cancer in people with Down's syndrome.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	Centers for Disease Control & Prevention - USA; University of British Columbia	Yang, QH (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.	qyang@cdc.gov		Friedman, Jan/0000-0002-7482-9570; Rasmussen, Sonja/0000-0002-0574-4928				[Anonymous], 2000, TERATOLOGY, V61, P86; BAIRD PA, 1988, LANCET, V2, P1354; BAIRD PA, 1988, AM J HUM GENET, V43, P239; BELL JA, 1989, J MED GENET, V26, P764, DOI 10.1136/jmg.26.12.764; Bishop J, 1997, AM J EPIDEMIOL, V145, P134; Boker LK, 2001, INT J CANCER, V93, P741, DOI 10.1002/ijc.1383; *CDCP, 1994, MMWR-MORBID MORTAL W, V43, P617; Conover WJ, 1999, PRACTICAL NONPARAMET; COOLEY WC, 1991, CLIN PEDIATR, V30, P233, DOI 10.1177/000992289103000407; Forrester MB, 1998, AM J EPIDEMIOL, V148, P1206; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; GITTELSOHN A, 1979, AM J PUBLIC HEALTH, V69, P680, DOI 10.2105/AJPH.69.7.680; HASLAM RHA, 1992, J CHILD NEUROL, V7, P304, DOI 10.1177/088307389200700312; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hayes C, 1997, INT J EPIDEMIOL, V26, P822, DOI 10.1093/ije/26.4.822; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; KULLER LH, 1995, AM J PUBLIC HEALTH, V85, P1198, DOI 10.2105/AJPH.85.9.1198; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MIETTINEN OS, 1981, AM J EPIDEMIOL, V114, P144, DOI 10.1093/oxfordjournals.aje.a113161; MULCAHY MT, 1979, CLIN GENET, V16, P103; *NAT CTR HLTH STAT, 1986, PUBL US DAT TAP DOC; Record RG, 1955, BRIT J PREV SOC MED, V9, P10; Rothman K., 1998, MODERN EPIDEMIOLOGY; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; Sawa A, 1999, J NEURAL TRANSM-SUPP, P87; SCHNEIDER EL, 1972, P SOC EXP BIOL MED, V141, P1092; SCHOLL T, 1982, DEV MED CHILD NEUROL, V24, P817; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; SMITH GF, 1984, JAMA-J AM MED ASSOC, V251, P229, DOI 10.1001/jama.251.2.229; SMITH KR, 1995, EPIDEMIOLOGY, V6, P55, DOI 10.1097/00001648-199501000-00011; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Yasui K, 1999, AM J MED GENET, V84, P406, DOI 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.3.CO;2-W	34	539	551	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2002	359	9311					1019	1025		10.1016/S0140-6736(02)08092-3	http://dx.doi.org/10.1016/S0140-6736(02)08092-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937181				2022-12-24	WOS:000174585800008
J	Liu, CM; Li, YM; Semenov, M; Han, C; Baeg, GH; Tan, Y; Zhang, ZH; Lin, XH; He, X				Liu, CM; Li, YM; Semenov, M; Han, C; Baeg, GH; Tan, Y; Zhang, ZH; Lin, XH; He, X			Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism	CELL			English	Article							F-BOX PROTEIN; GLYCOGEN-SYNTHASE KINASE-3; WNT SIGNALING PATHWAY; KAPPA-B-ALPHA; NEGATIVE REGULATOR; FUNCTIONAL INTERACTION; SUBSTRATE-SPECIFICITY; AXIS FORMATION; I-EPSILON; XENOPUS	Writ regulation of beta-catenin degradation is essential for development and carcinogenesis. beta-catenin degradation is initiated upon amino-terminal serine/threonine phosphorylation, which is believed to be performed by glycogen synthase kinase-3 (GSK-3) in complex with tumor suppressor proteins Axin and adnomatous polyposis coli (APC). Here we describe another Axin-associated kinase, whose phosphorylation of beta-catenin precedes and is required for subsequent GSK-3 phosphorylation of beta-catenin. This "priming" kinase is casein kinase 1alpha (CK1alpha). Depletion of CK1alpha inhibits beta-catenin phosphorylation and degradation and causes abnormal embryogenesis associated with excessive Wnt/beta-catenin signaling. Our study uncovers distinct roles and steps of beta-catenin phosphorylation, identifies CK1alpha as a component in Wnt/beta-catenin signaling, and has implications to pathogenesis/therapeutics of human cancers and diabetes.	Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA; Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Cell Signaling Inc, Beverly, MA 01915 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Harvard University; Harvard Medical School; Sanford Burnham Prebys Medical Discovery Institute	He, X (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol,Div Neurosci, Boston, MA 02115 USA.	xi.he@tch.harvard.edu	Baeg, Gyeong-Hun/A-2951-2008	Han, Chun/0000-0001-7319-8095				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Harwood AJ, 2001, CELL, V105, P821, DOI 10.1016/S0092-8674(01)00412-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; LEHMANN R, 1994, METHOD CELL BIOL, V44, P575, DOI 10.1016/S0091-679X(08)60933-4; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; McKay RM, 2001, DEV BIOL, V235, P388, DOI 10.1006/dbio.2001.0308; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Weston CR, 2001, SCIENCE, V292, P2439, DOI 10.1126/science.1063279; Willert K, 1999, DEVELOPMENT, V126, P4165; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOODGETT JR, 2001, SCI STKE, pRE12; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	67	1573	1626	2	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2002	108	6					837	847		10.1016/S0092-8674(02)00685-2	http://dx.doi.org/10.1016/S0092-8674(02)00685-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955436	Bronze			2022-12-24	WOS:000174563000012
J	Herlihy, CR; Eckert, CG				Herlihy, CR; Eckert, CG			Genetic cost of reproductive assurance in a self-fertilizing plant	NATURE			English	Article							INBREEDING DEPRESSION; CROSS-FERTILIZATION; SYSTEM EVOLUTION; MATING SYSTEM; INFERENCES; ECOLOGY	The transition from outcrossing to self-fertilization is one of the most common evolutionary trends in plants(1). Reproductive assurance, where self-fertilization ensures seed production when pollinators and/or potential mates are scarce, is the most long-standing and most widely accepted explanation for the evolution of selfing(2-8), but there have been few experimental tests of this hypothesis. Moreover, many apparently adaptive floral mechanisms that ensure the autonomous production of selfed seed might use ovules that would have otherwise been outcrossed. This seed discounting is costly if selfed offspring are less viable than their outcrossed counterparts, as often happens. The fertility benefit of reproductive assurance has never been examined in the light of seed discounting. Here we combine experimental measures of reproductive assurance with marker-gene estimates of self-fertilization, seed discounting and inbreeding depression to show that, during 2 years in 10 Ontario populations of Aquilegia canadensis (Ranunculaceae), reproductive assurance through self-fertilization increases seed production, but this benefit is greatly outweighed by severe seed discounting and inbreeding depression.	Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Eckert, CG (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	eckertc@biology.queensu.ca						BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 1996, PHILOS T R SOC B, V351, P1271, DOI 10.1098/rstb.1996.0110; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; Cruden R.W., 1989, EVOLUTIONARY ECOLOGY, P171; Darwin CR, 1876, EFFECTS CROSS SELF F; Eckert CG, 1998, AM J BOT, V85, P919, DOI 10.2307/2446357; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Griffin SR, 2000, AM J BOT, V87, P1246, DOI 10.2307/2656717; Holsinger KE, 1996, EVOL BIOL, V29, P107; Husband BC, 1996, EVOLUTION, V50, P54, DOI 10.2307/2410780; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; LANDE R, 1994, EVOLUTION, V48, P965, DOI 10.1111/j.1558-5646.1994.tb05286.x; Lloyd D. G., 1980, Demography and evolution in plant populations., P67; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; MACIOR LW, 1978, OIKOS, V30, P452, DOI 10.2307/3543340; Mavraganis K, 2001, OIKOS, V95, P300, DOI 10.1034/j.1600-0706.2001.950212.x; Morgan MT, 1997, AM NAT, V150, P618, DOI 10.1086/286085; Morgan MT, 1997, TRENDS ECOL EVOL, V12, P231, DOI 10.1016/S0169-5347(97)01045-8; PIPER JG, 1984, NATURE, V310, P50, DOI 10.1038/310050a0; PIPER JG, 1986, HEREDITY, V56, P207, DOI 10.1038/hdy.1986.33; RITLAND K, 1990, J HERED, V81, P235; RITLAND K, 1990, EVOLUTION, V44, P1230, DOI [10.2307/2409284, 10.1111/j.1558-5646.1990.tb05227.x]; Routley MB, 1999, HEREDITY, V82, P518, DOI 10.1038/sj.hdy.6885220; Schoen DJ, 1996, PHILOS T R SOC B, V351, P1281, DOI 10.1098/rstb.1996.0111; SCHOEN DJ, 1992, INT J PLANT SCI, V153, P381, DOI 10.1086/297042; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; YAHARA T, 1992, EVOLUTION, V46, P557, DOI [10.2307/2409872, 10.1111/j.1558-5646.1992.tb02059.x]	30	247	258	0	75	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					320	323		10.1038/416320a	http://dx.doi.org/10.1038/416320a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907577				2022-12-24	WOS:000174482200042
J	Malaty, HM; El-Kasabany, A; Graham, DY; Miller, CC; Reddy, SG; Srinivasan, SR; Yamaoka, Y; Berenson, GS				Malaty, HM; El-Kasabany, A; Graham, DY; Miller, CC; Reddy, SG; Srinivasan, SR; Yamaoka, Y; Berenson, GS			Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood	LANCET			English	Article							SOCIOECONOMIC-STATUS; DIAGNOSTIC-TESTS; GASTRIC-CANCER; UNITED-STATES; CHILDREN; CHILDHOOD; EPIDEMIOLOGY; ADOLESCENTS; POPULATION; PREVALENCE	Background Helicobacter pylori infection is common worldwide, but the time of acquisition is unclear. We investigated this issue in a cohort of children selected retrospectively from a population followed up for 21 years. Methods We monitored 224 children (99 black, 125 white; 110 male, 114 female) from 1975-76 (ages 1-3 years) to 1995-96. H pylori status was assessed by presence of serum IgG antibodies. Findings 18 (8.0%) children at age 1-3 years had H pylori antibodies (13% black vs 4% white children, p=0.008). By age 18-23 years, the prevalence of the infection was 24.5% (43% black vs 8% white participants, p<0.0001). Of the 206 children not infected at baseline, 40 (19%) became infected by age 21-23. The crude incidence rate per year was 1.4% for the whole cohort, ranging from 2.1% at 4-5 years and 1.5% at age 7-9 years to 0.3% at 21-23 years. The seroconversion rate was higher among black than among white children (relative risk 3.3, 95% CI 1.8-6.2, p=0.001). The median age for seroconversion was 7.5 years for both races. Nine of the 58 seropositive children cleared the infection during follow-up. The rate of seroreversion per year was 1.1%; it was highest among children at age 4-5 years (2.2% vs 0.2% at ages 18-19). Interpretation Most newly acquired H pylori infections happened before age 10 years. Treatment and preventive strategies should be aimed at children in this age-group.	Vet Affairs Med Ctr, Dept Med, Houston, TX 77030 USA; Vet Affairs Med Ctr, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Houston, TX 77030 USA; Tulane Sch Publ Hlth, Tulane Ctr Cardiovasc Hlth, New Orleans, LA USA; Univ Texas, Sch Med, Dept Surg, Houston, TX USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; Tulane University; University of Texas System	Malaty, HM (corresponding author), Vet Affairs Med Ctr, Dept Med, 111D,2002 Holcombe Blvd, Houston, TX 77030 USA.		Graham, David/AAL-2165-2021	Yamaoka, Yoshio/0000-0002-1222-5819				ASHORN M, 1995, SCAND J GASTROENTERO, V30, P876, DOI 10.3109/00365529509101594; BAMFORD KB, 1993, GUT, V34, P1348, DOI 10.1136/gut.34.10.1348; CHONG SKF, 1995, PEDIATRICS, V96, P211; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; CRANSTROM M, 1997, J CLIN MICROBIOL, V35, P468; EVANS DJ, 1989, GASTROENTEROLOGY, V96, P1004, DOI 10.1016/0016-5085(89)91616-8; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Graham DY, 1991, HELICOBACTER PYLORI, P97; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P97; Khanna B, 1998, J INFECT DIS, V178, P460, DOI 10.1086/515634; KLEIN PD, 1994, AM J GASTROENTEROL, V89, P2196; KUIPERS EJ, 1993, LANCET, V342, P328, DOI 10.1016/0140-6736(93)91473-Y; Kumagai T, 1998, J INFECT DIS, V178, P717, DOI 10.1086/515376; Malaty HM, 1999, CLIN INFECT DIS, V28, P279, DOI 10.1086/515105; Malaty HM, 1996, AM J EPIDEMIOL, V143, P257, DOI 10.1093/oxfordjournals.aje.a008736; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Malaty HM, 2001, CLIN INFECT DIS, V32, P1387, DOI 10.1086/320148; MALATY HM, 1991, SCAND J GASTROENTERO, V26, P927, DOI 10.3109/00365529108996244; MALATY HM, 1992, GASTROENTEROLOGY, V103, P813, DOI 10.1016/0016-5085(92)90011-M; MALATY HM, 1994, GUT, V35, P742, DOI 10.1136/gut.35.6.742; MEGRAUD F, 1989, J CLIN MICROBIOL, V27, P1870; MENDALL MA, 1992, LANCET, V339, P896, DOI 10.1016/0140-6736(92)90931-R; PARSONNET J, 1995, ALIMENT PHARM THERAP, V9, P45; Pickoff AS, 1995, AM J MED SCI, V310, pS1, DOI 10.1097/00000441-199512000-00001; Snyder JD, 1999, CAN J GASTROENTEROL, V13, P585, DOI 10.1155/1999/304679; Staat MA, 1996, J INFECT DIS, V174, P1120, DOI 10.1093/infdis/174.5.1120; TEH BH, 1994, ANTICANCER RES, V14, P1389; TYTGAT GNJ, 1993, GASTROENTEROL INT, V6, P76	29	283	296	2	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 16	2002	359	9310					931	935		10.1016/S0140-6736(02)08025-X	http://dx.doi.org/10.1016/S0140-6736(02)08025-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531AE	11918912				2022-12-24	WOS:000174391700012
J	Hoppe, HG; Gocke, K; Koppe, R; Begler, C				Hoppe, HG; Gocke, K; Koppe, R; Begler, C			Bacterial growth and primary production along a north-south transect of the Atlantic Ocean	NATURE			English	Article							EUPHOTIC ZONE; RESPIRATION; ECOSYSTEMS; BACTERIOPLANKTON; PHOTOSYNTHESIS; TEMPERATURE; BALANCE; BIOMASS; WATERS; FRESH	The oceanic carbon cycle is mainly determined by the combined activities of bacteria and phytoplankton(1,2), but the interdependence of climate, the carbon cycle and the microbes is not well understood. To elucidate this interdependence, we performed high-frequency sampling of sea water along a north-south transect of the Atlantic Ocean. Here we report that the interaction of bacteria and phytoplankton is closely related to the meridional profile of water temperature, a variable directly dependent on climate. Water temperature was positively correlated with the ratio of bacterial production to primary production, and, more strongly, with the ratio of bacterial carbon demand to primary production. In warm latitudes (25degrees N to 30degrees S), we observed alternating patches of predominantly heterotrophic and autotrophic community metabolism. The calculated regression lines (for data north and south of the Equator) between temperature and the ratio of bacterial production to primary production give a maximum value for this ratio of 40% in the oligotrophic equatorial regions. Taking into account a bacterial growth efficiency(3,4) of 30%, the resulting area of net heterotrophy (where the bacterial carbon demand for growth plus respiration exceeds phytoplankton carbon fixation(4-6)) expands from 8degrees N (27 degreesC) to 20degrees S (23 degreesC). This suggests an output of CO2 from parts of the ocean to the atmosphere(6,7).	Inst Marine Sci, Sect Marine Ecol, D-24105 Kiel, Germany; Inst Marine Sci, Sect Ocean Circulat & Climate, D-24105 Kiel, Germany		Hoppe, HG (corresponding author), Inst Marine Sci, Sect Marine Ecol, Dusternbroker Weg 20, D-24105 Kiel, Germany.	hhoppe@ifm.uni-kiel.de						AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; AZAM F, 1994, P INDIAN AS-EARTH, V103, P341; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Duarte MC, 2001, LIMNOL OCEANOGR, V46, P425, DOI 10.4319/lo.2001.46.2.0425; Ducklow HW, 1999, FEMS MICROBIOL ECOL, V30, P1, DOI 10.1111/j.1574-6941.1999.tb00630.x; Fasham MJR, 1999, LIMNOL OCEANOGR, V44, P80, DOI 10.4319/lo.1999.44.1.0080; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Geider RJ, 1997, NATURE, V388, P132, DOI 10.1038/40536; Hoppe H. G., 1993, CURRENT METHODS AQUA, P423; Hurtt GC, 1996, DEEP-SEA RES PT II, V43, P653, DOI 10.1016/0967-0645(96)00007-0; Karrasch B, 1996, J MAR RES, V54, P99, DOI 10.1357/0022240963213420; KIRCHMAN DL, 1995, DEEP-SEA RES PT II, V42, P603, DOI 10.1016/0967-0645(95)00021-H; Kuipers B, 2000, MAR ECOL PROG SER, V201, P13, DOI 10.3354/meps201013; Lochte K, 1997, DEEP-SEA RES PT II, V44, P321, DOI 10.1016/S0967-0645(96)00081-1; Longhurst A., 2010, ECOLOGICAL GEOGRAPHY; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Rivkin RB, 2001, SCIENCE, V291, P2398, DOI 10.1126/science.291.5512.2398; Rivkin RB, 1996, AQUAT MICROB ECOL, V10, P243, DOI 10.3354/ame010243; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; SIMON M, 1992, MAR ECOL PROG SER, V86, P103, DOI 10.3354/meps086103; SOROKIN YI, 1971, MAR BIOL, V11, P101; WILLIAMS PJ, 1999, SCIENCE, V284, P1735, DOI DOI 10.1126/SCIENCE.284.5421.1735B; Williams PJL, 1998, NATURE, V394, P55; Zubkov MV, 2001, DEEP-SEA RES PT II, V48, P987, DOI 10.1016/S0967-0645(00)00105-3	29	125	129	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 14	2002	416	6877					168	171		10.1038/416168a	http://dx.doi.org/10.1038/416168a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894092				2022-12-24	WOS:000174348100035
J	Sinha, R; Fisch, G; Teague, B; Tamborlane, WV; Banyas, B; Allen, K; Savoye, M; Rieger, V; Taksali, S; Barbetta, G; Sherwin, RS; Caprio, S				Sinha, R; Fisch, G; Teague, B; Tamborlane, WV; Banyas, B; Allen, K; Savoye, M; Rieger, V; Taksali, S; Barbetta, G; Sherwin, RS; Caprio, S			Prevalence of impaired glucose tolerance among children and adolescents with marked obesity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPE-2 DIABETES-MELLITUS; BETA-CELL DYSFUNCTION; INSULIN-RESISTANCE; IMMUNOREACTIVE PROINSULIN; RISK-FACTORS; NIDDM; SECRETION; PATHOGENESIS; INTOLERANCE; PREVENTION	Background: Childhood obesity, epidemic in the United States, has been accompanied by an increase in the prevalence of type 2 diabetes among children and adolescents. We determined the prevalence of impaired glucose tolerance in a multiethnic cohort of 167 obese children and adolescents. Methods: All subjects underwent a two-hour oral glucose-tolerance test (1.75 mg of glucose per kilogram of body weight), and glucose, insulin, and C-peptide levels were measured. Fasting levels of proinsulin were obtained, and the ratio of proinsulin to insulin was calculated. Insulin resistance was estimated by homeostatic model assessment, and beta-cell function was estimated by calculating the ratio between the changes in the insulin level and the glucose level during the first 30 minutes after the ingestion of glucose. Results: Impaired glucose tolerance was detected in 25 percent of the 55 obese children (4 to 10 years of age) and 21 percent of the 112 obese adolescents (11 to 18 years of age); silent type 2 diabetes was identified in 4 percent of the obese adolescents. Insulin and C-peptide levels were markedly elevated after the glucose-tolerance test in subjects with impaired glucose tolerance but not in adolescents with diabetes, who had a reduced ratio of the 30-minute change in the insulin level to the 30-minute change in the glucose level. After the body-mass index had been controlled for, insulin resistance was greater in the affected cohort and was the best predictor of impaired glucose tolerance. Conclusions: Impaired glucose tolerance is highly prevalent among children and adolescents with severe obesity, irrespective of ethnic group. Impaired oral glucose tolerance was associated with insulin resistance while beta-cell function was still relatively preserved. Overt type 2 diabetes was linked to beta-cell failure. (N Engl J Med 2002;346:802-10.) Copyright (C) 2002 Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Childrens Gen Clin Res Ctr, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Div Biostat, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Caprio, S (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,POB 208064, New Haven, CT 06520 USA.	sonia.caprio@yale.edu	Robles-Sardin, Alma E/M-7714-2015	Robles-Sardin, Alma E/0000-0003-2044-7793	NCRR NIH HHS [M01 RR 06022, M01 RR 00125] Funding Source: Medline; NICHD NIH HHS [R01 HD-28016, R01 HD 40787, K24HD01464] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040787, R01HD028016] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001464] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022, M01RR000125] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arslanian SA, 2001, J CLIN ENDOCR METAB, V86, P66, DOI 10.1210/jc.86.1.66; Bonora E, 1998, DIABETES, V47, P1643, DOI 10.2337/diabetes.47.10.1643; Dabelea D, 1999, ENDOCRIN METAB CLIN, V28, P709, DOI 10.1016/S0889-8529(05)70098-0; DeFronzo RA, 1997, DIABETES REV, V5, P177; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; EFENDIC S, 1984, ENDOCR REV, V5, P395, DOI 10.1210/edrv-5-3-395; FAGOTCOMPAGNA A, 2001, DIABETES CARE S5, V24, pS134; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Haffner SM, 1996, DIABETOLOGIA, V39, P1201, DOI 10.1007/BF02658507; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Haffner SM, 1997, DIABETOLOGIA, V40, P830, DOI 10.1007/s001250050756; HAMMER LD, 1991, AM J DIS CHILD, V145, P259, DOI 10.1001/archpedi.1991.02160030027015; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Polonsky KS, 1996, NEW ENGL J MED, V334, P777, DOI 10.1056/NEJM199603213341207; PORTE D, 1989, DIABETES, V38, P1333, DOI 10.2337/diabetes.38.11.1333; Porte D, 2001, DIABETES, V50, pS160, DOI 10.2337/diabetes.50.2007.S160; REAVEN GM, 1973, J CLIN ENDOCR METAB, V76, P44; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; STOKES ME, 1995, CATEGORICAL DATA ANA, P163; Tanner J.M., 1962, GROWTH ADOLESCENCE, V2nd ed.; TUOMILEHTO J, 1992, DIABETES METAB REV, V8, P339, DOI 10.1002/dmr.5610080403; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991	31	1159	1199	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					802	810		10.1056/NEJMoa012578	http://dx.doi.org/10.1056/NEJMoa012578			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893791				2022-12-24	WOS:000174328900003
J	Suster, ML; Bate, M				Suster, ML; Bate, M			Embryonic assembly of a central pattern generator without sensory input	NATURE			English	Article							XENOPUS-LAEVIS EMBRYOS; DROSOPHILA; EXPRESSION; BEHAVIOR; LOCOMOTION; MOVE	Locomotion depends on the integration of sensory information with the activity of central circuitry, which generates patterned discharges in motor nerves to appropriate muscles(1,2). Isolated central networks generate fictive locomotor rhythms (recorded in the absence of movement), indicating that the fundamental pattern of motor output depends on the intrinsic connectivity and electrical properties of these central circuits(3,4). Sensory inputs are required to modify the pattern of motor activity in response to the actual circumstances of real movement. A central issue for our understanding of how locomotor circuits are specified and assembled is the extent to which sensory inputs are required as such systems develop(5). Here we describe the effects of eliminating sensory function and structure on the development of the peristaltic motor pattern of Drosophila embryos and larvae. We infer that the circuitry for peristaltic crawling develops in the complete absence of sensory input; however, the integration of this circuitry into actual patterns of locomotion requires additional information from the sensory system. In the absence of sensory inputs, the polarity of movement is deranged, and backward peristaltic waves predominate at the expense of forward peristalsis.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Suster, ML (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERRIGAN D, 1995, J INSECT PHYSIOL, V41, P329, DOI 10.1016/0022-1910(94)00113-U; BOOTHBY KM, 1992, J COMP PHYSIOL A, V170, P171; BRAND AH, 1993, DEVELOPMENT, V118, P401; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; HAMBURGER V, 1967, J EXP ZOOL, V166, P171, DOI 10.1002/jez.1401660203; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; HILDAGO A, 1995, DEVELOPMENT, V121, P3703; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jan Yuh Nung, 1993, P1207; Kaliss N, 1939, GENETICS, V24, P244; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Pearson KG, 1995, CURR OPIN NEUROBIOL, V5, P786, DOI 10.1016/0959-4388(95)80107-3; Reynolds SA, 1998, J COMP NEUROL, V402, P168, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;168::AID-CNE3&gt;3.0.CO;2-W; Richards KS, 2000, J NEUROBIOL, V44, P31, DOI 10.1002/1097-4695(200007)44:1<31::AID-NEU4>3.0.CO;2-F; Sanes DH., 2000, DEV NERVOUS SYSTEM; SCHNEIDERMAN AM, 1986, NATURE, V323, P801, DOI 10.1038/323801a0; Siekhaus DE, 1999, J NEUROSCI, V19, P6942, DOI 10.1523/JNEUROSCI.19-16-06942.1999; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; VANMIER P, 1989, NEUROSCIENCE, V32, P113, DOI 10.1016/0306-4522(89)90111-5; Wang JW, 1997, J NEUROGENET, V11, P231, DOI 10.3109/01677069709115098	30	122	124	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					174	178		10.1038/416174a	http://dx.doi.org/10.1038/416174a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894094				2022-12-24	WOS:000174348100037
J	Skellett, S; Tibby, SM; Durward, A; Murdoch, IA				Skellett, S; Tibby, SM; Durward, A; Murdoch, IA			Lesson of the week - Immobilisation of the cervical spine in children	BRITISH MEDICAL JOURNAL			English	Review							TRAUMA; INJURY		Guys Hosp, Dept Paediat Intens Care, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Skellett, S (corresponding author), Guys Hosp, Dept Paediat Intens Care, London SE1 9RT, England.		Skellett, Sophie/AAF-5538-2020					*ADV LIF SUPP GROU, 1999, PREH PAED LIF SUPP; *ADV LIF SUPP GROU, 1995, ADV PAED LIF SUPP PR, P132; BACHULIS BL, 1987, AM J SURG, V153, P473, DOI 10.1016/0002-9610(87)90796-3; CHAMEIDES L, 1994, PEDIAT ADV LIFE SUPP, P8; Eleraky MA, 2000, J NEUROSURG, V92, P12, DOI 10.3171/spi.2000.92.1.0012; HARRIS JH, 1986, ORTHOP CLIN N AM, V17, P75; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; HUERTA C, 1987, ANN EMERG MED, V16, P1121, DOI 10.1016/S0196-0644(87)80468-7; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Lloyd DA, 1997, BRIT MED J, V315, P1308; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720	12	6	8	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 9	2002	324	7337					591	593		10.1136/bmj.324.7337.591	http://dx.doi.org/10.1136/bmj.324.7337.591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	530XJ	11884327	Green Published			2022-12-24	WOS:000174384000026
J	Smith, ZM; Delgutte, B; Oxenham, AJ				Smith, ZM; Delgutte, B; Oxenham, AJ			Chimaeric sounds reveal dichotomies in auditory perception	NATURE			English	Article							INTERAURAL TIME DIFFERENCES; SPEECH RECOGNITION; LOW-FREQUENCY; MECHANISMS; CORTEX; CAT	By Fourier's theorem(1), signals can be decomposed into a sum of sinusoids of different frequencies. This is especially relevant for hearing, because the inner ear performs a form of mechanical Fourier transform by mapping frequencies along the length of the cochlear partition. An alternative signal decomposition, originated by Hilbert(2), is to factor a signal into the product of a slowly varying envelope and a rapidly varying fine time structure. Neurons in the auditory brainstem(3-6) sensitive to these features have been found in mammalian physiological studies. To investigate the relative perceptual importance of envelope and fine structure, we synthesized stimuli that we call 'auditory chimaeras', which have the envelope of one sound and the fine structure of another. Here we show that the envelope is most important for speech reception, and the fine structure is most important for pitch perception and sound localization. When the two features are in conflict, the sound of speech is heard at a location determined by the fine structure, but the words are identified according to the envelope. This finding reveals a possible acoustic basis for the hypothesized 'what' and 'where' pathways in the auditory cortex(7-10).	Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; MIT, Elect Res Lab, Cambridge, MA 02139 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Speech & Hearing Biosci & Technol Program, Cambridge, MA 02139 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Delgutte, B (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA.		Smith, Zachary/B-2879-2009	Smith, Zachary/0000-0002-0819-4562; Oxenham, Andrew/0000-0002-9365-1157; Delgutte, Bertrand/0000-0003-1349-9608	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002258, R01DC005216] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002258-07, R01 DC002258, R01 DC005216-02, R01 DC005216] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERNSTEIN LR, 1985, J ACOUST SOC AM, V77, P1868, DOI 10.1121/1.391938; Delgutte B, 2001, AUDITORY CHIMERA DEM; DEPALLE P, 1994, P ICMC, P357; DODGE C, 1997, COMPUTER MUSIC SYNTH; Fourier J, 1829, MEM ACAD R SCI, V8, P581; Ghitza O, 2001, J ACOUST SOC AM, V110, P1628, DOI 10.1121/1.1396325; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; HENNING GB, 1981, HEARING RES, V4, P184; Hilbert D., 1912, GRUNDZUGE ALLGEMEINE; JORIS PX, 1995, J NEUROPHYSIOL, V73, P1043, DOI 10.1152/jn.1995.73.3.1043; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; LICKLIDER JCR, 1946, J ACOUST SOC AM, V18, P429, DOI 10.1121/1.1916383; Litvak L, 2001, J ACOUST SOC AM, V110, P368, DOI 10.1121/1.1375140; Maeder PP, 2001, NEUROIMAGE, V14, P802, DOI 10.1006/nimg.2001.0888; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; RHODE WS, 1983, J COMP NEUROL, V213, P448, DOI 10.1002/cne.902130408; Rubinstein JT, 1999, HEARING RES, V127, P108, DOI 10.1016/S0378-5955(98)00185-3; Saberi K, 1999, NATURE, V398, P760, DOI 10.1038/19652; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; TROULLINOS G, 1990, DIGIT SIGNAL PROCESS, P221; Ville J., 1948, CABLES TRANSM, V2A, P61; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yin T. C., 1990, J NEUROPHYSIOL, V65, P465	28	591	644	4	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					87	90		10.1038/416087a	http://dx.doi.org/10.1038/416087a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882898	Green Accepted			2022-12-24	WOS:000174211600044
J	Corcoran, M				Corcoran, M			An unhappy coincidence between multiple sclerosis and trauma?	LANCET			English	Editorial Material									Legal Hlth Consulting, Bristol BS6 7UN, Avon, England		Corcoran, M (corresponding author), Legal Hlth Consulting, Bristol BS6 7UN, Avon, England.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					726	726		10.1016/S0140-6736(02)07902-3	http://dx.doi.org/10.1016/S0140-6736(02)07902-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888581				2022-12-24	WOS:000174115200005
J	Iseki, M; Matsunaga, S; Murakami, A; Ohno, K; Shiga, K; Yoshida, K; Sugai, M; Takahashi, T; Hori, T; Watanabe, M				Iseki, M; Matsunaga, S; Murakami, A; Ohno, K; Shiga, K; Yoshida, K; Sugai, M; Takahashi, T; Hori, T; Watanabe, M			A blue-light-activated adenylyl cyclase mediates photoavoidance in Euglena gracilis	NATURE			English	Article							COMPLETE GENOME SEQUENCE; DOUBLE-STRANDED-RNA; STEP-DOWN; PHOTORECEPTOR; PROTEIN; GENE; TRANSDUCTION; PIGMENTS; ENCODES; CELLS	Blue light regulates processes such as the development of plants and fungi and the behaviour of microbes(1,2). Two types of blue-light receptor flavoprotein have been identified: cryptochromes, which have partial similarity to photolyases(3,4), and phototropins, which are photoregulated protein kinases(5,6). The former have also been found in animals with evidence of essential roles in circadian rhythms(7,8). Euglena gracilis, a unicellular flagellate, abruptly changes its swimming direction after a sudden increase or decrease in incident blue light intensity, that is, step-up or step-down photophobic responses, resulting in photoavoidance or photoaccumulation, respectively(9). Although these photobehaviours of Euglena have been studied for a century(10), the photoreceptor molecules mediating them have remained unknown(9). Here we report the discovery and biochemical characterization of a new type of blue-light receptor flavoprotein, photoactivated adenylyl cyclase, in the photoreceptor organelle of Euglena gracilis, with molecular genetic evidence that it mediates the step-up photophobic response.	Natl Inst Basic Biol, Okazaki 4448585, Japan; Biooriented Technol Res Advancement Inst, Minato Ku, Tokyo 1050001, Japan; Nagoya Univ, Ctr Gene Res, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Kobe Univ, Res Ctr Inland Seas, Awaji, Hyogo 6562401, Japan; Kumamoto Univ, Sch Med, Dept Physiol, Kumamoto 8608556, Japan; Toyama Univ, Fac Sci, Dept Biol, Toyama 9308555, Japan; Toho Univ, Sch Pharmaceut Sci, Chiba 2748510, Japan; Grad Univ Adv Studies, Sch Adv Sci, Dept Photosci, Kanagawa 2400193, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Nagoya University; University of Tsukuba; Kobe University; Kumamoto University; University of Toyama; Toho University; Graduate University for Advanced Studies - Japan	Watanabe, M (corresponding author), Natl Inst Basic Biol, Okazaki 4448585, Japan.	machakou@nibb.ac.jp		Ohno, Kaoru/0000-0001-7648-3940				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; BARGHIGIANI C, 1979, PHOTOCHEM PHOTOBIOL, V29, P1015, DOI 10.1111/j.1751-1097.1979.tb07806.x; BENEDETTI PA, 1977, PHOTOCHEM PHOTOBIOL, V26, P315, DOI 10.1111/j.1751-1097.1977.tb07492.x; BESSEY OA, 1949, J BIOL CHEM, V180, P755; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; BRODHUN B, 1990, PHOTOCHEM PHOTOBIOL, V52, P865, DOI 10.1111/j.1751-1097.1990.tb08695.x; Buder J, 1919, JB WISS BOTAN, V58, P105; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; DANCHIN A, 1993, ADV SEC MESS PHOSPH, V27, P109; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Gomelsky M, 1998, J BIOL CHEM, V273, P35319, DOI 10.1074/jbc.273.52.35319; HASEGAWA E, 1987, CELL MOTIL CYTOSKEL, V8, P302, DOI 10.1002/cm.970080403; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Kaneko T, 1996, DNA Res, V3, P109; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; KATAYAMA M, 1995, J BACTERIOL, V177, P3873, DOI 10.1128/jb.177.13.3873-3878.1995; Lebert M, 2001, COMPREHENSIVE SERIES, P297; Matsunaga S, 1998, PROTOPLASMA, V201, P45, DOI 10.1007/BF01280710; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Senger Horst, 1994, P301; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; Torre V, 1995, J NEUROSCI, V15, P7757; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WATANABE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P491, DOI 10.1111/j.1751-1097.1982.tb04407.x; WATANABE M, 1995, HDB ORGANIC PHOTOCHE, P1276	30	360	380	1	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1047	1051		10.1038/4151047a	http://dx.doi.org/10.1038/4151047a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875575				2022-12-24	WOS:000174075000051
J	Rasmussen, LEL; Riddle, HS; Krishnamurthy, V				Rasmussen, LEL; Riddle, HS; Krishnamurthy, V			Mellifluous matures to malodorous in musth	NATURE			English	Article									Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA; Riddles Elephant & Wildlife Sanctuary, Greenbrier, AR 72058 USA; Indian Inst Sci, Asian Elephant Res & Conservat Ctr, Bangalore 560012, Karnataka, India	Oregon Health & Science University; Indian Institute of Science (IISC) - Bangalore	Rasmussen, LEL (corresponding author), Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Biochem & Mol Biol, Beaverton, OR 97006 USA.							ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Chandrasekharan K., 1992, ASIAN ELEPHANT ECOLO, P71; EDGERTON F, 1931, ELEPHANT LORE HINDUS; FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; Free J. B., 1987, PHEROMONES SOCIAL BE; JAINUDEEN M R, 1972, Mammalia, V36, P247, DOI 10.1515/mamm.1972.36.2.247; KRISHNAN M, 1972, J BOMBAY NAT HIST SO, V69, P298; McKay G.M., 1973, Smithsonian Contributions to Zoology, VNo. 125, P1; PERRIN TE, 1996, J CHEM ECOL, V21, P207; PHILLIPS TW, 1989, J CHEM ECOL, V15, P1513, DOI 10.1007/BF01012380; Rasmussen LEL, 1998, ECOSCIENCE, V5, P410, DOI 10.1080/11956860.1998.11682469; Rasmussen LEL, 1999, PHYSIOL BEHAV, V67, P539, DOI 10.1016/S0031-9384(99)00114-6; Sukumar R., 1989, ASIAN ELEPHANT ECOLO	13	58	59	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					975	976		10.1038/415975a	http://dx.doi.org/10.1038/415975a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875552				2022-12-24	WOS:000174075000028
J	Barnes, DKA				Barnes, DKA			Biodiversity - Invasions by marine life on plastic debris	NATURE			English	Article							DISPERSAL; ISLAND		British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 OET, England; Univ Coll Cork, Dept Zool & Anim Ecol, Cork, Ireland	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University College Cork	Barnes, DKA (corresponding author), British Antarctic Survey, Nat Environm Res Council, High Cross,Madingley Rd, Cambridge CB3 OET, England.	dkab@bas.ac.uk						Barnes DK, 2000, P 11 INT BRYOZ ASS C, P154; Bonner W.N., 1982, BRIT ANTARCT SURV B, V57, P73; DUNTON K, 1992, TRENDS ECOL EVOL, V7, P183, DOI 10.1016/0169-5347(92)90070-R; Goldberg E.D., 1995, CHEM ECOL, V10, P3, DOI [DOI 10.1080/02757549508035325, 10.1080/02757549508035325]; Gregory MR, 1999, OCEAN COAST MANAGE, V42, P603, DOI 10.1016/S0964-5691(99)00036-8; HIGHSMITH RC, 1985, MAR ECOL PROG SER, V25, P169, DOI 10.3354/meps025169; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; MURPHY JM, 1995, J CLIMATE, V8, P496, DOI 10.1175/1520-0442(1995)008<0496:TROTHC>2.0.CO;2; Quayle WC, 2002, SCIENCE, V295, P645, DOI 10.1126/science.1064074; THRESHER RE, 1985, EVOLUTION, V39, P878, DOI 10.1111/j.1558-5646.1985.tb00429.x; Walker TR, 1997, MAR POLLUT BULL, V34, P61, DOI 10.1016/S0025-326X(96)00053-7; Winston Judith E., 1997, P81; 1999, BRIT ECOLOGICAL SOC	13	463	482	12	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2002	416	6883					808	809		10.1038/416808a	http://dx.doi.org/10.1038/416808a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976671				2022-12-24	WOS:000175163800039
J	Dean, B; Schachter, M; Vincent, C; Barber, N				Dean, B; Schachter, M; Vincent, C; Barber, N			Causes of prescribing errors in hospital inpatients: a prospective study	LANCET			English	Article							ADVERSE DRUG EVENTS; INTENSIVE-CARE; UNITED-KINGDOM; MEDICATION; RISK; SAFETY	Background To prevent errors made during the prescription of drugs, we need to know why they arise. Theories of human error used to understand the causes of mistakes made in high-risk industries are being used in health-care. They have not, however, been applied to prescribing errors, which are a great cause of patient harm. Our aim was to use this approach to investigate the causes of such errors. Methods Pharmacists at a UK teaching hospital prospectively identified 88 potentially serious prescribing errors. We interviewed the prescribers who made 44 of these, and analysed our findings with human error theory. Findings Our results suggest that most mistakes were made because of slips in attention, or because prescribers did not apply relevant rules. Doctors identified many risk factors-work environment, workload, whether or not they were prescribing for their own patient, communication within their team, physical and mental well-being, and lack of knowledge. Organisational factors were also identified, and included inadequate training, low perceived importance of prescribing, a hierarchical medical team, and an absence of self-awareness of errors. Interpretation To reduce prescribing errors, hospitals should train junior doctors in the principles of drug dosing before they start prescribing, and enforce good practice in documentation. They should also create a culture in which prescription writing is seen as important, and formally review interventions made by pharmacists, locum arrangements, and the workload of junior doctors, and make doctors aware of situations in which they are likely to commit errors.	Univ London, Sch Pharm, Ctr Practice & Policy, London WC1N 1AX, England; Imperial Coll Sch Med, London, England; UCL, Clin Risk Univ, London, England	University of London; University College London; University of London School of Pharmacy; Imperial College London; University of London; University College London	Dean, B (corresponding author), Hammersmith Hosp NHS Trust, Dept Pharm, Acad Pharm Unit, London W12 0HS, England.	bdean@hhnt.org	Dean, Brian/M-3558-2019; Vincent, Charles A/D-1134-2010	Dean, Brian/0000-0001-7773-4473; Vincent, Charles A/0000-0003-0270-0222; Franklin, Bryony/0000-0002-2892-1245				ADAMS JGU, 1988, ERGONOMICS, V31, P407, DOI 10.1080/00140138808966688; Barber N, 1993, INT J PHARM PRACT, V2, P152; Barber ND, 1997, AM J HEALTH-SYST PH, V54, P397, DOI 10.1093/ajhp/54.4.397; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Battles JB, 1998, ARCH PATHOL LAB MED, V122, P231; BLEYER WA, 1979, AM J DIS CHILD, V133, P366, DOI 10.1001/archpedi.1979.02130040020002; COTTER SM, 1994, AM J HOSP PHARM, V51, P2676, DOI 10.1093/ajhp/51.21.2676; Dean B, 2000, QUAL HEALTH CARE, V9, P232, DOI 10.1136/qhc.9.4.232; DEAN BS, IN PRESS QUAL HLTH C; *DEP HLTH SOC SERV, 1970, HM7036 DHHS DEP HLTH; Department of Health, 2000, EXP GROUP LEARN ADV; Institute of Medicine, 2000, ERR IS HUM BUILD SAF; Jacklin A, 2001, PHARM PRACT, V11, P100; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; LESAR TS, 1992, ANN INTERN MED, V117, P537, DOI 10.7326/0003-4819-117-6-537_2; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Lesar TS, 1998, ARCH PEDIAT ADOL MED, V152, P340; MCEWAN D, 1999, THESIS U LONDON; NEALE G, 1995, CLIN RISK MANAGEMENT, P253; PERLSTEIN PH, 1979, AM J DIS CHILD, V133, P376, DOI 10.1001/archpedi.1979.02130040030006; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Rowe C, 1998, ARCH DIS CHILD, V79, P56, DOI 10.1136/adc.79.1.56; Vincent C, 2000, BRIT MED J, V320, P777, DOI 10.1136/bmj.320.7237.777; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; VITILLO JA, 1991, DICP ANN PHARMAC, V25, P1388, DOI 10.1177/106002809102501221	27	389	404	0	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2002	359	9315					1373	1378		10.1016/S0140-6736(02)08350-2	http://dx.doi.org/10.1016/S0140-6736(02)08350-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978334				2022-12-24	WOS:000175076200009
J	Moynihan, R; Heath, I; Henry, D				Moynihan, R; Heath, I; Henry, D			Selling sickness: the pharmaceutical industry and disease mongering	BRITISH MEDICAL JOURNAL			English	Article							ERECTILE DYSFUNCTION; VERTEBRAL FRACTURES; MEDICALIZATION; ALENDRONATE; PREVALENCE; MEDICINE; LIMITS; TRIAL; WOMEN; RISK		Australian Financial Review, Sydney, NSW 2201, Australia; Caversham Grp, London NW5 2UP, England; Univ Newcastle, Fac Hlth, Sch med Practice & Populat Hlth, Newcastle, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Australian Financial Review, GPO Box 506, Sydney, NSW 2201, Australia.		Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020; Moynihan, Ray/ABC-3010-2020	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; 				Bentall Richard, 1999, J MENTAL HLTH, V8, P261, DOI DOI 10.1080/09638239917427; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Chew KK, 2000, INT J IMPOT RES, V12, P41, DOI 10.1038/sj.ijir.3900457; Cook J., 2001, PHARM MARKETING, V6, P1422; CRAWFORD R, 1980, INT J HEALTH SERV, V10, P365, DOI 10.2190/3H2H-3XJN-3KAY-G9NY; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Gilbert D, 2000, BRIT MED J, V321, P1341, DOI 10.1136/bmj.321.7272.1341; GREEN CJ, 1997, BONE MINERAL DENSITY; Heath I, 1999, BRIT MED J, V318, P439; HEATH S, 1998, AGE             0330, P16; HICKMAN B, 1998, AUSTRALIAN      0521, P4; ILLICH I, 1990, LIMITS MED; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; MOYNIHAN R, 1998, TOO MUCH MED, P137; MOYNIHAN R, 2000, AUSTR FINANCIAL 1113, P29; Payer Lynn, 1992, DIS MONGERS; Pinnock CB, 1999, MED J AUSTRALIA, V171, P353, DOI 10.5694/j.1326-5377.1999.tb123691.x; *US FDA, 2002, GLAX WELLC DEC WITHD; Wade JP, 2001, CAN MED ASSOC J, V165, P45; Wilkin TJ, 1999, BRIT MED J, V318, P862, DOI 10.1136/bmj.318.7187.862; Williams SJ, 1996, SOC SCI MED, V42, P1609, DOI 10.1016/0277-9536(95)00313-4; 2002, LOTRONEX INFORMATION; 2000, SYDNEY MORNING  1021, P76	23	540	560	0	64	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					886	890		10.1136/bmj.324.7342.886	http://dx.doi.org/10.1136/bmj.324.7342.886			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950740	Green Published			2022-12-24	WOS:000175052200025
J	Hanotte, O; Bradley, DG; Ochieng, JW; Verjee, Y; Hill, EW; Rege, JEO				Hanotte, O; Bradley, DG; Ochieng, JW; Verjee, Y; Hill, EW; Rege, JEO			African pastoralism: Genetic imprints of origins and migrations	SCIENCE			English	Article							BOS-TAURUS; CATTLE; TAURINE	The genetic history of African cattle pastoralism is controversial and poorly understood. We reveal the genetic signatures of its origins, secondary movements, and differentiation through the study of 15 microsatellite Loci in 50 indigenous cattle breeds spanning the present cattle distribution in Africa. The earliest cattle originated within the African continent, but Near East and European genetic influences are also identified. The initial expansion of African Bos taurus was Likely from a single region of origin. It reached the southern part of the continent by following an eastern route rather than a western one. The B. indicus genetic influence shows a major entry point through the Horn and the East Coast of Africa and two modes of introgression into the continent.	Int Livestock Res Inst, Nairobi, Kenya; Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland; Int Livestock Res Inst, Addis Ababa, Ethiopia	CGIAR; International Livestock Research Institute (ILRI); Trinity College Dublin; CGIAR; International Livestock Research Institute (ILRI)	Hanotte, O (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi, Kenya.	o.hanotte@cgiar.org	Bradley, Daniel G/A-3240-2012; Hanotte, Olivier/B-4669-2013	Hanotte, Olivier/0000-0002-2877-4767; Hill, Emmeline/0000-0002-1805-2250; Bradley, Daniel G/0000-0001-7335-7092				BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; BRADLEY DG, 2000, ORIGINS DEV AFRICAN, P244; Clutton-Brock J., 1993, ARCHAEOLOGY AFRICA F, V20, P61; Denbow J, 1990, AFR ARCHAEOL REV, V8, P139, DOI DOI 10.1007/BF01116874; Epstein H, 1971, ORIGINS DOMESTIC ANI, V1; Fix AG, 1997, HUM BIOL, V69, P663; Gifford-Gonzalez D., 2000, ARCHAEL REV, V17, P95, DOI DOI 10.1023/A:1006601020217; Grigson C., 1989, BAR International Series, P77; Hanotte O, 2000, MOL ECOL, V9, P387, DOI 10.1046/j.1365-294x.2000.00858.x; Harlan J. R, 1993, ARCHAEOLOGY AFRICA F, P53; Hassan F.A., 2000, ORIGINS DEV AFRICAN, P61; Loftus RT, 1999, MOL ECOL, V8, P2015, DOI 10.1046/j.1365-294x.1999.00805.x; MacDonald K., 2000, ORIGINS DEV AFRICAN; MacHugh DE, 1997, GENETICS, V146, P1071; Marshall F., 2000, ORIGIN DEV AFRICAN L, P191; MUZZOLINI A, 1983, THESIS U PROVENCE AI; NDERITO PC, 1976, AFRICAN DISTRIBUTION; Newman JL., 1995, PEOPLING AFRICA GEOG; REGE JEO, 1996, P 2 AFR C AN AGR PRE; ROBERTS DF, 1965, HUM BIOL, V37, P38; SMITH AB, 1992, ANNU REV ANTHROPOL, V21, P125; TROY C, 2000, THESIS TRINITY COLL; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319	25	337	349	2	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					336	339		10.1126/science.1069878	http://dx.doi.org/10.1126/science.1069878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951043				2022-12-24	WOS:000175000300055
J	Kyba, M; Perlingeiro, RCR; Daley, GQ				Kyba, M; Perlingeiro, RCR; Daley, GQ			HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors	CELL			English	Article							IN-VITRO; HOMEOBOX GENES; MOUSE EMBRYO; BONE-MARROW; EXPRESSION; OVEREXPRESSION; DIFFERENTIATION; SUBPOPULATIONS; ACTIVATION; CULTURE	The extent to which primitive embryonic blood progenitors contribute to definitive lymphoid-myeloid hematopoiesis In the adult remains uncertain. In an effort to characterize factors that distinguish the definitive adult hematopoietic stem cell (HSC) and primitive progenitors derived from yolk sac or embryonic stem (ES) cells, we examined the effect of ectopic expression of HoxB4, a homeotic selector gene implicated in self-renewal of definitive HSCs. Expression of HoxB4 in primitive progenitors combined with culture on hematopoietic stroma induces a switch to the definitive HSC phenotype. These progenitors engraft lethally irradiated adults and contribute to long-term, multilineage hematopoiesis in primary and secondary recipients. Our results suggest that primitive HSCs are poised to become definitive HSCs and that this transition can be promoted by HoxB4 expression. This strategy for blood engraftment enables modeling of hematopoietic transplantation from ES cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital	Daley, GQ (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			Kyba, Michael/0000-0002-5579-7534	NCI NIH HHS [CA86991] Funding Source: Medline; NIDDK NIH HHS [DK59279] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Brun A, 2001, BLOOD, V98, p66A; Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; Helgason CD, 1996, BLOOD, V87, P2740, DOI 10.1182/blood.V87.7.2740.bloodjournal8772740; Hole N, 1996, BLOOD, V88, P1266, DOI 10.1182/blood.V88.4.1266.bloodjournal8841266; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; McGrath KE, 1997, MOL REPROD DEV, V48, P145, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;145::AID-MRD1&gt;3.0.CO;2-S; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MULLER AM, 1993, DEVELOPMENT, V118, P1343; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; North T, 1999, DEVELOPMENT, V126, P2563; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Potocnik AJ, 1997, P NATL ACAD SCI USA, V94, P10295, DOI 10.1073/pnas.94.19.10295; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; TOLES JF, 1989, P NATL ACAD SCI USA, V86, P7456, DOI 10.1073/pnas.86.19.7456; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wang LC, 1998, GENE DEV, V12, P2392, DOI 10.1101/gad.12.15.2392; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Yoder MC, 2001, BLOOD, V98, P3, DOI 10.1182/blood.V98.1.3; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	35	589	629	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					29	37		10.1016/S0092-8674(02)00680-3	http://dx.doi.org/10.1016/S0092-8674(02)00680-3			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955444	Bronze			2022-12-24	WOS:000174888300006
J	Lu, QR; Sun, T; Zhu, ZM; Ma, N; Garcia, M; Stiles, CD; Rowitch, DH				Lu, QR; Sun, T; Zhu, ZM; Ma, N; Garcia, M; Stiles, CD; Rowitch, DH			Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTRAL NEURAL-TUBE; OLIGODENDROCYTE LINEAGE; SPINAL-CORD; CEREBRAL-CORTEX; CELL LINEAGE; ASTROCYTES; EXPRESSION; GENES; DIFFERENTIATION	The oligodendrocyte lineage genes Olig1 and Olig2 encode related bHLH proteins that are coexpressed in neural progenitors. Targeted disruption of these two genes sheds light on the ontogeny of oligodendroglia and genetic requirements for their development from multipotent CNS progenitors. Olig2 is required for oligodendrocyte and motor neuron specification in the spinal cord. Olig1 has roles in development and maturation of oligodendrocytes, evident especially within the brain. Both Olig genes contribute to neural pattern formation. Neither Olig gene is required for astrocytes. These findings, together with fate mapping analysis of Olig-expressing cells, indicate that oligodendrocytes are derived from Olig-specified progenitors that give rise also to neurons.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Stiles, CD (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.			Rowitch, David/0000-0002-0079-0060	NICHD NIH HHS [HD24296] Funding Source: Medline; NINDS NIH HHS [NS4051] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Barres BA, 2000, CURR OPIN NEUROBIOL, V10, P642, DOI 10.1016/S0959-4388(00)00134-3; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Franco D, 2001, EUR J MORPHOL, V39, P3, DOI 10.1076/ejom.39.1.3.7982; Hardy RJ, 1997, J NEUROSCI RES, V50, P139, DOI 10.1002/(SICI)1097-4547(19971015)50:2<139::AID-JNR3>3.0.CO;2-G; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kandel E R, 2000, PRINCIPLES NEURAL SC, P19; Lee JC, 2000, GLIA, V30, P105, DOI 10.1002/(SICI)1098-1136(200004)30:2<105::AID-GLIA1>3.0.CO;2-H; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; McMahon AP, 2000, GENE DEV, V14, P2261, DOI 10.1101/gad.840800; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nery S, 2001, DEVELOPMENT, V128, P527; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Park SK, 2001, J CELL BIOL, V154, P1245, DOI 10.1083/jcb.200104025; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; PRICE J, 1988, DEVELOPMENT, V104, P473; Pringle NP, 1998, NEURON, V20, P883, DOI 10.1016/S0896-6273(00)80470-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Qi YC, 2001, DEVELOPMENT, V128, P2723; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SKOFF RP, 1990, DEV BIOL, V139, P149, DOI 10.1016/0012-1606(90)90285-Q; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2001, DEVELOPMENT, V128, P4993; Sun T, 2001, CURR BIOL, V11, P1413, DOI 10.1016/S0960-9822(01)00441-9; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; TIMSIT S, 1995, J NEUROSCI, V15, P1012; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	41	802	831	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					75	86		10.1016/S0092-8674(02)00678-5	http://dx.doi.org/10.1016/S0092-8674(02)00678-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955448	Bronze			2022-12-24	WOS:000174888300010
J	Mitton-Fry, RM; Anderson, EM; Hughes, TR; Lundblad, V; Wuttke, DS				Mitton-Fry, RM; Anderson, EM; Hughes, TR; Lundblad, V; Wuttke, DS			Conserved structure for single-stranded telomeric DNA recognition	SCIENCE			English	Article							OXYTRICHA MACRONUCLEAR DNA; BINDING-PROTEIN; RAD9 CHECKPOINT; CDC13 PROTEIN; IN-VITRO; MUTANTS; VIVO	The essential Cdc13 protein in the yeast Saccharomyces cerevisiae is a single-stranded telomeric DNA binding protein required for chromosome end protection and telomere replication. Here we report the solution structure of the Cdc13 DNA binding domain in complex with telomeric DNA. The structure reveals the use of a single OB (oligonucleotide/oligosaccharide binding) fold augmented by an unusually large loop for DNA recognition. This OB fold is structurally similar to OB folds found in the ciliated protozoan telomere end-binding protein, although no sequence similarity is apparent between them. The common usage of an OB fold for telomeric DNA interaction demonstrates conservation of end-protection mechanisms among eukaryotes.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA	University of Colorado System; University of Colorado Boulder; Baylor College of Medicine; Baylor College of Medicine	Wuttke, DS (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059414] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM55867, GM59414, R01 GM059414] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Classen S, 2001, J MOL BIOL, V314, P1113, DOI 10.1006/jmbi.2000.5191; de Lange T, 2001, SCIENCE, V292, P1075; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Dietmann S, 2001, NAT STRUCT BIOL, V8, P953, DOI 10.1038/nsb1101-953; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; KLEYWEGT GJ, 1994, ESF CCP4 NEWSLETTER, V31, P9; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lustig AJ, 2001, NAT STRUCT BIOL, V8, P297, DOI 10.1038/86157; MITTONFRY RM, IN PRESS J BIOMOL NM; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; PRICE CM, 1987, GENE DEV, V1, P783, DOI 10.1101/gad.1.8.783; Shore D, 2001, CURR OPIN GENET DEV, V11, P189, DOI 10.1016/S0959-437X(00)00178-7; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; WEINERT TA, 1993, GENETICS, V134, P63; [No title captured]	31	168	175	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					145	147		10.1126/science.1068799	http://dx.doi.org/10.1126/science.1068799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935027				2022-12-24	WOS:000174858800049
J	Fried, TR; Bradley, EH; Towle, VR; Allore, H				Fried, TR; Bradley, EH; Towle, VR; Allore, H			Understanding the treatment preferences of seriously ill patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-SUSTAINING TREATMENT; DECISION-MAKING; CARE; END; SURVIVAL; OLDER; INTERVENTIONS; PHYSICIANS; PEOPLE; FAMILY	Background: The questions patients are asked about their preferences with regard to life-sustaining treatment usually focus on specific interventions, but the outcomes of treatment and their likelihood affect patients' preferences. Methods: We administered a questionnaire about treatment preferences to 226 persons who were 60 years of age or older and who had a limited life expectancy due to cancer, congestive heart failure, or chronic obstructive pulmonary disease. The study participants were asked whether they would want to receive a given treatment, first when the outcome was known with certainty and then with different likelihoods of an adverse outcome. The outcome without treatment was specified as death from the underlying disease. Results: The burden of treatment (i.e., the length of the hospital stay, extent of testing, and invasiveness of interventions), the outcome, and the likelihood of the outcome all influenced treatment preferences. For a low-burden treatment with the restoration of current health, 98.7 percent of participants said they would choose to receive the treatment (rather than not receive it and die), but 11.2 percent of these participants would not choose the treatment if it had a high burden. If the outcome was survival but with severe functional impairment or cognitive impairment, 74.4 percent and 88.8 percent of these participants, respectively, would not choose treatment. The number of participants who said they would choose treatment declined as the likelihood of an adverse outcome increased, with fewer participants choosing treatment when the possible outcome was functional or cognitive impairment than when it was death. Preferences did not differ according to the primary diagnosis. Conclusions: Advance care planning should take into account patients' attitudes toward the burden of treatment, the possible outcomes, and their likelihood. The likelihood of adverse functional and cognitive outcomes of treatment requires explicit consideration.	Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Unit, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Program Aging, New Haven, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Yale University	Fried, TR (corresponding author), Vet Affairs Connecticut Healthcare Syst, Clin Epidemiol Unit, 950 Campbell Ave, West Haven, CT 06516 USA.	terri.fried@yale.edu		Allore, Heather/0000-0001-7685-8175	NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG021342] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; BRETT AS, 1991, JAMA-J AM MED ASSOC, V266, P825, DOI 10.1001/jama.266.6.825; Brundage MD, 1997, J CLIN ONCOL, V15, P330, DOI 10.1200/JCO.1997.15.1.330; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *CONN HOSP, 1996, SUMM GUID IN ADV CAR; Dales RE, 1999, CHEST, V116, P792, DOI 10.1378/chest.116.3.792; Danis M, 1996, CRIT CARE MED, V24, P1811, DOI 10.1097/00003246-199611000-00009; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; DOUKAS DJ, 1991, J FAM PRACTICE, V32, P145; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1670, DOI 10.1001/jama.282.17.1670; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; GILLICK MR, 1995, ANN INTERN MED, V123, P621, DOI 10.7326/0003-4819-123-8-199510150-00009; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lynn J, 1997, J AM GERIATR SOC, V45, P526; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MCNEIL BJ, 1982, NEW ENGL J MED, V306, P1259, DOI 10.1056/NEJM198205273062103; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; MURPHY DJ, 1990, J CLIN EPIDEMIOL, V43, pS11, DOI 10.1016/0895-4356(90)90213-9; Navari RI, 2000, JAMA-J AM MED ASSOC, V284, P2449, DOI 10.1001/jama.284.19.2449; Patrick DL, 1997, ANN INTERN MED, V127, P509, DOI 10.7326/0003-4819-127-7-199710010-00002; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Ratner E, 2001, J AM GERIATR SOC, V49, P778, DOI 10.1046/j.1532-5415.2001.49155.x; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; SACHS GA, 1995, J AM GERIATR SOC, V43, P553, DOI 10.1111/j.1532-5415.1995.tb06106.x; SCHONWETTER RS, 1993, J GEN INTERN MED, V8, P295, DOI 10.1007/BF02600139; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; WU AW, 1995, ANN INTERN MED, V122, P342, DOI 10.7326/0003-4819-122-5-199503010-00004	37	916	922	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2002	346	14					1061	1066		10.1056/NEJMsa012528	http://dx.doi.org/10.1056/NEJMsa012528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	536YL	11932474	Bronze			2022-12-24	WOS:000174729400007
J	Schilling, FH; Spix, C; Berthold, F; Erttmann, R; Fehse, N; Hero, B; Klein, G; Sander, J; Schwarz, K; Treuner, J; Zorn, U; Michaelis, J				Schilling, FH; Spix, C; Berthold, F; Erttmann, R; Fehse, N; Hero, B; Klein, G; Sander, J; Schwarz, K; Treuner, J; Zorn, U; Michaelis, J			Neuroblastoma screening at one year of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CALCULATING SAMPLE SIZES; TRIALS; AMPLIFICATION; PATTERN; DISEASE; CANCER	Background: Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to neuroblastoma. Methods: We offered urine screening for neuroblastoma at approximately one year of age to 2,581,188 children in 6 of 16 German states from 1995 to 2000. A total of 2,117,600 eligible children in the remaining states served as controls. We compared the two groups in terms of the incidence of disseminated disease and mortality from neuroblastoma. Results: A total of 1,475,773 children (61.2 percent of those who were born between July 1, 1994, and October 31, 1999) underwent screening. In this group, neuroblastoma was detected by screening in 149 children, of whom 3 have died. Fifty-five children who had negative screening tests were subsequently given a diagnosis of neuroblastoma; 14 of these children have died. The screened group and children in the control area had a similar incidence of stage 4 neuroblastoma (3.7 cases per 100,000 screened children [95 percent confidence interval, 2.7 to 4.7] and 3.8 per 100,000 controls [95 percent confidence interval, 2.9 to 4.6]) and a similar rate of death among children with neuroblastoma (1.3 deaths per 100,000 screened children [95 percent confidence interval, 0.7 to 1.8] and 1.2 per 100,000 controls [95 percent confidence interval, 0.7 to 1.7]). Comparison of the screened group and the children in the control area revealed substantial overdiagnosis in the former group (an estimated rate of 7 cases per 100,000 children [95 percent confidence interval, 4.6 to 9.2]); the overdiagnosis rate represents children who had neuroblastoma that was diagnosed by screening but who would not benefit from earlier diagnosis and treatment. Conclusions: The present findings do not support the usefulness of general screening for neuroblastoma at one year of age.	Olga Hosp, Klinikum Stuttgart, D-70176 Stuttgart, Germany; Johannes Gutenberg Univ Mainz, German Childhood Canc Registry, D-6500 Mainz, Germany; Univ Cologne, Childrens Hosp, Cologne, Germany; Univ Hamburg, Univ Hosp Eppendorf, Hamburg, Germany; Landesgesundheitsamt Niedersachsen, Hannover, Germany	General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; Johannes Gutenberg University of Mainz; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schilling, FH (corresponding author), Olga Hosp, Klinikum Stuttgart, Bismarckstr 8, D-70176 Stuttgart, Germany.	f.schilling@olgahospital.de						Ambros PF, 2000, NEUROBLASTOMA, P21; BERTHOLD F, 1991, AM J PEDIAT HEMATOL, V13, P8; Berthold F, 1999, J CLIN ONCOL, V17, P1200, DOI 10.1200/JCO.1999.17.4.1200; Berthold F, 2000, DRUGS, V59, P1261, DOI 10.2165/00003495-200059060-00006; Bessho F, 1996, INT J CANCER, V67, P520, DOI 10.1002/(SICI)1097-0215(19960807)67:4<520::AID-IJC10>3.0.CO;2-B; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; CARLSEN NLT, 1988, ANTICANCER RES, V8, P255; CASAGRANDE JT, 1978, BIOMETRICS, V34, P483, DOI 10.2307/2530613; DANGIO GJ, 1971, LANCET, V1, P1046; DEBERNARDI B, 1995, J CLIN ONCOL, V13, P884, DOI 10.1200/JCO.1995.13.4.884; DEBERNARDI B, 1992, CANCER-AM CANCER SOC, V70, P1625, DOI 10.1002/1097-0142(19920915)70:6<1625::AID-CNCR2820700631>3.0.CO;2-6; ESTEVE, 1995, BRIT J CANCER, V72, P804; Esteve J, 1998, MED PEDIATR ONCOL, V31, P401; ESTEVE J, 1995, BRIT J CANCER, V71, P1125, DOI 10.1038/bjc.1995.219; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; HANAWA Y, 1990, MED PEDIATR ONCOL, V18, P472, DOI 10.1002/mpo.2950180607; JARO MA, 1989, J AM STAT ASSOC, V84, P414, DOI 10.2307/2289924; KAATSCH P, 1995, EUR J CANCER, V31A, P993, DOI 10.1016/0959-8049(95)00091-7; Kaneko M, 1998, MED PEDIATR ONCOL, V31, P1, DOI 10.1002/(SICI)1096-911X(199807)31:1<1::AID-MPO1>3.0.CO;2-H; Kawa K, 1999, J CLIN ONCOL, V17, P3216, DOI 10.1200/JCO.1999.17.10.3216; Lastowska M, 2001, J CLIN ONCOL, V19, P3080; Lemieux B, 2000, NEUROBLASTOMA, P265; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; McIntosh MW, 1999, STAT MED, V18, P2775, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2775::AID-SIM196>3.0.CO;2-I; MILLER AB, 1985, SCREENING CANCER, P3; MILLER AB, 1996, ADV CANC SCREENING, P1; Morrison AS, 1992, SCREENING CHRONIC DI; Moss S, 2001, EVALUATION MONITORIN, P29; Nishi M, 1997, INT J CANCER, V71, P552, DOI 10.1002/(SICI)1097-0215(19970516)71:4<552::AID-IJC8>3.0.CO;2-T; Powell JE, 1998, LANCET, V352, P682, DOI 10.1016/S0140-6736(97)11239-9; PROROK P, 1998, ENCY BIOSTATISTICS, P3976; SANKILA R, 2001, EVALUATION MONITORIN, P233; Sawada T, 1994, Prog Clin Biol Res, V385, P371; Sawada T, 2000, NEUROBLASTOMA, P245; Schilling FH, 2000, NEUROBLASTOMA, P281; SCHILLING FH, 1991, PROG CLIN BIOL RES, V366, P579; Schilling FH, 1998, MED PEDIATR ONCOL, V31, P435, DOI 10.1002/(SICI)1096-911X(199811)31:5<435::AID-MPO9>3.0.CO;2-Y; Spix C, 2001, EUR J CANCER, V37, P722, DOI 10.1016/S0959-8049(01)00003-X; TAKEDA T, 1989, MED PEDIATR ONCOL, V17, P368, DOI 10.1002/mpo.2950170504; TREUNER J, 1995, EUR J CANCER, V31A, P565, DOI 10.1016/0959-8049(95)00034-G; TUCHMAN M, 1987, CLIN BIOCHEM, V20, P173, DOI 10.1016/S0009-9120(87)80116-9; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; Woods WG, 1999, MED PEDIATR ONCOL, V33, P360; Woods WG, 2002, NEW ENGL J MED, V346, P1041, DOI 10.1056/NEJMoa012387; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; 1999, MED PEDIAT ONCOL, V33, P357	47	275	279	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2002	346	14					1047	1053		10.1056/NEJMoa012277	http://dx.doi.org/10.1056/NEJMoa012277			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YL	11932471				2022-12-24	WOS:000174729400003
J	Terada, N; Hamazaki, T; Oka, M; Hoki, M; Mastalerz, DM; Nakano, Y; Meyer, EM; Morel, L; Petersen, BE; Scott, EW				Terada, N; Hamazaki, T; Oka, M; Hoki, M; Mastalerz, DM; Nakano, Y; Meyer, EM; Morel, L; Petersen, BE; Scott, EW			Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion	NATURE			English	Article							STEM-CELLS; ES CELLS; IN-VIVO; RECEPTOR; BRAIN; MICE	Recent studies have demonstrated that transplanted bone marrow cells can turn into unexpected lineages including myocytes, hepatocytes, neurons and many others(1). A potential problem, however, is that reports discussing such 'transdifferentiation' in vivo tend to conclude donor origin of transdifferentiated cells on the basis of the existence of donor-specific genes such as Y-chromosome markers(1). Here we demonstrate that mouse bone marrow cells can fuse spontaneously with embryonic stem cells in culture in vitro that contains interleukin-3. Moreover, spontaneously fused bone marrow cells can subsequently adopt the phenotype of the recipient cells, which, without detailed genetic analysis, might be interpreted as 'dedifferentiation' or transdifferentiation.	Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Shands Canc Ctr, Program Stem Cell Biol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Pharmacol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Terada, N (corresponding author), Univ Florida, Coll Med, Dept Pathol, Gainesville, FL 32610 USA.							Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chiozzi P, 1997, J CELL BIOL, V138, P697, DOI 10.1083/jcb.138.3.697; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; ENELOW RI, 1992, AM J RESP CELL MOL, V6, P57; Everett CA, 1996, ZYGOTE, V4, P59, DOI 10.1017/S0967199400002896; FALZONI S, 1995, J CLIN INVEST, V95, P1207, DOI 10.1172/JCI117770; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; PARWARESCH MR, 1986, VIRCHOWS ARCH B, V51, P89, DOI 10.1007/BF02899019; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	25	1564	1733	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					542	545		10.1038/nature730	http://dx.doi.org/10.1038/nature730			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932747				2022-12-24	WOS:000174756500045
J	Walsh, DM; Klyubin, I; Fadeeva, JV; Cullen, WK; Anwyl, R; Wolfe, MS; Rowan, MJ; Selkoe, DJ				Walsh, DM; Klyubin, I; Fadeeva, JV; Cullen, WK; Anwyl, R; Wolfe, MS; Rowan, MJ; Selkoe, DJ			Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo	NATURE			English	Article							INSULIN-DEGRADING ENZYME; TRANSGENIC MICE; PRECURSOR PROTEIN; SYNAPTIC-TRANSMISSION; ALZHEIMERS-DISEASE; NEURODEGENERATION; FIBRILLOGENESIS; NEUROTOXICITY; A-BETA(1-42); AGGREGATION	Although extensive data support a central pathogenic role for amyloid beta protein (Abeta) in Alzheimer's disease(1), the amyloid hypothesis remains controversial, in part because a specific neurotoxic species of Abeta and the nature of its effects on synaptic function have not been defined in vivo. Here we report that natural oligomers of human Abeta are formed soon after generation of the peptide within specific intracellular vesicles and are subsequently secreted from the cell. Cerebral microinjection of cell medium containing these oligomers and abundant Abeta monomers but no amyloid fibrils markedly inhibited hippocampal long-term potentiation (LTP) in rats in vivo. Immunodepletion from the medium of all Ab species completely abrogated this effect. Pretreatment of the medium with insulin-degrading enzyme, which degrades Abeta monomers but not oligomers, did not prevent the inhibition of LTP. Therefore, Abeta oligomers, in the absence of monomers and amyloid fibrils, disrupted synaptic plasticity in vivo at concentrations found in human brain and cerebrospinal fluid. Finally, treatment of cells with gamma-secretase inhibitors prevented oligomer formation at doses that allowed appreciable monomer production, and such medium no longer disrupted LTP, indicating that synaptotoxic Abeta oligomers can be targeted therapeutically.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Dublin 2, Ireland; Univ Dublin Trinity Coll, Dept Physiol, Dublin 2, Ireland	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Trinity College Dublin; Trinity College Dublin	Selkoe, DJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.	dselkoe@rics.bwh.harvard.edu	hu, jenny/AAK-8712-2020	Rowan, Michael Joseph/0000-0002-3867-9536				Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; GETMAN DP, 1993, J MED CHEM, V36, P288, DOI 10.1021/jm00054a014; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Kim JH, 2001, J NEUROSCI, V21, P1327; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977	30	3451	3656	6	713	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2002	416	6880					535	539		10.1038/416535a	http://dx.doi.org/10.1038/416535a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932745				2022-12-24	WOS:000174756500043
J	Shavelle, DM; Takasu, J; Budoff, MJ; Mao, SS; Zhao, XQ; O'Brien, KD				Shavelle, DM; Takasu, J; Budoff, MJ; Mao, SS; Zhao, XQ; O'Brien, KD			HMG CoA reductase inhibitor (statin) and aortic valve calcium	LANCET			English	Article							CORONARY-ARTERY DISEASE	There Is no known pharmacological therapy for calcific aortic valvular sclerosis or stenosis. Because leaflet calcification occurs In areas of lipoprotein deposition, we hypothesised that 3-hydroxy-3-methylglutaryl-coenzyme A (HMG COA) reductase Inhibitors (statins) might slow aortic valve calcium (AVC) accumulation. We retrospectively identified 65 patients who had undergone two electron-beam computed tomography scans at a mean (SD) interval of 2.5 (1.6) years. 28 (43%) patients were receiving statins. Patients who were treated with statins had a 62-63% lower median rate of AVC accumulation (p=0.006) and 44-49% fewer statin patients had definite AVC progression (p=0.043). These findings suggest that statins may decrease AVC accumulation.	Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; Harbor UCLA Res & Educ Inst, Torrance, CA USA	University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	O'Brien, KD (corresponding author), Univ Washington, Dept Med, Div Cardiol, 1959 NE Pacific St, Seattle, WA 98195 USA.		O'Brien, Kevin/CAH-4638-2022; O'Brien, Kevin Douglas/HDO-1461-2022; Budoff, Matthew/ABD-5175-2021	O'Brien, Kevin/0000-0002-2293-9196; O'Brien, Kevin Douglas/0000-0002-2293-9196; Budoff, Matthew/0000-0002-9616-1946				Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Callister TQ, 1998, RADIOLOGY, V208, P807, DOI 10.1148/radiology.208.3.9722864; Kizer JR, 2001, J HEART VALVE DIS, V10, P361; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3	5	202	209	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1125	1126		10.1016/S0140-6736(02)08161-8	http://dx.doi.org/10.1016/S0140-6736(02)08161-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943265				2022-12-24	WOS:000174729200016
J	Thiele, A; Henning, P; Kubischik, M; Hoffmann, KP				Thiele, A; Henning, P; Kubischik, M; Hoffmann, KP			Neural mechanisms of saccadic suppression	SCIENCE			English	Article							EYE-MOVEMENTS; VISUAL PATHWAY; CHANGE-POINT; MOTION; SENSITIVITY; MACAQUE; NEURONS; STRIATE; CORTEX; MST	In normal vision our gaze leaps from detail to detail, resulting in rapid image motion across the retina. Yet we are unaware of such motion, a phenomenon known as saccadic suppression. We recorded neural activity in the middle temporal and middle superior temporal cortical areas during saccades and identical image motion under passive viewing conditions. Some neurons were selectively silenced during saccadic image motion, but responded well to identical external image motion. In addition, a subpopulation of neurons reversed their preferred direction of motion during saccades. Consequently, oppositely directed motion signals annul one another, and motion percepts are suppressed.	Ruhr Univ Bochum, D-44780 Bochum, Germany	Ruhr University Bochum	Hoffmann, KP (corresponding author), Ruhr Univ Bochum, D-44780 Bochum, Germany.			Thiele, Alexander/0000-0003-4894-0213				Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; CAMPBELL FW, 1978, VISION RES, V18, P1297, DOI 10.1016/0042-6989(78)90219-5; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; COMMENGES D, 1985, STAT MED, V4, P91, DOI 10.1002/sim.4780040113; COMMENGES D, 1986, COMPUT METH PROG BIO, V23, P123, DOI 10.1016/0169-2607(86)90107-0; Derrington AM, 1998, VISUAL NEUROSCI, V15, P875, DOI 10.1017/S0952523898155128; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Fischer WH, 1996, EXP BRAIN RES, V110, P435; Holt E., 1903, HARVARD PSYCHOL STUD, V1, P3; ILG UJ, 1993, VISION RES, V33, P211, DOI 10.1016/0042-6989(93)90159-T; JUDGE SJ, 1980, J NEUROPHYSIOL, V43, P1133, DOI 10.1152/jn.1980.43.4.1133; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; MACKAY D, 1970, NATURE, V255, P90; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; MATIN E, 1972, SCIENCE, V178, P179, DOI 10.1126/science.178.4057.179; NODA H, 1975, J PHYSIOL-LONDON, V250, P579, DOI 10.1113/jphysiol.1975.sp011071; Park J, 2001, VISION RES, V41, P3751, DOI 10.1016/S0042-6989(01)00211-5; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; SPERRY RW, 1950, VISION RES, V16, P1185; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	27	186	190	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2460	2462		10.1126/science.1068788	http://dx.doi.org/10.1126/science.1068788			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923539	Green Submitted			2022-12-24	WOS:000174712600058
J	Polo, S; Sigismund, S; Faretta, M; Guidi, M; Capua, MR; Bossi, G; Chen, H; De Camilli, P; Di Fiore, PP				Polo, S; Sigismund, S; Faretta, M; Guidi, M; Capua, MR; Bossi, G; Chen, H; De Camilli, P; Di Fiore, PP			A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteins	NATURE			English	Article							TYROSINE KINASE SUBSTRATE; 26-S PROTEASE SUBUNIT; SACCHAROMYCES-CEREVISIAE; BINDING; DOMAIN; EPS15; EH; FAMILY	Ubiquitination is a post-translation modification in which ubiquitin chains or single ubiquitin molecules are appended to target proteins, giving rise to poly- or monoubiquitination, respectively(1-4). Polyubiquitination targets proteins for destruction by the proteasome. The role of monoubiquitination is less understood, although a function in membrane trafficking is emerging, at least in yeast(1,3,5). Here we report that a short amino-acid stretch at the carboxy-termini of the monoubiquitinated endocytic proteins Eps15 and eps15R is indispensable for their monoubiquitination. A similar sequence, also required for this modification, is found in other cytosolic endocytic proteins, such as epsins and Hrs. These sequences comprise a protein motif, UIM (ref. 6), which has been proposed to bind to ubiquitin. We confirm this for the UIMs of eps15, eps15R, epsins and Hrs. Thus, the same motif in several endocytic proteins is responsible for ubiquitin recognition and monoubiquitination. Our results predict the existence of a UIM: ubiquitin-based intracellular network. Eps15/eps15R, epsins and Hrs may function as adaptors between ubiquitinated membrane cargo and either the clathrin coat or other endocytic scaffolds. In addition, through their own ubiquitination, they may further contribute to the amplification of this network in the endocytic pathway.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; IFOM, FIRC Inst Mol Oncol, I-20134 Milan, Italy; Univ Milan, Sch Med, I-20122 Milan, Italy	IRCCS European Institute of Oncology (IEO); Yale University; Howard Hughes Medical Institute; Yale University; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Di Fiore, PP (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Faretta, Mario/H-8946-2012; Sigismund, Sara/H-3687-2017; Di Fiore, Pier Paolo/K-2130-2012; Polo, Simona/P-3509-2014; Yang, Chen/G-1379-2010	Faretta, Mario/0000-0003-1678-5781; Sigismund, Sara/0000-0002-1396-4453; Di Fiore, Pier Paolo/0000-0002-2252-0950; Polo, Simona/0000-0001-5536-9399				Avantaggiati ML, 1996, EMBO J, V15, P2236, DOI 10.1002/j.1460-2075.1996.tb00577.x; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Coda L, 1998, J BIOL CHEM, V273, P3003, DOI 10.1074/jbc.273.5.3003; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Gagny B, 2000, J CELL SCI, V113, P3309; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Iannolo G, 1997, CANCER RES, V57, P240; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771; Santolini E, 1999, EXP CELL RES, V253, P186, DOI 10.1006/excr.1999.4694; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; vanDelft S, 1997, J BIOL CHEM, V272, P14013, DOI 10.1074/jbc.272.22.14013; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	30	532	539	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					451	455		10.1038/416451a	http://dx.doi.org/10.1038/416451a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919637				2022-12-24	WOS:000174607800052
J	El-Husseini, AE; Schnell, E; Dakoji, S; Sweeney, N; Zhou, Q; Prange, O; Gauthier-Campbell, C; Aguilera-Moreno, A; Nicoll, RA; Bredt, DS				El-Husseini, AE; Schnell, E; Dakoji, S; Sweeney, N; Zhou, Q; Prange, O; Gauthier-Campbell, C; Aguilera-Moreno, A; Nicoll, RA; Bredt, DS			Synaptic strength regulated by palmitate cycling on PSD-95	CELL			English	Article							DENSITY PROTEIN PSD-95; NITRIC-OXIDE SYNTHASE; LONG-TERM POTENTIATION; KINASE-LIKE DOMAIN; POSTSYNAPTIC DENSITY; AMPA RECEPTORS; K+ CHANNELS; INTRAMOLECULAR INTERACTION; DISTINCT MECHANISMS; SIGNAL-TRANSDUCTION	Dynamic regulation of AMPA-type glutamate receptors represents a primary mechanism for controlling synaptic strength, though mechanisms for this process are poorly understood. The palmitoylated postsynaptic density protein, PSD-95, regulates synaptic plasticity and associates with the AMPA receptor trafficking protein, stargazin. Here, we identify palmitate cycling on PSD-95 at the synapse and find that palmitate turnover on PSD-95 is regulated by glutamate receptor activity. Acutely blocking palmitoylation disperses synaptic clusters of PSD-95 and causes a selective loss of synaptic AMPA receptors. We also find that rapid glutamate-mediated AMPA receptor internalization requires depalmitoylation of PSD-95. In a nonneuronal model system, clustering of PSD-95 stargazin, and AMPA receptors is also regulated by ongoing palmitoylation of PSD-95 at the plasma membrane. These studies suggest that palmitate cycling on PSD-95 can regulate synaptic strength and regulates aspects of activity-dependent plasticity.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ British Columbia, Dept Psychiat, Kinsmen Lab, Vancouver, BC, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; University of British Columbia	El-Husseini, AE (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.			Schnell, Eric/0000-0002-5623-5015				ALALUF S, 1995, J NEUROCHEM, V64, P1548; ALVAREZ E, 1990, J BIOL CHEM, V265, P16644; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BERTHIAUME L, 1995, METHOD ENZYMOL, V250, P454; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burke NA, 1999, J GEN PHYSIOL, V113, P71, DOI 10.1085/jgp.113.1.71; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; KOMAU HC, 1997, CURR OPIN NEUROBIOL, V7, P368; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; MILLIGAN G, 1995, TRENDS BIOCHEM SCI, V20, P181, DOI 10.1016/S0968-0004(00)89004-0; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Mumby SM, 1997, CURR OPIN CELL BIOL, V9, P148, DOI 10.1016/S0955-0674(97)80056-7; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; ROBINSON LJ, 1995, J BIOL CHEM, V270, P995, DOI 10.1074/jbc.270.3.995; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; WALTERS BB, 1975, BIOCHEM SOC T, V3, P109, DOI 10.1042/bst0030109; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	57	365	374	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 22	2002	108	6					849	863		10.1016/S0092-8674(02)00683-9	http://dx.doi.org/10.1016/S0092-8674(02)00683-9			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955437	Bronze			2022-12-24	WOS:000174563000013
J	Tsujimoto, T; Jeromin, A; Saitoh, N; Roder, JC; Takahashi, T				Tsujimoto, T; Jeromin, A; Saitoh, N; Roder, JC; Takahashi, T			Neuronal calcium sensor 1 and activity-dependent facilitation of P/Q-type calcium currents at presynaptic nerve terminals	SCIENCE			English	Article							CENTRAL SYNAPTIC TRANSMISSION; RAT BRAIN-STEM; BINDING-PROTEIN; DEVELOPMENTAL-CHANGES; TRANSMITTER RELEASE; FREQUENIN; SYSTEM; NCS-1; PHOSPHORYLATION; DROSOPHILA	P/Q-type presynaptic calcium currents (I-pCa) undergo activity-dependent facilitation during repetitive activation at the calyx of the Held synapse. We investigated whether neuronal calcium sensor 1 (NCS-1) may underlie this phenomenon. Direct loading of NCS-1 into the nerve terminal mimicked activity-dependent I-pCa facilitation by accelerating the activation time of I-pCa in a Ca2+-dependent manner. A presynaptically loaded carboxyl-terminal peptide of NCS-1 abolished I-pCa facilitation. These results suggest that residual Ca2+ activates endogenous NCS-1, thereby facilitating I-pCa. Because both P/Q-type Ca2+ channels and NCS-1 are widely expressed in mammalian nerve terminals, NCS-1 may contribute to the activity-dependent synaptic facilitation at many synapses.	Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan; Mt Sinai Hosp, Res Inst, Toronto, ON M5G 1X5, Canada	University of Tokyo; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Tsujimoto, T (corresponding author), Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan.		Oka, Yoshitaka/C-9670-2010; Takahashi, Tomoyuki/G-5951-2015; Roder, John/G-6468-2013	Oka, Yoshitaka/0000-0002-3482-3051; Takahashi, Tomoyuki/0000-0002-8771-7666; 				Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; IKEDA SR, 1991, J PHYSIOL-LONDON, V439, P181, DOI 10.1113/jphysiol.1991.sp018663; Iwasaki S, 2000, J NEUROSCI, V20, P59, DOI 10.1523/JNEUROSCI.20-01-00059.2000; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; KASAI H, 1992, J PHYSIOL-LONDON, V448, P189, DOI 10.1113/jphysiol.1992.sp019036; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; Martone ME, 1999, CELL TISSUE RES, V295, P395, DOI 10.1007/s004410051246; NEF S, 1995, J RECEPT SIGNAL TR R, V15, P365, DOI 10.3109/10799899509045227; Olafsson P, 1997, MOL BRAIN RES, V44, P73, DOI 10.1016/S0169-328X(96)00188-X; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Sage C, 2000, HEARING RES, V150, P70, DOI 10.1016/S0378-5955(00)00183-0; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Tang YG, 2000, BIOPHYS J, V78, P2735, DOI 10.1016/S0006-3495(00)76819-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2	30	176	182	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2276	2279		10.1126/science.1068278	http://dx.doi.org/10.1126/science.1068278			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910115				2022-12-24	WOS:000174561700049
J	Dennis, C				Dennis, C			Stem-cell reverse angers Australian biologists	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					4	4		10.1038/416004b	http://dx.doi.org/10.1038/416004b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882855	Bronze			2022-12-24	WOS:000174211600005
J	Roger, VL; Jacobsen, SJ; Weston, SA; Goraya, TY; Killian, J; Reeder, GS; Kottke, TE; Yawn, BP; Frye, RL				Roger, VL; Jacobsen, SJ; Weston, SA; Goraya, TY; Killian, J; Reeder, GS; Kottke, TE; Yawn, BP; Frye, RL			Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; SEX-DIFFERENCES; MEDICAL-CARE; MORTALITY; RATES; ATHEROSCLEROSIS; PERSPECTIVE; MORBIDITY; PROJECT; HISTORY	Background: Evidence indicates that deaths from coronary disease are decreasing less in elderly persons and women. Understanding the determinants of these trends is important for prevention. Objective: To test the hypothesis that trends in incidence and survival of hospitalized myocardial infarction differ according to sex and age. Design: Longitudinal observational study. Setting: Community-dwelling persons in Olmsted County, Minnesota. Patients: 5117 patients who had an estimated 1820 incident myocardial infarctions from 1979 to 1994. Measurements: Myocardial infarctions were validated by using epidemiologic criteria. Rates were directly adjusted to the age distribution of the 2000 U.S. population. Results: Of the 1820 incident infarctions, 44% occurred in women and 36% in persons 75 years of age or older. In 1979, the age-adjusted incidence of myocardial infarction was 205 per 100000 persons (95% Cl, 162 to 247 per 100000 persons). Between 1979 and 1994, the age-adjusted incidence of myocardial infarction decreased by 8% (Cl, -23% to 10%) in men but increased by 36% (Cl, 9% to 70%) in women. A 31% decrease in the incidence of infarction over time was observed in men 40 years of age compared with a 49% increase in women 80 years of age. Survival improved predominately in younger persons. Conclusions: over time, the incidence of hospitalized infarction decreased in men but increased in women and elderly persons. Survival benefits were clustered among younger persons. These results suggest that both incidence and survival contribute to the contrasting mortality trends by age and sex and that the burden of coronary disease has shifted toward elderly persons, a finding that has public health implications in an aging population.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Olmsted Med Grp, Rochester, MN 55903 USA	Mayo Clinic; Mayo Clinic; Olmsted Medical Center	Roger, VL (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1st St SW, Rochester, MN 55905 USA.		Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NHLBI NIH HHS [AND RO1 HL 59205] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bergstralh EJ., 1992, CALCULATING INCIDENC; Daly SC, 2000, J CLIN EPIDEMIOL, V53, P661, DOI 10.1016/S0895-4356(99)00223-1; FEINLEIB M, 1988, TRENDS CORONARY HEAR; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Goff DC, 1997, CIRCULATION, V95, P1433; Goldberg RJ, 1999, J AM COLL CARDIOL, V33, P1533, DOI 10.1016/S0735-1097(99)00040-6; Goldberg RJ, 1998, AM J CARDIOL, V82, P1311, DOI 10.1016/S0002-9149(98)00633-X; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gurwitz JH, 1997, JAMA-J AM MED ASSOC, V277, P1723, DOI 10.1001/jama.277.21.1723; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Kurland LT, 1970, COMMUNITY EPIDEMIOLO, P47; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MELTON LJ, 1985, MAYO CLIN PROC, V60, P880, DOI 10.1016/S0025-6196(12)64794-6; Prineas R., 1982, MINNESOTA CODE MANUA; Roger VL, 1999, MAYO CLIN PROC, V74, P651, DOI 10.4065/74.7.651; Roger VL, 2001, AM J MED, V110, P267, DOI 10.1016/S0002-9343(00)00709-9; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	22	195	200	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					341	348		10.7326/0003-4819-136-5-200203050-00005	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874305				2022-12-24	WOS:000174095300001
J	Padera, TP; Kadambi, A; di Tomaso, E; Carreira, CM; Brown, EB; Boucher, Y; Choi, NC; Mathisen, D; Wain, J; Mark, EJ; Munn, LL; Jain, RK				Padera, TP; Kadambi, A; di Tomaso, E; Carreira, CM; Brown, EB; Boucher, Y; Choi, NC; Mathisen, D; Wain, J; Mark, EJ; Munn, LL; Jain, RK			Lymphatic metastasis in the absence of functional intratumor lymphatics	SCIENCE			English	Article							GROWTH-FACTOR-C; TUMOR LYMPHANGIOGENESIS; VESSELS; SYSTEM; RECRUITMENT; INDUCTION; LYVE-1; CANCER	Lymphatic metastasis contributes to mortality from solid tumors. Whether metastasizing cancer cells reach lymph nodes via intratumor lymphatic vessels is unknown. Here, we examine functional lymphatics associated with mouse tumors expressing normal or elevated levels of vascular endothelial growth factor-C (VEGF-C), a molecule that stimulates lymphangiogenesis. Although VEGF-C overexpression increased lymphatic surface area in the tumor margin and lymphatic metastasis, these tumors contained no functional lymphatics, as assessed by four independent functional assays and immunohistochemical staining. These findings suggest that the functional lymphatics in the tumor margin alone are sufficient for lymphatic metastasis and should be targeted therapeutically.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol,EL Steele Lab, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Jain, RK (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Radiat Oncol,EL Steele Lab, 100 Blossom St, Boston, MA 02114 USA.		Jain, Rakesh K/I-1384-2017; Munn, Lance L/L-3950-2016; Padera, Timothy/R-2982-2019	Jain, Rakesh K/0000-0001-7571-3548; Munn, Lance L/0000-0003-0698-7232; Padera, Timothy/0000-0002-3453-9384	NCI NIH HHS [R24-CA85140] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA085140] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Carreira CM, 2001, CANCER RES, V61, P8079; GULLINO PM, 1985, BIOL RESPONSES CANC, V4, P1; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Jackson DG, 2001, TRENDS IMMUNOL, V22, P317, DOI 10.1016/S1471-4906(01)01936-6; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Jain RK, 2002, JNCI-J NATL CANCER I, V94, P785, DOI 10.1093/jnci/94.11.785; Jain RK, 2002, J NATL CANCER I, V94, P417; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Kadambi A, 2001, CANCER RES, V61, P2404; Karpanen T, 2001, J EXP MED, V194, pF37, DOI 10.1084/jem.194.6.F37; Karpanen T, 2001, CANCER RES, V61, P1786; Lee FC, 1933, ARCH SURG-CHICAGO, V26, P602, DOI 10.1001/archsurg.1933.01170040065004; Leu AJ, 2000, CANCER RES, V60, P4324; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Padera TP, 2002, MOL IMAGING, V1, P9, DOI 10.1162/153535002753395662; Pepper MS, 2001, CLIN CANCER RES, V7, P462; Rofstad EK, 2002, CANCER RES, V62, P661; SCHMIDSCHONBEIN GW, 1990, PHYSIOL REV, V70, P987, DOI 10.1152/physrev.1990.70.4.987; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sleeman JP, 2001, MICROSC RES TECHNIQ, V55, P61, DOI 10.1002/jemt.1157; TODOROKI T, 1985, J SURG ONCOL, V29, P207, DOI 10.1002/jso.2930290402; Trzewik J, 2001, FASEB J, V15, P1711, DOI 10.1096/fj.01-0067com; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1	26	748	838	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1883	1886		10.1126/science.1071420	http://dx.doi.org/10.1126/science.1071420			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	11976409				2022-12-24	WOS:000176054300053
J	Strohman, R				Strohman, R			Maneuvering in the complex path from genotype to phenotype	SCIENCE			English	Editorial Material							ALZHEIMERS; DISEASE	Human disease phenotypes are controlled not only by genes but by [awful self-organizing networks that display system-wide dynamics. These networks range from metabolic pathways to signaling pathways that regulate hormone action. When perturbed, networks alter their output of matter and energy which, depending on the environmental context, can produce either a pathological or a normal phenotype. Study of the dynamics of these networks by approaches such as metabolic control analysis may provide new insights into the pathogenesis and treatment of complex diseases.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Strohman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall 3206, Berkeley, CA 94720 USA.							Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Chong L, 2002, SCIENCE, V295, P1661, DOI 10.1126/science.295.5560.1661; Fell D., 1997, UNDERSTANDING CONTRO; FOXKELLER E, 2001, CENTURY GENE; Garber K, 2002, NAT BIOTECHNOL, V20, P207, DOI 10.1038/nbt0302-207b; HORROBIN D, 2002, NAT BIOTECHNOL, V19, P1099; Hoshi M, 1997, J BIOL CHEM, V272, P2038, DOI 10.1074/jbc.272.4.2038; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; KUHN TS, 1996, STRUCTURE SCI REVOLU, pCH8; LARDY HA, 1945, ARCH BIOCHEM, V6, P41; Lewontin R, 2000, TRIPLE HELIX; PATTEE HH, 2000, DOWNWARD CAUSATION, P63; POLANYI M, 1968, SCIENCE, V160, P1308, DOI 10.1126/science.160.3834.1308; Riddihough G, 2001, SCIENCE, V293, P1063, DOI 10.1126/science.293.5532.1063; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Strohman RC, 1997, NAT BIOTECHNOL, V15, P194, DOI 10.1038/nbt0397-194; VEECH R, COMMUNICATION; Veech RL, 2001, IUBMB LIFE, V51, P241; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Zhang QH, 2002, SCIENCE, V295, P1895	23	143	146	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					701	703		10.1126/science.1070534	http://dx.doi.org/10.1126/science.1070534			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976445				2022-12-24	WOS:000175281700044
J	Yaffe, K; Fox, P; Newcomer, R; Sands, L; Lindquist, K; Dane, K; Covinsky, KE				Yaffe, K; Fox, P; Newcomer, R; Sands, L; Lindquist, K; Dane, K; Covinsky, KE			Patient and Caregiver characteristics and nursing home placement in patients with dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE DEMONSTRATION; INSTITUTIONALIZATION; PREDICTORS; CARE; TIME; INTERVENTION; ETHNICITY; ADMISSION; BURDEN; DEATH	Context The decision to institutionalize a patient with dementia is complex and is based on patient and caregiver characteristics and the sociocultural context of patients and caregivers. Most studies have determined predictors of nursing home placement primarily according to patient or caregiver characteristics alone. Objective To develop and validate a prognostic model to determine the comprehensive predictors of placement among an ethnically diverse population of patients with dementia. Design, Setting, and Participants The Medicare Alzheimer's Disease Demonstration and Evaluation study, a prospective study at 8 sites in the United States, with enrollment between December 1989 and December 1994 of 5788 community-living persons with advanced dementia. Main Outcome Measures Time to nursing home placement throughout a 36-month follow-up period, assessed by interview and review of Medicare records, and its association with patient and caregiver characteristics, obtained by interview at enrollment. Results Patients were divided into a development (n=3859) and validation (n=1929) cohort. In the development cohort, the Kaplan-Meier estimates of nursing home placement throughout 1, 2, and 3 years were 22%, 40%, and 52%, respectively. After multivariate adjustment, patient characteristics that were associated with nursing home placement were as follows: black ethnicity (hazard ratio, 0.60; 95% confidence interval [CI], 0.48-0.74), Hispanic ethnicity (HR, 0.40; 95% Cl, 0.28-0.56) (both ethnicities were inversely associated with placement), living alone (HR, 1.74; 95% Cl, 1.49-2.02), 1 or more dependencies in activities of daily living (HR, 1.38; 95% Cl, 1.20-1.60), high cognitive impairment (for Mini-Mental Status Examination score less than or equal to20: HR, 1.52; 95% Cl, 1.33-1.73), and 1 or more difficult behaviors (HR, 1.30; 95% Cl, 1.11-1.52). Caregiver characteristics associated with patient placement were age 65 to 74 years (HR, 1.17; 95% Cl, 1.01-1.37), age 75 years or older (HR, 1.55; 95% Cl, 1.31-1.84), and high Zarit Burden Scale score (for highest quartile: HR, 1.73; 95% Cl, 1.49-2.00). Patients were assigned to quartiles of risk based on this model. In the development cohort, patients in the first, second, third, and fourth quartile had a 25%, 42%, 64%, and 91% rate of nursing home placement at 3 years, respectively. In the validation cohort, the respective rates were 21%, 50%, 64%, and 89%. The C statistic for 3-year nursing home placement was 0.66 in the development cohort and 0.63 in the validation cohort. Conclusions Patient and caregiver characteristics are both important determinants of long-term care placement for patients with dementia. Interventions directed at delaying placement, such as reduction of caregiver burden or difficult patient behaviors, need to take into account the patient and caregiver as a unit.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Yaffe, K (corresponding author), Univ Calif San Francisco, Dept Psychiat, Box 111G,4150 Clement St, San Francisco, CA 94121 USA.	kyaffe@itsa.ucsf.edu	Sands, Laura P/E-8919-2015	Sands, Laura P/0000-0003-2446-4486; Lindquist, Karla/0000-0002-1971-2273	NATIONAL INSTITUTE ON AGING [K23AG000888] Funding Source: NIH RePORTER; NIA NIH HHS [K23-AG00888] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRODATY H, 1989, BMJ-BRIT MED J, V299, P1375, DOI 10.1136/bmj.299.6712.1375; Butler R, 1995, ADAPTATIONS AGING, P289; COLERICK EJ, 1986, J AM GERIATR SOC, V34, P493, DOI 10.1111/j.1532-5415.1986.tb04239.x; Covinsky KE, 2001, J GERONTOL A-BIOL, V56, pM707, DOI 10.1093/gerona/56.11.M707; Cummings JL, 1999, NEUROLOGY, V53, P899, DOI 10.1212/WNL.53.5.899; FALCONE D, 1994, J HEALTH POLIT POLIC, V19, P583, DOI 10.1215/03616878-19-3-583; Fisher L, 1999, GERONTOLOGIST, V39, P677, DOI 10.1093/geront/39.6.677; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox P, 2000, ALZ DIS ASSOC DIS, V14, P87, DOI 10.1097/00002093-200004000-00006; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KEMPER P, 1991, NEW ENGL J MED, V324, P595, DOI 10.1056/NEJM199102283240905; KEMPER P, 1992, HEALTH SERV RES, V27, P421; Knopman D, 1996, NEUROLOGY, V47, P166, DOI 10.1212/WNL.47.1.166; Knopman DS, 1999, NEUROLOGY, V52, P714, DOI 10.1212/WNL.52.4.714; KNOPMAN DS, 1988, J AM GERIATR SOC, V36, P108, DOI 10.1111/j.1532-5415.1988.tb01778.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leon J, 1998, HEALTH AFFAIR, V17, P206, DOI 10.1377/hlthaff.17.6.206; Michel JP, 2001, AGING CLIN EXP RES, V13, P255, DOI 10.1007/BF03351484; Miller SC, 1998, J GERONTOL B-PSYCHOL, V53, pS341, DOI 10.1093/geronb/53B.6.S341; MITTELMAN MS, 1993, GERONTOLOGIST, V33, P730, DOI 10.1093/geront/33.6.730; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MorrowHowell N, 1996, HEALTH SOC WORK, V21, P131, DOI 10.1093/hsw/21.2.131; Newcomer R, 1999, HEALTH SERV RES, V34, P669; Newcomer R, 1999, HEALTH SERV RES, V34, P645; RICE DP, 1993, HEALTH AFFAIR, V12, P164, DOI 10.1377/hlthaff.12.2.164; SALIVE ME, 1993, AM J PUBLIC HEALTH, V83, P1765, DOI 10.2105/AJPH.83.12.1765; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; SEVERSON MA, 1994, J AM GERIATR SOC, V42, P181; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; Wallace SP, 1998, J GERONTOL B-PSYCHOL, V53, pS104, DOI 10.1093/geronb/53B.2.S104; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	36	588	602	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2002	287	16					2090	2097		10.1001/jama.287.16.2090	http://dx.doi.org/10.1001/jama.287.16.2090			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	542ZK	11966383				2022-12-24	WOS:000175075700026
J	Sharma, DC				Sharma, DC			Indian groups demand ban on asbestos	LANCET			English	News Item																			0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1414	1414		10.1016/S0140-6736(02)08400-3	http://dx.doi.org/10.1016/S0140-6736(02)08400-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978351				2022-12-24	WOS:000175076200026
J	Lewis, JA; Jonsson, B; Kreutz, G; Sampaio, C; van Zwieten-Boot, B				Lewis, JA; Jonsson, B; Kreutz, G; Sampaio, C; van Zwieten-Boot, B			Placebo-control led trials and the Declaration of Helsinki	LANCET			English	Article								A revised version of the Declaration of Helsinki, issued in October, 2000, remains a vital expression of medical ethics, and deserves unanimous support. A strict interpretation of the declaration seems to rule out clinical trials that use a placebo control group whenever licensed therapeutic methods already exist, preferring active controls. Although the efficacy of some new medicines can be satisfactorily established without the use of a placebo, for others the judicious use of placebo remains essential to establish their effectiveness.	Hatch Green Cottage, Canterbury CT4 7LP, Kent, England; Med Prod Agcy, Uppsala, Sweden; Bundesinst Arzneimettel & Med Prod, Bonn, Germany; Hosp Santa Maria, Lisbon Sch Med, Lisbon, Portugal; Med Evaluat Board, The Hague, Netherlands	Medical Products Agency; Universidade de Lisboa; Hospital Santa Maria	Lewis, JA (corresponding author), Hatch Green Cottage, Chartham Hatch, Canterbury CT4 7LP, Kent, England.	johnlewis@clinitrial.co.uk						Christie B, 2000, BRIT MED J, V321, P913, DOI 10.1136/bmj.321.7266.913; *COMM PROPR MED PR, 2002, EMEA CPMP POS STAT U; Committee for Proprietary Medicinal Products, 2000, POINTS CONS SWITCH S; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Koski G, 2001, NEW ENGL J MED, V345, P136, DOI 10.1056/NEJM200107123450211; Moreno JD, 2001, ANN NEUROL, V49, P558; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Siegel JP, 2000, AM HEART J, V139, pS166, DOI 10.1016/S0002-8703(00)90066-8; Storosum JG, 2001, EUR NEUROPSYCHOPHARM, V11, P173, DOI 10.1016/S0924-977X(01)00083-9; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1997, E6 ICH EMEA; 1998, E9 ICH EMEA; 2000, E10 ICH EMEA	16	54	57	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2002	359	9314					1337	1340		10.1016/S0140-6736(02)08277-6	http://dx.doi.org/10.1016/S0140-6736(02)08277-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965296				2022-12-24	WOS:000174989700032
J	Begg, CB; Riedel, ER; Bach, PB; Kattan, MW; Schrag, D; Warren, JL; Scardino, PT				Begg, CB; Riedel, ER; Bach, PB; Kattan, MW; Schrag, D; Warren, JL; Scardino, PT			Variations in morbidity after radical prostatectomy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL VOLUME; RETROPUBIC PROSTATECTOMY; PANCREATIC RESECTION; COMPLICATION RATES; COLORECTAL-CANCER; BREAST-CANCER; OUTCOMES; MORTALITY; SURVIVAL; SURGERY	Background: Recent studies of surgery for cancer have demonstrated variations in outcomes among hospitals and among surgeons. We sought to examine variations in morbidity after radical prostatectomy for prostate cancer. Methods: We used the Surveillance, Epidemiology, and End Results-Medicare linked data base to evaluate health-related outcomes after radical prostatectomy. The rates of postoperative complications, late urinary complications (strictures or fistulas 31 to 365 days after the procedure), and long-term incontinence (more than 1 year after the procedure) were inferred from the Medicare claims records of 11,522 patients who underwent prostatectomy between 1992 and 1996. These rates were analyzed in relation to hospital volume and surgeon volume (the number of procedures performed at individual hospitals and by individual surgeons, respectively). Results: Neither hospital volume nor surgeon volume was significantly associated with surgery-related death. Significant trends in the relation between volume and outcome were observed with respect to postoperative complications and late urinary complications. Postoperative morbidity was lower in very-high-volume hospitals than in low-volume hospitals (27 percent vs. 32 percent, P=0.03) and was also lower when the prostatectomy was performed by very-high-volume surgeons than when it was performed by low-volume surgeons (26 percent vs. 32 percent, P<0.001). The rates of late urinary complications followed a similar pattern. Results for long-term preservation of continence were less clear-cut. In a detailed analysis of the 159 surgeons who had a high or very high volume of procedures, wide surgeon-to-surgeon variations in these clinical outcomes were observed, and they were much greater than would be predicted on the basis of chance or observed variations in the case mix. Conclusions: In men undergoing prostatectomy, the rates of postoperative and late urinary complications are significantly reduced if the procedure is performed in a high-volume hospital and by a surgeon who performs a high number of such procedures.	Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA; NCI, Appl Res Branch, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Begg, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 44, New York, NY 10021 USA.		Kattan, Michael/AAF-9735-2021	Kattan, Michael/0000-0002-3840-4161; Schrag, Deborah/0000-0002-4334-5717				Allison PD, 1999, LOGISTIC REGRESSION, P179; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Benoit RM, 2000, UROLOGY, V56, P116, DOI 10.1016/S0090-4295(00)00539-2; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Birkmeyer JD, 1999, SURGERY, V126, P178, DOI 10.1067/msy.1999.98741; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Catalona WJ, 1999, J UROLOGY, V162, P433, DOI 10.1016/S0022-5347(05)68578-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Davidson PJT, 1996, EUR UROL, V29, P168; Dillioglugil O, 1997, J UROLOGY, V157, P1760, DOI 10.1016/S0022-5347(01)64856-0; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Ellison LM, 2000, J UROLOGY, V163, P867, DOI 10.1016/S0022-5347(05)67821-4; Glasgow RE, 1996, WESTERN J MED, V165, P294; GORDON TA, 1995, ANN SURG, V221, P43, DOI 10.1097/00000658-199501000-00005; Heinzer H, 1997, UROL INT, V59, P30, DOI 10.1159/000283013; Hermanek P, 1996, EUR J SURG ONCOL, V22, P213, DOI 10.1016/S0748-7983(96)80004-7; Hewitt M, 1999, ENSURING QUALITY CAN; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; LEEFELDSTEIN A, 1994, JAMA-J AM MED ASSOC, V271, P1163, DOI 10.1001/jama.271.15.1163; LIEBERMAN MD, 1995, ANN SURG, V222, P638, DOI 10.1097/00000658-199511000-00006; Mettlin C, 1997, CA-CANCER J CLIN, V47, P265, DOI 10.3322/canjclin.47.5.265; Mettlin C, 1997, CA-CANCER J CLIN, V47, P325; Parry JM, 1999, BRIT J SURG, V86, P475, DOI 10.1046/j.1365-2168.1999.01064.x; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; POTOSKY AL, 1993, MED CARE, V31, P732; POTOSKY AL, IN PRESS MED CARE; RIES LAG, 1997, NIH PUBLICATION; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1081; Roohan PJ, 1998, AM J PUBLIC HEALTH, V88, P454, DOI 10.2105/AJPH.88.3.454; Schrag D, 2000, JAMA-J AM MED ASSOC, V284, P3028, DOI 10.1001/jama.284.23.3028; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Thompson IM, 1999, J UROLOGY, V162, P107, DOI 10.1097/00005392-199907000-00026; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950	39	645	661	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 11	2002	346	15					1138	1144		10.1056/NEJMsa011788	http://dx.doi.org/10.1056/NEJMsa011788			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539PX	11948274				2022-12-24	WOS:000174880600007
J	Richey, JE; Melack, JM; Aufdenkampe, AK; Ballester, VM; Hess, LL				Richey, JE; Melack, JM; Aufdenkampe, AK; Ballester, VM; Hess, LL			Outgassing from Amazonian rivers and wetlands as a large tropical source of atmospheric CO2	NATURE			English	Article							CARBON-DIOXIDE; BASIN; TRANSPORT; OXIDATION; EXCHANGE; FORESTS	Terrestrial ecosystems in the humid tropics play a potentially important but presently ambiguous role in the global carbon cycle. Whereas global estimates of atmospheric CO2 exchange indicate that the tropics are near equilibrium or are a source with respect to carbon(1,2), ground-based estimates indicate that the amount of carbon that is being absorbed by mature rainforests is similar to or greater than that being released by tropical deforestation(3,4) (about 1.6 Gt Cyr(-1)). Estimates of the magnitude of carbon sequestration are uncertain, however, depending on whether they are derived from measurements of gas fluxes above forests(5,6) or of biomass accumulation in vegetation and soils(3,7). It is also possible that methodological errors may overestimate rates of carbon uptake or that other loss processes have yet to be identified(3). Here we demonstrate that outgassing (evasion) of CO2 from rivers and wetlands of the central Amazon basin constitutes an important carbon loss process, equal to 1.2 +/- 0.3 Mg Cha(-1) yr(-1). This carbon probably originates from organic matter transported from upland and flooded forests, which is then respired and outgassed downstream. Extrapolated across the entire basin, this flux-at 0.5 Gt Cyr(-1) -is an order of magnitude greater than fluvial export of organic carbon to the ocean(8). From these findings, we suggest that the overall carbon budget of rainforests, summed across terrestrial and aquatic environments, appears closer to being in balance than would be inferred from studies of uplands alone(3,5-6).	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; Ctr Energia Nucl Agr, Piracicaba, SP, Brazil	University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara	Richey, JE (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	jrichey@u.washington.edu	Ballester, Maria V R/K-1926-2013	Ballester, Maria V R/0000-0003-2567-6747; Aufdenkampe, Anthony/0000-0002-5811-6458				[Anonymous], EOS; BARBOSA C, 2000, 9 LAT AM S REM SENS, P1168; CHAMBERS JQ, 2000, FOREST ECOL MANAG, V5348, P1; CLARK JF, 1994, TELLUS B, V46, P274, DOI 10.1034/j.1600-0889.1994.t01-2-00003.x; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; DEGENS ET, 1991, BIOGEOCHEMISTRY MAJO, P323, DOI [DOI 10.1007/B136008, DOI 10.1002/AQC.3270010209]; DEVOL AH, 1987, LIMNOL OCEANOGR, V32, P235, DOI 10.4319/lo.1987.32.1.0235; DEVOL AH, 1995, GLOBAL BIOGEOCHEM CY, V9, P307, DOI 10.1029/95GB01145; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; HESS LL, IN PRESS INT J REMOT; Hope D, 2001, LIMNOL OCEANOGR, V46, P847, DOI 10.4319/lo.2001.46.4.0847; KLING GW, 1991, SCIENCE, V251, P298, DOI 10.1126/science.251.4991.298; MacIntyre S, 2002, GEOPH MONOG SERIES, V127, P135; Malhi Y, 1998, J GEOPHYS RES-ATMOS, V103, P31593, DOI 10.1029/98JD02647; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; McClain M. E., 1996, Archiv fuer Hydrobiologie Supplement, V113, P111; McClain ME, 1997, GLOBAL BIOGEOCHEM CY, V11, P295, DOI 10.1029/97GB01056; Melack J.M., 2001, BIOGEOCHEMISTRY AMAZ, P235; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; RICHEY JE, 1988, LIMNOL OCEANOGR, V33, P551, DOI 10.4319/lo.1988.33.4.0551; RICHEY JE, 1980, SCIENCE, V207, P1348, DOI 10.1126/science.207.4437.1348; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; RICHEY JE, IN PRESS BIOSPHERIC; SARMIENTO JL, 1992, NATURE, V356, P589, DOI 10.1038/356589a0; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Sippel SJ, 1998, INT J REMOTE SENS, V19, P3055, DOI 10.1080/014311698214181; Siqueira P, 2000, IEEE T GEOSCI REMOTE, V38, P2638, DOI 10.1109/36.885210; Telmer K, 1999, CHEM GEOL, V159, P61, DOI 10.1016/S0009-2541(99)00034-0	30	760	822	22	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					617	620		10.1038/416617a	http://dx.doi.org/10.1038/416617a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948346				2022-12-24	WOS:000174901900038
J	Abbott, A				Abbott, A			Babies' cancer screens 'not needed'	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					356	356		10.1038/416356b	http://dx.doi.org/10.1038/416356b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919591	Bronze			2022-12-24	WOS:000174607800009
J	Cohn, MJ				Cohn, MJ			Evolutionary biology - Lamprey Hox genes and the origin of jaws	NATURE			English	Article							NEURAL CREST; LAMPETRA-JAPONICA; EXPRESSION		Univ Reading, Sch Anim & Microbial Sci, Div Zool, Reading RG6 6AJ, Berks, England	University of Reading	Cohn, MJ (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Div Zool, Reading RG6 6AJ, Berks, England.							Alexandre D, 1996, DEVELOPMENT, V122, P735; Grammatopoulos GA, 2000, DEVELOPMENT, V127, P5355; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; LANGILLE RM, 1988, DEVELOPMENT, V102, P301; Myojin M, 2001, J EXP ZOOL, V291, P68, DOI 10.1002/jez.6; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; NEWTH DR, 1951, J EXP BIOL, V28, P247; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; Pasqualetti M, 2000, DEVELOPMENT, V127, P5367; Schilling TF, 2001, DEV BIOL, V231, P201, DOI 10.1006/dbio.2000.9997; Trainor PA, 2000, NAT REV NEUROSCI, V1, P116, DOI 10.1038/35039056; Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369	13	71	77	3	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					386	387		10.1038/416386a	http://dx.doi.org/10.1038/416386a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919618				2022-12-24	WOS:000174607800033
J	Rhodes, M; Newman, C; Read, S				Rhodes, M; Newman, C; Read, S			National service framework for coronary heart disease: audit of English hospitals	BRITISH MEDICAL JOURNAL			English	Article									St Martins Coll, Dept Nursing Studies, Carlisle CA1 2HH, England; Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England; Univ Sheffield, Sch Nursing & Midwifery, Sheffield S10 2HL, S Yorkshire, England	University of Cumbria; Northern General Hospital; University of Sheffield; University of Sheffield	Rhodes, M (corresponding author), St Martins Coll, Dept Nursing Studies, Carlisle CA1 2HH, England.							*DEP HLTH, 2000, NAT SERV FRAM COR HE; *NHS CONF, 1999, BINL DIR NHS MAN	2	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2002	324	7339					709	709		10.1136/bmj.324.7339.709	http://dx.doi.org/10.1136/bmj.324.7339.709			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535ML	11909788	Green Published, Bronze			2022-12-24	WOS:000174648200019
J	Frischmeyer, PA; van Hoof, A; O'Donnell, K; Guerrerio, AL; Parker, R; Dietz, HC				Frischmeyer, PA; van Hoof, A; O'Donnell, K; Guerrerio, AL; Parker, R; Dietz, HC			An mRNA surveillance mechanism that eliminates transcripts lacking termination codons	SCIENCE			English	Article							MESSENGER-RNA TURNOVER; SACCHAROMYCES-CEREVISIAE; POLYADENYLATION SIGNAL; YEAST; GENE; DEGRADATION; SITE; DEADENYLATION; DETERMINANTS; STABILITY	Translation is an important mechanism to monitor the quality of messenger RNAs (mRNAs), as exemplified by the translation-dependent recognition and degradation of transcripts harboring premature termination codons (PTCs) by the nonsense-mediated mRNA decay (NMD) pathway. We demonstrate in yeast that mRNAs lacking all termination codons are as labile as nonsense transcripts. Decay of "nonstop" transcripts in yeast requires translation but is mechanistically distinguished from NMD and the major mRNA turnover pathway that requires deadenylation, decapping, and 5'-to-3' exonucleotytic decay. These data suggest that nonstop decay is initiated when the ribosome reaches the 3' terminus of the message. We demonstrate multiple physiologic sources of nonstop transcripts and conservation of their accelerated decay in mammalian cells. This process regulates the stability and expression of mRNAs that fail to signal translational termination.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Johns Hopkins University; Johns Hopkins University; University of Arizona; Howard Hughes Medical Institute	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA.		Guerrerio, Pamela/S-9360-2019; Guerrerio, Anthony/T-2632-2019	Guerrerio, Anthony/0000-0003-2458-7160; van Hoof, Ambro/0000-0002-7800-9764	NIGMS NIH HHS [GM55239] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055239] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Audibert A, 1998, P NATL ACAD SCI USA, V95, P14302, DOI 10.1073/pnas.95.24.14302; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Caponigro G, 1996, MICROBIOL REV, V60, P233, DOI 10.1128/MMBR.60.1.233-249.1996; CAPONIGRO G, 1995, GENE DEV, V9, P2421, DOI 10.1101/gad.9.19.2421; CHEN F, 1995, NUCLEIC ACIDS RES, V23, P2614, DOI 10.1093/nar/23.14.2614; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Graber JH, 1999, NUCLEIC ACIDS RES, V27, P888, DOI 10.1093/nar/27.3.888; HILGER C, 1991, J VIROL, V65, P4284, DOI 10.1128/JVI.65.8.4284-4291.1991; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kessler O, 1996, MOL CELL BIOL, V16, P4426; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; OLDHAM ER, 1993, MOL ENDOCRINOL, V7, P1379, DOI 10.1210/me.7.11.1379; Sparks KA, 1997, MOL CELL BIOL, V17, P4199, DOI 10.1128/MCB.17.8.4199; Sparks KA, 1998, NUCLEIC ACIDS RES, V26, P4676, DOI 10.1093/nar/26.20.4676; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; WANG XM, 1995, MOL CELL BIOL, V15, P1769; WEISS IM, 1994, MOL CELL BIOL, V14, P8123, DOI 10.1128/MCB.14.12.8123; Wolfe CL, 1996, J BIOL CHEM, V271, P4679	24	402	416	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2258	2261		10.1126/science.1067338	http://dx.doi.org/10.1126/science.1067338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910109				2022-12-24	WOS:000174561700043
J	Izumi, Y; Xu, L; di Tomaso, E; Fukumura, D; Jain, RK				Izumi, Y; Xu, L; di Tomaso, E; Fukumura, D; Jain, RK			Tumor biology - Herceptin acts as an anti-angiogenic cocktail	NATURE			English	Article									Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Izumi, Y (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol,Edwin L Steele Lab, Boston, MA 02114 USA.		Jain, Rakesh K/I-1384-2017; Mieszkowska, Magdalena/O-6753-2017; Xu, Lei/GRR-9174-2022	Jain, Rakesh K/0000-0001-7571-3548; 	NATIONAL CANCER INSTITUTE [P01CA080124] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA080124] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allgayer H, 2000, J CLIN ONCOL, V18, P2201, DOI 10.1200/JCO.2000.18.11.2201; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Fidler IJ, 2001, JNCI-J NATL CANCER I, V93, P1040, DOI 10.1093/jnci/93.14.1040; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Jain RK, 2001, SCI AM, V285, P38, DOI 10.1038/scientificamerican1201-38; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; JAIN RK, IN PRESS NATURE REV; Kerbel RS, 2000, EUR J CANCER, V36, P1248, DOI 10.1016/S0959-8049(00)00092-7; Nicolini G, 1996, J BIOL CHEM, V271, P30290, DOI 10.1074/jbc.271.47.30290; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	12	506	542	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					279	280		10.1038/416279b	http://dx.doi.org/10.1038/416279b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907566				2022-12-24	WOS:000174482200031
J	Xu, X; Makovicky, PJ; Wang, XL; Norell, MA; You, HL				Xu, X; Makovicky, PJ; Wang, XL; Norell, MA; You, HL			A Ceratopsian dinosaur from China and the early evolution of Ceratopsia	NATURE			English	Article								Ceratopsians (horned dinosaurs) represent one of the last and the most diverse radiations of non-avian dinosaurs(1-4). Although recent systematic work unanimously supports a basal division of Ceratopsia into parrot-like psittacosaurids and frilled neoceratopsians, the early evolution of the group remains poorly understood, mainly owing to its incomplete early fossil record. Here we describe a primitive ceratopsian from China. Cladistic analysis posits this new species as the most basal neoceratopsian. This new taxon demonstrates that some neoceratopsian characters evolved in a more incremental fashion than previously known and also implies mosaic evolution of characters early in ceratopsian history.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Field Museum, Chicago, IL 60605 USA; Amer Museum Nat Hist, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago); American Museum of Natural History (AMNH)	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China.			You, Hai-Lu/0000-0003-2203-6461				Bohlin B., 1953, FOSSIL REPTILES MONG; BROWN BARNUM, 1940, ANN NEW YORK ACAD SCI, V40, P133; Chinnery BJ, 1998, J VERTEBR PALEONTOL, V18, P569, DOI 10.1080/02724634.1998.10011085; COOMBS WP, 1982, PALAEONTOLOGY, V25, P89; Dodson P., 1990, P593; DODSON P, 1976, J PALEONTOL, V50, P929; Dodson P, 1997, ENCY DINOSAURS, P473; Dong Zhiming, 1997, P68; Lo Ching-Hua, 1999, Palaeoworld, V11, P328; MAKOVICKY PJ, 2000, MESOZOIC TERRESTRIAL, P243; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; SERENO P, 1997, ANN REV EARTH PLANET, V25, P234; Sereno P.C., 1990, P203, DOI 10.1017/CBO9780511608377.018; SERRENO PC, 2000, AGE DINOSAURS RUSSIA, P480; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; Swisher C.C., 2001, CHINESE SCI BULL, V46, P2009; Xu Xing, 2000, Vertebrata Palasiatica, V38, P318; Zhao XJ, 1999, J VERTEBR PALEONTOL, V19, P681	18	84	97	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					314	317		10.1038/416314a	http://dx.doi.org/10.1038/416314a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907575				2022-12-24	WOS:000174482200040
J	Onder, G; Penninx, BWJH; Balkrishnan, R; Fried, LP; Chaves, PHM; Williamson, J; Carter, C; Di Bari, M; Guralnik, JM; Pahor, M				Onder, G; Penninx, BWJH; Balkrishnan, R; Fried, LP; Chaves, PHM; Williamson, J; Carter, C; Di Bari, M; Guralnik, JM; Pahor, M			Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study	LANCET			English	Article							SKELETAL-MUSCLE; HEART-FAILURE; HEALTH; DISABILITY; PERFORMANCE; ASSOCIATION; ACTIVATION; PREVENTION; CYTOKINES; COMMUNITY	Background Angiotensin-converting enzyme (ACE) inhibitors prevent decline in physical function in patients with congestive heart failure (CHF). We aimed to see whether ACE inhibitors also prevent reduction in physical performance and in muscle strength in older women who do not have CHF. Methods We assessed 3-year rates of decline in both knee extensor muscle strength and walking speed in 641 women with hypertension who had participated in the Women's Health and Aging Study. Women were stratified into four groups according to type and duration of antihypertensive drug treatment. 61 had used ACE inhibitors continuously, 133 intermittently, 146 never, and 301 had used other hypertensive drugs either continuously or intermittently. Findings Participants who had taken ACE inhibitors continuously had a lower mean 3-year decline in muscle strength of -1.0 kg (SE 1.1) compared with -3.7 (0.5) kg in continuous/intermittent users of other anti hypertensive drugs (p=0.016) and with -3.9 kg in those who had never used antihypertensives (p=0.026). Muscle strength fell by 3.0 kg in 3 years in both continuous and intermittent users of ACE inhibitors (p=0.096). Mean 3-year decline in walking speed in continuous ACE inhibitor users was -1.7 cm/s compared with -13.6 cm/s in intermittent users of ACE inhibitors (p=0.015), -15.7 cm/s in continuous/intermittent users of other anti hypertensive drugs (p=0.002), and -17.9 cm/s in never users of anti hypertensive drugs (p=0.001). Interpretation ACE inhibitor treatment may halt or slow decline in muscle strength in elderly women with hypertension and without CHF.	Wake Forest Univ, Baptist Med Ctr, Sticht Ctr Aging, Sect Gerontol & Geriatr,Dept Internal Med,Sch Med, Winston Salem, NC 27157 USA; Univ Cattolica Sacro Cuore, Ctr Med Invecchiamento, Rome, Italy; Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; NIA, Epidemiol Demog & Biometry Program, Bethesda, MD 20892 USA	Wake Forest University; Wake Forest Baptist Medical Center; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Onder, G (corresponding author), Wake Forest Univ, Baptist Med Ctr, Sticht Ctr Aging, Sect Gerontol & Geriatr,Dept Internal Med,Sch Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	gonder@wfubmc.edu	Carter, Christy/A-6828-2011; Balkrishnan, Rajesh/L-4015-2019; Carter, Christy/E-6630-2011; DI BARI, MAURO/J-1524-2012; Penninx, Brenda WJH/S-7627-2017; Chaves, Paulo H. M./D-5878-2016	DI BARI, MAURO/0000-0002-5514-0524; Penninx, Brenda WJH/0000-0001-7779-9672; 	NATIONAL INSTITUTE ON AGING [P60AG010484, N01AG012112] Funding Source: NIH RePORTER; NIA NIH HHS [N01AG12112, 5P60 AG 10484-07] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bandinelli S, 1999, AGING-CLIN EXP RES, V11, P287, DOI 10.1007/BF03339802; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Dagenais GR, 2001, CIRCULATION, V104, P522, DOI 10.1161/hc3001.093502; DE CR, 1995, J CLIN INVEST, V96, P60; Di Bari M, 2000, CIRCULATION, V102, P843; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gambassi G, 2000, ARCH INTERN MED, V160, P53, DOI 10.1001/archinte.160.1.53; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; Guralnik JM, 1999, J GERONTOL A-BIOL, V54, pM410, DOI 10.1093/gerona/54.8.M410; GURALNIK JM, 2001, WOMENS HLTH AGING ST; Han YQ, 1999, CIRC RES, V84, P695, DOI 10.1161/01.RES.84.6.695; Henriksen EJ, 1999, AM J PHYSIOL-REG I, V277, pR332, DOI 10.1152/ajpregu.1999.277.1.R332; Hespel P, 1996, DIABETES, V45, pS99, DOI 10.2337/diab.45.1.S99; HYATT RH, 1990, AGE AGEING, V19, P330, DOI 10.1093/ageing/19.5.330; Kasper JD, 1999, ANN EPIDEMIOL, V9, P498, DOI 10.1016/S1047-2797(99)00026-5; Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623, DOI 10.1161/01.ATV.19.7.1623; LEVENS NR, 1986, J CARDIOVASC PHARM, V8, pS17, DOI 10.1097/00005344-198600101-00005; Moldawer LL, 1997, CANCER-AM CANCER SOC, V79, P1828; Montgomery H, 1999, LANCET, V353, P541, DOI 10.1016/S0140-6736(98)07131-1; Noguchi Y, 1996, SURG TODAY, V26, P467, DOI 10.1007/BF00311551; Parmley William W., 1998, American Journal of Medicine, V105, p27S, DOI 10.1016/S0002-9343(98)00208-3; Peeters ACTM, 1998, IMMUNOLOGY, V94, P376, DOI 10.1046/j.1365-2567.1998.00524.x; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Rantanen T, 1999, ARCH PHYS MED REHAB, V80, P130, DOI 10.1016/S0003-9993(99)90109-0; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; Schaufelberger M, 1996, EUR HEART J, V17, P1678; SCHIEFFER B, 1995, AM J PHYSIOL-HEART C, V269, pH1507, DOI 10.1152/ajpheart.1995.269.5.H1507; Schroll M, 1997, AGING-CLIN EXP RES, V9, P143, DOI 10.1007/BF03340140; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; Vescovo G, 1998, CIRCULATION, V98, P1742, DOI 10.1161/01.CIR.98.17.1742; Visser M, 2000, J AM GERIATR SOC, V48, P381, DOI 10.1111/j.1532-5415.2000.tb04694.x; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Woods D, 2001, J CLIN ENDOCR METAB, V86, P2200, DOI 10.1210/jc.86.5.2200	35	228	235	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2002	359	9310					926	930		10.1016/S0140-6736(02)08024-8	http://dx.doi.org/10.1016/S0140-6736(02)08024-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531AE	11918911				2022-12-24	WOS:000174391700011
J	Ruggeri, L; Capanni, M; Urbani, E; Perruccio, K; Shlomchik, WD; Tosti, A; Posati, S; Rogaia, D; Frassoni, F; Aversa, F; Martelli, MF; Velardi, A				Ruggeri, L; Capanni, M; Urbani, E; Perruccio, K; Shlomchik, WD; Tosti, A; Posati, S; Rogaia, D; Frassoni, F; Aversa, F; Martelli, MF; Velardi, A			Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants	SCIENCE			English	Article							LEUKEMIA; STIMULATION; REJECTION	T cells that accompany allogeneic hematopoietic grafts for treating leukemia enhance engraftment and mediate the graft-versus-leukemia effect. Unfortunatety, alloreactive T cells also cause graft-versus-host disease (GVHD). T cell depletion prevents GVHD but increases the risk of graft rejection and leukemic relapse. in human transplants, we show that donor-versus-recipient natural killer (NK)-cell alloreactivity could eliminate leukemia relapse and graft rejection and protect patients against GVHD. In mice, the pretransplant infusion of alloreactive NK cells obviated the need for high-intensity conditioning and reduced GVHD. NK cell alloreactivity may thus provide a powerful tool. for enhancing the efficacy and safety of allogeneic hematopoietic transplantation.	Univ Perugia, Sch Med, Dept Clin & Expt Med, Sect Hematol & Clin Immunol, I-06100 Perugia, Italy; Yale Univ, Sch Med, Dept Med, Sect Hematol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Oncol, New Haven, CT 06520 USA; Osped San Martino Genova, Dept Hematol, Genoa, Italy	University of Perugia; Yale University; Yale University; University of Genoa; IRCCS AOU San Martino IST	Velardi, A (corresponding author), Univ Perugia, Sch Med, Dept Clin & Expt Med, Sect Hematol & Clin Immunol, I-06100 Perugia, Italy.	velardi@unipg.it	Perruccio, Katia/ABF-8021-2020; Frassoni, Francesco/K-3971-2018	Frassoni, Francesco/0000-0003-1262-0648; Aversa, Franco/0000-0002-8871-6817	NHLBI NIH HHS [HL03979] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVERSA F, 1994, BLOOD, V84, P3948, DOI 10.1182/blood.V84.11.3948.bloodjournal84113948; Aversa F, 1998, NEW ENGL J MED, V339, P1186, DOI 10.1056/NEJM199810223391702; BACHARLUSTIG E, 1995, NAT MED, V1, P1268, DOI 10.1038/nm1295-1268; BELLONE G, 1993, J EXP MED, V177, P1117, DOI 10.1084/jem.177.4.1117; CICCONE E, 1992, J EXP MED, V175, P709, DOI 10.1084/jem.175.3.709; CICCONE E, 1992, J EXP MED, V176, P963, DOI 10.1084/jem.176.4.963; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; GIRALT S, 2000, NONMYELOABLATIVE STE; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KOSAKA H, 1992, J EXP MED, V176, P1291, DOI 10.1084/jem.176.5.1291; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Martelli MF, 2002, SEMIN HEMATOL, V39, P48, DOI 10.1053/shem.2002.29255; Moretta A, 1997, CURR OPIN IMMUNOL, V9, P694, DOI 10.1016/S0952-7915(97)80051-9; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; Reisner Y, 1999, IMMUNOL TODAY, V20, P343, DOI 10.1016/S0167-5699(98)01428-5; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; RUGGERI L, UNPUB; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; STOCKERLGOLDSTE.KE, 1999, HEMATOPOIETIC CELL T, P823; Valiante N M, 1997, Biol Blood Marrow Transplant, V3, P229; Valiante NM, 1997, IMMUNOL REV, V155, P155, DOI 10.1111/j.1600-065X.1997.tb00948.x; Yu YYL, 1996, IMMUNITY, V4, P67, DOI 10.1016/S1074-7613(00)80299-X	23	2446	2613	5	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2097	2100		10.1126/science.1068440	http://dx.doi.org/10.1126/science.1068440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896281				2022-12-24	WOS:000174450500056
J	Mead, GM				Mead, GM			Management of oral mucositis associated with cancer chemotherapy	LANCET			English	Editorial Material							COLONY-STIMULATING FACTOR; DOUBLE-BLIND; PREVENTION; PILOCARPINE; TRIAL; HEAD		Royal S Hants Hosp, Dept Med Oncol, Southampton SO14 0YG, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; Royal South Hants Hospital	Mead, GM (corresponding author), Royal S Hants Hosp, Dept Med Oncol, Southampton SO14 0YG, Hants, England.	Lynn.Mooney@suht.swest.nhs.uk						Awidi A, 2001, EUR J CANCER, V37, P2010, DOI 10.1016/S0959-8049(01)00189-7; Castagna L, 2001, ANN ONCOL, V12, P953, DOI 10.1023/A:1011119721267; Cheng KKF, 2001, EUR J CANCER, V37, P2056, DOI 10.1016/S0959-8049(01)00098-3; CHI KH, 1995, J CLIN ONCOL, V13, P2620, DOI 10.1200/JCO.1995.13.10.2620; CLARKSON JE, 2002, COCHRANE LIB; Dodd MJ, 2000, ORAL SURG ORAL MED O, V90, P39, DOI 10.1067/moe.2000.105713; GABRILOVE JL, 1988, NEW ENGL J MED, V318, P1414, DOI 10.1056/NEJM198806023182202; Hejna M, 2001, EUR J CANCER, V37, P1994, DOI 10.1016/S0959-8049(01)00132-0; Larson PJ, 1998, CANCER NURS, V21, P263, DOI 10.1097/00002820-199808000-00007; LEVEQUE FG, 1993, J CLIN ONCOL, V11, P1124, DOI 10.1200/JCO.1993.11.6.1124; MAHOOD DJ, 1991, J CLIN ONCOL, V9, P449, DOI 10.1200/JCO.1991.9.3.449; SARIS ST, 1999, CANCER, V85, P2103; Sonis ST, 1998, ORAL ONCOL, V34, P39, DOI 10.1016/S1368-8375(97)00053-5; Sprinzl GM, 2001, EUR J CANCER, V37, P2003, DOI 10.1016/S0959-8049(01)00170-8	14	35	35	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2002	359	9309					815	816		10.1016/S0140-6736(02)07960-6	http://dx.doi.org/10.1016/S0140-6736(02)07960-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YV	11897276				2022-12-24	WOS:000174329600005
J	Kuhn, RJ; Zhang, W; Rossmann, MG; Pletnev, SV; Corver, J; Lenches, E; Jones, CT; Mukhopadhyay, S; Chipman, PR; Strauss, EG; Baker, TS; Strauss, JH				Kuhn, RJ; Zhang, W; Rossmann, MG; Pletnev, SV; Corver, J; Lenches, E; Jones, CT; Mukhopadhyay, S; Chipman, PR; Strauss, EG; Baker, TS; Strauss, JH			Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion	CELL			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN-E; RECOMBINANT SUBVIRAL PARTICLES; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION; MODEL SYSTEM; GLYCOPROTEIN; REPLICATION	The first structure of a flavivirus has been determined by using a combination of cryoelectron microscopy and fitting of the known structure of glycoprotein E into the electron density map. The virus core, within a lipid bilayer, has a less-ordered structure than the external, icosahedral scaffold of 90 glycoprotein E dimers. The three E monomers per icosahedral asymmetric unit do not have quasiequivalent symmetric environments. Difference maps indicate the location of the small membrane protein M relative to the overlaying scaffold of E dimers. The structure suggests that flaviviruses, and by analogy also alphaviruses, employ a fusion mechanism in which the distal beta barrels of domain II of the glycoprotein E are inserted into the cellular membrane.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; California Institute of Technology	Kuhn, RJ (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; , Timothy/0000-0001-6543-8968; Corver, Jeroen/0000-0002-9262-5475; Chipman, Paul/0000-0003-3652-4087	NIAID NIH HHS [AI45976, AI10793, R01 AI020612, AI20612, P01 AI045976] Funding Source: Medline; NIGMS NIH HHS [GM08296, T32 GM008296] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010793, P01AI045976, R01AI020612, R01AI010793, R22AI020612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008296] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; CHEN ZG, 1989, SCIENCE, V245, P154, DOI 10.1126/science.2749253; CHENG RH, 1995, CELL, V80, P621; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; HAHN YS, 1988, VIROLOGY, V162, P167, DOI 10.1016/0042-6822(88)90406-0; HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; HEINZ FX, 1991, J VIROL, V65, P5579, DOI 10.1128/JVI.65.10.5579-5583.1991; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; LARSON SB, 1993, J MOL BIOL, V231, P375, DOI 10.1006/jmbi.1993.1289; Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7; LENARD J, 1980, TOGAVIRUSES, P335; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; Pletnev SV, 2001, CELL, V105, P127, DOI 10.1016/S0092-8674(01)00302-6; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 2001, CELL, V105, P5, DOI 10.1016/S0092-8674(01)00291-4; Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; *WHO, 1998, 117 WHO	42	1125	1187	3	164	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					717	725		10.1016/S0092-8674(02)00660-8	http://dx.doi.org/10.1016/S0092-8674(02)00660-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893341	Green Accepted, Bronze			2022-12-24	WOS:000174314800014
J	Teruel, MN; Meyer, T				Teruel, MN; Meyer, T			Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module	SCIENCE			English	Article							KINASE-C-ALPHA; DOMAIN; DESENSITIZATION; ENTRY; SITES	Time courses of translocation of fluorescently conjugated proteins to the plasma membrane were simultaneously measured in thousands of individual rat basophilic leukemia cells. We found that the C2 domain-a calcium-sensing, lipid-binding protein module that is an essential regulator of protein kinase C and numerous other proteins-targeted proteins to the plasma membrane transiently if calcium was released from internal stores, and persistently in response to entry of extracellular calcium across the plasma membrane. The C2 domain translocation time courses of stimulated cells clustered into only two primary modes. Hence, the reversible recruitment of families of signaling proteins from one cellular compartment to another is a rapid bifurcation mechanism for inducing discrete states of cellular signaling net works.	Stanford Univ, Sch Med, Dept Mol Pharmacol, Stanford, CA 94305 USA	Stanford University	Meyer, T (corresponding author), Stanford Univ, Sch Med, Dept Mol Pharmacol, 269 Campus Dr, Stanford, CA 94305 USA.			Teruel, Mary/0000-0002-2854-3598; Meyer, Tobias/0000-0003-4339-3804	NCI NIH HHS [CA83229] Funding Source: Medline; NHGRI NIH HHS [HG00057] Funding Source: Medline; NIGMS NIH HHS [GM062144] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R33CA083229, R21CA083229] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R43HG000057, R44HG000057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062144] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI H, 1994, J BIOL CHEM, V269, P24557; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; Corbalan-Garcia S, 1999, BIOCHEM J, V337, P513, DOI 10.1042/0264-6021:3370513; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GOUY H, 1990, EUR J IMMUNOL, V20, P2269, DOI 10.1002/eji.1830201016; HARDMAN JG, 1996, GOODMAN GILMANS PHAR, P38; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TERUEL M, UNPUB; Teruel MN, 1997, BIOPHYS J, V73, P1785, DOI 10.1016/S0006-3495(97)78209-2; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329	22	73	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1910	1912		10.1126/science.1065028	http://dx.doi.org/10.1126/science.1065028			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884760				2022-12-24	WOS:000174299500045
J	Yang, CH; Axelrod, JD; Simon, MA				Yang, CH; Axelrod, JD; Simon, MA			Regulation of Frizzled by fat-like cadherins during planar polarity signaling in the Drosophila compound eye	CELL			English	Article							4-JOINTED GENE; CELL POLARITY; ENCODES; WINGLESS; MEMBER; SUPERFAMILY; LOCUS; NOTCH; AXIS; MORPHOGENESIS	Planar polarity is evident in the coordinated orientation of ommatidia in the Drosophila eye. This process requires that the R3 photoreceptor precursor of each ommatidium have a higher level of Frizzled signaling than its neighboring R4 precursor. We show that two cadherin superfamily members, Fat and Dachsous, and the transmembrane/secreted protein Four-jointed play important roles in this process. Our data support a model in which the bias of Frizzled signaling between the R3/R4 precursors results from higher Fat function in the precursor cell closer to the equator, which becomes R3, We also provide evidence that positional information regulating Fat action is provided by graded expression of Dachsous across the eye and the action of Four-jointed, which is expressed in an opposing expression gradient and appears to modulate Dachsous function.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University	Simon, MA (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NEI NIH HHS [R01EY9845] Funding Source: Medline; NIGMS NIH HHS [R01GM59823-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Adler PN, 1998, DEVELOPMENT, V125, P959; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; ADLER PN, 1990, GENETICS, V126, P401; ADLER PN, 1987, DEV GENET, V8, P99, DOI 10.1002/dvg.1020080206; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Axelrod JD, 2001, GENE DEV, V15, P1182; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Brodsky MH, 1996, DEV BIOL, V173, P428, DOI 10.1006/dbio.1996.0038; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Chae J, 1999, DEVELOPMENT, V126, P5421; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; LAWRENCE PA, 1966, J EXP BIOL, V44, P607; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mohr O, 1923, STUDIA MENDELIANA AD, P266; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Raphael Y, 2001, HEARING RES, V151, P237, DOI 10.1016/S0378-5955(00)00233-1; Shimada Y, 2001, CURR BIOL, V11, P859, DOI 10.1016/S0960-9822(01)00233-0; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Strutt H, 1999, CURR OPIN GENET DEV, V9, P442, DOI 10.1016/S0959-437X(99)80067-7; STUMPF HF, 1966, NATURE, V212, P430, DOI 10.1038/212430a0; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wolff Tanya, 1993, P1277; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; ZHENG L, 1995, DEVELOPMENT, V121, P3045	41	297	305	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					675	688		10.1016/S0092-8674(02)00658-X	http://dx.doi.org/10.1016/S0092-8674(02)00658-X			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893338	Bronze			2022-12-24	WOS:000174314800011
J	Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR				Winston, FK; Kallan, MJ; Elliott, MR; Menon, RA; Durbin, DR			Risk of injury to child passengers in compact extended-cab pickup trucks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context An increasing number of compact pickup trucks can accommodate restrained rear occupants. Rear seats in these pickup trucks are exempt from regulatory safety testing though their relative safety has not been determined. Objectives To evaluate the risk of injury to children in compact extended-cab pickup trucks compared with children in other vehicles and to determine if any unique hazards exist. Design Cross-sectional study of children aged 15 years or younger in crashes of insured vehicles, with data collected via insurance claim records and a telephone survey. Setting and Participants Probability sample of 7192 multirow vehicles involved in crashes, with 11335 child occupants, in 3 large US regions from December 1, 1998, to November 30, 2000. Main Outcome Measure Relative risk of injury, defined as concussions and more serious brain injuries, spinal cord injuries, internal organ injuries, extremity fractures, and facial lacerations, estimated by odds ratios (ORs) adjusting for age, restraint use, point of impact, vehicle weight, and crash severity. Results Injuries were reported for 1356 children, representing 1.6% of the population. Children in compact extended-cab pickup trucks were at greater risk of injury than children in other vehicles (adjusted OR, 2.96; 95% confidence interval [CI], 1.68-5.21). Children in the rear seats of compact pickup trucks were at substantially greater risk of injury than rear-seated children in other vehicles (adjusted OR, 4.75; 95% CI, 2.39-9.43). Children seated in the front seat of compact extended-cab pickup trucks were at greater risk of injury than children in the front seats of other vehicles, but this risk was not statistically significant (adjusted OR, 1.70; 95% CI, 0.78-3.69). Conclusions Children in compact extended-cab pickup trucks are not as safe as children in other vehicles, primarily due to the increased relative risk of injury in the back seat. For families with another choice of vehicle, clinicians should advise parents against transporting children in compact pickup trucks. The current exemption for regulatory testing for occupant protection in the rear seats of compact pickup trucks should be reconsidered.	Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Gen Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Div Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Winston, FK (corresponding author), Childrens Hosp Philadelphia, TraumaLink Interdisciplinary Pediat Trauma Res Ct, 34th St & Civ Ctr Blvd,3535 TraumaLink,10th Floor, Philadelphia, PA 19104 USA.		Durbin, Dennis/AAD-7829-2022					AGRAN PF, 1990, JAMA-J AM MED ASSOC, V264, P712, DOI 10.1001/jama.264.6.712; *AM AC PED, 2001, INF CHILD RESTR; ANDERSON C, 2000, 44 ANN P ASS ADV AUT; Anderson CL, 2000, ACCIDENT ANAL PREV, V32, P533, DOI 10.1016/S0001-4575(99)00075-5; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Braver E R, 1998, Inj Prev, V4, P181; Bull MJ, 2000, PEDIATRICS, V106, P857; *BUR CENS, 1999, PUBL BUR CENS; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; EDWARDS J, 1997, SOC AUT ENG GOV IND; *INS I HIGHW SAF H, 1999, VINDICATOR 2000; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; *NAT HIGHW TRAFF S, 2001, CHILD SAF SEAT US CH; *NAT INS CRIM BUR, 2000, 2000 PASS VEH ID MAN; WILLIAMS AF, 1977, ACCIDENT ANAL PREV, V9, P69, DOI 10.1016/0001-4575(77)90007-0; Winston FK, 2000, PEDIATRICS, V105, P1179, DOI 10.1542/peds.105.6.1179; Wittenberg E, 1999, PEDIATRICS, V104, P1247, DOI 10.1542/peds.104.6.1247	18	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1147	1152		10.1001/jama.287.9.1147	http://dx.doi.org/10.1001/jama.287.9.1147			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	527KV	11879112	Bronze			2022-12-24	WOS:000174186000030
J	Zheng, N; Schulman, BA; Song, LZ; Miller, JJ; Jeffrey, PD; Wang, P; Chu, C; Koepp, DM; Elledge, SJ; Pagano, M; Conaway, RC; Conaway, JW; Harper, JW; Pavletich, NP				Zheng, N; Schulman, BA; Song, LZ; Miller, JJ; Jeffrey, PD; Wang, P; Chu, C; Koepp, DM; Elledge, SJ; Pagano, M; Conaway, RC; Conaway, JW; Harper, JW; Pavletich, NP			Structure of the Cul1-Rbx1-Skp1-F box(Skp2) SCF ubiquitin ligase complex	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; CYCLIN-E; CRYSTAL-STRUCTURE; PROTEIN; SUBUNIT; IDENTIFICATION; DEGRADATION; PROTEOLYSIS; MECHANISMS; P27(KIP1)	SCF complexes are the largest family of E3 ubiquitin-protein ligases and mediate the ubiquitination of diverse regulatory and signalling proteins. Here we present the crystal structure of the Cul1-Rbx1-Skp1-F box(Skp2) SCF complex, which shows that Cul1 is an elongated protein that consists of a long stalk and a globular domain. The globular domain binds the RING finger protein Rbx1 through an intermolecular beta-sheet, forming a two-subunit catalytic core that recruits the ubiquitin-conjugating enzyme. The long stalk, which consists of three repeats of a novel five-helix motif, binds the Skp1-F box(Skp2) protein substrate-recognition complex at its tip. Cul1 serves as a rigid scaffold that organizes the Skp1-F box(Skp2) and Rbx1 subunits, holding them over 100 Angstrom apart. The structure suggests that Cul1 may contribute to catalysis through the positioning of the substrate and the ubiquitin-conjugating enzyme, and this model is supported by Cul1 mutations designed to eliminate the rigidity of the scaffold.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; NYU, Med Ctr, Dept Pathol, New York, NY 10016 USA; NYU, Med Ctr, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; New York University; New York University; Stowers Institute for Medical Research	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA.	nikola@xray2.mskcc.org		pagano, michele/0000-0003-3210-2442; Jeffrey, Philip/0000-0002-4351-5341; Miller, Julie/0000-0002-1288-593X; Conaway, Joan/0000-0002-2786-0663	NIA NIH HHS [R01 AG011085] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Mathias N, 1996, MOL CELL BIOL, V16, P6634; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polakis P, 2000, GENE DEV, V14, P1837; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Stroschein SL, 2001, GENE DEV, V15, P2822; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	50	1119	1169	9	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2002	416	6882					703	709		10.1038/416703a	http://dx.doi.org/10.1038/416703a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961546				2022-12-24	WOS:000175033500033
J	Gottar, M; Gobert, V; Michel, T; Belvin, M; Duyk, G; Hoffmann, JA; Ferrandon, D; Royet, J				Gottar, M; Gobert, V; Michel, T; Belvin, M; Duyk, G; Hoffmann, JA; Ferrandon, D; Royet, J			The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein	NATURE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; DEFICIENCY IMD; HOST-DEFENSE; GENES; ANTIFUNGAL; INFECTION; SILKWORM; REQUIRES; FAMILY	The antimicrobial defence of Drosophila relies largely on the challenge-induced synthesis of an array of potent antimicrobial peptides by the fat body(1,2). The defence against Gram-positive bacteria and natural fungal infections is mediated by the Toll signalling pathway, whereas defence against Gram-negative bacteria is dependent on the Immune deficiency (IMD) pathway(3-18). Loss-of-function mutations in either pathway reduce the resistance to corresponding infections(3,9). The link between microbial infections and activation of these two pathways has remained elusive. The Toll pathway is activated by Gram-positive bacteria through a circulating Peptidoglycan recognition protein (PGRP-SA)(6). PGRPs appear to be highly conserved from insects to mammals, and the Drosophila genome contains 13 members(19-23). Here we report a mutation in a gene coding for a putative transmembrane protein, PGRP-LC, which reduces survival to Gram-negative sepsis but has no effect on the response to Gram-positive bacteria or natural fungal infections. By genetic epistasis, we demonstrate that PGRP-LC acts upstream of the imd gene. The data on PGRP-SA with respect to the response to Gram-positive infections, together with the present report, indicate that the PGRP family has a principal role in sensing microbial infections in Drosophila.	Inst Biol Mol & Cellulaire, CNRS, UPR 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.	Ferrandon, D (corresponding author), Inst Biol Mol & Cellulaire, CNRS, UPR 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.	D.Ferrandon@ibmc.u-strasbg.fr; J.Royet@ibmc.u-strasbg.fr		FERRANDON, Dominique/0000-0001-7680-7773; Michel, Tatiana/0000-0002-0146-9236				Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kimbrell DA, 2001, NAT REV GENET, V2, P256, DOI 10.1038/35066006; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sieling PA, 2002, CURR OPIN MICROBIOL, V5, P70, DOI 10.1016/S1369-5274(02)00288-6; Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wu LP, 2001, GENETICS, V159, P189; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854	30	509	547	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					640	644		10.1038/nature734	http://dx.doi.org/10.1038/nature734			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11912488				2022-12-24	WOS:000174901900045
J	Ramet, M; Manfruelli, P; Pearson, A; Mathey-Prevot, B; Ezekowitz, RAB				Ramet, M; Manfruelli, P; Pearson, A; Mathey-Prevot, B; Ezekowitz, RAB			Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E-coli	NATURE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; CELLS; GENE; HEMATOPOIESIS; MELANOGASTER; MECHANISMS; EXPRESSION; REGULATOR; CLONING	The recognition and phagocytosis of microbes by macrophages is a principal aspect of innate immunity that is conserved from insects to humans. Drosophila melanogaster has circulating macrophages that phagocytose microbes similarly to mammalian macrophages(1,2), suggesting that insect macrophages can be used as a model to study cell-mediated innate immunity. We devised a double-stranded RNA interference-based screen in macrophage-like Drosophila S2 cells, and have defined 34 gene products involved in phagocytosis. These include proteins that participate in haemocyte development, vesicle transport, actin cytoskeleton regulation and a cell surface receptor. This receptor, Peptidoglycan recognition protein LC (PGRP-LC), is involved in phagocytosis of Gram-negative but not Gram-positive bacteria. Drosophila humoral immunity also distinguishes between Gram-negative and Gram-positive bacteria through the Imd and Toll pathways, respectively; however, a receptor for the Imd pathway has not been identified. Here we show that PGRP-LC is important for antibacterial peptide synthesis induced by Escherichia coli both in vitro and in vivo. Furthermore, totem mutants, which fail to express PGRP-LC, are susceptible to Gram-negative (E. coli), but not Gram-positive, bacterial infection. Our results demonstrate that PGRP-LC is an essential component for recognition and signalling of Gram-negative bacteria. Furthermore, this functional genomic approach is likely to have applications beyond phagocytosis.	Massachusetts Gen Hosp Children, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02114 USA; Harvard Univ, Dept Pediat, Dana Faber Canc Inst, Div Pediat Oncol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Ramet, M (corresponding author), Massachusetts Gen Hosp Children, Lab Dev Immunol, 55 Fruit St, Boston, MA 02114 USA.							Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BJERKNES R, 1984, J IMMUNOL METHODS, V72, P229, DOI 10.1016/0022-1759(84)90451-4; FEHON RG, 1994, DEVELOPMENT, V120, P545; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Hackam DJ, 2001, J BIOL CHEM, V276, P18200, DOI 10.1074/jbc.M102009200; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Imler JL, 2000, CURR OPIN MICROBIOL, V3, P16, DOI 10.1016/S1369-5274(99)00045-4; Imler JL, 2000, J ENDOTOXIN RES, V6, P459, DOI 10.1177/09680519000060060801; Juang JL, 1999, ONCOGENE, V18, P5138, DOI 10.1038/sj.onc.1202911; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee S, 2000, J NEUROSCI, V20, P1096, DOI 10.1523/JNEUROSCI.20-03-01096.2000; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; Lukacsovich T, 2001, GENETICS, V157, P727; Madden K, 1999, DEV BIOL, V213, P301, DOI 10.1006/dbio.1999.9399; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 1999, J BIOL CHEM, V274, P11854, DOI 10.1074/jbc.274.17.11854; Oike Y, 1999, BLOOD, V93, P2771; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Perry DG, 1999, J IMMUNOL, V162, P380; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	31	567	585	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					644	648		10.1038/nature735	http://dx.doi.org/10.1038/nature735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11912489				2022-12-24	WOS:000174901900046
J	Taylor, WR				Taylor, WR			A 'periodic table' for protein structures	NATURE			English	Article							BETA-SHEET; CLASSIFICATION; PREDICTION; DATABASE	Current structural genomics programs aim systematically to determine the structures of all proteins coded in both human and other genomes, providing a complete picture of the number and variety of protein structures that exist. In the past, estimates have been made on the basis of the incomplete sample of structures currently known. These estimates have varied greatly (between 1,000 and 10,000; see for example refs 1 and 2), partly because of limited sample size but also owing to the difficulties of distinguishing one structure from another. This distinction is usually topological, based on the fold of the protein; however, in strict topological terms (neglecting to consider intra-chain cross-links), protein chains are open strings and hence are all identical. To avoid this trivial result, topologies are determined by considering secondary links in the form of intra-chain hydrogen bonds (secondary structure) and tertiary links formed by the packing of secondary structures. However, small additions to or loss of structure can make large changes to these perceived topologies and such subjective solutions are neither robust nor amenable to automation. Here I formalize both secondary and tertiary links to allow the rigorous and automatic definition of protein topology.	Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, Div Math Biol, Mill Hill, London NW7 1AA, England.	wtaylor@nimr.mrc.ac.uk						CHOTHIA C, 1993, STRUCTURE, V1, P217, DOI 10.1016/0969-2126(93)90010-E; CHOTHIA C, 1990, ANNU REV BIOCHEM, V59, P1007, DOI 10.1146/annurev.bi.59.070190.005043; COHEN FE, 1982, J MOL BIOL, V156, P821, DOI 10.1016/0022-2836(82)90144-9; COHEN FE, 1980, NATURE, V285, P378, DOI 10.1038/285378a0; Eidhammer I, 2000, J COMPUT BIOL, V7, P685, DOI 10.1089/106652701446152; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Hadley C, 1999, STRUCT FOLD DES, V7, P1099, DOI 10.1016/S0969-2126(99)80177-4; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Mizuguchi K, 1998, PROTEIN SCI, V7, P2469, DOI 10.1002/pro.5560071126; MURZIN AG, 1988, J MOL BIOL, V204, P749, DOI 10.1016/0022-2836(88)90366-X; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; MURZIN AG, 1994, J MOL BIOL, V236, P1396; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Taylor WR, 2002, MOL CELL PROTEOMICS, V1, P334, DOI 10.1074/mcp.T200001-MCP200; Taylor WR, 2001, J MOL BIOL, V310, P1135, DOI 10.1006/jmbi.2001.4817; TAYLOR WR, 1994, PROTEINS, V18, P281, DOI 10.1002/prot.340180309; Taylor WR, 2000, BIOCHEM SOC T, V28, P264, DOI 10.1042/bst0280264; Taylor WR, 1999, PROTEIN ENG, V12, P203, DOI 10.1093/protein/12.3.203	20	105	106	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					657	660		10.1038/416657a	http://dx.doi.org/10.1038/416657a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948354				2022-12-24	WOS:000174901900049
J	Kadan-Lottick, NS; Robison, LL; Gurney, JG; Neglia, JP; Yasui, Y; Hayashi, R; Hudson, M; Greenberg, M; Mertens, AC				Kadan-Lottick, NS; Robison, LL; Gurney, JG; Neglia, JP; Yasui, Y; Hayashi, R; Hudson, M; Greenberg, M; Mertens, AC			Childhood cancer survivors' knowledge about their past diagnosis and treatment - Childhood cancer survivor study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM SURVIVORS; ADOLESCENT CANCER; 5-YEAR SURVIVORS; ADULT SURVIVORS; LATE MORTALITY; MANAGEMENT; NEOPLASMS; CHILDREN; THERAPY; PATIENT	Context Adult survivors of childhood cancer are at risk for adverse effects later in life but may have limited access 10 information about their diagnosis and treatment. This knowledge is necessary to motivate them to seek medical follow-up and to report essential history to health care professionals. Objective To assess knowledge of adult survivors of childhood cancer about their primary cancer diagnosis and associated therapies. Design, Setting, and Participants Cross-sectional survey of 635 consecutive survivors (approximately 5%) drawn from 12156 participants 18 years or older participating in the Childhood Cancer Survivor Study (a multiinstitutional cohort of individuals diagnosed between January 1, 1970, and December 31,1986, at at-rage <21 years, who had survived 5 years from diagnosis). The survey assessed knowledge of their cancer diagnosis and associated therapies in a 3- to 5-minute telephone questionnaire. Main Outcome Measures Responses were compared with medical record data for accuracy, sensitivity, specificity, and positive and negative predictive value. Results Overall, 72% accurately reported their diagnosis with precision and 19% were accurate but not precise. Individuals with central nervous system (CNS) cancer (odds ratio, 5.1; 95% confidence interval, 2.6-9.9) and neuroblastoma (OR, 4.2; 95% CI, 1.8-9.6) were more likely not to know their cancer diagnosis. Participants' accuracy rates for reporting their treatment history was 94% for chemotherapy, 89% for radiation, and 93% for splenectomy. Among those who received anthracyclines, only 30% recalled receiving daunorubicin therapy and 52% recalled receiving doxorubicin therapy, even after prompting with the drugs' names. Among those who received radiotherapy, 70% recalled the site of radiotherapy. History of receiving a written medical summary, attending a long-term follow-up clinic, and anxiety about late effects were not associated with greater, knowledge. Conclusions Important knowledge deficits exist among adult survivors of childhood cancer regarding basic aspects of their diagnosis and treatment. Such deficits could impair survivors' ability to seek and receive appropriate long-term follow-up care.	Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; St Louis Childrens Hosp, St Louis, MO 63178 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; St. Louis Children's Hospital; Washington University (WUSTL); St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kadan-Lottick, NS (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, 420 Delaware St SE,Mayo Mail Code 715, Minneapolis, MN 55455 USA.	kadan@epi.umn.edu	hayashi, robert james/AAH-2077-2019; Kadan-Lottick, Nina Singh/HGE-5850-2022; Robison, Leslie/N-8122-2018; Yasui, Yutaka/E-2564-2015	hayashi, robert james/0000-0002-1140-1139; Kadan-Lottick, Nina Singh/0000-0002-6857-396X; Yasui, Yutaka/0000-0002-7717-8638; Neglia, Joseph/0000-0002-5525-0598	NCI NIH HHS [U24 CA055727, U24-CA55727] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U24CA055727] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhatia S, 1996, NEW ENGL J MED, V334, P745, DOI 10.1056/NEJM199603213341201; Blacklay A, 1998, ARCH DIS CHILD, V78, P340, DOI 10.1136/adc.78.4.340; Brigden ML, 2001, AM FAM PHYSICIAN, V63, P499; BYRNE J, 1989, ANN INTERN MED, V110, P400, DOI 10.7326/0003-4819-110-5-400; Eiser C, 1996, ARCH DIS CHILD, V75, P405, DOI 10.1136/adc.75.5.405; Grossi M, 1998, PEDIATR CLIN N AM, V45, P1637, DOI 10.1016/S0031-3955(05)70106-1; Hudson MM, 1997, J CLIN ONCOL, V15, P2205, DOI 10.1200/JCO.1997.15.6.2205; Hudson MM, 1999, INT J CANCER, P138; MEADOWS AT, 1981, LANCET, V2, P1015; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; NICHOLSON HS, 1994, CANCER, V73, P3094; NOVACK DH, 1979, JAMA-J AM MED ASSOC, V241, P897, DOI 10.1001/jama.241.9.897; Oeffinger KC, 1998, J CLIN ONCOL, V16, P2864, DOI 10.1200/JCO.1998.16.8.2864; RIED HL, 1994, SEMIN ROENTGENOL, V29, P6, DOI 10.1016/S0037-198X(05)80068-9; RIES LA, 1999, NIH PUBLICATION; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; STEINHERZ LJ, 1992, PEDIATRICS, V89, P942	18	250	252	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2002	287	14					1832	1839		10.1001/jama.287.14.1832	http://dx.doi.org/10.1001/jama.287.14.1832			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539QJ	11939869	Bronze			2022-12-24	WOS:000174881700036
J	Johnson, TC; Brown, ET; McManus, J; Barry, S; Barker, P; Gasse, F				Johnson, TC; Brown, ET; McManus, J; Barry, S; Barker, P; Gasse, F			A high-resolution paleoclimate record spanning the past 25,000 years in southern East Africa	SCIENCE			English	Article							LAKE MALAWI; TROPICS; SEDIMENTS; CLIMATE	High-resolution profiles of the mass accumulation rate of biogenic silica and other geochemical proxies in two piston cores from northern Lake Malawi provide a climate signal for this part of tropical Africa spanning the past 25,000 years. The biogenic silica mass accumulation rate was low during the relatively dry late Pleistocene, when the river flux of silica to the take was suppressed. Millennial-scale fluctuations, due to upwelling intensity, in the late Pleistocene climate of the Lake Malawi basin appear to have been closely linked to the Northern Hemisphere climate until 11 thousand years ago. Relatively cold conditions in the Northern Hemisphere coincided with more frequent north winds over the Malawi basin, perhaps resulting from a more southward migration of the Intertropical Convergence Zone.	Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; Univ Lancaster, Dept Geog, Lancaster LA1 4YB, England; Univ Aix Marseille 3, CNRS, Ctr European Rech & Enseignement Geosci Environm, F-13545 Aix En Provence, France	University of Minnesota System; University of Minnesota Duluth; Lancaster University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Johnson, TC (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	tcj@d.umn.edu	Johnson, Thomas/C-1423-2010; Barker, Philip/J-5938-2012	Barker, Philip/0000-0002-5334-9201; Brown, Erik T/0000-0001-7154-2729				ASPILA KI, 1976, ANALYST, V101, P187, DOI 10.1039/an9760100187; BARRY SL, 2001, THESIS U MINNESOTA; BOOTSMA HA, 1998, WATER QUALITY REPORT; Brown ET, 2000, GEOCHIM COSMOCHIM AC, V64, P3515, DOI 10.1016/S0016-7037(00)00460-9; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; *CLIM VAR PRED CLI, 1999, 161999 WCRP CLIVAR; DEMASTER DJ, 1979, THESIS YALE U; Filippelli GM, 1999, GEOLOGY, V27, P171, DOI 10.1130/0091-7613(1999)027<0171:EOCALD>2.3.CO;2; FINNEY BP, 1991, PALAEOGEOGR PALAEOCL, V85, P351, DOI 10.1016/0031-0182(91)90167-P; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; GASSE F, E AFRICAN GREAT LAKE; Harkin D. A., 1955, TANGANYIKA NOTES, V40, P20; JOHNSON TC, 1979, GEOCHIM COSMOCHIM AC, V43, P77, DOI 10.1016/0016-7037(79)90048-6; JOHNSON TC, 1990, AAPG MEMOIR, V50, P113; Johnson TC, 2001, GEOLOGY, V29, P83, DOI 10.1130/0091-7613(2001)029<0083:DROCVS>2.0.CO;2; JOHNSON TC, IN PRESS SEDIMENTATI; LIVINGSTONE DA, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P455; Nicholson S.E., 1996, LIMNOLOGY CLIMATOLOG, V1st ed., P25, DOI [DOI 10.1201/9780203748978-2, 10.1201/9780203748978-2]; Nicholson SE., 1998, ENV CHANGE RESPONSE, P207, DOI [https://doi.org/10.1007/978-94-017-1437-2_16, DOI 10.1007/978-94-017-1437-2_16]; PATTERSON G, 1995, FISHERY POTENTIAL PR, P1; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Vidal L, 1999, CLIM DYNAM, V15, P909, DOI 10.1007/s003820050321	22	174	184	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					113	+		10.1126/science.1070057	http://dx.doi.org/10.1126/science.1070057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935023				2022-12-24	WOS:000174858800044
J	Teder, P; Vandivier, RW; Jiang, DH; Liang, JR; Cohn, L; Pure, E; Henson, PM; Noble, PW				Teder, P; Vandivier, RW; Jiang, DH; Liang, JR; Cohn, L; Pure, E; Henson, PM; Noble, PW			Resolution of lung inflammation by CD44	SCIENCE			English	Article							HYALURONIC-ACID; TGF-BETA; MACROPHAGES; FIBROSIS; RECEPTOR	Successful repair after tissue injury and inflammation requires resolution of the inflammatory response and removal of extracellular matrix breakdown products. We have examined whether the cell-surface adhesion molecule and hyaluronan receptor CD44 plays a role in resolving lung inflammation. CD44-deficient mice succumb to unremitting inflammation following noninfectious lung injury, characterized by impaired clearance of apoptotic neutrophils, persistent accumulation of hyaluronan fragments at the site of tissue injury, and impaired activation of transforming growth factor-beta(1). This phenotype was partially reversed by reconstitution with CD44(+) cells, thus demonstrating a critical role for this receptor in resolving lung inflammation.	Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA; VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA; Ludwig Inst Canc Res, New York, NY 10158 USA; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; National Jewish Health; Ludwig Institute for Cancer Research; The Wistar Institute	Noble, PW (corresponding author), Yale Univ, Sch Med, Dept Med, Pulm & Crit Care Sect, New Haven, CT 06520 USA.	paul.noble@yale.edu	Liang, Carol Jiurong/AAI-4963-2021; Jiang, Dianhua/B-1421-2009	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060539] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL60539] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMSON IYR, 1974, AM J PATHOL, V77, P185; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; DeGrendele HC, 1997, J IMMUNOL, V159, P2549; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Guo MML, 1996, ANAL BIOCHEM, V233, P216, DOI 10.1006/abio.1996.0031; Hart SP, 1997, J IMMUNOL, V159, P919; HASLETT C, 1985, AM J PATHOL, V119, P101; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEE HG, 1994, ANAL BIOCHEM, V219, P278, DOI 10.1006/abio.1994.1267; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MCNEIL JD, 1985, ANN RHEUM DIS, V44, P780, DOI 10.1136/ard.44.11.780; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Rafi-Janajreh AQ, 1999, J IMMUNOL, V163, P1619; RODEN L, 1989, CIBA F SYMP, V143, P60; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; UNDERHILL CB, 1993, DEV BIOL, V155, P324, DOI 10.1006/dbio.1993.1032; Yu Q, 1997, J EXP MED, V186, P1985, DOI 10.1084/jem.186.12.1985; Yu Q, 2000, GENE DEV, V14, P163	21	523	546	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2002	296	5565					155	158		10.1126/science.1069659	http://dx.doi.org/10.1126/science.1069659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935029				2022-12-24	WOS:000174858800052
J	Rifai, N; Buring, JE; Lee, IM; Manson, JE; Ridker, PM				Rifai, N; Buring, JE; Lee, IM; Manson, JE; Ridker, PM			Is C-reactive protein specific for vascular disease in women?	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INFLAMMATION; RISK; CANCER; ATHEROSCLEROSIS; HEALTH; MEN	Background: C-reactive protein (CRP) predicts risk for future cardiovascular events in asymptomatic individuals. However, because CRP also predicts total mortality, its specificity for vascular disease is uncertain. Objective: To compare the predictive value of CRP for cancer and cardiovascular disease, the major determinants of mortality. Design: Prospective, nested case-control study. Setting: The Women's Health Study, an ongoing prospective cohort study involving 28345 U.S. women 45 years of age and older who were healthy at the time of enrollment. Participants: 643 women who subsequently developed cancer or had cardiovascular events; 643 age- and smoking-matched women who remained free of either disease during 58-month follow-up. Measurements: Baseline CRP levels. Results: Little evidence showed that increasing quartiles of baseline CRP predicted incident cancer (adjusted relative risks, 1.0, 1.2, 1.1, and 1.3; P for trend > 0.2). In contrast, increasing quartiles of baseline CRP were a strong marker of risk for future cardiovascular disease (adjusted relative risks, 1.0, 2.9, 3.4, and 5.6; P for trend < 0.001). \ Conclusion: C-reactive protein appears to independently predict cardiovascular events but not cancer.	Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org	Lee, I-Min/ABD-5409-2021		NHLBI NIH HHS [HL 58755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Gussekloo J, 2000, ARTERIOSCL THROM VAS, V20, P1047, DOI 10.1161/01.ATV.20.4.1047; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Kodama J, 1999, EUR J OBSTET GYN R B, V82, P107, DOI 10.1016/S0301-2115(98)00227-9; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Maseri A, 1997, NEW ENGL J MED, V336, P1014, DOI 10.1056/NEJM199704033361409; PEPYS MB, 1981, LANCET, V1, P653; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 1999, CLIN CHEM, V45, P2136; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121	15	61	62	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 2	2002	136	7					529	533		10.7326/0003-4819-136-7-200204020-00010	http://dx.doi.org/10.7326/0003-4819-136-7-200204020-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536CA	11926788				2022-12-24	WOS:000174682100005
J	Froehler, MT; Duffy, CJ				Froehler, MT; Duffy, CJ			Cortical neurons encoding path and place: Where you go is where you are	SCIENCE			English	Article							SUPERIOR TEMPORAL AREA; OPTIC FLOW STIMULI; MST NEURONS; MACAQUE MONKEY; EYE POSITION; DORSAL PART; RESPONSES; MOTION; SENSITIVITY; HIPPOCAMPUS	We recorded neuronal activity in monkey medial superior temporal (MST) cortex during movement on a motorized sled. Most neurons showed a preferred heading direction, but some responded only when that heading was part of a particular path. others responded only when the animal was at a certain place in the room, regardless of its path to that place. Video simulations of the self-movement scene evoked path, but not place, responses. Stationary positioning in the room revealed location preferences that matched place preferences recorded during movement. We conclude that MST encodes heading, path, and place information to support visuospatial orientation.	Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Dept Brain & Cognit Sci, Rochester, NY 14642 USA; Univ Rochester, Med Ctr, Ctr Visual Sci, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Duffy, CJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.				NEI NIH HHS [EY10287, T2-EY07125C] Funding Source: Medline; NIA NIH HHS [AG17596] Funding Source: Medline; NIGMS NIH HHS [T32-GM07356] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017596] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Batschelet E, 1981, CIRCULAR STAT BIOL; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Duffy CJ, 1997, EXP BRAIN RES, V114, P472, DOI 10.1007/PL00005656; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Gibson J. J., 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Hays A., 1982, WESCON C P, V2, P1; Inoue Y, 1998, EXP BRAIN RES, V121, P135, DOI 10.1007/s002210050445; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Mardia K., 1972, STAT DIRECTIONAL DAT, V37, DOI 10.2307/2984782; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; MCNAUGHTON BL, 1989, PSYCHOBIOLOGY, V17, P230; Nishijo H, 1997, NEUROSCI LETT, V226, P57, DOI 10.1016/S0304-3940(97)00255-3; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OBRIEN HL, 1921, CEREB CORTEX, V11, P1083; ONO T, 1993, J NEUROPHYSIOL, V70, P1516, DOI 10.1152/jn.1993.70.4.1516; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; Paolini M, 2000, J NEUROPHYSIOL, V84, P730, DOI 10.1152/jn.2000.84.2.730; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Rockland KS, 1999, CEREB CORTEX, V9, P232, DOI 10.1093/cercor/9.3.232; ROLLS ET, 1999, HIPPOCAMPAL PARIETAL, pCH17; ROY JP, 1992, J NEUROSCI, V12, P2478; SAITO H, 1986, J NEUROSCI, V6, P145; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642	30	52	57	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2462	2465		10.1126/science.1067426	http://dx.doi.org/10.1126/science.1067426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923540				2022-12-24	WOS:000174712600059
J	Kind, PC; Mitchell, DE; Ahmed, B; Blakemore, C; Bonhoeffer, T; Sengpiel, F				Kind, PC; Mitchell, DE; Ahmed, B; Blakemore, C; Bonhoeffer, T; Sengpiel, F			Correlated binocular activity guides recovery from monocular deprivation	NATURE			English	Article							VISUAL-CORTEX; SYNAPTIC PLASTICITY; KITTENS; STRABISMUS; EXPERIENCE; AMBLYOPIA; REVERSAL; MONKEYS; PERIOD; CATS	Monocular deprivation (MD) has much more rapid and severe effects on the ocular dominance of neurons in the primary visual cortex (V1) than does binocular deprivation(1). This finding underlies the widely held hypothesis that the developmental plasticity of ocular dominance reflects competitive interactions for synaptic space between inputs from the two eyes(2). According to this view, the relative levels of evoked activity in afferents representing the two eyes determine functional changes in response to altered visual experience. However, if the deprived eye of a monocularly deprived kitten is simply reopened, there is substantial physiological and behavioural recovery, leading to the suggestion that absolute activity levels, or some other noncompetitive mechanisms, determine the degree of recovery from MD3-7. Here we provide evidence that correlated binocular input is essential for such recovery. Recovery is far less complete if the two eyes are misaligned after a period of MD. This is a powerful demonstration of the importance of cooperative, associative mechanisms in the developing visual cortex.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Edinburgh, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; Dalhousie Univ, Dept Psychol, Halifax, NS B3H 4J1, Canada; Max Planck Inst Neurobiol, D-82152 Munich, Germany; Cardiff Sch Biosci, Cardiff CF10 3US, S Glam, Wales	University of Oxford; University of Edinburgh; Dalhousie University; Max Planck Society; Cardiff University	Kind, PC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Bonhoeffer, Tobias/B-9481-2009; Sengpiel, Frank/A-4682-2010	Bonhoeffer, Tobias/0000-0001-7897-6634; Sengpiel, Frank/0000-0002-7060-1851; Blakemore, Colin/0000-0003-2659-7899; Kind, Peter/0000-0002-4256-9639				BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLAKE R, 1974, INVEST OPHTH VISUAL, V13, P121; BLAKEMORE C, 1981, PROC R SOC SER B-BIO, V213, P399, DOI 10.1098/rspb.1981.0072; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Bonhoeffer Tobias, 1996, P55; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; GIFFIN F, 1978, J PHYSIOL-LONDON, V274, P511, DOI 10.1113/jphysiol.1978.sp012164; GUILLERY RW, 1988, MAKING NERVOUS SYSTE, P356; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Kind PC, 1999, CURR BIOL, V9, pR640, DOI 10.1016/S0960-9822(99)80412-6; Kiorpes L, 1998, J NEUROSCI, V18, P6411; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; MALACH R, 1989, VISUAL NEUROSCI, V3, P267, DOI 10.1017/S0952523800010014; MITCHELL DE, 1988, J PHYSIOL-LONDON, V395, P639, DOI 10.1113/jphysiol.1988.sp016939; MITCHELL DE, 1977, J COMP NEUROL, V176, P53, DOI 10.1002/cne.901760104; Mitchell DE, 1998, CURR BIOL, V8, P1179, DOI 10.1016/S0960-9822(07)00489-7; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; Mitchell DE, 1984, HDB PHYSL 1 1, V3, P507; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P175, DOI 10.1113/jphysiol.1976.sp011552; MURPHY KM, 1986, NATURE, V323, P536, DOI 10.1038/323536a0; QUICK MW, 1989, INVEST OPHTH VIS SCI, V30, P1012; Rittenhouse CD, 1999, NATURE, V397, P347, DOI 10.1038/16922; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980	27	62	65	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					430	433		10.1038/416430a	http://dx.doi.org/10.1038/416430a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919632				2022-12-24	WOS:000174607800047
J	Floyd, K; Blanc, L; Raviglione, M; Lee, JW				Floyd, K; Blanc, L; Raviglione, M; Lee, JW			Resources required for global tuberculosis control	SCIENCE			English	Article								We estimate that to achieve the World Health Organization's tuberculosis control targets, the 22 high-burden countries (HBCs) that collectively account for approximately 80% of the world's tuberculosis cases require about $1 billion per year during the period 2001 to 2005. A further $0.2 billion per year is needed for low and tower-middle income countries outside the 22 HBCs. There is a resource gap of up to around $300 million per year. Substantial progress in tuberculosis control could be achieved with increased investment that is large in the context of existing spending, but small in the wider context of global health expenditure.	WHO, Stop TB Dept, Communicable Dis Cluster, CH-1211 Geneva 27, Switzerland	World Health Organization	Floyd, K (corresponding author), WHO, Stop TB Dept, Communicable Dis Cluster, CH-1211 Geneva 27, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				[Anonymous], GLOBAL FUND FIGHT AI; APPAIX O, UNPUB; *COMM MACR HLTH, 2001, MACR HLTH INV HLTH E, P157; Migliori GB, 1999, B WORLD HEALTH ORGAN, V77, P467; Schwartlander B, 2001, SCIENCE, V294, P521; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; *UG MIN HLTH, 2001, NAT TUB LEPR PROGR 3; WHO, 2002, EV MALN CHILDR MAN S, P4; World Health Organization, 2000, WHOCDSDENIC20001, P10; 2000, MIN C TUB SUST DEV A; CHAIRS SUMMARY OKINA	11	45	57	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2040	2041		10.1126/science.1069771	http://dx.doi.org/10.1126/science.1069771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896267				2022-12-24	WOS:000174450500037
J	Moldoveanu, T; Hosfield, CM; Lim, D; Elce, JS; Jia, ZC; Davies, PL				Moldoveanu, T; Hosfield, CM; Lim, D; Elce, JS; Jia, ZC; Davies, PL			A Ca2+ switch aligns the active site of calpain	CELL			English	Article							MUSCLE-SPECIFIC CALPAIN; SMALL-SUBUNIT GENE; CRYSTAL-STRUCTURE; CA2+-BINDING DOMAIN; CALCIUM; PROTEASE; RESOLUTION; ACTIVATION; BINDING; CALPASTATIN	Ca2+ signaling by calpains leads to controlled proteolysis during processes ranging from cytoskeleton remodeling in mammals to sex determination in nematodes. Deregulated Ca2+ levels result in aberrant proteolysis by calpains, which contributes to tissue damage in heart and brain ischemias as well as neurodegeneration in Alzheimer's disease. Here we show that activation of the protease core of mu calpain requires cooperative binding of two Ca2+ atoms at two non-EF-hand sites revealed in the 2.1 Angstrom crystal structure. Conservation of the Ca2+ binding residues defines an ancestral general mechanism of activation for most calpain isoforms, including some that lack EF-hand domains. The protease region is not affected by the endogenous inhibitor, calpastatin, and may contribute to calpain-mediated pathologies when the core is released by autoproteolysis.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Prot Engn Network Ctr Excellence, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Moldoveanu, Tudor/N-8173-2018	Moldoveanu, Tudor/0000-0003-0791-318X				Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; *CCPA, 1994, ACTA CRYSTALLOGR D, V50, P760; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cox EA, 1998, MICROSC RES TECHNIQ, V43, P412, DOI 10.1002/(SICI)1097-0029(19981201)43:5<412::AID-JEMT7>3.0.CO;2-F; CRAWFORD C, 1993, BIOCHEM J, V296, P135, DOI 10.1042/bj2960135; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2000, BIOCHEM J, V348, P37, DOI 10.1042/0264-6021:3480037; ELCE JS, 1995, PROTEIN ENG, V8, P843, DOI 10.1093/protein/8.8.843; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Hosfield CM, 2001, J BIOL CHEM, V276, P7404, DOI 10.1074/jbc.M007352200; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KS, 1997, ANN NY ACAD SCI, V825, P95, DOI 10.1111/j.1749-6632.1997.tb48419.x; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakagawa K, 2001, J BIOCHEM-TOKYO, V130, P605, DOI 10.1093/oxfordjournals.jbchem.a003025; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NISHIMURA T, 1991, J BIOL CHEM, V266, P11842; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Santella L, 1998, CELL CALCIUM, V23, P123, DOI 10.1016/S0143-4160(98)90110-5; Sorimachi H, 2001, J BIOCHEM-TOKYO, V129, P653, DOI 10.1093/oxfordjournals.jbchem.a002903; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Strynadka NCJ, 1997, J MOL BIOL, V273, P238, DOI 10.1006/jmbi.1997.1257; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 1996, J BIOL CHEM, V271, P33161, DOI 10.1074/jbc.271.52.33161; Tompa P, 2001, BIOCHEM BIOPH RES CO, V280, P1333, DOI 10.1006/bbrc.2001.4279; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	55	253	259	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					649	660		10.1016/S0092-8674(02)00659-1	http://dx.doi.org/10.1016/S0092-8674(02)00659-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893336	Bronze			2022-12-24	WOS:000174314800009
J	Anderson, DM; Archer, D				Anderson, DM; Archer, D			Glacial-interglacial stability of ocean pH inferred from foraminifer dissolution rates	NATURE			English	Article							DEEP-SEA; CALCIUM-CARBONATE; ATMOSPHERIC CO2; PRESERVATION; WATER; CIRCULATION; SOLUBILITY; PRESSURE	The pH of the ocean is controlled by the chemistry of calcium carbonate. This system in turn plays a large role in regulating the CO2 concentration of the atmosphere on timescales of thousands of years and longer. Reconstructions of ocean pH and carbonate-ion concentration are therefore needed to understand the ocean's role in the global carbon cycle. During the Last Glacial Maximum (LGM), the pH of the whole ocean is thought to have been significantly more basic(1), as inferred from the isotopic composition of boron incorporated into calcium carbonate shells, which would partially explain the lower atmospheric CO2 concentration at that time. Here we reconstruct carbonate-ion concentration-and hence pH-of the glacial oceans, using the extent of calcium carbonate dissolution observed in foraminifer faunal assemblages as compiled in the extensive global CLIMAP data set(2). We observe decreased carbonate-ion concentrations in the glacial Atlantic Ocean, by roughly 20 mumol kg(-1), while little change occurred in the Indian and Pacific oceans relative to today. In the Pacific Ocean, a small (5 mumol kg(-1)) increase occurred below 3,000 m. This rearrangement of ocean pH may be due to changing ocean circulation from glacial to present times, but overall we see no evidence for a shift in the whole-ocean pH as previously inferred from boron isotopes(1).	NOAA, Paleoclimatol Program, Boulder, CO 80303 USA; Univ Colorado, Boulder, CO 80303 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Chicago	Anderson, DM (corresponding author), NOAA, Paleoclimatol Program, 325 Broadway, Boulder, CO 80303 USA.		anderson, david/E-6416-2011; Archer, David/K-7371-2012	Archer, David/0000-0002-4523-7912				ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; ARCHER D, 1994, NATURE, V367, P260, DOI 10.1038/367260a0; Archer DE, 1996, GLOBAL BIOGEOCHEM CY, V10, P159, DOI 10.1029/95GB03016; *CLIMAP PROJ MEMB, 1981, GEOLOGICAL SOC AM MA; Crowley T. J., 1985, CARBON CYCLE ATMOSPH, V32, P271; CURRY WB, 1985, CARBON CYCLE ATMOSPH, P285; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; EMERSON S, 1981, J MAR RES, V39, P139; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; HOWARD WR, 1994, PALEOCEANOGRAPHY, V9, P453, DOI 10.1029/93PA03524; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; MILLERO FJ, 1982, GEOCHIM COSMOCHIM AC, V46, P11, DOI 10.1016/0016-7037(82)90286-1; MIX AC, 1989, NATURE, V337, P541, DOI 10.1038/337541a0; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Oppo DW, 2000, PALEOCEANOGRAPHY, V15, P147, DOI 10.1029/1999PA000436; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; PETERSON LC, 1985, CARBON CYCLE ATMOSPH, P251; PRELL WL, 1985, TR025 DEP EN; Ravelo AC, 1990, PALEOCEANOGRAPHY, V5, P409, DOI 10.1029/PA005i003p00409; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Winguth A., 2000, INVERSE METHODS GLOB; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	24	77	83	4	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					70	73		10.1038/416070a	http://dx.doi.org/10.1038/416070a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882893				2022-12-24	WOS:000174211600039
J	Gewin, V				Gewin, V			Poor nations seek new biodiversity deal	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					949	949		10.1038/415949a	http://dx.doi.org/10.1038/415949a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875533	Bronze			2022-12-24	WOS:000174075000013
J	Hochedlinger, K; Jaenisch, R				Hochedlinger, K; Jaenisch, R			Monoclonal mice generated by nuclear transfer from mature B and T donor cells	NATURE			English	Article							EMBRYONIC STEM-CELLS; EXPRESSION; SELECTION; OOCYTES; CLONING; MOUSE	Cloning from somatic cells is inefficient, with most clones dying during gestation(1,2). Cloning from embryonic stem (ES) cells is much more effective, suggesting that the nucleus of an embryonic cell is easier to reprogram(3-7). It is thus possible that most surviving clones are, in fact, derived from the nuclei of rare somatic stem cells present in adult tissues rather than from the nuclei of differentiated cells as has been assumed(1,8,9). Here we report the generation of monoclonal mice by nuclear transfer from mature lymphocytes. In a modified two-step cloning procedure, we established ES cells from cloned blastocysts and injected them into tetraploid blastocysts to generate mice. In this approach, the embryo is derived from the ES cells and the extra-embryonic tissues from the tetraploid host(6). Animals cloned from a B-cell nucleus were viable and carried fully rearranged immunoglobulin alleles in all tissues. Similarly, a mouse cloned from a T-cell nucleus carried rearranged T-cell-receptor genes in all tissues. This is an unequivocal demonstration that a terminally differentiated cell can be reprogrammed to produce an adult cloned animal.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Vienna, A-1010 Vienna, Austria	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Vienna	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							BRIGGS ROBERT, 1957, J MORPH, V100, P269, DOI 10.1002/jmor.1051000204; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; DIBERARDINO MA, 1980, DIFFERENTIATION, V17, P17, DOI 10.1111/j.1432-0436.1980.tb01078.x; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Galli C, 1999, Cloning, V1, P161, DOI 10.1089/15204559950019924; GURDON JB, 1975, J EMBRYOL EXP MORPH, V34, P93; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Kouskoff V, 2001, LIFE SCI, V69, P1105, DOI 10.1016/S0024-3205(01)01219-X; Liu L, 2001, NAT BIOTECHNOL, V19, P406, DOI 10.1038/88052; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Novobrantseva TI, 1999, J EXP MED, V189, P75, DOI 10.1084/jem.189.1.75; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; WABL MR, 1975, SCIENCE, V190, P1310, DOI 10.1126/science.1198115; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X	30	392	464	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1035	1038		10.1038/nature718	http://dx.doi.org/10.1038/nature718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875572				2022-12-24	WOS:000174075000048
J	Crawford, LM				Crawford, LM			Treatment for liver tumors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Rockville, MD 20857 USA.								0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2203	2203		10.1001/jama.287.17.2203	http://dx.doi.org/10.1001/jama.287.17.2203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980508				2022-12-24	WOS:000175260600005
J	Barbour, V				Barbour, V			Science and myth	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Barbour, V (corresponding author), Lancet, London NW1 7BY, England.			Barbour, Virginia/0000-0002-2358-2440				2002, SCI CREATIONISM VIEW	1	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1364	1364		10.1016/S0140-6736(02)08391-5	http://dx.doi.org/10.1016/S0140-6736(02)08391-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978331				2022-12-24	WOS:000175076200006
J	Wallace, S				Wallace, S			A new technique for identifying risk for type 2 diabetes?	LANCET			English	News Item																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1411	1411		10.1016/S0140-6736(02)08396-4	http://dx.doi.org/10.1016/S0140-6736(02)08396-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978347				2022-12-24	WOS:000175076200022
J	Gaietta, G; Deerinck, TJ; Adams, SR; Bouwer, J; Tour, O; Laird, DW; Sosinsky, GE; Tsien, RY; Ellisman, MH				Gaietta, G; Deerinck, TJ; Adams, SR; Bouwer, J; Tour, O; Laird, DW; Sosinsky, GE; Tsien, RY; Ellisman, MH			Multicolor and electron microscopic imaging of connexin trafficking	SCIENCE			English	Article							HIGH-RESOLUTION; GAP-JUNCTIONS; PROTEIN; PHOTOOXIDATION; LIGHT; TRANSPORT; MECHANISM; COLOR; EOSIN	Recombinant proteins containing tetracysteine tags can be successively labeled in living cells with different colors of blarsenicat fluorophores so that older and younger protein molecules can be sharply distinguished by both fluorescence and electron microscopy. Here we used this approach to show that newly synthesized connexin43 was transported predominantly in 100- to 150-nanometer vesicles to the plasma membrane and incorporated at the periphery of existing gap junctions, whereas older connexins were removed from the center of the plaques into pleiomorphic vesicles of widely varying sizes. Selective imaging by correlated optical and electron microscopy of protein molecules of known ages wilt clarify fundamental processes of protein trafficking in situ.	Univ Calif San Diego, Dept Neurosci, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Western University (University of Western Ontario); Howard Hughes Medical Institute; University of California System; University of California San Diego	Ellisman, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, Natl Ctr Microscopy & Imaging Res, 0608,9500 Gilman Dr, La Jolla, CA 92093 USA.	mhellisman@ucsd.edu	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; 	NCRR NIH HHS [RR04050] Funding Source: Medline; NIDCD NIH HHS [DC03192] Funding Source: Medline; NIDDK NIH HHS [P01 DK54441] Funding Source: Medline; NIGMS NIH HHS [R01 GM065937] Funding Source: Medline; NINDS NIH HHS [NS27177, NS14718] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014718, R37NS027177, R01NS027177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003192] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMS SR, IN PRESS J AM CHEM S; Berthoud VM, 2000, METHODS, V20, P180, DOI 10.1006/meth.1999.0935; BEYER JG, 2000, GAP JUNCTIONS MOL BA, V49, P24; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Falk MM, 2001, MICROSC RES TECHNIQ, V52, P251, DOI 10.1002/1097-0029(20010201)52:3<251::AID-JEMT1011>3.0.CO;2-#; Falk MM, 2000, J CELL SCI, V113, P4109; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Griffin BA, 2000, METHOD ENZYMOL, V327, P565; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Jordan K, 2001, J CELL SCI, V114, P763; Laird DW, 1996, J BIOENERG BIOMEMBR, V28, P311, DOI 10.1007/BF02110107; Laird DW, 2001, MICROSC RES TECHNIQ, V52, P263, DOI 10.1002/1097-0029(20010201)52:3<263::AID-JEMT1012>3.0.CO;2-Q; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Marchant JS, 2001, NAT BIOTECHNOL, V19, P645, DOI 10.1038/90249; Martin PE, 2000, BIOCHEM J, V350, P943, DOI 10.1042/0264-6021:3500943; Martone ME, 2000, J HISTOTECHNOL, V23, P261, DOI 10.1179/his.2000.23.3.261; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Sosinsky G, 2000, CURR TOP MEMBR, V49, P1; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	28	732	769	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					503	507		10.1126/science.1068793	http://dx.doi.org/10.1126/science.1068793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964472				2022-12-24	WOS:000175179400038
J	Aidoo, M; Terlouw, DJ; Kolczak, M; McElroy, PD; ter Kuile, FO; Kariuki, S; Nahlen, BL; Lal, AA; Udhayakumar, V				Aidoo, M; Terlouw, DJ; Kolczak, M; McElroy, PD; ter Kuile, FO; Kariuki, S; Nahlen, BL; Lal, AA; Udhayakumar, V			Protective effects of the sickle cell gene against malaria morbidity and mortality	LANCET			English	Article							CHILDREN; COHORT	The high frequency of the sickle-cell haemoglobin (HbS) gene in malaria endemic regions is believed to be due to a heterozygote (HbAS) advantage against fatal malaria. Data to prospectively confirm the protection associated with HbAS against mortality are lacking. We show that HbAS provides significant protection against all-cause mortality, severe malarial anaemia, and high-density parasitaemia. This significant reduction in mortality was detected between the ages of 2 and 16 months, the highest risk period for severe malarial anaemia in this area. These data are important in understanding the role of malaria In the selection and maintenance of the sickle cell gene.	Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Kenya Govt Med Res Ctr, Vector Biol & Control Res Ctr, Kisumu, Kenya; Amsterdam Med Ctr, Dept Infect Dis Trop Med & AIDS, Amsterdam, Netherlands	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam	Aidoo, M (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA.		Kuile, Feiko ter/ABD-6681-2020; Nahlen, Bernard/AAH-2051-2021	Kuile, Feiko ter/0000-0003-3663-5617; Terlouw, Anja/0000-0001-5327-8995				ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; McElroy PD, 2001, AM J TROP MED HYG, V64, P18, DOI 10.4269/ajtmh.2001.64.18; McElroy PD, 1999, AM J TROP MED HYG, V61, P932, DOI 10.4269/ajtmh.1999.61.932	5	388	395	6	237	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 13	2002	359	9314					1311	1312		10.1016/S0140-6736(02)08273-9	http://dx.doi.org/10.1016/S0140-6736(02)08273-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965279				2022-12-24	WOS:000174989700016
J	Kim, MC; Panstruga, R; Elliott, C; Muller, J; Devoto, A; Yoon, HW; Park, HC; Cho, MJ; Schulze-Lefert, P				Kim, MC; Panstruga, R; Elliott, C; Muller, J; Devoto, A; Yoon, HW; Park, HC; Cho, MJ; Schulze-Lefert, P			Calmodulin interacts with MLO protein to regulate defence against mildew in barley	NATURE			English	Article							POWDERY MILDEW; ALPHA-SUBUNIT; OXIDATIVE BURST; ACTIVATION; RESISTANCE; CALCIUM; GENE; MUTATIONS; RESPONSES; INCREASE	In plants, defence against specific isolates of a pathogen can be triggered by the presence of a corresponding race-specific resistance gene(1), whereas resistance of a more broad-spectrum nature can result from recessive, presumably loss-of-regulatory-function, mutations(2). An example of the latter are mlo mutations in barley, which have been successful in agriculture for the control of powdery mildew fungus (Blumeria graminis f. sp. hordei; Bgh)(3). MLO protein resides in the plasma membrane, has seven transmembrane domains, and is the prototype of a sequence-diversified family unique to plants(4,5), reminiscent of the seven-transmembrane receptors in fungi and animals(5). In animals, these are known as G-protein-coupled receptors and exist in three main families, lacking sequence similarity, that are thought to be an example of molecular convergence(6). MLO seems to function independently of heterotrimeric G proteins. We have identified a domain in MLO that mediates a Ca2+-dependent interaction with calmodulin in vitro. Loss of calmodulin binding halves the ability of MLO to negatively regulate defence against powdery mildew in vivo. We propose a sensor role for MLO in the modulation of defence reactions.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci, BK21 Program, Chinju 660701, South Korea; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Max Planck Society; Gyeongsang National University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	mjcho@nongae.gsnu.ac.kr; schlef@mpiz-koeln.mpg.de	Schulze-Lefert, Paul/B-6707-2011; Bruening, Stefan/B-8505-2011; Schulze-Lefert, Paul/A-7746-2008; Panstruga, Ralph/F-3340-2011; Cho, Moo Je/F-1649-2010; Elliott, Candace/F-1860-2011	Panstruga, Ralph/0000-0002-3756-8957; Elliott, Candace/0000-0002-9174-0244				Aharon GS, 1998, FEBS LETT, V424, P17, DOI 10.1016/S0014-5793(98)00129-X; Apanovitch DM, 1998, J BIOL CHEM, V273, P28597, DOI 10.1074/jbc.273.44.28597; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; Jabs T, 1997, P NATL ACAD SCI USA, V94, P4800, DOI 10.1073/pnas.94.9.4800; Jarosch B, 1999, MOL PLANT MICROBE IN, V12, P508, DOI 10.1094/MPMI.1999.12.6.508; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kumar J, 2001, PHYTOPATHOLOGY, V91, P127, DOI 10.1094/PHYTO.2001.91.2.127; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; Lein W, 2001, BBA-MOL CELL BIOL L, V1530, P172, DOI 10.1016/S1388-1981(00)00182-7; Ma H, 2001, CURR BIOL, V11, pR869, DOI 10.1016/S0960-9822(01)00519-X; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Schweizer P, 2000, PLANT J, V24, P895, DOI 10.1046/j.1365-313x.2000.00941.x; Shirasu K, 1999, PLANT J, V17, P293, DOI 10.1046/j.1365-313X.1999.00376.x; Shirasu K, 2000, PLANT MOL BIOL, V44, P371, DOI 10.1023/A:1026552827716; SLEPAK VZ, 1993, J BIOL CHEM, V268, P21889; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; WINITZ S, 1994, METHOD ENZYMOL, V237, P321; Xu HX, 1998, PLANT CELL, V10, P585, DOI 10.1105/tpc.10.4.585	27	286	327	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					447	450		10.1038/416447a	http://dx.doi.org/10.1038/416447a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919636				2022-12-24	WOS:000174607800051
J	Medina, JF; Nores, WL; Mauk, MD				Medina, JF; Nores, WL; Mauk, MD			Inhibition of climbing fibres is a signal for the extinction of conditioned eyelid responses	NATURE			English	Article							INFERIOR OLIVE; CEREBELLUM; MECHANISMS; STIMULATION; PREDICTION; FLOCCULUS; BLOCKING; PATHWAY; NEURONS	A fundamental tenet of cerebellar learning theories asserts that climbing fibre afferents from the inferior olive provide a teaching signal that promotes the gradual adaptation of movements(1-3). Data from several forms of motor learning provide support for this tenet(4-8). In pavlovian eyelid conditioning, for example, where a tone is repeatedly paired with a reinforcing unconditioned stimulus like periorbital stimulation, the unconditioned stimulus promotes acquisition of conditioned eyelid responses by activating climbing fibres(9-12). Climbing fibre activity elicited by an unconditioned stimulus is inhibited during the expression of conditioned responses(9-11)-consistent with the inhibitory projection from the cerebellum to inferior olive(6,13). Here, we show that inhibition of climbing fibres serves as a teaching signal for extinction, where learning not to respond is signalled by presenting a tone without the unconditioned stimulus. We used reversible infusion of synaptic receptor antagonists to show that blocking inhibitory input to the climbing fibres prevents extinction of the conditioned response, whereas blocking excitatory input induces extinction. These results, combined with analysis of climbing fibre activity in a computer simulation of the cerebellar-olivary system(14-16), suggest that transient inhibition of climbing fibres below their background level is the signal that drives extinction.	Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System; University of Texas System	Mauk, MD (corresponding author), Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77030 USA.			Medina, Javier/0000-0001-8708-5315				ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; DEMER JL, 1985, BRAIN RES, V346, P22, DOI 10.1016/0006-8993(85)91090-X; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Hesslow G, 1996, EXP BRAIN RES, V110, P36; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; KEATING JG, 1995, J NEUROPHYSIOL, V73, P1329, DOI 10.1152/jn.1995.73.4.1329; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; Linden D J, 1993, Curr Opin Neurobiol, V3, P401, DOI 10.1016/0959-4388(93)90133-J; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thompson RF, 1998, NEUROBIOL LEARN MEM, V70, P150, DOI 10.1006/nlme.1998.3845; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6	25	186	188	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					330	333		10.1038/416330a	http://dx.doi.org/10.1038/416330a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907580				2022-12-24	WOS:000174482200045
J	Richardson, MI; Wilson, RJ				Richardson, MI; Wilson, RJ			A topographically forced asymmetry in the martian circulation and climate	NATURE			English	Article							MARS; SURFACE; SIMULATION; MODEL	Large seasonal and hemispheric asymmetries in the martian climate system are generally ascribed to variations in solar heating associated with orbital eccentricity(1). As the orbital elements slowly change (over a period of >10(4) years), characteristics of the climate such as dustiness and the vigour of atmospheric circulation are thought to vary(2-5), as should asymmetries in the climate (for example, the deposition of water ice at the northern versus the southern pole). Such orbitally driven climate change might be responsible for the observed layering in Mars' polar deposits by modulating deposition of dust and water ice(3,5,6). Most current theories assume that climate asymmetries completely reverse as the angular distance between equinox and perihelion changes by 180degrees. Here we describe a major climate mechanism that will not precess in this way. We show that Mars' global north-south elevation difference forces a dominant southern summer Hadley circulation that is independent of perihelion timing. The Hadley circulation, a tropical overturning cell responsible for trade winds, largely controls interhemispheric transport of water and the bulk dustiness of the atmosphere(7-11). The topography therefore imprints a strong handedness on climate, with water ice and the active formation of polar layered deposits more likely in the north.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	California Institute of Technology; National Oceanic Atmospheric Admin (NOAA) - USA	Richardson, MI (corresponding author), CALTECH, Div Geol & Planetary Sci, MC 150-21, Pasadena, CA 91125 USA.	mir@gps.caltech.edu		Richardson, Mark/0000-0001-9633-4141				Clancy RT, 1996, ICARUS, V122, P36, DOI 10.1006/icar.1996.0108; Fenton LK, 2001, J GEOPHYS RES-PLANET, V106, P32885, DOI 10.1029/2000JE001407; Forget F, 1999, J GEOPHYS RES-PLANET, V104, P24155, DOI 10.1029/1999JE001025; HABERLE RM, 1982, ICARUS, V50, P322, DOI 10.1016/0019-1035(82)90129-4; HABERLE RM, 1993, J GEOPHYS RES-PLANET, V98, P3093, DOI 10.1029/92JE02946; HABERLE RM, UNPUB ICARUS; Herkenhoff KE, 2000, ICARUS, V144, P243, DOI 10.1006/icar.1999.6287; Houben H, 1997, J GEOPHYS RES-PLANET, V102, P9069, DOI 10.1029/97JE00046; JAKOSKY BM, 1993, ICARUS, V102, P286, DOI 10.1006/icar.1993.1049; Kieffer H. H., 1992, MARS, P1180; LINDZEN RS, 1988, J ATMOS SCI, V45, P2416, DOI 10.1175/1520-0469(1988)045<2416:HCFZAH>2.0.CO;2; Molnar P, 1999, J GEOPHYS RES-ATMOS, V104, P24265, DOI 10.1029/1999JD900485; Murphy JR, 1995, J GEOPHYS RES-PLANET, V100, P26357, DOI 10.1029/95JE02984; MURRAY BC, 1973, SCIENCE, V180, P638, DOI 10.1126/science.180.4086.638; OORT AH, 1970, MON WEATHER REV, V98, P423, DOI 10.1175/1520-0493(1970)098<0423:OTAVOT>2.3.CO;2; Peixoto J. P., 1992, PHYS CLIMATE, DOI DOI 10.1063/1.2809772; RICHARDSON MI, IN PRESS J GEOPHYS R; RICHARDSON ML, UNPUB J GEOPHYS RES; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; Ward W. R., 1992, MARS, P298; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; Wilson RJ, 1996, J ATMOS SCI, V53, P1290, DOI 10.1175/1520-0469(1996)053<1290:CMSOTT>2.0.CO;2; Zurek R.W., 1992, MARS, P835	26	101	101	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					298	301		10.1038/416298a	http://dx.doi.org/10.1038/416298a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907570				2022-12-24	WOS:000174482200035
J	de Boer, J; Andressoo, JO; de Wit, J; Huijmans, J; Beems, RB; van Steeg, H; Weeda, G; van der Horst, GTJ; van Leeuwen, W; Themmen, APN; Meradji, M; Hoeijmakers, JHJ				de Boer, J; Andressoo, JO; de Wit, J; Huijmans, J; Beems, RB; van Steeg, H; Weeda, G; van der Horst, GTJ; van Leeuwen, W; Themmen, APN; Meradji, M; Hoeijmakers, JHJ			Premature aging in mice deficient in DNA repair and transcription	SCIENCE			English	Article							NUCLEOTIDE EXCISION-REPAIR; COCKAYNE-SYNDROME; COUPLED REPAIR; CANCER PREDISPOSITION; PREFERENTIAL REPAIR; INDUCED APOPTOSIS; WERNER-SYNDROME; RNA-POLYMERASE; ULTRAVIOLET-B; SYNDROME GENE	One of the factors postulated to drive the aging process is the accumulation of DNA damage. Here, we provide strong support for this hypothesis by describing studies of mice with a mutation in XPD, a gene encoding a DNA helicase that functions In both repair and transcription and that is mutated in the human disorder trichothiodystrophy (TTD). TTD mice were found to exhibit many symptoms of premature aging, Including osteoporosis and kyphosis, osteosclerosis, early greying, cachexia, infertility, and reduced life-span. TTD mice carrying an additional mutation in XPA, which enhances the DNA repair defect, showed a greatly accelerated aging phenotype, which correlated with an increased cellular sensitivity to oxidative DNA damage. We hypothesize that aging in TTD mice is caused by unrepaired DNA damage that compromises transcription, leading to functional inactivation of critical genes and enhanced apoptosis.	Erasmus Univ, Med Genet Ctr, Dept Cell Biol & Genet, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, MGC, Dept Clin Genet, CBG, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Expt Radiol, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Endocrinol & Reprod, NL-3000 DR Rotterdam, Netherlands; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; Sophia Childrens Univ Hosp, Dept Radiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Med Genet Ctr, Dept Cell Biol & Genet, Ctr Biomed Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Hoeijmakers, Jan/AAX-6972-2021; van der Horst, Gijsbertus TJ/E-3661-2015; Andressoo, Jaan-Olle/AAA-1216-2021	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Andressoo, Jaan-Olle/0000-0002-0271-3157; de Boer, Jan/0000-0001-9188-9324	NIA NIH HHS [AG 17242-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1761, UNPUB; Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Botta E, 1998, AM J HUM GENET, V63, P1036, DOI 10.1086/302063; Bremer HJ, 1981, DISTURBANCES AMINO A, P80; Brooks PJ, 2000, J BIOL CHEM, V275, P22355, DOI 10.1074/jbc.M002259200; Campisi J, 2000, IN VIVO, V14, P183; Citterio E, 2000, CELL, V101, P447, DOI 10.1016/S0092-8674(00)80854-5; Conforti G, 2000, ONCOGENE, V19, P2714, DOI 10.1038/sj.onc.1203583; Cooper PK, 1997, SCIENCE, V275, P990, DOI 10.1126/science.275.5302.990; Day BJ, 1996, TOXICOL APPL PHARM, V140, P94, DOI 10.1006/taap.1996.0201; de Boer J, 1999, CANCER RES, V59, P3489; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; DEVRIES A, 1995, NATURE, V377, P169, DOI 10.1038/377169a0; Dolle MET, 1997, NAT GENET, V17, P431, DOI 10.1038/ng1297-431; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; GOSDEN RG, 1983, BIOL REPROD, V28, P255, DOI 10.1095/biolreprod28.2.255; Goyns MH, 2000, MECH AGEING DEV, V114, P69, DOI 10.1016/S0047-6374(00)00095-6; Hanawalt PC, 2000, NATURE, V405, P415, DOI 10.1038/35013197; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; ITIN PH, 1990, J AM ACAD DERMATOL, V22, P705, DOI 10.1016/0190-9622(90)70096-Z; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; KUMAR P, 1988, BRIT J DERMATOL, V118, P397, DOI 10.1111/j.1365-2133.1988.tb02434.x; Kuraoka I, 2000, P NATL ACAD SCI USA, V97, P3832, DOI 10.1073/pnas.070471597; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; LEADON SA, 1993, P NATL ACAD SCI USA, V90, P10499, DOI 10.1073/pnas.90.22.10499; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Ljungman M, 1996, ONCOGENE, V13, P823; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Martin GM, 1996, NAT GENET, V13, P25, DOI 10.1038/ng0596-25; MCCUAIG C, 1993, J AM ACAD DERMATOL, V28, P820, DOI 10.1016/0190-9622(93)70109-7; MURAKAMI M, 1995, MUTAT RES-DNA REPAIR, V336, P215, DOI 10.1016/0921-8777(94)00059-F; NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0; Nehlin JO, 2000, ANN NY ACAD SCI, V908, P167; Oshima J, 2000, IN VIVO, V14, P165; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; STEFANINI M, 1986, HUM GENET, V74, P107, DOI 10.1007/BF00282072; Toelle SP, 2001, EUR J PEDIATR, V160, P728, DOI 10.1007/s004310100845; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; VERMEULEN W, 1994, AM J HUM GENET, V54, P191; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775; YU EE, 1996, SCIENCE, V272, P258	54	414	427	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1276	1279		10.1126/science.1070174	http://dx.doi.org/10.1126/science.1070174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	11950998				2022-12-24	WOS:000175713000043
J	Gifford, AL; Cunningham, WE; Heslin, KC; Andersen, RM; Nakazono, T; Lieu, DK; Shapiro, MF; Bozzette, SA				Gifford, AL; Cunningham, WE; Heslin, KC; Andersen, RM; Nakazono, T; Lieu, DK; Shapiro, MF; Bozzette, SA		HIV Cost Services Utilization Stud	Participation in research and access to experimental treatments by HIV-infected patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL PROBABILITY SAMPLES; LOW-PREVALENCE DISEASES; AIDS CLINICAL-TRIALS; SERVICES UTILIZATION; AFRICAN-AMERICANS; INFORMED CONSENT; UNITED-STATES; HEALTH-CARE; DRUG; COST	Background: Although there is concern that minority groups and women are underrepresented in research involving patients with human immunodeficiency virus (HIV) infection, the available data are inconclusive. Methods: We used nationally representative data from the HIV Cost and Services Utilization Study to determine the characteristics of the participants and nonparticipants in trials of medications for HIV infection and whether or not patients had access to experimental treatments. A probability sample of 2864 persons, representing all 231,400 adults with known HIV infection who are cared for in the contiguous United States, were interviewed on three occasions between 1996 and 1998. They were asked about participation in clinical research studies of medications and past receipt of experimental medications for HIV. Results: We estimate that 14 percent of adults receiving care for HIV infection participated in a medication trial or study; 24 percent had received experimental medications; and 8 percent had tried and failed to obtain experimental treatments. According to multivariate models, non-Hispanic blacks and Hispanics were less likely to be participating in trials than non-Hispanic whites (odds ratio for participation among non-Hispanic blacks, 0.50 [95 percent confidence interval, 0.28 to 0.91]; odds ratio among Hispanics, 0.58 [95 percent confidence interval, 0.37 to 0.93]) and to have received experimental medications (odds ratios, 0.41 [95 percent confidence interval, 0.32 to 0.54] and 0.56 [95 percent confidence interval, 0.41 to 0.78], respectively). Patients who were cared for in private health maintenance organizations were less likely to participate in trials than those with fee-for-service insurance (odds ratio, 0.43 [95 percent confidence interval, 0.21 to 0.88]). Women were not underrepresented in research trials and had a similar likelihood of receiving experimental treatments. Conclusions: Among patients with HIV infection, participation in research trials and access to experimental treatment is influenced by race or ethnic group and type of health insurance.	Vet Affairs San Diego Healthcare Syst, Ctr Res Patient Oriented Care & Qual Enhancement, San Diego, CA 92161 USA; Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; RAND Hlth, Santa Monica, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; RAND Corporation	Gifford, AL (corresponding author), Vet Affairs San Diego Healthcare Syst, Ctr Res Patient Oriented Care & Qual Enhancement, 3350 La Jolla Village Dr 111N-1, San Diego, CA 92161 USA.		Young, Alexander/A-1523-2009; Gifford, Allen L/D-9329-2016	Young, Alexander/0000-0002-9367-9213; Gifford, Allen L/0000-0001-6442-1128	AHRQ HHS [HS08578] Funding Source: Medline; NIAID NIH HHS [AI027670, AI038858] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038858, U01AI027670] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1993, KEYST NAT POL DIAL E; BELTANGADY M, 1993, BIOMETRIC B, V10, P7; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Brown J. A., 2002, HCSUS PATIENT QUESTI; CARTER SK, 1995, J ACQ IMMUN DEF SYND, V10, pS107; *CDCP, 1999, HIV AIDS SURVEILLANC, V11, P16; *CDCP, 2000, HIV AIDS SURV REP US, V12, P40; *CDCP, 2000, HIV AIDS SURVEILLANC, V12, P1; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; DIAZ T, 1995, J ACQ IMMUN DEF SYND, V10, P562; ELSADR W, 1992, JAMA-J AM MED ASSOC, V267, P954, DOI 10.1001/jama.267.7.954; Falloon J, 2000, AIDS, V14, pS209; FAUCI AS, 1989, ACAD MED, V64, P115, DOI 10.1097/00001888-198903000-00002; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Fureman I, 1997, AIDS EDUC PREV, V9, P330; Gesensway D, 2001, ANN INTERN MED, V135, P935, DOI 10.7326/0003-4819-135-10-200111200-00032; Gorkin L, 1996, CONTROL CLIN TRIALS, V17, P46, DOI 10.1016/0197-2456(95)00089-5; Hader SL, 2001, JAMA-J AM MED ASSOC, V285, P1186, DOI 10.1001/jama.285.9.1186; Hankins C, 1998, CAN MED ASSOC J, V159, P1359; Jacobson MA, 1996, J ACQ IMMUN DEF SYND, V11, P45, DOI 10.1097/00042560-199601010-00006; Johnson JA, 1997, J PHARM SCI, V86, P1328, DOI 10.1021/js9702168; KALTON G, 1983, COMPENSATING MISSING; Kao AC, 1998, JAMA-J AM MED ASSOC, V280, P1708, DOI 10.1001/jama.280.19.1708; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Klonoff EA, 1999, PREV MED, V28, P451, DOI 10.1006/pmed.1999.0463; KRANTZ DS, 1980, J PERS SOC PSYCHOL, V39, P977, DOI 10.1037/0022-3514.39.5.977; Longford NT, 1999, STAT MED, V18, P1467, DOI 10.1002/(SICI)1097-0258(19990630)18:12<1467::AID-SIM149>3.0.CO;2-H; MAHLER HIM, 1991, HEALTH PSYCHOL, V10, P399, DOI 10.1037/0278-6133.10.6.399; *NAT I ALL INF DIS, 2000, DIV AIDS RES MAT DEM; *NIH, 1994, OUTR NOTCB NIH GUID; NIH, 1994, FED REGISTER, V59, P14508; PIKE IM, 1994, CLIN INFECT DIS, V19, P1071, DOI 10.1093/clinids/19.6.1071; PIKE IM, 1993, CLIN INFECT DIS, V16, pS63, DOI 10.1093/clinids/16.Supplement_1.S63; Robinson D, 1996, J CLIN PSYCHOPHARM, V16, P170, DOI 10.1097/00004714-199604000-00009; Rossi P. H., 1983, HDB SURVEY RES; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Shapiro MF, 1999, HEALTH SERV RES, V34, P951; Shapiro MF, 1999, JAMA-J AM MED ASSOC, V281, P2305, DOI 10.1001/jama.281.24.2305; SMITH MD, 1991, JAMA-J AM MED ASSOC, V266, P2750, DOI 10.1001/jama.266.19.2750; Stone VE, 1997, J GEN INTERN MED, V12, P150, DOI 10.1046/j.1525-1497.1997.012003150.x; Stone VE, 1998, J ACQ IMMUN DEF SYND, V19, P245, DOI 10.1097/00042560-199811010-00006; SVENSSON CK, 1989, JAMA-J AM MED ASSOC, V261, P263, DOI 10.1001/jama.261.2.263; Tejeda HA, 1996, J NATL CANCER I, V88, P812, DOI 10.1093/jnci/88.12.812; TINDALL B, 1994, PATIENT EDUC COUNS, V24, P261, DOI 10.1016/0738-3991(94)90069-8; *US BUR CENS, 2002, ANN POPULATION ESTIM; Wizemann TM, 2001, EXPLORING BIOL CONTR, P173, DOI [10.17226/10028, DOI 10.17226/10028]	47	192	192	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 02	2002	346	18					1373	1382		10.1056/NEJMsa011565	http://dx.doi.org/10.1056/NEJMsa011565			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	546MZ	11986412	Bronze			2022-12-24	WOS:000175279000007
J	Pereira, MA; Jacobs, DR; Van Horn, L; Slattery, ML; Kartashov, AI; Ludwig, DS				Pereira, MA; Jacobs, DR; Van Horn, L; Slattery, ML; Kartashov, AI; Ludwig, DS			Dairy consumption, obesity, and the insulin resistance syndrome in young adults - The CARDIA study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; DEPENDENT DIABETES-MELLITUS; HIGH-CARBOHYDRATE DIETS; CARDIOVASCULAR-DISEASE; SYNDROME-X; POSTMENOPAUSAL WOMEN; NUTRITIONAL FACTORS; HDL-CHOLESTEROL; BLOOD-PRESSURE; UNITED-STATES	Context Components of the insulin resistance syndrome (IRS), including obesity, glucose intolerance, hypertension, and dyslipidemia, are major risk factors for type 2 diabetes and heart disease. Although diet has been postulated to influence IRS, the independent effects of dairy consumption on development of this syndrome have not been investigated. Objective To examine associations between dairy intake and incidence of IRS, adjusting for confounding lifestyle and dietary factors, Design The Coronary Artery Risk Development in Young Adults (CARDIA) study, a population-based prospective study. S etting and Participants General community sample from 4 US metropolitan areas of 3157 black and white adults aged 18 to 30 years who were followed up from 1985-1986 to 1995-1996. Main Outcome Measure Ten-year cumulative incidence of IRS and its association with dairy consumption, measured by diet history interview. Results Dairy consumption was inversely associated with the incidence of all IRS components among individuals who were overweight (body mass index greater than or equal to25 kg/m(2)) at baseline but not among leaner individuals (body mass index <25 kg/m(2)). The adjusted odds of developing IRS (2 or more components) were 72% lower (odds ratio, 0.28; 95% confidence interval, 0.14-0.58) among overweight individuals in the highest (&GE;35 times per week, 24/102 individuals) compared with the lowest (<10 times per week, 85/190 individuals) category of dairy consumption. Each daily occasion of dairy consumption was associated with a 21% lower odds of IRS (odds ratio, 0.79; 95% confidence interval, 0.70-0.88). These associations were similar for blacks and whites and for men and women. Other dietary factors, including macronutrients and micronutrients, did not explain the association between dairy intake and IRS. Conclusions Dietary patterns characterized by increased dairy consumption have a strong inverse association with IRS among overweight adults and may reduce risk of type 2 diabetes and cardiovascular disease.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Clin Res Program, Boston, MA 02115 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Oslo, Inst Nutr Res, Oslo, Norway; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA; Univ Utah, Sch Med, Salt Lake City, UT USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; Northwestern University; Utah System of Higher Education; University of Utah	Pereira, MA (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544; Jacobs, David/0000-0002-7232-0543; Pereira, Mark/0000-0002-6704-5276	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048048, N01HC048047, N01HC048049, N01HC048050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002440] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095] Funding Source: Medline; NIDDK NIH HHS [K08DK02440] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbasi F, 2000, AM J CARDIOL, V85, P45, DOI 10.1016/S0002-9149(99)00604-9; Abbott RD, 1996, STROKE, V27, P813, DOI 10.1161/01.STR.27.5.813; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arslanian S, 1996, J CLIN ENDOCR METAB, V81, P1058, DOI 10.1210/jc.81.3.1058; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; BAO WH, 1994, ARCH INTERN MED, V154, P1842; Barr SI, 2000, J AM DIET ASSOC, V100, P810, DOI 10.1016/S0002-8223(00)00236-4; Black HR, 1997, ARCH INTERN MED, V157, P2413; BLADES B, 1995, AM J CLIN NUTR, V62, P996, DOI 10.1093/ajcn/62.5.996; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; Cavadini C, 2000, ARCH DIS CHILD, V83, P18, DOI 10.1136/adc.83.1.18; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Frost G, 1999, LANCET, V353, P1045, DOI 10.1016/S0140-6736(98)07164-5; FUKAGAWA NK, 1990, AM J CLIN NUTR, V52, P524, DOI 10.1093/ajcn/52.3.524; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Iso H, 1999, STROKE, V30, P1772, DOI 10.1161/01.STR.30.9.1772; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jahns L, 2001, J PEDIATR-US, V138, P493, DOI 10.1067/mpd.2001.112162; Jeppesen J, 1997, ARTERIOSCL THROM VAS, V17, P1114, DOI 10.1161/01.ATV.17.6.1114; Jeppesen J, 1997, AM J CLIN NUTR, V65, P1027, DOI 10.1093/ajcn/65.4.1027; Kleinbaum D, 1988, APPL REGRESSION ANAL; KOROTKOV NS, 1956, CLASSICS ARTERIAL HY, P127; Krauss RM, 2000, CIRCULATION, V102, P2284; Lin PY, 2000, PEDIATR INFECT DIS J, V19, P754, DOI 10.1097/00006454-200008000-00016; Liu Kiang, 1994, Ethnicity and Disease, V4, P15; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; Ludwig DS, 2001, JAMA-J AM MED ASSOC, V286, P1427, DOI 10.1001/jama.286.12.1427; MA J, 1995, J CLIN EPIDEMIOL, V48, P927, DOI 10.1016/0895-4356(94)00200-A; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Mennen LI, 1999, THROMB RES, V94, P381, DOI 10.1016/S0049-3848(99)00027-4; Mennen LI, 2000, NUTR RES, V20, P335, DOI 10.1016/S0271-5317(00)00127-5; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; NELSON GJ, 1995, LIPIDS, V30, P969, DOI 10.1007/BF02536280; Ness AR, 2001, J EPIDEMIOL COMMUN H, V55, P379, DOI 10.1136/jech.55.6.379; POPKIN BM, 1992, AM J CLIN NUTR, V55, P823, DOI 10.1093/ajcn/55.4.823; Reaven G M, 2000, Curr Atheroscler Rep, V2, P503, DOI 10.1007/s11883-000-0050-z; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; *U MINN NCC NUTR C, 1984, NCC NUTR DAT TAP 10; *U MINN NCC NUTR C, 1991, NCC NUTR DAT TAP 20; WARRICK GR, 1982, CLIN CHEM, V28, P1379; WITTEMAN JCM, 1989, CIRCULATION, V80, P1320, DOI 10.1161/01.CIR.80.5.1320; Young-Hyman D, 2001, DIABETES CARE, V24, P1359, DOI 10.2337/diacare.24.8.1359; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; 1997, MMWR MORB MORTAL WKL, V46, P1014	56	806	839	1	58	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2002	287	16					2081	2089		10.1001/jama.287.16.2081	http://dx.doi.org/10.1001/jama.287.16.2081			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZK	11966382	Bronze			2022-12-24	WOS:000175075700025
J	Gonzalez, F; Delahodde, A; Kodadek, T; Johnston, SA				Gonzalez, F; Delahodde, A; Kodadek, T; Johnston, SA			Recruitment of a 19S proteasome subcomplex to an activated promoter	SCIENCE			English	Article							UBIQUITIN-MEDIATED PROTEOLYSIS; REGULATORY PARTICLE; BINDING PROTEIN; 26S PROTEASOME; GAL4; COMPLEX; TRANSCRIPTION; DEGRADATION; RECOGNITION; SEQUENCES	The 19S proteasome regulatory particle plays a critical role in cellular proteolysis. However, recent reports have demonstrated that 19S proteins play a nonproteolytic role in nucleotide excision repair and transcription elongation. We show by chromatin immunoprecipitation assays that proteins comprising the 19S complex are recruited to the GAL1-10 promoter by the Gal4 transactivator upon induction with galactose. This recruited complex does not contain proteins from the 20S proteolytic particle and includes a subset of the 19S proteins. This subset is also specifically retained from an extract by the Gal4 activation domain. These data indicate that in vivo, the base of the 19S complex functions independently of the larger complex and plays a direct, nonproteolytic role in RNA polymerase II transcription.	Univ Texas, SW Med Ctr, Ctr Biomed Invent, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Johnston, SA (corresponding author), Univ Texas, SW Med Ctr, Ctr Biomed Invent, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.			Kodadek, Thomas/0000-0003-1930-4795				Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CARRINGTON JC, 1987, NUCLEIC ACIDS RES, V15, P10066, DOI 10.1093/nar/15.23.10066; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F., UNPUB; JOHNSTON SA, 1982, P NATL ACAD SCI-BIOL, V79, P6971, DOI 10.1073/pnas.79.22.6971; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Saeki Y, 2000, BIOCHEM BIOPH RES CO, V273, P509, DOI 10.1006/bbrc.2000.2980; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94	25	283	290	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					548	550		10.1126/science.1069490	http://dx.doi.org/10.1126/science.1069490			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964484				2022-12-24	WOS:000175179400051
J	Tran, H; Brunet, A; Grenier, JM; Datta, SR; Fornace, AJ; DiStefano, PS; Chiang, LW; Greenberg, ME				Tran, H; Brunet, A; Grenier, JM; Datta, SR; Fornace, AJ; DiStefano, PS; Chiang, LW; Greenberg, ME			DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; DAMAGING AGENTS; GROWTH ARREST; LIFE-SPAN; EXPRESSION; INDUCTION; RESISTANCE; SIGNALS; DAF-16; FAMILY	The signaling pathway from phosphoinositide 3-kinase to the protein kinase Akt controls organismal life-span in invertebrates and cell survival and proliferation in mammals by inhibiting the activity of members of the FOXO family of transcription factors. We show that mammalian FOXO3a also functions at the G(2) to M checkpoint in the cell cycle and triggers the repair of damaged DNA. By gene array analysis, FOXO3a was found to modulate the expression of several genes that regulate the cellular response to stress at the G(2)-M checkpoint. The growth arrest and DNA damage response gene Gadd45a appeared to be a direct target of FOXO3a that mediates part of FOXO3a's effects on DNA repair. These findings indicate that in mammals FOXO3a regulates the resistance of cells to stress by inducing DNA repair and thereby may also affect organismal life-span.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; NCI, NIH, Bethesda, MD 20892 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA.		Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X	NICHD NIH HHS [P01-HD24926, NIHP30-HD18655] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024926] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BRUNET A, UNPUB; Chiang LW, 2001, P NATL ACAD SCI USA, V98, P2814, DOI 10.1073/pnas.051630598; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; KIRKWOOD TBL, 1989, MUTAT RES, V219, P1, DOI 10.1016/0921-8734(89)90035-0; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Smith ML, 1996, ONCOGENE, V13, P2255; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	677	704	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					530	534		10.1126/science.1068712	http://dx.doi.org/10.1126/science.1068712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964479				2022-12-24	WOS:000175179400046
J	Choi, HK; Hernan, MA; Seeger, JD; Robins, JM; Wolfe, F				Choi, HK; Hernan, MA; Seeger, JD; Robins, JM; Wolfe, F			Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study	LANCET			English	Article							LONG-TERM MORTALITY; CLINICAL-TRIALS; ATHEROSCLEROSIS; ASSOCIATION; DISEASE	Background Methotrexate is the most frequent choice of disease-modifying antirheumatic therapy for rheumatoid arthritis. Although results of studies have shown the efficacy of such drugs, including methotrexate, on rheumatoid arthritis morbidity measures, their effect on mortality in patients with the disease remains unknown. Our aim was to prospectively assess the effect on mortality of methotrexate in a cohort of patients with rheumatoid arthritis. Methods Our cohort included 1240 patients with rheumatoid arthritis seen at the Wichita Arthritis Center, an outpatient rheumatology facility. Patients' details were entered into a computerised database at the time of their first clinic visit. We also obtained and recorded demographic, clinical, laboratory, and self-reported data at each follow-up visit (average interval 3.5 months). We estimated the mortality hazard ratio of methotrexate with a marginal structural Cox proportional hazards model. Findings 191 individuals died during follow-up. Patients who began treatment with methotrexate (n=588) had worse prognostic factors for mortality. After adjustment for this confounding by indication, the mortality hazard ratio for methotrexate use compared with no methotrexate use was 0.4 (95% Cl 0.2-0.8). Other conventional disease-modifying antirheumatic drugs did not have a significant effect on mortality. The hazard ratio of methotrexate use for cardiovascular death was 0.3 (0.2-0.7), whereas that for non-cardiovascular deaths was 0.6 (0.2-1.2). Interpretation Our data indicate that methotrexate may provide a substantial survival benefit, largely by reducing cardiovascular mortality. This survival benefit of methotrexate would set a standard against which new disease-modifying antirheumatic drugs could be compared.	Univ Kansas, Sch Med, Arthrit Res Ctr Fdn, Natl Data Bank Rheumat Dis, Wichita, KS 67214 USA; Harvard Univ, Sch Publ Hlth, Harvard Sch Med,Massachusetts Gen Hosp, Dept Med,Arthrit Unit, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Igenix Epidemiol, Newton, MA USA	National Data Bank for Rheumatic Diseases; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wolfe, F (corresponding author), Univ Kansas, Sch Med, Arthrit Res Ctr Fdn, Natl Data Bank Rheumat Dis, 1035 N Emporia,Suite 230, Wichita, KS 67214 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032457, K08AI049392] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49392, R01-AI32457] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; ERHARDT CC, 1989, ANN RHEUM DIS, V48, P7, DOI 10.1136/ard.48.1.7; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Firestein GS, 1999, J CLIN INVEST, V103, P3, DOI 10.1172/JCI5929; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Kremer JM, 1998, RHEUM DIS CLIN N AM, V24, P651, DOI 10.1016/S0889-857X(05)70032-6; Kremer JM, 1997, ARTHRITIS RHEUM, V40, P984, DOI 10.1002/art.1780400533; Landewe RBM, 2000, LANCET, V355, P1616, DOI 10.1016/S0140-6736(00)02222-4; LEIGH JP, 1991, J RHEUMATOL, V18, P1307; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; MEENAN RF, 1980, ARTHRITIS RHEUM, V23, P146, DOI 10.1002/art.1780230203; MUTRU O, 1989, CARDIOLOGY, V76, P71, DOI 10.1159/000174474; Oppenheimer-Marks N, 1998, SPRINGER SEMIN IMMUN, V20, P95, DOI 10.1007/BF00832001; Pasceri V, 1999, CIRCULATION, V100, P2124, DOI 10.1161/01.CIR.100.21.2124; PINCUS T, 1994, ANN INTERN MED, V120, P26, DOI 10.7326/0003-4819-120-1-199401010-00005; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1234, DOI 10.1002/1529-0131(200106)44:6<1234::AID-ART213>3.0.CO;2-R; PRIOR P, 1984, BRIT J RHEUMATOL, V23, P92; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Symmons DPM, 1998, J RHEUMATOL, V25, P1072; THOMPSON PW, 1991, J RHEUMATOL, V18, P661; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; WallbergJonsson S, 1997, J RHEUMATOL, V24, P445; Ward MM, 2001, ARTHRITIS RHEUM-US, V44, P1467, DOI 10.1002/1529-0131(200106)44:6<1467::AID-ART243>3.0.CO;2-6; WEINBLATT ME, 1990, ARTHRITIS RHEUM, V33, P330, DOI 10.1002/art.1780330305; WOLFE F, 1991, J RHEUMATOL, V18, P672; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	30	872	909	1	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 6	2002	359	9313					1173	1177		10.1016/S0140-6736(02)08213-2	http://dx.doi.org/10.1016/S0140-6736(02)08213-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AB	11955534				2022-12-24	WOS:000174846300006
J	Trotter, CL; Edmunds, WJ				Trotter, CL; Edmunds, WJ			Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales	BRITISH MEDICAL JOURNAL			English	Article							DISEASE	Objectives To assess die cost effectiveness of a meningococcal serogroup C conjugate vaccination campaign in 0-17 year olds. Design Cost effectiveness analysis from the perspective of die healthcare provider. Setting England and Wales. Main outcome measure Cost per life year saved. Results In 1998-9, immediately before the introduction of meningococcal C vaccination, die burden of serogroup C disease was considerable, with an estimated 1137 cases in people aged 0-17 years and at least 72 deaths. The vaccination campaign is estimated to have cost between pound126m ($180m, E207m) and pound241 m ($343m, E395m), depending on the price of the vaccine. Under base case assumptions die cost per life year saved from the vaccination campaign is estimated to be pound6259 ($8919, E10 264). School based vaccination was more cost effective than general practice based vaccination because of lower delivery Costs. Immunisation of infants aged under I year was the least cost effective component of the campaign because, although this maximises the life years gained, the three dose schedule required is more expensive than other methods of delivery. Estimates of the cost per life year saved were sensitive to assumptions on the future incidence of disease and the case fatality ratio. Conclusions Meningococcal C vaccination is likely to be more cost effective in all age groups when the incidence of disease is high. It is also more cost effective when given to children aged 1-4 (by general practitioners) and to children and young people aged 5-17 years at school than when administered to infants under 12 months of age or youths aged 16-17 years who are not at school.	Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Div Immunizat, London NW9 5EQ, England; City Univ London, Dept Econ, London EC1V 0HB, England	Public Health England; City University London	Trotter, CL (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Div Immunizat, London NW9 5EQ, England.		Trotter, Caroline L/H-5077-2013	Trotter, Caroline/0000-0003-4000-2708				BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; Barker R M, 1999, Commun Dis Public Health, V2, P168; Barquet N, 1999, ARCH INTERN MED, V159, P2329, DOI 10.1001/archinte.159.19.2329; BEGG N, 1995, MENINGOCOCCAL DIS, P285; *BRIT MED ASS ROYA, 2000, BRIT NAT FORM, V39; *CDSC, 2001, COMMUN DIS REP WEEKL, V11; *CDSC, 1997, CDR, V7, P393; *CDSC, 1999, COMMUN DIS REP CDR W, V9, P297; *CDSC, 1996, COMMOUN DIS REP CDR, V6, P311; *CHIEF MED OFF CHI, 1999, INTRO IMM GROUP C ME; *DEP HLTH, 1995, POL APPR HLTH; Erickson L, 1998, CLIN INFECT DIS, V26, P1159, DOI 10.1086/520303; Gold MR, 1996, COST EFFECTIVENESS H; Irwin DJ, 1997, J PUBLIC HEALTH MED, V19, P162, DOI 10.1093/oxfordjournals.pubmed.a024604; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Netten A.P., 2000, UNIT COSTS HLTH SOCI; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; RAMSAY ME, 1997, EUROSURVEILLANCE, V2, P1; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; SALISBURY DM, 1999, IMMINISATION INFECT; SALISLBURY DM, 1999, IMMUNISATION INFECT; Schildkamp RL, 1996, SCAND J INFECT DIS, V28, P47, DOI 10.3109/00365549609027149; Stuart J M, 1997, Commun Dis Rep CDR Rev, V7, pR3; STUARTJM, 1997, COMMUN DIS REP CDR R, V7, pR3; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774; 2000, CURRENT PROBLEMS PHA, V26, P14	27	53	54	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2002	324	7341					809	812B		10.1136/bmj.324.7341.809	http://dx.doi.org/10.1136/bmj.324.7341.809			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540ZG	11934772	Green Submitted, Green Accepted, Bronze, Green Published			2022-12-24	WOS:000174960300013
J	Li, WM; Scott, AP; Siefkes, MJ; Yan, HG; Liu, Q; Yun, SS; Gage, DA				Li, WM; Scott, AP; Siefkes, MJ; Yan, HG; Liu, Q; Yun, SS; Gage, DA			Bile acid secreted by male sea lamprey that acts as a sex pheromone	SCIENCE			English	Article							PETROMYZON-MARINUS; SPAWNING BEHAVIOR; STEROIDS; GOLDFISH; PROSTAGLANDINS; MATURATION; EXCRETION; RELEASE; LAKES	We show that reproductively mature mate sea lampreys release a bile acid that acts as a potent sex pheromone, inducing preference and searching behavior in ovulated female lampreys. The secreted bile acid 7alpha,12alpha,24-trihydroxy-5alpha-cholan-3-one 24-sulfate was released in much higher amounts relative to known vertebrate steroid pheromones and may be secreted through the gills. Hence, the mate of this fish species signals both its reproductive status and location to females by secreting a pheromone that can act over long distances.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Ctr Environm Fisheries & Aquaculture Sci, Weymouth DT4 8UB, Dorset, England	Michigan State University; Michigan State University; Centre for Environment Fisheries & Aquaculture Science	Li, WM (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	Liweim@msu.edu	Li, Weiming/D-9615-2013; li, weiming/E-4652-2011	Li, Weiming/0000-0001-5437-1518; Scott, Alexander Pickering/0000-0002-5540-1317; Yun, Sang Seon/0000-0001-6723-0482				APPLEGATE VC, 1950, 55 US DEP INT FISH W; Barnes S., 1988, BILE ACIDS, V4, P65; Bjerselius R, 2000, CAN J FISH AQUAT SCI, V57, P557, DOI 10.1139/cjfas-57-3-557; Bjerselius R, 1995, P 5 INT S REPR PHYS, P271; CARDE RT, 1995, ANNU REV ENTOMOL, V40, P559, DOI 10.1146/annurev.en.40.010195.003015; DULKA JG, 1987, NATURE, V325, P251, DOI 10.1038/325251a0; Fontaine PR, 1938, B SCO OCEANOGR FR, V97, P1681; HASLEWOOD GA, 1969, BIOCHEM J, V114, P179, DOI 10.1042/bj1140179; KELSO JRM, 2000, N AM J FISH MANAGE, V20, P132; Li, 1994, THESIS U MINNESOTA; LI W, 1995, J GEN PHYSIOL, V105, P567; MANION PJ, 1980, CAN J FISH AQUAT SCI, V37, P1635, DOI 10.1139/f80-211; MAREN TH, 1968, COMP BIOCHEM PHYSIOL, V26, P853, DOI 10.1016/0010-406X(68)90005-4; MASON RT, 1989, SCIENCE, V245, P290, DOI 10.1126/science.2749261; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; PICKERING AD, 1977, CELL TISSUE RES, V180, P1; Rasmussen LEL, 1996, NATURE, V379, P684, DOI 10.1038/379684a0; SCOTT AP, 1994, GEN COMP ENDOCR, V96, P309, DOI 10.1006/gcen.1994.1186; Scott AP, 1997, GEN COMP ENDOCR, V105, P62, DOI 10.1006/gcen.1996.6798; SMITH BR, 1980, CAN J FISH AQUAT SCI, V37, P1780, DOI 10.1139/f80-222; Sorensen Peter W., 1999, P15; SORENSEN PW, 1988, BIOL REPROD, V39, P1039, DOI 10.1095/biolreprod39.5.1039; SVEINSSON T, 1995, ENVIRON BIOL FISH, V42, P253, DOI 10.1007/BF00004919; TEETER J, 1980, CAN J FISH AQUAT SCI, V37, P2123, DOI 10.1139/f80-254; Vermeirssen ELM, 1996, GEN COMP ENDOCR, V101, P180, DOI 10.1006/gcen.1996.0020; YAMAMOTO K, 1986, HEPATOLOGY, V6, P54, DOI 10.1002/hep.1840060111; Yambe H, 1999, J FISH BIOL, V55, P158, DOI 10.1111/j.1095-8649.1999.tb00665.x	27	303	314	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2002	296	5565					138	141		10.1126/science.1067797	http://dx.doi.org/10.1126/science.1067797			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935026				2022-12-24	WOS:000174858800047
J	Barouch, LA; Harrison, RW; Skaf, MW; Rosas, GO; Cappola, TP; Kobeissi, ZA; Hobai, IA; Lemmon, CA; Burnett, AL; O'Rourke, B; Rodriguez, ER; Huang, PL; Lima, JAC; Berkowitz, DE; Hare, JM				Barouch, LA; Harrison, RW; Skaf, MW; Rosas, GO; Cappola, TP; Kobeissi, ZA; Hobai, IA; Lemmon, CA; Burnett, AL; O'Rourke, B; Rodriguez, ER; Huang, PL; Lima, JAC; Berkowitz, DE; Hare, JM			Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms	NATURE			English	Article							CARDIAC-SPECIFIC OVEREXPRESSION; CALCIUM-RELEASE CHANNEL; FUNCTION IN-VIVO; SKELETAL-MUSCLE; INHIBITION; POTENTIATION; HYPERTROPHY; ACTIVATION; RECEPTOR; FAILURE	Subcellular localization of nitric oxide (NO) synthases with effector molecules is an important regulatory mechanism for NO signalling(1). In the heart, NO inhibits L-type Ca2+ channels 2 but stimulates sarcoplasmic reticulum (SR) Ca2+ release(3-5), leading to variable effects on myocardial contractility. Here we show that spatial confinement of specific NO synthase isoforms regulates this process. Endothelial NO synthase (NOS3) localizes to caveolae(6-8), where compartmentalization with beta-adrenergic receptors and L-type Ca2+ channels(9) allows NO to inhibit beta-adrenergic-induced inotropy(8,10). Neuronal NO synthase (NOS1), however, is targeted to cardiac SR11. NO stimulation of SR Ca2+ release via the ryanodine receptor (RyR) in vitro(3,4) suggests that NOS1 has an opposite, facilitative effect on contractility. We demonstrate that NOS1-deficient mice have suppressed inotropic response, whereas NOS3-deficient mice have enhanced contractility, owing to corresponding changes in SR Ca2+ release. Both NOS1(-/-) and NOS3(-/-) mice develop age-related hypertrophy, although only NOS3(-/-) mice are hypertensive. NOS1/3(-/-) double knockout mice have suppressed beta-adrenergic responses and an additive phenotype of marked ventricular remodelling. Thus, NOS1 and NOS3 mediate independent, and in some cases opposite, effects on cardiac structure and function.	Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Biomed Engn, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; Johns Hopkins Med Inst, Dept Anaesthesiol & Crit Care Med, Baltimore, MD 21287 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital	Hare, JM (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21287 USA.		Lemmon, Christopher/GPP-1470-2022	O'Rourke, Brian/0000-0002-5548-4853; Lemmon, Christopher/0000-0002-9049-6366; Hobai, Ion/0000-0002-3729-0422; Huang, Paul/0000-0002-5436-8658				Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; CARCIACARDENA G, 1997, J BIOL CHEM, V272, P25437; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Gyurko R, 2000, AM J PHYSIOL-HEART C, V278, pH971, DOI 10.1152/ajpheart.2000.278.3.H971; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Hare JM, 1999, NAT MED, V5, P1241, DOI 10.1038/15193; Hare JM, 1998, CIRCULATION, V97, P161, DOI 10.1161/01.CIR.97.2.161; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; MERY PF, 1993, J BIOL CHEM, V268, P26286; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Schmidt AG, 2000, J MOL CELL CARDIOL, V32, P1735, DOI 10.1006/jmcc.2000.1209; Schwencke C, 1999, MOL ENDOCRINOL, V13, P1061, DOI 10.1210/me.13.7.1061; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; TOPOL EJ, 1985, NEW ENGL J MED, V312, P277, DOI 10.1056/NEJM198501313120504; Varghese P, 2000, J CLIN INVEST, V106, P697, DOI 10.1172/JCI9323; VERDECCHIA P, 1995, J AM COLL CARDIOL, V25, P871, DOI 10.1016/0735-1097(94)00424-O; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang XP, 1999, HYPERTENSION, V34, P24, DOI 10.1161/01.HYP.34.1.24; Zhai J, 2000, J BIOL CHEM, V275, P10538, DOI 10.1074/jbc.275.14.10538	29	629	654	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					337	340		10.1038/416337a	http://dx.doi.org/10.1038/416337a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907582				2022-12-24	WOS:000174482200047
J	Graham, HK				Graham, HK			Painful hip dislocation in cerebral palsy	LANCET			English	Editorial Material									Royal Childrens Hosp, Dept Orthopaed Surg, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Graham, HK (corresponding author), Royal Childrens Hosp, Dept Orthopaed Surg, Parkville, Vic 3052, Australia.		Graham, Kerr/AAK-4383-2020					BAX M C, 1964, Dev Med Child Neurol, V6, P295; Bjornson KF, 2001, EUR J NEUROL, V8, P183, DOI 10.1046/j.1468-1331.2001.00051.x; Brown J. K., 1989, SEM ORTHOP, V4, P236; COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P379; DOBSON F, IN PRESS J BONE JOIN; Goldstein Murray, 2001, Developmental Medicine and Child Neurology, V43, P563, DOI 10.1017/S0012162201001025; Graham HK, 2001, EUR J NEUROL, V8, P30, DOI 10.1046/j.1468-1331.2001.00036.x; Little WJ., 1861, T OBSTET SOC LOND, P293; MACKEITH RC, 1958, LANCET, V1, P61; Owers KL, 2001, J BONE JOINT SURG BR, V83B, P1161, DOI 10.1302/0301-620X.83B8.11266; RANG M, 2000, STORY ORTHOPAEDICS, P229; Scrutton D, 2001, DEV MED CHILD NEUROL, V43, P586, DOI 10.1017/S0012162201001086; ZIV I, 1984, DEV MED CHILD NEUROL, V26, P94	13	38	41	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 16	2002	359	9310					907	908		10.1016/S0140-6736(02)08015-7	http://dx.doi.org/10.1016/S0140-6736(02)08015-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531AE	11918905				2022-12-24	WOS:000174391700005
J	Liu, MS; Deora, R; Doulatov, SR; Gingery, M; Eiserling, FA; Preston, A; Maskell, DJ; Simons, RW; Cotter, PA; Parkhill, J; Miller, JF				Liu, MS; Deora, R; Doulatov, SR; Gingery, M; Eiserling, FA; Preston, A; Maskell, DJ; Simons, RW; Cotter, PA; Parkhill, J; Miller, JF			Reverse transcriptase-mediated tropism switching in Bordetella bacteriophage	SCIENCE			English	Article							VIRULENCE; REGULON; PROTEIN	Host-pathogen interactions are often driven by mechanisms that promote genetic variability. We have identified a group of temperate bacteriophages that generate diversity in a gene, designated mtd (major tropism determinant), which specifies tropism for receptor molecules on host Bordetella species. Tropism switching is the result of a template-dependent, reverse transcriptase-mediated process that introduces nucleotide substitutions at defined locations within mtd. This cassette-based mechanism is capable of providing a vast repertoire of potential ligand-receptor interactions.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Cambridge, Dept Clin Vet Med, Ctr Vet Sci, Cambridge CB3 0ES, England; Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Sanger Ctr, Cambridge, England	University of California System; University of California Los Angeles; University of Cambridge; University of California System; University of California Santa Barbara; Wellcome Trust Sanger Institute	Miller, JF (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	jfmiller@ucla.edu	Parkhill, Julian/G-4703-2011	Parkhill, Julian/0000-0002-7069-5958; Preston, Andrew/0000-0002-1489-280X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038417, R01AI043986] Funding Source: NIH RePORTER; NIAID NIH HHS [AI38417, AI43986] Funding Source: Medline; NIGMS NIH HHS [GM-08042] Funding Source: Medline; PHS HHS [T32A107323] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Cotter P.A., 2001, PRINCIPLES BACTERIAL, P620; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; DOI H, 1991, P NATL ACAD SCI USA, V88, P9282, DOI 10.1073/pnas.88.20.9282; DOULATOV S, UNPUB; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; Martinez-Abarca F, 2000, MOL MICROBIOL, V38, P917, DOI 10.1046/j.1365-2958.2000.02197.x; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; SINGER MF, 1995, J BIOL CHEM, V270, P24623, DOI 10.1074/jbc.270.42.24623; Stockbauer KE, 2001, MOL MICROBIOL, V39, P65, DOI 10.1046/j.1365-2958.2001.02191.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x	15	168	183	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2091	2094		10.1126/science.1067467	http://dx.doi.org/10.1126/science.1067467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896279				2022-12-24	WOS:000174450500054
J	Stocker, H; Andjelkovic, M; Oldham, S; Laffargue, M; Wymann, MP; Hemmings, BA; Hafen, E				Stocker, H; Andjelkovic, M; Oldham, S; Laffargue, M; Wymann, MP; Hemmings, BA; Hafen, E			Living with lethal PIP3 levels: Viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB	SCIENCE			English	Article							TUMOR-SUPPRESSOR PTEN; PROTEIN-KINASE-B; SIGNALING PATHWAY; CAENORHABDITIS-ELEGANS; CELL-SIZE; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; DROSOPHILA; ACTIVATION; PHOSPHATASE; HOMOLOG	The phosphoinositide phosphatase PTEN is mutated in many human cancers. Although the role of PTEN has been studied extensively, the relative contributions of its numerous potential downstream effectors to deregulated growth and tumorigenesis remain uncertain. We provide genetic evidence in Drosophila melanogaster for the paramount importance of the protein kinase Akt [also called protein kinase B (PKB)] in mediating the effects of increased phosphatidylinositol 3,4,5-trisphosphate (PIP3) concentrations that are caused by the loss of PTEN function. A mutation in the pleckstrin homology (PH) domain of Akt that reduces its affinity for PIP3 sufficed to rescue the lethality of flies devoid of PTEN activity. Thus, Akt appears to be the only critical target activated by increased PIP3 concentrations in Drosophila.	Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Fribourg, CH-1700 Fribourg, Switzerland	University of Zurich; Friedrich Miescher Institute for Biomedical Research; University of Fribourg	Hafen, E (corresponding author), Univ Zurich, Inst Zool, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Danyushevsky, Leonid V/C-5346-2013; Tyson, Gene W/C-6558-2013; Yaxley, Greg M/A-1167-2008; Kamenetsky, Vadim/K-2200-2019; Krivolutskaya, Nadezhda A./C-3554-2015; Wymann, Matthias P/C-3227-2008; Sobolev, Alexander/E-6367-2010; Thelen, Michael P/G-2032-2014; Chung, Sun-Lin/F-5559-2010; Stoecker, Horst/F-8382-2012; Laffargue, Muriel/AAE-7849-2021; Kerr, Andrew C/A-1206-2008; Kamenetsky, Vadim S/B-1019-2008	Danyushevsky, Leonid V/0000-0003-4050-6850; Tyson, Gene W/0000-0001-8559-9427; Yaxley, Greg M/0000-0003-0445-8812; Krivolutskaya, Nadezhda A./0000-0002-5709-7785; Wymann, Matthias P/0000-0003-3349-4281; Sobolev, Alexander/0000-0002-1997-2032; Thelen, Michael P/0000-0002-2479-5480; Chung, Sun-Lin/0000-0002-5362-4496; Stoecker, Horst/0000-0002-3282-3664; Kerr, Andrew C/0000-0001-5569-4730; Kamenetsky, Vadim S/0000-0002-2734-8790; Laffargue, Muriel/0000-0003-1833-639X				Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; ANDJELKOVIC M, 1995, J BIOL CHEM, V270, P4066, DOI 10.1074/jbc.270.8.4066; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; ANDJELKOVIC M, UNPUB; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Coffer PJ, 1998, BIOCHEM J, V335, P1; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Huang H, 1999, DEVELOPMENT, V126, P5365; Lawlor MA, 2001, J CELL SCI, V114, P2903; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; OLDHAM S, UNPUB; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rouault JP, 1999, CURR BIOL, V9, P329, DOI 10.1016/S0960-9822(99)80143-2; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Spradling AC, 1999, GENETICS, V153, P135; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STOCKER H, UNPUB; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293	35	158	164	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2088	2091		10.1126/science. 1068094	http://dx.doi.org/10.1126/science. 1068094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11872800	Green Submitted			2022-12-24	WOS:000174450500053
J	Nielsen, PR; Nietlispach, D; Mott, HR; Callaghan, J; Bannister, A; Kouzarides, T; Murzin, AG; Murzina, NV; Laue, ED				Nielsen, PR; Nietlispach, D; Mott, HR; Callaghan, J; Bannister, A; Kouzarides, T; Murzin, AG; Murzina, NV; Laue, ED			Structure of the HP1 chromodomain bound to histone H3 methylated at lysine 9	NATURE			English	Article							NMR-SPECTROSCOPY; MACROMOLECULAR STRUCTURE; INTERMOLECULAR NOES; DOMAIN; PROGRAM	Specific modifications to histones are essential epigenetic markers(1)-heritable changes in gene expression that do not affect the DNA sequence. Methylation of lysine 9 in histone H3 is recognized by heterochromatin protein 1 (HP1), which directs the binding of other proteins to control chromatin structure and gene expression(2-4). Here we show that HP1 uses an induced-fit mechanism for recognition of this modification, as revealed by the structure of its chromodomain bound to a histone H3 peptide dimethylated at Nzeta of lysine 9. The binding pocket for the N-methyl groups is provided by three aromatic side chains, Tyr 21, Trp 42 and Phe 45, which reside in two regions that become ordered on binding of the peptide. The side chain of Lys 9 is almost fully extended and surrounded by residues that are conserved in many other chromodomains. The QTAR peptide sequence preceding Lys 9 makes most of the additional interactions with the chromodomain, with HP1 residues Val 23, Leu 40, Trp 42, Leu 58 and Cys 60 appearing to be a major determinant of specificity by binding the key buried Ala 7. These findings predict which other chromodomains will bind methylated proteins and suggest a motif that they recognize.	Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, Cambridge CB2 1GA, England; Univ Cambridge, Wellcome Canc Res UK, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Murzina, NV (corresponding author), Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, 80 Tennis Court Rd, Cambridge CB2 1GA, England.		Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436; Nietlispach, Daniel/0000-0003-4364-9291; Laue, Ernest/0000-0002-7476-4148				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Horita DA, 2001, J MOL BIOL, V307, P861, DOI 10.1006/jmbi.2001.4515; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; MEANS GE, 1968, BIOCHEMISTRY-US, V7, P2192, DOI 10.1021/bi00846a023; Melacini G, 2000, J AM CHEM SOC, V122, P9735, DOI 10.1021/ja0015996; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	27	479	492	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					103	107		10.1038/nature722	http://dx.doi.org/10.1038/nature722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882902				2022-12-24	WOS:000174211600048
J	Brundtland, GH				Brundtland, GH			Smallpox revisited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Brundtland, GH (corresponding author), WHO, CH-1211 Geneva, Switzerland.							2002, JAMA-J AM MED ASSOC, V287, P706	1	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1104	1104		10.1001/jama.287.9.1104	http://dx.doi.org/10.1001/jama.287.9.1104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879094				2022-12-24	WOS:000174186000008
J	Loscertales, IG; Barrero, A; Guerrero, I; Cortijo, R; Marquez, M; Ganan-Calvo, AM				Loscertales, IG; Barrero, A; Guerrero, I; Cortijo, R; Marquez, M; Ganan-Calvo, AM			Micro/nano encapsutation via electrified coaxial liquid jets	SCIENCE			English	Article							ELECTROSPRAY-IONIZATION; SELECTIVE WITHDRAWAL; DRUG-DELIVERY; TAYLOR CONES; MICROENCAPSULATION; MICROPARTICLES; NANOPARTICLES; MICROSPHERE; GENERATION; PEPTIDES	We report a method to generate steady coaxial jets of immiscible liquids with diameters in the range of micrometer/nanometer size. This compound jet is generated by the action of electro-hydrodynamic (EHD) forces with a diameter that ranges from tens of nanometers to tens of micrometers. The eventual jet breakup results in an aerosol of monodisperse compound droplets with the outer liquid surrounding or encapsulating the inner one. Following this approach, we have produced monodisperse capsules with diameters varying between 10 and 0.15 micrometers, depending on the running parameters.	Univ Malaga, Escuela Tecn Super Ingn Ind, Malaga 29013, Spain; Univ Seville, Escuela Super Ingn, Seville 41092, Spain; Kraft Foods R&D, Nanotechnol Lab, Glenview, IL 60025 USA; Los Alamos Natl Lab, Chem Sci & Technol Div, Los Alamos, NM 87545 USA	Universidad de Malaga; University of Sevilla; Kraft Heinz; United States Department of Energy (DOE); Los Alamos National Laboratory	Loscertales, IG (corresponding author), Univ Malaga, Escuela Tecn Super Ingn Ind, Plaza El Ejido,S-N, Malaga 29013, Spain.	loscertales@uma.es; barrero@eurus2.us.es	Ganan-Calvo, Alfonso M./F-1169-2013	Ganan-Calvo, Alfonso M./0000-0002-7552-6184; Loscertales, Ignacio G./0000-0001-7634-8757				Aboubakar M, 1999, INT J PHARM, V183, P63, DOI 10.1016/S0378-5173(99)00045-9; Barrero A, 1998, PHYS REV E, V58, P7309, DOI 10.1103/PhysRevE.58.7309; Bartus RT, 1998, SCIENCE, V281, P1161, DOI 10.1126/science.281.5380.1161; BLAKE S, 1986, J VOLCANOL GEOTH RES, V27, P153, DOI 10.1016/0377-0273(86)90084-3; Burlak G, 2001, OPT COMMUN, V187, P91, DOI 10.1016/S0030-4018(00)01105-6; CIACH T, 2001, J AEROSOL SCI, V32, pS1001; CLOUPEAU M, 1994, J AEROSOL SCI, V25, P1021, DOI 10.1016/0021-8502(94)90199-6; Cohen I, 2001, SCIENCE, V292, P265, DOI 10.1126/science.1059175; DELAMORA JF, 1994, J FLUID MECH, V260, P155, DOI 10.1017/S0022112094003472; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Gamero-Castano M, 2000, ANAL CHIM ACTA, V406, P67, DOI 10.1016/S0003-2670(99)00596-6; Ganan-Calvo AM, 1999, J AEROSOL SCI, V30, P117, DOI 10.1016/S0021-8502(98)00029-9; Ganan-Calvo AM, 1997, J AEROSOL SCI, V28, P249, DOI 10.1016/S0021-8502(96)00433-8; Ganan-Calvo AM, 1998, PHYS REV LETT, V80, P285, DOI 10.1103/PhysRevLett.80.285; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Hardas N, 2000, LEBENSM-WISS TECHNOL, V33, P506, DOI 10.1006/fstl.2000.0696; Hildebrand GE, 2000, INT J PHARM, V196, P173, DOI 10.1016/S0378-5173(99)00415-9; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Jung T, 2000, EUR J PHARM BIOPHARM, V50, P147, DOI 10.1016/S0939-6411(00)00084-9; Langer R, 1998, NATURE, V392, P5; Lee SJ, 2000, LEBENSM-WISS TECHNOL, V33, P80, DOI 10.1006/fstl.1999.0619; Lee YH, 2001, POLYMER, V42, P8277, DOI 10.1016/S0032-3861(01)00342-1; LISTER JR, 1989, J FLUID MECH, V198, P231, DOI 10.1017/S002211208900011X; LOSCERTALES IG, 1995, J CHEM PHYS, V103, P5041, DOI 10.1063/1.470591; LOSCERTALES IG, 1993, SYNTHESIS CHARACTERI, P115; LOSCERTALES IG, 2001, Patent No. 200100231; Mathiowitz E, 1997, NATURE, V386, P410, DOI 10.1038/386410a0; Mathiowitz E., 1999, ENCY CONTROLLED DRUG; Reithmeier H, 2001, INT J PHARM, V218, P133, DOI 10.1016/S0378-5173(01)00620-2; ROSELLLLOMPART J, 1994, J AEROSOL SCI, V25, P1093, DOI 10.1016/0021-8502(94)90204-6; RosellLlompart J, 1996, J AEROSOL SCI, V27, P695, DOI 10.1016/0021-8502(96)00016-X; WOLTERS GHJ, 1992, J APPL BIOMATER, V3, P281, DOI 10.1002/jab.770030407; YOSII H, 2001, INN FOOD SCI EM TECH, V2, P55	33	819	978	9	490	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1695	1698		10.1126/science.1067595	http://dx.doi.org/10.1126/science.1067595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872835				2022-12-24	WOS:000174212900041
J	Winthrop, KL; Abrams, M; Yakrus, M; Schwartz, I; Ely, J; Gillies, D; Vugia, DJ				Winthrop, KL; Abrams, M; Yakrus, M; Schwartz, I; Ely, J; Gillies, D; Vugia, DJ			An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRINKING-WATER SAMPLES; NONTUBERCULOUS MYCOBACTERIA; NOSOCOMIAL OUTBREAKS; ELECTROPHORESIS; PATTERNS; DNA	Background: In September 2000, a physician in northern California described four patients with persistent, culture-negative boils on the lower extremities. The patients had received pedicures at the same nail salon. We identified and investigated an outbreak of Mycobacterium fortuitum furunculosis among customers of this nail salon. Methods: Patients were defined as salon customers with persistent skin infections below the knee. A case-control study was conducted that included the first 48 patients identified, and 56 unaffected friends and family members who had had a pedicure at the same salon served as controls. Selected M. fortuitum isolates, cultured from patients and the salon environment, were compared by pulsed-field gel electrophoresis. Results: We identified 110 customers of the nail salon who had furunculosis. Cultures from 34 were positive for rapidly growing mycobacteria (32 M. fortuitum and 2 unidentified). Most of the affected patients had more than 1 boil (median, 2; range, 1 to 37). All patients and controls had had whirlpool footbaths. Shaving the legs with a razor before pedicure was a risk factor for infection (70 percent of patients vs. 31 percent of controls; adjusted odds ratio, 4.8; 95 percent confidence interval, 2.1 to 11.1). Cultures from all 10 footbaths at the salon yielded M. fortuitum. The M. fortuitum isolates from three footbaths and 14 patients were indistinguishable by electrophoresis. Conclusions: We identified a large outbreak of rapidly growing mycobacterial infections among persons who had had footbaths and pedicures at one nail salon. Physicians should suspect this cause in patients with persistent furunculosis after exposure to whirlpool footbaths.	Calif Dept Hlth Serv, Div Communicable Dis Control, Berkeley, CA 94704 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ctr Dis Control & Prevent, Div AIDS Sexually Transmitted Dis & TB Lab Res, TB Mycobacterial Branch, Atlanta, GA USA; Santa Cruz Cty Dept Hlth, Santa Cruz, CA USA	California Department of Health Care Services; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Winthrop, KL (corresponding author), Calif Dept Hlth Serv, Div Communicable Dis Control, Rm 708,2151 Berkeley Way, Berkeley, CA 94704 USA.							AUBUCHON C, 1986, J BONE JOINT SURG AM, V68A, P766, DOI 10.2106/00004623-198668050-00021; BROWN BA, 2000, MANDELL DOUGLAS BENN, V2, P2630; Butler WR, 2001, CLIN MICROBIOL REV, V14, P704, DOI 10.1128/CMR.14.4.704-726.2001; CARSON LA, 1978, APPL ENVIRON MICROB, V36, P839, DOI 10.1128/AEM.36.6.839-846.1978; COLLINS CH, 1984, J APPL BACTERIOL, V57, P193, DOI 10.1111/j.1365-2672.1984.tb01384.x; Covert TC, 1999, APPL ENVIRON MICROB, V65, P2492; Da Costa Cruz JC, 1938, ACTA MED RIO DE JANE, V1, P297; FISCHEDER R, 1991, ZBL HYG UMWELTMED, V192, P154; HECTOR JSR, 1992, J CLIN MICROBIOL, V30, P1250, DOI 10.1128/JCM.30.5.1250-1255.1992; JONES RJ, 1965, CAN J MICROBIOL, V11, P127, DOI 10.1139/m65-018; Kent P. T., 1985, PUBLIC HLTH MYCOBACT, P31; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P57; Lee W J, 2000, J Dermatol, V27, P264; Nolte N.F., 1999, MANUAL CLIN MICROBIO, P399; SCHULZEROBBECKE R, 1991, J MICROBIOL METH, V14, P177, DOI 10.1016/0167-7012(91)90021-H; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; WALLACE RJ, 1983, REV INFECT DIS, V5, P657; Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453; WOLINSKY E, 1968, AM REV RESPIR DIS, V97, P1032; YAKRUS MA, 1992, J CLIN MICROBIOL, V30, P1474, DOI 10.1128/JCM.30.6.1474-1478.1992; 2001, NAILS MAGAZINE, V18, P33	21	143	148	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 02	2002	346	18					1366	1371		10.1056/NEJMoa012643	http://dx.doi.org/10.1056/NEJMoa012643			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546MZ	11986410				2022-12-24	WOS:000175279000004
J	Ferguson, TB; Coombs, LP; Peterson, ED				Ferguson, TB; Coombs, LP; Peterson, ED		Soc Thoracic Surg Natl Adult Cardi	Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY BYPASS; STS NATIONAL DATABASE; ELDERLY-PATIENTS; HEART-FAILURE; OFF-PUMP; THERAPY; RISK; PREDICTORS; INTERVENTION	Context beta-Blockade therapy has recently been shown to convey a survival benefit in preoperative noncardiac vascular surgical settings. The effect of preoperative beta-blocker therapy on coronary artery bypass graft surgery (CABG) outcomes has not been assessed. Objectives To examine patterns of use of preoperative beta-blockers in patients undergoing isolated CABG and to determine whether use of beta-blockers is associated with lower operative mortality and morbidity. Design, Setting, and Patients Observational study using the Society of Thoracic Surgeons National Adult Cardiac Surgery Database (NCD) to assess beta-blocker use and outcomes among 629877 patients undergoing isolated CABG between 1996 and 1999 at 497 US and Canadian sites. Main Outcome Measure influence of beta-blockers on operative mortality, examined using both direct risk adjustment and a matched-pairs analysis based on propensity for preoperative beta-blocker therapy. Results From 1996 to 1999, overall use of preoperative beta-blockers increased from 50% to 60% in the NCD (P<.001 for time trend). Major predictors of use included recent myocardial infarction; hypertension; worse angina; younger age; better left ventricular systolic function; and absence of congestive heart failure, chronic lung disease, and diabetes. Patients who received beta-blockers had lower mortality than those who did not (unadjusted 30-day mortality, 2.8% vs 3.4%; odds ratio [OR], 0.80; 95% confidence interval [CI], 0.78-0.82). Preoperative beta-blocker use remained associated with slightly lower mortality after adjusting for patient risk and center effects using both risk adjustment (OR, 0.94; 95% CI, 0.91-0.97) and treatment propensity matching (OR, 0.97; 95% CI, 0.93-1.00). Procedural complications also tended to be lower among treated patients. This treatment advantage was seen among the majority of patient subgroups, including women; elderly persons; and those with chronic lung disease, diabetes, or moderately depressed ventricular function. Among patients with a left ventricular ejection fraction of less than 30%, however, preoperative beta-blocker therapy was associated with a trend toward a higher mortality rate (OR, 1.13; 95% CI, 0,96-1,33; P=.23). Conclusions In this large North American observational analysis, preoperative beta-blocker therapy was associated with a small but consistent survival benefit for patients undergoing CABG, except among patients with a left ventricular ejection fraction of less than 30%. This analysis further suggests that preoperative beta-blocker therapy may be a useful process measure for CABG quality improvement assessment.	Soc Thorac Surgeons, Natl Database Comm, Chicago, IL USA; Duke Clin Res Inst, Durham, NC USA	Society of Thoracic Surgeons; Duke University	Ferguson, TB (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Surg, 1542 Tulane Ave,7th Floor, New Orleans, LA 70012 USA.	tbruceferg732@pol.net	Peterson, Eric David/ABF-5033-2021		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010403] Funding Source: NIH RePORTER; AHRQ HHS [R01-HS 10403] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*1 INT STUD INF SU, 1988, LANCET, V1, P921; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; Chen J, 2000, ARCH INTERN MED, V160, P947, DOI 10.1001/archinte.160.7.947; Farrell MH, 2002, JAMA-J AM MED ASSOC, V287, P890, DOI 10.1001/jama.287.7.890; FENNINGER M, 2001, ANESTHESIOLOGY, V95, pA250; Ferguson TB, 2002, ANN THORAC SURG, V73, P480, DOI 10.1016/S0003-4975(01)03339-2; Ferguson TB, 2001, ANN THORAC SURG, V72, P697, DOI 10.1016/S0003-4975(01)02955-1; Ferguson TB, 2000, ANN THORAC SURG, V69, P680, DOI 10.1016/S0003-4975(99)01538-6; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; Gheorghiade Mihai, 2001, American Journal of Medicine, V110, p68S; GIBBONS RJ, IN PRESS J AM COLL C; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GRIGORE AM, 1999, ANESTH ANALG, V88; Grover FL, 2000, ANN THORAC SURG, V70, P1143, DOI 10.1016/S0003-4975(00)02168-8; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Peterson ED, 2000, J AM COLL CARDIOL, V36, P2174, DOI 10.1016/S0735-1097(00)01022-6; Plomondon ME, 2001, ANN THORAC SURG, V72, P114, DOI 10.1016/S0003-4975(01)02670-4; Radford MJ, 2001, JAMA-J AM MED ASSOC, V286, P1228, DOI 10.1001/jama.286.10.1228; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Sharma SK, 2000, CIRCULATION, V102, P166, DOI 10.1161/01.CIR.102.2.166; SHROYER AL, IN PRESS ANN THORAC; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; SWEDBERG K, 1979, LANCET, V1, P1374; van Dijk D, 2001, CIRCULATION, V104, P1761, DOI 10.1161/hc4001.097036; Vetrovec GW, 2000, CIRCULATION, V102, P147, DOI 10.1161/01.CIR.102.2.147; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; Weightman WM, 1999, ANESTH ANALG, V88, P286, DOI 10.1097/00000539-199902000-00011; Whorlow SL, 2000, AM J CARDIOL, V86, P886, DOI 10.1016/S0002-9149(00)01114-0; 2001, N ENGL J MED, V334, P1659	37	190	200	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2221	2227		10.1001/jama.287.17.2221	http://dx.doi.org/10.1001/jama.287.17.2221			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980522	Bronze			2022-12-24	WOS:000175260600022
J	Ben-Shahar, Y; Robichon, A; Sokolowski, MB; Robinson, GE				Ben-Shahar, Y; Robichon, A; Sokolowski, MB; Robinson, GE			Influence of gene action across different time scales on behavior	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; DIVISION-OF-LABOR; NITRIC-OXIDE; DROSOPHILA; BRAIN	Genes can affect natural behavioral variation in different ways. Allelic variation causes alternative behavioral phenotypes, whereas changes in gene expression can influence the initiation of behavior at different ages. We show that the age-related transition by honey bees from hive work to foraging is associated with an increase in the expression of the foraging (for) gene, which encodes a guanosine 3',5'-monophosphate (cGMP)-dependent protein kinase (PKG). cGMP treatment elevated PKG activity and caused foraging behavior. Previous research showed that allelic differences in PKG expression result in two Drosophila foraging variants. The same gene can thus exert different types of influence on a behavior.	Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA; Univ Bourgogne, CNRS, CESG, F-21000 Dijon, France; Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; University of Toronto; University Toronto Mississauga	Robinson, GE (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.			Sokolowski, Marla/0000-0002-7462-8007; robichon, alain/0000-0003-1075-9646				Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; Bloch G, 2001, J BIOL RHYTHM, V16, P444, DOI 10.1177/074873001129002123; COX DR, 1972, J R STAT SOC B, V34, P187; DELLAFERA MA, 1981, PHYSIOL BEHAV, V26, P799, DOI 10.1016/0031-9384(81)90102-5; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; FRANCIS SH, 1988, MOL PHARMACOL, V34, P506; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; MORLEY JE, 1995, PHARMACOL BIOCHEM BE, V50, P369, DOI 10.1016/0091-3057(94)00276-O; Moroz LL, 2000, J COMP NEUROL, V427, P274; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Page RE, 2002, GENETICS, V160, P375; ROBINSON GE, IN PRESS AM NAT; SEELEY TD, 1997, WISDOM HIVE; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; WILSON EO, 1975, SOCIOBIOLOGY; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691	21	368	390	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					741	744		10.1126/science.1069911	http://dx.doi.org/10.1126/science.1069911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976457				2022-12-24	WOS:000175281700057
J	Boss, PK; Thomas, MR				Boss, PK; Thomas, MR			Association of dwarfism and floral induction with a grape 'green revolution' mutation	NATURE			English	Article							GIBBERELLIN RESPONSES; ARABIDOPSIS-THALIANA; GENES; EXPRESSION; PATHWAY; MUTANT	The transition from vegetative to reproductive growth is an essential process in the life cycle of plants. Plant floral induction pathways respond to both environmental and endogenous cues and much has been learnt about these genetic pathways by studying mutants of Arabidopsis(1,2). Gibberellins (GAs) are plant growth regulators important in many aspects of plant growth and in Arabidopsis they promote flowering(3-5). Here we provide genetic evidence that GAs inhibit flowering in grapevine. A grapevine dwarf mutant derived from the L1 cell layer of the champagne cultivar Pinot Meunier produces inflorescences along the length of the shoot where tendrils are normally formed. The mutated gene associated with the phenotype is a homologue of the wheat 'green revolution' gene Reduced height-1 (ref. 6) and the Arabidopsis gene GA insensitive (GAI)(7). The conversion of tendrils to inflorescences in the mutant demonstrates that the grapevine tendril is a modified inflorescence inhibited from completing floral development by GAs.	CSIRO, Plant Ind & Cooperat Res Ctr Viticulture, Glen Osmond, SA 5064, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thomas, MR (corresponding author), CSIRO, Plant Ind & Cooperat Res Ctr Viticulture, POB 350, Glen Osmond, SA 5064, Australia.		Boss, Paul K/A-1292-2010; Thomas, Mark/A-3117-2010	Boss, Paul K/0000-0003-0356-9342; 				Araki T, 2001, CURR OPIN PLANT BIOL, V4, P63, DOI 10.1016/S1369-5266(00)00137-0; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 2000, NATURE, V404, P889, DOI 10.1038/35009125; Boss P. K., 2000, Australian Journal of Grape and Wine Research, V6, P168, DOI 10.1111/j.1755-0238.2000.tb00176.x; Boss PK, 1996, PLANT PHYSIOL, V111, P1059, DOI 10.1104/pp.111.4.1059; Buttrose M. S., 1974, Horticultural Abstracts, V44, P319; ELLIS RH, 1983, VITIS, V22, P211; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Hempel FD, 2000, TRENDS PLANT SCI, V5, P17, DOI 10.1016/S1360-1385(99)01511-3; KOORNNEEF M, 1985, PHYSIOL PLANTARUM, V65, P33, DOI 10.1111/j.1399-3054.1985.tb02355.x; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; MULLINS MG, 1968, J EXP BOT, V19, P532, DOI 10.1093/jxb/19.3.532; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng JR, 1999, PLANT PHYSIOL, V119, P1199, DOI 10.1104/pp.119.4.1199; Peng JR, 1997, PLANT SCI, V130, P181, DOI 10.1016/S0168-9452(97)00216-1; PRATT C, 1971, AM J ENOL VITICULT, V22, P92; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Rives M, 2000, AGRONOMIE, V20, P79, DOI 10.1051/agro:2000109; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; SKENE KGM, 1983, J EXP BOT, V34, P1271, DOI 10.1093/jxb/34.10.1271; THOMAS MR, 1993, THEOR APPL GENET, V86, P173, DOI 10.1007/BF00222076; THOMPSON MM, 1963, AM J BOT, V50, P901, DOI 10.2307/2439777; UTSUNOMIYA N, 1978, J JPN SOC HORTIC SCI, V47, P151, DOI 10.2503/jjshs.47.151; VIALA P, 2001, AMPELOGRAPHIE, V2	27	300	353	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					847	850		10.1038/416847a	http://dx.doi.org/10.1038/416847a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976683				2022-12-24	WOS:000175163800051
J	Pelkmans, L; Puntener, D; Helenius, A				Pelkmans, L; Puntener, D; Helenius, A			Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae	SCIENCE			English	Article							TYROSINE PHOSPHORYLATION; SIMIAN VIRUS-40; MEMBRANE; SIGNAL; ENDOTHELIUM; MOTILITY; VACCINIA; VESICLES; COMPLEX	Simian virus 40 (SV40) utilizes endocytosis through caveolae for infectious entry into host cells. We found that after binding to caveolae, virus particles induced transient breakdown of actin stress fibers. Actin was then recruited to virus-loaded caveolae as actin patches that served as sites for actin "tail" formation. Dynamin II was also transiently recruited. These events depended on the presence of cholesterol and on the activation of tyrosine kinases that phosphorylated proteins in caveolae. They were necessary for formation of caveolae-derived endocytic vesicles and for infection of the cell. Thus, caveolar endocytosis is ligand-triggered and involves extensive rearrangement of the actin cytoskeleton.	ETH Honggerberg, Swiss Fed Inst Technol ETHZ, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH Honggerberg, Swiss Fed Inst Technol ETHZ, HPM1 Bldg, CH-8093 Zurich, Switzerland.			Pelkmans, Lucas/0000-0002-6754-9730				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Benmerah A, 1999, J CELL SCI, V112, P1303; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chen YZ, 1999, EXP CELL RES, V246, P83, DOI 10.1006/excr.1998.4301; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Frischknecht F, 1999, CURR BIOL, V9, P89, DOI 10.1016/S0960-9822(99)80020-7; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Kang YS, 2000, EXP CELL RES, V255, P221, DOI 10.1006/excr.1999.4792; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; May RC, 2001, J CELL SCI, V114, P1061; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; PALADE GE, 1953, J APPL PHYS, V24, P1424; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; PELKMANS L, UNPUB; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Shin JS, 2001, MICROBES INFECT, V3, P755, DOI 10.1016/S1286-4579(01)01423-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; YAMADA M, 1993, J VIROL, V67, P119, DOI 10.1128/JVI.67.1.119-130.1993	33	558	579	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					535	539		10.1126/science.1069784	http://dx.doi.org/10.1126/science.1069784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964480				2022-12-24	WOS:000175179400047
J	Vrebalov, J; Ruezinsky, D; Padmanabhan, V; White, R; Medrano, D; Drake, R; Schuch, W; Giovannoni, J				Vrebalov, J; Ruezinsky, D; Padmanabhan, V; White, R; Medrano, D; Drake, R; Schuch, W; Giovannoni, J			A MADS-box gene necessary for fruit ripening at the tomato ripening-inhibitor (Rin) locus	SCIENCE			English	Article							EXPRESSION; ETHYLENE	Tomato plants harboring the ripening-inhibitor (rin) mutation yield fruits that fail to ripen. Additionally, rin plants display enlarged sepals and loss of inflorescence determinacy. Positional cloning of the rin locus revealed two tandem MADS-box genes (LeMADS-RIN and LeMADS-MC), whose expression patterns suggested roles in fruit ripening and sepal development, respectively. The rin mutation alters expression of both genes. Gene repression and mutant complementation demonstrate that LeMADS-RIN regulates ripening, whereas LeMADS-MC affects sepal development and inflorescence determinacy. LeMADS-RIN demonstrates an agriculturally important function of plant MADS-box genes and provides molecular insight into nonhormonal (developmental) regulation of ripening.	ARS, USDA, Plant Soil & Nutr Lab, Ithaca, NY 14853 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; Zeneca Plant Sci Syngenta, Jeallots Hill Res Stn, Bracknell RG12 6EY, Berks, England	United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research; Texas A&M University System; Texas A&M University College Station; Syngenta	Giovannoni, J (corresponding author), ARS, USDA, Plant Soil & Nutr Lab, Ithaca, NY 14853 USA.							Alvarez-Buylla ER, 2000, PLANT J, V24, P457, DOI 10.1046/j.1365-313x.2000.00891.x; [Anonymous], 1993, BIOCH FRUIT RIPENING; Fillatti J. J., 1987, Tomato biotechnology. Proceedings of a symposium held at the University of California, Davis, California, August 20-22, 1986, P199; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; GIOVANNONI JJ, 1995, MOL GEN GENET, V248, P195, DOI 10.1007/BF02190801; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; LINCOLN JE, 1988, PLANT PHYSIOL, V88, P370, DOI 10.1104/pp.88.2.370; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; REICHMANN JL, 1997, BIOL CHEM, V378, P1079; REICHMANN JL, 1996, P NATL ACAD SCI USA, V93, P4793; Rhodes M. J. C., 1980, Senescence in plants., P157; Robinson R., 1968, REP TOMATO GENET COO, V18, P36; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; TIGCHELAAR EC, 1978, HORTSCIENCE, V13, P508; VREBALOV J, UNPUB; YEN HC, 1995, PLANT PHYSIOL, V107, P1343, DOI 10.1104/pp.107.4.1343	21	809	912	11	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					343	346		10.1126/science.1068181	http://dx.doi.org/10.1126/science.1068181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951045				2022-12-24	WOS:000175000300057
J	Kramps, T; Peter, O; Brunner, E; Nellen, D; Froesch, B; Chatterjee, S; Murone, M; Zullig, S; Basler, K				Kramps, T; Peter, O; Brunner, E; Nellen, D; Froesch, B; Chatterjee, S; Murone, M; Zullig, S; Basler, K			Wnt/Wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex	CELL			English	Article							E-CADHERIN; GENE; ARMADILLO; INTERACTS; POLARITY; ACTIVATION; PATHWAY; PROTEIN	Wnt/Wingless signaling controls many fundamental processes during animal development. Wnt transduction is mediated by the association of beta-catenin with nuclear TCF DNA binding factors. Here we report the identification of two segment polarity genes in Drosophila, legless (lgs), and pygopus (pygo), and we show that their products are required for Wnt signal transduction at the level of nuclear beta-catenin. Lgs encodes the homolog of human BCL9, and we provide genetic and molecular evidence that these proteins exert their function by physically linking Pygo to beta-catenin. Our results suggest that the recruitment of Pygo permits beta-catenin to transcriptionally activate Wnt target genes and raise the possibility that a deregulation of these events may play a causal role in the development of B cell malignancies.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; Genet Co Inc, CH-8952 Schlieren, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529; Peter, Oliver/0000-0001-7091-6653				AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Ahmad K, 1998, GENETICS, V148, P775; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; BRIDGES C. B., 1935, Biol. Z., V4, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Collins RT, 2000, GENE DEV, V14, P3140, DOI 10.1101/gad.854300; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; MULLER HJ, 1957, DROSOPHILA INFORM, V31, P140; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1991, DEVELOPMENT, V111, P1029; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Polakis P, 2000, GENE DEV, V14, P1837; Prieve MG, 1999, MOL CELL BIOL, V19, P4503; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sambrook J., 2001, MOL CLONING LAB MANU; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Willis TG, 1998, BLOOD, V91, P1873, DOI 10.1182/blood.V91.6.1873.1873_1873_1881; Willis TG, 2000, BLOOD, V96, P808, DOI 10.1182/blood.V96.3.808.015k30_808_822; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59	41	476	508	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2002	109	1					47	60		10.1016/S0092-8674(02)00679-7	http://dx.doi.org/10.1016/S0092-8674(02)00679-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955446	Bronze, Green Accepted			2022-12-24	WOS:000174888300008
J	Bucciantini, M; Giannoni, E; Chiti, F; Baroni, F; Formigli, L; Zurdo, JS; Taddei, N; Ramponi, G; Dobson, CM; Stefani, M				Bucciantini, M; Giannoni, E; Chiti, F; Baroni, F; Formigli, L; Zurdo, JS; Taddei, N; Ramponi, G; Dobson, CM; Stefani, M			Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases	NATURE			English	Article							AMYLOID-BETA-PROTEIN; FIBRIL FORMATION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MTT REDUCTION; SH3 DOMAIN; CELL-DEATH; NEUROTOXICITY; FIBRILLIZATION; ACCELERATION	A range of human degenerative conditions, including Alzheimer's disease, light-chain amyloidosis and the spongiform encephalopathies, is associated with the deposition in tissue of proteinaceous aggregates known as amyloid fibrils or plaques. It has been shown previously that fibrillar aggregates that are closely similar to those associated with clinical amyloidoses can be formed in vitro from proteins not connected with these diseases, including the SH3 domain from bovine phosphatidyl-inositol-3'-kinase and the amino-terminal domain of the Escherichia coli HypF protein. Here we show that species formed early in the aggregation of these non-disease-associated proteins can be inherently highly cytotoxic. This finding provides added evidence that avoidance of protein aggregation is crucial for the preservation of biological function and suggests common features in the origins of this family of protein deposition diseases.	Univ Florence, Dipartimento Sci Biochim, I-50134 Florence, Italy; Univ Florence, Dipartimento Anat Istol & Med Legale, I-50134 Florence, Italy; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Florence; University of Florence; University of Cambridge	Stefani, M (corresponding author), Univ Florence, Dipartimento Sci Biochim, Viale Morgagni 50, I-50134 Florence, Italy.		Zurdo, Jesús/C-3110-2015; Giannoni, Elisa/AAE-2092-2020	Zurdo, Jesús/0000-0001-5186-8633; Giannoni, Elisa/0000-0001-7136-1098; bucciantini, monica/0000-0002-5243-9301; STEFANI, MASSIMO/0000-0002-4490-1922; Taddei, Niccolo/0000-0003-2513-1018	Telethon [686, 453/BI] Funding Source: Medline	Telethon(Fondazione Telethon)		Abe K, 1998, NEUROSCI RES, V31, P295, DOI 10.1016/S0168-0102(98)00055-8; BOOKER GW, 1993, CELL, V73, P813, DOI 10.1016/0092-8674(93)90259-S; Butterfield DA, 1999, METHOD ENZYMOL, V309, P746; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2001, PROTEIN SCI, V10, P2541, DOI 10.1110/ps.ps.10201; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fezoui Y, 2000, NAT STRUCT BIOL, V7, P1095, DOI 10.1038/81937; GLENNER GG, 1974, J HISTOCHEM CYTOCHEM, V22, P1141, DOI 10.1177/22.12.1141; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEROUX MR, 1999, MECH PROTEIN FOLDING, P364; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Monji A, 2000, NEUROSCI LETT, V278, P81, DOI 10.1016/S0304-3940(99)00899-X; Perutz MF, 2001, NATURE, V412, P143, DOI 10.1038/35084141; Pillot T, 1999, J NEUROCHEM, V73, P1626, DOI 10.1046/j.1471-4159.1999.0731626.x; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Weatherall DJ, 1995, OXFORD TXB MED, V2, P1512; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	34	2067	2134	3	434	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					507	511		10.1038/416507a	http://dx.doi.org/10.1038/416507a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932737				2022-12-24	WOS:000174756500035
J	Gaggiotti, OE; Jones, F; Lee, WM; Amos, W; Harwood, J; Nichols, RA				Gaggiotti, OE; Jones, F; Lee, WM; Amos, W; Harwood, J; Nichols, RA			Patterns of colonization in a metapopulation of grey seals	NATURE			English	Article							POPULATION-STRUCTURE	The colonization of a new habitat is a fundamental process in metapopulation biology(1), but it is difficult to study. The emigration of colonists from established populations might be induced by resource competition owing to high local population density(2,3). Migration distances are also important because they determine the frequency and scale of recolonization and hence the spatial scale of the metapopulation(4). Traditionally, these factors have been investigated with demographic approaches that are labour-intensive and are only possible in amenable species. In many cases, genetic differentiation is minimal, preventing traditional genetic approaches from identifying the source of colonists unambiguously. Here we present a bayesian approach that integrates genetic, demographic and geographic distance data. We apply the method to study the British metapopulation of grey seals, which has been growing at 6% per year over the last few decades(5). Our method reveals differential recruitment to three newly founded colonies and implicates density-dependent dispersal in metapopulation dynamics by using genetic data.	Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ St Andrews, NERC, Sea Mammal Res Unit, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of London; Queen Mary University London; University of Cambridge; University of Edinburgh; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of St Andrews	Nichols, RA (corresponding author), Queen Mary Univ London, Sch Biol Sci, Mile End Rd, London E1 4NS, England.	r.a.nichols@qmul.ac.uk	Nichols, Richard/B-7732-2008; Gaggiotti, Oscar E/G-2459-2010; Nichols, Richard Alan/T-4773-2019; Jones, Felicity C/AAY-3523-2021	Nichols, Richard/0000-0002-4801-9312; Gaggiotti, Oscar E/0000-0003-1827-1493; Jones, Felicity C/0000-0002-5027-1031				Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Giles BE, 1997, AM NAT, V149, P507, DOI 10.1086/286002; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; HIBY AR, 1996, NERC NEWS        JAN; Ingvarsson PK, 1998, HEREDITY, V80, P456, DOI 10.1046/j.1365-2540.1998.00306.x; Johnson C. G., 1969, INSECT MIGRATION DIS; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MILNER GB, 1985, MAR FISH REV, V47, P1; Pomeroy PP, 2000, ETHOLOGY, V106, P899, DOI 10.1046/j.1439-0310.2000.00610.x; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; SPIEGELHALTER DJ, IN PRESS J R STAT B, V64; WHITLOCK MC, 1992, AM NAT, V139, P952, DOI 10.1086/285368	15	72	74	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					424	427		10.1038/416424a	http://dx.doi.org/10.1038/416424a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919630				2022-12-24	WOS:000174607800045
J	Welch, HCE; Coadwell, WJ; Ellson, CD; Ferguson, GJ; Andrews, SR; Erdjument-Bromage, H; Tempst, P; Hawkins, PT; Stephens, LR				Welch, HCE; Coadwell, WJ; Ellson, CD; Ferguson, GJ; Andrews, SR; Erdjument-Bromage, H; Tempst, P; Hawkins, PT; Stephens, LR			P-Rex1, a PtdIns(3,4,5)P-3- and G beta gamma-regulated guanine-nucleotide exchange factor for Rac	CELL			English	Article							PROTEIN-KINASE B; RHO FAMILY; GUANOSINE TRIPHOSPHATASES; PLECKSTRIN HOMOLOGY; CRYSTAL-STRUCTURE; FACTOR TIAM1; GTPASE RAC2; ACTIVATION; BINDING; VAV	Rac, a member of the Rho family of monomeric GTPases, is an integrator of intracellular signaling in a wide range of cellular processes. We have purified a PtdIns(3,4,5)P-3-sensitive activator of Rac from neutrophil cytosol. It is an abundant, 185 kDa guanine-nucleotide exchange factor (GEF), which we cloned and named P-Rex1. The recombinant enzyme has Rac-GEF activity that is directly, substantially, and synergistically activated by PtdIns(3,4,5)P-3 and Gbetagammas both in vitro and in vivo. P-Rex1 antisense oligonucleotides reduced endogenous P-Rex1 expression and C5a-stimulated reactive oxygen species formation in a neutrophil-like cell line. P-Rex1 appears to be a coincidence detector in PtdIns(3,4,5)P3 and Gbetagamma signaling pathways that is particularly adapted to function downstream of heterotrimeric G proteins in neutrophils.	Babraham Inst, Inositide Lab, Cambridge CB2 4AT, England; Babraham Inst, Bioinformat Grp Signalling, Cambridge CB2 4AT, England; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Memorial Sloan Kettering Cancer Center	Stephens, LR (corresponding author), Babraham Inst, Inositide Lab, Cambridge CB2 4AT, England.	len.stephens@bbsrc.ac.uk		Welch, Heidi/0000-0001-7865-7000; Erdjument-Bromage, Hediye/0000-0003-0224-3594; stephens, len/0000-0002-2771-3487; Hawkins, Phillip/0000-0002-6979-0464; Tempst, Paul/0000-0002-6680-3987				Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Condliffe AM, 2000, NATURE, V404, P135, DOI 10.1038/35004693; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DORSEUIL O, 1992, J BIOL CHEM, V267, P20540; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Gaffney PRJ, 1997, BIOORG MED CHEM LETT, V7, P3171, DOI 10.1016/S0960-894X(97)10166-4; Geijsen N, 1999, BLOOD, V94, P1121, DOI 10.1182/blood.V94.3.1121.415k04_1121_1130; Geiszt M, 2001, BIOCHEM J, V355, P851, DOI 10.1042/bj3550851; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Krugmann S, 2002, MOL CELL, V9, P95, DOI 10.1016/S1097-2765(02)00434-3; LANOTTE M, 1991, BLOOD, V77, P1080; Lemmon MA, 2000, FR MOLEC B, V27, P131; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Painter GF, 1999, J CHEM SOC PERK T 1, P923, DOI 10.1039/a900278b; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STERNWEIS PC, 1990, RECEPTOR EFFECTOR CO, P1; Tapon N, 1997, CURR OPIN CELL BIOL, V9, P86, DOI 10.1016/S0955-0674(97)80156-1; van der Kaay J, 1998, Methods Mol Biol, V105, P109; Welch H, 1998, J BIOL CHEM, V273, P11248, DOI 10.1074/jbc.273.18.11248; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936	48	403	411	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2002	108	6					809	821		10.1016/S0092-8674(02)00663-3	http://dx.doi.org/10.1016/S0092-8674(02)00663-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955434	Bronze			2022-12-24	WOS:000174563000010
J	Xin, HB; Senbonmatsu, T; Cheng, DS; Wang, YX; Copello, JA; Ji, GJ; Collier, ML; Deng, KY; Jeyakumar, LH; Magnuson, MA; Inagami, T; Kotlikoff, MI; Fleischer, S				Xin, HB; Senbonmatsu, T; Cheng, DS; Wang, YX; Copello, JA; Ji, GJ; Collier, ML; Deng, KY; Jeyakumar, LH; Magnuson, MA; Inagami, T; Kotlikoff, MI; Fleischer, S			Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy	NATURE			English	Article							CALCIUM-RELEASE CHANNEL; LEFT-VENTRICULAR HYPERTROPHY; RYANODINE RECEPTOR FUNCTION; FK506 BINDING-PROTEIN; HORMONE REPLACEMENT; SELECTIVE BINDING; SMOOTH-MUSCLE; HEART; COMPLEX; CARDIOMYOPATHY	FK506 binding proteins 12 and 12.6 (FKBP12 and FKBP12.6) are intracellular receptors for the immunosuppressant drug FK506 (ref. 1). The skeletal muscle ryanodine receptor (RyR1) is isolated as a hetero-oligomer with FKBP12 (ref. 2), whereas the cardiac ryanodine receptor (RyR2) more selectively associates with FKBP12.6 (refs 3, 4, 5). FKBP12 modulates Ca2+ release from the sarcoplasmic reticulum in skeletal muscle(6,7) and developmental cardiac defects have been reported in FKBP12-deficient mice(8), but the role of FKBP12.6 in cardiac excitation contraction coupling remains unclear. Here we show that disruption of the FKBP12.6 gene in mice results in cardiac hypertrophy in male mice, but not in females. Female hearts are normal, despite the fact that male and female knockout mice display similar dysregulation of Ca2+ release, seen as increases in the amplitude and duration of Ca2+ sparks and calcium-induced calcium release gain. Female FKBP12.6-null mice treated with tamoxifen, an oestrogen receptor antagonist, develop cardiac hypertrophy similar to that of male mice. We conclude that FKBP12.6 modulates cardiac excitation-contraction coupling and that oestrogen plays a protective role in the hypertrophic response of the heart to Ca2+ dysregulation.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37235 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University; University of Pennsylvania	Fleischer, S (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.		Magnuson, Mark/AAY-7172-2021; Magnuson, Mark A/B-1335-2009	Magnuson, Mark/0000-0002-8824-6499; Magnuson, Mark A/0000-0002-8824-6499				ALDAPE RA, 1992, J BIOL CHEM, V267, P16029; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Collier ML, 2000, J GEN PHYSIOL, V115, P653, DOI 10.1085/jgp.115.5.653; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Fentzke RC, 1997, J AM SOC ECHOCARDIOG, V10, P915, DOI 10.1016/S0894-7317(97)80008-9; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Kadokami T, 2000, J CLIN INVEST, V106, P589, DOI 10.1172/JCI9307; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Lim WK, 1999, AM J CARDIOL, V83, P1132, DOI 10.1016/S0002-9149(99)00029-6; LOUIE EK, 1994, PROG CARDIOVASC DIS, V36, P275, DOI 10.1016/S0033-0620(05)80036-2; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Pelzer T, 1997, ADV EXP MED BIOL, V432, P83; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302; Wang YX, 1997, P NATL ACAD SCI USA, V94, P14918, DOI 10.1073/pnas.94.26.14918; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315	30	242	264	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					334	337		10.1038/416334a	http://dx.doi.org/10.1038/416334a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907581				2022-12-24	WOS:000174482200046
J	D'Hondt, S; Rutherford, S; Spivack, AJ				D'Hondt, S; Rutherford, S; Spivack, AJ			Metabolic activity of subsurface life in deep-sea sediments	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; MARINE-SEDIMENTS; ORGANIC-MATTER; REDUCTION; METHANE; OXIDATION; BIOSPHERE; RATES	Global maps of sulfate and methane in marine sediments reveal two provinces of subsurface metabolic activity: a sulfate-rich open-ocean province, and an ocean-margin province where sulfate is limited to shallow sediments. Methane is produced in both regions but is abundant only in sulfate-depleted sediments. Metabolic activity is greatest in narrow zones of sulfate-reducing methane oxidation along ocean margins. The metabolic rates of subseafloor life are orders of magnitude lower than those of life on Earth's surface. Most microorganisms in subseafloor sediments are either inactive or adapted for extraordinarily low metabolic activity.	Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	D'Hondt, S (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.		chen, qi/C-8585-2011					Adler M, 2000, INT J EARTH SCI, V88, P641, DOI 10.1007/s005310050294; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BERNER RA, 1980, EARLY DIAGENESIS; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borowski WS, 1996, GEOLOGY, V24, P655, DOI 10.1130/0091-7613(1996)024<0655:MPWSPI>2.3.CO;2; CANFIELD DE, 1991, AM J SCI, V291, P177, DOI 10.2475/ajs.291.2.177; CRAGG BA, COMMUNICATION; Dickens G, 2001, GEOCHEM GEOPHY GEOSY, V2; FENCHEL T, 1998, BACTERIAL BIOGEOCHEM; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; FRYER P, 1990, P ODP INIT REP, V125, P687; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P49; KING GM, 1984, GEOMICROBIOL J, V3, P275, DOI 10.1080/01490458409377807; Knoblauch C, 1999, APPL ENVIRON MICROB, V65, P4230; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Niewohner C, 1998, GEOCHIM COSMOCHIM AC, V62, P455, DOI 10.1016/S0016-7037(98)00055-6; OREMLAND RS, 1982, INITIAL REP DEEP SEA, V64, P759; Parkes RJ, 2000, HYDROGEOL J, V8, P11, DOI 10.1007/PL00010971; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pilson M. E. Q., 1998, INTRO CHEM SEA; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Smith DC, 2000, GEOMICROBIOL J, V17, P207; SPIVACK AJ, 2000, EOS, V81, pF216; TARAFA ME, 1987, INITIAL REP DEEP SEA, V95, P635; TAYLOR B, 1999, P ODP INIT REP, V180, P4; Wellsbury P, 1997, NATURE, V388, P573, DOI 10.1038/41544; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	28	384	397	4	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2067	2070		10.1126/science.1064878	http://dx.doi.org/10.1126/science.1064878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896277				2022-12-24	WOS:000174450500047
J	Ellis, AS; Johnson, TM; Bullen, TD				Ellis, AS; Johnson, TM; Bullen, TD			Chromium isotopes and the fate of hexavalent chromium in the environment	SCIENCE			English	Article							REDUCTION; GROUNDWATER; BEHAVIOR; CR(VI)	Measurements of chromium (Cr) stable-isotope fractionation in laboratory experiments and natural waters show that lighter isotopes reacted preferentially during Cr(VI) reduction by magnetite and sediments. The Cr-53/Cr-52 ratio of the product was 3.4 +/- 0.1 per mil less than that of the reactant. Cr-53/Cr-52 shifts in water samples indicate the extent of reduction, a critical process that renders toxic Cr(VI) in the environment immobile and less toxic.	Univ Illinois, Dept Geol, Urbana, IL 61801 USA; US Geol Survey, Div Water Resources, Menlo Pk, CA 94025 USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of the Interior; United States Geological Survey	Johnson, TM (corresponding author), Univ Illinois, Dept Geol, 245 Nat Hist Bldg, Urbana, IL 61801 USA.	tmjohnsn@uiuc.edu	Johnson, Thomas/A-2740-2008	Johnson, Thomas/0000-0003-1620-1408				ANDERSON LD, 1994, ENVIRON SCI TECHNOL, V28, P178, DOI 10.1021/es00050a025; BARTLETT RJ, 1988, CHROMIUM NATURAL HUM, P267; Blowes DW, 1997, ENVIRON SCI TECHNOL, V31, P3348, DOI 10.1021/es960844b; BOTTCHER J, 1990, J HYDROL, V114, P413, DOI 10.1016/0022-1694(90)90068-9; Buerge IJ, 1998, ENVIRON SCI TECHNOL, V32, P2092, DOI 10.1021/es970932b; CARY EE, 1982, CHROMIUM AIR SOIL NA; GOVINDARAJU K, 1989, GEOSTAND NEWSL, V13; Hoefs J., 1987, STABLE ISOTOPE GEOCH, V3rd; JAMES BR, 1983, J ENVIRON QUAL, V12, P177, DOI 10.2134/jeq1983.00472425001200020005x; JAMES BR, 1984, J ENVIRON QUAL, V13, P67, DOI 10.2134/jeq1984.00472425001300010012x; Johnson TM, 1999, GEOCHIM COSMOCHIM AC, V63, P2775, DOI 10.1016/S0016-7037(99)00279-3; Kortenkamp A, 1996, ARCH BIOCHEM BIOPHYS, V329, P199, DOI 10.1006/abbi.1996.0209; Loyaux-Lawniczak S, 2001, ENVIRON SCI TECHNOL, V35, P1350, DOI 10.1021/es001073l; Lytle CM, 1998, ENVIRON SCI TECHNOL, V32, P3087, DOI 10.1021/es980089x; Makdisi RS, 2000, NATURAL ATTENUATION CONSIDERATIONS AND CASE STUDIES, P185; Robles-Camacho J, 2000, J GEOCHEM EXPLOR, V68, P167, DOI 10.1016/S0375-6742(99)00083-7; ROTARU M, 1992, NATURE, V358, P465, DOI 10.1038/358465a0; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; Thode H.G., 1965, FLUIDS SUBSURFACE, V4; U.S. E.P.A, 1992, SW 846 TEST METH EV; Wittbrodt PR, 1996, ENVIRON SCI TECHNOL, V30, P2470, DOI 10.1021/es950731c	21	360	377	11	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2060	2062		10.1126/science.1068368	http://dx.doi.org/10.1126/science.1068368			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896274				2022-12-24	WOS:000174450500044
J	Kobayashi, K; Inohara, N; Hernandez, LD; Galan, JE; Nunez, G; Janeway, CA; Medzhitov, R; Flavell, RA				Kobayashi, K; Inohara, N; Hernandez, LD; Galan, JE; Nunez, G; Janeway, CA; Medzhitov, R; Flavell, RA			RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems	NATURE			English	Article							NF-KAPPA-B; PROTEIN; KINASE; RECOGNITION; EXPRESSION; INHIBITOR; APOPTOSIS; PATHWAYS; DOMAIN; MICE	The immune system consists of two evolutionarily different but closely related responses, innate immunity and adaptive immunity. Each of these responses has characteristic receptors-Toll-like receptors (TLRs) for innate immunity and antigen-specific receptors for adaptive immunity. Here we show that the caspase recruitment domain (CARD)-containing serine/threonine kinase Rip2 (also known as RICK, CARDIAK, CCK and Ripk2)(1-4) transduces signals from receptors of both immune responses. Rip2 was recruited to TLR2 signalling complexes after ligand stimulation. Moreover, cytokine production in Rip2-deficient cells was reduced on stimulation of TLRs with lipopolysaccharide, peptidoglycan and double-stranded RNA, but not with bacterial DNA, indicating that Rip2 is downstream of TLR2/3/4 but not TLR9. Rip2-deficient cells were also hyporesponsive to signalling through interleukin (IL)-1 and IL-18 receptors, and deficient for signalling through Nod proteins-molecules also implicated in the innate immune response. Furthermore, Rip2-deficient T cells showed severely reduced NF-kappaB activation, IL-2 production and proliferation on T-cell-receptor (TCR) engagement, and impaired differentiation to T-helper subtype 1 (T(H)1) cells, indicating that Rip2 is required for optimal TCR signalling and T-cell differentiation. Rip2 is therefore a signal transducer and integrator of signals for both the innate and adaptive immune systems.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Ctr Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.		Nuñez, Gabriel/A-7160-2014	Kobayashi, Koichi/0000-0003-2930-0114				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Demuth A, 1996, INFECT IMMUN, V64, P3475, DOI 10.1128/IAI.64.9.3475-3483.1996; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 1998, J BIOL CHEM, V273, P12296, DOI 10.1074/jbc.273.20.12296; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Leitenberg D, 1999, SEMIN IMMUNOL, V11, P283, DOI 10.1006/smim.1999.0184; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264	29	712	749	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					194	199		10.1038/416194a	http://dx.doi.org/10.1038/416194a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894098	Green Published			2022-12-24	WOS:000174348100042
J	Strasser, K; Masuda, S; Mason, P; Pfannstiel, J; Oppizzi, M; Rodriguez-Navarro, S; Rondon, AG; Aguilera, A; Struhl, K; Reed, R; Hurt, E				Strasser, K; Masuda, S; Mason, P; Pfannstiel, J; Oppizzi, M; Rodriguez-Navarro, S; Rondon, AG; Aguilera, A; Struhl, K; Reed, R; Hurt, E			TREX is a conserved complex coupling transcription with messenger RNA export	NATURE			English	Article							NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEX; YEAST HOMOLOG; IN-VIVO; GENE; ELONGATION; SUB2P; THO2; IDENTIFICATION	The essential yeast proteins Yra1 and Sub2 are messenger RNA export factors that have conserved counterparts in metazoans, designated Aly and UAP56, respectively(1-7). These factors couple the machineries that function in splicing and export of mRNA(1-7). Here we show that both Yra1 and Sub2 are stoichiometrically associated with the heterotetrameric THO complex(8),which functions in transcription in yeast(8-11). We also show that Sub2 and Yra1 interact genetically with all four components of the THO complex (Tho2, Hpr1, Mft1 and Thp2). Moreover, these components operate in the export of bulk poly(A)(+) RNA as well as of mRNA derived from intronless genes. Both Aly and UAP56 associate with human counterparts of the THO complex. Together, these data define a conserved complex, designated the TREX ('transcription/export') complex. The TREX complex is specifically recruited to activated genes during transcription and travels the entire length of the gene with RNA polymerase II. Our data indicate that the TREX complex has a conserved role in coupling transcription to mRNA export.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Heidelberg Univ, BZH, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Univ Seville, Dept Genet, E-41012 Seville, Spain	Harvard University; Harvard Medical School; Ruprecht Karls University Heidelberg; Harvard University; Harvard Medical School; University of Sevilla	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Kevin@hms.harvard.edu; rreed@hms.harvard.edu; cg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Rodríguez-Navarro, Susana/B-5182-2014; Rondon, Ana G/C-2102-2017; Aguilera, Andres/L-1825-2014	Ed Hurt, Dr./0000-0002-4535-8255; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Aguilera, Andres/0000-0003-4782-1714; Strasser, Katja/0000-0003-3533-5516; , Ana/0000-0002-9481-1255				Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Fan HY, 2001, MOL CELL BIOL, V21, P5459, DOI 10.1128/MCB.21.16.5459-5470.2001; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Jensen TH, 2001, CURR BIOL, V11, P1711, DOI 10.1016/S0960-9822(01)00529-2; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Piruat JI, 1997, GENETICS, V147, P1585; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schneiter R, 1999, MOL CELL BIOL, V19, P3415; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; West RW, 2000, GENE, V243, P195, DOI 10.1016/S0378-1119(99)00510-7; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	25	631	652	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					304	308		10.1038/nature746	http://dx.doi.org/10.1038/nature746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	11979277				2022-12-24	WOS:000175592100051
J	Stevens, JL; Cantin, GT; Wang, G; Shevchenko, A; Shevchenko, A; Berk, AJ				Stevens, JL; Cantin, GT; Wang, G; Shevchenko, A; Shevchenko, A; Berk, AJ			Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit	SCIENCE			English	Article							SERUM RESPONSE ELEMENTS; SIGNALING PATHWAY; COMPLEX; COACTIVATOR; INDUCTION; PROTEIN; TERNARY; GENES	Sur2 is a metazoan Mediator subunit that interacts with the adenovirus E1A protein and functions in a mitogen-activated protein kinase pathway required for vulva development in Caenorhabditis elegans. We generated sur2(-/-) embryonic stem cells to analyze its function as a mammalian Mediator component. Our results show that Sur2 forms a subcomplex of the Mediator with two other subunits, TRAP/Med100 and 95. Knock-out of Sur2 prevents activation by E1A-CR3 and the mitogen-activated protein kinase-regulated ETS transcription factor Elk-1, but not by multiple other transcription factors. These results imply that specific activation domains stimulate transcription by binding to distinct Mediator subunits. Activation by EIIA and Elk-1 requires recruitment of Mediator to a promoter by binding to its Sur2 subunit.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Max Planck Society; University of California System; University of California Los Angeles	Berk, AJ (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.		BERK, ARNOLD/AAF-7052-2020	WANG, Gang/0000-0002-4582-501X	NCI NIH HHS [CA25235] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA025235, R37CA025235] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; JOHANSEN FE, 1995, BBA-REV CANCER, V1242, P1, DOI 10.1016/0304-419X(94)00014-S; Lee DH, 2000, DATA KNOWL ENG, V34, P77, DOI 10.1016/S0169-023X(00)00009-4; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MCMAHON SB, 1995, MOL CELL BIOL, V15, P1086; MILTENBERGER RJ, 1993, J BIOL CHEM, V268, P15674; MONTELL C, 1984, CELL, V36, P951, DOI 10.1016/0092-8674(84)90045-X; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; ROEDER RG, COMMUNICATION; SINGH N, 1995, GENE DEV, V9, P2251, DOI 10.1101/gad.9.18.2251; Stevens J. D., UNPUB; Wang G, 2001, MOL CELL BIOL, V21, P4604, DOI 10.1128/MCB.21.14.4604-4613.2001; WANG GC, UNPUB; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5	21	199	208	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					755	758		10.1126/science.1068943	http://dx.doi.org/10.1126/science.1068943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11934987				2022-12-24	WOS:000175281700062
J	Ji, Q; Luo, ZX; Yuan, CX; Wible, JR; Zhang, JP; Georgi, JA				Ji, Q; Luo, ZX; Yuan, CX; Wible, JR; Zhang, JP; Georgi, JA			The earliest known eutherian mammal	NATURE			English	Article							MONGOLIA; EVOLUTION; PHYLOGENY; TREE	The skeleton of a eutherian (placental) mammal has been discovered from the Lower Cretaceous Yixian Formation of northeastern China. We estimate its age to be about 125 million years (Myr), extending the date of the oldest eutherian records with skull and skeleton by about 40-50 Myr. Our analyses place the new fossil at the root of the eutherian tree and among the four other known Early Cretaceous eutherians, and suggest an earlier and greater diversification of stem eutherians that occurred well before the molecular estimate for the diversification of extant placental superorders (104-64 Myr). The new eutherian has limb and foot features that are known only from scansorial (climbing) and arboreal (tree-living) extant mammals, in contrast to the terrestrial or cursorial (running) features of other Cretaceous eutherians. This suggests that the earliest eutherian lineages developed different locomotory adaptations, facilitating their spread to diverse niches in the Cretaceous.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Chinese Acad Geol Sci, Beijing 100037, Peoples R China; Geosci Univ China, Beijing 100083, Peoples R China	Chinese Academy of Geological Sciences; China University of Geosciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, 4400 Forbes Ave, Pittsburgh, PA 15213 USA.		Luo, Zhe-XI/AAU-2263-2021					Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Averianov A, 2000, LETHAIA, V33, P330, DOI 10.1080/002411600750053899; Averianov AO, 2001, ACTA PALAEONTOL POL, V46, P431; BEARD KC, 1992, PRIMATES THEIR RELAT, P63; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; de Muizon Christian, 1998, Geodiversitas, V20, P19; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; GEE H, 2001, RISE DRAGON READINGS, P1; GRADSTEIN FM, 1995, SEPM SPEC PUBL, V54, P95; Horovitz I, 2000, J VERTEBR PALEONTOL, V20, P547, DOI 10.1671/0272-4634(2000)020[0547:TTOUNE]2.0.CO;2; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; HU YM, 1998, VERT PALASIATIC, V38, P102; Jenkins F.A. Jr., 1974, P85; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 1977, Palaeontologia Polonica, V37, P65; Kielan-Jaworowska Z., 1978, PALAEONTOLOGICA POLO, V38, P5; Kielan-Jaworowska Z, 1981, PALAEONTOLOGIA POLON, V42, P25; Kielan-Jaworowska Zofia, 1994, Fossils and Strata, V36, P1; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; KRAUSE D W, 1983, Bulletin of the Museum of Comparative Zoology, V150, P199; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Loope DB, 1998, GEOLOGY, V26, P27, DOI 10.1130/0091-7613(1998)026<0027:LADIAL>2.3.CO;2; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; McKenna M.C., 1997, CLASSIFICATION MAMMA, P1; McKenna MC, 2000, ACTA PALAEONTOL POL, V45, P1; MCLEOD N, 1993, AM J SCI, V293, P300; Meng J, 1997, NATURE, V385, P712, DOI 10.1038/385712a0; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich Thomas H., 2001, Records of the Queen Victoria Museum, V110, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; ROUGIER GW, 1993, THESIS U NAC BUENOS; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Schilling N, 1999, Z SAUGETIERKD, V64, P129; SIGOGNEAURUSSELL D, 1992, ZOOL SCR, V21, P205, DOI 10.1111/j.1463-6409.1992.tb00322.x; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; Szalay FS, 1994, EVOLUTIONARY HIST MA, P1; Szalay FS., 1996, NEW MEX MUS NAT HIST, V7, P1; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; [No title captured]; [No title captured]	50	345	393	7	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					816	822		10.1038/416816a	http://dx.doi.org/10.1038/416816a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976675				2022-12-24	WOS:000175163800043
J	Tinetti, ME; Baker, D; Gallo, WT; Nanda, A; Charpentier, P; O'Leary, J				Tinetti, ME; Baker, D; Gallo, WT; Nanda, A; Charpentier, P; O'Leary, J			Evaluation of restorative care vs usual care for older adults receiving an acute episode of home care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; BRAIN-INJURY; HEALTH-CARE; INTERVENTION; MANAGEMENT; PROGRAM; PEOPLE; HOSPITALIZATION	Context Illness and hospitalization often trigger functional decline among older persons. Home care services implemented for functional decline provide an opportunity, to intervene to improve outcomes. Objective To compare functional status and the likelihood of remaining at home for persons receiving restorative care vs usual home care. Design and Setting Intervention using prospective individual matching conducted between November 1, 1998, and April 30, 2000. Six offices of a home care agency in Connecticut were used. One branch office served as the restorative care unit and the other 5 served as usual care offices. Participants Patients receiving home care through the restorative care office who were 65 years or older; in receipt of Medicare-covered home care lasting at beast 7 days; with absence of severe cognitive impairment; and not terminal, bedridden, or requiring total care were matched with patients from 1 of the usual care offices. The matching factors included age, sex, race, baseline self-care function, cognitive status, whether hospitalization preceded the home care episode, and date of the home care episode. Of the 712 eligible restorative care patients, 691 (97%) were matched with a usual care patient. Intervention Restorative care, provided by the home care agency nursing, therapy, and home health aide staff, was based on principles from geriatric medicine., nursing, rehabilitation, and goal attainment. Main Outcome Measures Remaining at home, functional status at completion of the home care episode, and duration and intensity of home care episode. Results Compared with usual care, and after adjusting for baseline characteristics and other factors, restorative care was associated with a greater likelihood of remaining at home (82% vs 71%; odds ratio [OR], 1.99; 95% confidence interval [CI], 1.47-2.69) and a reduced likelihood of visiting an emergency department (10% vs 20%; OR, 0.44; 95% CI, 0.32-0.61). Home care episodes were shorter (mean [SD], 24.8 [26.8] days vs 34.3 [44.2] days; S = -17821; P<.001). Restorative care patients had better mean (SD) scores than usual care patients in self-care (11.0 [2.1] vs 10.7 [2.5]; P=.07 after adjustment), home management (9.5 [2.9] vs 9.2 [3.0]; P=.05 after adjustment), and mobility (3.3 [0.8] vs 3.2 [0.9]; P=.02 after adjustment). Conclusions This trial suggests that reorganizing the structure and goals of home care can enhance health outcomes of older patients without increasing health care utilization.	Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA	Yale University; Yale University	Tinetti, ME (corresponding author), 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu		Nanda, Aman/0000-0002-3860-3267	NIA NIH HHS [AG10469] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P60AG010469] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADAMS CE, 1995, J NURS ADMIN, V25, P27, DOI 10.1097/00005110-199509000-00007; Baker DI, 2001, GERONTOLOGIST, V41, P257, DOI 10.1093/geront/41.2.257; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Bradley EH, 1999, SOC SCI MED, V49, P267, DOI 10.1016/S0277-9536(99)00107-0; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; CRISLER KS, 1994, STUDY DEV OUTCOME BA, V1; CUMMINGS JE, 1990, ARCH INTERN MED, V150, P1274, DOI 10.1001/archinte.150.6.1274; Eng C, 1997, J AM GERIATR SOC, V45, P223, DOI 10.1111/j.1532-5415.1997.tb04513.x; FEINSTEIN AR, 2002, PRINCIPLES MED STAT, P417; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 1999, J GERONTOL A-BIOL, V54, pM377, DOI 10.1093/gerona/54.7.M377; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Graney MJ, 2000, GERONTOLOGIST, V40, P582, DOI 10.1093/geront/40.5.582; Gruber-Baldini AL, 2000, J AM GERIATR SOC, V48, P1601, DOI 10.1111/j.1532-5415.2000.tb03870.x; HOLFORD TR, 1989, AM J EPIDEMIOL, V130, P1247, DOI 10.1093/oxfordjournals.aje.a115453; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KANE RL, 1994, HEALTH CARE FINANC R, V16, P131; KOCH M, 1994, PHYS THER, V74, P286, DOI 10.1093/ptj/74.4.286; KRAVITZ RL, 1994, J AM GERIATR SOC, V42, P1229, DOI 10.1111/j.1532-5415.1994.tb06502.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leff B, 1999, J AM GERIATR SOC, V47, P697, DOI 10.1111/j.1532-5415.1999.tb01592.x; Lorig K, 1993, GENERATIONS, V3, P11; Madigan E A, 2000, Home Health Care Serv Q, V18, P49; Makuch RW, 1998, STAT MED, V17, P1517, DOI 10.1002/(SICI)1097-0258(19980715)17:13<1517::AID-SIM859>3.0.CO;2-0; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; McCurren C, 1999, APPL NURS RES, V12, P185, DOI 10.1016/S0897-1897(99)80249-3; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; PROCHASKA JO, 1991, CANCER-AM CANCER SOC, V67, P805, DOI 10.1002/1097-0142(19910201)67:3+<805::AID-CNCR2820671409>3.0.CO;2-4; PRYOR GA, 1988, LANCET, V1, P401; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; ROCKWOOD K, 1993, J CLIN EPIDEMIOL, V46, P1113, DOI 10.1016/0895-4356(93)90110-M; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Shaughnessy PW, 1997, MED CARE, V35, P1225, DOI 10.1097/00005650-199712000-00007; Siu AL, 1996, ARCH INTERN MED, V156, P76, DOI 10.1001/archinte.156.1.76; SOLOMON DH, 1993, J AM GERIATR SOC, V41, P961, DOI 10.1111/j.1532-5415.1993.tb06762.x; Stessman J, 1996, J AM GERIATR SOC, V44, P591; Stinemann MG, 2000, J AM GERIATR SOC, V48, P1734, DOI 10.1111/j.1532-5415.2000.tb03893.x; Tinetti ME, 1999, ARCH PHYS MED REHAB, V80, P916, DOI 10.1016/S0003-9993(99)90083-7; Tinetti ME, 1997, ARCH PHYS MED REHAB, V78, P1237, DOI 10.1016/S0003-9993(97)90338-5; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; VLADECK BC, 1994, HEALTH CARE FINANC R, V16, P7; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008	45	99	99	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 24	2002	287	16					2098	2105		10.1001/jama.287.16.2098	http://dx.doi.org/10.1001/jama.287.16.2098			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	542ZK	11966384	Bronze			2022-12-24	WOS:000175075700027
J	Reich, JG				Reich, JG			Embryonic stem cells - The debate in Germany	SCIENCE			English	Editorial Material									Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Reich, JG (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.								0	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					265	265		10.1126/science.1070574	http://dx.doi.org/10.1126/science.1070574			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951019				2022-12-24	WOS:000175000300028
J	Fitze, G; Cramer, J; Ziegler, A; Schierz, M; Schreiber, M; Kuhlisch, E; Roesner, D; Schackert, HK				Fitze, G; Cramer, J; Ziegler, A; Schierz, M; Schreiber, M; Kuhlisch, E; Roesner, D; Schackert, HK			Association between c135G/A genotype and RET proto-oncogene germline mutations and phenotype of Hirschsprung's disease	LANCET			English	Article							TOTAL COLONIC AGANGLIONOSIS; MULTIGENIC INHERITANCE; MISSENSE MUTATION; LONG ARM; PROTOONCOGENE; GENE; HETEROZYGOSITY; POLYMORPHISMS; CHROMOSOME-10; EXPRESSION	Background Several genes, including the major susceptibility gene RET, have roles in development of Hirschsprung's disease. Results of genetic-linkage analysis of patients with familial disease with both long-segment and short-segment phenotypes have shown close linkage with the RET locus. We aimed to investigate whether both RET mutations and polymorphisms contribute to phenotype of Hirschsprung's disease. Methods We looked at the coding region of all 21 exons of the RET proto-oncogene, including the flanking intronic sequences, by direct DNA sequencing in 76 caucasians from Germany with Hirschsprung's disease. Findings 20 different mutations were detected in 18 patients. Mutations were under-represented in patients with a homozygous RET c135A/A genotype in association with short-segment phenotype. Short-segment phenotype also arose if the RET mutation was on the c135A allele; conversely, a RET germline mutation on the c135G allele resulted in long-segment phenotype, particularly in heterozygous c135G/A patients. Interpretation These observations lend support to the idea that both RET alleles have a role in pathogenesis of Hirschsprung's disease, in a dose-dependent fashion. We also showed that the c135G/A polymorphism modifies the phenotype by a within-gene interaction between the c135A variant and a mutation.	Dresden Univ Technol, Dept Paediat Surg, D-01307 Dresden, Germany; Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; Univ Erlangen Nurnberg, Dept Paediat Surg, Erlangen, Germany; Dresden Univ Technol, Dept Surg Res, D-8027 Dresden, Germany; Dresden Univ Technol, Inst Med Informat & Biometry, D-8027 Dresden, Germany	Technische Universitat Dresden; University of Lubeck; University of Erlangen Nuremberg; Technische Universitat Dresden; Technische Universitat Dresden	Fitze, G (corresponding author), Dresden Univ Technol, Dept Paediat Surg, Fetscherstr 74, D-01307 Dresden, Germany.		Ziegler, Andreas/G-4246-2012	Ziegler, Andreas/0000-0002-8386-5397				Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; BADNER JA, 1990, AM J HUM GENET, V46, P568; BOLANDE RP, 1974, HUM PATHOL, V5, P409, DOI 10.1016/S0046-8177(74)80021-3; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Borrego S, 1998, J CLIN ENDOCR METAB, V83, P3361, DOI 10.1210/jc.83.9.3361; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; BUCHIN PJ, 1986, J CLIN GASTROENTEROL, V8, P111, DOI 10.1097/00004836-198604000-00002; CECCHERINI I, 1994, ONCOGENE, V9, P3025; Cosma MP, 1998, MOL CELL BIOL, V18, P3321, DOI 10.1128/MCB.18.6.3321; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; Fitze G, 1999, AM J HUM GENET, V65, P1469, DOI 10.1086/302618; Geneste O, 1999, HUM MOL GENET, V8, P1989, DOI 10.1093/hmg/8.11.1989; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Inoue K, 2000, AM J MED GENET, V93, P278, DOI 10.1002/1096-8628(20000814)93:4<278::AID-AJMG5>3.0.CO;2-Q; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; MARTUCCIELLO G, 1992, PEDIATR SURG INT, V7, P308; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Onochie CI, 2000, J MED GENET, V37, P674, DOI 10.1136/jmg.37.9.674; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Seri M, 1997, HUM MUTAT, V9, P243; Svensson PJ, 1998, CLIN GENET, V54, P39; Vladutiu GD, 2001, MOL GENET METAB, V74, P51, DOI 10.1006/mgme.2001.3240; Vockley J, 2000, MOL GENET METAB, V71, P10, DOI 10.1006/mgme.2000.3066; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860	35	88	100	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 6	2002	359	9313					1200	1205		10.1016/S0140-6736(02)08218-1	http://dx.doi.org/10.1016/S0140-6736(02)08218-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AB	11955539				2022-12-24	WOS:000174846300011
J	ten Kate, K				ten Kate, K			Global genetic resources - Science and the convention on biological diversity	SCIENCE			English	Editorial Material									Royal Bot Gardens, Richmond TW9 3AE, Surrey, England	Royal Botanic Gardens, Kew	ten Kate, K (corresponding author), Royal Bot Gardens, Richmond TW9 3AE, Surrey, England.							GLOWKA L, COMMUNICATION; Laird S.A, 2002, BIODIVERSITY TRADITI; *SECR CONV BIOL DI, 2001, GLOB BIOD OUTL 2001; Ten Kate K, 1999, COMMERCIAL USE BIODI; TENKATE K, 2002, C COMM INT PROP RIGH	5	21	21	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2371	2372						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923511				2022-12-24	WOS:000174712600024
J	Check, E				Check, E			Alternative therapies leave US commission divided	NATURE			English	News Item																		Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					355	355		10.1038/416355b	http://dx.doi.org/10.1038/416355b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919588	Bronze			2022-12-24	WOS:000174607800007
J	Tsai, E				Tsai, E			Should family members be present during cardiopulmonary resuscitation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WATCH RESUSCITATION; RELATIVES; ROOM		Kingston Gen Hosp, Dept Pediat, Kingston, ON K7L 2V7, Canada	Queens University - Canada	Tsai, E (corresponding author), Kingston Gen Hosp, Dept Pediat, Watkins 3,76 Stuart St, Kingston, ON K7L 2V7, Canada.							ADAMS S, 1994, BRIT MED J, V308, P1687, DOI 10.1136/bmj.308.6945.1687; Back D, 1994, Nurs Times, V90, P34; Back K J, 1991, Pediatr Nurs, V17, P571; Barratt F, 1998, J ACCID EMERG MED, V15, P109; Bassler P C, 1999, J Nurses Staff Dev, V15, P126, DOI 10.1097/00124645-199905000-00007; Belanger M A, 1997, J Emerg Nurs, V23, P238, DOI 10.1016/S0099-1767(97)90015-5; Boie ET, 1999, ANN EMERG MED, V34, P70, DOI 10.1016/S0196-0644(99)70274-X; Boyd R, 2000, Eur J Emerg Med, V7, P51; Brown J R, 1989, Nursing, V19, P46; Connors P, 1996, Nurs Stand, V10, P42; CRISCI C, 1994, BRIT MED J, V309, P406; DOYLE CJ, 1987, ANN EMERG MED, V16, P673, DOI 10.1016/S0196-0644(87)80069-0; DUBIN WR, 1986, ANN EMERG MED, V15, P54, DOI 10.1016/S0196-0644(86)80488-7; Eichhorn D J, 1996, J Cardiovasc Nurs, V10, P59; *EM NURS ASS, 1995, PRES OPT FAM PRES; *EM NURS ASS, 1998, FAM PRES BEDS INV PR; GOLDSCHMIDT D, 2001, CNN MED NEWS    0504; Gyulay J E, 1989, Issues Compr Pediatr Nurs, V12, P71, DOI 10.3109/01460868909038030; Hanson C, 1992, J Emerg Nurs, V18, P104; Hartley D, 2001, JAMA-J AM MED ASSOC, V285, P380, DOI 10.1001/jama.285.4.380; Jarvis A S, 1998, Intensive Crit Care Nurs, V14, P3, DOI 10.1016/S0964-3397(98)80029-3; Meyers T A, 1998, J Emerg Nurs, V24, P400, DOI 10.1016/S0099-1767(98)70005-4; Meyers TA, 2000, AM J NURS, V100, P32, DOI 10.2307/3521954; Mitchell MH, 1997, J ACCID EMERG MED, V14, P366; Offord R J, 1998, Intensive Crit Care Nurs, V14, P288, DOI 10.1016/S0964-3397(98)80690-3; Osuagwu C C, 1991, J Emerg Nurs, V17, P363; Post H, 1989, Nursing, V19, P43; Rattrie E, 2000, Nurs Stand, V14, P32; Reese V, 1994, Nursing, V24, p32V; REESE V, 1994, NURSING, V24, pV32; Resuscitation Council (UK), 1996, SHOULD REL WITN RES; Robinson SM, 1998, LANCET, V352, P614, DOI 10.1016/S0140-6736(97)12179-1; SCHILLING RJ, 1994, BRIT MED J, V309, P406, DOI 10.1136/bmj.309.6951.406; TULLER D, 2001, NY TIMES        0515, pF6; 2000, CIRCULATION S1, V102, P12	35	47	49	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 28	2002	346	13					1019	1021		10.1056/NEJM200203283461312	http://dx.doi.org/10.1056/NEJM200203283461312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534UY	11919313				2022-12-24	WOS:000174608600011
J	Sharp, D				Sharp, D			Hot, cold, and now bubble fusion	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Kennedy D, 2002, SCIENCE, V295, P1793, DOI 10.1126/science.295.5561.1793; PARK B, 2002, BUBBLE FUSION COLLEC; PARK R, 2000, VOODOO SCI; SHAPIRA D, 2002, COMMENTS REPORTED NU; Taleyarkhan RP, 2002, SCIENCE, V295, P1868, DOI 10.1126/science.1067589; TALEYARKHAN RP, COMMENTS SHAPIRA SAL	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2002	359	9310					908	908		10.1016/S0140-6736(02)08016-9	http://dx.doi.org/10.1016/S0140-6736(02)08016-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531AE	11918906				2022-12-24	WOS:000174391700006
J	Friml, J; Benkova, E; Blilou, I; Wisniewska, J; Hamann, T; Ljung, K; Woody, S; Sandberg, G; Scheres, B; Jurgens, G; Palme, K				Friml, J; Benkova, E; Blilou, I; Wisniewska, J; Hamann, T; Ljung, K; Woody, S; Sandberg, G; Scheres, B; Jurgens, G; Palme, K			AtPIN4 mediates sink-driven auxin gradients and root patterning in Arabidopsis	CELL			English	Article							EFFLUX CARRIER; TRANSPORT; GRAVITROPISM; PROTEIN; GENE; THALIANA; PLANTS; ACID	In contrast to animals, little is known about pattern formation in plants. Physiological and genetic data suggest the involvement of the phytohormone auxin in this process. Here, we characterize a novel member of the PIN family of putative auxin efflux carriers,Arabidopsis PIN4, that is localized in developing and mature root meristems. Atpin4 mutants are defective in establishment and maintenance of endogenous auxin gradients, fail to canalize externally applied auxin, and display various patterning defects in both embryonic and seedling roots. We propose a role for AtPIN4 in generating a sink for auxin below the quiescent center of the root meristem that is essential for auxin distribution and patterning.	Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic; ASCR, Inst Biophys, Brno 61265, Czech Republic; Univ Utrecht, Dept Mol Cell Biol, NL-3584 CH Utrecht, Netherlands; Inst Gen & Mol Biol, Dept Biotechnol, PL-87100 Torun, Poland; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Freiburg, Inst Biol Zellbiol 2, D-79104 Freiburg, Germany	Max Planck Society; Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Utrecht University; Nicolaus Copernicus University; Eberhard Karls University of Tubingen; Swedish University of Agricultural Sciences; Umea University; University of Wisconsin System; University of Wisconsin Madison; University of Freiburg	Palme, K (corresponding author), Max Planck Gesell, Max Delbruck Lab, Carl von Linne Weg 10, D-50829 Cologne, Germany.		Wisniewska, Justyna/D-4351-2009; Friml, Jiri/D-9511-2012; Palme, Klaus/A-9524-2013; Benkova, Eva/E-2910-2012; Ljung, Karin/AAE-8691-2019	Friml, Jiri/0000-0002-8302-7596; Palme, Klaus/0000-0002-2728-3835; Ljung, Karin/0000-0003-2901-189X; Scheres, Ben/0000-0001-5400-9578; Blilou, Ikram/0000-0001-8003-3782				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEJSOVEC A, 1995, GENETICS, V139, P309; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; BENNETT SRM, 1995, PLANT J, V8, P505, DOI 10.1046/j.1365-313X.1995.8040505.x; Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Chen RJ, 1998, P NATL ACAD SCI USA, V95, P15112, DOI 10.1073/pnas.95.25.15112; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Dotson SB, 1996, PLANT J, V10, P383, DOI 10.1046/j.1365-313X.1996.10020383.x; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDLUND A, 1995, PLANT PHYSIOL, V108, P1043, DOI 10.1104/pp.108.3.1043; FRIMI J, 2000, THESIS U COLOGNE KOL; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Hadfi K, 1998, DEVELOPMENT, V125, P879; KERK N, 1994, PROTOPLASMA, V183, P100, DOI 10.1007/BF01276817; Lomax Terri L., 1995, P509; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rashotte AM, 2001, PLANT CELL, V13, P1683, DOI 10.1105/tpc.13.7.1683; RAVEN JA, 1975, NEW PHYTOL, V74, P163, DOI 10.1111/j.1469-8137.1975.tb02602.x; RUBERY PH, 1974, PLANTA, V118, P101, DOI 10.1007/BF00388387; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649, DOI 10.1093/pcp/41.6.649; SACHS T, 1985, P LIF SCI PLANT GROW, P231; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Teleman AA, 2001, CELL, V105, P559, DOI 10.1016/S0092-8674(01)00377-4; Uggla C, 1996, P NATL ACAD SCI USA, V93, P9282, DOI 10.1073/pnas.93.17.9282; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9	39	622	666	4	137	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					661	673		10.1016/S0092-8674(02)00656-6	http://dx.doi.org/10.1016/S0092-8674(02)00656-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893337	Green Published, Bronze			2022-12-24	WOS:000174314800010
J	Sincich, LC; Horton, JC				Sincich, LC; Horton, JC			Divided by cytochrome oxidase: A map of the projections from V1 to V2 in Macaques	SCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; MONKEY VISUAL-CORTEX; AREA V2; FUNCTIONAL ARCHITECTURE; SEGREGATION; SYSTEM; COLOR; FORM; ORGANIZATION; CONNECTIONS	Current models partition the primate visual system into dorsal (magno) and ventral (parvo, konio) streams. Perhaps the strongest evidence for this idea has come from the pattern of projections between the primary visual area (V1) and the second visual area (V2). Prior studies describe three distinct pathways: magno to thick stripes, parvo to pate stripes, and konio to thin stripes. We now demonstrate that V1 output arises from just two sources: patch columns and interpatch columns. Patch columns project to thin stripes and interpatch columns project to pate and thick stripes. Projection of interpatches to common V2-stripe types (pate and thick) merges parvo and magno inputs, making it likely that these functional channels are distributed strongly to both dorsal and ventral streams.	Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sincich, LC (corresponding author), Univ Calif San Francisco, Beckman Vis Ctr, San Francisco, CA 94143 USA.			Horton, Jonathan/0000-0002-3952-435X	NEI NIH HHS [EY13676, EY10217, EY02162] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY002162, F32EY013676, R56EY010217, R01EY010217] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; DEYOE EA, 1985, NATURE, V317, P58, DOI 10.1038/317058a0; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gegenfurtner KR, 1996, VISUAL NEUROSCI, V13, P161, DOI 10.1017/S0952523800007203; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HUBEL DH, 1987, J NEUROSCI, V7, P3378; KRUBITZER L, 1990, VISUAL NEUROSCI, V5, P609, DOI 10.1017/S0952523800000778; KUYPERS HGJ, 1965, EXP NEUROL, V11, P245, DOI 10.1016/0014-4886(65)90016-6; LEVAY S, 1990, EXP BRAIN RES, V82, P77; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3371; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; MARTIN KAC, 1988, TRENDS NEUROSCI, V11, P380, DOI 10.1016/0166-2236(88)90072-0; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mettler FA, 1935, J COMP NEUROL, V61, P221, DOI 10.1002/cne.900610203; Olavarria JF, 1997, CEREB CORTEX, V7, P395, DOI 10.1093/cercor/7.5.395; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; ROE AW, 1995, J NEUROSCI, V15, P3689; Roe AW, 1997, CEREBR CORT, V12, P295; RYE DB, 1984, J HISTOCHEM CYTOCHEM, V32, P1145, DOI 10.1177/32.11.6548485; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; SINCICH LC, 2002, IN PRESS J COMP NEUR; TOOTELL RBH, 1983, SCIENCE, V220, P737, DOI 10.1126/science.6301017; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3	35	119	121	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1734	1737		10.1126/science.1067902	http://dx.doi.org/10.1126/science.1067902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872845				2022-12-24	WOS:000174212900052
J	Asai, T; Tena, G; Plotnikova, J; Willmann, MR; Chiu, WL; Gomez-Gomez, L; Boller, T; Ausubel, FM; Sheen, J				Asai, T; Tena, G; Plotnikova, J; Willmann, MR; Chiu, WL; Gomez-Gomez, L; Boller, T; Ausubel, FM; Sheen, J			MAP kinase signalling cascade in Arabidopsis innate immunity	NATURE			English	Article							BACTERIAL ELICITOR FLAGELLIN; ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTORS; PATHOGEN DEFENSE; RESISTANCE GENE; RECEPTOR; PLANTS; THALIANA; PERCEPTION; INDUCTION	There is remarkable conservation in the recognition of pathogen-associated molecular patterns (PAMPs) by innate immune responses of plants, insects and mammals. We developed an Arabidopsis thaliana leaf cell system based on the induction of early-defence gene transcription by flagellin, a highly conserved component of bacterial flagella that functions as a PAMP in plants and mammals. Here we identify a complete plant MAP kinase cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) and WRKY22/WRKY29 transcription factors that function downstream of the flagellin receptor FLS2, a leucine-rich-repeat (LRR) receptor kinase. Activation of this MAPK cascade confers resistance to both bacterial and fungal pathogens, suggesting that signalling events initiated by diverse pathogens converge into a conserved MAPK cascade.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Inst Desarrollo Reg, Secc Biotecnol, E-02071 Albacete, Spain; Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Friedrich Miescher Institute for Biomedical Research	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.		Gomez-Gomez, Lourdes/AAF-2371-2020; Boller, Thomas/G-3500-2012	Gomez-Gomez, Lourdes/0000-0003-2586-4457; Boller, Thomas/0000-0001-6768-7503; Willmann, Matthew R./0000-0002-4146-8158; Tena, Guillaume/0000-0001-8652-905X				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Cardinale F, 2000, J BIOL CHEM, V275, P36734, DOI 10.1074/jbc.M007418200; Cohn J, 2001, CURR OPIN IMMUNOL, V13, P55, DOI 10.1016/S0952-7915(00)00182-5; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Frye CA, 2001, P NATL ACAD SCI USA, V98, P373, DOI 10.1073/pnas.011405198; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; HART H, 2000, RESULTS PROBLEMS CEL, P85; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Jouannic S, 1999, GENE, V233, P1, DOI 10.1016/S0378-1119(99)00152-3; Khush RS, 2000, TRENDS GENET, V16, P442, DOI 10.1016/S0168-9525(00)02095-3; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Mizoguchi T, 2000, RES PRO CEL, V27, P29; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Patharkar OR, 2000, PLANT J, V24, P679, DOI 10.1046/j.1365-313x.2000.00912.x; Peck SC, 2001, PLANT CELL, V13, P1467, DOI 10.1105/tpc.13.6.1467; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Romeis T, 1999, PLANT CELL, V11, P273, DOI 10.1105/tpc.11.2.273; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; SHEEN J, IN PRESS PLANT PHYSL; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2001, PLANT J, V26, P101, DOI 10.1046/j.1365-313x.2001.01014.x; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; Zhang SQ, 1998, PLANT CELL, V10, P435, DOI 10.1105/tpc.10.3.435; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7433, DOI 10.1073/pnas.95.13.7433	46	1860	2041	22	500	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					977	983		10.1038/415977a	http://dx.doi.org/10.1038/415977a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875555				2022-12-24	WOS:000174075000031
J	Gewin, V				Gewin, V			Academy proposes tighter crop monitoring	NATURE			English	News Item																			0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					948	948		10.1038/415948b	http://dx.doi.org/10.1038/415948b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875531	Bronze			2022-12-24	WOS:000174075000010
J	Arase, H; Mocarski, ES; Campbell, AE; Hill, AB; Lanier, LL				Arase, H; Mocarski, ES; Campbell, AE; Hill, AB; Lanier, LL			Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors	SCIENCE			English	Article							NATURAL-KILLER-CELLS; MURINE CYTOMEGALOVIRUS; MHC MOLECULES; GENE-COMPLEX; HLA-C; RESISTANCE; MECHANISMS; INFECTION; BINDING; CMV-1	Natural killer (NK) cells express inhibitory receptors for major histocompatibility complex (MHC) class I antigens, preventing attack against healthy cells. Mouse cytomegatovirus (MCMV) encodes an MHC-like protein (m157) that binds to an inhibitory NK cell receptor in certain MCMV-susceptible mice. In MCMV-resistant mice, this viral protein engages a related activating receptor (Ly49H) and confers host protection. These activating and inhibitory receptors are highly homologous, suggesting the possibility that one evolved from the other in response to selective pressure imposed by the pathogen.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23507 USA; Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Eastern Virginia Medical School; Oregon Health & Science University	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	lanier@itsa.ucsf.edu	Arase, Hisashi/C-8442-2009; Mocarski, Edward/ABC-2893-2020; Lanier, Lewis L/E-2139-2014	Arase, Hisashi/0000-0002-1153-3166; Lanier, Lewis L/0000-0003-1308-3952	NCI NIH HHS [CA89294] Funding Source: Medline; NIAID NIH HHS [AI30363] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI030363, R01AI030363] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alcami A, 2000, MOL MED TODAY, V6, P365, DOI 10.1016/S1357-4310(00)01775-5; Anderson SK, 2001, IMMUNOL REV, V181, P79, DOI 10.1034/j.1600-065X.2001.1810106.x; ARASE H, UNPUB; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Brown MG, 2001, IMMUNOGENETICS, V53, P584, DOI 10.1007/s002510100365; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cavanaugh VJ, 1996, J VIROL, V70, P1365, DOI 10.1128/JVI.70.3.1365-1374.1996; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Chapman TL, 1998, J VIROL, V72, P460, DOI 10.1128/JVI.72.1.460-466.1998; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; GRUNDY JE, 1981, INFECT IMMUN, V32, P277, DOI 10.1128/IAI.32.1.277-286.1981; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lee SH, 2001, IMMUNOGENETICS, V53, P501, DOI 10.1007/s002510100359; Makrigiannis AP, 2001, J IMMUNOL, V166, P5034, DOI 10.4049/jimmunol.166.8.5034; MORETTA A, 1995, J EXP MED, V182, P875, DOI 10.1084/jem.182.3.875; Orange JS, 1996, J IMMUNOL, V156, P1138; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Smith KM, 1998, J IMMUNOL, V161, P7; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; TAY CH, 1995, J IMMUNOL, V154, P780; THALE R, 1995, J VIROL, V69, P6098; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; Vink C, 2000, J VIROL, V74, P7656, DOI 10.1128/JVI.74.16.7656-7665.2000; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	31	931	955	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1323	1326		10.1126/science.1070884	http://dx.doi.org/10.1126/science.1070884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	11950999				2022-12-24	WOS:000175713000057
J	Celeste, A; Petersen, S; Romanienko, PJ; Fernandez-Capetillo, O; Chen, HT; Sedelnikova, OA; Reina-San-Martin, B; Coppola, V; Meffre, E; Difilippantonio, MJ; Redon, C; Pilch, DR; Olaru, A; Eckhaus, M; Camerini-Otero, RD; Tessarollo, L; Livak, F; Manova, K; Bonner, WM; Nussenzweig, MC; Nussenzweig, A				Celeste, A; Petersen, S; Romanienko, PJ; Fernandez-Capetillo, O; Chen, HT; Sedelnikova, OA; Reina-San-Martin, B; Coppola, V; Meffre, E; Difilippantonio, MJ; Redon, C; Pilch, DR; Olaru, A; Eckhaus, M; Camerini-Otero, RD; Tessarollo, L; Livak, F; Manova, K; Bonner, WM; Nussenzweig, MC; Nussenzweig, A			Genomic instability in mice lacking histone H2AX	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; END-JOINING PATHWAY; ATM-DEFICIENT MICE; DNA-REPAIR; ATAXIA-TELANGIECTASIA; TARGETED DISRUPTION; IONIZING-RADIATION; VERTEBRATE CELLS; RECOMBINATION; STABILITY	Higher order chromatin structure presents a barrier to the recognition and repair of DNA damage. Double-strand breaks (DSBs) induce histone H2AX phosphorylation, which is associated with the recruitment of repair factors to damaged DNA. To help clarify the physiological role of H2AX, we targeted H2AX in mice. Although H2AX is not essential for irradiation-induced cell-cycle checkpoints, H2AX(-/-) mice were radiation sensitive, growth retarded, and immune deficient, and mutant males were infertile. These pleiotropic phenotypes were associated with chromosomal instability, repair defects, and impaired recruitment of Nbs1, 53bp1, and Brca1, but not Rad51, to irradiation-induced foci. Thus, H2AX is critical for facilitating the assembly of specific DNA-repair complexes on damaged DNA.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; NIH, Mol Pharmacol Lab, Bethesda, MD 20892 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Immunol, New York, NY 10021 USA; NIH, Mouse Canc Genet Program, Frederick, MD 20892 USA; NCI, Dept Genet, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; NIH, Vet Resources Program, Natl Ctr Res Resources, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Fernandez-Capetillo, Oscar/H-3508-2015; Difilippantonio, Michael/AAF-2839-2021; Coppola, Vincenzo/D-5352-2014; Nussenzweig, Michel/AAE-7292-2019; Reina-San-Martin, Bernardo/I-9484-2016; Coppola, Vincenzo/E-2917-2011	Fernandez-Capetillo, Oscar/0000-0002-2690-6885; Difilippantonio, Michael/0000-0002-4676-7034; Coppola, Vincenzo/0000-0001-6163-1779; Reina-San-Martin, Bernardo/0000-0003-2083-6166; Coppola, Vincenzo/0000-0001-6163-1779; Martin (nee Sedelnikova), Olga/0000-0003-3470-2935	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK052008] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CELESTE A, UNPUB; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Essers J, 2000, EMBO J, V19, P1703, DOI 10.1093/emboj/19.7.1703; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; GU Y, 1997, IMMUNITY, V7; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Liyanage M, 2000, BLOOD, V96, P1940, DOI 10.1182/blood.V96.5.1940.h8001940_1940_1946; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Maser RS, 2001, MOL CELL BIOL, V21, P6006, DOI 10.1128/MCB.21.17.6006-6016.2001; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Nussenzweig A, 1997, P NATL ACAD SCI USA, V94, P13588, DOI 10.1073/pnas.94.25.13588; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; SHROFF R, COMMUNICATION; Sonoda E, 1998, EMBO J, V17, P598, DOI 10.1093/emboj/17.2.598; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	33	1064	1100	0	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2002	296	5569					922	927		10.1126/science.1069398	http://dx.doi.org/10.1126/science.1069398			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549KF	11934988	Green Accepted			2022-12-24	WOS:000175442500048
J	Lasser, KE; Allen, PD; Woolhandler, SJ; Himmelstein, DU; Wolfe, SN; Bor, DH				Lasser, KE; Allen, PD; Woolhandler, SJ; Himmelstein, DU; Wolfe, SN; Bor, DH			Timing of new black box warnings and withdrawals for prescription medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIANS DESK REFERENCE; ADVERSE DRUG-REACTIONS; UNITED-KINGDOM; SAFETY; DISCONTINUATIONS; INFORMATION; PROMOTION; STATES; FDA	Context Recently approved drugs may be more likely to have unrecognized adverse drug reactions (ADRs) than established drugs, but no recent studies have examined how frequently postmarketing surveillance identifies important ADRs. Objective To determine the frequency and timing of discovery of new ADRs described in black box warnings or necessitating withdrawal of the drug from the market. Design and Setting Examination of the Physicians' Desk Reference for all new chemical entities approved by the US Food and Drug Administration between 1975 and 1999, and all drugs withdrawn from the market between 1975 and 2000 (with or without a prior black box warning). Main Outcome Measures Frequency of and time to a new black box warning or drug withdrawal. Results A total of 548 new chemical entities were approved in 1975-1999; 56 (10.2%) acquired a new black box warning or were withdrawn. Forty-five drugs (8.2%) acquired 1 or more black box warnings and 16 (2.9%) were withdrawn from the market. In Kaplan-Meier analyses, the estimated probability of acquiring a new black box warning or being withdrawn from the market over 25 years was 20%. Eighty-one major changes to drug labeling in the Physicians' Desk Reference occurred including the addition of 1 or more black box warnings per drug, or drug withdrawal. In Kaplan-Meier analyses, half of these changes occurred within 7 years of drug introduction; half of the withdrawals occurred within 2 years. Conclusions Serious ADRs commonly emerge after Food and Drug Administration approval. The safety of new agents cannot be known with certainty until a drug has been on the market for many years.	Cambridge Hosp, Dept Med, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA; Publ Citizen Hlth Res Grp, Washington, DC USA	Harvard University; Cambridge Health Alliance; Cambridge Hospital; Harvard University	Lasser, KE (corresponding author), Cambridge Hosp, Dept Med, Macht 4th Floor,1493 Cambridge St, Cambridge, MA 02139 USA.			Lasser, Karen/0000-0003-3777-6075	BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER	BHP HRSA HHS; DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))		[Anonymous], 1995, PHYS DESK REF; [Anonymous], 1991, PHYS DESK REF; [Anonymous], 1997, PHYS DESK REF; [Anonymous], 2000, PHYS DESK REF; [Anonymous], 1998, PHYS DESK REF; BAKKE OM, 1995, CLIN PHARMACOL THER, V58, P108, DOI 10.1016/0009-9236(95)90078-0; BAKKE OM, 1984, CLIN PHARMACOL THER, V35, P559, DOI 10.1038/clpt.1984.78; Basara L. R., 1996, DRUG INF J, V30, P715, DOI DOI 10.1177/009286159603000315; Beach JE, 1998, FOOD DRUG LAW J, V53, P403; Brewer T, 1999, JAMA-J AM MED ASSOC, V281, P824, DOI 10.1001/jama.281.9.824; *CDER, 1999, CDER REP NAT; *CDER, 2000, CDER REP NAT; Cohen JS, 2001, ARCH INTERN MED, V161, P880, DOI 10.1001/archinte.161.6.880; Cohen JS, 1996, ARCH INTERN MED, V156, P1375, DOI 10.1001/archinte.156.13.1375; Food and Drug Administration, 1998, FED REG, V63, P195; Hayes TA, 1998, CLIN PHARMACOL THER, V63, P607, DOI 10.1016/S0009-9236(98)90083-2; HURWITZ MA, 1988, J LAW ECON, V31, P299, DOI 10.1086/467158; Jones MI, 2001, BMJ-BRIT MED J, V323, P378, DOI 10.1136/bmj.323.7309.378; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lurie P, 1999, JAMA-J AM MED ASSOC, V282, P2297, DOI 10.1001/jama.282.24.2297; *MED EC CO, 1994, PHYS DESK REF; *MED EC CO, 1999, PHYS DESK REF; *MED EC CO, 1988, PHYS DESK REF; *MED EC CO, 1996, PHYS DESK REF; *MED EC CO, 1977, PHYS DESK REF; *MED EC CO, 1993, PHYS DESK REF; *MED EC CO, 1978, PHYS DESK REF; *MED EC CO, 1975, PHYS DESK REF; *MED EC CO, 1980, PHYS DESK REF; *MED EC CO, 1983, PHYS DESK REF; *MED EC CO, 1984, PHYS DESK REF; *MED EC CO, 1985, PHYS DESK REF; *MED EC CO, 1992, PHYS DESK REF; *MED EC CO, 1990, PHYS DESK REF; *MED EC CO, 1976, PHYS DESK REF; *MED EC CO, 1987, PHYS DESK REF; *MED EC CO, 1979, PHYS DESK REF; *MED EC CO, 1986, PHYS DESK REF; *MED EC CO, 1989, PHYS DESK REF; *MED EC CO, 1982, PHYS DESK REF; *MED EC CO, 1981, PHYS DESK REF; Merrill RA, 1999, HEALTH AFFAIR, V18, P96, DOI 10.1377/hlthaff.18.2.96; Mullen WH, 1997, ANN EMERG MED, V29, P255, DOI 10.1016/S0196-0644(97)70277-4; MURPHY MN, 1992, J DRUG ISSUES, V22, P305, DOI 10.1177/002204269202200210; PEAY MY, 1988, SOC SCI MED, V26, P1183, DOI 10.1016/0277-9536(88)90149-9; STROSS JK, 1987, J GEN INTERN MED, V2, P155, DOI 10.1007/BF02596142; Thase ME, 1999, J CLIN PSYCHIAT, V60, P23; *TUFTS CTR STUD DR, 2001, US APPR DRUGS DATA S; *US GEN ACC OFF, 1990, PUBL; Wood AJJ, 1999, JAMA-J AM MED ASSOC, V281, P1753, DOI 10.1001/jama.281.18.1753; Wood AJJ, 2000, NEW ENGL J MED, V342, P1824, DOI 10.1056/NEJM200006153422410; 2000, FED REG, V65, P81081; 2000, LOS ANGELES TIM 1220, pA1; 2000, NY TIMES        1005, pC1	54	713	752	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2215	2220		10.1001/jama.287.17.2215	http://dx.doi.org/10.1001/jama.287.17.2215			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	546EZ	11980521	Bronze, Green Published			2022-12-24	WOS:000175260600021
J	Boettger, T; Hubner, CA; Maier, H; Rust, MB; Beck, FX; Jentsch, TJ				Boettger, T; Hubner, CA; Maier, H; Rust, MB; Beck, FX; Jentsch, TJ			Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4	NATURE			English	Article							INNER-EAR; SENSORINEURAL DEAFNESS; DOMINANT DEAFNESS; HAIR-CELLS; POTASSIUM; GENE; COTRANSPORTER; MUTATIONS; CHANNEL; COCHLEA	Hearing depends on a high K+ concentration bathing the apical membranes of sensory hair cells. K+ that has entered hair cells through apical mechanosensitive channels is transported to the stria vascularis for re-secretion into the scala media(1). K+ probably exits outer hair cells by KCNQ4 K+ channels(2,3), and is then transported-by means of a gap junction system connecting supporting Deiters' cells and fibrocytes(4)-back to the stria vascularis. We show here that mice lacking the K+/Cl- (K-Cl) co-transporter Kcc4 (coded for by Slc12a7) are deaf because their hair cells degenerate rapidly after the beginning of hearing. In the mature organ of Corti, Kcc4 is restricted to supporting cells of outer and inner hair cells. Our data suggest that Kcc4 is important for K+ recycling(1,5) by siphoning K+ ions after their exit from outer hair cells into supporting Deiters' cells, where K+ enters the gap junction pathway. Similar to some human genetic syndromes(6), deafness in Kcc4-deficient mice is associated with renal tubular acidosis. It probably results from an impairment of Cl- recycling across the basolateral membrane of acid-secreting alpha-intercalated cells of the distal nephron.	Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Univ Hamburg, ZMNH, HNO Klin, D-20246 Hamburg, Germany; Univ Munich, Inst Physiol, D-80336 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Munich	Jentsch, TJ (corresponding author), Univ Hamburg, ZMNH, Zentrum Mol Neurobiol, Falkenried 94, D-20246 Hamburg, Germany.		Hannes, Maier/AAE-5070-2020; Hübner, Christian/A-2950-2017; Hannes, Maier/A-9457-2012; Boettger, Thomas/E-3406-2012	Hannes, Maier/0000-0001-8457-5327; Hübner, Christian/0000-0002-1030-4943; Hannes, Maier/0000-0001-8457-5327; Boettger, Thomas/0000-0003-4280-8449; Jentsch, Thomas/0000-0002-3509-2553				BECK FX, 1988, KIDNEY INT, V34, P455, DOI 10.1038/ki.1988.202; BECK FX, 1992, AM J PHYSIOL, V262, pF849, DOI 10.1152/ajprenal.1992.262.5.F849; Bruce LJ, 1997, J CLIN INVEST, V100, P1693, DOI 10.1172/JCI119694; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dixon MJ, 1999, HUM MOL GENET, V8, P1579, DOI 10.1093/hmg/8.8.1579; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JOHNSTONE BM, 1989, J PHYSIOL-LONDON, V408, P77, DOI 10.1113/jphysiol.1989.sp017448; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kharkovets T, 2000, P NATL ACAD SCI USA, V97, P4333, DOI 10.1073/pnas.97.8.4333; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Kikuchi T, 2000, BRAIN RES REV, V32, P163, DOI 10.1016/S0165-0173(99)00076-4; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lauf PK, 2000, CELL PHYSIOL BIOCHEM, V10, P341, DOI 10.1159/000016357; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Nenov AP, 1998, HEARING RES, V123, P168, DOI 10.1016/S0378-5955(98)00121-X; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P11663, DOI 10.1073/pnas.90.24.11663; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Rodriguez-Soriano J, 2000, PEDIATR NEPHROL, V14, P1121, DOI 10.1007/s004670000407; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P185, DOI 10.1177/40.2.1313059; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Voss AK, 1997, EXP CELL RES, V230, P45, DOI 10.1006/excr.1996.3418; WADA J, 1979, ARCH OTO-RHINO-LARYN, V225, P79, DOI 10.1007/BF00455206; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006	30	295	308	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					874	878		10.1038/416874a	http://dx.doi.org/10.1038/416874a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976689				2022-12-24	WOS:000175163800057
J	Rosner, I				Rosner, I			Uses of error - Early and late	LANCET			English	Article																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1422	1422		10.1016/S0140-6736(02)08356-3	http://dx.doi.org/10.1016/S0140-6736(02)08356-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978357				2022-12-24	WOS:000175076200031
J	Boeckxstaens, GE; Tytgat, GNJ				Boeckxstaens, GE; Tytgat, GNJ			More pathophysiologically oriented treatment of GORD?	LANCET			English	Editorial Material							ESOPHAGEAL SPHINCTER RELAXATIONS; REFLUX; INVOLVEMENT		Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Boeckxstaens, GE (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Boeckxstaens, Guy/AAP-2502-2020					Blackshaw LA, 2001, AM J PHYSIOL-GASTR L, V281, pG311, DOI 10.1152/ajpgi.2001.281.2.G311; Boeckxstaens GE, 1998, AM J GASTROENTEROL, V93, P1823; Hirsch DP, 2002, ALIMENT PHARM THER, V16, P17, DOI 10.1046/j.1365-2036.2002.01153.x; Hirsch DP, 1998, GASTROENTEROLOGY, V115, P1374, DOI 10.1016/S0016-5085(98)70015-0; HIRSCH DP, IN PRESS DIG DIS SCI; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; Lehmann A, 1999, GASTROENTEROLOGY, V117, P1147, DOI 10.1016/S0016-5085(99)70400-2; Lidums I, 2000, GASTROENTEROLOGY, V118, P7, DOI 10.1016/S0016-5085(00)70408-2; McDermott CM, 2001, GASTROENTEROLOGY, V120, P1749, DOI 10.1053/gast.2001.24849; Mittal RK, 1997, NEW ENGL J MED, V336, P924, DOI 10.1056/NEJM199703273361306; MITTAL RK, 1995, GASTROENTEROLOGY, V109, P1547, DOI 10.1016/0016-5085(95)90643-6; Penagini R, 1997, GASTROENTEROLOGY, V113, P409, DOI 10.1053/gast.1997.v113.pm9247457; Vela MF, 2001, GASTROENTEROLOGY, V120, P1599, DOI 10.1053/gast.2001.24840; Zhang Q, 2002, GUT, V50, P19, DOI 10.1136/gut.50.1.19	14	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 13	2002	359	9314					1267	1268		10.1016/S0140-6736(02)08285-5	http://dx.doi.org/10.1016/S0140-6736(02)08285-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965270				2022-12-24	WOS:000174989700007
J	Ray, S; Samuel, T; Hawker, J; Smith, S				Ray, S; Samuel, T; Hawker, J; Smith, S			Hepatitis B immunisation in renal units in the United Kingdom: questionnaire study	BRITISH MEDICAL JOURNAL			English	Article									Birmingham Heartlands Hosp, Ctr Communicable Dis Surveillance, Birmingham B9 5SS, W Midlands, England; Birmingham Heartlands Hosp, Renal Unit, Birmingham B9 5ST, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham	Smith, S (corresponding author), Birmingham Heartlands Hosp, Bordesley Green E, Birmingham B9 5ST, W Midlands, England.							*DEP HLTH, 1996, IMM AG INF DIS 1996; JIBANI MM, 1994, NEPHROL DIAL TRANSPL, V9, P1765; *LOND DEP HLTH PUB, IN PRESS DRAFT GOOD; *ROYAL COLL PHYS R, 1997, TREATM AD PAT REN FA, P64	4	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					877	878		10.1136/bmj.324.7342.877	http://dx.doi.org/10.1136/bmj.324.7342.877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950735	Green Published, Bronze			2022-12-24	WOS:000175052200020
J	Wu, H; Kanatous, SB; Thurmond, FA; Gallardo, T; Isotani, E; Bassel-Duby, R; Williams, RS				Wu, H; Kanatous, SB; Thurmond, FA; Gallardo, T; Isotani, E; Bassel-Duby, R; Williams, RS			Regulation of mitochondrial biogenesis in skeletal muscle by CaMK	SCIENCE			English	Article							PROTEIN-KINASE-I; GENE-EXPRESSION; FIBER-TYPE; CONTRACTILE ACTIVITY; COACTIVATOR PGC-1; ENZYME-ACTIVITY; CDNA CLONING; NUCLEAR; CALCINEURIN; PHOSPHORYLATION	Endurance exercise training promotes mitochondrial biogenesis in skeletal muscle and enhances muscle oxidative capacity, but the signaling mechanisms involved are poorly understood. To investigate this adaptive process, we generated transgenic mice that selectively express in skeletal muscle a constitutively active form of calcium/calmodulin-dependent protein kinase IV (CaMKIV*). Skeletal muscles from these mice showed augmented mitochondrial DNA replication and mitochondrial biogenesis, up-regulation of mitochondrial enzymes involved in fatty acid metabolism and electron transport, and reduced susceptibility to fatigue during repetitive contractions. CaMK induced expression of peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1), a master regulator of mitochondrial biogenesis in vivo, and activated the PGC-1 gene promoter in cultured myocytes. Thus, a calcium-regulated signaling pathway controls mitochondrial biogenesis in mammalian cells.	Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Duke University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Williams, RS (corresponding author), Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL006296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR040849, R01AR040849] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL06296] Funding Source: Medline; NIAMS NIH HHS [AR40849] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alevizopoulos A, 1997, J BIOL CHEM, V272, P23597, DOI 10.1074/jbc.272.38.23597; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Grange RW, 2001, AM J PHYSIOL-CELL PH, V281, pC1487, DOI 10.1152/ajpcell.2001.281.5.C1487; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; PETTE D, 1992, REV PHYSIOL BIOCH P, V120, P115, DOI 10.1007/BFb0036123; PICCIOTTO MR, 1993, J BIOL CHEM, V268, P26512; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang H, 1999, EUR J APPL PHYSIOL O, V80, P22, DOI 10.1007/s004210050553; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	23	510	542	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					349	352		10.1126/science.1071163	http://dx.doi.org/10.1126/science.1071163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951046				2022-12-24	WOS:000175000300059
J	Yamaguchi, A; Clayton, RN; Mayeda, TK; Ebihara, M; Oura, Y; Miura, YN; Haramura, H; Misawa, K; Kojima, H; Nagao, K				Yamaguchi, A; Clayton, RN; Mayeda, TK; Ebihara, M; Oura, Y; Miura, YN; Haramura, H; Misawa, K; Kojima, H; Nagao, K			A new source of basaltic meteorites inferred from Northwest Africa 011	SCIENCE			English	Article							PARENT BODY; NOBLE-GASES; EUCRITES; METAMORPHISM; ACHONDRITES; ELEMENTS; CRUST	Eucrites are a class of basaltic meteorites that share common mineralogical, isotopic, and chemical properties and are thought to have been derived from the same parent body, possibly asteroid 4 Vesta. The texture, mineralogy, and noble gas data of the recently recovered meteorite, Northwest Africa (NWA) 011, are similar to those of basaltic eucrites. However, the oxygen isotopic composition of NWA011 is different from that of other eucrites, indicating that NWA011 may be derived from a different parent body. The presence of basaltic meteorites with variable oxygen isotopic composition suggests the occurrence of multiple basaltic meteorite parent bodies, perhaps similar to 4 Vesta, in the early solar system.	Natl Inst Polar Res, Antarctic Meteorite Res Ctr, Tokyo 1738515, Japan; Grad Univ Adv Studies, Tokyo 1738515, Japan; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; Univ Tokyo, Earthquake Chem Lab, Tokyo 1130033, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Graduate University for Advanced Studies - Japan; University of Chicago; Tokyo Metropolitan University; University of Tokyo; University of Tokyo	Yamaguchi, A (corresponding author), Natl Inst Polar Res, Antarctic Meteorite Res Ctr, Tokyo 1738515, Japan.							Afanasiev SV, 2000, METEORIT PLANET SCI, V35, pA19; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P2; Ebihara M, 1996, GEOCHIM COSMOCHIM AC, V60, P5133, DOI 10.1016/S0016-7037(96)00282-7; EBIHARA M, UNPUB; ELGORESY A, 1975, P LUN SCI C, V6, P729; EUGSTER O, 1995, GEOCHIM COSMOCHIM AC, V59, P177, DOI 10.1016/0016-7037(94)00327-I; Floss C., 2000, ANTARCT METEORITE RE, V13, P222; Gibson E. K.  Jr., 1978, Meteoritics, V13, P277, DOI 10.1111/j.1945-5100.1978.tb00467.x; Haramura H., 1983, MEM NATL I POLAR RES, V30, P109; HIROI T, UNPUB; IKEDA Y, 1985, P LUNAR PLANET SCI S, V15, pC649; KRETZ R, 1982, GEOCHIM COSMOCHIM AC, V46, P411, DOI 10.1016/0016-7037(82)90232-0; Latif SA, 1999, J RADIOANAL NUCL CH, V239, P577, DOI 10.1007/BF02349072; Lazzaro D, 2000, SCIENCE, V288, P2033, DOI 10.1126/science.288.5473.2033; Mason B., 1979, SMITHSON CONTRIB EAR, V22, P27; MITTLEFEHLDT DW, REV MINERALOGY, V36, P1; Miura YN, 1998, GEOCHIM COSMOCHIM AC, V62, P2369, DOI 10.1016/S0016-7037(98)00118-5; MIYAMOTO M, 1985, P LUNAR PLANET SCI C, V15, pC629; Shinotsuka K, 1997, ANAL CHIM ACTA, V338, P237, DOI 10.1016/S0003-2670(96)00528-4; TAKEDA H, 1991, METEORITICS, V26, P129, DOI 10.1111/j.1945-5100.1991.tb01028.x; Wasson J.T., 1979, ASTEROIDS, P926; WILLIS J, 1982, J GEOPHYS RES, V87, pA435, DOI 10.1029/JB087iS01p0A435; Yamaguchi A, 1996, ICARUS, V124, P97, DOI 10.1006/icar.1996.0192; Yamaguchi A, 1997, J GEOPHYS RES-PLANET, V102, P13381, DOI 10.1029/97JE00519; Yamaguchi A, 2001, GEOCHIM COSMOCHIM AC, V65, P3577, DOI 10.1016/S0016-7037(01)00681-0	29	117	119	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					334	336		10.1126/science.1069408	http://dx.doi.org/10.1126/science.1069408			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951042				2022-12-24	WOS:000175000300054
J	Rosenbloom, M				Rosenbloom, M			Chlorpromazine and the psychopharmacologic revolution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Columbia University	Rosenbloom, M (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.							Artigues M F, 2000, N C Med J, V61, P90; Ban TA, 2001, PROG NEURO-PSYCHOPH, V25, P709, DOI 10.1016/S0278-5846(01)00160-9; Cancro R, 2000, PSYCHIATR SERV, V51, P333, DOI 10.1176/appi.ps.51.3.333; CORYELL W, 1987, AM J PSYCHIAT, V144, P913; FREEMAN H, 1999, CENTURY PSYCHIAT; JOS CJ, 1985, AM J PSYCHIAT, V142, P660, DOI 10.1176/ajp.142.5.660; LIPTON MA, 1978, PSYCHOPHARMACOLOGY G, P4; Meyer JM, 1997, PSYCHIATR SERV, V48, P1137; Shorter Edward., 1997, HIST PSYCHIAT ERA AS; SNYDER SH, 1996, DRUGS BRAIN; 1976, AM J PSYCHIAT, V27, P505	11	16	17	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2002	287	14					1860	1861		10.1001/jama.287.14.1860	http://dx.doi.org/10.1001/jama.287.14.1860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539QJ	11939878	hybrid			2022-12-24	WOS:000174881700044
J	French, AL; Cohen, MH; Gange, SJ; Burger, H; Gao, W; Semba, RD; Meyer, WA; Robison, E; Anastos, K				French, AL; Cohen, MH; Gange, SJ; Burger, H; Gao, W; Semba, RD; Meyer, WA; Robison, E; Anastos, K			Vitamin A deficiency and genital viral burden in women infected with HIV-1	LANCET			English	Article							A-DEFICIENCY; TRANSMISSION; PREGNANCY	The relation between vitamin A (retinol) deficiency and perinatal transmission of HIV-1, If It exists, might be mediated through an increased viral load in the mother's genital tract. To ascertain whether or not such an association is present, we measured the serum concentration of retinol with high performance liquid chromatography, and correlated the results with concurrent quantified HIV-1 RNA concentrations In cervicovaginal lavage fluid In 301 women Infected with the virus. We noted no association between retinol status and genital HIV-1 load. Our findings lend support to those of studies that reported no association between retinol deficiency and perinatal HIV-1. transmission.	Cook Cty Hosp, Div Infect Dis, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; Montefiore Med Ctr, Bronx, NY 10467 USA; Johns Hopkins Sch Med, Baltimore, MD USA; Queat Diagnost Inc, Baltimore, MD USA; Lincoln Med Ctr, Bronx, NY USA	John H Stroger Junior Hospital Cook County; Rush University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; State University of New York (SUNY) System; Wadsworth Center; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	French, AL (corresponding author), Cook Cty Hosp, Div Infect Dis, Durand 115,1835 W Harrison St, Chicago, IL 60612 USA.		Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X; French, Audrey/0000-0002-9776-8934	NIAID NIH HHS [U01-AI-35004, AI-34989, U01-AI-34994, U01-AI-42590, U01-AI-31834, U01-AI-34993] Funding Source: Medline; NICHD NIH HHS [U01-HD-32632] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, U01AI034989, U01AI042590, U01AI034993, U01AI034994, U01AI031834] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Burns DN, 1999, CLIN INFECT DIS, V29, P328, DOI 10.1086/520210; Greenberg BL, 1997, AIDS, V11, P325, DOI 10.1097/00002030-199703110-00010; John GC, 1997, J INFECT DIS, V175, P57, DOI 10.1093/infdis/175.1.57; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; SEMBA RD, 1994, LANCET, V343, P1593, DOI 10.1016/S0140-6736(94)93056-2	5	8	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 6	2002	359	9313					1210	1212		10.1016/S0140-6736(02)08226-0	http://dx.doi.org/10.1016/S0140-6736(02)08226-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AB	11955543				2022-12-24	WOS:000174846300015
J	Grieco, F; van Noordwijk, AJ; Visser, ME				Grieco, F; van Noordwijk, AJ; Visser, ME			Evidence for the effect of learning on timing of reproduction in blue tits	SCIENCE			English	Article							BIRDS	We experimentally show that in blue tits (Parus caeruleus) egg-laying date is causally linked to experience in the previous year. Females that received additional food in the nestling period in one year laid eggs later in the next year compared with the control birds, whatever the degree of synchronization with the natural food abundance in the previous year. As a result, they raised their brood much later than the peak period of nestling food availability in the next year. The response to experience is adaptive for blue tits, which live in heterogeneous habitats where the peak period of food varies, but once settled will breed at the same location for life.	Netherlands Inst Ecol, Ctr Terr Ecol, NL-6666 ZG Heteren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Grieco, F (corresponding author), Netherlands Inst Ecol, Ctr Terr Ecol, POB 40, NL-6666 ZG Heteren, Netherlands.		van noordwijk, arie/A-8880-2011; Visser, Marcel E/A-9151-2009	Visser, Marcel E/0000-0002-1456-1939				GIBB JA, 1963, J ANIM ECOL, V32, P489, DOI 10.2307/2605; Gustafsson L., 1990, NATO ASI Series Series G Ecological Sciences, V24, P235; Hau M, 2000, J EXP ZOOL, V286, P494, DOI 10.1002/(SICI)1097-010X(20000401)286:5<494::AID-JEZ7>3.0.CO;2-3; HOUSTON DC, 1999, P 22 INT ORN C DURB, P52; Lambrechts M.M., 1999, P 22 INT ORN C DURB, P249; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; Lessells C.M., 1991, P32; NAGER RG, 1995, AM NAT, V146, P454, DOI 10.1086/285809; Nilsson J-A, 1999, P 22 INT ORN C DURB, P234; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; TINBERGEN JM, 1994, FUNCT ECOL, V8, P563, DOI 10.2307/2389916	12	77	78	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					136	138		10.1126/science.1068287	http://dx.doi.org/10.1126/science.1068287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935025				2022-12-24	WOS:000174858800046
J	Anderson, MJ; Dixson, AF				Anderson, MJ; Dixson, AF			Sperm competition - Motility and the midpiece in primates	NATURE			English	Article							DOMESTIC-FOWL; DETERMINES; MOBILITY		Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA	Zoological Society of San Diego	Anderson, MJ (corresponding author), Zool Soc San Diego, Ctr Reprod Endangered Species, POB 120551, San Diego, CA 92112 USA.							Birkhead T, 2000, PROMISCUITY EVOLUTIO; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Birkhead TR, 1998, SPERM COMPETITION SE; CARDULLO RA, 1991, CELL MOTIL CYTOSKEL, V19, P180, DOI 10.1002/cm.970190306; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Froman DP, 1998, BIOL REPROD, V58, P379, DOI 10.1095/biolreprod58.2.379; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Katz D.F., 1990, P125; Parker G.A., 1984, P1; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Smuts B. B., 1987, PRIMATE SOC; WOOLLEY DM, 1967, NATURE, V215, P94, DOI 10.1038/215094a0	13	180	183	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					496	496		10.1038/416496a	http://dx.doi.org/10.1038/416496a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932733				2022-12-24	WOS:000174756500031
J	Lehn, JM				Lehn, JM			Toward self-organization and complex matter	SCIENCE			English	Article							DYNAMIC COMBINATORIAL CHEMISTRY; MOLECULAR RECOGNITION; SUPRAMOLECULAR CHEMISTRY; ORGANIC-CHEMISTRY; CHEMICAL-SYSTEMS; NANOSTRUCTURES; INFORMATION; COMPUTATION; GENERATION; EVOLUTION	Beyond molecular chemistry based on the covalent bond, supramolecular chemistry aims at developing highly complex chemical systems from components interacting through noncovalent intermolecular forces. Over the past quarter century, supramolecular chemistry has grown into a major field and has fueled numerous developments at the interfaces with biology and physics. Some of the conceptual advances and future challenges are profited here.	Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France; Coll France, F-75005 Paris, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France	Lehn, JM (corresponding author), Univ Strasbourg 1, ISIS, F-67000 Strasbourg, France.	lehn@chimie.u-strasbg.fr						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Atwood J.L., 1996, COMPREHENSIVE SUPRAM, DOI DOI 10.1021/jacs.6b12949; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Balzani V., 1991, SUPRAMOLECULAR PHOTO; Bard A.J., 1994, INTEGRATED CHEM SYST; Berl V, 2000, CHEM-EUR J, V6, P1938; Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q; Chandross EA, 1999, CHEM REV, V99, P1641, DOI 10.1021/cr990020n; Chen JH, 2000, P NATL ACAD SCI USA, V97, P1328, DOI 10.1073/pnas.97.4.1328; Cousins GRL, 2000, CURR OPIN CHEM BIOL, V4, P270, DOI 10.1016/S1367-5931(00)00088-0; Czarnik A.W., 1997, CHEMOSENSORS ION MOL; de Silva AP, 2000, J AM CHEM SOC, V122, P3965; Desiraju GR, 1995, CRYSTAL SUPRAMOLECUL, V2; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Funeriu DP, 2000, CHEM-EUR J, V6, P2103; Fyfe MCT, 1997, ACCOUNTS CHEM RES, V30, P393, DOI 10.1021/ar950199y; Gokel GW, 2001, CHEM SOC REV, V30, P274, DOI 10.1039/b008667n; Hasenknopf B, 1997, J AM CHEM SOC, V119, P10956, DOI 10.1021/ja971204r; Hasenknopf B, 1998, ANGEW CHEM INT EDIT, V37, P3265, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3265::AID-ANIE3265>3.0.CO;2-B; JORTNER JR, 1997, MOL ELECT; KRAMER R, 1993, P NATL ACAD SCI USA, V90, P5394, DOI 10.1073/pnas.90.12.5394; LAWRENCE DS, 1995, CHEM REV, V95, P2229, DOI 10.1021/cr00038a018; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; Lehn JM, 2000, CHEM-EUR J, V6, P2097, DOI 10.1002/1521-3765(20000616)6:12<2097::AID-CHEM2097>3.0.CO;2-T; Lehn JM, 2001, SCIENCE, V291, P2331, DOI 10.1126/science.1060066; Lehn JM, 1999, CHEM-EUR J, V5, P2455; LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041; Lehn JM, 1999, NATO ADV SCI I C-MAT, V527, P287; Leininger S, 2000, CHEM REV, V100, P853, DOI 10.1021/cr9601324; Lindoy L.F., 2000, SELF ASSEMBLY SUPRAM; Marchi-Artzner V, 2001, CHEMPHYSCHEM, V2, P367, DOI 10.1002/1439-7641(20010618)2:6<367::AID-CPHC367>3.0.CO;2-#; MENGER FM, 1995, ANGEW CHEM INT EDIT, V34, P2091, DOI 10.1002/anie.199520911; ORGEL LE, 1995, ACCOUNTS CHEM RES, V28, P109, DOI 10.1021/ar00051a004; Paleos CM, 2001, CHEMBIOCHEM, V2, P305, DOI 10.1002/1439-7633(20010504)2:5<305::AID-CBIC305>3.0.CO;2-9; Philp D, 1996, ANGEW CHEM INT EDIT, V35, P1154, DOI 10.1002/anie.199611541; Prins LJ, 2001, ANGEW CHEM INT EDIT, V40, P2382, DOI 10.1002/1521-3773(20010702)40:13<2382::AID-ANIE2382>3.0.CO;2-G; Quinkert G, 1996, HELV CHIM ACTA, V79, P1260, DOI 10.1002/hlca.19960790504; Robertson A, 2000, CHEM SOC REV, V29, P141, DOI 10.1039/a803602k; Rothemund PWK, 2000, P NATL ACAD SCI USA, V97, P984, DOI 10.1073/pnas.97.3.984; Sauvage, 1999, MOL CATENANES ROTAXA; Service RF, 2001, SCIENCE, V293, P782, DOI 10.1126/science.293.5531.782; Smith VCM, 1996, CHEM COMMUN, P2733, DOI 10.1039/cc9960002733; STODDART JF, 2001, ACCOUNTS CHEM RES, V34, P409; Suarez M, 1998, J AM CHEM SOC, V120, P9526, DOI 10.1021/ja981722h; Swiegers GF, 2000, CHEM REV, V100, P3483, DOI 10.1021/cr990110s; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006; Yates FE., 1987, SELF ORG SYSTEMS; [No title captured]	49	1973	2001	15	702	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2400	2403		10.1126/science.1071063	http://dx.doi.org/10.1126/science.1071063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923524	Green Submitted			2022-12-24	WOS:000174712600040
J	Sumper, M				Sumper, M			A phase separation model for the nanopatterning of diatom biosilica	SCIENCE			English	Article							MESOPOROUS MOLECULAR-SIEVES; MORPHOGENESIS; MORPHOLOGY; SILICA	Diatoms are encased in an intricately patterned wall that consists of amorphous silica. Species-specific fabrication of this ornate biomineral enables taxonomists to identify thousands of diatom species. The molecular mechanisms that control this nanofabrication and generate the diversity of patterns is not well understood. A simple model is described, in which repeated phase separation events during wait biogenesis are assumed to produce self-similar silica patterns in smaller and smaller scales, On the basis of this single assumption, the apparently complex patterns found in the valves of the diatom genus Coscinodiscus can be predicted. Microscopic analysis of valves in statu nascendi from three different Coscinodiscus species supports the conclusions derived from the model.	Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany	University of Regensburg	Sumper, M (corresponding author), Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany.							DRUM RW, 1964, J ULTRA MOL STRUCT R, V10, P217, DOI 10.1016/S0022-5320(64)80006-X; GORDON R, 1994, INT REV CYTOL, V150, P243; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; Hasle Grethe Rytter, 1992, Diatom Research, V7, P37; Imhof A, 1997, NATURE, V389, P948, DOI 10.1038/40105; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Lin HP, 1996, SCIENCE, V273, P765, DOI 10.1126/science.273.5276.765; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; PICKETTHEAPS JD, 1979, BIOL CELLULAIRE, V35, P199; Schacht S, 1996, SCIENCE, V273, P768, DOI 10.1126/science.273.5276.768; SCHMID AMM, 1983, J PHYCOL, V19, P387, DOI 10.1111/j.0022-3646.1983.00387.x; Tanaka H, 1996, PHYS REV LETT, V76, P787, DOI 10.1103/PhysRevLett.76.787; Tomas CR, 1997, IDENTIFYING MARINE P; WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0; Yang H, 1997, NATURE, V386, P692, DOI 10.1038/386692a0	20	293	299	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2430	2433		10.1126/science.1070026	http://dx.doi.org/10.1126/science.1070026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923533				2022-12-24	WOS:000174712600049
J	Bernstein, MP; Dworkin, JP; Sandford, SA; Cooper, GW; Allamandola, LJ				Bernstein, MP; Dworkin, JP; Sandford, SA; Cooper, GW; Allamandola, LJ			Racemic amino acids from the ultraviolet photolysis of interstellar ice analogues	NATURE			English	Article							ALLENDE MINERALS; SOLAR-SYSTEM; DENSE CLOUDS; HYDROGEN; INVENTORY; METHANOL	The delivery of extraterrestrial organic molecules to Earth by meteorites may have been important for the origin and early evolution of life(1). Indigenous amino acids have been found in meteorites(2)-over 70 in the Murchison meteorite alone(3). Although it has been generally accepted that the meteoritic amino acids formed in liquid water(4) on a parent body, the water in the Murchison meteorite is depleted in deuterium(5) relative to the indigenous organic acids(6,7). Moreover, the meteoritical evidence(8) for an excess of laevo-rotatory amino acids is hard to understand in the context of liquid-water reactions on meteorite parent bodies. Here we report a laboratory demonstration that glycine, alanine and serine naturally form from ultraviolet photolysis of the analogues of icy interstellar grains. Such amino acids would naturally have a deuterium excess similar to that seen in interstellar molecular clouds, and the formation process could also result in enantiomeric excesses if the incident radiation is circularly polarized. These results suggest that at least some meteoritic amino acids are the result of interstellar photochemistry, rather than formation in liquid water on an early Solar System body.	SETI Inst, Ctr Study Life Universe, Mountain View, CA 94043 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Bernstein, MP (corresponding author), SETI Inst, Ctr Study Life Universe, 2035 Landings Dr, Mountain View, CA 94043 USA.	mbernstein@mail.arc.nasa.gov	Dworkin, Jason P./C-9417-2012	Dworkin, Jason P./0000-0002-3961-8997				ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROPHYS J, V399, P134, DOI 10.1086/171909; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bonner WA, 2000, ORIGINS LIFE EVOL B, V30, P513, DOI 10.1023/A:1026571209426; Chiar JE, 2000, ASTROPHYS J, V537, P749, DOI 10.1086/309047; Cronin J R, 1983, Adv Space Res, V3, P5, DOI 10.1016/0273-1177(83)90036-4; Cronin JR, 1997, SCIENCE, V275, P951, DOI 10.1126/science.275.5302.951; CRONIN JR, 1993, NATO ADV SCI INST SE, V416, P209; Ehrenfreund P, 2001, ASTROPHYS J, V550, pL95, DOI 10.1086/319491; Gerakines PA, 1996, ASTRON ASTROPHYS, V312, P289; Gibb EL, 2000, ASTROPHYS J, V536, P347, DOI 10.1086/308940; Irvine WM, 1996, NATURE, V383, P418, DOI 10.1038/383418a0; Kerridge JF, 1999, SPACE SCI REV, V90, P275, DOI 10.1023/A:1005222804192; Lacy JH, 1998, ASTROPHYS J, V501, pL105, DOI 10.1086/311452; LERNER NR, 1995, GEOCHIM COSMOCHIM AC, V59, P1623, DOI 10.1016/0016-7037(95)00068-B; Lerner NR, 1997, GEOCHIM COSMOCHIM AC, V61, P4885, DOI 10.1016/S0016-7037(97)00275-5; MATTHEWS CN, 1967, NATURE, V215, P1230, DOI 10.1038/2151230a0; ORO J, 1961, NATURE, V190, P389, DOI 10.1038/190389a0; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; PRASAD SS, 1983, ASTROPHYS J, V267, P603, DOI 10.1086/160896; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; RUBENSTEIN E, 1983, NATURE, V306, P118, DOI 10.1038/306118a0; RUBENSTEIN E, 1999, SCIENCE, V283, P1415; Sandford SA, 1996, METEORIT PLANET SCI, V31, P449, DOI 10.1111/j.1945-5100.1996.tb02088.x; Sorrell WH, 2001, ASTROPHYS J, V555, pL129, DOI 10.1086/322525; TEGLER SC, 1993, ASTROPHYS J, V411, P260, DOI 10.1086/172825; Teixeira TC, 1999, ASTRON ASTROPHYS, V347, pL19; Turner BE, 2001, ASTROPHYS J SUPPL S, V136, P579, DOI 10.1086/322536; WARNECK P, 1962, APPL OPTICS, V1, P721, DOI 10.1364/AO.1.000721; ZHAO MX, 1995, J CHROMATOGR A, V690, P55, DOI 10.1016/0021-9673(94)00927-2	30	601	606	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					401	403		10.1038/416401a	http://dx.doi.org/10.1038/416401a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919623				2022-12-24	WOS:000174607800038
J	Karim, SA; Karim, QA; Adhikari, M; Cassol, S; Chersich, M; Cooper, P; Coovadia, A; Coovadia, H; Cotton, M; Coutsoudis, A; Hide, W; Hussey, G; Maartens, G; Madhi, S; Martin, D; Pettifor, JM; Rollins, N; Sherman, G; Thula, S; Urban, M; Velaphi, S; Williamson, C				Karim, SA; Karim, QA; Adhikari, M; Cassol, S; Chersich, M; Cooper, P; Coovadia, A; Coovadia, H; Cotton, M; Coutsoudis, A; Hide, W; Hussey, G; Maartens, G; Madhi, S; Martin, D; Pettifor, JM; Rollins, N; Sherman, G; Thula, S; Urban, M; Velaphi, S; Williamson, C			Vertical HIV transmission in South Africa: translating research into policy and practice	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; COST-EFFECTIVENESS; RANDOMIZED TRIAL; PREVENTION; ZIDOVUDINE; NEVIRAPINE; WOMEN		Univ Natal, ZA-4041 Durban, South Africa; Chris Hani Baragwanath Hosp, Johannesburg, South Africa; Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; Univ Witwatersrand, ZA-2050 Wits, South Africa; Univ Western Cape, ZA-7535 Bellville, South Africa; Univ Cape Town, ZA-7700 Rondebosch, South Africa	University of Kwazulu Natal; Stellenbosch University; University of Witwatersrand; University of the Western Cape; University of Cape Town	Karim, SA (corresponding author), Univ Natal, ZA-4041 Durban, South Africa.		Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Maartens, Gary/F-3836-2014; Hide, Winston A/V-2727-2017; Cotton, Mark/AAQ-9936-2020; Abdool Karim, Quarraisha/GVS-1160-2022; Pettifor, John/M-4579-2019	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Maartens, Gary/0000-0003-3080-6606; Hide, Winston A/0000-0002-8621-3271; Cotton, Mark/0000-0003-2559-6034; Abdool Karim, Quarraisha/0000-0002-0985-477X; Pettifor, John/0000-0003-1155-0334; Urban, Michael/0000-0002-9392-0206; chersich, matthew/0000-0002-4320-9168; , Carolyn/0000-0003-0125-1226				Abdullah MF, 2001, S AFR MED J, V91, P579; Coates TJ, 1996, LANCET, V348, P1143, DOI 10.1016/S0140-6736(96)02307-0; COOVADIA HM, 2001, AIDSCIENCE, V1, P1; Coutsoudis A, 2002, HEALTH POLICY PLANN, V17, P154, DOI 10.1093/heapol/17.2.154; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; GRAY G, 2000, 13 INT AIDS C DURB S; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; MOODLEY D, 2000, 13 INT AIDS C DURB S; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; OWOR M, 2000, 13 INT AIDS C DURB S; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stringer JSA, 2002, AM J PUBLIC HEALTH, V92, P365, DOI 10.2105/AJPH.92.3.365; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Wilkinson D, 2000, S AFR MED J, V90, P794	19	11	11	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 23	2002	359	9311					992	993		10.1016/S0140-6736(02)08063-7	http://dx.doi.org/10.1016/S0140-6736(02)08063-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937176				2022-12-24	WOS:000174585800003
J	O'Hagan, D; Schaffrath, C; Cobb, SL; Hamilton, JTG; Murphy, CD				O'Hagan, D; Schaffrath, C; Cobb, SL; Hamilton, JTG; Murphy, CD			Biosynthesis of an organofluorine molecule - A fluorinase enzyme has been discovered that catalyses carbon-fluorine bond formation.	NATURE			English	Article							FLUOROACETALDEHYDE		Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland; Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; Queens Univ Belfast, Dept Food Sci, Microbial Biochem Sect, Belfast BT9 SPX, Antrim, North Ireland	University of St Andrews; University of St Andrews; Queens University Belfast	O'Hagan, D (corresponding author), Univ St Andrews, Sch Chem, N Haugh, St Andrews KY16 9ST, Fife, Scotland.	dol@st-andrews.ac.uk	Cobb, Steven L/F-3926-2012; Murphy, Cormac D/I-4758-2013	Cobb, Steven L/0000-0002-3790-7023; Murphy, Cormac D/0000-0002-2137-3338; O'Hagan, David/0000-0002-0510-5552				GANI D, 1982, J CHEM SOC PERK T 1, P1197, DOI 10.1039/p19820001197; Gribble GW, 1999, CHEM SOC REV, V28, P335, DOI 10.1039/a900201d; HALL RJ, 1972, NEW PHYTOL, V71, P855, DOI 10.1111/j.1469-8137.1972.tb01965.x; HARPER DB, 1994, NAT PROD REP, V11, P123, DOI 10.1039/np9941100123; Moss SJ, 2000, CHEM COMMUN, P2281, DOI 10.1039/b007261n; Murphy CD, 2001, APPL ENVIRON MICROB, V67, P4919, DOI 10.1128/AEM.67.10.4919-4921; O'Hagan D, 2000, ACS SYM SER, V746, P210; PETERS RA, 1967, NATURE, V216, P80, DOI 10.1038/216080a0; SANADA M, 1986, J ANTIBIOT, V39, P259, DOI 10.7164/antibiotics.39.259	9	303	308	8	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					279	279		10.1038/416279a	http://dx.doi.org/10.1038/416279a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	532NP	11907567	Bronze			2022-12-24	WOS:000174482200030
J	Okazaki, IM; Kinoshita, K; Muramatsu, M; Yoshikawa, K; Honjo, T				Okazaki, IM; Kinoshita, K; Muramatsu, M; Yoshikawa, K; Honjo, T			The AID enzyme induces class switch recombination in fibroblasts	NATURE			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; S-REGIONS; GENE; HYPERMUTATION; SPECIFICITY; EXPRESSION; SEQUENCES; SITES	The switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA is mediated by class switch recombination (CSR). CSR changes the immunoglobulin heavy chain constant region (C-H) gene from Cmu to one of the other C-H genes(1,2). Somatic hypermutation introduces massive numbers of point mutations in the immunoglobulin variable (V) region gene, giving rise to immunoglobulin with higher affinity(3). Activation-induced cytidine deaminase (AID), a putative RNA-editing cytidine deaminase, is expressed strictly in activated B cells and is indispensable in both CSR and somatic hypermutation(4,5). But the exact function of AID is unknown. Here we show that ectopic expression of AID induces CSR in an artificial switch construct in fibroblasts at a level comparable to that in stimulated B cells. Sequences around recombination junctions in the artificial substrate have features similar to endogenous CSR junctions. Furthermore, AID-induced CSR in fibroblasts is dependent on transcription of the target S region, as shown in endogenous CSR in B cells. The results show that AID is the only B-cell-specific factor required for initiation of the CSR reaction in the activated locus.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Radioisotope Res Ctr, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Okazaki, Il-mi/0000-0001-8644-0100				Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; Chen XC, 2001, P NATL ACAD SCI USA, V98, P13860, DOI 10.1073/pnas.241524898; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; IWASATO T, 1992, J EXP MED, V175, P1539, DOI 10.1084/jem.175.6.1539; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; Kinoshita K, 1998, IMMUNITY, V9, P849, DOI 10.1016/S1074-7613(00)80650-0; Kinoshita K, 2001, NAT REV MOL CELL BIO, V2, P493, DOI 10.1038/35080033; Kitamura T, 1998, INT J HEMATOL, V67, P351; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; LUPTON SD, 1991, MOL CELL BIOL, V11, P3374, DOI 10.1128/MCB.11.6.3374; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Tashiro J, 2001, INT IMMUNOL, V13, P495, DOI 10.1093/intimm/13.4.495; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	30	205	214	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					340	345		10.1038/nature727	http://dx.doi.org/10.1038/nature727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11875397				2022-12-24	WOS:000174482200048
J	Serruya, MD; Hatsopoulos, NG; Paninski, L; Fellows, MR; Donoghue, JP				Serruya, MD; Hatsopoulos, NG; Paninski, L; Fellows, MR; Donoghue, JP			Instant neural control of a movement signal	NATURE			English	Article							NEURONS		Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Serruya, MD (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.							Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Maynard EM, 1999, J NEUROSCI, V19, P8083; PANINSKI L, UNPUB J NEUROSCI; PANINSKI L, 1999, SOC NEUR ABSTR; SERRUYA MD, IN PRESS BIOL CYBERN; Taylor DM, 2001, P 6 ANN IFESS C 2001, P132; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	9	947	1014	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					141	142		10.1038/416141a	http://dx.doi.org/10.1038/416141a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894084				2022-12-24	WOS:000174348100026
J	Nakatogawa, H; Ito, K				Nakatogawa, H; Ito, K			The ribosomal exit tunnel functions as a discriminating gate	CELL			English	Article							ESCHERICHIA-COLI SECA; ERYTHROMYCIN RESISTANCE; ENDOPLASMIC-RETICULUM; RNA; GENE; TRANSLATION; MUTATIONS; SITE; MECHANISM; SEQUENCE	Translation of SecM stalls unless its N-terminal part is "pulled" by the protein export machinery. Here we show that the sequence motif FXXXXWIXXXXGIRAGP that includes a specific arrest point (Pro) causes elongation arrest within the ribosome. Mutations that bypass the elongation arrest were isolated in 23S rRNA and L22 r protein. Such suppressor mutations occurred at a few specific residues of these components, which all face the narrowest constriction of the ribosomal exit tunnel. Thus, we suggest that this region of the exit tunnel interacts with nascent translation products and functions as a discriminating gate.	Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; Kyoto Univ, Japan Sci & Technol Corp, CREST, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University	Ito, K (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	kito@virus.kyoto-u.ac.jp	Nakatogawa, Hitoshi/D-5155-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; DEGNEN GE, 1974, J BACTERIOL, V117, P477, DOI 10.1128/JB.117.2.477-487.1974; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; McNicholas P, 1997, J MOL BIOL, V265, P128, DOI 10.1006/jmbi.1996.0723; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; Sarker S, 2000, J BACTERIOL, V182, P5592, DOI 10.1128/JB.182.19.5592-5595.2000; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHIMOIKE T, 1995, J BIOL CHEM, V270, P5519, DOI 10.1074/jbc.270.10.5519; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; VESTER B, 1987, BIOCHIMIE, V69, P891, DOI 10.1016/0300-9084(87)90217-3; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; Young JC, 1996, EMBO J, V15, P172, DOI 10.1002/j.1460-2075.1996.tb00345.x	26	397	408	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 8	2002	108	5					629	636		10.1016/S0092-8674(02)00649-9	http://dx.doi.org/10.1016/S0092-8674(02)00649-9			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893334	Bronze			2022-12-24	WOS:000174314800007
J	Johnson, D; Campbell, CD; Lee, JA; Callaghan, TV; Gwynn-Jones, D				Johnson, D; Campbell, CD; Lee, JA; Callaghan, TV; Gwynn-Jones, D			Arctic microorganisms respond more to elevated UV-B radiation than CO2	NATURE			English	Article							MICROBIAL COMMUNITIES; EXTRACTION METHOD; HEATH ECOSYSTEM; CARBON; SOIL; NITROGEN	Surface ultraviolet-B radiation and atmospheric CO2 concentrations have increased as a result of ozone depletion and burning of fossil fuels(1,2). The effects are likely to be most apparent in polar regions(3) where ozone holes have developed and ecosystems are particularly sensitive to disturbance(4). Polar plant communities are dependent on nutrient cycling by soil microorganisms, which represent a significant and highly labile portion of soil carbon (C) and nitrogen (N). It was thought(5) that the soil microbial biomass was unlikely to be affected by exposure of their associated plant communities to increased UV-B. In contrast, increasing atmospheric CO2 concentrations were thought to have a strong effect as a result of greater below-ground C allocation(6). In addition, there is a growing belief that ozone depletion is of only minor environmental concern because the impacts of UV-B radiation on plant communities are often very subtle(7). Here we show that 5 years of exposure of a subarctic heath to enhanced UV-B radiation both alone and in combination with elevated CO2 resulted in significant changes in the C:N ratio and in the bacterial community structure of the soil microbial biomass.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland; Abisko Sci Res Stn, SE-98107 Abisko, Sweden; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales	University of Sheffield; James Hutton Institute; Aberystwyth University	Johnson, D (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Callaghan, Terens V./N-7640-2014; Johnson, David/N-3193-2013	Campbell, Colin/0000-0002-5163-7656; Johnson, David/0000-0003-2299-2525				Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; BJORN LO, 1996, ECOLOGICAL B, V45, P204; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Caldwell M, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P241; CALDWELL MM, 1982, ARCTIC ALPINE RES, V14, P195, DOI 10.2307/1551152; CALLAGHAN TV, 1995, PHILOS T R SOC A, V352, P259, DOI 10.1098/rsta.1995.0069; Campbell CD, 1997, J MICROBIOL METH, V30, P33, DOI 10.1016/S0167-7012(97)00041-9; Ellenberg H., 1988, VEGETATION ECOLOGY C; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; GwynnJones D, 1997, PLANT ECOL, V128, P242; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; JOHANSON U, 1995, AMBIO, V24, P106; MOORHEAD DL, 1994, BIOL FERT SOILS, V18, P19, DOI 10.1007/BF00336439; Muller R, 1997, NATURE, V389, P709, DOI 10.1038/39564; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; SCHEINER D, 1976, WATER RES, V10, P31, DOI 10.1016/0043-1354(76)90154-8; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; SONESSON M, 1974, OIKOS, V25, P121, DOI 10.2307/3543633; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6	20	78	94	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					82	83		10.1038/416082a	http://dx.doi.org/10.1038/416082a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882896	Green Accepted			2022-12-24	WOS:000174211600042
J	Schwetz, BA				Schwetz, BA			New indication for Gleevec	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-24	WOS:000174186000005
J	Patz, JA; Khaliq, M				Patz, JA; Khaliq, M			Global climate change and health: Challenges for future practitioners	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NINO-SOUTHERN OSCILLATION; EL-NINO; MALARIA		Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Patz, JA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.							[Anonymous], CONTRIBUTION WORKING; Bouma MJ, 1997, TROP MED INT HEALTH, V2, P1122, DOI 10.1046/j.1365-3156.1997.d01-210.x; BRAUER M, 1998, WHO WORKSH HLTH IMP; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Gaffen DJ, 1998, NATURE, V396, P529, DOI 10.1038/25030; GOBLER DJ, 2001, ENVIRON HEALTH PER S, V109, P223; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 SCI; KARL TR, 1995, NATURE, V377, P217, DOI 10.1038/377217a0; Kilboume E.M., 1997, PUBLIC HLTH CONSEQUE, P51; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Malilay JF, 1997, PUBLIC HLTH CONSEQUE, P287; McConnell R, 2002, LANCET, V359, P386, DOI 10.1016/S0140-6736(02)07597-9; MCMICHAEL AJ, 1996, CLIMAGE CHANGE HUMAN; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Myers N., 1995, ENV EXODUS EMERGENT; NICHOLLS R, 1995, CLIMATE CHANGES INT, P92; Noji EK, 1997, PUBLIC HLTH CONSEQUE, P3; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Patz JA, 2001, HUM ECOL RISK ASSESS, V7, P1317, DOI 10.1080/20018091095023; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515	23	28	28	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2283	2284		10.1001/jama.287.17.2283	http://dx.doi.org/10.1001/jama.287.17.2283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980532				2022-12-24	WOS:000175260600031
J	Drazen, JM				Drazen, JM			Perspective - Smallpox and bioterrorism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Drazen, Jeffrey M/E-5841-2012	Drazen, Jeffrey/0000-0003-2715-9890					0	18	21	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 25	2002	346	17					1262	1263		10.1056/NEJM2e020038	http://dx.doi.org/10.1056/NEJM2e020038			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544GX	11923485				2022-12-24	WOS:000175150800001
J	Churchland, PS				Churchland, PS			Self-representation in nervous systems	SCIENCE			English	Article								The brain's earliest self-representational capacities arose as evolution found neural network solutions for coordinating and regulating inner-body signals, thereby improving behavioral strategies. Additional flexibility in organizing coherent behavioral options emerges from neural models that represent some of the brain's inner states as states of its body, while representing other signals as perceptions of the external world. Brains manipulate inner models to predict the distinct consequences in the external world of distinct behavioral options. The self thus turns out to be identifiable not with a nonphysical, soul, but rather with a set of representational capacities of the physical brain.	Univ Calif San Diego, Philosophy Dept 0119, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Churchland, PS (corresponding author), Univ Calif San Diego, Philosophy Dept 0119, La Jolla, CA 92093 USA.							Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; Churchland P. S., 1986, NEUROPHILOSOPHY; Churchland Paul M., 1988, MATTER CONSCIOUSNESS; CHURCHLAND PS, BRAIN WISE STUDIES N; CRICK F, IN PRESS PROBLEMS SY; Damasio A. R., 1999, FEELING WHAT HAPPENS; DAMASIO AR, 1994, DESCARTES ERROR; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; Fodor J. A., 1974, SYNTHESE, V28, P97, DOI DOI 10.1007/BF00485230; Frith CD., 1992, COGNITIVE NEUROSCIEN; Grush R, 1997, PHILOS PSYCHOL, V10, P5, DOI 10.1080/09515089708573201; HARTER S, 1999, CONSTRUCTION SELF DE; HOBSON AR, 1989, SLEEP; Hume David, 1952, TREATISE HUMAN NATUR, V2; Lakoff G., 1999, PHILOS FLESH; LeDoux J. E., 1996, EMOTIONAL BRAIN; LLINAS RR, 2001, I VORTEX; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Palmer S., 1999, VISION SCI; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Pinker S., 1997, MIND WORKS; SCHORE AN, 1994, AFFECT REGULATION OR; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; Squire LR., 1999, MEMORY MIND MOL; STEPHENS GL, 2000, WHEN SELF CONSCIOUSN; Tomasello M, 1997, PRIMATE COGNITION; VENDLER Z, 1994, MIND BODY PROBLEM GU; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	30	91	95	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					308	310		10.1126/science.1070564	http://dx.doi.org/10.1126/science.1070564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951034				2022-12-24	WOS:000175000300045
J	Green, RM; Cusotvic, A; Sanderson, G; Hunter, J; Johnston, SL; Woodcock, A				Green, RM; Cusotvic, A; Sanderson, G; Hunter, J; Johnston, SL; Woodcock, A			Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDOOR ALLERGENS; EXPOSURE; SENSITIZATION; CHILDREN; EXACERBATIONS; INFLAMMATION; PURIFICATION; INFECTIONS; ANTIBODIES	Objective To investigate the importance of sensitisation and exposure to allergens and viral infection in precipitating acute asthma in adults resulting in admission to hospital. Design Case-control study. Setting Large district general hospital. Participants 60 patients aged 17-50 admitted to hospital over a year with acute asthma, matched with two controls: patients with stable asthma recruited from die outpatient department and patients admitted to hospital with non-respiratory conditions (inpatient controls). Main outcome measures Atopic status (skin testing and total and specific IgE), presence of common respiratory Viruses and atypical bacteria (polymerase chain reaction), dust samples from homes, and exposure to allergens (enzyme linked immunosorbent assay (ELISA): Der p 1, Fel d 1, Can f 1, and Bla g 2). Results Viruses were detected in 31 of 177 patients. The difference in the frequency of viruses detected between the groups was significant (admitted with asthma 26%, stable asthma 18%, inpatient controls 9%; P=0.04). A significantly higher proportion of patients admitted with asthma (66%) were sensitised and exposed to either mite, cat, or dog allergen than patients with stable asthma (37%) and inpatient controls (15%; P < 0.001). Being sensitised and exposed to allergens was all independent associate of the group admitted to hospital (odds ratio 2.3, 95% confidence interval 1.0 to 5.4; P=0.05), whereas the combination of sensitisation, high exposure to one or more allergens, and viral detection considerably increased the risk of being admitted with asthma (8.4, 2.1 to 32.8; P=0.002). Conclusions Allergens and viruses may act together to exacerbate asthma.	Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Resp Med, London W2 1PG, England; Southampton Gen Hosp, Univ Med, Southampton SO9 6YD, Hants, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Imperial College London; University of Southampton	Cusotvic, A (corresponding author), Wythenshawe Hosp, NW Lung Ctr, Manchester M23 9LT, Lancs, England.	acustovic@fs1.with.man.ac.uk	Custovic, Adnan/A-2435-2012; Johnston, Sebastian Lennox/I-2423-2012	Custovic, Adnan/0000-0001-5218-7071; Johnston, Sebastian Lennox/0000-0003-3009-9200; Woodcock, Ashley/0000-0002-5428-8578				Busse WW, 1997, J ALLERGY CLIN IMMUN, V100, P147, DOI 10.1016/S0091-6749(97)70216-1; CALHOUN WJ, 1994, J CLIN INVEST, V94, P2200, DOI 10.1172/JCI117581; Campbell MJ, 1997, BRIT MED J, V315, P1012, DOI 10.1136/bmj.315.7114.1012; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Chauhan AJ, 2001, LUNG BIOL HEALTH DIS, V154, P221; Custovic A, 1997, AM J RESP CRIT CARE, V155, P94, DOI 10.1164/ajrccm.155.1.9001295; Custovic A, 1996, J ALLERGY CLIN IMMUN, V98, P64, DOI 10.1016/S0091-6749(96)70227-0; DUFF AL, 1993, PEDIATRICS, V92, P535; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Grunberg K, 1997, AM J RESP CRIT CARE, V156, P609; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; LEMANSKE RF, 1989, J CLIN INVEST, V83, P1, DOI 10.1172/JCI113843; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; MILLS TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS1; *NAT ASTHM CAMP, 1999, NAT ASTHM AUD 1999 2, P12; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; POLLART SM, 1991, J ALLERGY CLIN IMMUN, V87, P511, DOI 10.1016/0091-6749(91)90010-L; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Simpson A, 1999, AM J RESP CRIT CARE, V160, P45, DOI 10.1164/ajrccm.160.1.9809091; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Tunnicliffe WS, 1999, EUR RESPIR J, V13, P654, DOI 10.1183/09031936.99.13365499	24	256	267	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2002	324	7340					763	766A		10.1136/bmj.324.7340.763	http://dx.doi.org/10.1136/bmj.324.7340.763			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538KY	11923159	Green Published, Bronze			2022-12-24	WOS:000174816200016
J	Humphrey, D; Duggan, C; Saha, D; Smith, D; Kas, J				Humphrey, D; Duggan, C; Saha, D; Smith, D; Kas, J			Active fluidization of polymer networks through molecular motors	NATURE			English	Article							F-ACTIN; MYOSIN; FILAMENTS; MINIFILAMENTS; REPTATION; DYNAMICS; INVITRO; CHAIN	Entangled polymer solutions and melts exhibit elastic, solid-like resistance to quick deformations and a viscous, fluid-like response to slow deformations. This viscoelastic behaviour reflects the dynamics of individual polymer chains driven by brownian motion(1) : since individual chains can only move in a snake-like fashion through the mesh of surrounding polymer molecules, their diffusive transport, described by reptation(2-4),is so slow that the relaxation of suddenly imposed stress is delayed. Entangled polymer solutions and melts therefore elastically resist deforming motions that occur faster than the stress relaxation time. Here we show that the protein myosin II permits active control over the viscoelastic behaviour of actin filament solutions. We find that when each actin filament in a polymerized actin solution interacts with at least one myosin minifilament, the stress relaxation time of the polymer solution is significantly shortened. We attribute this effect to myosin's action as a 'molecular motor', which allows it to interact with randomly oriented actin filaments and push them through the solution, thus enhancing longitudinal filament motion. By superseding reptation with sliding motion, the molecular motors thus overcome a fundamental principle of complex fluids: that only depolymerization makes an entangled, isotropic polymer solution fluid for quick deformations.	Univ Texas, Ctr Nonlinear Dynam, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Austin, TX 78712 USA; Univ Texas, Ctr Nano & Mol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Kas, J (corresponding author), Univ Texas, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	kas@chaos.ph.utexas.edu		Kas, Josef A./0000-0003-3158-2480				ADELSTEIN RS, 1963, BIOCHEM BIOPH RES CO, V12, P34, DOI 10.1016/0006-291X(63)90409-1; Bray D., 1992, CELL MOVEMENTS; DEGENNES PG, 1971, J CHEM PHYS, V55, P572, DOI 10.1063/1.1675789; Doi M., 1986, THEORY POLYM DYNAMIC; Gupta R. K, 2000, POLYM COMPOSITE RHEO; HONDA H, 1986, J MOL BIOL, V191, P131, DOI 10.1016/0022-2836(86)90428-6; Isambert H, 1996, MACROMOLECULES, V29, P1036, DOI 10.1021/ma946418x; KAS J, 1994, NATURE, V368, P226, DOI 10.1038/368226a0; Kas J, 1996, BIOPHYS J, V70, P609, DOI 10.1016/S0006-3495(96)79630-3; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Liverpool TB, 2001, PHYS REV LETT, V86, P4171, DOI 10.1103/PhysRevLett.86.4171; MACLEANFLETCHER SD, 1980, J CELL BIOL, V85, P414, DOI 10.1083/jcb.85.2.414; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Morse DC, 1998, MACROMOLECULES, V31, P7044, DOI 10.1021/ma980304u; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; PERKINS TT, 1994, SCIENCE, V264, P819, DOI 10.1126/science.8171335; REISLER E, 1980, J MOL BIOL, V143, P129, DOI 10.1016/0022-2836(80)90127-8; SINARD JH, 1990, J BIOL CHEM, V265, P3654; Straub FB., 1943, STUDIES I MED CHEM U, VIII, P23; Taylor D L, 1979, Int Rev Cytol, V56, P57, DOI 10.1016/S0074-7696(08)61821-5; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2	23	242	246	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					413	416		10.1038/416413	http://dx.doi.org/10.1038/416413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919627				2022-12-24	WOS:000174607800042
J	Campbell, EA; Masuda, S; Sun, JL; Muzzin, O; Olson, CA; Wang, S; Darst, SA				Campbell, EA; Masuda, S; Sun, JL; Muzzin, O; Olson, CA; Wang, S; Darst, SA			Crystal structure of the Bacillus stearothermophilus anti-sigma factor SpoIIAB with the sporulation sigma factor sigma(F)	CELL			English	Article							TRANSCRIPTION FACTOR SIGMA(F); CELL-SPECIFIC TRANSCRIPTION; ANTISIGMA FACTOR SPOIIAB; CORE RNA-POLYMERASE; ESCHERICHIA-COLI; SUBTILIS SPORULATION; ATPASE REACTION; PROTEIN-KINASE; GENE; BINDING	Cell type-specific transcription during Bacillus sporulation is established by sigma(F). SpollAB is an anti-sigma that binds and negatively regulates sigma(F), as well as a serine kinase that phosphorylates and inactivates the anti-anti-sigma SpoIIAA. The crystal structure of sigma(F) bound to the SpollAB dimer in the low-affinity, ADP form has been determined at 2.9 Angstrom resolution. SpollAB adopts the GHKL superfamily fold of ATPases and histidine kinases. A domain of sigma(F) contacts both SpoIIAB monomers, while 80% of the sigma factor is disordered. The interaction occludes an RNA polymerase binding surface of sigma(F), explaining the SpollAB anti-sigma activity. The structure also explains the specificity of SpollAB for its target sigma factors and, in combination with genetic and biochemical data, provides insight into the mechanism of SpoIIAA anti-anti-sigma activity.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu		Campbell, Elizabeth/0000-0002-1332-128X	NIGMS NIH HHS [GM53759, GM20470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; BOWN JA, 1997, NUCL ACIDS MOL BIOL, P41; Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468; BROWN KL, 1995, MOL MICROBIOL, V16, P397, DOI 10.1111/j.1365-2958.1995.tb02405.x; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Campbell EA, 2000, J MOL BIOL, V300, P17, DOI 10.1006/jmbi.2000.3838; CAMPBELL EA, 2002, IN PRESS MOL CELL; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Decatur AL, 1996, GENE DEV, V10, P2348, DOI 10.1101/gad.10.18.2348; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; DRIKS A, 1991, P NATL ACAD SCI USA, V88, P9934, DOI 10.1073/pnas.88.22.9934; DUNCAN L, 1993, P NATL ACAD SCI USA, V90, P2325, DOI 10.1073/pnas.90.6.2325; DUNCAN L, 1994, CURR OPIN GENET DEV, V4, P630, DOI 10.1016/0959-437X(94)90127-O; Duncan L, 1996, J MOL BIOL, V260, P147, DOI 10.1006/jmbi.1996.0389; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; ERRINGTON J, 1993, MICROBIOL REV, V57, P1; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; FOULGER D, 1993, J GEN MICROBIOL, V139, P3197, DOI 10.1099/00221287-139-12-3197; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Garsin DA, 1998, J MOL BIOL, V284, P557, DOI 10.1006/jmbi.1998.2201; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joo DM, 1998, J BACTERIOL, V180, P1095, DOI 10.1128/JB.180.5.1095-1102.1998; Kellner EM, 1996, MOL MICROBIOL, V21, P913, DOI 10.1046/j.1365-2958.1996.461408.x; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; KIRCHMAN PA, 1993, MOL MICROBIOL, V8, P663, DOI 10.1111/j.1365-2958.1993.tb01610.x; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; LOSICK R, 1981, CELL, V25, P582, DOI 10.1016/0092-8674(81)90164-1; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Magnin T, 1997, J BACTERIOL, V179, P3922, DOI 10.1128/jb.179.12.3922-3927.1997; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; MARGOLIS P, 1991, SCIENCE, V254, P562, DOI 10.1126/science.1948031; MIN KT, 1993, CELL, V74, P735, DOI 10.1016/0092-8674(93)90520-Z; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Park SG, 1997, GENE, V194, P25, DOI 10.1016/S0378-1119(97)00096-6; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; Smith CV, 1998, BIOCHEMISTRY-US, V37, P9658, DOI 10.1021/bi9801309; Stock J. B., 1995, 2 COMPONENT SIGNAL T; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; STRAGIER P, 1985, FEBS LETT, V187, P11, DOI 10.1016/0014-5793(85)81203-5; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; YOON MY, 1987, BIOCHEMISTRY-US, V26, P4118, DOI 10.1021/bi00387a056; YUDKIN MD, 1987, J GEN MICROBIOL, V133, P475; Zhang CC, 1996, MOL MICROBIOL, V20, P9, DOI 10.1111/j.1365-2958.1996.tb02483.x; Zhou HJ, 1997, BIOCHEMISTRY-US, V36, P699, DOI 10.1021/bi961663p	73	91	93	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 22	2002	108	6					795	807		10.1016/S0092-8674(02)00662-1	http://dx.doi.org/10.1016/S0092-8674(02)00662-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	534AT	11955433	Bronze			2022-12-24	WOS:000174563000009
J	Fernandez-Gonzalez, A; La Spada, AR; Treadaway, J; Higdon, JC; Harris, BS; Sidman, RL; Morgan, JI; Zuo, J				Fernandez-Gonzalez, A; La Spada, AR; Treadaway, J; Higdon, JC; Harris, BS; Sidman, RL; Morgan, JI; Zuo, J			Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1	SCIENCE			English	Article							CEREBELLAR MUTANT MOUSE; RETINAL DEGENERATION; NEUROLOGICAL MUTATION; THALAMIC NEURONS; MICE; NEURODEGENERATION; EXPRESSION	The classical recessive mouse mutant, Purkinje cell degeneration (pcd), exhibits adult-onset degeneration of cerebellar Purkinje neurons, retinal photoreceptors, olfactory bulb mitral neurons, and selected thalamic neurons, and has defective spermatogenesis. Here we identify Nna1 as the gene mutated in the original pcd and two additional pcd alleles (pcd(2J) and pcd(3J)). Nna1 encodes a putative nuclear protein containing a zinc carboxypeptidase domain initially identified by its induction in spinal motor neurons during axonal regeneration. The present study suggests an unexpected molecular link between neuronal degeneration and regeneration, and its results have potential implications for neurodegenerative diseases and male infertility.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Div Med Genet Med, Seattle, WA 98195 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Jackson Laboratory; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Zuo, J (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jian.zuo@stjude.org	Morgan, James/GRO-2905-2022; La Spada, Albert/AAG-8809-2020; Morgan, James/N-8104-2018	Morgan, James/0000-0002-8920-1065; 	NCI NIH HHS [CA 23944, CA21765, R25 CA023944] Funding Source: Medline; NCRR NIH HHS [RR 01183] Funding Source: Medline; NEI NIH HHS [EY 12950] Funding Source: Medline; NIDCD NIH HHS [DC 04761] Funding Source: Medline; NIEHS NIH HHS [ES 10772] Funding Source: Medline; NINDS NIH HHS [NS 40361] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R25CA023944] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001183] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004761] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Blake JA, 2001, NUCLEIC ACIDS RES, V29, P91, DOI 10.1093/nar/29.1.91; BLANKS JC, 1982, J COMP NEUROL, V212, P231, DOI 10.1002/cne.902120303; Campbell DB, 1996, MOL BRAIN RES, V37, P79, DOI 10.1016/0169-328X(95)00275-W; Fernandez-Gonzalez A, 2000, EUR J NEUROSCI, V12, P1573, DOI 10.1046/j.1460-9568.2000.00044.x; GOODLETT CR, 1992, BEHAV BRAIN RES, V47, P129, DOI 10.1016/S0166-4328(05)80119-6; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; HANDEL MA, 1981, GAMETE RES, V4, P185, DOI 10.1002/mrd.1120040303; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hatten ME, 1997, CURR OPIN NEUROBIOL, V7, P40, DOI 10.1016/S0959-4388(97)80118-3; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Heintz N, 2000, ANNU REV PHYSIOL, V62, P779, DOI 10.1146/annurev.physiol.62.1.779; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; MULLEN RJ, 1977, NATURE, V270, P245, DOI 10.1038/270245a0; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; OGORMAN S, 1985, J COMP NEUROL, V234, P277, DOI 10.1002/cne.902340302; OGORMAN S, 1985, J COMP NEUROL, V234, P298, DOI 10.1002/cne.902340303; SERVADIO A, 1995, GENOMICS, V29, P812, DOI 10.1006/geno.1995.9925; Sidman RL., 1965, CATALOG NEUROLOGICAL, DOI [10.4159/harvard.9780674424326, DOI 10.4159/HARVARD.9780674424326]	21	171	178	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1904	1906		10.1126/science.1068912	http://dx.doi.org/10.1126/science.1068912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884758				2022-12-24	WOS:000174299500043
J	Saint Andre, AV; Blackwell, NM; Hall, LR; Hoerauf, A; Brattig, NW; Volkmann, L; Taylor, MJ; Ford, L; Hise, AG; Lass, JH; Diaconu, E; Pearlman, E				Saint Andre, AV; Blackwell, NM; Hall, LR; Hoerauf, A; Brattig, NW; Volkmann, L; Taylor, MJ; Ford, L; Hise, AG; Lass, JH; Diaconu, E; Pearlman, E			The role of endosymbiotic Wolbachia bacteria in the pathogenesis of river blindness	SCIENCE			English	Article							TOLL-LIKE RECEPTOR-4; ONCHOCERCA-VOLVULUS; LIPOPOLYSACCHARIDE; NEUTROPHIL; RECRUITMENT; CORNEA; ENDOBACTERIA; CHEMOTHERAPY; EXPRESSION; RESPONSES	Parasitic filarial nematodes infect more than 200 million individuals worldwide, causing debilitating inflammatory diseases such as river blindness and lymphatic filariasis. Using a murine model for river blindness in which soluble extracts of filarial nematodes were injected into the corneal stroma, we demonstrated that the predominant inflammatory response in the cornea was due to species of endosymbiotic Wolbachia bacteria. In addition, the inflammatory response induced by these bacteria was dependent on expression of functional Toll-like receptor 4 (TLR4) on host cells.	Univ Hosp Cleveland, Div Geog Med, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Dept Ophthalmol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University Hospitals of Cleveland; University Hospitals of Cleveland; Case Western Reserve University; Bernhard Nocht Institut fur Tropenmedizin; Liverpool School of Tropical Medicine; University of Liverpool	Pearlman, E (corresponding author), Univ Hosp Cleveland, Div Geog Med, Cleveland, OH 44106 USA.	exp2@po.cwru.edu		Hise, Amy/0000-0001-5075-5792; Taylor, Mark/0000-0003-3396-9275; Blackwell, Nathan/0000-0002-7242-5812; Ford, Louise/0000-0001-7919-2866; Pearlman, Eric/0000-0003-0137-7582	NATIONAL EYE INSTITUTE [P30EY011373, R01EY010320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI054652] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brattig NW, 2000, MICROBES INFECT, V2, P1147, DOI 10.1016/S1286-4579(00)01269-7; Brattig NW, 2001, MICROBES INFECT, V3, P439, DOI 10.1016/S1286-4579(01)01399-5; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cross HF, 2001, LANCET, V358, P1873, DOI 10.1016/S0140-6736(01)06899-4; GutierrezPena EJ, 1996, PARASITOLOGY, V113, P403, DOI 10.1017/S0031182000066543; Hall LR, 1999, J IMMUNOL, V163, P4970; Hall LR, 1999, CLIN MICROBIOL REV, V12, P445, DOI 10.1128/CMR.12.3.445; Hall LR, 2001, J IMMUNOL, V167, P919, DOI 10.4049/jimmunol.167.2.919; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kaifi JT, 2001, J IMMUNOL, V166, P6795, DOI 10.4049/jimmunol.166.11.6795; Li J, 2000, INVEST OPHTH VIS SCI, V41, P2945; PEARLMAN E, 1995, J EXP MED, V182, P931, DOI 10.1084/jem.182.4.931; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Taylor MJ, 2000, J EXP MED, V191, P1429, DOI 10.1084/jem.191.8.1429; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Taylor MJ, 2001, CURR OPIN INFECT DIS, V14, P727, DOI 10.1097/00001432-200112000-00011; VONSAINTANDRE A, UNPUB; *WHO, 1995, ONCH ITS CONTR, V852	22	245	251	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 8	2002	295	5561					1892	1895		10.1126/science.1068732	http://dx.doi.org/10.1126/science.1068732			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884755	Green Submitted			2022-12-24	WOS:000174299500039
J	Browne, J; Tunnacliffe, A; Burnell, A				Browne, J; Tunnacliffe, A; Burnell, A			Anhydrobiosis - Plant desiccation gene found in a nematode	NATURE			English	Article							VITRIFICATION; DEHYDRATION; SURVIVAL		Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; Natl Univ Ireland, Inst Bioengn & Agroecol, Maynooth, Kildare, Ireland; Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England	Maynooth University; Maynooth University; University of Cambridge	Browne, J (corresponding author), Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland.			Tunnacliffe, Alan/0000-0001-8570-125X				Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; HIGA LM, 1993, J EXP ZOOL, V267, P120, DOI 10.1002/jez.1402670205; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Solomon A, 2000, PARASITOLOGY, V121, P409, DOI 10.1017/S0031182099006563; Sun WQ, 1997, COMP BIOCHEM PHYS A, V117, P327, DOI 10.1016/S0300-9629(96)00271-X; Wolkers WF, 2001, BBA-PROTEIN STRUCT M, V1544, P196, DOI 10.1016/S0167-4838(00)00220-X	12	218	248	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					38	38		10.1038/416038a	http://dx.doi.org/10.1038/416038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882885	Green Accepted, Bronze			2022-12-24	WOS:000174211600031
J	Sundararajan, V; Mitra, N; Jacobson, JS; Grann, VR; Heitjan, DF; Neugut, AI				Sundararajan, V; Mitra, N; Jacobson, JS; Grann, VR; Heitjan, DF; Neugut, AI			Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer	ANNALS OF INTERNAL MEDICINE			English	Article							COLORECTAL-CANCER; PROGNOSTIC-FACTORS; CLINICAL-TRIALS; CLAIMS DATA; THERAPY; AGE; BIAS; CARE; SENSITIVITY; FLUOROURACIL	Background: Randomized clinical trials have demonstrated the efficacy of adjuvant 5-fluorouracil (5-FU)-based chemotherapy after surgical resection of node-positive colon cancer. Although this treatment became the standard in 1990 following a National Institutes of Health Consensus Conference, among those at least 65 years of age it is less likely to be offered to older or nonwhite patients. Objective: To determine the association between 5-FU-based chemotherapy and survival in older patients. Design: Retrospective cohort study. Setting: Combined database of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program and Medicare. Patients: 4768 patients 65 years of age or older who received a diagnosis of node-positive colon cancer from 1992 to 1996, were covered by Medicare Parts A and B, and resided in the population covered by the SEER program. Measurements: Propensity scores to control for known predictors of receiving treatment, Cox proportional hazards models to assess the association of 5-FU therapy with survival, and sensitivity analyses to estimate the possible effects of unknown confounders. Results: Fifty-two percent of patients received 5-FU therapy. For this sample, the hazard ratio for death associated with 5-FU therapy was 0.66 (95% Cl, 0.60 to 0.73). Confounding could have accounted for this association only if an unmeasured confounder were extremely unequally distributed between the treated and untreated groups or increased mortality by at least 50%. Conclusions: 5-Fluorouracil adjuvant therapy is significantly associated with reduced mortality in older patients, similar to the association found in randomized, controlled trials among younger patients. More frequent use of 5-FU therapy in older patients would probably reduce death from colon cancer.	Columbia Univ, Joseph L Mailman Sch Publ Hlth, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Neugut, AI (corresponding author), New York Presbyterian Hosp, Div Med Oncol, PH 18-127,630 W 168th St, New York, NY 10032 USA.	ain1@columbia.edu		Sundararajan, Vijaya/0000-0001-9387-1865	NATIONAL CANCER INSTITUTE [K05CA089155, P30CA013696, T32CA009529] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09529, P30 CA13696, K05 CA89155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTMAN K, 1985, J CLIN ONCOL, V3, P1142, DOI 10.1200/JCO.1985.3.8.1142; BEGG CB, 1983, CANCER, V52, P1986, DOI 10.1002/1097-0142(19831201)52:11<1986::AID-CNCR2820521103>3.0.CO;2-7; Bellemare S, 1998, ANN CHIR, V52, P711; BROWN ML, 1994, J NATL CANCER I, V86, P424, DOI 10.1093/jnci/86.6.424; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Cooper GS, 1999, MED CARE, V37, P436, DOI 10.1097/00005650-199905000-00003; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; EDLER L, 1986, EUR J CANCER CLIN ON, V22, P1231, DOI 10.1016/0277-5379(86)90325-1; FINDLAY MPN, 1991, EUR J CANCER, V27, P1597, DOI 10.1016/0277-5379(91)90422-A; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; FRANCIS AM, 1984, MED CARE, V22, P418, DOI 10.1097/00005650-198405000-00006; GIOVANAZZIBANNON S, 1994, J CLIN ONCOL, V12, P2447, DOI 10.1200/JCO.1994.12.11.2447; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Guadagnoli E, 1997, J CLIN ONCOL, V15, P2338, DOI 10.1200/JCO.1997.15.6.2338; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jessup JM, 1996, CANCER-AM CANCER SOC, V78, P918; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; LOPRINZI CL, 1994, J CLIN ONCOL, V12, P601, DOI 10.1200/JCO.1994.12.3.601; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; *NAT CANC I, 1999, SEER CANC STAT REV 1; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; NEWCOMB PA, 1993, J NATL CANCER I, V85, P1580, DOI 10.1093/jnci/85.19.1580; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Ooi BS, 1999, DIS COLON RECTUM, V42, P403, DOI 10.1007/BF02236362; PEDERSEN H, 1983, ACTA CHIR SCAND, V149, P329; Pitot HC, 2001, ONCOLOGY-NY, V15, P31; POTOSKY AL, 1993, MED CARE, V31, P732; Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V; Retchin SM, 1997, ARCH INTERN MED, V157, P1878, DOI 10.1001/archinte.157.16.1878; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Sundararajan V, 2001, CANCER J, V7, P213; SUNDARARAJAN V, 1999, P AN M AM SOC CLIN, V18, P1228; Yancik R, 1997, CANCER, V80, P1273, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4; Zaniboni A, 1998, CANCER, V82, P2135, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U	43	174	178	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					349	357		10.7326/0003-4819-136-5-200203050-00007	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525VT	11874307				2022-12-24	WOS:000174095300002
J	Velcich, A; Yang, WC; Heyer, J; Fragale, A; Nicholas, C; Viani, S; Kucherlapati, R; Lipkin, M; Yang, K; Augenlicht, L				Velcich, A; Yang, WC; Heyer, J; Fragale, A; Nicholas, C; Viani, S; Kucherlapati, R; Lipkin, M; Yang, K; Augenlicht, L			Colorectal cancer in mice genetically deficient in the mucin Muc2	SCIENCE			English	Article							ABERRANT CRYPT FOCI; APC GENE; COLON; EXPRESSION; CLONING; IDENTIFICATION; NEOPLASIA; MUTATION	The gastrointestinal tract is tined by a layer of mucus comprised of highly glycosylated proteins called mucins. To evaluate the importance of mucin in intestinal carcinogenesis, we constructed mice genetically deficient in Muc2, the most abundant secreted gastrointestinal mucin. Muc2(-/-) mice displayed aberrant intestinal crypt morphology and altered cell maturation and migration. Most notably, the mice frequently developed adenomas in the small intestine that progressed to invasive adenocarcinoma, as welt as rectal tumors. Thus, Muc2 is involved in the suppression of colorectal cancer.	Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA; Memory Pharmaceut Corp, Montvale, NJ 07645 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Strang Canc Prevent Ctr, New York, NY 10021 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Velcich, A (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, 111 E 210 St, Bronx, NY 10467 USA.		Yang, Wancai/G-3750-2010; Fragale, Alessandra/K-1071-2016; Kucherlapati, Raju/ABC-8807-2021; Yang, Wancai/O-7655-2019	Fragale, Alessandra/0000-0002-0362-1983; Yang, Wancai/0000-0001-7437-9197	NATIONAL CANCER INSTITUTE [P30CA013330, R01CA072835, R01CA090808] Funding Source: NIH RePORTER; NCI NIH HHS [CA 72835, CA 90808, P0 CA 13330] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aslam F, 2001, CANCER RES, V61, P570; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Engle SJ, 1999, CANCER RES, V59, P3379; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; KIM YS, 1995, GASTROENTEROLOGY, V109, P999, DOI 10.1016/0016-5085(95)90412-3; Kim YS, 1996, GLYCOCONJUGATE J, V13, P693, DOI 10.1007/BF00702333; OTORI K, 1995, CANCER RES, V55, P4743; Pretlow T. P., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P126; PRETLOW TP, 1991, CANCER RES, V51, P1564; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sands BE, 1996, ANNU REV PHYSIOL, V58, P253, DOI 10.1146/annurev.ph.58.030196.001345; SHEKELS LL, 1995, BIOCHEM J, V311, P775, DOI 10.1042/bj3110775; Shekels LL, 1998, BIOCHEM J, V330, P1301, DOI 10.1042/bj3301301; Siu IM, 1999, CANCER RES, V59, P63; STEELE GD, 1990, JAMA-J AM MED ASSOC, V264, P1444; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Klinken BJW, 1999, AM J PHYSIOL-GASTR L, V276, pG115, DOI 10.1152/ajpgi.1999.276.1.G115; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200	22	691	716	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 1	2002	295	5560					1726	1729		10.1126/science.1069094	http://dx.doi.org/10.1126/science.1069094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872843				2022-12-24	WOS:000174212900050
J	Boggon, TJ; Murray, J; Chappuis-Flament, S; Wong, E; Gumbiner, BM; Shapiro, L				Boggon, TJ; Murray, J; Chappuis-Flament, S; Wong, E; Gumbiner, BM; Shapiro, L			C-cadherin ectodomain structure and implications for cell adhesion mechanisms	SCIENCE			English	Article							EXTRACELLULAR DOMAIN; HOMOPHILIC ADHESION; BINDING; COMPLEX	Cadherins are transmembrane proteins that mediate adhesion between cells in the solid tissues of animals. Here we present the 3.1 angstrom resolution crystal structure of the whole, functional extracellular domain from C-cadherin, a representative "classical" cadherin. The structure suggests a molecular mechanism for adhesion between cells by classical cadherins, and it provides a new framework for understanding both cis (same cell) and trans (juxtaposed cell) cadherin interactions. The trans adhesive interface is a twofold symmetric interaction defined by a conserved tryptophan side chain at the membrane-distal end of a cadherin molecule from one cell, which inserts into a hydrophobic pocket at the membrane-distal end of a cadherin molecule from the opposing cell.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center	Shapiro, L (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biol, 630 W 168th St, New York, NY 10032 USA.	Shapiro@convex.hhmi.columbia.edu	Shapiro, Lawrence/AAE-7172-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052717, R01GM062270] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062270, R01 GM52717] Funding Source: Medline; NCPDCID CDC HHS [NCI-P30-CA-08784] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCPDCID CDC HHS		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berx G, 1998, CELL ADHES COMMUN, V6, P171, DOI 10.3109/15419069809004474; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Kitagawa M, 2000, BIOCHEM BIOPH RES CO, V271, P358, DOI 10.1006/bbrc.2000.2636; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Takeichi M, 2000, PHILOS T ROY SOC B, V355, P885, DOI 10.1098/rstb.2000.0624; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; TANIHARA H, 1994, CELL ADHES COMMUN, V2, P15, DOI 10.3109/15419069409014199; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Troyanovsky RB, 1999, J CELL SCI, V112, P4379; Troyanovsky SM, 1999, CURR OPIN CELL BIOL, V11, P561, DOI 10.1016/S0955-0674(99)00021-6; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	36	504	516	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1308	1313		10.1126/science.1071559	http://dx.doi.org/10.1126/science.1071559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	11964443				2022-12-24	WOS:000175713000052
J	Maxwell, SL; Ruiz, AL; Lappin, KJ; Cosgrove, AP				Maxwell, SL; Ruiz, AL; Lappin, KJ; Cosgrove, AP			Quality improvement report - Clinical screening for developmental dysplasia of the hip in Northern Ireland	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGENITAL DISLOCATION	Problem The incidence of late diagnosed developmental dysplasia of the hip requiring surgery in Northern Ireland is high. The reported incidence was 1.14 per 1000 children born during 1983-7. Design Comparative retrospective study. Background and setting Clinical screening programme in Northern Ireland. Key measure for improvement Reduced rate of operative intervention in children with developmental dysplasia of the hip detected after 6 months of age. Strategies for change Increased emphasis on staff training, introduction of a centralised nurse led clinic to improve access to orthopaedic surgeons, and increased use of ultrasonography. Effects of change The incidence of developmental dysplasia of the hip diagnosed after 6 months in children born between January 1991 and December 1997 fell to 0.59 per 1000, presumably due to improved early detection. Nevertheless, 29 (16%) of the affected hips were not diagnosed when the child was first referred in die first 3 months of life. In addition, for 27 affected hips in children diagnosed after the age of 6 months there was a known risk factor (family history or breech delivery). Lessons learnt Improvements to screening processes can reduce late incidence of developmental dysplasia of the hip. Further steps to improve detection in children with known risk factors mid rate of detection at first referral could reduce late presentation further.	Musgrave Pk Hosp, Musculoskeletal Educ & Res Unit, Belfast BT9 7JB, Antrim, North Ireland; Musgrave Pk Hosp, Dept Orthopaed, Belfast BT9 7JB, Antrim, North Ireland		Maxwell, SL (corresponding author), Musgrave Pk Hosp, Musculoskeletal Educ & Res Unit, Belfast BT9 7JB, Antrim, North Ireland.	lorrainemaxwell@hotmail.com						BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; CATTERALL A, 1994, J BONE JOINT SURG BR, V76B, P515, DOI 10.1302/0301-620X.76B4.8027129; DAVID TJ, 1983, LANCET, V2, P147; Dezateux C, 1995, J Med Screen, V2, P200; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; Jones D, 1998, J BONE JOINT SURG BR, V80B, P943, DOI 10.1302/0301-620X.80B6.0800943; Jones D, 2000, J BONE JOINT SURG BR, V82B, P160, DOI 10.1302/0301-620X.82B2 .10761; JONES D, 1977, J BONE JOINT SURG BR, V59, P318, DOI 10.1302/0301-620X.59B3.893510; KLISIC P, 1993, J PEDIATR ORTHOP B, V2, P108, DOI 10.1097/01202412-199302020-00003; MACNICOL MF, 1990, J BONE JOINT SURG BR, V72, P1057, DOI 10.1302/0301-620X.72B6.2246288; MANKEY MG, 1993, J BONE JOINT SURG AM, V75A, P1334, DOI 10.2106/00004623-199309000-00008; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; MCKEE L, 1998, BRIT MED J, V346, pI265; Ortolani M., 1937, PEDIATRIA NAPOLI, V45, P129; PATTERSON CC, 1995, PAEDIATR PERINAT EP, V9, P90, DOI 10.1111/j.1365-3016.1995.tb00121.x; SANFRIDSON J, 1991, ACTA ORTHOP SCAND, V62, P87, DOI 10.3109/17453679108999228; Standing Medical Advisory Committee and the Standing Nursing and Midwifery Advisory Committee, 1986, SCREEN DET CONG DISL; WILLIAMSON J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P13	18	22	27	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2002	324	7344					1031	1033		10.1136/bmj.324.7344.1031	http://dx.doi.org/10.1136/bmj.324.7344.1031			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547UP	11976249	Green Published			2022-12-24	WOS:000175350900027
J	Mecklenbrauker, I; Saijo, K; Zheng, NY; Leitges, M; Tarakhovsky, A				Mecklenbrauker, I; Saijo, K; Zheng, NY; Leitges, M; Tarakhovsky, A			Protein kinase C delta controls self-antigen-induced B-cell tolerance	NATURE			English	Article							REACTIVE LYMPHOCYTES-B; PROTEOLYTIC ACTIVATION; RECEPTOR; ANTIBODY; EXPRESSION; APOPTOSIS; DIVISION; LYSOZYME; MICE	Interaction of a B cell expressing self-specific B-cell antigen receptor (BCR) with an auto-antigen results in either clonal deletion or functional inactivation(1-3). Both of these processes lead to B-cell tolerance and are essential for the prevention of auto-immune diseases. Whereas clonal deletion results in the death of developing autoreactive B cells, functional inactivation of self-reactive B lymphocytes leads to complex changes in the phenotype of peripheral B cells, described collectively as anergy(1-3). Here we demonstrate that deficiency in protein kinase Cdelta (PKC-delta) prevents B-cell tolerance, and allows maturation and terminal differentiation of self-reactive B cells in the presence of the tolerizing antigen. The importance of PKC-delta in B-cell tolerance is further underscored by the appearance of autoreactive anti-DNA and anti-nuclear antibodies in the serum of PKC-delta-deficient mice. As deficiency of PKC-delta does not affect BCR-mediated B-cell activation in vitro and in vivo, our data suggest a selective and essential role of PKC-delta in tolerogenic, but not immunogenic, B-cell responses.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany	Rockefeller University; Max Planck Society	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.		Leitges, Michael/AAN-1953-2021					Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Doerre S, 1999, J IMMUNOL, V163, P269; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Kang SW, 2001, EMBO J, V20, P5692, DOI 10.1093/emboj/20.20.5692; Kozono Y, 1998, J IMMUNOL, V160, P1565; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Leitges M, 2001, J CLIN INVEST, V108, P1505; Lipford GB, 1997, EUR J IMMUNOL, V27, P2340, DOI 10.1002/eji.1830270931; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; METZGER DW, 1984, EUR J IMMUNOL, V14, P87, DOI 10.1002/eji.1830140116; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MIYAKE K, 1994, J EXP MED, V180, P1217, DOI 10.1084/jem.180.4.1217; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; SMITHGILL SJ, 1982, J IMMUNOL, V128, P314; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; YAMAGATA T, 1995, ISSCC DIG TECH PAP I, V38, P248, DOI 10.1109/ISSCC.1995.535542	27	210	220	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					860	865		10.1038/416860a	http://dx.doi.org/10.1038/416860a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976686				2022-12-24	WOS:000175163800054
J	Negro, JJ; Grande, JM; Tella, JL; Garrido, J; Hornero, D; Donazar, JA; Sanchez-Zapata, JA; Benitez, JR; Barcell, M				Negro, JJ; Grande, JM; Tella, JL; Garrido, J; Hornero, D; Donazar, JA; Sanchez-Zapata, JA; Benitez, JR; Barcell, M			Coprophagy: An unusual source of essential carotenoids - A yellow-faced vulture includes ungulate faeces in its diet for cosmetic purposes.	NATURE			English	Article							PLASMA CAROTENOIDS; PIGMENTS; BIRDS		CSIC, Estac Biol Donana, Dept Appl Biol, Seville 41013, Spain; CSIC, Inst Grasa, Food Biotechnol Dept, Seville 41012, Spain; Univ Miguel Hernandez, Dept Biol Aplicada, Area Ecol, Alicante 03312, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); Universidad Miguel Hernandez de Elche	Negro, JJ (corresponding author), CSIC, Estac Biol Donana, Dept Appl Biol, Avda Maria Luisa S-N, Seville 41013, Spain.		Negro, Juan Jose/I-2653-2015; Sanchez-Zapata, Jose Antonio/H-1413-2015; Tella, José L/I-3707-2015	Negro, Juan Jose/0000-0002-8697-5647; Sanchez-Zapata, Jose Antonio/0000-0001-8230-4953; Tella, José L/0000-0002-3038-7424; Donazar, Jose Antonio/0000-0002-9433-9755; Grande, Juan Manuel/0000-0002-8183-0780				Britton G, 1995, FASEB J, V9, P1551, DOI 10.1096/fasebj.9.15.8529834; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Diaz-Delgado R, 2001, FOREST ECOL MANAG, V147, P67, DOI 10.1016/S0378-1127(00)00434-5; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hurd PL, 1991, BEHAV ECOL, V2, P69, DOI 10.1093/beheco/2.1.69; Hutchings MR, 2001, ANIM BEHAV, V62, P955, DOI 10.1006/anbe.2001.1837; MINGUEZMOSQUERA MI, 1993, J AGR FOOD CHEM, V41, P1616, DOI 10.1021/jf00034a018; Mundy P., 1992, VULTURES AFRICA; Negro JJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P97, DOI 10.1086/316724; ROHWER S, 1975, EVOLUTION, V29, P593, DOI 10.1111/j.1558-5646.1975.tb00853.x; Tella JL, 1998, PHYSIOL ZOOL, V71, P708, DOI 10.1086/515991; Vogel A. I., 1957, ELEMENTARY PRACTICAL; Zahavi A., 1997, HANDICAP PRINCIPLE	13	85	89	6	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					807	808		10.1038/416807a	http://dx.doi.org/10.1038/416807a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976670	Green Submitted			2022-12-24	WOS:000175163800038
J	Sehgal, AR; Leon, JB; Siminoff, LA; Singer, ME; Bunosky, LM; Cebul, RD				Sehgal, AR; Leon, JB; Siminoff, LA; Singer, ME; Bunosky, LM; Cebul, RD			Improving the quality of hemodialysis treatment - A community-based randomized controlled trial to overcome patient-specific barriers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORE INDICATORS PROJECT; DIALYSIS; ADEQUACY; SURVIVAL; CLUSTER	Context Mortality rates among US hemodialysis patients are the highest in the industrialized world at 23% per year. Measures of dialysis dose (Kt/V) correspond strongly with survival and are inadequate in one sixth of patients. Inadequate dialysis is also associated with increased hospitalizations and high inpatient costs. Our previous work identified 3 barriers to adequate hemodialysis: dialysis underprescription, catheter use, and shortened treatment time. Objective To determine the effect of a tailored intervention on adequacy of hemodialysis. Design and Setting Community-based randomized controlled trial with recruitment from April 1999 to June 2000 at 29 hemodialysis facilities in northeast Ohio. Participants Forty-four nephrologists and their 169 randomly selected adult patients receiving inadequate hemodialysis. Intervention Nephrologists were randomly assigned to an intervention (n=21) or control (n=23) group. For patients in the intervention group (n=85), depending on the barrier(s) present, a study coordinator gave nephrologists recommendations about optimizing dialysis prescriptions, expedited conversion of catheters to surgically created grafts or fistulas, and educated patients about the importance of compliance with treatment time. Patients in the control group (n=84) continued to receive usual care. Main Outcome Measures Changes in Kt/V and specific barriers after 6 months. Results At baseline, intervention and control patients had similar Kt/V measurements, specific barriers, and demographic and medical characteristics. After 6 months, intervention patients had 2-fold larger increases in Kt/V compared with control patients (+0.20 vs +0.10; P<.001) and were more likely to achieve their facility Kt/V goal (62% vs 42%; P=.01). Intervention patients also had nearly 3-fold larger increases in dialysis prescription (+0.16 vs +0.06; P<.001) and were 4 times more likely to change from use of catheters to use of fistulas/grafts (28% vs 7%; P=.04). Conclusions An intervention tailored to patient-specific barriers resulted in increased hemodialysis dose. Extending this approach to the 33000 persons in the United States receiving inadequate hemodialysis may substantially enhance patient survival, diminish hospitalizations, and decrease inpatient expenditures.	Metrohlth Med Ctr, Div Nephrol, Cleveland, OH 44109 USA; Metrohlth Med Ctr, Ctr Hlth Care Res & Policy, Cleveland, OH 44109 USA; Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Biomed Eth, Cleveland, OH 44106 USA	MetroHealth System; MetroHealth System; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Sehgal, AR (corresponding author), Metrohlth Med Ctr, Div Nephrol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.		Siminoff, Laura A/H-6277-2012; Singer, Mendel/S-8775-2019	Singer, Mendel/0000-0002-3331-3340	NIDDK NIH HHS [DK54178, DK51472] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051472, P50DK054178] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRYK A, 1996, HIERARCHICAL LINEAR; Chertow GM, 1997, KIDNEY INT, V51, P1578, DOI 10.1038/ki.1997.216; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Depner TA., 1991, PRESCRIBING HEMODIAL, V2nd Ed.; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; DONNER A, 1981, AM J EPIDEMIOL, V114, P906, DOI 10.1093/oxfordjournals.aje.a113261; Frankenfield DL, 1999, AM J KIDNEY DIS, V34, P721, DOI 10.1016/S0272-6386(99)70399-9; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Hakim RM, 2001, HDB DIALYSIS, V3rd, P236; HAYS RD, 1994, QUAL LIFE RES, V3, P329, DOI 10.1007/BF00451725; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; Helgerson SD, 1997, AM J KIDNEY DIS, V29, P851, DOI 10.1016/S0272-6386(97)90458-3; *HLTH CAR FIN ADM, 1998, PROF MED CHARTB 1998; *HLTH CAR FIN ADM, 2000, 2000 ANN REP ESRD CL; Hulley S. B., 1988, DESIGNING CLIN RES; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kloppenburg WD, 1999, KIDNEY INT, V55, P1961, DOI 10.1046/j.1523-1755.1999.00412.x; Leggat JE, 1998, AM J KIDNEY DIS, V32, P139, DOI 10.1053/ajkd.1998.v32.pm9669435; Leon JB, 2001, AM J NEPHROL, V21, P200, DOI 10.1159/000046248; Lowrie EG, 1999, KIDNEY INT, V56, P729, DOI 10.1046/j.1523-1755.1999.00584.x; McClellan WM, 1999, AM J KIDNEY DIS, V34, P1075, DOI 10.1016/S0272-6386(99)70013-2; McCullough K. P., 2000, Journal of the American Society of Nephrology, V11, p325A; MCLAUGHLIN CP, 1994, CONTINUOUS QUALITY I; *NAT KIDN FDN, 1997, AM J KIDNEY DIS S, V30, pS15; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; Sehgal AR, 2002, SEMIN DIALYSIS, V15, P35, DOI 10.1046/j.1525-139x.2002.00013.x; Sehgal AR, 1998, AM J KIDNEY DIS, V31, P593, DOI 10.1053/ajkd.1998.v31.pm9531174; Sehgal AR, 2001, AM J KIDNEY DIS, V37, P1223, DOI 10.1053/ajkd.2001.24526; Sehgal AR, 1997, AM J KIDNEY DIS, V30, P514, DOI 10.1016/S0272-6386(97)90310-3; *US REN DAT SYST, 2000, USRDS 2000 ANN DAT R; Wickstrom G, 2000, SCAND J WORK ENV HEA, V26, P363, DOI 10.5271/sjweh.555	32	47	53	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2002	287	15					1961	1967		10.1001/jama.287.15.1961	http://dx.doi.org/10.1001/jama.287.15.1961			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NC	11960538				2022-12-24	WOS:000174989800024
J	Hart, G; Wellings, K				Hart, G; Wellings, K			Sexual behaviour and its medicalisation: in sickness and in health	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DYSFUNCTION		Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ London London Sch Hyg & Trop Med, Ctr Sexual Hlth Res, Dept Publ Hlth & Policy, London WC1E 7HT, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of London; London School of Hygiene & Tropical Medicine	Hart, G (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.	g.hart@msoc.mrc.gla.ac.uk	Hart, Graham J/C-1591-2008	Hart, Graham/0000-0001-9676-6577				ACTON W, 1857, FUNCTIONS DISORDERS; ALTHOF SE, 1995, PSYCHIAT CLIN N AM, V18, P171, DOI 10.1016/S0193-953X(18)30078-9; Berridge V., 1987, OPIUM PEOPLE OPIATE; BOLOURI Y, 1996, SUN             1114, P1; *CHIEF MED OFF, 1998, MAIN REP CMOS EXP AD; Conrad P, 2001, HEALTH, V5, P373, DOI 10.1177/136345930100500306; Davidson Roger, 2001, SEX SIN SUFFERING VE; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Foucault M., 1980, HIST SEXUALITY, V1; Hall L, 2001, SEX SIN SUFFERING VE; HALL L, 1991, HIDDEN ANXIETIES MAL; HALL LA, 1997, NEW SEXUAL AGENDAS; Hall Lesley, 1994, SEXUAL KNOWLEDGE SEX; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; JOWELL R, 2000, BRIT SOCIAL ATTITUDE; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey AC, 1953, SEXUAL BEHAV HUMAN F; Kutchins H, 1997, MAKING US CRAZY DSM; Larkin Philip, 1990, COLLECTED POEMS; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Marcuse H., 1998, EROS CIVILIZATION; MARKS L V, 2001, SEXUAL CHEM HIST CON; Masters WH., 1966, HUMAN SEXUAL RESPONS; Porter Roy, 1995, FACTS LIFE CREATION; Sigerist HE., 1951, LASTRES HENRY SIGERI; Sim J., 1990, MED POWER PRISONS PR; Weeks J., 1985, SEXUALITY ITS DISCON; Wellings F, 2001, LANCET, V358, P1843, DOI 10.1016/S0140-6736(01)06885-4	30	65	65	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 13	2002	324	7342					896	900		10.1136/bmj.324.7342.896	http://dx.doi.org/10.1136/bmj.324.7342.896			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950742	Green Accepted, Green Published			2022-12-24	WOS:000175052200028
J	Johanson, R; Newburn, M; Macfarlane, A				Johanson, R; Newburn, M; Macfarlane, A			Has the medicalisation of childbirth gone too far?	BRITISH MEDICAL JOURNAL			English	Article							CARE; CONTINUITY; MIDWIFERY; BIRTH; TRIAL		Natl Childbirth Trust, London W3 6NH, England; N Staffordshire Matern Hosp, Acad Dept Obstet & Gynaecol, Stoke On Trent ST4 6QG, Staffs, England; City Univ London, St Bartholomew Sch Nursing & Midwifery, Dept Midwifery, London EC1A 7QN, England	University Hospital of North Staffordshire NHS Trust; City University London; University of London; Queen Mary University London	Newburn, M (corresponding author), Natl Childbirth Trust, Alexandra House,Oldham Terrace, London W3 6NH, England.		Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				ABOUZAHR C, 1998, GLOBAL BURDEN DIS IN, V3; [Anonymous], [No title captured]; Bosch X, 1998, BRIT MED J, V317, P1406, DOI 10.1136/bmj.317.7170.1406b; Chamberlain G, 1997, HOME BIRTHS REPORT 1; Donnison J., 1977, MIDWIVES MED MEN; *EXP ADV GROUP CAE, 2001, SCOTT PROGR CLIN EFF; FARQUHAR M, 1996, EVALUATION MIDWIFERY; Ferriman A, 2001, BRIT MED J, V322, P1081, DOI 10.1136/bmj.322.7294.1081; Flint C, 1989, Midwifery, V5, P11, DOI 10.1016/S0266-6138(89)80059-2; *GEN REG OFF, 1938, REG GEN DEC SUPPL A, V2; GLAZENER CMA, 1995, BRIT J OBSTET GYNAEC, V102, P282, DOI 10.1111/j.1471-0528.1995.tb09132.x; Homer CSE, 2001, BRIT J OBSTET GYNAEC, V108, P16, DOI 10.1016/S0306-5456(00)00022-X; Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3; HOWELL CJ, 2002, COCHRANE DATABASE SY, DOI UNSP CD000331; KAUNITZ AM, 1984, AM J OBSTET GYNECOL, V150, P826, DOI 10.1016/0002-9378(84)90457-5; Kirkham M, 1999, J ADV NURS, V30, P732, DOI 10.1046/j.1365-2648.1999.01139.x; Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415; Loudon, 2000, TRAGEDY CHILDBED FEV; Loudon I., 1992, DEATH CHILDBIRTH; MCCOURT C, 1996, REPORT EVALUATION ON; MOULLA J, 2000, MIDW MOD EXC C 17 MA; NEWBURN M, 2002, MIDIRS MIDWIFERY DIG, V12, P122; Olsson P, 2000, MIDWIFERY, V16, P123, DOI 10.1054/midw.1999.0201; *ONT WOM HLTH COUN, 2000, ATT MAINT BEST PRACT; PARANJOTHY S, 2001, NATL SENTINEL CAESAR; ROWLEY MJ, 1995, MED J AUSTRALIA, V163, P289, DOI 10.5694/j.1326-5377.1995.tb124592.x; *ROYAL COLL MIDW R, 2001, MOD MAT CAR COMM TOO; Saunders D, 2000, EVALUATION EDGWARE B; THACKER SB, 2002, COCHRANE DB SYST REV; Turrentine MA, 1999, OBSTET GYNECOL, V94, P185, DOI 10.1016/S0029-7844(99)00315-4; Waldenstrom U, 1998, BRIT J OBSTET GYNAEC, V105, P1160, DOI 10.1111/j.1471-0528.1998.tb09969.x; Waldenstrom U, 1997, BRIT J OBSTET GYNAEC, V104, P410, DOI 10.1111/j.1471-0528.1997.tb11491.x; WILEY S, 2000, NOTTINGHAM EVEN 1019	33	228	232	1	31	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					892	895		10.1136/bmj.324.7342.892	http://dx.doi.org/10.1136/bmj.324.7342.892			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	542PA	11950741	Green Published			2022-12-24	WOS:000175052200027
J	Bustamante, CD; Nielsen, R; Sawyer, SA; Olsen, KM; Purugganan, MD; Hartl, DL				Bustamante, CD; Nielsen, R; Sawyer, SA; Olsen, KM; Purugganan, MD; Hartl, DL			The cost of inbreeding in Arabidopsis	NATURE			English	Article							SELECTION; POLYMORPHISM; POPULATIONS; DIVERGENCE; DROSOPHILA; PATTERNS; MUTATION; THALIANA; LOCUS	Population geneticists have long sought to estimate the distribution of selection intensities among genes of diverse function across the genome. Only recently have DNA sequencing and analytical techniques converged to make this possible. Important advances have come from comparing genetic variation within species (polymorphism) with fixed differences between species (divergence)(1,2). These approaches have been used to examine individual genes for evidence of selection. Here we use the fact that the time since species divergence allows combination of data across genes. In a comparison of amino-acid replacements among species of the mustard weed Arabidopsis with those among species of the fruitfly Drosophila, we find evidence for predominantly beneficial gene substitutions in Drosophila but predominantly detrimental substitutions in Arabidopsis. We attribute this difference to the Arabidopsis mating system of partial self-fertilization, which corroborates a prediction of population genetics theory(3-6) that species with a high frequency of inbreeding are less efficient in eliminating deleterious mutations owing to their reduced effective population size.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Cornell Univ, Dept Biometr, Ithaca, NY 14853 USA; Washington Univ, Dept Math, St Louis, MO 63130 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA	Harvard University; Cornell University; Washington University (WUSTL); University of North Carolina; North Carolina State University	Hartl, DL (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave, Cambridge, MA 02138 USA.		Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Bustamante, Carlos D./0000-0002-4187-7920; Olsen, Kenneth/0000-0002-8338-3638				ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; AKASHI H, 1995, GENETICS, V139, P1067; Caballero A, 1995, GENET RES, V66, P213, DOI 10.1017/S0016672300034662; CACCONE A, 1988, GENETICS, V118, P671; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Gelman A, 1997, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Gilks R, 1996, MARKOV CHAIN MONTE C; HARTL DL, 1994, GENETICS, V138, P227; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Savolainen O, 2000, MOL BIOL EVOL, V17, P645, DOI 10.1093/oxfordjournals.molbev.a026343; SAWYER SA, 1992, GENETICS, V132, P1161; Wang JL, 1999, GENET RES, V74, P165, DOI 10.1017/S0016672399003900; [No title captured]	18	241	242	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					531	534		10.1038/416531a	http://dx.doi.org/10.1038/416531a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932744				2022-12-24	WOS:000174756500042
J	Gendreau, MA; DeJohn, C				Gendreau, MA; DeJohn, C			Current concepts - Responding to medical events during commercial airline flights	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CARDIAC-ARREST; AIR-QUALITY; EMERGENCIES; AIRCRAFT; TRAVEL; TUBERCULOSIS; OUTBREAK		Lahey Clin Fdn, Dept Emergency Med, Burlington, MA 01805 USA; FAA, Civil Aerosp Med Inst, Oklahoma City, OK USA	Lahey Hospital & Medical Center	Gendreau, MA (corresponding author), Lahey Clin Fdn, Dept Emergency Med, 41 Mall Rd, Burlington, MA 01805 USA.	mgndru@massmed.org						*AER MED ASS, 1997, MED GUID AIRL TRAV; *AIR TRANSP ASS, 1997, AIR TRANSP ASS MED I; Alexander J K, 1995, Cardiol Clin, V13, P271; AMLER RW, 1982, JAMA-J AM MED ASSOC, V248, P2129, DOI 10.1001/jama.248.17.2129; [Anonymous], 1976, MMWR MORB MORTAL WKL, V25, P317; *AV CONS PROT DIV, 2001, FACT SHEET STEPS TAK; BARRY M, 1989, JAMA-J AM MED ASSOC, V261, P728, DOI 10.1001/jama.261.5.728; Bettes TN, 1999, AM FAM PHYSICIAN, V60, P801; BLUMEN IJ, 1992, CRIT CARE CLIN, V8, P597, DOI 10.1016/S0749-0704(18)30243-4; Cheatham ML, 1999, AM SURGEON, V65, P1160; COLWELL C, 1999, PHYSICIANS WKLY, V16; *CONS UN, 1999, SEEING RED AIR RAG, V15, P15; COTTRELL JJ, 1988, CHEST, V93, P81, DOI 10.1378/chest.93.1.81; CREWDSON J, 1998, CHICAGO TRIBUNE 1122; CUMMINS RO, 1988, JAMA-J AM MED ASSOC, V260, P3668; CUMMINS RO, 1989, JAMA-J AM MED ASSOC, V261, P1295, DOI 10.1001/jama.261.9.1295; *DAN, 2002, DIV AL NETW; DAVIES GRW, 1982, AVIAT SPACE ENVIR MD, V53, P694; DEJOHN CA, 2000, DOTFAAAM0013 FED AV; Donaldson E, 1996, AUST NZ J SURG, V66, P431, DOI 10.1111/j.1445-2197.1996.tb00777.x; Dowdall N, 2000, BRIT MED J, V321, P1336, DOI 10.1136/bmj.321.7272.1336; EberhartPhillips J, 1997, EPIDEMIOL INFECT, V118, P79, DOI 10.1017/S095026889600948X; GILMORE A, 1989, CAN MED ASSOC J, V140, P197; GONG H, 1992, CHEST, V101, P1104, DOI 10.1378/chest.101.4.1104; Goodwin T, 2000, BRIT MED J, V321, P1338, DOI 10.1136/bmj.321.7272.1338; Han HM, 2000, AVIAT SPACE ENV MED, V71, P330; HARDING RM, 1993, AVIATION MED, P30; HEDBERG CW, 1992, JAMA-J AM MED ASSOC, V268, P3208, DOI 10.1001/jama.268.22.3208; Hedouin V, 1998, Med Law, V17, P503; Hocking MB, 1998, AM IND HYG ASSOC J, V59, P446, DOI 10.1080/15428119891010181; Hocking MB, 2000, CHEMOSPHERE, V41, P603, DOI 10.1016/S0045-6535(99)00537-8; HORDINSKY JR, 1991, DOTFAAAM912 FED AV A; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Kovac C, 1999, BRIT MED J, V318, P12; KUKJIAN S, 2001, BOSTON GLOBE    1223, pA1; Lien D, 1998, Can Respir J, V5, P95; Lyznicki JM, 2000, AVIAT SPACE ENVIR MD, V71, P832; MCKENAS DK, 2000, AVIATION TODAY   MAR; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; NewsonSmith MS, 1997, AVIAT SPACE ENVIR MD, V68, P1134; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Parmet AJ, 1999, AVIAT SPACE ENVIR MD, V70, P817; Rayman RB, 1997, AVIAT SPACE ENVIR MD, V68, P432; Rayman RB, 1998, AVIAT SPACE ENVIR MD, V69, P1007; Robertson RM, 2000, NEW ENGL J MED, V343, P1259, DOI 10.1056/NEJM200010263431709; Rosenberg Craig A., 1997, Journal of Emergency Medicine, V15, P159, DOI 10.1016/S0736-4679(96)00314-9; SCHWARTZ GB, 1982, JAMA-J AM MED ASSOC, V247, P1007; *SEL COMM SCI TECH, 2000, 5 SEL COMM SCI TECH; SKJENNA OW, 1991, CAN MED ASSOC J, V144, P287; SPEIZER C, 1989, ANN EMERG MED, V18, P26, DOI 10.1016/S0196-0644(89)80306-3; Thibeault C, 1997, AVIAT SPACE ENVIR MD, V68, P80; *US HOUS REPR SUBC, 1997, MED KITS COMM AIRL; WALLACE WA, 1995, BRIT MED J, V311, P374, DOI 10.1136/bmj.311.7001.374; WICK RL, 1995, AVIAT SPACE ENVIR MD, V66, P220; 2001, CABIN CREW SAFET NOV; 2001, MMWR MORB MORTAL WKL, V50, P485; 1999, BMJ, V318, P672; 1998, CABIN AIR SAFETY OCT	59	117	119	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 4	2002	346	14					1067	1073		10.1056/NEJMra012774	http://dx.doi.org/10.1056/NEJMra012774			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YL	11932475				2022-12-24	WOS:000174729400008
J	Judson, H; Hayward, BE; Sheridan, E; Bonthron, DT				Judson, H; Hayward, BE; Sheridan, E; Bonthron, DT			A global disorder of imprinting in the human female germ line	NATURE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; METHYLATED CPG ISLAND; HYDATIDIFORM MOLE; SNRPN GENE; LOCUS; TRANSCRIPT; ESTABLISHMENT; PROTEINS; PATTERN; DEFINE	Imprinted genes are expressed differently depending on whether they are carried by a chromosome of maternal or paternal origin. Correct imprinting is established by germline-specific modifications; failure of this process underlies several inherited human syndromes(1-5). All these imprinting control defects are cis-acting, disrupting establishment or maintenance of allele-specific epigenetic modifications across one contiguous segment of the genome. In contrast, we report here an inherited global imprinting defect. This recessive maternal-effect mutation disrupts the specification of imprints at multiple, non-contiguous loci, with the result that genes normally carrying a maternal methylation imprint assume a paternal epigenetic pattern on the maternal allele. The resulting conception is phenotypically indistinguishable from an androgenetic complete hydatidiform mole(6),in which abnormal extra-embryonic tissue proliferates while development of the embryo is absent or nearly so. This disorder offers a genetic route to the identification of trans-acting oocyte factors that mediate maternal imprint establishment.	Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Bonthron, DT (corresponding author), Univ Leeds, St Jamess Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England.	d.t.bonthron@leeds.ac.uk		Bonthron, David/0000-0001-8132-8179				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Fisher RA, 2000, HUM REPROD, V15, P594, DOI 10.1093/humrep/15.3.594; Gardner RJ, 2000, HUM MOL GENET, V9, P589, DOI 10.1093/hmg/9.4.589; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Helwani MN, 1999, HUM GENET, V105, P112, DOI 10.1007/s004390051071; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kamiya M, 2000, HUM MOL GENET, V9, P453, DOI 10.1093/hmg/9.3.453; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Murphy SK, 2001, GENOMICS, V71, P110, DOI 10.1006/geno.2000.6419; Ohta T, 1999, AM J HUM GENET, V64, P397, DOI 10.1086/302233; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52	27	167	173	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2002	416	6880					539	542		10.1038/416539a	http://dx.doi.org/10.1038/416539a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932746	Green Accepted			2022-12-24	WOS:000174756500044
J	Rubin, MA; Zhou, M; Dhanasekaran, SM; Varambally, S; Barrette, TR; Sanda, MG; Pienta, KJ; Ghosh, D; Chinnaiyan, AM				Rubin, MA; Zhou, M; Dhanasekaran, SM; Varambally, S; Barrette, TR; Sanda, MG; Pienta, KJ; Ghosh, D; Chinnaiyan, AM			alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIGITAL RECTAL EXAMINATION; COA RACEMASE; MOLECULAR CLASSIFICATION; ANTIBODY 34-BETA-E12; DIAGNOSIS; ANTIGEN; CYTOKERATIN; CARCINOMA; SPECIMENS; GENETICS	Context Molecular profiling of prostate cancer has led to the identification of candidate biomarkers and regulatory genes. Discoveries from these genome-scale approaches may have applicability in the analysis of diagnostic prostate specimens. Objectives To determine the expression and clinical utility of a-methylacyl coenzyme A racemase (AMACR), a gene identified as being overexpressed in prostate cancer by global profiling strategies. Design Four gene expression data sets from independent DNA microarray analyses were examined to identify genes expressed in prostate cancer (n = 128 specimens). A lead candidate gene, AMACR, was validated at the transcript level by reverse transcriptase polymerase chain reaction (RT-PCR) and at the protein level by immunoblot and immunohistochemical analysis. AMACR levels were examined using prostate cancer tissue microarrays in 342 samples representing different stages of prostate cancer progression. Protein expression was characterized as negative (score=1), weak (2), moderate (3), or strong (4). Clinical utility of AMACR was evaluated using 94 prostate needle biopsy specimens. Main Outcome Measures Messenger RNA transcript and protein levels of AMACR; sensitivity and specificity of AMACR as a tissue biomarker for prostate cancer in needle biopsy specimens. Results Three of 4 independent DNA microarray analyses (n = 128 specimens) revealed significant overexpression of AMACR in prostate cancer (P<.001). AMACR upregulation in prostate cancer was confirmed by both RT-PCR and immunoblot analysis. Immunohistochemical analysis demonstrated an increased expression of AMACR in malignant prostate epithelia relative to benign epithelia. Tissue microarrays to assess AMACR expression in specimens consisting of benign prostate (n = 108 samples), atrophic prostate (n = 26), prostatic intraepithelial neoplasia (n=75), localized prostate cancer (n = 116), and metastatic prostate cancer (n = 17) demonstrated mean AMACR protein staining intensity of 1.31 (95% confidence interval, 1.23-1.40), 2.33 (95% Cl, 2.13-2.52), 2.67 (95% Cl, 2.52-2.81), 3.20 (95% Cl, 3.10-3.28), and 2.50 (95% Cl, 2.20-2.80), respectively (P<.001). Pairwise comparisons demonstrated significant differences in staining intensity between clinically localized prostate cancer compared with benign prostate tissue, with mean expression scores of 3.2 and 1.3, respectively (mean difference, 1.9; 95% Cl, 1.7-2.1; P<.001). Using moderate or strong staining intensity as positive (score=3 or 4), evaluation of AMACR protein expression in 94 prostate needle biopsy specimens demonstrated 97% sensitivity and 100% specificity for detecting prostate cancer. Conclusions AMACR was shown to be overexpressed in prostate cancer using independent experimental methods and prostate cancer specimens. AMACR may be useful in the interpretation of prostate needle biopsy specimens that are diagnostically challenging.	Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rubin, MA (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1301 Catherine Rd, Ann Arbor, MI 48109 USA.		Sanda, Martin G/B-2023-2015; Sanda, Martin G/A-6202-2013; Pienta, Kenneth/E-7679-2015	Varambally, Sooryanarayana/0000-0002-2277-1127; Pienta, Kenneth/0000-0002-4138-2186; Rubin, Mark/0000-0002-8321-9950; Ghosh, Debashis/0000-0001-6618-1316; Dhanasekaran, saravana mohan/0000-0002-0489-2224	NCI NIH HHS [P50 CA69568] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA069568] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bostwick D G, 1999, Semin Urol Oncol, V17, P222; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Epstein JI, 2001, J UROLOGY, V166, P402, DOI 10.1016/S0022-5347(05)65953-8; Etzioni R, 1999, J NATL CANCER I, V91, P1033, DOI 10.1093/jnci/91.12.1033; Ferdinandusse S, 2000, J LIPID RES, V41, P1890; Ferdinandusse S, 2001, J LIPID RES, V42, P137; Ferdinandusse S, 2000, NAT GENET, V24, P188, DOI 10.1038/72861; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GLEASON DONALD F., 1966, CANCER CHEMO THERAP REP, V50, P125; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Googe PB, 1997, AM J CLIN PATHOL, V107, P219, DOI 10.1093/ajcp/107.2.219; Hedges L.V., 1985, STAT METHODS META AN; Hollenbeck BK, 2000, J UROLOGY, V164, P1583, DOI 10.1016/S0022-5347(05)67033-4; JACOBSEN SJ, 1995, JAMA-J AM MED ASSOC, V274, P1445, DOI 10.1001/jama.274.18.1445; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kotti TJ, 2000, J BIOL CHEM, V275, P20887, DOI 10.1074/jbc.M002067200; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Luo J, 2001, CANCER RES, V61, P4683; Maattanen L, 1999, BRIT J CANCER, V79, P1210, DOI 10.1038/sj.bjc.6690194; Magee JA, 2001, CANCER RES, V61, P5692; Manley S, 2001, AM J PATHOL, V159, P837, DOI 10.1016/S0002-9440(10)61759-2; OMALLEY FP, 1990, VIRCHOWS ARCH A, V417, P191, DOI 10.1007/BF01600133; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Perrone EE, 2000, JNCI-J NATL CANCER I, V92, P937, DOI 10.1093/jnci/92.11.937; Putzi MJ, 2000, UROLOGY, V56, P828, DOI 10.1016/S0090-4295(00)00776-7; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Ruijter E, 1999, ENDOCR REV, V20, P22, DOI 10.1210/er.20.1.22; Scheffe H., 1959, ANAL VARIANCE; Schroder FH, 1998, JNCI-J NATL CANCER I, V90, P1817, DOI 10.1093/jnci/90.23.1817; Shah R, 2001, AM J PATHOL, V158, P1767, DOI 10.1016/S0002-9440(10)64132-6; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Sreekumar A, 2001, CANCER RES, V61, P7585; Welsh JB, 2001, CANCER RES, V61, P5974; WOJNO KJ, 1995, AM J SURG PATHOL, V19, P251, DOI 10.1097/00000478-199503000-00002	41	518	575	0	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1662	1670		10.1001/jama.287.13.1662	http://dx.doi.org/10.1001/jama.287.13.1662			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926890	Bronze			2022-12-24	WOS:000174730300020
J	Frazzetta, TH; Kardong, KV				Frazzetta, TH; Kardong, KV			Biomechanics - Prey attack by a large theropod dinosaur	NATURE			English	Article									Univ Illinois, Dept Anim Biol Ecol Ethol & Evolut, Urbana, IL 61801 USA; Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	University of Illinois System; University of Illinois Urbana-Champaign; Washington State University	Frazzetta, TH (corresponding author), Univ Illinois, Dept Anim Biol Ecol Ethol & Evolut, Urbana, IL 61801 USA.		Rayfield, Emily/F-5038-2010	Rayfield, Emily/0000-0002-2618-750X				Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; FARLOW JO, 1976, AM MIDL NAT, V95, P186, DOI 10.2307/2424244; Frazzetta T., 1983, P222; FRAZZETTA TH, 1962, J MORPHOL, V111, P287, DOI 10.1002/jmor.1051110306; FRAZZETTA TH, 1986, EVOLUTIONARY BIOL, P419; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Schwenk Kurt, 2000, P175, DOI 10.1016/B978-012632590-4/50009-5	10	8	8	9	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					387	388		10.1038/416387a	http://dx.doi.org/10.1038/416387a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919619				2022-12-24	WOS:000174607800034
J	Froemke, RC; Dan, Y				Froemke, RC; Dan, Y			Spike-timing-dependent synaptic modification induced by natural spike trains	NATURE			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL CELLS; BARREL CORTEX; NEURONS; PLASTICITY; SYNAPSES; COINCIDENCE; HIPPOCAMPUS; PATTERNS; EFFICACY	The strength of the connection between two neurons can be modified by activity, in a way that depends on the timing of neuronal firing on either side of the synapse(1-10). This spike-timing-dependent plasticity (STDP) has been studied by systematically varying the intervals between pre- and postsynaptic spikes. Here we studied how STDP operates in the context of more natural spike trains. We found that in visual cortical slices the contribution of each pre-/postsynaptic spike pair to synaptic modification depends not only on the interval between the pair, but also on the timing of preceding spikes. The efficacy of each spike in synaptic modification was suppressed by the preceding spike in the same neuron, occurring within several tens of milliseconds. The direction and magnitude of synaptic modifications induced by spike patterns recorded in vivo in response to natural visual stimuli were well predicted by incorporating the suppressive inter-spike interaction within each neuron. Thus, activity-induced synaptic modification depends not only on the relative spike timing between the neurons, but also on the spiking pattern within each neuron. For natural spike trains, the timing of the first spike in each burst is dominant in synaptic modification.	Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Dept Neurobiol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Dan, Yang/0000-0002-3818-877X; Froemke, Robert/0000-0002-1230-6811				Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dobrunz LE, 1999, NEURON, V22, P157, DOI 10.1016/S0896-6273(00)80687-X; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Varela JA, 1997, J NEUROSCI, V17, P7926; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	28	574	584	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					433	438		10.1038/416433a	http://dx.doi.org/10.1038/416433a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919633				2022-12-24	WOS:000174607800048
J	Doyle, PS; Bibette, J; Bancaud, A; Viovy, JL				Doyle, PS; Bibette, J; Bancaud, A; Viovy, JL			Self-assembled magnetic matrices for DNA separation chips	SCIENCE			English	Article							ELECTROPHORESIS; ARRAY		Inst Curie, Lab PCC, UMR CNRS IC 168, F-75248 Paris 05, France; MIT, Dept Chem Engn, Cambridge, MA 02139 USA; ESPCI, Lab Colloides & Nanostruct, F-75213 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Viovy, JL (corresponding author), Inst Curie, Lab PCC, UMR CNRS IC 168, 26 Rue Ulm, F-75248 Paris 05, France.		bancaud, aurelien/C-3075-2017; Doyle, Patrick S/H-7031-2013	bancaud, aurelien/0000-0002-0308-249X; Doyle, Patrick S/0000-0003-2147-9172; Viovy, Jean-Louis/0000-0002-8223-4040				Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; LIU J, 1995, PHYS REV LETT, V74, P2828, DOI 10.1103/PhysRevLett.74.2828; Mayer P, 1997, MAT RES S C, V463, P57; MITNIK L, 1995, SCIENCE, V267, P219, DOI 10.1126/science.7809626; Viovy JL, 2000, REV MOD PHYS, V72, P813, DOI 10.1103/RevModPhys.72.813; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0	6	431	492	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2237	2237		10.1126/science.1068420	http://dx.doi.org/10.1126/science.1068420			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910102				2022-12-24	WOS:000174561700035
J	Lorig, K				Lorig, K			Partnerships between expert patients and physicians	LANCET			English	Editorial Material							SELF-MANAGEMENT PROGRAM; ARTHRITIS; EDUCATION; OUTCOMES		Stanford Univ, Sch Med, Dept Med,Stanford Patient Educ Res Ctr, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA	Stanford University	Lorig, K (corresponding author), Stanford Univ, Sch Med, Dept Med,Stanford Patient Educ Res Ctr, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA.							Barlow JH, 1998, BRIT J RHEUMATOL, V37, P1315; CLARK NM, 1988, GERONTOLOGIST, V28, P491, DOI 10.1093/geront/28.4.491; Corbin J. M., 1988, UNENDING WORK CARE M; Department of Health, 2001, EXP PAT NEW APPR CHR; Hart JT, 1995, J PUBLIC HEALTH MED, V17, P383; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Schwarzer R., 1992, SELF EFFICACY THOUGH	10	111	111	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 9	2002	359	9309					814	815		10.1016/S0140-6736(02)07959-X	http://dx.doi.org/10.1016/S0140-6736(02)07959-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YV	11897275				2022-12-24	WOS:000174329600004
J	Lee, SJ; Evers, S; Roeder, D; Parlow, AF; Risteli, J; Risteli, L; Lee, YC; Feizi, T; Langen, H; Nussenzweig, MC				Lee, SJ; Evers, S; Roeder, D; Parlow, AF; Risteli, J; Risteli, L; Lee, YC; Feizi, T; Langen, H; Nussenzweig, MC			Mannose receptor-mediated regulation of serum glycoprotein homeostasis	SCIENCE			English	Article							CYSTEINE-RICH DOMAIN; DOWN-REGULATION; I PROCOLLAGEN; MACROPHAGES; LUTROPIN; BINDING; OLIGOSACCHARIDES; RECOGNITION; EXPRESSION; PROPEPTIDE	Carbohydrates are thought to function as tags that mark circulatory glycoproteins for rapid clearance. To examine the role of the mannose receptor (MR) in glycoprotein clearance, we generated mice genetically deficient in MR. MR-/- mice were defective in clearing proteins bearing accessible mannose and N-acetylglucosamine residues and had elevated levels of eight different lysosomal hydrolases. Proteomic analysis of MR-/- and control mouse sera showed that an additional 4 out of 52 proteins identified were elevated in MR-/- serum. Each of these is up-regulated during inflammation and wound heating. Thus, MR appears to operate as an essential regulator of serum glycoprotein homeostasis.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; F Hoffmann La Roche & Co Ltd, Infect Dis, CH-4070 Basel, Switzerland; F Hoffmann La Roche & Co Ltd, Genet, CH-4070 Basel, Switzerland; Univ Calif Los Angeles, Harbor Med Ctr, Natl Hormone & Pituitary Program, Torrance, CA 90509 USA; Univ Oulu, Dept Clin Chem, FIN-90014 Oulu, Finland; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Northwick Pk Inst Med Res, Glycosci Lab, Harrow HA1 3UJ, Middx, England; Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Roche Holding; Roche Holding; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Oulu; Johns Hopkins University; Imperial College London; Howard Hughes Medical Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave,Box 220, New York, NY 10021 USA.		Nussenzweig, Michel/AAE-7292-2019	Risteli, Leila/0000-0002-5532-5895; Feizi, Ten/0000-0001-6495-0329	NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BENOFF S, 1993, FERTIL STERIL, V59, P854; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; CLARK CC, 1979, J BIOL CHEM, V254, P798; EZEKOWITZ RAB, 1986, BIOCHEM BIOPH RES CO, V136, P737; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098; HAUKIPURO K, 1987, ANN SURG, V206, P752, DOI 10.1097/00000658-198712000-00011; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; MELKKO J, 1990, CLIN CHEM, V36, P1328; Olivier E, 2000, BIOCHEM J, V350, P589, DOI 10.1042/0264-6021:3500589; SHEPHERD VL, 1985, J BIOL CHEM, V260, P160; SHEPHERD VL, 1990, J IMMUNOL, V145, P1530; Sohar I, 1998, BIOCHEM J, V330, P903, DOI 10.1042/bj3300903; STAHL P, 1976, NATURE, V264, P86, DOI 10.1038/264086a0; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; TAYLOR ME, 1987, AM J PHYSIOL, V252, pE690, DOI 10.1152/ajpendo.1987.252.5.E690; TAYLOR ME, 1993, J BIOL CHEM, V268, P399	24	364	396	3	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1898	1901		10.1126/science.1069540	http://dx.doi.org/10.1126/science.1069540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884756				2022-12-24	WOS:000174299500041
J	Lever, C; Wills, T; Cacucci, F; Burgess, N; O'Keefe, J				Lever, C; Wills, T; Cacucci, F; Burgess, N; O'Keefe, J			Long-term plasticity in hippocampal place-cell representation of environmental geometry	NATURE			English	Article							RECEPTIVE-FIELDS; CORTEX; MEMORY; RAT; LESIONS; NEURONS; INPUTS; TASK	The hippocampus is widely believed to be involved in the storage or consolidation of long-term memories(1-4). Several reports have shown short-term changes in single hippocampal unit activity during memory and plasticity experiments(5-12), but there has been no experimental demonstration of long-term persistent changes in neuronal activity in any region except primary cortical areas(13-16). Here we report that, in rats repeatedly exposed to two differently shaped environments, the hippocampal-place-cell representations of those environments gradually and incrementally diverge; this divergence is specific to environmental shape, occurs independently of explicit reward, persists for periods of at least one month, and transfers to new enclosures of the same shape. These results indicate that place cells may be a neural substrate for long-term incidental learning, and demonstrate the long-term stability of an experience-dependent firing pattern in the hippocampal formation.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Lever, C (corresponding author), UCL, Dept Anat & Dev Biol, Mortimer St, London WC1E 6BT, England.	John@maze.ucl.ac.uk	Wills, Tom J/B-3621-2011; Burgess, Neil/B-2420-2009; Lever, Colin/B-4860-2008	Burgess, Neil/0000-0003-0646-6584; Lever, Colin/0000-0002-8955-2885; Wills, Thomas/0000-0002-1331-2869; Cacucci, Francesca/0000-0002-1968-5156	Medical Research Council [G117/433] Funding Source: Medline; MRC [G117/433] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARNES CA, 1988, TRENDS NEUROSCI, V11, P163, DOI 10.1016/0166-2236(88)90143-9; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; CLARK SA, 1988, NATURE, V332, P444, DOI 10.1038/332444a0; Cohen NJ, 1993, MEMORY AMNESIA HIPPO; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Jeffery KJ, 1999, EXP BRAIN RES, V127, P151, DOI 10.1007/s002210050785; JEFFERY KJ, 2000, NEURONAL MECH MEMORY, P100; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1975, EXP NEUROL, V48, P152, DOI 10.1016/0014-4886(75)90230-7; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharp PE, 1997, BEHAV BRAIN RES, V85, P71, DOI 10.1016/S0166-4328(96)00165-9; Squire L. R., 1987, MEMORY BRAIN; SUTHERLAND RJ, 1982, NEUROSCI LETT, V31, P271, DOI 10.1016/0304-3940(82)90032-5; Tanila H, 1997, J NEUROSCI, V17, P5155; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	30	321	323	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					90	94		10.1038/416090a	http://dx.doi.org/10.1038/416090a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882899				2022-12-24	WOS:000174211600045
J	Templeton, AR				Templeton, AR			Out of Africa again and again	NATURE			English	Article							NESTED CLADISTIC-ANALYSIS; HUMAN MITOCHONDRIAL-DNA; GEOGRAPHICAL-DISTRIBUTION; POPULATION HISTORY; SEQUENCE VARIATION; EVOLUTION; HAPLOTYPES; ORIGIN; PHYLOGEOGRAPHY; HYPOTHESES	The publication of a haplotype tree of human mitochondrial DNA variation in 1987 provoked a controversy about the details of recent human evolution that continues to this day. Now many haplotype trees are available, and new analytical techniques exist for testing hypotheses about recent evolutionary history using haplotype trees. Here I present formal statistical analysis of human haplotype trees for mitochondrial DNA, Y-chromosomal DNA, two X-linked regions and six autosomal regions. A coherent picture of recent human evolution emerges with two major themes. First is the dominant role that Africa has played in shaping the modern human gene pool through at least two-not one-major expansions after the original range extension of Homo erectus out of Africa. Second is the ubiquity of genetic interchange between human populations, both in terms of recurrent gene flow constrained by geographical distance and of major population expansion events resulting in interbreeding, not replacement.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Templeton, AR (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	temple_a@biology.wustl.edu	Templeton, Alan R./F-5963-2011	Templeton, Alan/0000-0002-0167-845X				Aguirre E, 2001, QUATERN INT, V75, P11, DOI 10.1016/S1040-6182(00)00073-2; Alonso S, 2001, P NATL ACAD SCI USA, V98, P864, DOI 10.1073/pnas.011244998; Bar-Yosef O, 2001, QUATERN INT, V75, P19, DOI 10.1016/S1040-6182(00)00074-4; Bernatchez L, 2001, EVOLUTION, V55, P351, DOI 10.1111/j.0014-3820.2001.tb01300.x; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CRANDALL KA, 1993, GENETICS, V134, P959; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; EXCOFFIER L, 1989, AM J HUM GENET, V44, P73; EXCOFFIER L, 1990, J MOL EVOL, V30, P125, DOI 10.1007/BF02099939; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Gomez A, 2000, P ROY SOC B-BIOL SCI, V267, P2189, DOI 10.1098/rspb.2000.1268; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Harding RM, 1997, AM J HUM GENET, V60, P772; Harris EE, 1999, P NATL ACAD SCI USA, V96, P3320, DOI 10.1073/pnas.96.6.3320; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jin L, 1999, P NATL ACAD SCI USA, V96, P3796, DOI 10.1073/pnas.96.7.3796; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; MADDISON DR, 1991, SYST ZOOL, V40, P355, DOI 10.2307/2992327; Nielson M, 2001, EVOLUTION, V55, P147; OTTE M, 1999, ARCHAEOGENETICS DNA, P41; Pickford M, 2001, CR ACAD SCI II A, V332, P145, DOI 10.1016/S1251-8050(01)01528-2; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; POSADA D, 2000, TCS 1 06; Rana BK, 1999, GENETICS, V151, P1547; Rannala B, 2001, HUM MUTAT, V18, P87, DOI 10.1002/humu.1158; RELETHFORD JH, 2001, GENETICS SEARCH MODE; Rogers EJ, 2000, HUM MOL GENET, V9, P2675, DOI 10.1093/hmg/9.18.2675; Saragusti I, 2001, QUATERN INT, V75, P85, DOI 10.1016/S1040-6182(00)00080-X; SMITH FH, 1989, YEARB PHYS ANTHROPOL, V32, P35; Stoneking M, 1996, CURR OPIN GENET DEV, V6, P731, DOI 10.1016/S0959-437X(96)80028-1; SYKES B, 1995, AM J HUM GENET, V57, P1463; Takahata N, 2001, MOL BIOL EVOL, V18, P172, DOI 10.1093/oxfordjournals.molbev.a003791; TEMPLETON AR, 1995, GENETICS, V140, P767; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; TEMPLETON AR, 1992, SCIENCE, V255, P737, DOI 10.1126/science.1590849; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; Templeton AR., 1997, CONCEPTUAL ISSUES MO, P329; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Turner TF, 2000, GENETICS, V154, P777; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Weidenreich Franz, 1946, APES GIANTS MAN; WOLPOFF MH, 1994, INTERD CONT, P175; Wolpoff MH, 2000, AM J PHYS ANTHROPOL, V112, P129, DOI 10.1002/(SICI)1096-8644(200005)112:1<129::AID-AJPA11>3.0.CO;2-K; Zhang J, 2000, GENETICS, V156, P1949	50	385	405	0	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					45	51		10.1038/416045a	http://dx.doi.org/10.1038/416045a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527WU	11882887				2022-12-24	WOS:000174211600033
J	Pope, CA; Burnett, RT; Thun, MJ; Calle, EE; Krewski, D; Ito, K; Thurston, GD				Pope, CA; Burnett, RT; Thun, MJ; Calle, EE; Krewski, D; Ito, K; Thurston, GD			Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION; PREVENTION; COHORT; INDEX	Context Associations have been found between day-to-day particulate air pollution and increased risk of various adverse health outcomes, including cardiopulmonary mortality, However, studies of health effects of long-term particulate air pollution have been less conclusive. Objective To assess the relationship between long-term exposure to fine particulate air pollution and all-cause, lung cancer, and cardiopulmonary mortality. Design, Setting, and Participants Vital status and cause of death data were collected by the American Cancer Society as part of the Cancer Prevention II study, an ongoing prospective mortality study, which enrolled approximately 1.2 million adults in 1982. Participants completed a questionnaire detailing individual risk factor data (age, sex, race, weight, height, smoking history, education, marital status, diet, alcohol consumption, and occupational exposures). The risk factor data for approximately 500000 adults were linked with air pollution data for metropolitan areas throughout the United States and combined with vital status and cause of death data through December 31, 1998. Main Outcome Measure All-cause, lung cancer, and cardiopulmonary mortality. Results Fine particulate and sulfur oxide-related pollution were associated with all-cause, lung cancer, and cardiopulmonary mortality. Each 10-mug/m(3) elevation in fine particulate air pollution was associated with approximately a 4%, 6%, and 8% increased risk of all-cause, cardiopulmonary, and lung cancer mortality, respectively, Measures of coarse particle fraction and total suspended particles were not consistently associated with mortality. Conclusion Long-term exposure to combustion-related fine particulate air pollution is an important environmental risk factor for cardiopulmonary and lung cancer mortality.	Brigham Young Univ, Dept Econ, Provo, UT 84602 USA; Hlth Canada, Ottawa, ON K1A 0L2, Canada; Univ Ottawa, Ottawa, ON, Canada; Amer Canc Soc, Atlanta, GA 30329 USA; NYU, Sch Med, Tuxedo Pk, NY USA	Brigham Young University; Health Canada; University of Ottawa; American Cancer Society; New York University	Pope, CA (corresponding author), Brigham Young Univ, Dept Econ, 142 FOB, Provo, UT 84602 USA.	cap3@cmail.byu.edu	Pope, C. Arden/ABD-5522-2021		NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009560, P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES000260, R01 ES009560, ES00260, ES09560-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Burnett R, 2001, ENVIRON HEALTH PERSP, V109, P375, DOI 10.2307/3434784; BURNETT RT, 1995, ENVIRONMETRICS, V6, P85, DOI 10.1002/env.3170060108; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALLE EE, 1993, AM J EPIDEMIOL, V137, P235, DOI 10.1093/oxfordjournals.aje.a116664; CEPA/FPAC Working Group, 1998, NAT AMB AIR QUAL OBJ; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; CIOCCO A, 1961, AM J PUBLIC HEALTH N, V51, P155, DOI 10.2105/AJPH.51.2.155; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Committee on the Medical Effects of Air Pollutants, 1995, NONB PART HLTH; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; *ENV PROT AG, 1996, EPA600P95001CF; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firket J., 1931, 1930 B ACAD ROYAL ME, V11, P683; Fleming T. R., 1991, COUNTING PROCESSES S; Hastie TJ., 1990, GEN ADDITIVE MODELS; Kaiser J, 1997, SCIENCE, V277, P466, DOI 10.1126/science.277.5325.466; Krewski D., 2000, REANALYSIS HARVARD 6; LOGAN WPD, 1953, LANCET, V264, P336; *MATH SOFT, 2000, S PLUS 2000 PROGR GU; *NAT RES COUNC, 2001, RES PRIOR AIRB PART, V3; *NAT RES COUNC, 1998, RES PRIOR AIRB PART, V1; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope III C.A., 1999, AIR POLLUTION HLTH, V31, P673, DOI DOI 10.1016/B978-012352335-8/50106-X; Priestly M. B., 1981, SPECTRAL ANAL TIME S; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; SIEMIATYCKI J, 1991, RISK FACTORS CANC WO, P45; *US POST SERV, 1989, 1989 NAT 5 DIG ZIP C; *WHO EUR REG, 1995, EURICPEHAZ9405PB01	30	5590	5885	49	1366	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1132	1141		10.1001/jama.287.9.1132	http://dx.doi.org/10.1001/jama.287.9.1132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879110	Green Accepted			2022-12-24	WOS:000174186000028
J	Raviglione, MC; Pio, A				Raviglione, MC; Pio, A			Evolution of WHO policies for tuberculosis control, 1948-2001	LANCET			English	Review							DEVELOPING-COUNTRIES; EPIDEMIOLOGY; VACCINATION; SITUATION; THERAPY; IMPACT; TB	We examine the evolution of WHO managerial policies for tuberculosis control during 1948-2001 to provide a new framework that will accelerate control expansion in the near future. In the first period (1948-63), a vertical approach to tuberculosis control was the policy adopted by WHO and the international community. However, although this approach was successful in more-developed countries, it largely failed in resource-poor settings. As a result, involvement of general health services was soon deemed essential. During 1989-98, a new framework for effective tuberculosis control was created and a new five-element strategy was branded with the name of DOTS. This period was characterised by the recognition of tuberculosis control as a public-health priority, the intensification of tuberculosis control efforts worldwide, and the return of tuberculosis to the political agenda of governments. However, although nominal adoption of DOTS increased rapidly due to massive promotion by WHO and partners, expansion to provide full access was too slow and only 23% of all infectious cases in 1999 were managed under DOTS. A truly multisectoral approach based on advocacy and social mobillsation, community involvement, and engagement of private-for-profit practitioners is becoming the way forward for tuberculosis control. HIV-associated tuberculosis and multidrug-resistant tuberculosis must be tackled as priority issues. We conclude that, based on the lessons of the past, the future of tuberculosis control should be focused on a pragmatic approach combining a specialised, well-defined management system with a fully integrated service delivery. A multisectoral approach that builds on global and national partnerships is the key to future tuberculosis control.	WHO, Stop TB Dept, TB Strategy & Operat, CH-1211 Geneva 27, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, TB Strategy & Operat, 20 Ave Appla, CH-1211 Geneva 27, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				BANERJI D, 1965, MED CARE, V3, P151, DOI 10.1097/00005650-196507000-00005; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; BERMAN PA, 1995, HLTH POLICY, V1, P13; CAIRNCROSS S, 1997, LANCET S3, V349, pS20; Cauthen GM, 1988, WHOTB88154; COMSTOCK GW, 1994, CLIN INFECT DIS, V19, P528, DOI 10.1093/clinids/19.3.528; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1962, Bull Int Union Tuberc, V32, P307; FOX W, 1958, Tubercle, V39, P269, DOI 10.1016/S0041-3879(58)80088-4; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Mahler H, 1966, B INT UNION TUBERC, V37, P77; MICHEL CC, 1993, PHLEBOLOGY, V8, P1; Miller B, 2000, INT J TUBERC LUNG D, V4, P593; Murray C J, 1990, Bull Int Union Tuberc Lung Dis, V65, P6; NARAIN JP, 1992, TUBERCLE LUNG DIS, V73, P311, DOI 10.1016/0962-8479(92)90033-G; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Schatz A, 1944, P SOC EXP BIOL MED, V57, P244, DOI 10.3181/00379727-57-14769; Styblo K, 1980, Adv Tuberc Res, V20, P1; STYBLO K, 1976, TUBERCLE, V57, P17, DOI 10.1016/0041-3879(76)90015-5; STYBLO K, 1989, REV INFECT DIS, V11, pS339; SUDRE P, 1992, B WORLD HEALTH ORGAN, V70, P149; *WHO, 1973, HDB RES DEC WORLD HL, V1, P85; *WHO, 1964, WHO TECHN REP SER, V290; *WHO, 2001, WHOCDSSTB200111; WHO, 1998, WHOTB98245; *WHO, 1974, TECHN REP SER, V552; *WHO, 1978, 6 GEN PROGR WORK COV; WHO, 2001, REP M GROUND LARV BL; WHO, 1998, WHOTB98255; WHO, 2000, WHOCDSSTB20006; *WHO, 1947, 6 WHO; World Bank, 1993, WORLD DEV REP 1993 I, P63; World Health Organization, 1994, WHOTB94179; World Health Organization, 1991, WHA441991REC1 WHO; 2001, LANCET, V357, P1	43	169	181	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					775	780		10.1016/S0140-6736(02)07880-7	http://dx.doi.org/10.1016/S0140-6736(02)07880-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888605				2022-12-24	WOS:000174115200029
J	Goodman, MB; Ernstrom, GG; Chelur, DS; O'Hagan, R; Yao, CA; Chalfie, M				Goodman, MB; Ernstrom, GG; Chelur, DS; O'Hagan, R; Yao, CA; Chalfie, M			MEC-2 regulates C-elegans DEG/ENaC channels needed for mechanosensation	NATURE			English	Article							CAENORHABDITIS-ELEGANS; MEMBRANE-PROTEIN; STOMATIN; NEURONS; AMILORIDE; SUBUNITS; DEGENERATION; SENSITIVITY; MUTATIONS; MEMBER	Touch sensitivity in animals relies on nerve endings in the skin that convert mechanical force into electrical signals. In the nematode Caenorhabditis elegans, gentle touch to the body wall is sensed by six mechanosensory neurons(1) that express two amiloride-sensitive Na+ channel proteins (DEG/ENaC). These proteins, MEC-4 and MEC-10, are required for touch sensation and can mutate to cause neuronal degeneration(2,3). Here we show that these mutant or 'd' forms of MEC-4 and MEC-10 produce a constitutively active, amiloride-sensitive ionic current when co-expressed in Xenopus oocytes, but not on their own. MEC-2, a stomatin-related protein needed for touch sensitivity(4), increased the activity of mutant channels about 40-fold and allowed currents to be detected with wild-type MEC-4 and MEC-10. Whereas neither the central, stomatin-like domain of MEC-2 nor human stomatin retained the activity of full-length MEC-2, both produced amiloride-sensitive currents with MEC-4d. Our findings indicate that MEC-2 regulates MEC-4/MEC-10 ion channels and raise the possibility that similar ion channels may be formed by stomatin-like proteins and DEG/ENaC proteins that are co-expressed in both vertebrates and invertebrates(5-8). Some of these channels may mediate mechanosensory responses.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu	Goodman, Miriam B./H-3036-2019; O'Hagan, Robert/AAE-9789-2020	Goodman, Miriam B./0000-0002-5810-1272; O'Hagan, Robert/0000-0001-7580-1441	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM030997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chillaron J, 1997, J BIOL CHEM, V272, P9543; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 1998, NEURON, V20, P1231, DOI 10.1016/S0896-6273(00)80503-6; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gu GQ, 1996, P NATL ACAD SCI USA, V93, P6577, DOI 10.1073/pnas.93.13.6577; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUANG M, 1995, THESIS COLUMBIA U; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lai CC, 1996, J CELL BIOL, V133, P1071, DOI 10.1083/jcb.133.5.1071; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; Mannsfeldt AG, 1999, MOL CELL NEUROSCI, V13, P391, DOI 10.1006/mcne.1999.0761; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; MULLER AHJ, 1993, MECH DEVELOP, V42, P77, DOI 10.1016/0925-4773(93)90100-C; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Rajaram S, 1999, GENETICS, V153, P1673; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687	30	254	268	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1039	1042		10.1038/4151039a	http://dx.doi.org/10.1038/4151039a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875573				2022-12-24	WOS:000174075000049
J	Hu, FB; Bronner, L; Willett, WC; Stampfer, MJ; Rexrode, KM; Albert, CM; Hunter, D; Manson, JE				Hu, FB; Bronner, L; Willett, WC; Stampfer, MJ; Rexrode, KM; Albert, CM; Hunter, D; Manson, JE			Fish and omega-3 fatty acid intake and risk of coronary heart disease in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD FREQUENCY QUESTIONNAIRE; ALPHA-LINOLENIC ACID; DIETARY-INTAKE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CONSUMPTION; DEATH; REPRODUCIBILITY; PREVENTION; GREENLAND	Context Higher consumption of fish and omega-3 fatty acids has been associated with a lower risk of coronary heart disease (CND) in men, but limited data are available regarding women. Objective To examine the association between fish and long-chain omega-3 fatty acid consumption and risk of CHD in women. Design, Setting, and Participants Dietary consumption and follow-up data from 84688 female nurses enrolled in the Nurses' Health Study, aged 34 to 59 years and free from cardiovascular disease and cancer at baseline in 1980, were compared from validated questionnaires completed in 1980, 1984, 1986, 1990, and 1994. Main Outcome Measures Incident nonfatal myocardial infarction and CHD deaths. Results During 16 years of follow-up, there were 1513 incident cases of CHID (484 CHD deaths and 1029 nonfatal myocardial infarctions). Compared with women who rarely ate fish (<1 per month), those with a higher intake of fish had a lower risk of CHD. After adjustment forage, smoking, and other cardiovascular risk factors, the multivariable relative risks (RRs) of CHD were 0.79 (95% confidence interval [CI], 0.64-0.97) for fish consumption 1 to 3 times per month, 0.71 (95% CI, 0.58-0.87) for once per week, 0.69 (95% CI, 0.55-0.88) for 2 to 4 times per week, and 0.66 (95% Cl, 0.50-0.89) for 5 or more times per week (P for trend =.001). Similarly, women with a higher intake of omega-3 fatty acids had a lower risk of CHD, with multivariable RRs of 1.0, 0.93, 0.78, 0.68, and 0.67 (P<.001 for trend) across quintiles of intake. For fish intake and omega-3 fatty acids, the inverse association appeared to be stronger for CHID deaths (multivariate RR for fish consumption 5 times per week, 0.55 [95% Cl, 0.33-0.90] for CHID deaths vs 0.73 [0.51-1.04]) than for nonfatal myocardial infarction. Conclusion Among women, higher consumption of fish and omega-3 fatty acids is associated with a lower risk of CHID, particularly CHID deaths.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Duke University	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.		Hu, Frank/C-1919-2013; Rexrode, Kathryn M/I-1177-2018	Albert, Christine/0000-0002-2081-1121; Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL24074] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BANG HO, 1976, ACTA MED SCAND, V200, P69; BURING JE, 1996, PREVENTION MYOCARDIA, P308; BURR ML, 1989, LANCET, V2, P757; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502; De Caterina R, 2000, AM J CLIN NUTR, V71, p213S, DOI 10.1093/ajcn/71.1.213S; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; FLEISCHHAUER FJ, 1993, J AM COLL CARDIOL, V21, P982, DOI 10.1016/0735-1097(93)90357-7; GABH Rose, 1982, WHO MONOGRAPH SERIES; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; HARRIS WS, 1989, J LIPID RES, V30, P785; HIRAI A, 1980, LANCET, V2, P1132; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kang JX, 1996, CIRCULATION, V94, P1774, DOI 10.1161/01.CIR.94.7.1774; Kang JX, 2000, AM J CLIN NUTR, V71, p202S, DOI 10.1093/ajcn/71.1.202S; KINSELLA JE, 1988, FOOD TECHNOL-CHICAGO, V42, P124; KINSELLA JE, 1987, AM J CARDIOL, V60, pG23, DOI 10.1016/0002-9149(87)90588-1; Krauss RM, 2000, CIRCULATION, V102, P2284; KROMANN N, 1980, ACTA MED SCAND, V208, P401; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; MCLENNAN PL, 1992, AM HEART J, V123, P1555, DOI 10.1016/0002-8703(92)90809-A; MIDDAUGH JP, 1990, AM J PUBLIC HEALTH, V80, P282, DOI 10.2105/AJPH.80.3.282; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; Nair SSD, 1997, J NUTR, V127, P383, DOI 10.1093/jn/127.3.383; NEWMAN WP, 1993, LANCET, V341, P1056, DOI 10.1016/0140-6736(93)92413-N; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Therneau T.M., 1997, P 1 SEATTL S BIOST S, P51; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; von Schacky C, 2000, AM J CLIN NUTR, V71, p224S, DOI 10.1093/ajcn/71.1.224s; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	40	700	746	0	56	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2002	287	14					1815	1821		10.1001/jama.287.14.1815	http://dx.doi.org/10.1001/jama.287.14.1815			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539QJ	11939867	Bronze			2022-12-24	WOS:000174881700034
J	Rhee, I; Bachman, KE; Park, BH; Jair, KW; Yen, RWC; Schuebel, KE; Cui, HM; Feinberg, AP; Lengauer, C; Kinzler, KW; Baylin, SB; Vogelstein, B				Rhee, I; Bachman, KE; Park, BH; Jair, KW; Yen, RWC; Schuebel, KE; Cui, HM; Feinberg, AP; Lengauer, C; Kinzler, KW; Baylin, SB; Vogelstein, B			DNMT1 and DNMT3b cooperate to silence genes in human cancer cells	NATURE			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; CYTOSINE-5 METHYLTRANSFERASES; WILMS-TUMOR; HYPERMETHYLATION; RELAXATION; NEOPLASIA; LETHALITY; TISSUE	Inactivation of tumour suppressor genes is central to the development of all common forms of human cancer(1). This inactivation often results from epigenetic silencing associated with hypermethylation rather than intragenic mutations(2-7). In human cells, the mechanisms underlying locus-specific or global methylation patterns remain unclear(8,9). The prototypic DNA methyltransferase, Dnmt1, accounts for most methylation in mouse cells(10,11), but human cancer cells lacking DNMT1 retain significant genomic methylation and associated gene silencing(12). We disrupted the human DNMT3b gene in a colorectal cancer cell line. This deletion reduced global DNA methylation by less than 3%. Surprisingly, however, genetic disruption of both DNMT1 and DNMT3b nearly eliminated methyltransferase activity, and reduced genomic DNA methylation by greater than 95%. These marked changes resulted in demethylation of repeated sequences, loss of insulin-like growth factor II (IGF2) imprinting, abrogation of silencing of the tumour suppressor gene p16(INK4a), and growth suppression. Here we demonstrate that two enzymes cooperatively maintain DNA methylation and gene silencing in human cancer cells, and provide compelling evidence that such methylation is essential for optimal neoplastic proliferation.	Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Human Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Baylin, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu; vogelbe@welch.jhu.edu	Feinberg, Andrew/AAY-7666-2020; Cui, Hengmi/A-2598-2008; jia, xu/A-8386-2016	Feinberg, Andrew/0000-0002-8364-1991	NATIONAL CANCER INSTITUTE [R01CA054358, R37CA054358] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA054358-12, R37 CA054358, R01 CA054358] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bachman KE, 1999, CANCER RES, V59, P798; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Eads CA, 1999, CANCER RES, V59, P2302; FEINBERG AP, 1988, CANCER RES, V48, P1159; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; KUO KC, 1980, NUCLEIC ACIDS RES, V8, P4763, DOI 10.1093/nar/8.20.4763; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; Myohanen SK, 1998, CANCER RES, V58, P591; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schmutte C, 1996, CANCER RES, V56, P2375; Siegfried Z, 1997, CURR BIOL, V7, pR305, DOI 10.1016/S0960-9822(06)00144-8; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Tycko B, 2000, J CLIN INVEST, V105, P401, DOI 10.1172/JCI9462; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Vogelstein B., 1998, GENETIC BASIS HUMAN	30	975	1042	4	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2002	416	6880					552	556		10.1038/416552a	http://dx.doi.org/10.1038/416552a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932749				2022-12-24	WOS:000174756500048
J	Rahi, JS; Dezateux, C				Rahi, JS; Dezateux, C			Improving the detection of childhood visual problems and eye disorders	LANCET			English	Editorial Material							AMBLYOPIA		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Great Ormond St Hosp Sick Children, Dept Ophthalmol, London, England; Inst Ophthalmol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Rahi, JS (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		Dezateux, Carol/A-3416-2009	Rahi, Jugnoo/0000-0002-5718-9209; Dezateux, Carol/0000-0001-9787-6276				CAMPOS E, 1995, SURV OPHTHALMOL, V40, P23, DOI 10.1016/S0039-6257(95)80044-1; *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV C; DEWINTER M, 1995, SCREENING CHILD HLTH; DIGUISEPPI C, 2001, ACTA OPHTHALMOL SCAN, V79, P240; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; HARRARD RA, 1999, SURV OPHTHALMOL, V43, P375; Hartmann EE, 2001, OPHTHALMOLOGY, V108, P479, DOI 10.1016/S0161-6420(00)00588-1; Juttmann R, 2001, BRIT J OPHTHALMOL, V85, P1332, DOI 10.1136/bjo.85.11.1332; Kvarnstrom G, 2001, ACTA OPHTHALMOL SCAN, V79, P240, DOI 10.1034/j.1600-0420.2001.790306.x; Moseley MJ, 1998, BRIT J OPHTHALMOL, V82, P722, DOI 10.1136/bjo.82.7.722; Rahi JS, 1997, BMJ-BRIT MED J, V315, P1247, DOI 10.1136/bmj.315.7118.1247; Rahi JS, 2001, BRIT J OPHTHALMOL, V85, P257, DOI 10.1136/bjo.85.3.257; SMITH LK, 1994, J PUBLIC HEALTH MED, V16, P348; SNOWDON SK, 1997, 9 CRD U YORK NHS CTR; Williams C, 2001, Ophthalmic Epidemiol, V8, P279; WRIGHT C, 2001, PROTOCOL 00PRT 1 MUL	16	7	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1083	1084		10.1016/S0140-6736(02)08127-8	http://dx.doi.org/10.1016/S0140-6736(02)08127-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943253				2022-12-24	WOS:000174729200004
J	Lewis, JH; Schonlau, M; Munoz, JA; Asch, SM; Rosen, MR; Yang, H; Escarce, JJ				Lewis, JH; Schonlau, M; Munoz, JA; Asch, SM; Rosen, MR; Yang, H; Escarce, JJ			Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPACT	Background: Several states have developed prescription-drug discount programs for Medicare beneficiaries. In California, Senate Bill 393, enacted in 1999, requires pharmacies participating in the state Medicaid program (Medi-Cal) to charge customers who present a Medicare card amounts based on Medi-Cal rates. Because Medicare beneficiaries may not be accustomed to presenting their Medicare cards at pharmacies, we assessed the compliance of pharmacies with Senate Bill 393. Methods: Fifteen Medicare beneficiaries who received special training and acted as ``standardized patients'' visited a random sample of pharmacies in the San Francisco Bay area and Los Angeles County in April and May 2001. According to a script, they asked for the prices of three commonly prescribed drugs: rofecoxib, sertraline, and atorvastatin. The script enabled us to determine whether and when, during their interactions with pharmacists or salespeople, the discounts specified in Senate Bill 393 were offered. Pharmacies at which the appropriate discounts were offered were considered compliant. Results: The patients completed visits to 494 pharmacies. Seventy-five percent of the pharmacies complied with the prescription-drug discount program; at only 45 percent, however, was the discount offered before it was specifically requested. The discount was offered at 91 percent of pharmacies that were part of a chain, as compared with 58 percent of independent pharmacies (P<0.001). Compliance was higher in the San Francisco Bay area than in Los Angeles County (84 percent vs. 72 percent, P=0.004) and was higher in high-income than low-income neighborhoods (81 percent vs. 69 percent, P=0.002). A Medicare beneficiary taking all three drugs would have saved an average of $55.70 per month as compared with retail prices (a savings of 20 percent). Conclusions: Discounts required under California's prescription-drug discount program for Medicare beneficiaries offer substantial savings. Many patients, however, especially those who use independent pharmacies or who live in low-income neighborhoods, may not receive the discounts. (N Engl J Med 2002;346:830-5.) Copyright (C) 2002 Massachusetts Medical Society.	RAND Corp, Hlth, Santa Monica, CA 90407 USA; Greater Los Angeles Vet Affairs Hlth Care Syst, Los Angeles, CA USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Lewis, JH (corresponding author), RAND Corp, Hlth, 1700 Main St, Santa Monica, CA 90407 USA.							Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; *BUR CENS, 2000, STAT ABSTR US 2000, P13; *CAL BOARD PHARM, 2002, CAL STAT BOARD PHARM; *CAL DEP HLTH SERV, 2001, PRESCR DRUG DISC PRO; Cochran W. G., 1977, SAMPLING TECHNIQUES; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; GIBSON MJ, 1999, MUCH MED BENEFICIARI; Glassman P A, 2000, Jt Comm J Qual Improv, V26, P644; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Hughes SL, 1995, ARTHRIT CARE RES, V8, P257, DOI 10.1002/art.1790080409; Lebowitz BD, 1997, JAMA-J AM MED ASSOC, V278, P1186, DOI 10.1001/jama.278.14.1186; *LEG COUNS CAL, 2002, OFF CAL LEG INF; Mueller C, 1997, AM J PUBLIC HEALTH, V87, P1626, DOI 10.2105/AJPH.87.10.1626; Newhouse JP, 2000, JAMA-J AM MED ASSOC, V283, P2161, DOI 10.1001/jama.283.16.2161; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Soumerai SB, 1999, NEW ENGL J MED, V340, P976; Stuart B, 2001, HEALTH AFFAIR, V20, P86, DOI 10.1377/hlthaff.20.2.86; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	21	6	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					830	835		10.1056/NEJMsa122601	http://dx.doi.org/10.1056/NEJMsa122601			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893795	Bronze			2022-12-24	WOS:000174328900007
J	Zhao, XM; Herr, W				Zhao, XM; Herr, W			A regulated two-step mechanism of TBP binding to DNA: A solvent-exposed surface of TBP inhibits TATA box recognition	CELL			English	Article							RNA-POLYMERASE-II; GENERAL TRANSCRIPTION FACTORS; YEAST TFIIA/TBP/DNA COMPLEX; CRYSTAL-STRUCTURE; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; FUNCTIONAL DOMAINS; IN-VIVO; PROTEIN; ELEMENT	The TATA box binding protein TBP plays a universally important role in eukaryotic nuclear transcription. By mutagenesis, we have discovered a solvent-exposed surface of the structured TBP core domain that is important for inhibition of the DNA binding and DNA-bending activities of full-length wild-type TBP. Full-length wild-type TBP initially binds the TATA box to form an unstable complex containing unbent DNA, and then it slowly forms a stable complex containing bent DNA. TFIIB greatly accelerates formation of a bent TFIIB-TBP-TATA box complex, and the inhibitory DNA binding surface of TBP contributes to the cooperativity of binding to TFIIB. Using TBP and TFIIB, we show that TBP can bind the TATA box through a regulated two-step mechanism, involving a transition from unbent complex to bent complex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Herr, W (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [CA13106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berk AJ, 2000, CELL, V103, P5, DOI 10.1016/S0092-8674(00)00098-2; BURATOWSKI S, 1994, CELL, V77, P1, DOI 10.1016/0092-8674(94)90226-7; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Gillitzer E, 2000, EMBO J, V19, P3069, DOI 10.1093/emboj/19.12.3069; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOOPES BC, 1992, J BIOL CHEM, V267, P11539; HORIKOSHI M, 1992, P NATL ACAD SCI USA, V89, P1060, DOI 10.1073/pnas.89.3.1060; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM TK, 1995, J BIOL CHEM, V270, P10976, DOI 10.1074/jbc.270.18.10976; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; LAI JS, 1992, GENE DEV, V6, P2058, DOI 10.1101/gad.6.11.2058; Lee M, 2001, GENETICS, V158, P87; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; MARTINEZ E, 1995, P NATL ACAD SCI USA, V92, P11864, DOI 10.1073/pnas.92.25.11864; Mittal V, 1997, SCIENCE, V275, P1136, DOI 10.1126/science.275.5303.1136; Nikolov DB, 1996, P NATL ACAD SCI USA, V93, P4862, DOI 10.1073/pnas.93.10.4862; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Ruppert SML, 1996, HYBRIDOMA, V15, P55, DOI 10.1089/hyb.1996.15.55; STARR DB, 1995, J MOL BIOL, V250, P434; STRUBIN M, 1992, CELL, V68, P721, DOI 10.1016/0092-8674(92)90147-5; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang H, 1996, P NATL ACAD SCI USA, V93, P1119, DOI 10.1073/pnas.93.3.1119; TANSEY WP, 1995, P NATL ACAD SCI USA, V92, P10550, DOI 10.1073/pnas.92.23.10550; TANSEY WP, 1994, GENE DEV, V8, P2756, DOI 10.1101/gad.8.22.2756; Tansey WP, 1997, SCIENCE, V275, P829, DOI 10.1126/science.275.5301.829; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0	39	58	59	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					615	627		10.1016/S0092-8674(02)00648-7	http://dx.doi.org/10.1016/S0092-8674(02)00648-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893333	Bronze			2022-12-24	WOS:000174314800006
J	Schwetz, BA				Schwetz, BA			Drug for pediatric liver disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commiss Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commiss Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1103	1103		10.1001/jama.287.9.1103-b	http://dx.doi.org/10.1001/jama.287.9.1103-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879090				2022-12-24	WOS:000174186000006
J	Rodriguez-Fornells, A; Rotte, M; Heinze, HJ; Nosselt, T; Munte, TF				Rodriguez-Fornells, A; Rotte, M; Heinze, HJ; Nosselt, T; Munte, TF			Brain potential and functional MRI evidence for how to handle two languages with one brain	NATURE			English	Article							LEXICAL ACCESS; WORD; INDEPENDENCE; RECOGNITION; BILINGUALS; REPETITION; SENTENCES; ANATOMY; CORTEX; FMRI	Bilingual individuals need effective mechanisms to prevent interference from one language while processing material in the other(1). Here we show, using event-related brain potentials and functional magnetic resonance imaging (fMRI), that words from the nontarget language are rejected at an early stage before semantic analysis in bilinguals. Bilingual Spanish/Catalan and monolingual Spanish subjects were instructed to press a button when presented with words in one language, while ignoring words in the other language and pseudowords. The brain potentials of bilingual subjects in response to words of the non-target language were not sensitive to word frequency, indicating that the meaning of non-target words was not accessed in bilinguals. The fMRI activation patterns of bilinguals included a number of areas previously implicated in phonological and pseudoword processing(2-5), suggesting that bilinguals use an indirect phonological access route to the lexicon of the target language to avoid interference(6).	Otto von Guericke Univ, Dept Neuropsychol, D-39106 Magdeburg, Germany; Otto von Guericke Univ, Klin Neurol 2, D-39120 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Munte, TF (corresponding author), Otto von Guericke Univ, Dept Neuropsychol, Univ Pl 2,Gebaude 24, D-39106 Magdeburg, Germany.		Münte, Thomas/C-2077-2014; Rodriguez-Fornells, Antoni/L-5878-2014	Rodriguez-Fornells, Antoni/0000-0002-3249-6931; Noesselt, Toemme/0000-0002-9611-9713				Alameda J.R., 1995, DICCIONARIO FRECUENC; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; Comrie B, 1987, WORLDS MAJOR LANGUAG; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; GERARD LD, 1989, J EXP PSYCHOL LEARN, V15, P305, DOI 10.1037/0278-7393.15.2.305; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACNAMARA J, 1971, J VERB LEARN VERB BE, V10, P480, DOI 10.1016/S0022-5371(71)80018-X; NOBRE AC, 1995, J NEUROSCI, V15, P1090; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Penfield W., 1959, SPEECH BRAIN MECH; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Rafel i Fontanals J., 1998, DICCIONARI FREQUENCI; RUGG MD, 1990, MEM COGNITION, V18, P367, DOI 10.3758/BF03197126; SCARBOROUGH DL, 1984, J VERB LEARN VERB BE, V23, P84, DOI 10.1016/S0022-5371(84)90519-X; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Weber-Fox C., 1997, J COGNITIVE NEUROSCI, V8, P231; Winer BJ, 1991, STAT PRINCIPLES EXPT; Xu B, 2001, CEREB CORTEX, V11, P267, DOI 10.1093/cercor/11.3.267; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	30	196	204	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1026	1029		10.1038/4151026a	http://dx.doi.org/10.1038/4151026a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	525MF	11875570				2022-12-24	WOS:000174075000046
J	Smith, NGC; Eyre-Walker, A				Smith, NGC; Eyre-Walker, A			Adaptive protein evolution in Drosophila	NATURE			English	Article							DELETERIOUS MUTATIONS; SELECTION; SEQUENCE; PROGRAM	For over 30 years a central question in molecular evolution has been whether natural selection plays a substantial role in evolution at the DNA sequence level(1,2). Evidence has accumulated over the last decade that adaptive evolution does occur at the protein level(3,4), but it has remained unclear how prevalent adaptive evolution is. Here we present a simple method by which the number of adaptive substitutions can be estimated and apply it to data from Drosophila simulans and D. yakuba. We estimate that 45% of all amino-acid substitutions have been fixed by natural selection, and that on average one adaptive substitution occurs every 45 years in these species.	Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex; University of Sussex	Eyre-Walker, A (corresponding author), Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England.	a.c.eyre-walker@sussex.ac.uk	Eyre-Walker, Adam/G-6216-2011	Eyre-Walker, Adam/0000-0001-5527-8729				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Fay JC, 2001, GENETICS, V158, P1227; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; HALDANE J. B. S., 1957, JOUR GENETICS, V55, P511, DOI 10.1007/BF02984069; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M, 1985, NEUTRAL THEORY MOL E; Kliman RM, 1999, J MOL EVOL, V49, P343, DOI 10.1007/PL00006557; KREITMAN M, 1995, ANNU REV ECOL SYST, V26, P403, DOI 10.1146/annurev.es.26.110195.002155; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; POWELL JR, 1995, EVOL BIOL, V28, P87; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; XIA X, 2000, DATA ANAL MOL BIOL E; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	20	492	496	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1022	1024		10.1038/4151022a	http://dx.doi.org/10.1038/4151022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875568				2022-12-24	WOS:000174075000044
J	Tavare, S; Marshall, CR; Will, O; Soligo, C; Martin, RD				Tavare, S; Marshall, CR; Will, O; Soligo, C; Martin, RD			Using the fossil record to estimate the age of the last common ancestor of extant primates	NATURE			English	Article							MAMMALS; EVOLUTION; DIVERSITY; ORIGINS	Divergence times estimated from molecular data often considerably predate the earliest known fossil representatives of the groups studied. For the order Primates, molecular data calibrated with various external fossil dates uniformly suggest a mid-Cretaceous divergence from other placental mammals, some 90 million years (Myr) ago(1-9), whereas the oldest known fossil primates are from the basal Eocene epoch (54-55 Myr ago). The common ancestor of primates should be earlier than the oldest known fossils(10,11), but adequate quantification is needed to interpret possible discrepancies between molecular and palaeontological estimates. Here we present a new statistical method, based on an estimate of species preservation derived from a model of the diversification pattern, that suggests a Cretaceous last common ancestor of primates, approximately 81.5 Myr ago, close to the initial divergence time inferred from molecular data. It also suggests that no more than 7% of all primate species that have ever existed are known from fossils. The approach unites all the available palaeontological methods of timing evolutionary events: the fossil record, extant species and clade diversification models.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Math, Los Angeles, CA 90089 USA; Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Zurich Irchel, Inst Anthropol, CH-8057 Zurich, Switzerland; Univ Zurich Irchel, Museum, CH-8057 Zurich, Switzerland; Nat Hist Museum, Human Origins Grp, London SW7 5BD, England; Field Museum, Chicago, IL 60605 USA	University of Southern California; University of Southern California; University of Southern California; Harvard University; Harvard University; University of Washington; University of Washington Seattle; University of Zurich; University of Zurich; Natural History Museum London; Field Museum of Natural History (Chicago)	Tavare, S (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.							Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Alroy J, 1998, BIODIVERSITY DYNAMICS, P232; ALROY J, 1994, THESIS U CHICAGO; Arnason U, 1998, J MOL EVOL, V47, P718, DOI 10.1007/PL00006431; Davison A. C., 1997, BOOTSTRAP METHODS TH; Easteal S., 1995, MAMMALIAN MOL CLOCK; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Foote M, 1999, SCIENCE, V283, P1310, DOI 10.1126/science.283.5406.1310; Foote M, 1997, PALEOBIOLOGY, V23, P278, DOI 10.1017/S0094837300019692; Foote M, 1999, NATURE, V398, P415, DOI 10.1038/18872; GINGERICH PD, 1994, J HUM EVOL, V27, P443, DOI 10.1006/jhev.1994.1058; Harris T. E., 1963, THEORY BRANCHING PRO; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Huelsenbeck JP, 2000, GENETICS, V154, P1879; JANKE A, 1994, GENETICS, V137, P243; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Marshall CR, 1998, ADEQUACY OF THE FOSSIL RECORD, P23; Martin R.D., 1986, P1; Martin R.D., 1990, PRIMATE ORIGINS EVOL; MARTIN RD, 1993, NATURE, V363, P223, DOI 10.1038/363223a0; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Wolfheim J, 1983, PRIMATES WORLD DISTR	28	189	194	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					726	729		10.1038/416726a	http://dx.doi.org/10.1038/416726a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961552				2022-12-24	WOS:000175033500039
J	Nielsen, TO; West, RB; Linn, SC; Alter, O; Knowling, MA; O'Connell, JX; Zhu, S; Fero, M; Sherlock, G; Pollack, JR; Brown, PO; Botstein, D; van de Rijn, M				Nielsen, TO; West, RB; Linn, SC; Alter, O; Knowling, MA; O'Connell, JX; Zhu, S; Fero, M; Sherlock, G; Pollack, JR; Brown, PO; Botstein, D; van de Rijn, M			Molecular characterisation of soft tissue tumours: a gene expression study	LANCET			English	Article							GASTROINTESTINAL STROMAL TUMORS; CELLS; CLASSIFICATION	Background Soft-tissue tumours are derived from mesenchymal cells such as fibroblasts, muscle cells, or adipocytes, but for many such tumours the histogenesis is controversial. We aimed to start molecular characterisation of these rare neoplasms and to do a genome-wide search for new diagnostic markers. Methods We analysed gene-expression patterns of 41 soft-tissue tumours with spotted cDNA microarrays. After removal of errors introduced by use of different microarray batches, the expression patterns of 5520 genes that were well defined were used to separate tumours into discrete groups by hierarchical clustering and singular value decomposition. Findings Synovial sarcomas, gastrointestinal stromal tumours, neural tumours, and a subset of the leiomyosarcomas, showed strikingly distinct gene-expression patterns. Other tumour categories-malignant fibrous histiocytoma, liposarcoma, and the remaining leiomyosarcomas-shared molecular profiles that were not predicted by histological features or immunohistochemistry. Strong expression of known genes, such as KIT in gastrointestinal stromal tumours, was noted within gene sets that distinguished the different sarcomas. However, many uncharacterised genes also contributed to the distinction between tumour types. Interpretation These results suggest a new method for classification of soft-tissue tumours, which could improve on the method based on histological findings, Large numbers of uncharacterised genes contributed to distinctions between the tumours, and some of these could be useful markers for diagnosis, have prognostic significance, or prove possible targets for treatment.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; University of British Columbia; British Columbia Cancer Agency; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	van de Rijn, M (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Room L225,300 Pasteur Dr, Stanford, CA 94305 USA.		Sherlock, Gavin J/E-9110-2012; Sherlock, Gavin J/B-1831-2009	van de Rijn, Matt/0000-0002-1909-9739; Sherlock, Gavin/0000-0002-1692-4983; Alter, Orly/0000-0002-0418-1078; West, Robert/0000-0002-8330-8283	NCI NIH HHS [CA84967, CA85129] Funding Source: Medline; NHGRI NIH HHS [K01 HG000038, 1 K01 HG00038-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA084967, U01CA085129] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG000038] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Brennan MF., 2001, CANC PRINCIPLES PRAC, P1841; Calamante F, 2000, MAGN RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Choudhury A, 2000, J BIOL CHEM, V275, P33929, DOI 10.1074/jbc.M005115200; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; dos Santos NR, 2001, GENE CHROMOSOME CANC, V30, P1, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1056>3.0.CO;2-G; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fletcher CDM, 2001, J CLIN ONCOL, V19, P3045, DOI 10.1200/JCO.2001.19.12.3045; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gomez-Skarmeta JL, 1998, EMBO J, V17, P181, DOI 10.1093/emboj/17.1.181; Hernandez MC, 1998, EXP CELL RES, V242, P470, DOI 10.1006/excr.1998.4109; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Klein I, 1999, BBA-BIOMEMBRANES, V1461, P237, DOI 10.1016/S0005-2736(99)00161-3; Miettinen M, 2000, MODERN PATHOL, V13, P1134, DOI 10.1038/modpathol.3880210; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phimister B, 1999, NAT GENET, V21, P1, DOI 10.1038/4423; Plaat BEC, 2000, J CLIN ONCOL, V18, P3211, DOI 10.1200/JCO.2000.18.18.3211; Ryan PD, 2000, CLIN CANCER RES, V6, P4607; SHEARMAN MS, 1993, EMBO J, V12, P3817, DOI 10.1002/j.1460-2075.1993.tb06060.x; Shin DM, 2001, CLIN CANCER RES, V7, P1204; Suster S, 1998, AM J SURG PATHOL, V22, P863, DOI 10.1097/00000478-199807000-00008; Swinnen A, 2000, MED BIOL ENG COMPUT, V38, P297, DOI 10.1007/BF02347050; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WEISS SW, 2001, SOFT TISSUE TUMORS; Zabel M, 2000, CIRCULATION, V102, P1252, DOI 10.1161/01.CIR.102.11.1252	32	423	460	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2002	359	9314					1301	1307		10.1016/S0140-6736(02)08270-3	http://dx.doi.org/10.1016/S0140-6736(02)08270-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965276				2022-12-24	WOS:000174989700013
J	Freed, EO				Freed, EO			Virology: Rafting with Ebola	SCIENCE			English	Editorial Material							LIPID RAFTS; VIRUS; GLYCOPROTEINS		NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Freed, EO (corresponding author), NIAID, Mol Microbiol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000772] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali A, 2000, J VIROL, V74, P8709, DOI 10.1128/JVI.74.18.8709-8719.2000; Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500; FREED EO, IN PRESS J VIROL; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Luban J, 2001, NAT MED, V7, P1278, DOI 10.1038/nm1201-1278; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Vincent S, 2000, J VIROL, V74, P9911, DOI 10.1128/JVI.74.21.9911-9915.2000; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	11	12	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					279	279		10.1126/science.1070868	http://dx.doi.org/10.1126/science.1070868			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951027				2022-12-24	WOS:000175000300038
J	Medzhitov, R; Janeway, CA				Medzhitov, R; Janeway, CA			Decoding the patterns of self and nonself by the innate immune system	SCIENCE			English	Article							NKG2D RECEPTOR; CELL-DEATH; ACTIVATION; APOPTOSIS; FAMILY		Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.		Abrams, William R/A-5782-2008					Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Austen K F, 1979, Adv Exp Med Biol, V120B, P3; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Crocker PR, 2001, TRENDS IMMUNOL, V22, P337, DOI 10.1016/S1471-4906(01)01930-5; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JANEWAY CA, 1989, COLD SH Q B, V54, P1; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kelm S, 1997, INT REV CYTOL, V175, P137, DOI 10.1016/S0074-7696(08)62127-0; Lanier LL, 2001, NAT IMMUNOL, V2, P23, DOI 10.1038/83130; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6	23	1538	1630	6	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					298	300		10.1126/science.1068883	http://dx.doi.org/10.1126/science.1068883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951031	Green Submitted			2022-12-24	WOS:000175000300042
J	Schmid, B; Ribbe, MW; Einsle, O; Yoshida, M; Thomas, LM; Dean, DR; Rees, DC; Burgess, BK				Schmid, B; Ribbe, MW; Einsle, O; Yoshida, M; Thomas, LM; Dean, DR; Rees, DC; Burgess, BK			Structure of a cofactor-deficient nitrogenase MoFe protein	SCIENCE			English	Article							IRON-MOLYBDENUM COFACTOR; AZOTOBACTER-VINELANDII; BIOSYNTHESIS; RESOLUTION; COPPER	One of the most complex biosynthetic processes in metallobiochemistry is the assembly of nitrogenase, the key enzyme in biological nitrogen fixation. We describe here the crystal structure of an iron-molybdenum cofactor-deficient form of the nitrogenase MoFe protein, into which the cofactor is inserted in the final step of MoFe protein assembly. The MoFe protein folds as a heterotetramer containing two copies each of the homologous alpha and beta subunits. In this structure, one of the three alpha subunit domains exhibits a substantially changed conformation, whereas the rest of the protein remains essentially unchanged. A predominantly positively charged funnel is revealed; this funnel is of sufficient size to accommodate insertion of the negatively charged cofactor.	CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California Irvine; Virginia Polytechnic Institute & State University	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Mail Code 147-75ch, Pasadena, CA 91125 USA.	dcrees@caltech.edu		Einsle, Oliver/0000-0001-8722-2893				ALLEN RM, 1994, CRIT REV BIOTECHNOL, V14, P225, DOI 10.3109/07388554409079834; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; BURGESS BK, 1990, CHEM REV, V90, P1377, DOI 10.1021/cr00106a002; Christiansen J, 2001, ANNU REV PLANT PHYS, V52, P269, DOI 10.1146/annurev.arplant.52.1.269; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KIM J, 1993, BIOCHEMISTRY-US, V32, P7104, DOI 10.1021/bi00079a006; KIM JS, 1992, NATURE, V360, P553, DOI 10.1038/360553a0; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lee HI, 1997, J AM CHEM SOC, V119, P11395, DOI 10.1021/ja971508d; Mayer SM, 1999, J MOL BIOL, V292, P871, DOI 10.1006/jmbi.1999.3107; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Rangaraj P, 2001, J BIOL CHEM, V276, P15968, DOI 10.1074/jbc.M100907200; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Rosenzweig AC, 2001, ACCOUNTS CHEM RES, V34, P119, DOI 10.1021/ar000012p; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SCHMID B, 2001, HDB METALLOPROTEINS, V2, P1025; SHAH VK, 1977, P NATL ACAD SCI USA, V74, P3249, DOI 10.1073/pnas.74.8.3249; Smith BE, 1999, ADV INORG CHEM, V47, P159, DOI 10.1016/S0898-8838(08)60078-1; Valentine JS, 1997, SCIENCE, V278, P817, DOI 10.1126/science.278.5339.817; Yoo SJ, 2000, J AM CHEM SOC, V122, P4926, DOI 10.1021/ja000254k	29	128	134	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					352	356		10.1126/science.1070010	http://dx.doi.org/10.1126/science.1070010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951047				2022-12-24	WOS:000175000300060
J	Makova, KD; Li, WH				Makova, KD; Li, WH			Strong male-driven evolution of DNA sequences in humans and apes	NATURE			English	Article							MUTATION-RATE; NUCLEOTIDE; CHROMOSOME; RATES	Studies of human genetic diseases have suggested a higher mutation rate in males than in females 1 and the male-to-female ratio (alpha) of mutation rate has been estimated from DNA sequence and microsatellite data to be about 4-6 in higher primates(2-5). Two recent studies, however, claim that alpha is only about 2 in humans(6,7). This is even smaller than the estimates (alpha > 4) for carnivores and birds(8,9); humans should have a higher alpha than carnivores and birds because of a longer generation time and a larger sex difference in the number of germ cell cycles. To resolve this issue, we sequenced a noncoding fragment on Y of about 10.4 kilobases (kb) and a homologous region on chromosome 3 in humans, greater apes, and lesser apes. Here we show that our estimate of alpha from the internal branches of the phylogeny is 5.25 (95% confidence interval (CI) 2.44 to infinity), similar to the previous estimates(2-5), but significantly higher than the two recent ones(6,7). In contrast, for the external (short, species-specific) branches, alpha is only 2.23 (95% CI: 1.47-3.84). We suggest that closely related species are not suitable for estimating alpha, because of ancient polymorphism and other factors. Moreover, we provide an explanation for the small estimate of a in a previous study(6). Our study reinstates a high alpha in hominoids and supports the view that DNA replication errors are the primary source of germline mutation.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	whli@uchicago.edu		Li, Wen-Hsiung/0000-0003-1086-1456				Agulnik AI, 1998, HUM MOL GENET, V7, P1371, DOI 10.1093/hmg/7.9.1371; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Bohossian HB, 2000, NATURE, V406, P622, DOI 10.1038/35020557; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Erlandsson R, 2000, MOL BIOL EVOL, V17, P804, DOI 10.1093/oxfordjournals.molbev.a026359; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1977, GENETICS, V85, P331; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Nachman MW, 2000, GENETICS, V156, P297; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; SHIMMIN LC, 1993, J MOL EVOL, V37, P160, DOI 10.1007/BF02407351; Slattery JP, 1998, GENETICS, V148, P1245; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; XIA X, 2000, DATA ANAL MOL BIOL E	20	180	185	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					624	626		10.1038/416624a	http://dx.doi.org/10.1038/416624a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948348				2022-12-24	WOS:000174901900040
J	Taylor, AH; Allen, JI; Clark, PA				Taylor, AH; Allen, JI; Clark, PA			Extraction of a weak climatic signal by an ecosystem	NATURE			English	Article							NORTH-SOUTH SHIFTS; GULF-STREAM; DYNAMICS; SEA; ZOOPLANKTON; ABUNDANCE; PLANKTON; ATLANTIC; TEMPERATURE; CARBON	The complexity of ecosystems can cause subtle(1) and chaotic responses to changes in external forcing(2). Although ecosystems may not normally behave chaotically(3), sensitivity to external influences associated with nonlinearity can lead to amplification of climatic signals. Strong correlations between an El Nino index and rainfall and maize yield in Zimbabwe have been demonstrated(4); the correlation with maize yield was stronger than that with rainfall. A second example is the 100,000-year ice-age cycle, which may arise from a weak cycle in radiation through its influence on the concentration of atmospheric CO2 (ref. 5). Such integration of a weak climatic signal has yet to be demonstrated in a realistic theoretical system. Here we use a particular climatic phenomenon-the observed association between plankton populations around the UK and the position of the Gulf Stream(6,7)-as a probe to demonstrate how a detailed marine ecosystem model extracts a weak signal that is spread across different meteorological variables. Biological systems may therefore respond to climatic signals other than those that dominate the driving variables.	Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England; Univ Plymouth, Dept Math & Stat, Plymouth PL4 8AA, Devon, England; Univ Sussex, Dept Geog, Brighton BN1 9SJ, E Sussex, England	Plymouth Marine Laboratory; University of Plymouth; University of Sussex	Taylor, AH (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth PL1 3DH, Devon, England.							Allen JI, 1998, MAR POLLUT BULL, V37, P295; Allen JI, 1998, J MARINE SYST, V18, P265, DOI 10.1016/S0924-7963(98)00015-3; Baretta J. W., 1997, J SEA RES, V38, P229; Baretta-Bekker JG, 1998, AQUAT MICROB ECOL, V14, P91, DOI 10.3354/ame014091; BERRYMAN AA, 1989, TRENDS ECOL EVOL, V4, P26, DOI 10.1016/0169-5347(89)90014-1; Blumberg A.F., 1980, MATH MODELLING ESTUA, P203; BROEKHUIZEN N, 1995, NETH J SEA RES, V33, P381, DOI 10.1016/0077-7579(95)90054-3; CANE MA, 1994, NATURE, V370, P204, DOI 10.1038/370204a0; COLEBROOK JM, 1985, MAR BIOL, V84, P261, DOI 10.1007/BF00392495; DROOP MR, 1974, J MAR BIOL ASSOC UK, V54, P825, DOI 10.1017/S002531540005760X; Ebenhoh W, 1997, J SEA RES, V38, P173, DOI 10.1016/S1385-1101(97)00043-9; Frid CLJ, 1996, ICES J MAR SCI, V53, P972, DOI 10.1006/jmsc.1996.0120; GEORGE DG, 1995, NATURE, V378, P139, DOI 10.1038/378139a0; George DG, 2000, FRESHWATER BIOL, V45, P111, DOI 10.1046/j.1365-2427.2000.00673.x; GLOVER R. S., 1967, SYMP ZOOL SOC LONDON, V19, P189; Huisman J, 1999, LIMNOL OCEANOGR, V44, P1781, DOI 10.4319/lo.1999.44.7.1781; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Mysterud A, 2001, NATURE, V410, P1096, DOI 10.1038/35074099; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; SUGIHARA G, 1990, PHILOS T R SOC B, V330, P235, DOI 10.1098/rstb.1990.0195; Taylor AH, 1996, INT J CLIMATOL, V16, P559, DOI 10.1002/(SICI)1097-0088(199605)16:5<559::AID-JOC26>3.0.CO;2-Z; TAYLOR AH, 1995, ICES J MAR SCI, V52, P711, DOI 10.1016/1054-3139(95)80084-0; TAYLOR AH, 1992, J MAR BIOL ASSOC UK, V72, P919, DOI 10.1017/S0025315400060161; TAYLOR AH, IN PRESS CHANGING ST	24	140	143	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					629	632		10.1038/416629a	http://dx.doi.org/10.1038/416629a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948350				2022-12-24	WOS:000174901900042
J	Delos Reyes, CM				Delos Reyes, CM			Overcoming pessimism about treatment of addiction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG-ABUSE; OUTCOMES; ALCOHOL		Case Western Reserve Univ, Sch Med, Cleveland, OH 44109 USA	Case Western Reserve University	Delos Reyes, CM (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44109 USA.							Allen JP, 1997, J STUD ALCOHOL, V58, P7; *AM SOC ADD MED, 1998, PRINC ADD MED; CHAPPEL JN, 1977, JAMA-J AM MED ASSOC, V237, P2318, DOI 10.1001/jama.237.21.2318; *DHHS, 2000, IMPR SUBST AB TREATM; Ewing GB, 1999, AM J PREV MED, V17, P62, DOI 10.1016/S0749-3797(99)00032-X; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; Hoffmann NG, 2000, J ADDICT DIS, V19, P1, DOI 10.1300/J069v19n03_01; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; Isaacson JH, 2000, J STUD ALCOHOL, V61, P912, DOI 10.15288/jsa.2000.61.912; LEWIS DC, 1987, JAMA-J AM MED ASSOC, V257, P2945, DOI 10.1001/jama.257.21.2945; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; National Institute on Drug Abuse, 1999, NIH PUBL; *PLNDP NAT PROJ OF, 2000, POS PAP DRUG POL	13	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 10	2002	287	14					1857	1857		10.1001/jama.287.14.1857	http://dx.doi.org/10.1001/jama.287.14.1857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539QJ	11939875				2022-12-24	WOS:000174881700041
J	Antonchuk, J; Sauvageau, G; Humphries, RK				Antonchuk, J; Sauvageau, G; Humphries, RK			HOXB4-induced expansion of adult hematopoietic stem cells ex vivo	CELL			English	Article							BONE-MARROW-CELLS; IN-VITRO; REPOPULATING ACTIVITY; QUANTITATIVE ASSAY; HOMEOBOX GENES; OVEREXPRESSION; PROLIFERATION; TRANSDUCTION; HOXB4	Hox transcription factors have emerged as important regulators of primitive hematopoietic cell proliferation and differentiation. In particular, HOXB4 appears to be a strong positive regulator of hernatopoietic stem cell (HSC) self-renewal. Here we demonstrate the potency of HOXB4 to enable high-level ex vivo HSC expansion. Cultures of nontransduced or GFP-transduced murine bone marrow cells experienced large HSC losses over 10-14 days. In sharp contrast, cultures of HOXB4-transduced cells achieved rapid, extensive, and highly polyclonal HSC expansions, resulting in over 1000-fold higher levels relative to controls and a 40-fold net HSC increase. Importantly, these HSCs retained full lympho-myeloid repopulating potential and enhanced in vivo regenerative potential, demonstrating the feasibility of achieving significant ex vivo expansion of HSCs without functional impairment.	British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Univ Montreal, Maisonneuve Rosemont Hosp, Dept Med, Div Hematol, Montreal, PQ H1T 2M2, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1Z1, Canada	British Columbia Cancer Agency; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of British Columbia	Sauvageau, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	khumphri@bccancer.bc.ca; sauvagg@ircm.qc.ca		Sauvageau, Guy/0000-0002-4333-7266; Humphries, Richard/0000-0003-0540-7005	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048642] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL65430] Funding Source: Medline; NIDDK NIH HHS [R01 DK48642] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Bunting KD, 2000, BLOOD, V96, P902, DOI 10.1182/blood.V96.3.902.015k40_902_909; Bunting KD, 1998, BLOOD, V92, P2269, DOI 10.1182/blood.V92.7.2269.2269_2269_2279; Buske C, 2000, INT J HEMATOL, V71, P301; Conneally E, 1997, P NATL ACAD SCI USA, V94, P9836, DOI 10.1073/pnas.94.18.9836; Daga A, 2000, EXP HEMATOL, V28, P569, DOI 10.1016/S0301-472X(00)00135-1; DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; FRASER CC, 1990, BLOOD, V76, P1071; Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168; Krosl J, 2000, ONCOGENE, V19, P5134, DOI 10.1038/sj.onc.1203897; Kyba M, 2001, BLOOD, V98, p451A; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Purton LE, 2000, BLOOD, V95, P470, DOI 10.1182/blood.V95.2.470; Sambrook JFE, 1989, MOL CLONING LAB MANU; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Thorsteinsdottir U, 1999, BLOOD, V94, P2605, DOI 10.1182/blood.V94.8.2605.420k19_2605_2612; Thorsteinsdottir U, 1997, MOL CELL BIOL, V17, P495, DOI 10.1128/MCB.17.1.495; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390	26	530	578	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2002	109	1					39	45		10.1016/S0092-8674(02)00697-9	http://dx.doi.org/10.1016/S0092-8674(02)00697-9			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955445	Bronze			2022-12-24	WOS:000174888300007
J	Nemoto, S; Finkel, T				Nemoto, S; Finkel, T			Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway	SCIENCE			English	Article							TRANSCRIPTION FACTOR; OXIDATIVE STRESS; LIFE-SPAN; SURVIVAL; ELEGANS; FKHR; AKT; AFX	Genetic determinants of longevity include the forkhead-related transcription factor DAF-16 in the worm Caenorhabditis elegans and the p66shc locus in mice. We demonstrate that p66shc regulates intracellular oxidant levels in mammalian cells and that hydrogen peroxide can negatively regulate forkhead activity. In p66shc(-/-) cells, the activity of the mammalian forkhead homolog FKHRL1 is increased and redox-dependent forkhead inactivation is reduced. In addition, expression of FKHRL1 results in an increase in both hydrogen peroxide scavenging and oxidative stress resistance. These results demonstrate an important functional relation between three distinct elements linked to aging: forkhead proteins, p66shc, and intracellular oxidants.	NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10-6N-240,10 Ctr Dr, Bethesda, MD 20892 USA.		Franzeck, Fabian C/B-5055-2011					Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; HANG H, 2001, J BIOL CHEM, V276, P26357; Harman D., 1957, J GERONTOL, V2, P298; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leenders H, 2000, EUR J IMMUNOL, V30, P2980, DOI 10.1002/1521-4141(200010)30:10<2980::AID-IMMU2980>3.0.CO;2-9; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Murakami S, 2001, CURR BIOL, V11, P1517, DOI 10.1016/S0960-9822(01)00453-5; NEMOTO S, UNPUB; Salinas M, 2001, MOL CELL NEUROSCI, V17, P67, DOI 10.1006/mcne.2000.0921; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Taub J, 1999, NATURE, V399, P162, DOI 10.1038/20208; Wang XT, 2001, J BIOL CHEM, V276, P28364, DOI 10.1074/jbc.M102693200; YEE RYN, 2001, CURR BIOL, V11, P1950; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200	24	706	736	4	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2450	2452		10.1126/science.1069004	http://dx.doi.org/10.1126/science.1069004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11884717				2022-12-24	WOS:000174712600055
J	Dennis, C				Dennis, C			Baiting plan to remove fox threat to Tasmanian wildlife	NATURE			English	News Item																			0	9	9	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					357	357		10.1038/416357b	http://dx.doi.org/10.1038/416357b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919593	Bronze			2022-12-24	WOS:000174607800011
J	Bowen, GJ; Clyde, WC; Koch, PL; Ting, SY; Alroy, J; Tsubamoto, T; Wang, YQ; Wang, Y				Bowen, GJ; Clyde, WC; Koch, PL; Ting, SY; Alroy, J; Tsubamoto, T; Wang, YQ; Wang, Y			Mammalian dispersal at the Paleocene/Eocene boundary	SCIENCE			English	Article							MARINE; END	A profound faunal reorganization occurred near the Paleocene/Eocene boundary, when several groups of mammals abruptly appeared on the Holarctic continents. To test the hypothesis that this event featured the dispersal of groups from Asia to North America and Europe, we used isotope stratigraphy, magnetostratigraphy, and quantitative biochronology to constrain the relative age of important Asian faunas. The extinct family Hyaenodontidae appeared in Asia before it did so in North America, and the modern orders Primates, Artiodactyla, and Perissodactyla first appeared in Asia at or before the Paleocene/Eocene boundary. These results are consistent with Asia being a center for early mammalian origination.	Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA; Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan	University of California System; University of California Santa Cruz; University System Of New Hampshire; University of New Hampshire; Louisiana State University System; Louisiana State University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Kyoto University	Bowen, GJ (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.	gbowen@es.ucsc.edu	Clyde, William/C-9595-2017; Alroy, John/B-4585-2009; Bowen, Gabriel J/C-1708-2008	Clyde, William/0000-0001-8814-3409; Alroy, John/0000-0002-9882-2111; 				ALROY J, 1994, PALEOBIOLOGY, V20, P191, DOI 10.1017/S0094837300012677; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Bains S, 1999, SCIENCE, V285, P724, DOI 10.1126/science.285.5428.724; Beard KC, 1999, B SOC GEOL FR, V170, P697; BEARD KC, 1998, DAWN AGE MAMMALS ASI, P5; Bowen GJ., 2001, PALEOCENE EOCENE STR, P73; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Cojan I, 2000, GEOLOGY, V28, P259, DOI 10.1130/0091-7613(2000)028<0259:SCISOT>2.3.CO;2; DASHZEVEG D, 1988, J GEOL SOC LONDON, V145, P473, DOI 10.1144/gsjgs.145.3.0473; Gingerich P.D., 1989, U MICHIGAN PAPERS PA, V28, P1; Gingerich Philip D., 2001, Museum of Paleontology Papers on Paleontology, V33, P37; Hooker JJ, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P428; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; KOCH PL, 1992, NATURE, V358, P319, DOI 10.1038/358319a0; Lucas SG, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P451; Maas M. C., 1990, GEOL SOC AM SPEC PAP, V243, P71; MCKENNA MC, 1983, ANN MO BOT GARD, V70, P459, DOI 10.2307/2992083; Meng Jin, 1998, Bulletin of Carnegie Museum of Natural History, V34, P148; Peters RB, 2000, GEOLOGY, V28, P979, DOI 10.1130/0091-7613(2000)28<979:HCOGGA>2.0.CO;2; Rohl U, 2000, GEOLOGY, V28, P927, DOI 10.1130/0091-7613(2000)28<927:NCFTLP>2.0.CO;2; TING S, 1998, DAWN AGE MAMMALS ASI, P124; WANG Y, 1998, DAWN AGE MAMMALS ASI, P89; Wing Scott L., 1999, WARM CLIMATES EARTH, P197; ZCHOS J, 2001, SCIENCE, V292, P686	24	192	222	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 15	2002	295	5562					2062	2065		10.1126/science.1068700	http://dx.doi.org/10.1126/science.1068700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896275				2022-12-24	WOS:000174450500045
J	Arca, M; Zuliani, G; Wilund, K; Campagna, F; Fellin, R; Bertolini, S; Calandra, S; Ricci, G; Glorioso, N; Maioli, M; Pintus, P; Carru, C; Cossu, F; Cohen, J; Hobbs, HH				Arca, M; Zuliani, G; Wilund, K; Campagna, F; Fellin, R; Bertolini, S; Calandra, S; Ricci, G; Glorioso, N; Maioli, M; Pintus, P; Carru, C; Cossu, F; Cohen, J; Hobbs, HH			Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis	LANCET			English	Article							LOW-DENSITY-LIPOPROTEIN; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; LDL-RECEPTOR; BETA-THALASSEMIA; CHOLESTEROL; POPULATION; INTERNALIZATION; ATHEROSCLEROSIS; PATHWAY; DISEASE	Background Autosomal recessive hypercholesterolaemia (ARH) is caused by mutations in a putative adaptor protein called ARH. This recessive disorder, characterised by severe hypercholesterolaemia, xanthomatosis, and premature coronary artery disease, is rare except on the island of Sardinia, Italy. Our aim was to ascertain why ARH is more common on Sardinia than elsewhere. Methods We obtained detailed medical histories, did physical examinations, measured concentrations of lipoproteins, and harvested genomic DNA from 28 Sardinians with ARH from 17 unrelated families. We sequenced the coding regions and consensus splice sites of ARH in probands from these families, and from 40 individuals of non-Sardinian origin who had an autosomal recessive form of hypercholesterolaemia of unknown cause. Findings Two ARH mutations, a frameshift mutation (c432insA) in exon 4 (ARH1) and a nonsense mutation (c65G-->A) in exon 1 (ARH2), were present in all of the 17 unrelated families with ARH. Three of the ARH alleles contained both mutations, as a result of an ancient recombination between ARH1 and ARH2. No regional clustering of the three mutant alleles within Sardinia was apparent. Furthermore, four Italians from the mainland with autosomal recessive hypercholesterolaemia were homozygous for ARH1. Interpretation The small number, high frequency, and dispersed distribution of ARH mutations on Sardinia are consistent with these mutations being ancient and maintained in the Sardinian population because of geographic isolation.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Roma La Sapienza, Dept Med Therapy, Rome, Italy; Univ Ferrara, Inst Med 2, I-44100 Ferrara, Italy; Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; Osped Microcitemico, Bone Marrow Transplant Unit, Cagliari, Italy; Brotzu Hosp, Cagliari, Italy; Univ Sassari, Inst Internal Med, Clin Biochem & Metab Dis Unit, I-07100 Sassari, Italy	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome; University of Ferrara; University of Genoa; Universita di Modena e Reggio Emilia; University of Sassari	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines, Dallas, TX 75390 USA.		Pintus, Paolo/AAQ-7789-2021; /V-4899-2019; Carru, Ciriaco/AAI-9996-2021; ARCA, Marcello/AAC-3883-2022	Pintus, Paolo/0000-0002-8666-8399; ARCA, Marcello/0000-0003-3786-0883; Zuliani, Giovanni/0000-0003-0969-3184; Carru, Ciriaco/0000-0002-6985-4907; Cossu, Fausto/0000-0001-5485-2098	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047619, P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL47619, HL20948, HL0360] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bertolini S, 1999, ARTERIOSCL THROM VAS, V19, P408, DOI 10.1161/01.ATV.19.2.408; BILHEIMER DW, 1983, P NATL ACAD SCI-BIOL, V80, P4124, DOI 10.1073/pnas.80.13.4124; BJORKHEM I, 2001, METABOLIC MOL BASES, P2961; BORK P, 1995, CELL, V80, P93; Braunwald E., 2001, HEART DIS TXB CARDIO; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BUJA LM, 1979, AM J PATHOL, V97, P327; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CUCCA F, 1998, FORUM TGRENDS EXP S, P23; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DEVITA G, 1989, AM J HUM GENET, V44, P233; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; HARADASHIBA M, 1992, ARTERIOSCLER THROMB, V12, P1071, DOI 10.1161/01.ATV.12.9.1071; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Linton MF, 1999, J BIOL CHEM, V274, P19204, DOI 10.1074/jbc.274.27.19204; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; MUNTONI S, 1991, EUR J EPIDEMIOL, V7, P39; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; PIAZZA A, 1985, ANN HUM GENET, V49, P47, DOI 10.1111/j.1469-1809.1985.tb01675.x; PIRASTU M, 1987, P NATL ACAD SCI USA, V84, P2882, DOI 10.1073/pnas.84.9.2882; Raal FJ, 2000, ATHEROSCLEROSIS, V150, P421, DOI 10.1016/S0021-9150(99)00435-9; Rendine S, 1997, ANN HUM GENET, V61, P411; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Schmidt HHJ, 1998, J CLIN ENDOCR METAB, V83, P2167, DOI 10.1210/jc.83.6.2167; SPOOR CF, 1986, J HUM EVOL, V15, P399, DOI 10.1016/S0047-2484(86)80019-7; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; WARNICK GR, 1979, CLIN CHEM, V25, P596; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	36	108	111	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 9	2002	359	9309					841	847		10.1016/S0140-6736(02)07955-2	http://dx.doi.org/10.1016/S0140-6736(02)07955-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YV	11897284				2022-12-24	WOS:000174329600012
J	Brierley, AS; Fernandes, PG; Brandon, MA; Armstromg, F; Millard, NW; McPhail, SD; Stevenson, P; Pebody, M; Perrett, J; Squires, M; Bone, DG; Griffiths, G				Brierley, AS; Fernandes, PG; Brandon, MA; Armstromg, F; Millard, NW; McPhail, SD; Stevenson, P; Pebody, M; Perrett, J; Squires, M; Bone, DG; Griffiths, G			Antarctic krill under sea ice: Elevated abundance in a narrow band just south of ice edge	SCIENCE			English	Article							NORTHERN WEDDELL SEA; EUPHAUSIA-SUPERBA; ACOUSTIC OBSERVATIONS; EXTENT; ZONE	We surveyed Antarctic krill (Euphausia superba) under sea ice using the autonomous underwater vehicle Autosub-2. Krill were concentrated within a band under ice between 1 and 13 kilometers south of the ice edge. Within this band, krill densities were fivefold greater than that of open water. The under-ice environment has tong been considered an important habitat for krill, but sampling difficulties have previously prevented direct observations under ice over the scale necessary for robust krill density estimation. Autosub-2 enabled us to make continuous high-resolution measurements of krill density under ice reaching 27 kilometers beyond the ice edge.	British Antarctic Survey, Cambridge CB3 0ET, England; Marine Lab Aberdeen, Fisheries Res Serv, Aberdeen AB11 9DB, Scotland; Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Open University - UK; NERC National Oceanography Centre; University of Southampton	Brierley, AS (corresponding author), Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland.		Brierley, Andrew S/G-8019-2011; Fernandes, Paul/H-2972-2013; Brandon, Mark A/A-5804-2010	Brierley, Andrew S/0000-0002-6438-6892; Fernandes, Paul/0000-0003-4135-115X; Brandon, Mark A/0000-0002-7779-0958				Arrigo KR, 1998, J GEOPHYS RES-OCEANS, V103, P15587, DOI 10.1029/98JC00930; Brierley A.S., 1999, CCAMLR Science, V6, P47; Brierley AS, 2000, CAN J FISH AQUAT SCI, V57, P24, DOI 10.1139/cjfas-57-S3-24; BRIERLEY AS, IN PRESS FISHERIES R; DALY KL, 1991, MAR ECOL PROG SER, V79, P37, DOI 10.3354/meps079037; DALY KL, 1988, DEEP-SEA RES, V35, P21, DOI 10.1016/0198-0149(88)90055-6; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; FERNANDES PG, 1999, ICES CM 1999 M, V1; GODLEWSKA M, 1993, POLAR BIOL, V13, P507; ICHII T, 1990, P NIPR S POLAR BIOL, V3, P36; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Marr J., 1962, DISCOVERY REP, V32, P33; McGehee DE, 1998, DEEP-SEA RES PT II, V45, P1273, DOI 10.1016/S0967-0645(98)00036-8; Millard NW, 1998, UNDERWATER TECHNOL, V23, P7, DOI 10.3723/175605498783259894; Murray AWA, 1996, ICES J MAR SCI, V53, P415, DOI 10.1006/jmsc.1996.0058; Ona E, 1996, ICES J MAR SCI, V53, P677, DOI 10.1006/jmsc.1996.0087; PARK NS, 1991, KOREAN J MED CHEM, V1, P36; Quetin Langdon B., 1996, Antarctic Research Series, V70, P357; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; SIEGEL V, 1990, POLAR BIOL, V10, P549; SIEGEL V, 1992, POLAR BIOL, V12, P15; SPRONG I, 1992, POLAR BIOL, V12, P261; TURNER DR, 1995, DEEP-SEA RES PT II, V42, P907, DOI 10.1016/0967-0645(95)00056-V; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; WATKINS JL, 1997, WGEMM9746 CCAMLR; Worby A.P., 1999, OBSERVING ANTARCTIC	26	189	201	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1890	1892		10.1126/science.1068574	http://dx.doi.org/10.1126/science.1068574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884754				2022-12-24	WOS:000174299500038
J	Peier, AM; Moqrich, A; Hergarden, AC; Reeve, AJ; Andersson, DA; Story, GM; Earley, TJ; Dragoni, I; McIntyre, P; Bevan, S; Patapoutian, A				Peier, AM; Moqrich, A; Hergarden, AC; Reeve, AJ; Andersson, DA; Story, GM; Earley, TJ; Dragoni, I; McIntyre, P; Bevan, S; Patapoutian, A			A TRP channel that senses cold stimuli and menthol	CELL			English	Article							CAPSAICIN-RECEPTOR; CA2+ CHANNEL; PAIN; NOCICEPTORS; HOMOLOG; CLONING; PROTEIN; HEAT	A distinct subset of sensory neurons are thought to directly sense changes in thermal energy through their termini in the skin. Very little is known about the molecules that mediate thermoreception by these neurons. Vanilloid Receptor 1 (VR1), a member of the TRP family of channels, is activated by noxious heat. Here we describe the cloning and characterization of TRPM8, a distant relative of VR1. TRPM8 is specifically expressed in a subset of pain- and temperature-sensing neurons. Cells overexpressing the TRPM8 channel can be activated by cold temperatures and by a cooling agent, menthol. Our identification of a cold-sensing TRP channel in a distinct subpopulation of sensory neurons implicates an expanded role for this family of ion channels in somatic sensory detection.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Inst Med Sci, London WC1E 6BN, England	Novartis; Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.		Bevan, Stuart/A-8821-2008; Andersson, David A/C-3435-2008; Mcintyre, Peter/N-4109-2013	Andersson, David A/0000-0001-7451-8548; Bevan, Stuart John/0000-0002-8977-1797; McIntyre, Peter/0000-0001-9506-5998; moqrich, aziz/0000-0002-1937-1675				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hensel H, 1981, THERMORECEPTION TEMP; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Savidge JR, 2001, NEUROSCIENCE, V102, P177, DOI 10.1016/S0306-4522(00)00447-4; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Scott SA, 1992, SENSORY NEURONS DIVE; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsavaler L, 2001, CANCER RES, V61, P3760; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229	28	1542	1628	10	140	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					705	715		10.1016/S0092-8674(02)00652-9	http://dx.doi.org/10.1016/S0092-8674(02)00652-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893340	Bronze			2022-12-24	WOS:000174314800013
J	Soutoglou, E; Talianidis, I				Soutoglou, E; Talianidis, I			Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation	SCIENCE			English	Article							EPITHELIAL-CELL LINE; RNA-POLYMERASE-II; TRANSCRIPTION FACTORS; ORDERED RECRUITMENT; PROMOTER; ACETYLATION; EXPRESSION; CACO-2; FORMS	We analyzed the ordered recruitment of factors to the human alpha(1) antitrypsin promoter around the initial activation of the gene during enterocyte differentiation. We found that a complete preinitiation complex, including phosphorylated RNA pol II, was assembled at the promoter long before transcriptional activation. The histone acetyltransferases CBP and P/CAF were recruited subsequently, but local histone hyperacetylation was delayed. After transient recruitment of the human Brahma homolog hBrm, remodeling of the neighboring nucleosome coincided with transcription initiation. The results suggest that, at this promoter, chromatin reconfiguration is a defining step of the initiation process, acting after the assembly of the Pol II machinery.	Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH)	Talianidis, I (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, POB 1527, Iraklion 71110, Crete, Greece.		Talianidis, Iannis/F-7556-2016	Talianidis, Iannis/0000-0002-1209-3609; Soutoglou, Evi/0000-0002-3724-5613				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Bell B, 1999, EXP CELL RES, V246, P11, DOI 10.1006/excr.1998.4294; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Cosma MP, 2001, MOL CELL, V7, P1213, DOI 10.1016/S1097-2765(01)00266-0; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; GREENBERG ME, 1999, CURRENT PROTOCOLS MO, V1, pCH4; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hu CB, 1999, AM J PHYSIOL-GASTR L, V276, pG1181, DOI 10.1152/ajpgi.1999.276.5.G1181; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; MONACI P, 1988, EMBO J, V7, P2075, DOI 10.1002/j.1460-2075.1988.tb03047.x; PERLMUTTER DH, 1989, J BIOL CHEM, V264, P9485; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; PETERSON MD, 1992, J CELL SCI, V102, P581; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Soutoglou E, 2001, EMBO J, V20, P1984, DOI 10.1093/emboj/20.8.1984; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136	26	263	264	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1901	1904		10.1126/science.1068356	http://dx.doi.org/10.1126/science.1068356			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884757				2022-12-24	WOS:000174299500042
J	Sheridan, E; Aitken, C; Jeffries, D; Hird, M; Thayalasekaran, P				Sheridan, E; Aitken, C; Jeffries, D; Hird, M; Thayalasekaran, P			Congenital rubella syndrome: a risk in immigrant populations	LANCET			English	Article								An infant with congenital rubella syndrome was born to a young mother who had recently arrived In the UK. The infection was not detected before birth, and transmission to another infant was documented. This case highlights the emerging importance of rubella as an imported Infection in the developed world and the need to maintain a high Index of suspicion for this disorder in recent immigrants from countries with no immunisation programme. Targeted immunisation for such groups is recommended.	Royal London Hosp, Dept Med Microbiol, London E1 1BB, England; Royal London Hosp, Directorate Womens & Childrens Hlth, London E1 1BB, England; St Bartholomews Hosp, Dept Virol, London, England; Wapping Hlth Ctr, London, England	Barts Health NHS Trust; Royal London Hospital; Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Sheridan, E (corresponding author), Royal London Hosp, Dept Med Microbiol, London E1 1BB, England.			Sheridan, Elizabeth/0000-0002-7804-3217				COOPER LZ, 1965, MMWR-MORBID MORTAL W, V14, P44; Cutts FT, 1999, INT J EPIDEMIOL, V28, P1176, DOI 10.1093/ije/28.6.1176; MILLER E, 1990, BRIT MED J, V301, P1391, DOI 10.1136/bmj.301.6765.1391; Miller E, 1997, Commun Dis Rep CDR Rev, V7, pR26; Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1	5	32	32	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					674	675		10.1016/S0140-6736(02)07805-4	http://dx.doi.org/10.1016/S0140-6736(02)07805-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879866				2022-12-24	WOS:000174107400014
J	Burns, WCG				Burns, WCG			Climate change and human health: The critical policy agenda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Pacific Inst Studies Dev Environm & Secur, Oakland, CA USA		Burns, WCG (corresponding author), Pacific Inst Studies Dev Environm & Secur, Oakland, CA USA.							[Anonymous], 2002, CLEAN ENERGY JOBS; BURNS WCG, 2001, GEORGETOWN INT ENV L, V13, P335; CLAUSSEN E, 2002, CLIMATE CHANGE MOVIN; *HADL CTR, 1999, GREENH EFF CLIM CHAN; *INT PAN CLIM CHAN, 2002, CLIM CHANG 2001 SCI; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; *UNFCCC, 2001, C PART ITS 7 SESS MA; *UNFCCC, 1997, C PART ITS 3 SESS KY; [No title captured]	9	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2287	2287		10.1001/jama.287.17.2287	http://dx.doi.org/10.1001/jama.287.17.2287			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980535				2022-12-24	WOS:000175260600034
J	Novotny, V; Basset, Y; Miller, SE; Weiblen, GD; Bremer, B; Cizek, L; Drozd, P				Novotny, V; Basset, Y; Miller, SE; Weiblen, GD; Bremer, B; Cizek, L; Drozd, P			Low host specificity of herbivorous insects in a tropical forest	NATURE			English	Article							PHYLOGENETIC-RELATIONSHIPS; SEQUENCES; RBCL	Two decades of research(1-4) have not established whether tropical insect herbivores are dominated by specialists or generalists. This impedes our understanding of species coexistence in diverse rainforest communities. Host specificity and species richness of tropical insects are also key parameters in mapping global patterns of biodiversity(1,4,5). Here we analyse data for over 900 herbivorous species feeding on 51 plant species in New Guinea and show that most herbivorous species feed on several closely related plant species. Because species-rich genera are dominant in tropical floras, monophagous herbivores are probably rare in tropical forests. Furthermore, even between phylogenetically distant hosts, herbivore communities typically shared a third of their species. These results do not support the classical view that the coexistence of herbivorous species in the tropics is a consequence of finely divided plant resources; non-equilibrium models of tropical diversity(6) should instead be considered. Low host specificity of tropical herbivores reduces global estimates of arthropod diversity from 31 million (ref. 1) to 4-6 million species. This finding agrees with estimates based on taxonomic collections, reconciling an order of magnitude discrepancy between extrapolations of global diversity based on ecological samples of tropical communities with those based on sampling regional faunas (7,8).	Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; Univ S Bohemia, Fac Biol, Ceske Budejovice 37005, Czech Republic; Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Smithsonian Inst, Natl Museum Nat Hist, Dept Systemat Biol, Washington, DC 20560 USA; Univ Minnesota, Dept Plant Biol, Ctr Biol Sci 220, St Paul, MN 55108 USA; Royal Swedish Acad Sci, Bergius Fdn, SE-10405 Stockholm, Sweden; Univ Ostrava, Dept Biol, Ostrava, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Minnesota System; University of Minnesota Twin Cities; Royal Swedish Academy of Sciences; University of Ostrava	Novotny, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	novotny@entu.cas.cz	Novotny, Vojtech/G-9434-2014; Cizek, Lukas/K-7111-2015; Cizek, Lukas/G-7905-2014; Drozd, Pavel/J-3943-2013; Basset, Yves F/B-6642-2014	Novotny, Vojtech/0000-0001-7918-8023; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Drozd, Pavel/0000-0002-4602-8856; Basset, Yves F/0000-0002-1942-5717; Miller, Scott/0000-0002-4138-1378				Backlund M, 2000, AM J BOT, V87, P1029, DOI 10.2307/2657003; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; Basset Y, 2000, BIOSCIENCE, V50, P899, DOI 10.1641/0006-3568(2000)050[0899:QBEWPA]2.0.CO;2; BASSET Y, 1992, BIOL J LINN SOC, V47, P115, DOI 10.1111/j.1095-8312.1992.tb00659.x; Basset Y, 1996, BIOL J LINN SOC, V59, P201, DOI 10.1111/j.1095-8312.1996.tb01461.x; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Burger W., 1993, FIELDIANA BOT, V33, P1, DOI DOI 10.5962/BHL.TITLE.2550; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; GENTRY AH, 1990, 4 NEOTROPICAL FOREST; Hoft R., 1992, PLANTS NEW GUINEA SO; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; Jolivet P., 1995, HOST PLANTS CHRYSOME; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Mabberley DJ, 1987, PLANT BOOK; Marquis R.J., 1991, P179; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; May Robert M., 2000, P30; MILLER SE, IN PRESS FDN TROPICA; NIELSEN ES, 2000, NATURE HUMAN SOC QUE, P312; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Parsons M., 1999, BUTTERFLIES PAPUA NE, DOI DOI 10.7717/peerj.2653; POWELL JA, 1998, LEPIDOPTERA MOTHS BU, V1, P403; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Sekhran N., 1996, PAPUA NEW GUINEA COU; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI [10.1111/j.1095-8339.2000.tb01588.x, 10.1006/bojl.2000.0380]; STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669; THOMAS CD, 1990, ECOLOGY, V71, P610, DOI 10.2307/1940314; Weiblen GD, 2000, AM J BOT, V87, P1342, DOI 10.2307/2656726	30	472	498	3	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2002	416	6883					841	844		10.1038/416841a	http://dx.doi.org/10.1038/416841a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976681				2022-12-24	WOS:000175163800049
J	Singer, LT; Arendt, R; Minnes, S; Farkas, K; Salvator, A; Kirchner, HL; Kliegman, R				Singer, LT; Arendt, R; Minnes, S; Farkas, K; Salvator, A; Kirchner, HL; Kliegman, R			Cognitive and motor outcomes of cocaine-exposed infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DRUG EXPOSURE; CHILDREN; ABUSE; BRAIN; MECHANISMS; MECONIUM; GROWTH; AGE	Context Maternal use of cocaine during pregnancy remains a significant public health problem, particularly in urban areas of the United States and among women of low socioeconomic status. Few longitudinal studies have examined cocaine-exposed infants, however, and findings are contradictory because of methodologic limitations. Objective To assess the effects of prenatal cocaine exposure on child developmental outcomes. Design Longitudinal, prospective, masked, comparison birth cohort study with recruitment in 1994-1996. Setting Obstetric unit of a large US urban teaching hospital. Participants Four hundred fifteen consecutively enrolled infants (218 cocaine-exposed and 197 unexposed) identified from a high-risk, low-socioeconomic status, primarily black (80%) population screened through clinical interview and urine and meconium samples for drug use. The retention rate was 94% at 2 years of age. Main Outcome Measures The Bayley Mental and Motor Scales of Infant Development, assessed at 6.5, 12, and 24 months of corrected age. Results Controlled for confounding variables, cocaine exposure had significant effects on cognitive development, accounting for a 6-point deficit in Bayley Mental and Motor Scales of Infant Development scores at 2 years, with cocaine-exposed children twice as likely to have significant delay (mental development index <80) (odds ratio, 1.98; 95% confidence interval, 1.21-3.24; P=.006). For motor outcomes, there were no significant cocaine effects. Conclusions Cocaine-exposed children had significant cognitive deficits and a doubling of the rate of developmental delay during the first 2 years of life. Because 2-year outcomes are predictive of later cognitive outcomes, it is possible that these children will continue to have learning difficulties at school age.	Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Mandel Sch Appl Social Sci, Cleveland, OH 44106 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA	Case Western Reserve University; Case Western Reserve University; Medical College of Wisconsin	Singer, LT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, Triangle Bldg,11400 Euclid Ave,Suite 250, Cleveland, OH 44106 USA.		Singer, Lynn/Q-2045-2019	Singer, Lynn/0000-0003-2950-9460	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007957] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00080] Funding Source: Medline; NIDA NIH HHS [R01 DA007957] Funding Source: Medline; PHS HHS [R01-07957] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alessandri SM, 1998, DEV PSYCHOL, V34, P565, DOI 10.1037/0012-1649.34.3.565; Arendt R, 1999, PEDIATRICS, V103, P86, DOI 10.1542/peds.103.1.86; Arendt RE, 1999, J DRUG ISSUES, V29, P203, DOI 10.1177/002204269902900203; AZUMA SD, 1993, PEDIATRICS, V92, P396; Barron R. M., 1986, J PERS SOC PSYCHOL, V51, P1173, DOI DOI 10.1037/0022-3514.51.6.1173; Bayley N., 1993, BAYLEY SCALES INFANT; Bayley N., 1969, BAYLEY SCALES INFANT; CHOUTEAU M, 1988, OBSTET GYNECOL, V72, P351; CREGLER LL, 1986, NEW ENGL J MED, V315, P1495, DOI 10.1056/NEJM198612043152327; Derogatis LR., 1992, BRIEF SYMPTOM INVENT; Dunn L. M., 1981, PEABODY PICTURE VOCA; Fagan JF, 1983, ADV INFANCY RES, V2, P31; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; HOBEL CJ, 1973, AM J OBSTET GYNECOL, V117, P1; HURT H, 1995, J DEV BEHAV PEDIATR, V16, P29, DOI 10.1097/00004703-199502000-00005; JACOBSON SH, 1991, POLYM PREPR, V32, P390; Jacobson SW, 1996, J PEDIATR-US, V129, P581, DOI 10.1016/S0022-3476(96)70124-5; JOHNS JM, 1992, NEUROTOXICOL TERATOL, V14, P343, DOI 10.1016/0892-0362(92)90041-8; KANDEL DB, 1998, DRUG ADDICTION RES H, P105; Kosofsky BE, 1998, ANN NY ACAD SCI, V846, P248, DOI 10.1111/j.1749-6632.1998.tb09742.x; Lester BM, 1998, SCIENCE, V282, P633, DOI 10.1126/science.282.5389.633; LEWIS DE, 1994, J TOXICOL-CLIN TOXIC, V32, P697, DOI 10.3109/15563659409017976; LIDOW MS, 1995, SYNAPSE, V21, P332, DOI 10.1002/syn.890210408; LITTLE BB, 1991, OBSTET GYNECOL, V77, P361; Mayes LC, 1999, DEV PSYCHOPATHOL, V11, P685, DOI 10.1017/S0954579499002278; Molfese VJ, 1997, INT J BEHAV DEV, V20, P595, DOI 10.1080/016502597385072; *NAT I DRUG AB, 1992, PUBL NAT I DRUG AB; OSTREA EM, 1989, J PEDIATR-US, V115, P474, DOI 10.1016/S0022-3476(89)80860-1; Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P519, DOI 10.1016/0892-0362(96)00062-1; Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P627, DOI 10.1016/S0892-0362(96)00121-3; Singer L, 1997, DEV PSYCHOPATHOL, V9, P473, DOI 10.1017/S0954579497001259; SINGER L, 1994, ARCH PEDIAT ADOL MED, V148, P959, DOI 10.1001/archpedi.1994.02170090073014; Singer LT, 1999, INFANT BEHAV DEV, V22, P1, DOI 10.1016/S0163-6383(99)80002-2; Singer LT, 1999, J DRUG ISSUES, V29, P253, DOI 10.1177/002204269902900207; Singer LT, 2001, PEDIATRICS, V107, P1057, DOI 10.1542/peds.107.5.1057; SINGER LT, IN PRESS NEUROTOXICO; Singh VK, 2000, IMMUNOL RES, V22, P1, DOI 10.1385/IR:22:1:1; STREISSGUTH AP, 1986, BEHAV TERATOLOGY ALC; Strupp B. J., 1998, Neurotoxicology and Teratology, V20, P355, DOI 10.1016/S0892-0362(98)80587-4; VOLPE JJ, 1992, NEW ENGL J MED, V327, P399, DOI 10.1056/NEJM199208063270607; WECHSLER D, 1989, WESCHLER ADULT INTEL; Wilkins AS, 1998, NEUROTOXICOL TERATOL, V20, P239, DOI 10.1016/S0892-0362(97)00128-1; WOODS JR, 1987, JAMA-J AM MED ASSOC, V257, P957, DOI 10.1001/jama.257.7.957; ZUCKERMAN B, 1989, NEW ENGL J MED, V320, P762, DOI 10.1056/NEJM198903233201203	44	150	155	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 17	2002	287	15					1952	1960		10.1001/jama.287.15.1952	http://dx.doi.org/10.1001/jama.287.15.1952			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	541NC	11960537	Bronze			2022-12-24	WOS:000174989800023
J	D'Acremont, V; Landry, P; Darioli, R; Stuerchler, D; Pecoud, A; Genton, B				D'Acremont, V; Landry, P; Darioli, R; Stuerchler, D; Pecoud, A; Genton, B			Treatment of imported malaria in an ambulatory setting: prospective study	BRITISH MEDICAL JOURNAL			English	Article									Policlin Med Univ, CH-1005 Lausanne, Switzerland; Swiss Fed Off Publ Hlth, Bern, Switzerland		Genton, B (corresponding author), Policlin Med Univ, CH-1005 Lausanne, Switzerland.			Whitty, Christopher/0000-0002-6076-5027				Evans MRW, 2000, HOSP MED, V61, P162, DOI 10.12968/hosp.2000.61.3.1308; GENTON B, 2001, TRAVELERS MALARIA, P371; HATZ C, 2001, TRAVELERS MALARIA, P431; Kain KC, 1998, CLIN INFECT DIS, V27, P142, DOI 10.1086/514616	4	37	37	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					875	876		10.1136/bmj.324.7342.875	http://dx.doi.org/10.1136/bmj.324.7342.875			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950734	Green Published, Bronze			2022-12-24	WOS:000175052200018
J	Tanaka, M; Munsterberg, A; Anderson, WG; Prescott, AR; Hazon, N; Tickle, C				Tanaka, M; Munsterberg, A; Anderson, WG; Prescott, AR; Hazon, N; Tickle, C			Fin development in a cartilaginous fish and the origin of vertebrate limbs	NATURE			English	Article							APICAL ECTODERMAL RIDGE; POLARIZING ACTIVITY; SONIC-HEDGEHOG; CHICK-EMBRYOS; HOX GENES; EVOLUTION	Recent fossil finds and experimental analysis of chick and mouse embryos highlighted the lateral fin fold theory, which suggests that two pairs of limbs in tetrapods evolved by subdivision of an elongated single fin(1). Here we examine fin development in embryos of the primitive cartilaginous fish, Scyliorhinus canicula (dogfish) using scanning electron microscopy and investigate expression of genes known to be involved in limb positioning, identity and patterning in higher vertebrates. Although we did not detect lateral fin folds in dogfish embryos, Engrailed-1 expression suggests that the body is compartmentalized dorsoventrally. Furthermore, specification of limb identity occurs through the Tbx4 and Tbx5 genes, as in higher vertebrates. In contrast, unlike higher vertebrates, we did not detect Shh transcripts in dogfish fin-buds, although dHand (a gene involved in establishing Shh) is expressed. In S. canicula, the main fin axis seems to lie parallel to the body axis. 'Freeing' fins from the body axis and establishing a separate 'limb' axis has been proposed to be a crucial step in evolution of tetrapod limbs(2,3). We suggest that Shh plays a critical role in this process.	Univ Dundee, Wellcome Trust Bioctr, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland; Univ Dundee, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Univ St Andrews, Sch Biol, Div Environm & Evolutionary Biol, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of Dundee; University of Dundee; University of St Andrews	Tanaka, M (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Div Cell & Dev Biol, Dow St, Dundee DD1 5EH, Scotland.		Prescott, Alan/Y-5956-2018; Tanaka, Mikiko/X-1904-2019; Tanaka, Mikiko/B-9329-2015; Munsterberg, Andrea E/E-2205-2011	Prescott, Alan/0000-0002-0747-7317; Tanaka, Mikiko/0000-0001-8092-8594; Tanaka, Mikiko/0000-0001-8092-8594; Munsterberg, Andrea E/0000-0002-4577-4240				Altabef M, 1997, DEVELOPMENT, V124, P4547; Balfour F M, 1876, J Anat Physiol, V11, P128; Balinsky B. I., 1933, ROUXS ARCH, V130, P704; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; COATES M, 1993, NATURE, V364, P195, DOI 10.1038/364195b0; COATES MI, 1994, DEVELOPMENT, P169; COATES MI, 1995, CURR BIOL, V5, P844, DOI 10.1016/S0960-9822(95)00169-2; Cohn MJ, 2000, NATURE, V406, P953, DOI 10.1038/35023216; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; EKKER SC, 1995, CURR BIOL, V5, P44; JARVIK E, 1980, BASIC STRUCTURE EVOL, P109; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; KURATANI S, 1997, J COMP NEUROL, V384, P482; Mazan S, 2000, EVOL DEV, V2, P186, DOI 10.1046/j.1525-142x.2000.00062.x; MOYTHOMAS JA, 1936, SCH SCI REV, V36, P592; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Ruvinsky I, 2000, GENETICS, V156, P1249; Schlosser G, 1997, BRAIN BEHAV EVOLUT, V50, P61, DOI 10.1159/000113323; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; TABIN C, 1993, NATURE, V361, P692, DOI 10.1038/361692a0; Tamura K, 2001, J ANAT, V199, P195, DOI 10.1017/S0021878201008081; Tanaka M, 1998, DEV GROWTH DIFFER, V40, P423; Tanaka M, 2000, DEVELOPMENT, V127, P4011; Thacher J.K., 1877, T CONN ACAD ARTS SCI, V3, P281; TUMPEL S, UNPUB DEV BIOL; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	28	97	99	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					527	531		10.1038/416527a	http://dx.doi.org/10.1038/416527a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11932743	Green Accepted			2022-12-24	WOS:000174756500041
J	Bodary, PF; Westrick, RJ; Wickenheiser, KJ; Shen, YC; Eitzman, DT				Bodary, PF; Westrick, RJ; Wickenheiser, KJ; Shen, YC; Eitzman, DT			Effect of leptin on arterial thrombosis following vascular injury in mice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; NECROSIS-FACTOR-ALPHA; OBESITY; GENE; RECEPTOR; DISEASE	Context Complications of atherosclerosis are the leading cause of morbidity and mortality in industrialized societies. Obesity has emerged as an independent risk factor for complications of atherosclerotic vascular disease. Leptin, a hormone produced by the adipocyte, increases with obesity and appears to modulate energy balance and food intake. In addition, other actions of leptin have been proposed, including an in vitro effect on platelet aggregation. Thus, the elevated plasma leptin levels in obese individuals may promote vascular thrombosis. Objective To test the hypothesis that leptin contributes to in vivo thrombosis via the leptin receptor. Design and Materials Between September 2000 and September 2001, a vascular thrombosis model was used to test male 10- to 12-week-old mice completely deficient in leptin or the leptin receptor and mice with platelet leptin-receptor deficiency. Main Outcome Measure Time to formation of an occlusive thrombus in the common carotid artery following experimentally induced endothelial injury. Results Following onset of vascular injury, wild-type mice (n=8) formed occlusive thrombosis in a mean (SD) of 42.2 (4.6) minutes, whereas leptin-deficient (n=5) and leptin receptor-deficient mice (n=7) formed occlusive thrombosis in 75.2 (10.1) and 68.6 (10.3) minutes, respectively (leptin deficient vs wild-type mice, P=.008; leptin-receptor-deficient vs wild-type, P=.03). When recombinant murine leptin was administered to leptin-deficient mice (n=4), the time to occlusion was reduced to 41.8 (6.6) minutes (P=.035 vs vehicle control). Following bone marrow transplantation from leptin receptor-deficient (donor) mice to wild-type (recipient) mice, the time to occlusion was prolonged from 22.3 (2.8) minutes in wild-type mice receiving wild-type marrow (n=3) to 56.8 (5.0) minutes in wild-type mice receiving leptin receptor-deficient bone marrow (n=5) (P=.003). Conclusions Leptin contributes to arterial thrombosis following vascular injury in vivo and these prothrombotic effects appear to be mediated through the platelet leptin receptor.	Univ Michigan, Dept Internal Med, Div Cardiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eitzman, DT (corresponding author), 7301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL035989, R44HL035989] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-36195, HL-35989] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Eitzman DT, 2000, BLOOD, V95, P577, DOI 10.1182/blood.V95.2.577; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; FUSTER V, 1990, CIRCULATION, V82, P47; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Ishizuka T, 1999, DIABETES, V48, P1061, DOI 10.2337/diabetes.48.5.1061; Juhan-Vague I, 2000, ANN MED, V32, P78; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Lundgren CH, 1996, CIRCULATION, V93, P106, DOI 10.1161/01.CIR.93.1.106; Maruyama I, 2000, ANN NY ACAD SCI, V902, P315; Nakata M, 1999, DIABETES, V48, P426, DOI 10.2337/diabetes.48.2.426; Samad F, 1998, P NATL ACAD SCI USA, V95, P7591, DOI 10.1073/pnas.95.13.7591; Samad F, 1999, P NATL ACAD SCI USA, V96, P6902, DOI 10.1073/pnas.96.12.6902; Samad F, 1996, J CLIN INVEST, V97, P37, DOI 10.1172/JCI118404; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Westrick RJ, 2001, CIRCULATION, V103, P3044, DOI 10.1161/hc2501.092492; Winkler UH, 1997, ARCH GYNECOL OBSTET, V261, P25, DOI 10.1007/s004040050193	18	193	207	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1706	1709		10.1001/jama.287.13.1706	http://dx.doi.org/10.1001/jama.287.13.1706			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926895				2022-12-24	WOS:000174730300025
J	Benger, JR; Pearce, AV				Benger, JR; Pearce, AV			Quality improvement report - Simple intervention to improve detection of child abuse in emergency departments	BRITISH MEDICAL JOURNAL			English	Article							NEGLECT	Problem Child abuse is easily overlooked in a busy emergency department. Design Two stage audit of 1000 children before and after introduction of reminder flowchart. Background and setting An emergency department in a suburban teaching hospital seeing about 4000 injured preschool children a year. Key measures for improvement Number of records in which intentional injury was adequately documented and considered and the number of children referred for further assessment before and after introduction of reminder flowchart into emergency department notes. Strategies for change Nurses were asked to insert a reminder flowchart for assessing intentional injury into the notes of A children aged 0-5 years attending the department with any injury and to record the results of checking the child protection register. Effect of change Documentation of all eight indicators that intentional injury had been considered had increased in die second audit. Records of compatibility, of history with injury and consistency of history increased from less than 2% to more than 70% (P < 0.0001). More children were referred for further assessment in the second audit than the first, although the difference was not significant (6 (0.6%) v 14 (1.4%), P = 0.072). The general level of awareness and vigilance increased in the second audit, even for children whose records did not contain the flowchart. Lessons learnt Inclusion of a simple reminder flowchart in the notes of injured preschool children attending the emergency department increases awareness, consideration, and documentation of intentional injury. Rates of referral for further assessment also increase.	Frenchay Hosp, Emergency Dept, Bristol BS16 1LE, Avon, England; Frenchay Hosp, Dept Community Child Hlth, Bristol BS16 1LE, Avon, England		Benger, JR (corresponding author), Bristol Royal Infirm & Gen Hosp, Emergency Dept, Bristol BS2 8BW, Avon, England.			Benger, Jonathan/0000-0001-6131-0916				Benger JR, 2001, EMERG MED J, V18, P172, DOI 10.1136/emj.18.3.172; *BRIT PAED ASS BRI, 1988, JOINT STAT CHILDR AT; Clark KD, 1997, PEDIATR EMERG CARE, V13, P259, DOI 10.1097/00006565-199708000-00005; HOBSON MI, 1994, BURNS, V20, P442, DOI 10.1016/0305-4179(94)90039-6; MCCLAIN PW, 1993, PEDIATRICS, V91, P338; *NAT CTR CHILD AB, 1988, STUD FIND STUD NAT I; Nicol MF, 1999, J ACCID EMERG MED, V16, P77; PLESS IB, 1987, CHILD ABUSE NEGLECT, V11, P193, DOI 10.1016/0145-2134(87)90058-5; SIDEBOTHAM PD, 1997, BRIT MED J, V315, P338; Van Haeringen AR, 1998, CHILD ABUSE NEGLECT, V22, P159, DOI 10.1016/S0145-2134(97)00172-5	10	75	77	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2002	324	7340					780	782		10.1136/bmj.324.7340.780	http://dx.doi.org/10.1136/bmj.324.7340.780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538KY	11924662	Green Published			2022-12-24	WOS:000174816200022
J	Barnes, I; Matheus, P; Shapiro, B; Jensen, D; Cooper, A				Barnes, I; Matheus, P; Shapiro, B; Jensen, D; Cooper, A			Dynamics of Pleistocene population extinctions in Beringian brown bears	SCIENCE			English	Article							URSUS-ARCTOS; MITOCHONDRIAL; PHYLOGEOGRAPHY; SEQUENCES; ORIGINS; COMPLEX	The climatic and environmental changes associated with the last glaciation (90,000 to 10,000 years before the present; 90 to 10 ka B.P.) are an important example of the effects of global climate change on biological diversity. These effects were particularly marked in Beringia (northeastern Siberia, northwestern North America, and the exposed Bering Strait) during the late Pleistocene. To investigate the evolutionary impact of these events, we studied genetic change in the brown bear, Ursus arctos, in eastern Beringia over the past 60,000 years using DNA preserved in permafrost remains. A marked degree of genetic structure is observed in populations throughout this period despite local extinctions, reinvasions, and potential interspecies competition with the short-faced bear, Arctodus simus. The major phylogeographic changes occurred 35 to 21 ka B.P., before the glacial maximum, and little change is observed after this time. Late Pleistocene histories of mammalian taxa may be more complex than those that might be inferred from the fossil record or contemporary DNA sequences atone.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; Univ Alaska, Alaska Quaternary Ctr, Fairbanks, AK 99775 USA	University of Oxford; University of Oxford; University of Alaska System; University of Alaska Fairbanks	Cooper, A (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoo.ox.ac.uk	Barnes, Ian C/B-8081-2008; Cooper, Alan/E-8171-2012	Barnes, Ian C/0000-0001-8322-6918; Cooper, Alan/0000-0002-7738-7851				Anderson PH, 2001, QUATERNARY SCI REV, V20, P93, DOI 10.1016/S0277-3791(00)00129-3; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Brigham-Grette J, 2001, QUATERNARY SCI REV, V20, P15, DOI 10.1016/S0277-3791(00)00134-7; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Flagstad O, 2001, P ROY SOC B-BIOL SCI, V268, P667, DOI 10.1098/rspb.2000.1416; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Guthrie R.D., 1990, FROZEN FAUNA MAMMOTH; HANNI C, 1994, P NATL ACAD SCI USA, V91, P12336, DOI 10.1073/pnas.91.25.12336; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Jensen-Seaman MI, 2001, MOL ECOL, V10, P2241, DOI 10.1046/j.0962-1083.2001.01365.x; KOTILAINEN AT, 1995, NATURE, V377, P323, DOI 10.1038/377323a0; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; LISTER AM, 1995, NATURE, V378, P23, DOI 10.1038/378023a0; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Matheus P. E., 1997, THESIS U ALASKA FAIR; Matheus Paul E., 2001, BAR International Series, V944, P79; Matheus PE, 1995, QUATERNARY RES, V44, P447, DOI 10.1006/qres.1995.1090; Matsuhashi T, 1999, MOL BIOL EVOL, V16, P676, DOI 10.1093/oxfordjournals.molbev.a026150; Miller C. M., COMMUNICATION; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Richards M, 1996, AM J HUM GENET, V59, P185; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; SWOFFORD DL, 1999, PAUP STAR PHYLOGENET; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Thomas MG, 2000, P ROY SOC B-BIOL SCI, V267, P2493, DOI 10.1098/rspb.2000.1310; Vila C, 2001, SCIENCE, V291, P474, DOI 10.1126/science.291.5503.474; Waits LP, 1998, CONSERV BIOL, V12, P408, DOI 10.1046/j.1523-1739.1998.96351.x	27	257	270	10	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2267	2270		10.1126/science.1067814	http://dx.doi.org/10.1126/science.1067814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910112				2022-12-24	WOS:000174561700046
J	Anand, P				Anand, P			Public health - Decision-making when science is ambiguous	SCIENCE			English	Editorial Material									Open Univ, Dept Econ, Milton Keynes MK7 6AA, Bucks, England	Open University - UK	Anand, P (corresponding author), Open Univ, Dept Econ, Milton Keynes MK7 6AA, Bucks, England.			Anand, Paul/0000-0002-7701-6903				Anand P., 1993, ANAND; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Levi Isaac, 2000, RISK DECISION POLICY, V5, P111; LUCE RD, 1972, GAMES DECISIONS INTR	4	18	19	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1839	1839		10.1126/science.1061744	http://dx.doi.org/10.1126/science.1061744			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	529KW	11884737				2022-12-24	WOS:000174299500019
J	Liang, SY; Linthicum, KJ; Gaydos, JC				Liang, SY; Linthicum, KJ; Gaydos, JC			Climate change and the monitoring of vector-borne disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MALARIA TRANSMISSION; RISK; VILLAGES		Univ Maryland, Sch Med, Baltimore, MD 21201 USA; US Dept Def Global Emerging Infect Surveillance &, Silver Spring, MD 20910 USA	University System of Maryland; University of Maryland Baltimore; United States Department of Defense	Liang, SY (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.							Beck LR, 1997, AM J TROP MED HYG, V56, P99, DOI 10.4269/ajtmh.1997.56.99; BECK LR, 1994, AM J TROP MED HYG, V51, P271, DOI 10.4269/ajtmh.1994.51.271; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; ENGLEMAN RC, 1975, 200 YEARS MILITARY M; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; *NAT RES COUNC, 2000, WEATH CLIM EC INF DI; Peters C. J., 1994, HDB ZOONOSES B, P125; Randolph SE, 2000, ADV PARASIT, V47, P217, DOI 10.1016/S0065-308X(00)47010-7; Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023; Yoganathan D, 2001, AM J IND MED, V40, P199, DOI 10.1002/ajim.1088	10	8	10	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2002	287	17					2286	2286		10.1001/jama.287.17.2286	http://dx.doi.org/10.1001/jama.287.17.2286			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546EZ	11980534	hybrid			2022-12-24	WOS:000175260600033
J	Brem, RB; Yvert, G; Clinton, R; Kruglyak, L				Brem, RB; Yvert, G; Clinton, R; Kruglyak, L			Genetic dissection of transcriptional regulation in budding yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSGRESSIVE SEGREGATION; EXPRESSION; STRAINS; GENOME; S288C	To begin to understand the genetic architecture of natural variation in gene expression, we carried out genetic linkage analysis of genomewide expression patterns in a cross between a laboratory strain and a wild strain of Saccharomyces cerevisiae. Over 1500 genes were differentially expressed between the parent strains. Expression levels of 570 genes were linked to one or more different loci, with most expression levels showing complex inheritance patterns. The loci detected by linkage felt largely into two categories: cis-acting modulators of single genes and trans-acting modulators of many genes. We found eight such trans-acting loci, each affecting the expression of a group of 7 to 94 genes of related function.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Kruglyak, L (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D4-100, Seattle, WA 98109 USA.			Yvert, Gael/0000-0003-1955-4786	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064268] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM64268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brachmann CB, 1998, YEAST, V14, P115; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; CHURCHILL GA, 1994, GENETICS, V138, P963; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DEVICENTE MC, 1993, GENETICS, V134, P585; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kobayashi O, 1999, CURR GENET, V36, P256, DOI 10.1007/s002940050498; Kron SJ, 1997, TRENDS MICROBIOL, V5, P450, DOI 10.1016/S0966-842X(97)01131-1; Lindgren B. W, 1968, STAT THEORY; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359	22	1009	1048	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					752	755		10.1126/science.1069516	http://dx.doi.org/10.1126/science.1069516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11923494				2022-12-24	WOS:000175281700061
J	Siegel, DA; Doney, SC; Yoder, JA				Siegel, DA; Doney, SC; Yoder, JA			The North Atlantic spring phytoplankton bloom and Sverdrup's critical depth hypothesis	SCIENCE			English	Article							UPPER OCEAN; MODEL	More than 50 years ago, Harald Sverdrup developed a simple model for the necessary conditions leading to the spring bloom of phytoplankton. Although this model has been used extensively across a variety of aquatic ecosystems, its application requires knowledge of community compensation irradiance (I-C), the light [eve[ where photosynthetic and ecosystem community loss processes balance. However, reported I-C values have varied by an order of magnitude. Here, I-C estimates are determined using satellite and hydrographic data sets consistent with the assumptions in Sverdrup's 1953 critical depth hypothesis. Retrieved values of I-C are approximately uniform throughout much of the North Atlantic with a mean value of 1.3 mol photons meter(-2) day(-1). These community-based I-C determinations are roughly twice typical values found for phytoptankton alone indicating that phytoplankton account for approximately one-half of community ecosystem losses. This work also suggests that important aspects of heterotrophic community dynamics can be assessed using satellite observations.	Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; Natl Ctr Atmospher Res, Boulder, CO 80305 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; National Center Atmospheric Research (NCAR) - USA; University of Rhode Island	Siegel, DA (corresponding author), Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA.		Siegel, David A/C-5587-2008; Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437				ANTONOV JI, 1998, 27 NOAA NESDIS; BANSE K, 1994, J GEOPHYS RES-OCEANS, V99, P7323, DOI 10.1029/93JC02155; Behrenfeld MJ, 2001, SCIENCE, V291, P2594, DOI 10.1126/science.1055071; Carton JA, 2000, J PHYS OCEANOGR, V30, P294, DOI 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2; Doney SC, 1999, GLOBAL BIOGEOCHEM CY, V13, P705, DOI 10.1029/1999GB900039; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P1, DOI 10.1016/0967-0645(93)90003-6; Dutkiewicz S, 2001, DEEP-SEA RES PT II, V48, P2323, DOI 10.1016/S0967-0645(00)00178-8; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; GIESKES W W C, 1975, Netherlands Journal of Sea Research, V9, P166, DOI 10.1016/0077-7579(75)90014-9; GRAN H. H., 1931, Conseil Perm. Internat. pour I'Explor. de la Mer. Rapp. et Proces-Verb., V75, P37; LANGDON C, 1988, J PLANKTON RES, V10, P1291, DOI 10.1093/plankt/10.6.1291; Longhurst A., 1988, ECOLOGICAL GEOGRAPHY; Lucas LV, 1998, J MAR RES, V56, P375, DOI 10.1357/002224098321822357; MCCLAIN CR, 1993, J GEOPHYS RES-OCEANS, V98, P12327, DOI 10.1029/93JC00868; MCCLAIN CR, 1990, J GEOPHYS RES-OCEANS, V95, P18027, DOI 10.1029/JC095iC10p18027; MCLAIN CR, 1988, SEA TECHNOL, V39, P10; MONTEREY GI, 1997, 14 NOAA NESDIS; MOREL A, 1988, J GEOPHYS RES-OCEANS, V93, P10749, DOI 10.1029/JC093iC09p10749; Najjar RG, 1997, J MAR RES, V55, P117, DOI 10.1357/0022240973224481; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650; Obata A, 1996, J GEOPHYS RES-OCEANS, V101, P20657, DOI 10.1029/96JC01734; PLATT T, 1991, P ROY SOC B-BIOL SCI, V246, P205, DOI 10.1098/rspb.1991.0146; RILEY GA, 1957, LIMNOL OCEANOGR, V2, P252, DOI 10.1002/lno.1957.2.3.0252; SIEGEL DA, 1990, J MAR RES, V48, P379, DOI 10.1357/002224090784988791; SMETACEK V, 1990, LIMNOL OCEANOGR, V35, P228, DOI 10.4319/lo.1990.35.1.0228; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; Williams RG, 1998, DEEP-SEA RES PT I, V45, P461, DOI 10.1016/S0967-0637(97)00094-0; Williams RG, 2000, GLOBAL BIOGEOCHEM CY, V14, P1299, DOI 10.1029/2000GB001260; YODER JA, 1993, GLOBAL BIOGEOCHEM CY, V7, P181, DOI 10.1029/93GB02358	30	391	407	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					730	733		10.1126/science.1069174	http://dx.doi.org/10.1126/science.1069174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976453				2022-12-24	WOS:000175281700053
J	Beldade, P; Koops, K; Brakefield, PM				Beldade, P; Koops, K; Brakefield, PM			Developmental constraints versus flexibility in morphological evolution	NATURE			English	Article							QUANTITATIVE GENETICS; EYESPOT PATTERNS; SELECTION; SPANDRELS	Evolutionary developmental biology has encouraged a change of research emphasis from the sorting of phenotypic variation by natural selection to the production of that variation through development(1). Some morphologies are more readily generated than others, and developmental mechanisms can limit or channel evolutionary change(2). Such biases determine how readily populations are able to respond to selection(3), and have been postulated to explain stasis in morphological evolution(4) and unexplored morphologies(5). There has been much discussion about evolutionary constraints(6-8) but empirical data testing them directly are sparse(9,10). The spectacular diversity in butterfly wing patterns(11) is suggestive of how little constrained morphological evolution can be. However, for wing patterns involving serial repeats of the same element, developmental properties suggest that some directions of evolutionary change might be restricted(12,13). Here we show that despite the developmental coupling between different eyespots in the butterfly Bicyclus anynana, there is great potential for independent changes. This flexibility is consistent with the diversity of wing patterns across species and argues for a dominant role of natural selection, rather than internal constraints, in shaping existing variation.	Leiden Univ, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Beldade, P (corresponding author), Leiden Univ, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.	pbeldade@rulsfb.leidenuniv.nl; brakefield@rulsfb.leidenuniv.nl	Beldade, Patrícia/E-1970-2011; Rohlf, F J/A-8710-2008	Beldade, Patrícia/0000-0001-7831-979X; 				ANTONOVICS J, 1991, TRENDS ECOL EVOL, V6, P166, DOI 10.1016/0169-5347(91)90059-7; Barton N, 2000, BIOESSAYS, V22, P1075, DOI 10.1002/1521-1878(200012)22:12&lt;1075::AID-BIES5&gt;3.0.CO;2-M; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; Brakefield PM, 1998, HEREDITY, V80, P265, DOI 10.1038/sj.hdy.6883660; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brakefield PM, 2001, J EXP ZOOL, V291, P93, DOI 10.1002/jez.1062; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; Condamin M., 1973, MONOGRAPHIE GENRE BI; FRENCH V, 1995, DEV BIOL, V168, P112, DOI 10.1006/dbio.1995.1065; GOULD SJ, 1989, EVOLUTION, V43, P516, DOI 10.1111/j.1558-5646.1989.tb04249.x; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Monteiro A, 1997, EVOLUTION, V51, P1207, DOI 10.1111/j.1558-5646.1997.tb03968.x; MONTEIRO AF, 1994, EVOLUTION, V48, P1147, DOI [10.1111/j.1558-5646.1994.tb05301.x, 10.2307/2410374]; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1994, DEVELOPMENT, P225; NIJHOUT HF, 1985, DEV BIOL, V108, P146, DOI 10.1016/0012-1606(85)90016-8; PAULSEN SM, 1993, EVOLUTION, V47, P593, DOI 10.1111/j.1558-5646.1993.tb02115.x; PAULSEN SM, 1994, DEV GENET, V15, P79, DOI 10.1002/dvg.1020150109; Pigliucci M, 2000, TRENDS ECOL EVOL, V15, P66, DOI 10.1016/S0169-5347(99)01762-0; ROFF D, 1999, EVOLUTIONARY QUANTIT; SCHARLOO W, 1983, ORG CONSTRAINTS DYNA, P197; SMITH JM, 1985, Q REV BIOL, V60, P265, DOI 10.1086/414425; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; WAGNER GP, 1988, J EVOLUTION BIOL, V1, P45, DOI 10.1046/j.1420-9101.1988.1010045.x; WEBER KE, 1992, GENETICS, V130, P345; WILLIAMSON PG, 1987, RATES EVOLUTION; Zar JH, 1999, BIOSTATISTICAL ANAL	30	225	230	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2002	416	6883					844	847		10.1038/416844a	http://dx.doi.org/10.1038/416844a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976682				2022-12-24	WOS:000175163800050
J	Miyamoto, A; Nakayama, K; Imaki, H; Hirose, S; Jiang, Y; Abe, M; Tsukiyama, T; Nagahama, H; Ohno, S; Hatakeyama, S; Nakayama, KI				Miyamoto, A; Nakayama, K; Imaki, H; Hirose, S; Jiang, Y; Abe, M; Tsukiyama, T; Nagahama, H; Ohno, S; Hatakeyama, S; Nakayama, KI			Increased proliferation of B cells and auto-immunity in mice lacking protein kinase C delta	NATURE			English	Article							PHORBOL ESTER; PROTEOLYTIC ACTIVATION; TUMOR PROMOTION; TRANSGENIC MICE; EXPRESSION; GROWTH; ALPHA; DIFFERENTIATION; OVEREXPRESSION; INHIBITION	Protein kinase C (PKC), which comprises 11 closely related isoforms, has been implicated in a wide variety of cellular processes, such as growth, differentiation, secretion, apoptosis and tumour development(1-4). Among the PKC isotypes, PKC-delta is unique in that its overexpression results in inhibition of cell growth(5-11). Here we show that mice that lack PKC-delta exhibit expansion of the B-lymphocyte population with the formation of numerous germinal centres in the absence of stimulation. The rate of proliferation in response to stimulation was greater for B cells from PKC-delta-deficient mice than for those from wild-type mice. Adoptive transfer experiments suggested that the hyperproliferation phenotype is B-cell autonomous. Production of interleukin-6 was markedly increased in B cells of PKC-delta-null mice as a result of an increase in the DNA-binding activity of NF-IL6. Furthermore, the PKC-delta-deficient mice contain circulating autoreactive antibodies and display immune-complex-type glomerulonephritis, as well as lymphocyte infiltration in many organs. These results suggest that PKC-delta has an indispensable function in negative regulation of B-cell proliferation, and is particularly important for the establishment of B-cell tolerance.	Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; Juntendo Univ, Sch Med, Dept Pathol 2, Bunkyo Ku, Tokyo 1138421, Japan; Yokohama City Univ, Sch Med, Dept Biol Mol, Kanagawa 2360004, Japan	Kyushu University; Japan Science & Technology Agency (JST); Kyushu University; Juntendo University; Yokohama City University	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan.		Hatakeyama, Shigetsugu/C-8333-2012; Ohno, Shigeo/B-1768-2010; Tsukiyama, Tadasuke/D-7589-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979; Ohno, Shigeo/0000-0002-1294-5269; Tsukiyama, Tadasuke/0000-0001-5205-8202				AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; BURLINGAME RW, 1990, J IMMUNOL METHODS, V134, P187, DOI 10.1016/0022-1759(90)90380-E; Emoto Y, 1996, BLOOD, V87, P1990; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Fukumoto S, 1997, J BIOL CHEM, V272, P13816, DOI 10.1074/jbc.272.21.13816; GEIGES D, 1995, EXP CELL RES, V219, P299, DOI 10.1006/excr.1995.1231; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Gschwendt M, 1999, EUR J BIOCHEM, V259, P555, DOI 10.1046/j.1432-1327.1999.00120.x; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; LAPORTA CAM, 1995, CARCINOGENESIS, V16, P1233; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Li W, 1996, CURR TOP MICROBIOL, V211, P55; Li WQ, 1996, ONCOGENE, V13, P731; Livneh E, 1997, EUR J BIOCHEM, V248, P1, DOI 10.1111/j.1432-1033.1997.t01-4-00001.x; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; MISHIMA K, 1994, BIOCHEM BIOPH RES CO, V201, P363, DOI 10.1006/bbrc.1994.1710; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; PESSINO A, 1995, BIOCHEM J, V312, P549, DOI 10.1042/bj3120549; Reddig PJ, 1999, CANCER RES, V59, P5710; SUEMATSU S, 1989, P NATL ACAD SCI USA, V86, P7547, DOI 10.1073/pnas.86.19.7547; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TRAUTWEIN C, 1994, J CLIN INVEST, V93, P2554, DOI 10.1172/JCI117266; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4	30	336	351	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					865	869		10.1038/416865a	http://dx.doi.org/10.1038/416865a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976687				2022-12-24	WOS:000175163800055
J	Li, ZX; Dullmann, J; Schiedlmeier, B; Schmidt, M; von Kalle, C; Meyer, J; Forster, M; Stocking, C; Wahlers, A; Frank, O; Ostertag, W; Kuhlcke, K; Eckert, HG; Fehse, B; Baum, C				Li, ZX; Dullmann, J; Schiedlmeier, B; Schmidt, M; von Kalle, C; Meyer, J; Forster, M; Stocking, C; Wahlers, A; Frank, O; Ostertag, W; Kuhlcke, K; Eckert, HG; Fehse, B; Baum, C			Murine leukemia induced by retroviral gene marking	SCIENCE			English	Article									Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany; Hannover Med Sch, D-30625 Hannover, Germany; Univ Hamburg, Hosp Eppendorf, D-20249 Hamburg, Germany; Univ Freiburg, D-79106 Freiburg, Germany; EUFETS AG, D-55743 Idar Oberstein, Germany	Heinrich Pette Institute; Hannover Medical School; University of Hamburg; University of Freiburg	Baum, C (corresponding author), Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany.		Fehse, Boris/A-8721-2012	Fehse, Boris/0000-0001-9780-7211				Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Lee FS, 2001, CURR OPIN NEUROBIOL, V11, P281, DOI 10.1016/S0959-4388(00)00209-9; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; NUCIFORA G, 2001, TRANSCRIPTION FACTOR, P393; Reuther GW, 2000, MOL CELL BIOL, V20, P8655, DOI 10.1128/MCB.20.23.8655-8666.2000; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; STOCKING C, 1993, GROWTH FACTORS, V8, P197, DOI 10.3109/08977199309011023; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426	9	517	558	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					497	497		10.1126/science.1068893	http://dx.doi.org/10.1126/science.1068893			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964471				2022-12-24	WOS:000175179400036
J	Saaddine, JB; Engelgau, MM; Beckles, GL; Gregg, EW; Thompson, TJ; Narayan, KMV				Saaddine, JB; Engelgau, MM; Beckles, GL; Gregg, EW; Thompson, TJ; Narayan, KMV			A diabetes report card for the United States: Quality of care in the 1990s	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCEMIC CONTROL; ETHNIC-DIFFERENCES; HEALTH-CARE; IMPROVEMENT PROJECT; COST-EFFECTIVENESS; MEDICAL-CARE; ADULTS; RISK; DISEASE; CHOLESTEROL	Background: Improving diabetes care in the United States is a topic of concern. Objective: To document the quality of diabetes care during 1988-1995. Design: National population-based cross-sectional surveys. Setting: Third U.S. National Health and Nutrition Examination Survey (NHANES 111) (1988-1994) and the Behavioral Risk Factors Surveillance System (BRFSS) (1995). Participants: Participants in NHANES III (n = 1026) or BRFSS (n = 3059) who were 18 to 75 years of age and reported a physician diagnosis of diabetes. Women with gestational diabetes were excluded. Measurements: Glycemic control, blood pressure, low-density lipoprotein (LDL) cholesterol level, biannual cholesterol monitoring, and annual foot and dilated eye examination, as defined by the Diabetes Quality Improvement Project. Results: 18.0% of participants (95% Cl, 15.7% to 22.3%) had poor glycemic control (hemoglobin A,, level > 9.5%), and 65.7% (Cl, 62.0% to 69.4%) had blood pressure less than 140/90 mm Hg. Cholesterol was monitored biannually in 85.3% (Cl, 83.1% to 88.6%) of participants, but only 42.0% (Cl, 34.9% to 49.1%) had LDL cholesterol levels less than 3.4 mmol/L (<130 mg/dL). During the previous year, 63.3% (Cl, 59.6% to 67.0%) had a dilated eye examination and 54.8% (Cl, 51.3% to 58.3%) had a foot examination. When researchers controlled for age, sex, ethnicity, education, health insurance, insulin use, and duration of diabetes, insured persons were more likely than uninsured persons to have a dilated eye examination (66.5% [Cl, 62.6% to 70.4%]) vs. 43.2% [Cl, 29.5% to 56.9%]) and were less likely to have a hemoglobin A, level greater than or equal to 9.5%. Persons taking insulin were more likely than those who were not to have annual dilated eye examination (72.2% [Cl, 66.3% to 78.1%] vs. 57.6% [Cl, 53.7% to 61.5%]) and foot examination (67.3% [Cl, 61.4% to 73.2%] vs. 47.1% [Cl, 43.2% to 51.0%]) but were also more likely to have poor glycemic control (24.2% [Cl, 18.3% to 30.1%] vs. 15.5% [Cl, 11.6% to 19.4%]). Conclusions: According to U.S. data collected during 1988-m1995, a gap exists between recommended diabetes care and the care patients actually receive. These data offer a benchmark for monitoring changes in diabetes care.	CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Saaddine, JB (corresponding author), CDCP, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway NE,MS-K10, Atlanta, GA 30341 USA.	zna2@cdc.gov	Narayan, K.M. Venkat/J-9819-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Gregg, Edward/0000-0003-2381-6822				Acton KJ, 2001, DIABETES CARE, V24, P22, DOI 10.2337/diacare.24.1.22; Ayanian JZ, 2000, JAMA-J AM MED ASSOC, V284, P2061, DOI 10.1001/jama.284.16.2061; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Bridges RB, 1996, J PERIODONTOL, V67, P1185, DOI 10.1902/jop.1996.67.11.1185; Cowie CC, 1997, DIABETES CARE, V20, P142, DOI 10.2337/diacare.20.2.142; Curb JD, 2002, DIABETES CARE, V25, P386; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; EBERHARDT MS, 1994, J CLIN EPIDEMIOL, V47, P1181, DOI 10.1016/0895-4356(94)90105-8; Engelgau MM, 1998, DIABETES CARE, V21, P2062, DOI 10.2337/diacare.21.12.2062; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; FRAZIER E, 1992, CHRONIC DIS DATA HDB; Gerstein HC, 2000, LANCET, V355, P253; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gregg EW, 1999, DIABETES CARE, V22, P1734; Harris EL, 1999, DIABETES CARE, V22, P779, DOI 10.2337/diacare.22.5.779; Harris MI, 1996, ANN INTERN MED, V124, P117, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00007; Harris MI, 2000, DIABETES CARE, V23, P754, DOI 10.2337/diacare.23.6.754; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Harris MI, 1999, DIABETES CARE, V22, P1679, DOI 10.2337/diacare.22.10.1679; Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454; Institute of Medicine, 2001, CROSSING QUALITY CHA; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Jonsson B, 1999, DIABETOLOGIA, V42, P1293, DOI 10.1007/s001250051441; KENNY SJ, 1993, DIABETES CARE, V16, P1507, DOI 10.2337/diacare.16.11.1507; KORN EL, 1999, WILEY S PRO STAT SUR, P1; LITZELMAN DK, 1993, ANN INTERN MED, V119, P36, DOI 10.7326/0003-4819-119-1-199307010-00006; Martin WE, 1999, CLIN GERIATR MED, V15, P339; McCabe CJ, 1998, DIABETIC MED, V15, P80, DOI 10.1002/(SICI)1096-9136(199801)15:1<80::AID-DIA517>3.0.CO;2-K; Mealey B, 1999, J PERIODONTOL, V70, P935; Narayan KMV, 2000, DIABETES CARE, V23, P1794, DOI 10.2337/diacare.23.12.1794; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; *NAT I DIAB DIG KI, 2001, TRANSL RES PREV CONT; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; National Center for Health Statistics, 1996, NHANES 3 REF MAN REP; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; O'Connor PJ, 1998, J FAM PRACTICE, V47, P290; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Quickel KE, 1996, ANN INTERN MED, V124, P160, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00016; Ray NF, 1998, DIABETES CARE, V21, P296; *RES RRIANGL I, 2001, SUDAAN US MAN REL 8; SAS Institute, 1990, SAS PROC GUID VERS 6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SIEGEL JE, 1992, J AM SOC NEPHROL, V3, pS111; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US DEP HHS, 1997, DIAB SURV 1997; *US DEP HHS, 1997, NAT HLTH NUTR EX SUR; US Department of Health and Human Services, 1994, PLAN OP 3 NAT HLTH N; 1999, MMWR MORB MORTAL WKL, V48, P961	58	440	442	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 16	2002	136	8					565	574		10.7326/0003-4819-136-8-200204160-00005	http://dx.doi.org/10.7326/0003-4819-136-8-200204160-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543WY	11955024				2022-12-24	WOS:000175125800001
J	Tannock, IF				Tannock, IF			Eradication of a disease: how we cured symptomless prostate cancer	LANCET			English	Editorial Material							ACID-PHOSPHATASE; RECENT DECLINES; ANTIGEN; CARCINOMA; MORTALITY; SURVEILLANCE; HISTORY		Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; Univ Toronto, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Tannock, IF (corresponding author), Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada.	ian.tannock@uhn.on.ca						[Anonymous], 1997, Br J Urol, V79, P235; Brawley OW, 1997, CANCER-AM CANCER SOC, V80, P1857, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1857::AID-CNCR26>3.0.CO;2-3; COLEMAN CN, 1994, INT J RADIAT ONCOL, V28, P303, DOI 10.1016/0360-3016(94)90171-6; Etzioni R, 1998, AM J EPIDEMIOL, V148, P775; Etzioni R, 1999, J NATL CANCER I, V91, P1033, DOI 10.1093/jnci/91.12.1033; Hugosson J, 2000, BJU INT, V85, P1078, DOI 10.1046/j.1464-410x.2000.00679.x; Iselin CE, 1999, J UROLOGY, V161, P163, DOI 10.1016/S0022-5347(01)62088-3; Klotz LH, 1997, UROLOGY, V50, P831, DOI 10.1016/S0090-4295(97)00490-1; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; SEAMONDS B, 1986, UROLOGY, V28, P472, DOI 10.1016/0090-4295(86)90146-9; Shibata A, 1998, J NATL CANCER I, V90, P1230, DOI 10.1093/jnci/90.16.1230; SIDDALL JK, 1986, EUR UROL, V12, P123; Smart CR, 1997, CANCER, V80, P1835, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1835::AID-CNCR23>3.0.CO;2-5; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; STEIN BS, 1982, AM J SURG PATHOL, V6, P553, DOI 10.1097/00000478-198209000-00007; Talcott JA, 1998, J CLIN ONCOL, V16, P275, DOI 10.1200/JCO.1998.16.1.275; Tarone RE, 2000, EPIDEMIOLOGY, V11, P167, DOI 10.1097/00001648-200003000-00014; WANG TY, 1986, ANN CLIN LAB SCI, V16, P461; YANTANI R, 1982, INT J CANCER, V29, P611; ZIETMAN AL, 1993, CANCER, V71, P959, DOI 10.1002/1097-0142(19930201)71:3+<959::AID-CNCR2820711411>3.0.CO;2-L	20	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 13	2002	359	9314					1341	1342		10.1016/S0140-6736(02)08278-8	http://dx.doi.org/10.1016/S0140-6736(02)08278-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	541NB	11965297				2022-12-24	WOS:000174989700033
J	Nishihama, R; Soyano, T; Ishikawa, M; Araki, S; Tanaka, H; Asada, T; Irie, K; Ito, M; Terada, M; Banno, H; Yamazaki, Y; Machida, Y				Nishihama, R; Soyano, T; Ishikawa, M; Araki, S; Tanaka, H; Asada, T; Irie, K; Ito, M; Terada, M; Banno, H; Yamazaki, Y; Machida, Y			Expansion of the cell plate in plant cytokinesis requires a kinesin-like protein/MAPKKK complex	CELL			English	Article							KINASE KINASE KINASE; TOBACCO BY-2 CELLS; MAP KINASE; CENP-E; SIGNAL-TRANSDUCTION; YEAST; ARABIDOPSIS; ACTIVATION; GENE; ENCODES	The tobacco mitogen-activated protein kinase kinase kinase NPK1 regulates lateral expansion of the cell plate at cytokinesis. Here, we show that the kinesin-like proteins NACK1 and NACK2 act as activators of NPK1. Biochemical analysis suggests that direct binding of NACK1 to NPK1 stimulates kinase activity. NACK1 is accumulated specifically in M phase and colocalized with NPK1 at the phragmoplast equator. Overexpression of a truncated NACK1 protein that lacks the motor domain disrupts NPK1 concentration at the phragmoplast equator and cell plate formation. Incomplete cytokinesis is also observed when expression of NACK1 and NACK2 is repressed by virus-induced gene silencing and in embryonic cells from Arabidopsis mutants in which a NACK1 ortholog is disrupted. Thus, we conclude that expansion of the cell plate requires NACK1/2 to regulate the activity and localization of NPK1.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	Nagoya University; Osaka University	Machida, Y (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.		Nishihama, Ryuichi/X-8623-2019; Ishikawa, Masaki/Q-7598-2018; Ishikawa, Masaki/AAC-8162-2022	Nishihama, Ryuichi/0000-0002-7032-732X; Ishikawa, Masaki/0000-0002-6491-5539; Ishikawa, Masaki/0000-0002-6491-5539; Tanaka, Hirokazu/0000-0003-4414-0649; Soyano, Takashi/0000-0002-0620-6734				Adams RR, 1998, GENE DEV, V12, P1483, DOI 10.1101/gad.12.10.1483; Angell SM, 1999, PLANT J, V20, P357, DOI 10.1046/j.1365-313X.1999.t01-1-00597.x; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; ASADA T, 1994, J CELL SCI, V107, P2249; Asada T, 1997, J CELL SCI, V110, P179; Assaad FF, 2001, J CELL BIOL, V152, P531, DOI 10.1083/jcb.152.3.531; BANNO H, 1993, MOL CELL BIOL, V13, P4745, DOI 10.1128/MCB.13.8.4745; BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Bogre L, 1999, PLANT CELL, V11, P101, DOI 10.1105/tpc.11.1.101; Calderini O, 1998, J CELL SCI, V111, P3091; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; EMIARTI E, 2001, DEVELOPMENT, V128, P1771; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gunning B. E. S., 1982, CYTOSKELETON PLANT G, P229; Heese M, 1998, CURR OPIN PLANT BIOL, V1, P486, DOI 10.1016/S1369-5266(98)80040-X; Hunter AW, 2000, J CELL SCI, V113, P4379; Ingram R, 1999, PLANT CELL, V11, P1047, DOI 10.1105/tpc.11.6.1047; IRIE K, 1994, SCIENCE, V265, P1716, DOI 10.1126/science.8085159; Ito M, 1998, PLANT CELL, V10, P331; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; KAKIMOTO T, 1988, Protoplasma Supplementum, V2, P95; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; LEE KS, 1995, MOL CELL BIOL, V15, P7143; Lee YRJ, 2001, PLANT CELL, V13, P2427, DOI 10.1105/tpc.13.11.2427; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Lukowitz W, 1996, CELL, V84, P61, DOI 10.1016/S0092-8674(00)80993-9; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MIYAJIMA I, 1987, CELL, V50, P1011, DOI 10.1016/0092-8674(87)90167-X; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; Nishihama R, 2001, CURR OPIN PLANT BIOL, V4, P507, DOI 10.1016/S1369-5266(00)00208-9; Nishihama R, 2001, GENE DEV, V15, P352, DOI 10.1101/gad.863701; Nishihama R, 1997, PLANT J, V12, P39, DOI 10.1046/j.1365-313X.1997.12010039.x; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; SAMUELS AL, 1995, J CELL BIOL, V130, P1345, DOI 10.1083/jcb.130.6.1345; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Staehlin LA, 1996, CELL, V84, P821, DOI 10.1016/S0092-8674(00)81060-0; STEVENSON BJ, 1992, GENE DEV, V6, P1293, DOI 10.1101/gad.6.7.1293; Strompen G, 2002, CURR BIOL, V12, P153, DOI 10.1016/S0960-9822(01)00655-8; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Tanaka H, 2001, DEVELOPMENT, V128, P4681; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; YASUHARA H, 1993, PLANT CELL PHYSIOL, V34, P21; Yasuhara H, 2000, PLANT CELL PHYSIOL, V41, P300, DOI 10.1093/pcp/41.3.300; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; YEN TJ, 1992, NATURE, V359, P536, DOI 10.1038/359536a0; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	54	176	194	2	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 5	2002	109	1					87	99		10.1016/S0092-8674(02)00691-8	http://dx.doi.org/10.1016/S0092-8674(02)00691-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955449	Bronze			2022-12-24	WOS:000174888300011
J	Rideout, WM; Hochedlinger, K; Kyba, M; Daley, GQ; Jaenisch, R				Rideout, WM; Hochedlinger, K; Kyba, M; Daley, GQ; Jaenisch, R			Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy	CELL			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; HEMATOPOIETIC-CELLS; ES CELLS; MICE; DIFFERENTIATION; OVEREXPRESSION; ENGRAFTMENT; DERIVATION; GENERATION	Immune-deficient Rag2(-/-) mice were used as nuclear donors for transfer into enucleated oocytes, and the resulting blastocysts were cultured to isolate an isogenic embryonic stem cell line. One of the mutated alleles in the Rag2(-/-) ES cells was repaired by homologous recombination, thereby restoring normal Rag2 gene structure. Mutant mice were treated with the repaired ES cells in two ways. (1) Immune-competent mice were generated from the repaired ES cells by tetraploid embryo complementation and were used as bone marrow donors for transplantation. (2) Hematopoietic precursors were derived by in vitro differentiation from the repaired ES cells and engrafted into mutant mice. Mature myeloid and lymphoid cells as well as immunoglobulins became detectable 3-4 weeks after transplantation. Our results establish a paradigm for the treatment of a genetic disorder by combining therapeutic cloning with gene therapy.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Vienna, A-1010 Vienna, Austria; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Vienna; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Kyba, Michael/0000-0002-5579-7534	NCI NIH HHS [5-R37-CA84198, CA86991] Funding Source: Medline; NIDDK NIH HHS [DK59279] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA086991, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Brun A, 2001, BLOOD, V98, p66A; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cibelli JB, 1998, NAT BIOTECHNOL, V16, P642, DOI 10.1038/nbt0798-642; Colman A, 2000, TRENDS BIOTECHNOL, V18, P192, DOI 10.1016/S0167-7799(00)01434-7; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Doevendans PA, 2000, J MOL CELL CARDIOL, V32, P839, DOI 10.1006/jmcc.2000.1128; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hole N, 1996, BLOOD, V88, P1266, DOI 10.1182/blood.V88.4.1266.bloodjournal8841266; HUANG H, 1993, P NATL ACAD SCI USA, V90, P10110, DOI 10.1073/pnas.90.21.10110; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KUNG SKP, 1995, J IMMUNOL, V154, P1624; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee LA, 1996, TRANSPLANTATION, V61, P125, DOI 10.1097/00007890-199601150-00024; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Mazurier F, 1999, J INTERF CYTOK RES, V19, P533, DOI 10.1089/107999099313983; MULLER AM, 1993, DEVELOPMENT, V118, P1343; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Notarangelo LD, 1999, CURR OPIN IMMUNOL, V11, P435, DOI 10.1016/S0952-7915(99)80073-9; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Potocnik AJ, 1997, IMMUNOL LETT, V57, P131, DOI 10.1016/S0165-2478(97)00089-8; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rozen S., 1998, PRIMER3; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; SCHLISSEL MS, 1991, J EXP MED, V173, P711, DOI 10.1084/jem.173.3.711; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Taniguchi M, 1998, NUCLEIC ACIDS RES, V26, P679, DOI 10.1093/nar/26.2.679; Vogelstein B, 2002, SCIENCE, V295, P1237, DOI 10.1126/science.1070247; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wang ZQ, 1997, MECH DEVELOP, V62, P137, DOI 10.1016/S0925-4773(97)00655-2; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; WILES MV, 1991, DEVELOPMENT, V111, P259; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	47	430	458	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 5	2002	109	1					17	27		10.1016/S0092-8674(02)00681-5	http://dx.doi.org/10.1016/S0092-8674(02)00681-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	539TY	11955443	Bronze			2022-12-24	WOS:000174888300005
J	Jackson, JP; Lindroth, AM; Cao, XF; Jacobsen, SE				Jackson, JP; Lindroth, AM; Cao, XF; Jacobsen, SE			Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase	NATURE			English	Article							LYSINE-9 METHYLATION; EPIGENETIC ALLELES; PROTEIN; MUTATIONS; DOMAINS; CHROMO; SITE; HETEROCHROMATIN; SPECIFICITY	Gene silencing in eukaryotes is associated with the formation of heterochromatin, a complex of proteins and DNA that block transcription. Heterochromatin is characterized by the methylation of cytosine nucleotides of the DNA, the methylation of histone H3 at lysine 9 (H3 Lys 9), and the specific binding of heterochromatin protein 1 (HP1) to methylated H3 Lys 9 (refs 1-7). Although the relationship between these chromatin modifications is generally unknown, in the fungus Neurospora crassa, DNA methylation acts genetically downstream of H3 Lys 9 methylation(8). Here we report the isolation of KRYPTONITE, a methyltransferase gene specific to H3 Lys 9, identified in a mutant screen for suppressors of gene silencing at the Arabidopsis thaliana SUPERMAN (SUP) locus. Loss-of-function kryptonite alleles resemble mutants in the DNA methyltransferase gene CHROMOMETHYLASE3 (CMT3)(9), showing loss of cytosine methylation at sites of CpNpG trinucleotides (where N is A, C, G or T) and reactivation of endogenous retrotransposon sequences. We show that CMT3 interacts with an Arabidopsis homologue of HP1, which in turn interacts with methylated histones. These data suggest that CpNpG DNA methylation is controlled by histone H3 Lys 9 methylation, through interaction of CMT3 with methylated chromatin.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	jia, xu/A-8386-2016; Hu, Ruogu/B-2203-2008; Lindroth, Anders M/C-7744-2015	Lindroth, Anders M/0000-0002-8291-2745				Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Henikoff S, 1998, GENETICS, V149, P307; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kishimoto N, 2001, PLANT MOL BIOL, V46, P171, DOI 10.1023/A:1010636222327; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	27	937	1012	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 4	2002	416	6880					556	560		10.1038/nature731	http://dx.doi.org/10.1038/nature731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11898023				2022-12-24	WOS:000174756500049
J	Crawford, LM				Crawford, LM			New therapy for non-Hodgkin lymphoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Crawford, LM (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1640	1640		10.1001/jama.287.13.1640-a	http://dx.doi.org/10.1001/jama.287.13.1640-a			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926876				2022-12-24	WOS:000174730300005
J	Karlseder, J; Smogorzewska, A; de Lange, T				Karlseder, J; Smogorzewska, A; de Lange, T			Senescence induced by altered telomere state, not telomere loss	SCIENCE			English	Article							LIFE-SPAN; TRF2; CELLS; FIBROBLASTS; EXTENSION; PROTEIN; MUTANT; LENGTH; END; P53	Primary human cells in culture invariably stop dividing and enter a state of growth arrest called replicative senescence. This transition is induced by programmed telomere shortening, but the underlying mechanisms are unclear. Here, we report that overexpression of TRF2, a telomeric DNA binding protein, increased the rate of telomere shortening in primary cells without accelerating senescence. TRF2 reduced the senescence setpoint, defined as telomere length at senescence, from 7 to 4 kilobases. TRF2 protected critically short telomeres from fusion and repressed chromosome-end fusions in presenescent cultures, which explains the ability of TRF2 to delay senescence. Thus, replicative senescence is induced by a change in the protected status of shortened telomeres rather than by a complete loss of telomeric DNA.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.		Smogorzewska, Agata/B-8891-2011; de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NCI NIH HHS [CA76027] Funding Source: Medline; NIA NIH HHS [AG16643] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; Huffman KE, 2000, J BIOL CHEM, V275, P19719, DOI 10.1074/jbc.M002843200; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0	22	619	643	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 29	2002	295	5564					2446	2449		10.1126/science.1069523	http://dx.doi.org/10.1126/science.1069523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923537				2022-12-24	WOS:000174712600054
J	Zhang, MD; Schmid, S; Carrington, M; O'Brien, TR				Zhang, MD; Schmid, S; Carrington, M; O'Brien, TR			Antibodies to varicella-zoster virus in blood donors with genetic variance in CC chemokine receptor 5	LANCET			English	Article							HIV-1 INFECTION; ALLELE; AIDS	Carriers of a 32 bp deletion (Delta32) allele of the CC chemokine receptor 5 (CCR5) gene are reported to be more likely to lack antibodies to varicella-zoster virus than CCR5 wild-type individuals. To find out whether CCR5-Delta32 Is associated with the seroprevalence of varicella-zoster virus Infection, we tested blood donors with different CCR5-Delta32 genotypes for varicella-zoster virus IgG. Antibody to varicella-zoster virus was present In 209 (99.5%) of 210 CCR5-Delta32 carriers and exactly the same proportion of CCR5 wild-type Individuals (209 of 210). We have therefore found no evidence that the CCR5-Delta32 allele is associated with decreased seroprevalence of varicella-zoster virus Infection.	NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; NCI, Intramural Res Support Program, Sci Applicat Int Corp, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	O'Brien, TR (corresponding author), NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,MSC 7248, Rockville, MD 20852 USA.				OFFICE OF THE DIRECTOR, NCI [N01CO056000] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-56000] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Carrington M, 1999, HUM MOL GENET, V8, P1939, DOI 10.1093/hmg/8.10.1939; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Nguyen GT, 1999, J ACQ IMMUN DEF SYND, V22, P75, DOI 10.1097/00042560-199909010-00010; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; Wiencke JK, 2001, LANCET, V357, P360, DOI 10.1016/S0140-6736(00)03646-1	5	2	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 23	2002	359	9311					1034	1036		10.1016/S0140-6736(02)08066-2	http://dx.doi.org/10.1016/S0140-6736(02)08066-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937186				2022-12-24	WOS:000174585800013
J	Schultz, JC				Schultz, JC			How plants fight dirty - Biochemical ecology	NATURE			English	Editorial Material									Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schultz, JC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.		Schultz, Jack C./V-8661-2019	Schultz, Jack/0000-0001-9870-3537				Chiu J, 1999, MOL BIOL EVOL, V16, P826, DOI 10.1093/oxfordjournals.molbev.a026167; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Karban R, 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598	4	34	39	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					267	267		10.1038/416267a	http://dx.doi.org/10.1038/416267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907557				2022-12-24	WOS:000174482200023
J	Vatta, M; Stetson, SJ; Perez-Verdia, A; Entman, ML; Noon, GP; Torre-Amione, G; Bowles, NE; Towbin, JA				Vatta, M; Stetson, SJ; Perez-Verdia, A; Entman, ML; Noon, GP; Torre-Amione, G; Bowles, NE; Towbin, JA			Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy	LANCET			English	Article							DILATED CARDIOMYOPATHY; GENE; MUTATIONS; COLLAGEN; HYPERTROPHY; MYOCARDIUM; REGRESSION; APOPTOSIS; SYSTEM	Background Mutations that lead to disruption of cytoskeletal proteins have been recorded in patients with familial dilated cardiomyopathy. We postulated that changes in cytoskeletal and sarcolemmal proteins provide a final common pathway for dilation and contractile dysfuncton in dilated cardiomyopathy. In this study, we investigated the integrity of dystrophin in the myocardium of patients with end-stage heart failure due to ischaemic or dilated cardiomyopathy, and the response to treatment with left-ventricular assistance devices (LVAD). Methods We assessed the expression and integrity of dystrophin in myocardial biopsy samples by immunohistochemistry and westem-blot analysis using antibodies against the amino-terminal, carboxyl-terminal, and midrod domains. We took samples from the myocardia of ten controls, ten patients with dilated cardiomyopathy, ten with ischaemic heart disease, and six with dilated cardiomyopathy who underwent placement of a left-ventricular assistance device for progressive refractory heart failure. Findings Immunohistochemical staining identified a disruption to the amino-terminus of dystrophin in 18 of 20 patients with end-stage cardiomyopathy (dilated or ischaemic), whereas staining with antibodies against other domains of dystrophin was normal. Westem-blot analysis confirmed these observations, suggesting that remodelling of dystrophin is a common pathway for dysfunction of failing cardiomyocytes. Furthermore, this disruption was reversible in four patients after LVAD support. Interpretation Dystrophin remodelling is a useful indicator of left-ventricular function in patients with dilated and ischaemic cardiomyopathy. Our results lend support to the hypothesis that changes in cytoskeletal proteins and, in particular, dystrophin might provide a final common pathway for contractile dysfunction in heart failure and these changes might be reversible by reduction of mechanical stress.	Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Cardiovasc Sci Sect, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA; Baylor Coll Med, Gene & Judy Campbell Lab Cardiac Transplant Res, Houston, TX 77030 USA; Baylor Coll Med, Methodist Hosp, DeBakey Heart Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, 1 Baylor Plaza,Room 333E, Houston, TX 77030 USA.	jtowbin@bcm.tmc.edu	Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Torre-Amione, Guillermo/0000-0001-9950-0416				Association TCCotNYH, 1994, NOMENCLATURE CRITERI, P253; Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Bowles KR, 1996, J CLIN INVEST, V98, P1355, DOI 10.1172/JCI118922; Bruckner BA, 2001, J HEART LUNG TRANSPL, V20, P457, DOI 10.1016/S1053-2498(00)00321-1; Carlson CG, 1998, NEUROBIOL DIS, V5, P3, DOI 10.1006/nbdi.1998.0188; Di Bella I, 2000, EUR J CARDIO-THORAC, V18, P112, DOI 10.1016/S1010-7940(00)00427-9; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Helman DN, 2000, ANN THORAC SURG, V70, P1255, DOI 10.1016/S0003-4975(00)01826-9; Helman DN, 2000, J HEART LUNG TRANSPL, V19, P121, DOI 10.1016/S1053-2498(99)00116-3; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; LEVIN HR, 1995, CIRCULATION, V91, P2717, DOI 10.1161/01.CIR.91.11.2717; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; MANOLIO TA, 1992, AM J CARDIOL, V69, P1458, DOI 10.1016/0002-9149(92)90901-A; MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7; MICHELS VV, 1993, J MED GENET, V30, P955, DOI 10.1136/jmg.30.11.955; Milasin J, 1996, HUM MOL GENET, V5, P73, DOI 10.1093/hmg/5.1.73; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; OCONNELL JB, 1994, J HEART LUNG TRANSPL, V13, pS107; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; PUCHTLER H, 1988, HISTOCHEMISTRY, V88, P243; Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656	31	136	140	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2002	359	9310					936	941		10.1016/S0140-6736(02)08026-1	http://dx.doi.org/10.1016/S0140-6736(02)08026-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531AE	11918913				2022-12-24	WOS:000174391700013
J	Aphasizhev, R; Sbicego, S; Peris, M; Jang, SH; Aphasizheva, I; Simpson, AM; Rivlin, A; Simpson, L				Aphasizhev, R; Sbicego, S; Peris, M; Jang, SH; Aphasizheva, I; Simpson, AM; Rivlin, A; Simpson, L			Trypanosome mitochondrial 3 ' terminal uridylyl transferase (TUTase): The key enzyme in U-insertion/deletion RNA editing	CELL			English	Article							MAMMALIAN POLY(A) POLYMERASE; LEISHMANIA-TARENTOLAE; MESSENGER-RNA; GUIDE RNA; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; KINETOPLASTID MITOCHONDRIA; GLUTAMATE-DEHYDROGENASE; BRUCEI MITOCHONDRIA; MUTATIONAL ANALYSIS; LIGASE ACTIVITIES	A 3' terminal RNA uridylyltransferase was purified from mitochondria of Leishmania tarentolae and the gene cloned and expressed from this species and from Trypanosoma brucei. The enzyme is specific for 3' U-addition in the presence of Mg2+. TUTase is present in vivo in at least two stable configurations: one contains a similar to500 kDa TUTase oligomer and the other a similar to700 kDa TUTase complex. Anti-TUTase antiserum specifically coprecipitates a small portion of the p45 and p50 RNA ligases and approximately 40% of the guide RNAs. Inhibition of TUTase expression in procyclic T. brucei by RNAi downregulates RNA editing and appears to affect parasite viability.	Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Taegu Univ, Dept Mol Biol, Kyung San 712714, Kyung Pook, South Korea; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Simpson, L (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.			Afasizhev, Ruslan/0000-0002-4595-6618; Afasizheva, Inna/0000-0003-2695-2950	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009102, R01AI009102] Funding Source: NIH RePORTER; NIAID NIH HHS [AI09102] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADLER BK, 1991, MOL CELL BIOL, V11, P5878, DOI 10.1128/MCB.11.12.5878; Alfonzo JD, 1997, NUCLEIC ACIDS RES, V25, P3751, DOI 10.1093/nar/25.19.3751; ANDREWS NC, 1986, P NATL ACAD SCI USA, V83, P221, DOI 10.1073/pnas.83.2.221; Aphasizhev R, 2001, J BIOL CHEM, V276, P21280, DOI 10.1074/jbc.M100297200; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; BAKALARA N, 1989, J BIOL CHEM, V264, P18679; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Blanc V, 1999, J BIOL CHEM, V274, P24289, DOI 10.1074/jbc.274.34.24289; Blom D, 2001, NUCLEIC ACIDS RES, V29, P2950, DOI 10.1093/nar/29.14.2950; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; BRALY P, 1974, J PROTOZOOL, V21, P782, DOI 10.1111/j.1550-7408.1974.tb03752.x; Bringaud F, 1997, MOL CELL BIOL, V17, P3915, DOI 10.1128/MCB.17.7.3915; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V36, P197, DOI 10.1016/0166-6851(89)90192-8; CARRUTHERS VB, 1992, P NATL ACAD SCI USA, V89, P8818, DOI 10.1073/pnas.89.18.8818; CHEN J, 1992, MOL CELL BIOL, V12, P3470, DOI 10.1128/MCB.12.8.3470; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Estevez AM, 1999, GENE, V240, P247, DOI 10.1016/S0378-1119(99)00437-0; Estevez AM, 1999, MOL BIOCHEM PARASIT, V100, P5, DOI 10.1016/S0166-6851(99)00024-9; FRECH GC, 1995, EMBO J, V14, P178, DOI 10.1002/j.1460-2075.1995.tb06988.x; GREIDER CW, 1991, MOL CELL BIOL, V11, P4572, DOI 10.1128/MCB.11.9.4572; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Igo RP, 2000, MOL CELL BIOL, V20, P8447, DOI 10.1128/MCB.20.22.8447-8457.2000; Kapushoc ST, 1999, RNA, V5, P656, DOI 10.1017/S1355838299982250; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Madison-Antenucci S, 1998, EMBO J, V17, P6368, DOI 10.1093/emboj/17.21.6368; Martin G, 1999, PROTEIN SCI, V8, P2380; Martin G, 1998, RNA, V4, P226; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; McManus MT, 2000, MOL CELL BIOL, V20, P883, DOI 10.1128/MCB.20.3.883-891.2000; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; MILCHEV GI, 1978, EUR J BIOCHEM, V84, P113, DOI 10.1111/j.1432-1033.1978.tb12147.x; Militello KT, 2000, MOL CELL BIOL, V20, P2308, DOI 10.1128/MCB.20.7.2308-2316.2000; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Peris M, 1997, MOL BIOCHEM PARASIT, V85, P9, DOI 10.1016/S0166-6851(96)02795-8; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Rusche LN, 2001, MOL CELL BIOL, V21, P979, DOI 10.1128/MCB.21.4.979-989.2001; SABATINI R, 1995, J BIOL CHEM, V270, P7233, DOI 10.1074/jbc.270.13.7233; SACHS A, 1993, J BIOL CHEM, V268, P22955; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simpson L, 1998, NUCLEIC ACIDS RES, V26, P170, DOI 10.1093/nar/26.1.170; Trippe R, 1998, NUCLEIC ACIDS RES, V26, P3119, DOI 10.1093/nar/26.13.3119; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; WHITE TC, 1987, NUCLEIC ACIDS RES, V15, P3275, DOI 10.1093/nar/15.8.3275; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; ZABEL P, 1981, NUCLEIC ACIDS RES, V9, P2433, DOI 10.1093/nar/9.11.2433	53	112	117	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 8	2002	108	5					637	648		10.1016/S0092-8674(02)00647-5	http://dx.doi.org/10.1016/S0092-8674(02)00647-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	529TN	11893335	Bronze			2022-12-24	WOS:000174314800008
J	Townsend, A; Drakesmith, H				Townsend, A; Drakesmith, H			Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload	LANCET			English	Article							HEMOCHROMATOSIS PROTEIN HFE; TRANSFERRIN RECEPTOR; HLA-H; EXPRESSION; TRANSPORTER; GENE; MICE; ASSOCIATION; ABSORPTION; MODEL	Hereditary haemochromatosis Is an iron overloading disorder caused by common mutations in the HFE gene. However, Information with respect to the function of HFE protein does not explain how mutations in HFE lead to hereditary haemochromatosis. We propose a molecular model In which HFE has two mutually exclusive activities in cells: Inhibition of uptake. or inhibition of release of iron. The balance between serum transferrin saturation and serum transferrin-receptor concentrations determines which of these functions predominates. With this input, HFE enables the intestinal crypt cells and reticuloendothelial system to interpret the body's iron requirements and regulate iron absorption and distribution. In our model, mutations in HFE result in overabsorption of dietary iron, and patterns of tissue iron deposition in agreement with clinical observations of hereditary haemochromatosis.	Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Townsend, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.			Townsend, Alain/0000-0002-3702-0107; Drakesmith, Alexander/0000-0002-8503-6103				Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Bastin JM, 1998, BRIT J HAEMATOL, V103, P931, DOI 10.1046/j.1365-2141.1998.01102.x; BLOCK M, 1965, AM J PATHOL, V47, P89; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Cazzola M, 1999, BRIT J HAEMATOL, V106, P752, DOI 10.1046/j.1365-2141.1999.01600.x; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; DRAKESMITH H, IN PRESS NATURE; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V294, P239, DOI 10.1006/jmbi.1999.3252; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Montosi G, 2000, BLOOD, V96, P1125, DOI 10.1182/blood.V96.3.1125.015k19_1125_1129; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Njajou OT, 2001, NAT GENET, V28, P213, DOI 10.1038/90038; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Raja KB, 1999, BLOOD, V94, P3185, DOI 10.1182/blood.V94.9.3185.421a20_3185_3192; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Santos M, 1996, J EXP MED, V184, P1975, DOI 10.1084/jem.184.5.1975; Sheldon J. H., 1935, HAEMOCHROMATOSIS; TAYLOR MRH, 1966, BRIT J HAEMATOL, V12, P747, DOI 10.1111/j.1365-2141.1966.tb00161.x; Waheed A, 1999, P NATL ACAD SCI USA, V96, P1579, DOI 10.1073/pnas.96.4.1579; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0	31	63	66	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					786	790		10.1016/S0140-6736(02)07885-6	http://dx.doi.org/10.1016/S0140-6736(02)07885-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888608				2022-12-24	WOS:000174115200032
J	Hutchinson, JR; Garcia, M				Hutchinson, JR; Garcia, M			Tyrannosaurus was not a fast runner	NATURE			English	Article							LEG MUSCLES; MECHANICS; ALLOMETRY; MAMMALS; POSTURE; MASS	The fastest gait and speed of the largest theropod (carnivorous) dinosaurs, such as Tyrannosaurus, is controversial. Some studies contend that Tyrannosaurus was limited to walking, or at best an 11 m s(-1) top speed(1-4), whereas others argue for at least 20 m s(-1) running speeds(5-7). We demonstrate a method of gauging running ability by estimating the minimum mass of extensor (supportive) muscle needed for fast running. The model's predictions are validated for living alligators and chickens. Applying the method to small dinosaurs corroborates other studies by showing that they could have been competent runners. However, models show that in order to run quickly, an adult Tyrannosaurus would have needed an unreasonably large mass of extensor muscle, even with generous assumptions. Therefore, it is doubtful that Tyrannosaurus and other huge dinosaurs (similar to6,000 kg) were capable runners or could reach high speeds.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hutchinson, JR (corresponding author), Stanford Univ, Biomech Engn Div, Stanford, CA 94305 USA.	jrhutch@stanford.edu	Hutchinson, John/AAH-1593-2020	Hutchinson, John/0000-0002-6767-7038				ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; ALEXANDER RM, 1985, J EXP BIOL, V115, P231; ALEXANDER RM, 1981, J ZOOL, V194, P539, DOI 10.1111/j.1469-7998.1981.tb04600.x; ALEXANDER RM, 1983, J ZOOL, V201, P135, DOI 10.1111/j.1469-7998.1983.tb04266.x; ALEXANDER RM, 1979, J ZOOL, V187, P169; ALEXANDER RM, 1989, DYAMICS DINOSAURS OT; Bakker RT., 1986, DINOSAUR HERESIES; Bennett MB, 1996, J ZOOL, V238, P435, DOI 10.1111/j.1469-7998.1996.tb05404.x; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; CARRANO M, IN PRESS J MORPHOL; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Christiansen Per, 2000, Gaia (Lisboa), V15, P241; COOMBS WP, 1975, PALAEOGEOGR PALAEOCL, V17, P1, DOI 10.1016/0031-0182(75)90027-9; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Farlow JO, 1995, J VERTEBR PALEONTOL, V15, P713, DOI 10.1080/02724634.1995.10011257; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GRAND TI, 1977, AM J PHYS ANTHROPOL, V47, P211, DOI 10.1002/ajpa.1330470204; Hallgrimsson B, 2000, BIOL J LINN SOC, V70, P571, DOI 10.1111/j.1095-8312.2000.tb00218.x; Horner J.R, 1993, COMPLETE T REX; Hutchinson J.R., 2001, THESIS U CALIFORNIA; IRBY GV, 1999, MUS N ARIZONA B, V60, P109; JOHNSTON IA, 1985, J EXP BIOL, V115, P239; MENDEZ J, 1960, METABOLISM, V9, P184; Paul G., 1988, PREDATORY DINOSAURS; Paul Gregory S., 2000, Gaia (Lisboa), V15, P257; Roberts Thomas J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P283; Roberts TJ, 1998, J EXP BIOL, V201, P2753	28	129	133	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					1018	1021		10.1038/4151018a	http://dx.doi.org/10.1038/4151018a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875567				2022-12-24	WOS:000174075000043
J	Margolis, DJ; Knauss, J; Bilker, W				Margolis, DJ; Knauss, J; Bilker, W			Hormone replacement therapy and prevention of pressure ulcers and venous leg ulcers	LANCET			English	Article								Pressure ulcers and venous leg ulcers are common chronic wounds. Oestrogens in the form of hormone replacement therapy (HRT) might have an effect on wound healing, but this possibility has not been studied In detail. Using a case-cohort study including elderly patients in the UK General Practice Research Database, we showed that patients who received HRT were less likely to develop a venous leg ulcer (age-adjusted relative risk 0.65 [95% CI 0.61-0.69]) or a pressure ulcer (0.68 [0.62-0.76]) than those who did not use HRT. Therefore, we believe that HRT could be beneficial for the prevention of these wounds.	Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Margolis, DJ (corresponding author), Univ Penn, Sch Med, Dept Dermatol, 815 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Bilker, Warren/AAS-3515-2021		NIAMS NIH HHS [AR-44695, AR-02212] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044695, R01AR044695, K24AR002212] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Calvin M, 2000, MATURITAS, V34, P195, DOI 10.1016/S0378-5122(99)00079-1; Krasner D., 2001, CHRONIC WOUND CARE C; MARGOLIS DJ, IN PRESS ANN EPIDEMI; PRENTICE RL, 1986, BIOMETRIKA, V73, P1	5	69	71	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					675	677		10.1016/S0140-6736(02)07806-6	http://dx.doi.org/10.1016/S0140-6736(02)07806-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879867				2022-12-24	WOS:000174107400015
J	Fraser, HB; Hirsh, AE; Steinmetz, LM; Scharfe, C; Feldman, MW				Fraser, HB; Hirsh, AE; Steinmetz, LM; Scharfe, C; Feldman, MW			Evolutionary rate in the protein interaction network	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; GENES	High-throughput screens have begun to reveal the protein interaction network that underpins most cellular functions in the yeast Saccharomyces cerevisiae. How the organization of this network affects the evolution of the proteins that compose it is a fundamental question in molecular evolution. We show that the connectivity of welt-conserved proteins in the network is negatively correlated with their rate of evolution. Proteins with more interactors evolve more slowly not because they are more important to the organism, but because a greater proportion of the protein is directly involved in its function. At sites important for interaction between proteins, evolutionary changes may occur largely by coevolution, in which substitutions in one protein result in selection pressure for reciprocal changes in interacting partners. We confirm one predicted outcome of this process-namely, that interacting proteins evolve at similar rates.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Biol Sci, Ctr Computat Genet & Biol Modeling, Stanford, CA 94305 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94306 USA	University of California System; University of California Berkeley; Stanford University; Stanford University	Fraser, HB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Steinmetz, Lars/0000-0002-3962-2865				Chervitz SA, 1998, SCIENCE, V282, P2022, DOI 10.1126/science.282.5396.2022; Dickerson R E., 1971, Journal Molec Evol, V1, P26, DOI 10.1007/BF01659392; Feng DF, 1997, J MOL EVOL, V44, P361, DOI 10.1007/PL00006155; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GIBBONS JD, 1993, SAGE U PAPERS, P3; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; GRISHIN NV, 1995, J MOL EVOL, V41, P675; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; KAPLAN D, 2000, ADV QUANTITATIVE TEC, P13; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; Rawson PD, 2000, GENE, V248, P15, DOI 10.1016/S0378-1119(00)00145-1; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; SMITH V, 1995, P NATL ACAD SCI USA, V92, P6479, DOI 10.1073/pnas.92.14.6479; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; ZUCKERKANDL E, 1976, J MOL EVOL, V7, P167, DOI 10.1007/BF01731487	22	649	665	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					750	752		10.1126/science.1068696	http://dx.doi.org/10.1126/science.1068696			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976460	Green Submitted			2022-12-24	WOS:000175281700060
J	Hinnebusch, BJ; Rudolph, AE; Cherepanov, P; Dixon, JE; Schwan, TG; Forsberg, A				Hinnebusch, BJ; Rudolph, AE; Cherepanov, P; Dixon, JE; Schwan, TG; Forsberg, A			Role of Yersinia murine toxin in survival of Yersinia pestis in the midgut of the flea vector	SCIENCE			English	Article							PHOSPHOLIPID SYNTHASES; ESCHERICHIA-COLI; VIRULENCE; IDENTIFICATION; MUTAGENESIS; SUPERFAMILY; PLAGUE; FAMILY; MEMBER; LOCUS	Transmission by flea bite is a relatively recent adaptation that distinguishes Yersinia pestis, the plague bacillus, from closely related enteric bacteria. Here, a plasmid-encoded phospholipase D (PLD), previously characterized as Yersinia murine toxin (Ymt), was shown to be required for survival of Y, pestis in the midgut of its principal vector, the rat flea Xenopsylla cheopis. Intracellular PLD activity appeared to protect Y. pestis from a cytotoxic digestion product of blood plasma in the flea gut. By enabling colonization of the flea midgut, acquisition of this PLD may have precipitated the transition of Y. pestis to obligate arthropod-borne transmission.	NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; Swedish Def Res Agcy, Dept Med Countermeasures, S-90182 Umea, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; Umea University; Saab Group	Hinnebusch, BJ (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.							Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; AJL SJ, 1955, J BACTERIOL, V70, P158, DOI 10.1128/JB.70.2.158-169.1955; Bacot A. W., 1914, Journal of Hygiene Cambridge Plague Suppl, V3; BROWN SD, 1977, INFECT IMMUN, V18, P85, DOI 10.1128/IAI.18.1.85-93.1977; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Du YD, 1995, CONTRIB TO MICROBIOL, V13, P321; ESKEY CR, 1940, PUBLIC HLTH B, V254; FORSBERG A, UNPUB; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Koonin EV, 1996, TRENDS BIOCHEM SCI, V21, P242, DOI 10.1016/0968-0004(96)30024-8; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; MONTIE TC, 1970, MICROBIAL TOXINS, V3, P1; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; POLLITZER R, 1954, MONOGRAPH SERIES WHO, V22; Ponting CP, 1996, PROTEIN SCI, V5, P914; Rudolph AE, 1999, J BIOL CHEM, V274, P11824, DOI 10.1074/jbc.274.17.11824; SCHAR M, 1956, Schweiz Z Pathol Bakteriol, V19, P51; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; VAUGHAN JA, 1993, J MED ENTOMOL, V30, P214, DOI 10.1093/jmedent/30.1.214	27	225	244	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					733	735		10.1126/science.1069972	http://dx.doi.org/10.1126/science.1069972			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976454				2022-12-24	WOS:000175281700054
J	Roos, D; Winterbourn, CC				Roos, D; Winterbourn, CC			Immunology - Lethal weapons	SCIENCE			English	Editorial Material							SUPEROXIDE-DISMUTASE; POLYMORPHONUCLEAR NEUTROPHILS; NOCARDIA-ASTEROIDES; ESCHERICHIA-COLI; MYELOPEROXIDASE		Netherlands Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Christchurch Sch Med, Dept Pathol, Christchurch, New Zealand	University of Amsterdam; Academic Medical Center Amsterdam; University of Otago	Roos, D (corresponding author), Netherlands Blood Transfus Serv, Cent Lab, Amsterdam, Netherlands.							ALBRICH JM, 1982, FEBS LETT, V144, P157, DOI 10.1016/0014-5793(82)80591-7; BEAMAN BL, 1983, J BIOL CHEM, V258, P91; BEAMAN BL, 1985, INFECT IMMUN, V47, P135, DOI 10.1128/IAI.47.1.135-141.1985; BEAMAN L, 1990, INFECT IMMUN, V58, P3122, DOI 10.1128/IAI.58.9.3122-3128.1990; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Elsbach P, 1999, INFLAMMATION BASIC P, P801; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gerber CE, 2001, BLOOD, V98, P3097, DOI 10.1182/blood.V98.10.3097; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; JOHNSTON RB, 1970, BLOOD-J HEMATOL, V35, P350, DOI 10.1182/blood.V35.3.350.350; Kettle AJ, 2001, BIOCHEMISTRY-US, V40, P10204, DOI 10.1021/bi010940b; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; KLEBANOFF SJ, 1968, J BACTERIOL, V95, P2131, DOI 10.1128/JB.95.6.2131-2138.1968; KUSUNOSE E, 1976, J BIOCHEM, V80, P1343, DOI 10.1093/oxfordjournals.jbchem.a131407; Langford PR, 1996, INFECT IMMUN, V64, P5035, DOI 10.1128/IAI.64.12.5035-5041.1996; MANDELL GL, 1969, J BACTERIOL, V100, P531, DOI 10.1128/JB.100.1.531-532.1969; MANDELL GL, 1974, INFECT IMMUN, V9, P337, DOI 10.1128/IAI.9.2.337-341.1974; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; SPIEGELHALDER C, 1993, INFECT IMMUN, V61, P5315, DOI 10.1128/IAI.61.12.5315-5325.1993; VOETMAN AA, 1981, J CLIN INVEST, V67, P1541, DOI 10.1172/JCI110185; WEISS J, 1982, J CLIN INVEST, V69, P959, DOI 10.1172/JCI110535	26	140	143	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					669	671		10.1126/science.1071271	http://dx.doi.org/10.1126/science.1071271			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976433				2022-12-24	WOS:000175281700033
J	Clancy, DJ; Gems, D; Hafen, E; Leevers, SJ; Partridge, L				Clancy, DJ; Gems, D; Hafen, E; Leevers, SJ; Partridge, L			Dietary restriction in long-lived dwarf flies	SCIENCE			English	Article							LIFE-SPAN; NUTRITION		UCL, Dept Biol, London WC1E 6BT, England; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Imperial Canc Res Fund, Growth Regulat Lab, London WC2A 3PX, England	University of London; University College London; University of Zurich; Cancer Research UK	Partridge, L (corresponding author), UCL, Dept Biol, Gower ST, London WC1E 6BT, England.	l.partridge@ucl.ac.uk	Clancy, David J/F-4882-2011; Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094; Clancy, David John/0000-0002-0299-7946; Gems, David/0000-0002-6653-4676	Biotechnology and Biological Sciences Research Council [SF19106] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Chapman T, 1996, P ROY SOC B-BIOL SCI, V263, P755, DOI 10.1098/rspb.1996.0113; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X	7	217	227	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					319	319		10.1126/science.1069366	http://dx.doi.org/10.1126/science.1069366			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951037	Green Accepted			2022-12-24	WOS:000175000300048
J	McMichael, AJ				McMichael, AJ			Population, environment, disease, and survival: past patterns, uncertain futures	LANCET			English	Article							PUBLIC-HEALTH; EPIDEMIOLOGY	Societies are exploring what sustainable development means for development choices. Increasingly, we recognise that human population health is not just an input to socioeconomic development, but is an essential outcome, and, over time, a marker of sustainability. There has been recent attention to how stocks of social and human capital precondition gains in population health. However, recognition of how environmental change can limit health and survival has been slower. Over many millennia, disease and longevity profiles in populations: have reflected changes In environmental conditions and, often, excedances of carrying capacity. Today, population growth and the aggregated pressures of consumption and emissions are beginning to impair various global environmental systems. The research tasks In detecting, attributing, and projecting the resultant health effects are complex. Have recent health gains, in part, depended on depleting natural environmental capital? Population health sciences have a crucial contribution to make to the sustainability project.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.							[Anonymous], 1989, STORY IODINE DEFICIE; [Anonymous], 1997, GUNS GERMS STEEL; BOYDEN S, 1987, W CIVILIZATION BIOL; Butler CD, 2000, GLOBAL CHANGE HUMAN, V1, P156, DOI DOI 10.1023/A:1010029222095; Epstein PR, 1997, B AM METEOROL SOC, V78, P409; *FOOD AGR ORG, 2001, STAT FOOD AGR; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kovats RS, 2001, PHILOS T R SOC B, V356, P1057, DOI 10.1098/rstb.2001.0894; LEE K, 2001, INT COOPERATION HLTH, P13; Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8; LOMBORG J, 2001, SCEPTICAL ENV; McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1067; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; McMichael AJ, 2001, ECOSYST HEALTH, V7, P107, DOI 10.1046/j.1526-0992.2001.007002107.x; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; MCMICHAEL AJ, 2000, ETHNICITY HLTH, P133; McMichael AJ, 2001, HUMAN FRONTIERS ENV, DOI [10.1017/CBO9781139106924, DOI 10.1017/CBO9781139106924]; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Pearce N, 1996, AM J PUBLIC HEALTH, V86, P678, DOI 10.2105/AJPH.86.5.678; POWLES JW, IN PRESS ENCY LIFE S; PRENTICE AM, 1995, BRIT MED J, V311, P437, DOI 10.1136/bmj.311.7002.437; REES WE, 2000, ECOLOGICAL INTEGRITY, P139; ROTBERG R, 1985, HUNGER HIST; Trowell H. C., 1981, W DIS THEIR EMERGENC; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; World Health Organization, 1999, WORLD HLTH REP MAK D; World Health Organization (WHO), 1990, WHO TECHN REP SER, V797	28	38	39	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1145	1148		10.1016/S0140-6736(02)08164-3	http://dx.doi.org/10.1016/S0140-6736(02)08164-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943282				2022-12-24	WOS:000174729200032
J	Ikkala, O; ten Brinke, G				Ikkala, O; ten Brinke, G			Functional materials based on self-assembly of polymeric supramolecules	SCIENCE			English	Article							COPOLYMER; POLYANILINE; SURFACTANT; COMPLEXES	Self-assembty of polymeric supramolecules is a powerful too[ for producing functional materials that combine several properties and may respond to external conditions. We illustrate the concept using a comb-shaped architecture. Examples include the hexagonal self-organization of conjugated conducting polymers and the polarized luminance in solid-state films of rodlike polymers obtained by removing the hydrogen-bonded side chains from the aligned thermotropic smectic phase. Hierarchically structured materials obtained by applying different self-organization and recognition principles and directed assembly form a basis for tunable nanoporous materials, smart membranes, preparation of nano-objects, and anisotropic properties, such as proton conductivity.	Aalto Univ, Dept Engn Math & Phys, FIN-02015 Espoo, Finland; Aalto Univ, Ctr New Mat, FIN-02015 Espoo, Finland; Univ Groningen, Dept Polymer Sci, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Mat Sci, NL-9747 AG Groningen, Netherlands	Aalto University; Aalto University; University of Groningen; University of Groningen	Ikkala, O (corresponding author), Aalto Univ, Dept Engn Math & Phys, POB 2200, FIN-02015 Espoo, Finland.	Olli.ikkala@hut.fi; G.ten.Brinke@chem.rug.nl	Ikkala, Olli T./K-7447-2012	Ikkala, Olli T./0000-0002-0470-1889				Antonietti M, 1996, ADV MATER, V8, P41, DOI 10.1002/adma.19960080106; ANTONIETTI M, 1994, MACROMOLECULES, V27, P6007, DOI 10.1021/ma00099a011; BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521; de Moel K, 2001, CHEM MATER, V13, P4580, DOI 10.1021/cm0110932; Edrington AC, 2001, ADV MATER, V13, P421, DOI 10.1002/1521-4095(200103)13:6<421::AID-ADMA421>3.0.CO;2-#; KNAAPILA M, UNPUB APPL PHYS LETT; Kosonen H, 2000, MACROMOLECULES, V33, P8671, DOI 10.1021/ma0010783; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; Maki-Ontto R, 2002, ADV MATER, V14, P357, DOI 10.1002/1521-4095(20020304)14:5<357::AID-ADMA357>3.0.CO;2-Q; Maki-Ontto R, 2001, ADV MATER, V13, P117, DOI 10.1002/1521-4095(200101)13:2<117::AID-ADMA117>3.0.CO;2-1; Makinen R, 2000, MACROMOLECULES, V33, P3441, DOI 10.1021/ma991127f; Mena-Osteritz E, 2000, ANGEW CHEM INT EDIT, V39, P2680; Muthukumar M, 1997, SCIENCE, V277, P1225, DOI 10.1126/science.277.5330.1225; Park C, 2001, APPL PHYS LETT, V79, P848, DOI 10.1063/1.1389766; Pease AR, 2001, ACCOUNTS CHEM RES, V34, P433, DOI 10.1021/ar000178q; Rehahn M, 1998, ACTA POLYM, V49, P201, DOI 10.1002/(SICI)1521-4044(199805)49:5<201::AID-APOL201>3.3.CO;2-S; Ruokolainen J, 1999, ADV MATER, V11, P777, DOI 10.1002/(SICI)1521-4095(199906)11:9<777::AID-ADMA777>3.0.CO;2-M; Ruokolainen J, 1998, SCIENCE, V280, P557, DOI 10.1126/science.280.5363.557; Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X; Saito R, 2001, MACROMOLECULES, V34, P4299, DOI 10.1021/ma002115t; Sanger J, 1997, MACROMOLECULES, V30, P7621, DOI 10.1021/ma970709z; Schon JH, 2000, SCIENCE, V289, P599, DOI 10.1126/science.289.5479.599; Schon JH, 2001, NATURE, V410, P189, DOI 10.1038/35065565; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Simon PFW, 2001, CHEM MATER, V13, P3464, DOI 10.1021/cm0110674; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Wang LL, 2001, CHEM MATER, V13, P1273, DOI 10.1021/cm000869g; Wosten HAB, 2001, ANNU REV MICROBIOL, V55, P625, DOI 10.1146/annurev.micro.55.1.625; ZHENG WY, 1995, MACROMOL CHEM PHYSIC, V196, P2443, DOI 10.1002/macp.1995.021960803	32	894	911	16	572	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2002	295	5564					2407	2409		10.1126/science.1067794	http://dx.doi.org/10.1126/science.1067794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923526				2022-12-24	WOS:000174712600042
J	Klassen, PS; Lowrie, EG; Reddan, DN; DeLong, ER; Coladonato, JA; Szczech, LA; Lazarus, JM; Owen, WF				Klassen, PS; Lowrie, EG; Reddan, DN; DeLong, ER; Coladonato, JA; Szczech, LA; Lazarus, JM; Owen, WF			Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISOLATED SYSTOLIC HYPERTENSION; LARGE ARTERY COMPLIANCE; BLOOD-PRESSURE; CARDIOVASCULAR MORTALITY; HEART-FAILURE; RISK; TERM; REFLECTIONS; POPULATION; STIFFNESS	Context Although increased blood pressure is associated with adverse outcomes in the general population, elevated blood pressure is associated with decreased mortality in patients with end-stage renal disease undergoing maintenance hemodialysis. Recent investigations in the general population have demonstrated the predictive utility of pulse pressure (systolic minus diastolic blood pressure), a measure reflecting the pulsatile nature of the cardiac cycle. Objectives To estimate the relationship between pulse pressure and mortality in patients undergoing maintenance hemodialysis and to test our hypothesis that an increasing pulse pressure would be associated with increased risk of death up to 1 year despite the inverse relationship between conventional blood pressure measures and mortality in patients with end-stage renal disease. Design, Setting, and Patients Retrospective cohort investigation of patients with end-stage renal disease undergoing maintenance hemodialysis at 782 hemodialysis facilities throughout the United States. Of 44 069 eligible patients as of January 1, 1998, 37069 with complete demographic data were included in the analyses of clinical and laboratory data collected from October I through December 31, 1997. Patients were followed up through December 31, 1998. Main Outcome Measures The primary study outcome was death at I year. A secondary outcome was the magnitude of the pulse pressure. Results The final patient cohort was similar to national averages with respect to age, sex, race, and diabetic status. Mean (SD) pulse pressures before dialysis were 75.0 (15.0) mm Hg and 66.9 (13.9) mm Hg after dialysis, By the end of the 1-year follow-up, 5731 patients (18.4%) died. After adjusting for level of systolic blood pressure, multivariable Cox proportional hazards modeling showed a direct and consistent relationship between increasing pulse pressure and increasing death risk. Each incremental elevation of 10 mm Hg in postdialysis pulse pressure was associated with a 12% increase in the hazard for death (hazard ratio, 1.12; 95% confidence interval, 1.06-1.18). Postdialysis systolic blood pressure was inversely related to mortality with a 13% decreased hazard for death for each incremental elevation of 10 mm Hg (hazard ratio, 0.87; 95% confidence interval, 0.84-0.90). In a multivariable linear regression model, important variables directly associated with elevated pulse pressure included age, diabetes, white race, female sex, and number of years receiving dialysis (all P<.001). Conclusions Pulse pressure is associated with risk of death in a large, nationally representative sample of patients undergoing maintenance hemodialysis. The recognition of pulse pressure as an important correlate of mortality in patients receiving dialysis highlights the need to investigate the relationship between potential therapeutic implications of conduit vessel function and clinical outcomes in patients with end-stage renal disease.	Duke Univ, Med Ctr, Duke Inst Renal Outcomes Res & Hlth Policy, Dept Med, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; Fresenius Med Care N Amer, Lexington, MA USA	Duke University; Duke University	Klassen, PS (corresponding author), Duke Univ, Med Ctr, Duke Inst Renal Outcomes Res & Hlth Policy, Dept Med, Box 3646, Durham, NC 27710 USA.	klass001@mc.duke.edu						Amar J, 2000, KIDNEY INT, V57, P2485, DOI 10.1046/j.1523-1755.2000.00107.x; [Anonymous], 1982, ARTERIAL FUNCTION HL; [Anonymous], 1982, JAMA-J AM MED ASSOC, V247, P633; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; AVOLIO AP, 1986, ARTERIOSCLEROSIS, V6, P166, DOI 10.1161/01.ATV.6.2.166; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; Benetos A, 1998, HYPERTENSION, V32, P560, DOI 10.1161/01.HYP.32.3.560; Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570; CAMERON D, 1994, AM J PHYSL 2, V262, pH693; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; DECESARIS R, 1992, AM J HYPERTENS, V5, P624; *DEP HLTH HUM SERV, 1999, 1999 ANN REP ESRD CL; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Domanski MJ, 1999, HYPERTENSION, V34, P375, DOI 10.1161/01.HYP.34.3.375; FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; FRANKLIN SS, 1994, AM HEART J, V128, P793, DOI 10.1016/0002-8703(94)90278-X; Girerd X, 1998, J AM COLL CARDIOL, V31, P1064, DOI 10.1016/S0735-1097(98)00043-6; Glynn RJ, 2000, ARCH INTERN MED, V160, P2765, DOI 10.1001/archinte.160.18.2765; HARNETT JD, 1995, KIDNEY INT, V47, P884, DOI 10.1038/ki.1995.132; Heesen WF, 1998, J CARDIOVASC PHARM, V31, P187, DOI 10.1097/00005344-199802000-00003; Herpin D, 1996, THERAPIE, V51, P11; *HYP DET FOLL UP P, 1979, JAMA-J AM MED ASSOC, V242, P2562; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KLASSEN P, 2000, J AM SOC NEPHROL, V11; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; NEATON JD, 1984, AM HEART J, V108, P759, DOI 10.1016/0002-8703(84)90669-0; Nichols W, 1998, MCDONALDS BLOOD FLOW; NICHOLS WW, 1992, J HYPERTENS, V10, pS73; Owen WF, 1998, JAMA-J AM MED ASSOC, V280, P1764, DOI 10.1001/jama.280.20.1764; PANNIER BM, 1994, AM J HYPERTENS, V7, P168, DOI 10.1093/ajh/7.2.168; Port FK, 1999, AM J KIDNEY DIS, V33, P507, DOI 10.1016/S0272-6386(99)70188-5; Safar ME, 1997, J VASC RES, V34, P67, DOI 10.1159/000159204; Salem MM, 1999, NEPHROL DIAL TRANSPL, V14, P125, DOI 10.1093/ndt/14.1.125; Salem MM, 1996, AM J KIDNEY DIS, V28, P737, DOI 10.1016/S0272-6386(96)90257-7; Sytkowski PA, 1996, CIRCULATION, V93, P697, DOI 10.1161/01.CIR.93.4.697; TING CT, 1995, HYPERTENSION, V26, P524, DOI 10.1161/01.HYP.26.3.524; Tozawa M, 2002, KIDNEY INT, V61, P717, DOI 10.1046/j.1523-1755.2002.00173.x; *US REN DAT SYST, 2000, USRDS 2000 ANN DAT R; WATANABE H, 1993, J AM COLL CARDIOL, V21, P1497, DOI 10.1016/0735-1097(93)90330-4; WESTERHOF N, 1995, J HYPERTENS, V13, P943, DOI 10.1097/00004872-199509000-00002; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x	44	325	343	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2002	287	12					1548	1555		10.1001/jama.287.12.1548	http://dx.doi.org/10.1001/jama.287.12.1548			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533VF	11911757	Bronze			2022-12-24	WOS:000174550400026
J	Gehring, WJ; Willoughby, AR				Gehring, WJ; Willoughby, AR			The medial frontal cortex and the rapid processing of monetary gains and losses	SCIENCE			English	Article							ANTERIOR CINGULATE; ERROR-DETECTION; NEURAL SYSTEM; ACTIVATION; CHOICE	We report the observation of neural processing that occurs within 265 milliseconds after outcome stimuli that inform human participants about gains and losses in a gambling task. A negative-polarity event-related brain potential, probably generated by a medial-frontal region in or near the anterior cingulate cortex, was greater in amplitude when a participant's choice between two alternatives resulted in a toss than when it resulted in a gain. The sensitivity to losses was not simply a reflection of detecting an error; gains did not elicit the medial-frontal activity when the alternative choice would have yielded a greater gain, and losses elicited the activity even when the alternative choice would have yielded a greater loss. Choices made after losses were riskier and were associated with greater toss-related activity than choices made after gains. It follows that medial-frontal computations may contribute to mental states that participate in higher level decisions, including economic choices.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Gehring, WJ (corresponding author), Univ Michigan, Dept Psychol, 525 E Univ, Ann Arbor, MI 48109 USA.	wgehring@umich.edu						Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 1999, WELL BEING FDN HEDON, DOI DOI 10.7758/9781610443258; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1017/S0048577200990231; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Luu P, 2001, CLIN NEUROPHYSIOL, V112, P1295, DOI 10.1016/S1388-2457(01)00559-4; Mellers BA, 2000, PSYCHOL BULL, V126, P910, DOI 10.1037/0033-2909.126.6.910; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Scherg M, 1990, ADV AUDIOL, P40, DOI DOI 10.1016/J.BSPC.2015.01.004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; Tucker DM, 1999, BIOL PSYCHOL, V50, P103, DOI 10.1016/S0301-0511(99)00005-8; Yates F.J., 1992, RISK TAKING BEHAV, P1; [No title captured]; [No title captured]	27	1310	1365	15	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2279	2282		10.1126/science.1066893	http://dx.doi.org/10.1126/science.1066893			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	534AD	11910116				2022-12-24	WOS:000174561700050
J	Pennartz, CMA; de Jeu, MTG; Bos, NPA; Schaap, J; Geurtsen, AMS				Pennartz, CMA; de Jeu, MTG; Bos, NPA; Schaap, J; Geurtsen, AMS			Diurnal modulation of pacemaker potentials and calcium current in the mammalian circadian clock	NATURE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CELLULAR MECHANISMS; MEMBRANE-PROPERTIES; GRANULE NEURONS; MULTIPLE TYPES; GUINEA-PIG; CHANNELS; SLICES; CELLS; RHYTHMICITY	The central biological clock of the mammalian brain is located in the suprachiasmatic nucleus. This hypothalamic region contains neurons that generate a circadian rhythm on a single-cell basis. Clock cells transmit their circadian timing signals to other brain areas by diurnal modulation of their spontaneous firing rate. The intracellular mechanism underlying rhythm generation is thought to consist of one or more self-regulating molecular loops, but it is unknown how these loops interact with the plasma membrane to modulate the ionic conductances that regulate firing behaviour. Here we demonstrate a diurnal modulation of Ca2+ current in suprachiasmatic neurons. This current strongly contributes to the generation of spontaneous oscillations in membrane potential, which occur selectively during daytime and are tightly coupled to spike generation. Thus, day-night modulation of Ca2+ current is a central step in transducing the intracellular cycling of molecular clocks to the rhythm in spontaneous firing rate.	Netherlands Inst Brain Res, Grad Sch Neurosci Amsterdam, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam	Pennartz, CMA (corresponding author), Netherlands Inst Brain Res, Grad Sch Neurosci Amsterdam, Meibergdreef 33, NL-1105 AZ Amsterdam, Netherlands.		Elassaiss-Schaap, Jeroen/Q-5451-2016; Pennartz, Cyriel/B-7508-2015	Pennartz, Cyriel/0000-0001-8328-1175				ADAMS ME, 1993, MOL PHARMACOL, V44, P681; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Avery RB, 1996, J NEUROSCI, V16, P5567; BLAXTER TJ, 1989, J PHYSIOL-LONDON, V412, P93, DOI 10.1113/jphysiol.1989.sp017605; BLOCK GD, 1993, INT REV CYTOL, V146, P83, DOI 10.1016/S0074-7696(08)60381-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; de Jeu M, 1998, NEUROREPORT, V9, P3725, DOI 10.1097/00001756-199811160-00028; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; DSouza T, 1996, NATURE, V382, P165, DOI 10.1038/382165a0; Fisher TE, 1996, TRENDS NEUROSCI, V19, P440; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; HUANG RC, 1993, J NEUROPHYSIOL, V70, P1692, DOI 10.1152/jn.1993.70.4.1692; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; OROURKE B, 1992, SCIENCE, V257, P245, DOI 10.1126/science.1321495; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; RANDALL A, 1995, J NEUROSCI, V15, P2995; REPPERT SM, 2001, ANNU REV PHYSIOL, V63, P547; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; TAKAHASHI JS, 1982, SCIENCE, V217, P1104, DOI 10.1126/science.6287576; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7	30	186	189	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					286	290		10.1038/nature728	http://dx.doi.org/10.1038/nature728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11875398				2022-12-24	WOS:000174482200033
J	Sanchez, PA				Sanchez, PA			Ecology - Soil fertility and hunger in Africa	SCIENCE			English	Editorial Material							IMPROVED FALLOWS; ADOPTION; KENYA		Int Ctr Res Agroforestry, Nairobi, Kenya	CGIAR; World Agroforestry (ICRAF)	Sanchez, PA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.							BURESH RJ, 1997, SPEC PUBL SOIL SCI S, V51; *CONS GROUP INT AG, 2001, CONTR MAD CGIAR ITS; Franzel S, 1999, AGROFOREST SYST, V47, P305, DOI 10.1023/A:1006292119954; Gyiele, 1999, EC ASSESSMENT SOIL N; *INT FOOD POL RES, 2001, SUST FOOD SEC ALL 20; Jama B, 2000, AGROFOREST SYST, V49, P201, DOI 10.1023/A:1006339025728; Kwesiga FR, 1999, AGROFOREST SYST, V47, P49, DOI 10.1023/A:1006256323647; Lynam JK, 1998, AGR ECOSYST ENVIRON, V71, P1; *MICH STAT U, 2001, PARTN CUT HUNG AFR 2; Narayan D, 2000, VOICES POOR; PINSTRUPANDERSE.P, 2000, FOOD SECURITY PROBLE; PINSTRUPANDERSE.P, 1999, WORLD FOOD PROSPECTS; Place F, 1999, AGROFOREST SYST, V47, P323, DOI 10.1023/A:1006248304024; ROMELSEE R, 2001, 20013 INT CTR RES AG; Sanchez P. A., 2002, P23; Sanchez P. A., 2001, Tradeoffs or synergies? Agricultural intensification, economic development and the environment, P325, DOI 10.1079/9780851994352.0325; Sanchez P.A., 1997, SSSA SPECIAL PUBLICA, P1, DOI DOI 10.2136/SSSASPECPUB51.C1; Sanchez PA, 1997, PHILOS T R SOC B, V352, P949, DOI 10.1098/rstb.1997.0074; SMALING EMA, 1998, AGR ECOSYST ENV, V71; [No title captured]	20	624	648	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2019	2020		10.1126/science.1065256	http://dx.doi.org/10.1126/science.1065256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896257				2022-12-24	WOS:000174450500025
J	Bell, FI; McEwen, IJ; Viney, C				Bell, FI; McEwen, IJ; Viney, C			Fibre science - Supercontraction stress in wet spider dragline	NATURE			English	Article							AMPULLATE SILK FIBERS; BEHAVIOR; ARANEAE		Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University	Bell, FI (corresponding author), Heriot Watt Univ, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland.	c.viney@hw.ac.uk						Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292; Craven JP, 2000, COMPOS PART A-APPL S, V31, P653, DOI 10.1016/S1359-835X(00)00042-7; GOSLINE J, 1995, BIOMIMETICS DESIGN P, P237; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; STAUFFER SL, 1994, J ARACHNOL, V22, P5; THIEL B, 1994, MATER RES SOC SYMP P, V330, P21; Tillinghast E.K., 1987, P203; WORK RW, 1985, J EXP BIOL, V118, P379; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; WORK RW, 1981, J ARACHNOL, V9, P299; Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099	13	94	96	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					37	37		10.1038/416037a	http://dx.doi.org/10.1038/416037a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882884	Bronze			2022-12-24	WOS:000174211600030
J	Jameson, J; Ugarte, K; Chen, N; Yachi, P; Fuchs, E; Boismenu, R; Havran, WL				Jameson, J; Ugarte, K; Chen, N; Yachi, P; Fuchs, E; Boismenu, R; Havran, WL			A rote for skin gamma delta T cells in wound repair	SCIENCE			English	Article							KERATINOCYTE GROWTH-FACTOR; ANTIGEN RECEPTORS; EPIDERMAL-CELLS; THY-1 ANTIGEN; EXPRESSION; REEPITHELIALIZATION; CLONING; FGF10; MODEL; LIMB	gammadelta T cell receptor-bearing dendritic epidermal T cells (DETCs) found in murine skin recognize antigen expressed by damaged or stressed keratinocytes. Activated DETCs produce keratinocyte growth factors (KGFs) and chemokines, raising the possibility that DETCs play a role in tissue repair. We performed wound healing studies and found defects in keratinocyte proliferation and tissue reepithelialization in the absence of wild-type DETCs. In vitro skin organ culture studies demonstrated that adding DETCs or recombinant KGF restored normal wound healing in gammadelta DETC-deficient skin. We propose that DETCs recognize antigen expressed by injured keratinocytes and produce factors that directly affect wound repair.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Chicago, Howard Hughes Med Inst, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Scripps Research Institute; Howard Hughes Medical Institute; University of Chicago	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI032751, R01AI036964, R21AI032751, R01AI032751, T32AI007244] Funding Source: NIH RePORTER; NIAID NIH HHS [5T32 AI07244, AI36964, AI32751] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; Beer HD, 1997, ONCOGENE, V15, P2211, DOI 10.1038/sj.onc.1201383; BERGSTRESSER PR, 1983, J INVEST DERMATOL, V81, P286, DOI 10.1111/1523-1747.ep12518332; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; BOTTARO DP, 1993, J BIOL CHEM, V268, P9180; CHEN Y, IN PRESS P NATL ACAD; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jaakkola P, 1998, FASEB J, V12, P959, DOI 10.1096/fasebj.12.11.959; JAMESON JR, UNPUB; Jimenez PA, 1999, J SURG RES, V81, P238, DOI 10.1006/jsre.1998.5501; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Sakai S, 2000, J INVEST DERMATOL, V114, P1184, DOI 10.1046/j.1523-1747.2000.00992.x; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; STAIANOCOICO L, 1993, J EXP MED, V178, P865, DOI 10.1084/jem.178.3.865; Tagashira S, 1997, GENE, V197, P399, DOI 10.1016/S0378-1119(97)00187-X; TSCHACHLER E, 1983, J INVEST DERMATOL, V81, P282, DOI 10.1111/1523-1747.ep12518326; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; WERNER S, 1992, P NATL ACAD SCI USA, V89, P6896, DOI 10.1073/pnas.89.15.6896; Xia YP, 1999, J PATHOL, V188, P431, DOI 10.1002/(SICI)1096-9896(199908)188:4<431::AID-PATH362>3.0.CO;2-B; Yamasaki M, 1996, J BIOL CHEM, V271, P15918, DOI 10.1074/jbc.271.27.15918	28	480	510	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					747	749		10.1126/science.1069639	http://dx.doi.org/10.1126/science.1069639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976459				2022-12-24	WOS:000175281700059
J	Kimple, RJ; Kimple, ME; Betts, L; Sondek, J; Siderovski, DP				Kimple, RJ; Kimple, ME; Betts, L; Sondek, J; Siderovski, DP			Structural determinants for GoLoco-induced inhibition of nucleotide release by G alpha subunits	NATURE			English	Article							DISSOCIATION INHIBITOR; G-PROTEINS; GDP; G(I-ALPHA-1); ACTIVATION; MECHANISM; ARGININE; COMPLEX; SYSTEM; MOTIF	Heterotrimeric G-proteins bind to cell-surface receptors and are integral in transmission of signals from outside the cell. Upon activation of the Galpha subunit by binding of GTP, the Galpha and Gbetagamma subunits dissociate and interact with effector proteins for signal transduction. Regulatory proteins with the 19-amino-acid GoLoco motif(1,2) can bind to Galpha subunits and maintain G-protein subunit dissociation in the absence of Galpha activation(3-7). Here we describe the structural determinants of GoLoco activity as revealed by the crystal structure of Galpha(il)-GDP bound to the GoLoco region of the 'regulator of G-protein signalling' protein RGS14. Key contacts are described between the GoLoco motif and Ga protein, including the extension of GoLoco's highly conserved Asp/Glu-Gln-Arg triad into the nucleotide-binding pocket of Ga to make direct contact with the GDP alpha- and beta-phosphates. The structural organization of the GoLoco-Galpha(il) complex, when combined with supporting data from domain-swapping experiments, suggests that the Galpha all-helical domain and GoLoco-region carboxy-terminal residues control the specificity of GoLoco- Galpha interactions.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Siderovski, DP (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; Kimple, Randall/L-6460-2019	Siderovski, David Peter/0000-0002-0688-8210; Kimple, Randall/0000-0001-8336-8000; Sondek, John/0000-0002-1127-8310	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008570] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008570] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; BRANDT DR, 1985, J BIOL CHEM, V260, P266; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Coleman DE, 1998, BIOCHEMISTRY-US, V37, P14376, DOI 10.1021/bi9810306; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Remmers AE, 1999, BIOCHEMISTRY-US, V38, P13795, DOI 10.1021/bi990887f; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; [No title captured]	30	203	206	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2002	416	6883					878	881		10.1038/416878a	http://dx.doi.org/10.1038/416878a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976690				2022-12-24	WOS:000175163800058
J	Cheng, Y; Austin, SC; Rocca, B; Koller, BH; Coffman, TM; Grosser, T; Lawson, JA; FitzGerald, GA				Cheng, Y; Austin, SC; Rocca, B; Koller, BH; Coffman, TM; Grosser, T; Lawson, JA; FitzGerald, GA			Role of prostacyclin in the cardiovascular response to thromboxane A(2)	SCIENCE			English	Article							INHIBITS PLATELET-AGGREGATION; CORONARY ANGIOPLASTY; PROSTAGLANDIN ENDOPEROXIDES; RECEPTOR; BIOSYNTHESIS; EXPRESSION; RESTENOSIS; CYCLOOXYGENASE-2; DESENSITIZATION; ACTIVATION	Thromboxane (Tx) A(2) is a vasoconstrictor and platelet agonist. Aspirin affords cardioprotection through inhibition of TxA(2) formation by platelet cyclooxygenase (COX-1). Prostacyclin (PGI(2)) is a vasodilator that inhibits platelet function. Here we show that injury-induced vascular proliferation and platelet activation are enhanced in mice that are genetically deficient in the PGI(2) receptor (IP) but are depressed in mice genetically deficient in the TxA(2) receptor (TP) or treated with a TP antagonist. The augmented response to vascular injury was abolished in mice deficient in both receptors. Thus, PGI(2) modulates platelet-vascular interactions in vivo and specifically limits the response to TxA(2). This interplay may help explain the adverse cardiovascular effects associated with selective COX-2 inhibitors, which, unlike aspirin and nonsteroidal anti-Inflammatory drugs (NSAIDs), inhibit PGI(2) but not TxA(2).	Univ Penn, Sch Med, Ctr Expt Therapeut, Philadelphia, PA 19104 USA; Univ N Carolina, Dept Med, Chapel Hill, NC 27559 USA; Duke Univ, Dept Med, Durham, NC 27705 USA	University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; Duke University	FitzGerald, GA (corresponding author), Univ Penn, Sch Med, Ctr Expt Therapeut, 153 Johnson Pavil,3620 Hamilton Walk, Philadelphia, PA 19104 USA.		Grosser, Tilo/A-1057-2007; FitzGerald, Garret A/A-4222-2010; rocca, bianca/K-3922-2018	Grosser, Tilo/0000-0001-8569-8396; 	NHLBI NIH HHS [HL 54500, HL 62250] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL054500, P01HL062250] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; BRADEN GA, 1991, CIRCULATION, V84, P679, DOI 10.1161/01.CIR.84.2.679; BUNTING S, 1976, PROSTAG OTH LIPID M, V12, P897, DOI 10.1016/0090-6980(76)90125-8; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Caughey GE, 2001, J BIOL CHEM, V276, P37839; Cheng Y., UNPUB; Cheung WM, 1999, ARTERIOSCL THROM VAS, V19, P3014, DOI 10.1161/01.ATV.19.12.3014; Cimetiere B, 1998, BIOORG MED CHEM LETT, V8, P1375, DOI 10.1016/S0960-894X(98)00220-0; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1065, DOI 10.1056/NEJM198404263101701; FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y; HIRATA M, 1991, NATURE, V349, P617, DOI 10.1038/349617a0; MARCUS AJ, 1980, J CLIN INVEST, V66, P979, DOI 10.1172/JCI109967; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; MURRAY R, 1990, J BIOL CHEM, V265, P21670; NAMBA T, 1994, J BIOL CHEM, V269, P9986; NICHOLSON NS, 1984, THROMB RES, V35, P183, DOI 10.1016/0049-3848(84)90213-5; NOWAK J, 1989, J CLIN INVEST, V83, P380, DOI 10.1172/JCI113895; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; PEDERSEN ML, 1983, THROMB RES, V35, P99; Rocca B, 2000, NAT MED, V6, P219, DOI 10.1038/72334; ROY L, 1985, CIRCULATION, V71, P434, DOI 10.1161/01.CIR.71.3.434; SAVAGE MP, 1995, CIRCULATION, V92, P3194, DOI 10.1161/01.CIR.92.11.3194; SCHWARTZ L, 1988, NEW ENGL J MED, V318, P1714, DOI 10.1056/NEJM198806303182603; SERRUYS PW, 1991, CIRCULATION, V84, P1568, DOI 10.1161/01.CIR.84.4.1568; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Walsh MT, 2000, J BIOL CHEM, V275, P20412, DOI 10.1074/jbc.M907881199	32	654	704	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					539	541		10.1126/science.1068711	http://dx.doi.org/10.1126/science.1068711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964481				2022-12-24	WOS:000175179400048
J	Moreno, E; Basler, K; Morata, G				Moreno, E; Basler, K; Morata, G			Cells compete for Decapentaplegic survival factor to prevent apoptosis in Drosophila wing development	NATURE			English	Article							CELLULAR GROWTH; DPP; GRADIENT; BRINKER; DEATH; COMPARTMENTS; PARAMETERS; DIVISION; SEQUENCE; HOMOLOG	During the growth of Drosophila imaginal discs a process called 'cell competition'(1) eliminates slow-proliferating but otherwise viable cells. We report here that cell competition requires the function of the brinker (brk) gene, whose expression is normally repressed by Decapentaplegic (Dpp) signalling(2-4) but is upregulated in slow-growing Minute/+ cells. Excess brk expression activates the c-Jun amino-terminal kinase pathway, which in turn triggers apoptosis in these cells. We propose that slow-proliferating cells upregulate Brk levels owing to a disadvantage in competing for, or in transducing, the Dpp survival signal. This sequence of events might represent a general mechanism by which weaker cells are eliminated from a growing population, and might serve as a method of controlling cell number and optimizing tissue fitness and hence organ function.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; UAM, CSIC, Ctr Biol Mol, Madrid 28049, Spain	University of Zurich; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch; gmorata@cbm.uam.es	Moreno, Eduardo/D-7262-2011	moreno, eduardo/0000-0001-5040-452X; Morata, Gines/0000-0003-3274-5173; Basler, Konrad/0000-0003-3534-1529				Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Burke R, 1996, DEVELOPMENT, V122, P2261; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; HAY BA, 1994, DEVELOPMENT, V120, P2121; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lawrence PA, 2001, NAT CELL BIOL, V3, pE151, DOI 10.1038/35083096; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Milan M, 1997, P NATL ACAD SCI USA, V94, P5691, DOI 10.1073/pnas.94.11.5691; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Struhl G, 1997, DEVELOPMENT, V124, P2155; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201	27	325	332	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2002	416	6882					755	759		10.1038/416755a	http://dx.doi.org/10.1038/416755a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961558				2022-12-24	WOS:000175033500046
J	Takayanagi, H; Kim, S; Matsuo, K; Suzuki, H; Suzuki, T; Sato, K; Yokochi, T; Oda, H; Nakamura, K; Ida, N; Wagner, EF; Taniguchi, T				Takayanagi, H; Kim, S; Matsuo, K; Suzuki, H; Suzuki, T; Sato, K; Yokochi, T; Oda, H; Nakamura, K; Ida, N; Wagner, EF; Taniguchi, T			RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta	NATURE			English	Article							LYMPH-NODE ORGANOGENESIS; OSTEOCLAST DIFFERENTIATION; DEFECTIVE INTERLEUKIN-1; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; GENE INDUCTION; KEY REGULATOR; CROSS-TALK; MICE; OSTEOPROTEGERIN	Osteoclasts are cells of monocyte/macrophage origin that erode bone matrix: regulation of their differentiation is central to the understanding of the pathogenesis and treatment of bone diseases such as osteoporosis(1,2). Signalling by RANKL (receptor activator of NF-kappaB ligand), also known as Tnfsf11, is essential for the induction of osteoclast differentiation(3-5), and it must be strictly regulated to maintain bone homeostasis. But it is not known whether RANKL signalling to the cell interior is linked to any regulatory mechanisms. Here we show that RANKL induces the interferon-beta (IFN-beta) gene in osteoclast precursor cells, and that IFN-beta inhibits the differentiation by interfering with the RANKL-induced expression of c-Fos, an essential transcription factor for the formation of osteoclasts. This IFN-beta gene induction mechanism is distinct from that induced by virus, and is dependent on c-Fos itself. Thus an autoregulatory mechanism operates-the RANKL-induced c-Fos induces its own inhibitor. The importance of this regulatory mechanism for bone homeostasis is emphasized by the observation that mice deficient in IFN-beta signalling exhibit severe osteopenia (loss of bone mass) accompanied by enhanced osteoclastogenesis. Our study places the IFN-beta system in a new context, and may offer a molecular basis for the treatment of bone diseases.	Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Res Inst Mol Pathol, A-1030 Vienna, Austria; NILS, Aichi 4748522, Japan; Toray Industries Ltd, Pharmaceut Res Labs, Kanagawa 2488555, Japan	University of Tokyo; University of Tokyo; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Toray Industries, Inc.	Taniguchi, T (corresponding author), Univ Tokyo, Fac Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Matsuo, Koichi/K-5695-2012	Matsuo, Koichi/0000-0002-1490-8955; Wagner, Erwin F/0000-0001-7872-0196; Suzuki, Hiroshi/0000-0003-4682-5086				Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roodman GD, 1999, EXP HEMATOL, V27, P1229, DOI 10.1016/S0301-472X(99)00061-2; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Takayanagi H, 2000, ARTHRITIS RHEUM-US, V43, P259, DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 1999, J CLIN INVEST, V104, P137, DOI 10.1172/JCI6093; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	30	544	567	4	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					744	749		10.1038/416744a	http://dx.doi.org/10.1038/416744a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961557				2022-12-24	WOS:000175033500044
J	Nasrallah, JB				Nasrallah, JB			Recognition and rejection of self in plant reproduction	SCIENCE			English	Article							S-RECEPTOR KINASE; BRASSICA-CAMPESTRIS; HIGHLY DIVERGENT; INCOMPATIBILITY; LOCUS; DETERMINANT; HAPLOTYPES; SEQUENCES; EVOLUTION; ALLELES	Plant self-incompatibility (SI) systems are unique among self/nonself recognition systems in being based on the recognition of self rather than nonself. SI in crucifer species is controlled by highly polymorphic and co-evolving genes linked in a complex. Self recognition is based on allele-specific interactions between stigma receptors and pollen ligands that result in the arrest of pollen tube development. Commonalities and differences between SI and other self/nonself discrimination systems are discussed.	Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University	Nasrallah, JB (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jbn2@cornell.edu						Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Boyes DC, 1997, PLANT CELL, V9, P237, DOI 10.1105/tpc.9.2.237; Brown AJ, 2001, TRENDS GENET, V17, P393, DOI 10.1016/S0168-9525(01)02343-5; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Charlesworth D, 2000, CURR BIOL, V10, pR184, DOI 10.1016/S0960-9822(00)00347-X; Cui YH, 2000, P NATL ACAD SCI USA, V97, P3713, DOI 10.1073/pnas.050480297; Ferris PJ, 1997, P NATL ACAD SCI USA, V94, P8634, DOI 10.1073/pnas.94.16.8634; Ferris PJ, 2002, GENETICS, V160, P181; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Hatakeyama K, 2001, PLANT J, V26, P69, DOI 10.1046/j.1365-313x.2001.01009.x; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; Ida K, 2001, J MOL BIOL, V314, P103, DOI 10.1006/jmbi.2001.5127; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Klein J., 1986, NATURAL HIST MAJOR H; Kusaba M, 2002, PLANT PHYSIOL, V128, P17, DOI 10.1104/pp.010790; Kusaba M, 2001, PLANT CELL, V13, P627, DOI 10.1105/tpc.13.3.627; Matton DP, 1999, PLANT CELL, V11, P2087, DOI 10.1105/tpc.11.11.2087; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; Nettancourt, 2001, INCOMPATIBILITY INCO; Nishio T, 2000, ANN BOT-LONDON, V85, P141, DOI 10.1006/anbo.1999.1041; NOU IS, 1993, SEX PLANT REPROD, V6, P79, DOI 10.1007/BF00227652; Rudd JJ, 2001, NEW PHYTOL, V151, P7, DOI 10.1046/j.1469-8137.2001.00173.x; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stone SL, 1999, SCIENCE, V286, P1729, DOI 10.1126/science.286.5445.1729; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Uyenoyama MK, 2001, GENETICS, V157, P1805; UYENOYAMA MK, 1995, GENETICS, V139, P975; Vanoosthuyse V, 2001, PLANT MOL BIOL, V46, P17, DOI 10.1023/A:1010664704926; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	36	94	99	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 12	2002	296	5566					305	308		10.1126/science.296.5566.305	http://dx.doi.org/10.1126/science.296.5566.305			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11951033				2022-12-24	WOS:000175000300044
J	Macfarlane, J				Macfarlane, J			Severe pneumonia and a second antibiotic	LANCET			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA; ETIOLOGY		City Hosp Nottingham, Clin Resp Med Unit, Nottingham NG5 1PB, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital	Macfarlane, J (corresponding author), City Hosp Nottingham, Clin Resp Med Unit, Hucknall Rd, Nottingham NG5 1PB, England.	john.macfarlane@tinyworld.co.uk						Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; Jokinen C, 2001, CLIN INFECT DIS, V32, P1141, DOI 10.1086/319746; Kalin M, 2000, J INFECT DIS, V182, P840, DOI 10.1086/315760; Lieberman D, 1996, THORAX, V51, P179, DOI 10.1136/thx.51.2.179; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Mandell LA, 2000, CLIN INFECT DIS, V31, P422, DOI 10.1086/313965; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Roson B, 2001, CLIN INFECT DIS, V33, P158, DOI 10.1086/321808; Waterer GW, 2001, RESP MED, V95, P78, DOI 10.1053/rmed.2000.0977; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837	12	8	8	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 6	2002	359	9313					1170	1172		10.1016/S0140-6736(02)08250-8	http://dx.doi.org/10.1016/S0140-6736(02)08250-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539AB	11955532				2022-12-24	WOS:000174846300004
J	Serageldin, I				Serageldin, I			The rice genome - World poverty and hunger - the challenge for science	SCIENCE			English	Editorial Material									Lib Alexandria, Bibliotheca Alexandrina, Alexandria 21526, Egypt		Serageldin, I (corresponding author), Lib Alexandria, Bibliotheca Alexandrina, Alexandria 21526, Egypt.							Bronowski J., 1956, SCI HUMAN VALUES, DOI DOI 10.1111/J.1468-2273.1956.TB00909.X; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637	2	29	33	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					54	+		10.1126/science.1072035	http://dx.doi.org/10.1126/science.1072035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	539FA	11935007				2022-12-24	WOS:000174858800028
J	Xiong, JP; Stehle, T; Zhang, RG; Joachimiak, A; Frech, M; Goodman, SL; Arnaout, MA				Xiong, JP; Stehle, T; Zhang, RG; Joachimiak, A; Frech, M; Goodman, SL; Arnaout, MA			Crystal structure of the extracellular segment of integrin alpha V beta 3 in complex with an Arg-Gly-Asp ligand	SCIENCE			English	Article							CD11B A-DOMAIN; BINDING-SITE; I-DOMAIN; SUBUNIT; ECHISTATIN	The structural basis for the divalent cation-dependent binding of heterodimeric alphabeta integrins to their ligands, which contain the prototypical Arg-Gly-Asp sequence, is unknown. Interaction with ligands triggers tertiary and quaternary structural rearrangements in integrins that are needed for cell signaling. Here we report the crystal structure of the extracellular segment of integrin alphaVbeta3 in complex with a cyclic peptide presenting the Arg-Gly-Asp sequence. The ligand binds at the major interface between the alphaV and beta3 subunits and makes extensive contacts with both. Both tertiary and quaternary changes are observed in the presence of ligand. The tertiary rearrangements take place in betaA, the ligand-binding domain of beta3; in the complex, betaA acquires two cations, one of which contacts the ligand Asp directly and the other stabilizes the ligand-binding surface. Ligand binding induces small changes in the orientation of alphaV relative to beta3.	Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Argonne Natl Lab, Div Biosci, Struct Biol Ctr, Argonne, IL 60439 USA; Merck KGaA, Dept Target Res, D-64271 Darmstadt, Germany; Merck KGaA, Biomed Res, D-64271 Darmstadt, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Merck KGaA; Merck KGaA	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	arnaout@receptor.mgh.harvard.edu						ANDRIEUX A, 1991, J BIOL CHEM, V266, P14202; ATKINSON RA, 1994, INT J PEPT PROT RES, V43, P563; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; SAUDEK V, 1991, BIOCHEMISTRY-US, V30, P7369, DOI 10.1021/bi00244a003; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200	19	1332	1425	7	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					151	155		10.1126/science.1069040	http://dx.doi.org/10.1126/science.1069040			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11884718				2022-12-24	WOS:000174858800051
J	Reinhoudt, DN; Crego-Calama, M				Reinhoudt, DN; Crego-Calama, M			Synthesis beyond the molecule	SCIENCE			English	Article							NONCOVALENT SYNTHESIS; CHEMISTRY; AMPLIFICATION; RECOGNITION; COMPLEXES; DISCOVERY; CHIRALITY	Weak, noncovalent interactions between molecules control many biological functions. In chemistry, noncovalent interactions are now exploited for the synthesis in solution of large supramolecular aggregates. The aim of these syntheses is not only the creation of a particular structure, but also the introduction of specific chemical functions in these supramolecules.	Univ Twente, MESA Res Inst, Lab Supramol Chem & Technol, NL-7500 AE Enschede, Netherlands; Univ Twente, Fac Chem Technol, NL-7500 AE Enschede, Netherlands	University of Twente; University of Twente	Reinhoudt, DN (corresponding author), Univ Twente, MESA Res Inst, Lab Supramol Chem & Technol, POB 217, NL-7500 AE Enschede, Netherlands.	d.n.reinhoudt@ct.utwente.nl	Reinhoudt, David N/K-4767-2012					Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Bielejewska AG, 2001, J AM CHEM SOC, V123, P7518, DOI 10.1021/ja010664o; Bosman AW, 1999, CHEM REV, V99, P1665, DOI 10.1021/cr970069y; Buschmann H, 2000, ANGEW CHEM INT EDIT, V39, P4033, DOI 10.1002/1521-3773(20001117)39:22<4033::AID-ANIE4033>3.0.CO;2-2; Castelli VV, 2000, CHEM-EUR J, V6, P1193, DOI 10.1002/(SICI)1521-3765(20000403)6:7<1193::AID-CHEM1193>3.3.CO;2-6; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Cousins GRL, 2001, ANGEW CHEM INT EDIT, V40, P423, DOI 10.1002/1521-3773(20010119)40:2<423::AID-ANIE423>3.0.CO;2-6; CRAM DJ, 1988, ANGEW CHEM INT EDIT, V27, P1009, DOI 10.1002/anie.198810093; CREGOCALAMA M, 2000, ANGEW CHEM INT EDIT, V39, P755; Diederich, 2000, TEMPLATED ORGANIC SY; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Friggeri A, 2001, J AM CHEM SOC, V123, P6388, DOI 10.1021/ja010257c; Hamuro Y, 1997, ANGEW CHEM INT EDIT, V36, P2680, DOI 10.1002/anie.199726801; Huc I, 1999, EUR J INORG CHEM, P1415; Jimenez MC, 2000, ANGEW CHEM INT EDIT, V39, P3284, DOI 10.1002/1521-3773(20000915)39:18<3284::AID-ANIE3284>3.0.CO;2-7; Lavigne JJ, 2001, ANGEW CHEM INT EDIT, V40, P3118, DOI 10.1002/1521-3773(20010903)40:17<3118::AID-ANIE3118>3.0.CO;2-Y; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; LEHN JM, 1988, ANGEW CHEM INT EDIT, V27, P89, DOI 10.1002/anie.198800891; Ludwig R, 2000, FRESEN J ANAL CHEM, V367, P103, DOI 10.1007/s002160051611; Luther A, 1998, NATURE, V396, P245, DOI 10.1038/24343; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marty M, 1998, CHEM COMMUN, P2265, DOI 10.1039/a806070c; NICOLAOU KC, 1995, ANGEW CHEM INT EDIT, V34, P2079, DOI 10.1002/anie.199520791; Paraschiv V, 2001, J ORG CHEM, V66, P8297, DOI 10.1021/Jo0105742; PEDERSEN CJ, 1988, ANGEW CHEM INT EDIT, V27, P1021, DOI 10.1002/anie.198810211; Prins LJ, 1999, NATURE, V398, P498, DOI 10.1038/19053; Prins LJ, 2000, NATURE, V408, P181, DOI 10.1038/35041530; Prins LJ, 2001, J AM CHEM SOC, V123, P10153, DOI 10.1021/ja010610e; Ramstrom O, 2002, NAT REV DRUG DISCOV, V1, P26, DOI 10.1038/nrd704; Rivera JM, 1998, SCIENCE, V279, P1021, DOI 10.1126/science.279.5353.1021; Saghatelian A, 2001, NATURE, V409, P797, DOI 10.1038/35057238; Schenning APHJ, 1998, CHEM-EUR J, V4, P871, DOI 10.1002/(SICI)1521-3765(19980515)4:5<871::AID-CHEM871>3.0.CO;2-3; Ungaro R, 1996, PURE APPL CHEM, V68, P1213, DOI 10.1351/pac199668061213; Wallimann P, 1997, CHEM REV, V97, P1567, DOI 10.1021/cr960373b; WHITESIDES GM, 1995, ACCOUNTS CHEM RES, V28, P37, DOI 10.1021/ar00049a006; Zimmerman SC, 1996, SCIENCE, V271, P1095, DOI 10.1126/science.271.5252.1095	36	403	407	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2002	295	5564					2403	2407		10.1126/science.1069197	http://dx.doi.org/10.1126/science.1069197			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923525				2022-12-24	WOS:000174712600041
J	Reeves, EP; Lu, H; Lortat-Jacob, H; Messina, CGM; Bolsover, S; Gabella, G; Potma, EO; Warley, A; Roes, J; Segal, AW				Reeves, EP; Lu, H; Lortat-Jacob, H; Messina, CGM; Bolsover, S; Gabella, G; Potma, EO; Warley, A; Roes, J; Segal, AW			Killing activity of neutrophils is mediated through activation of proteases by K+ flux	NATURE			English	Article							BIOLOGICAL DEFENSE-MECHANISMS; CHRONIC GRANULOMATOUS-DISEASE; NADPH OXIDASE; POLYMORPHONUCLEAR LEUKOCYTES; RESPIRATORY BURST; HYDROGEN-PEROXIDE; HOST-DEFENSE; CATHEPSIN-G; MYELOPEROXIDASE; SUPEROXIDE	According to the hitherto accepted view, neutrophils kill ingested microorganisms by subjecting them to high concentrations of highly toxic reactive oxygen species (ROS) and bringing about myeloperoxidase-catalysed halogenation. We show here that this simple scheme, which for many years has served as a satisfactory working hypothesis, is inadequate. We find that mice made deficient in neutrophil-granule proteases but normal in respect of superoxide production and iodinating capacity, are unable to resist staphylococcal and candidal infections. We also show that activation provokes the influx of an enormous concentration of ROS into the endocytic vacuole. The resulting accumulation of anionic charge is compensated for by a surge of K+ ions that cross the membrane in a pH-dependent manner. The consequent rise in ionic strength engenders the release of cationic granule proteins, including elastase and cathepsin G, from the anionic sulphated proteoglycan matrix. We show that it is the proteases, thus activated, that are primarily responsible for the destruction of the bacteria.	UCL, Ctr Mol Med, Dept Physiol, London WC1E 6JJ, England; UCL, Ctr Mol Med, Dept Anat, London WC1E 6JJ, England; UCL, Windeyer Inst Med Sci, London WC1E 6JJ, England; Inst Biol Struct, F-38027 Grenoble, France; Univ Groningen, Ctr Mat Sci, Ultrafast Laser & Spect Lab, NL-9747 AG Groningen, Netherlands; St Thomas Hosp, Rayne Inst, London SE1 7EH, England	University of London; University College London; University of London; University College London; University of London; University College London; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Groningen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Segal, AW (corresponding author), UCL, Ctr Mol Med, Dept Physiol, 5 Univ St, London WC1E 6JJ, England.	rmhaase@ucl.ac.uk	Reeves, Emer/C-6026-2012; Messina, Carlo/CAG-9260-2022; Lu, Hui/AAB-5476-2021	Lu, Hui/0000-0002-7029-2681; Segal, Anthony/0000-0001-7602-9043; Roes, Jurgen/0000-0003-3235-2345				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Amos BJ, 1996, EXP PHYSIOL, V81, P623, DOI 10.1113/expphysiol.1996.sp003963; Aratani Y, 1999, INFECT IMMUN, V67, P1828; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BABIOR BM, 1975, J LAB CLIN MED, V85, P235; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P561; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; BUGHANIM HN, 1995, BLOOD, V86, P3575, DOI 10.1182/blood.V86.9.3575.bloodjournal8693575; Clapp LH, 1998, CURR OPIN NEPHROL HY, V7, P91; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; Grogan A, 1997, J CELL SCI, V110, P3071; Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000; Hall T.A., 1986, PRINCIPLES ANAL ELEC, P219; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hampton MB, 1996, INFECT IMMUN, V64, P3512, DOI 10.1128/IAI.64.9.3512-3517.1996; Henderson LM, 1999, J GEN PHYSIOL, V114, P771, DOI 10.1085/jgp.114.6.771; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; INCE C, 1987, BIOCHIM BIOPHYS ACTA, V905, P195, DOI 10.1016/0005-2736(87)90023-X; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; Kettle AJ, 2001, BIOCHEMISTRY-US, V40, P10204, DOI 10.1021/bi010940b; KLEBANOFF SJ, 1975, SEMIN HEMATOL, V12, P117; KLEBANOFF SJ, 1977, J LAB CLIN MED, V89, P675; KLEBANOFF SJ, 1971, J CLIN INVEST, V50, P2226, DOI 10.1172/JCI106718; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; LOVE WD, 1953, J LAB CLIN MED, V41, P351; MANDELL GL, 1974, INFECT IMMUN, V9, P337, DOI 10.1128/IAI.9.2.337-341.1974; Maturana A, 2001, J BIOL CHEM, V276, P30277, DOI 10.1074/jbc.M010438200; McCord JM, 1979, OXYGEN FREE RADICALS, P343; Menegazzi R, 1996, J CELL BIOL, V135, P511, DOI 10.1083/jcb.135.2.511; METCHNIKOFF B, 2002, IMMUNITY INFECT DIS; NANDA A, 1994, J BIOL CHEM, V269, P27280; NANDA A, 1991, P NATL ACAD SCI USA, V88, P10816, DOI 10.1073/pnas.88.23.10816; ODEBERG H, 1975, J CLIN INVEST, V56, P1118, DOI 10.1172/JCI108186; OLSEN RL, 1983, BIOCHEM J, V209, P781, DOI 10.1042/bj2090781; Potma EO, 2001, P NATL ACAD SCI USA, V98, P1577, DOI 10.1073/pnas.031575698; Rizoli SB, 2000, AM J PHYSIOL-CELL PH, V279, pC619, DOI 10.1152/ajpcell.2000.279.3.C619; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; SBARRA AJ, 1959, J BIOL CHEM, V234, P1355; SEGAL AW, 1979, FEBS LETT, V100, P27, DOI 10.1016/0014-5793(79)81124-2; SEGAL AW, 1978, BIOCHEM BIOPH RES CO, V84, P611, DOI 10.1016/0006-291X(78)90749-0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; STYRT B, 1982, FEBS LETT, V149, P113, DOI 10.1016/0014-5793(82)81083-1; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Vita Francesca, 1997, Methods in Cell Science, V19, P197, DOI 10.1023/A:1009711726462; WINTERBOURN CC, 1985, BIOCHEM J, V228, P583, DOI 10.1042/bj2280583	49	854	880	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 21	2002	416	6878					291	297		10.1038/416291a	http://dx.doi.org/10.1038/416291a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907569				2022-12-24	WOS:000174482200034
J	Chin, AI; Dempsey, PW; Bruhn, K; Miller, JF; Xu, Y; Cheng, GH				Chin, AI; Dempsey, PW; Bruhn, K; Miller, JF; Xu, Y; Cheng, GH			Involvement of receptor-interacting protein 2 in innate and adaptive immune responses	NATURE			English	Article							MICE; CYTOKINE; KINASE; DEATH; CELLS	Host defences to microorganisms rely on a coordinated interplay between the innate and adaptive responses of immunity(1). Infection with intracellular bacteria triggers an immediate innate response requiring macrophages, neutrophils and natural killer cells, whereas subsequent activation of an adaptive response through development of T-helper subtype 1 cells (T(H)1) proceeds during persistent infection(1). To understand the physiological role of receptor-interacting protein 2 (Rip2), also known as RICK and CARDIAK, we generated mice with a targeted disruption of the gene coding for Rip2. Here we show that Rip2-deficient mice exhibit a profoundly decreased ability to defend against infection by the intracellular pathogen Listeria monocytogenes. Rip2-deficient macrophages infected with L. monocytogenes or treated with lipopolysaccharide (LPS) have decreased activation of NF-kappaB, whereas dominant negative Rip2 inhibited NF-kappaB activation mediated by Toll-like receptor 4 and Nod1. In vivo, Rip2-deficient mice were resistant to the lethal effects of LPS-induced endotoxic shock. Furthermore, Rip2 deficiency results in impaired interferon-gamma production in both T(H)1 and natural killer cells, attributed in part to defective interleukin-12-induced Stat4 activation. Our data reflect requirements for Rip2 in multiple pathways regulating immune and inflammatory responses.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Cheng, GH (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.		Bruhn, Kevin/F-9772-2013	Xu, Yang/0000-0001-5574-921X				Dai WJ, 1997, J IMMUNOL, V158, P5297; DiTirro J, 1998, INFECT IMMUN, V66, P2284, DOI 10.1128/IAI.66.5.2284-2289.1998; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Inohara N, 1998, J BIOL CHEM, V273, P18675; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; KHAN KD, 1993, P NATL ACAD SCI USA, V90, P6806, DOI 10.1073/pnas.90.14.6806; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Medzhitov R, 1998, SEMIN IMMUNOL, V10, P351, DOI 10.1006/smim.1998.0136; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; REINER SL, 1994, J IMMUNOL METHODS, V175, P275, DOI 10.1016/0022-1759(94)90370-0; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Yang JF, 1999, EUR J IMMUNOL, V29, P548, DOI 10.1002/(SICI)1521-4141(199902)29:02<548::AID-IMMU548>3.0.CO;2-Z; Yip HC, 1999, J IMMUNOL, V162, P3942	22	320	329	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					190	194		10.1038/416190a	http://dx.doi.org/10.1038/416190a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894097				2022-12-24	WOS:000174348100041
J	Myers, J; Prakash, M; Froelicher, V; Do, D; Partington, S; Atwood, JE				Myers, J; Prakash, M; Froelicher, V; Do, D; Partington, S; Atwood, JE			Exercise capacity and mortality among men referred for exercise testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALL-CAUSE MORTALITY; ACUTE MYOCARDIAL-INFARCTION; PHYSICAL-ACTIVITY; PROGNOSTIC VALUE; HEART-FAILURE; FITNESS; DISEASE; SURVIVAL; PREDICTOR; NOMOGRAM	Background: Exercise capacity is known to be an important prognostic factor in patients with cardiovascular disease, but it is uncertain whether it predicts mortality equally well among healthy persons. There is also uncertainty regarding the predictive power of exercise capacity relative to other clinical and exercise-test variables. Methods: We studied a total of 6213 consecutive men referred for treadmill exercise testing for clinical reasons during a mean (+/-SD) of 6.2+/-3.7 years of follow-up. Subjects were classified into two groups: 3679 had an abnormal exercise-test result or a history of cardiovascular disease, or both, and 2534 had a normal exercise-test result and no history of cardiovascular disease. Overall mortality was the end point. Results: There were a total of 1256 deaths during the follow-up period, resulting in an average annual mortality of 2.6 percent. Men who died were older than those who survived and had a lower maximal heart rate, lower maximal systolic and diastolic blood pressure, and lower exercise capacity. After adjustment for age, the peak exercise capacity measured in metabolic equivalents (MET) was the strongest predictor of the risk of death among both normal subjects and those with cardiovascular disease. Absolute peak exercise capacity was a stronger predictor of the risk of death than the percentage of the age-predicted value achieved, and there was no interaction between the use or nonuse of beta-blockade and the predictive power of exercise capacity. Each 1-MET increase in exercise capacity conferred a 12 percent improvement in survival. Conclusions: Exercise capacity is a more powerful predictor of mortality among men than other established risk factors for cardiovascular disease. (N Engl J Med 2002;346:793-801.) Copyright (C) 2002 Massachusetts Medical Society.	Vet Affairs Palo Alto Hlth Care Syst, Cardiol Div 111C, Palo Alto, CA 94304 USA; Stanford Univ, Med Ctr, Div Cardiovasc Med, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Myers, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Cardiol Div 111C, 3081 Miranda Ave, Palo Alto, CA 94304 USA.	drj993@aol.com	Prakash, Mysore N/AFW-6802-2022	Froelicher, Victor/0000-0001-8831-4853				AARONSON KD, 1995, J HEART LUNG TRANSPL, V14, P981; American College of Sports Medicine, 2000, GUID EX TEST PRESCR; Blair S. N., 1994, Physical activity, fitness, and health: international proceedings and consensus statement., P579; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 2001, MED SCI SPORT EXER, V33, P762; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; CHANG JA, 1994, CURR PROB CARDIOLOGY, V19, P537; Dorn J, 1999, CIRCULATION, V100, P1764, DOI 10.1161/01.CIR.100.17.1764; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Froelicher V, 2001, PRIMARY CARE, V28, P1, DOI 10.1016/S0095-4543(05)70004-X; FROELICHER V, 1996, PHYSICIANS COMPUTERS, V14, P40; FROELICHER V, 1998, VETERANS HLTH SY MAR, P53; Froelicher VF, 1999, CHEST, V116, P1442, DOI 10.1378/chest.116.5.1442; FROELICHER VF, 2000, EXERCISE HEART; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Goraya TY, 2000, ANN INTERN MED, V132, P862, DOI 10.7326/0003-4819-132-11-200006060-00003; HASKELL WL, 1992, MED SCI SPORT EXER, V24, pS201, DOI 10.1249/00005768-199206001-00004; KANNEL WB, 1985, AM HEART J, V109, P876, DOI 10.1016/0002-8703(85)90653-2; LACHTERMAN B, 1990, ANN INTERN MED, V113, P333; LACHTERMAN B, 1990, ANN INTERN MED, V112, P11, DOI 10.7326/0003-4819-112-1-11; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; MURRAY DP, 1988, BRIT HEART J, V60, P474; Myers J, 1998, ANN INTERN MED, V129, P286, DOI 10.7326/0003-4819-129-4-199808150-00004; MYERS J, 1994, AM J CARDIOL, V73, P591, DOI 10.1016/0002-9149(94)90340-9; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Myers J, 1996, ESSENTIALS CARDIOPUL; National Center for Chronic Disease Prevention and Health Promotion, 1996, PHYS ACT HLTH REP SU; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Roger VL, 1998, CIRCULATION, V98, P2836, DOI 10.1161/01.CIR.98.25.2836; RONNEVIK PK, 1992, EUR HEART J, V13, P1468, DOI 10.1093/oxfordjournals.eurheartj.a060087; Shaw L J, 2000, Cardiol Rev, V8, P65, DOI 10.1097/00045415-200008010-00011; SHUE P, 1998, J NONINVASIVE TESTIN, V2, P21; Stelken AM, 1996, J AM COLL CARDIOL, V27, P345, DOI 10.1016/0735-1097(95)00464-5; WEINER DA, 1995, AM J CARDIOL, V75, P865, DOI 10.1016/S0002-9149(99)80677-8; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; WOLTHUIS RA, 1977, AM J CARDIOL, V39, P697, DOI 10.1016/S0002-9149(77)80131-8; YANG JC, 1991, ARCH INTERN MED, V151, P349, DOI 10.1001/archinte.151.2.349	41	2565	2679	3	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 14	2002	346	11					793	801		10.1056/NEJMoa011858	http://dx.doi.org/10.1056/NEJMoa011858			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529YM	11893790				2022-12-24	WOS:000174328900002
J	Tong, S; Meagher, S; Vollenhoven, B				Tong, S; Meagher, S; Vollenhoven, B			Sonography - Dizygotic twin survival in early pregnancy	NATURE			English	Article									Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia; Epworth Med Fdn, Monash IVF, Monash Ultrasound Women, Richmond, Vic 3121, Australia	Monash University; Epworth Medical Foundation	Tong, S (corresponding author), Monash Univ, Monash Med Ctr, Dept Obstet & Gynaecol, Clayton, Vic 3168, Australia.			Tong, Stephen/0000-0002-2319-0586				Durfee SM, 1999, J CLIN ULTRASOUND, V27, P55; Frates MC, 2001, J ULTRAS MED, V20, P821; Gilfillan CP, 1996, J CLIN ENDOCR METAB, V81, P1557, DOI 10.1210/jc.81.4.1557; Short R. V., 1977, The ovary. I. General aspects., P1; Short R. V., 1978, CIBA F S, V64, P377; [No title captured]	6	9	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					142	142		10.1038/416142a	http://dx.doi.org/10.1038/416142a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894085	Bronze			2022-12-24	WOS:000174348100027
J	Brookmeyer, R; Blades, N				Brookmeyer, R; Blades, N			Prevention of inhalational anthrax in the US outbreak	SCIENCE			English	Article									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Brookmeyer, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.							Brookmeyer R, 2001, Biostatistics, V2, P233, DOI 10.1093/biostatistics/2.2.233; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702	4	53	54	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1861	1861		10.1126/science.1068474	http://dx.doi.org/10.1126/science.1068474			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884746				2022-12-24	WOS:000174299500029
J	Williams, SR; Stuart, GJ				Williams, SR; Stuart, GJ			Dependence of EPSP efficacy on synapse location in neocortical pyramidal neurons	SCIENCE			English	Article							DENDRITIC I-H; TIME-COURSE; INTEGRATION; DYNAMICS; CELLS	Neurons receive thousands of synaptic inputs throughout elaborate dendritic trees. Here we determine the somatic impact of excitatory postsynaptic potentials (EPSPs) generated at known dendritic sites in neocortical pyramidal neurons. As inputs became more distal, somatic EPSP amplitude decreased, whereas use-dependent depression increased. Despite marked attenuation (>40-fold), when coactivated within a narrow time window (similar to10 milliseconds), distal EPSPs could directly influence action potential output following dendritic spike generation. These findings reveal that distal EPSPs are ineffective sources of background somatic excitation, but through coincidence detection have a powerful transient signaling role.	Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Australian National University; John Curtin School of Medical Research	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia.		stuart, greg j/F-7328-2011	Williams, Stephen/0000-0001-5352-7947; stuart, greg/0000-0001-9395-2219				BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 1997, J NEUROSCI, V17, P7606; IANSEK R, 1973, J PHYSIOL-LONDON, V234, P665, DOI 10.1113/jphysiol.1973.sp010366; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; kandel, 1977, NERVOUS SYSTEM, V1; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; London M, 2001, NAT NEUROSCI, V4, P853, DOI 10.1038/nn0901-853; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Rall W., 1995, THEORETICAL FDN DEND, P122; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; REDMAN SJ, 1973, J PHYSIOL-LONDON, V234, P637, DOI 10.1113/jphysiol.1973.sp010365; Rhodes PA, 2001, J PHYSIOL-LONDON, V536, P167, DOI 10.1111/j.1469-7793.2001.00167.x; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHEPHERD GM, 1985, P NATL ACAD SCI USA, V82, P2192, DOI 10.1073/pnas.82.7.2192; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x	23	259	269	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1907	1910		10.1126/science.1067903	http://dx.doi.org/10.1126/science.1067903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884759				2022-12-24	WOS:000174299500044
J	Buneo, CA; Jarvis, MR; Batista, AP; Andersen, RA				Buneo, CA; Jarvis, MR; Batista, AP; Andersen, RA			Direct visuomotor transformations for reaching	NATURE			English	Article							POSTERIOR PARIETAL CORTEX; AREA 5; ARM MOVEMENTS; REPRESENTATION; INFORMATION; LOCATION; PREMOTOR	The posterior parietal cortex (PPC) is thought to have a function in the sensorimotor transformations that underlie visually guided reaching, as damage to the PPC can result in difficulty reaching to visual targets in the absence of specific visual or motor deficits(1). This function is supported by findings that PPC neurons in monkeys are modulated by the direction of hand movement, as well as by visual, eye position and limb position signals(2-9). The PPC could transform visual target locations from retinal coordinates to hand-centred coordinates by combining sensory signals in a serial manner to yield a body-centred representation of target location(10-12), and then subtracting the body-centred location of the hand. We report here that in dorsal area 5 of the PPC, remembered target locations are coded with respect to both the eye and hand. This suggests that the PPC transforms target locations directly between these two reference frames. Data obtained in the adjacent parietal reach region (PRR) indicate that this transformation may be achieved by vectorially subtracting hand location from target location, with both locations represented in eye-centred coordinates.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Div Biol, Mail Code 216-76, Pasadena, CA 91125 USA.	anderson@vis.caltech.edu		Batista, Aaron/0000-0002-1719-0061				Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Battaglia-Mayer A, 2000, J NEUROPHYSIOL, V83, P2374, DOI 10.1152/jn.2000.83.4.2374; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; Buneo C. A., 1998, Society for Neuroscience Abstracts, V24, P262; Carrozzo M, 1999, EXP BRAIN RES, V129, P201, DOI 10.1007/s002210050890; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Effron B, 1993, INTRO BOOTSTRAP; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Henriques DYP, 1998, J NEUROSCI, V18, P1583; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; LACQUANITI F, 1995, CEREB CORTEX, V5, P391, DOI 10.1093/cercor/5.5.391; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; RONDOT P, 1977, BRAIN, V100, P355, DOI 10.1093/brain/100.2.355; SALINAS E, 1995, J NEUROSCI, V15, P6461; Scott SH, 1997, J NEUROPHYSIOL, V78, P2413, DOI 10.1152/jn.1997.78.5.2413; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STRICK PL, 1978, BRAIN RES, V157, P325, DOI 10.1016/0006-8993(78)90035-5; WIESENDANGER R, 1979, NEUROSCIENCE, V4, P747, DOI 10.1016/0306-4522(79)90004-6; Zar JH, 1999, BIOSTATISTICAL ANAL	29	441	452	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 11	2002	416	6881					632	636		10.1038/416632a	http://dx.doi.org/10.1038/416632a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11948351				2022-12-24	WOS:000174901900043
J	Vitovski, S; Dunkin, KT; Howard, AJ; Sayers, JR				Vitovski, S; Dunkin, KT; Howard, AJ; Sayers, JR			Nontypeable Haemophilus influenzae in carriage and disease - A difference in IgA1 protease activity levels	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNOGLOBULIN A1 PROTEASE; HEMOPHILUS-INFLUENZAE; NEISSERIA-GONORRHOEAE; SEROTYPE-B; PATHOGENESIS; BACTERIA; STRAINS; CELLS; COLONIZATION; GENE	Context Nontypeable Haemophilus influenzae strains form part of the normal flora of the human upper respiratory tract but are also implicated in a wide range of diseases. infections caused by nontypeable H influenzae are major health and socioeconomic burdens. No single bacterial trait has been associated with disease as opposed to colonization. Objectives To compare IgA1 protease activity in nontypeable H influenzae strains isolated from patients with symptomatic Haemophilus infection (sputum, cerebrospinal fluid, blood, or normally sterile tissue) vs strains from throat swabs of asymptomatic carriers and to compare iga gene carriage and variability in nontypeable H influenzae strains. Design and Setting Retrospective study of 63 strains (44 clinical and 19 carriage) collected between 1991 and 2000 and maintained at the Public Health Laboratory, Gwynedd General Hospital, Bangor, Wales. Main Outcome Measures Levels of IgA1 protease activity produced by carriage strains and clinical isolates from symptomatic patients; the determination of the size and sequence of a variable region of the iga gene. Results Bacterial IgA1 protease activity was significantly higher (P<.001) in strains isolated from sputum, blood, cerebrospinal fluid, or normally sterile tissue of symptomatic individuals (median, 155 mU; interquartile range [IQR], 80-220 mU; mean, 169 mU; 95% confidence interval (01, 126-211 mU) than in those isolated from throat swabs of asymptomatic carriers (median, 30 mU; IQR, 15-90 mU; mean, 56 mU; 95% CI, 26-86 mU; assayed on secretory IgA). The iga gene was detected in 97% of all strains examined. Variations in the sizes and sequences of part of the iga genes were also apparent. This variable region encodes a polypeptide linker connecting the protease domain to the &beta;-core autotranslocator, a porelike structure required for secretion of the protease. Conclusions These findings reveal the importance of iga gene variability and expression levels in the establishment of disease phenotype. They identify nontypeable H influenzae IgA1 protease as a virulence factor and as a potential target for the development of new strategies to fight these important pathogens.	Royal Hallamshire Hosp, Div Genome Med, Infect & Immun Grp, Sheffield S10 2RX, S Yorkshire, England; Gwynedd Gen Hosp, Publ Hlth Lab, Bangor, Gwynedd, Wales	University of Sheffield	Sayers, JR (corresponding author), Royal Hallamshire Hosp, Div Genomic Med, Infect & Immun Grp, Sheffield S10 2RX, S Yorkshire, England.		Sayers, Jon R/AAP-6179-2020; Sayers, Jon R/I-8974-2012	Sayers, Jon R/0000-0002-5082-1443; Sayers, Jon R/0000-0002-5082-1443				Brooks GF, 1995, JAWETZ MELNICK ADELB; COOPER MD, 1984, J INFECT DIS, V150, P737, DOI 10.1093/infdis/150.5.737; FALLA TJ, 1993, LANCET, V341, P851, DOI 10.1016/0140-6736(93)93059-A; FARLEY MM, 1986, J INFECT DIS, V154, P752, DOI 10.1093/infdis/154.5.752; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; GRIFFISS JM, 1995, MENINGOCOCCAL DIS, P35; HALTER R, 1989, EMBO J, V8, P2737, DOI 10.1002/j.1460-2075.1989.tb08415.x; HARRISON LH, 1987, LANCET, V2, P761; Hauck CR, 1997, FEBS LETT, V405, P86, DOI 10.1016/S0014-5793(97)00163-4; Hopper S, 2000, INFECT IMMUN, V68, P906, DOI 10.1128/IAI.68.2.906-911.2000; KETT K, 1986, J IMMUNOL, V136, P3631; Kilian M, 1996, APMIS, V104, P321, DOI 10.1111/j.1699-0463.1996.tb00724.x; KILIAN M, 1983, INFECT IMMUN, V42, P126, DOI 10.1128/IAI.42.1.126-132.1983; KILIAN M, 1979, INFECT IMMUN, V26, P143, DOI 10.1128/IAI.26.1.143-149.1979; KILLIAN M, 1976, J GEN MICROBIOL, V93, P9; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Lin L, 1997, MOL MICROBIOL, V24, P1083, DOI 10.1046/j.1365-2958.1997.4191776.x; LOMHOLT H, 1992, P NATL ACAD SCI USA, V89, P2120, DOI 10.1073/pnas.89.6.2120; Lorenzen DR, 1999, J EXP MED, V190, P1049, DOI 10.1084/jem.190.8.1049; MANSA B, 1986, INFECT IMMUN, V52, P171, DOI 10.1128/IAI.52.1.171-174.1986; MULKS MH, 1978, NEW ENGL J MED, V299, P973, DOI 10.1056/NEJM197811022991802; MULKS MH, 1994, METHOD ENZYMOL, V235, P543; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; POHLNER J, 1995, MOL MICROBIOL, V17, P1073, DOI 10.1111/j.1365-2958.1995.mmi_17061073.x; POULSEN K, 1988, INFECT IMMUN, V56, P987, DOI 10.1128/IAI.56.4.987-992.1988; POULSEN K, 1989, INFECT IMMUN, V57, P3097, DOI 10.1128/IAI.57.10.3097-3105.1989; POULSEN K, 1992, J BACTERIOL, V174, P2913, DOI 10.1128/JB.174.9.2913-2921.1992; REINHOLDT J, 1983, J IMMUNOL METHODS, V63, P367, DOI 10.1016/S0022-1759(83)80010-6; Reinholdt J, 1997, INFECT IMMUN, V65, P4452, DOI 10.1128/IAI.65.11.4452-4459.1997; StGeme JW, 1997, PEDIATR INFECT DIS J, V16, P931, DOI 10.1097/00006454-199710000-00005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; Vitovski S, 1999, FASEB J, V13, P331, DOI 10.1096/fasebj.13.2.331; WALLACE RJ, 1983, REV INFECT DIS, V5, P123	36	53	54	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1699	1705		10.1001/jama.287.13.1699	http://dx.doi.org/10.1001/jama.287.13.1699			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926894	Bronze			2022-12-24	WOS:000174730300024
J	Cruz, I; Morales, MA; Noguer, I; Rodriguez, A; Alvar, J				Cruz, I; Morales, MA; Noguer, I; Rodriguez, A; Alvar, J			Leishmania in discarded syringes from intravenous drug users	LANCET			English	Article								Needle sharing by Intravenous drug users (IVDUs) has been proposed as providing an alternative, artificial, and anthroponotic cycle for leishmania transmission. We looked for parasites In syringes discarded by IVDUs using two different PCR techniques. Leishmania spp were detected In 65 (52%) of 125 syringes collected In southern Madrid, Spain, In 1998, and In 52 (34%) of 154 collected In southwestern Madrid In 2000-01. We found shared restriction fragment length polymorphisms In 1.2 of 65 positive samples tested, suggesting that syringe sharing can Indeed promote the spread of leishmania clones among IVDUs.	Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, WHO Collaborating Ctr Leishmaniasis, Madrid 28220, Spain; Minist Sanidad & Consumo, Secretaria Plan Nacl Sida, Madrid, Spain; Medicos Mundo Espana, Desk Cuarto Mundo, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Alvar, J (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, WHO Collaborating Ctr Leishmaniasis, Madrid 28220, Spain.		Rodriguez-Arenas, M. Angeles/AAE-2705-2021	Rodriguez-Arenas, M. Angeles/0000-0002-8115-054X; Cruz, Israel/0000-0002-2200-2360				Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; ALVAR J, 1992, LANCET, V339, P264; DESJEUX P, 1998, WHOCTDLEISH989; MOLINA R, 1994, AIDS, V8, P277, DOI 10.1097/00002030-199402000-00024; Morales MA, 2001, T ROY SOC TROP MED H, V95, P104, DOI 10.1016/S0035-9203(01)90352-9	5	95	104	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1124	1125		10.1016/S0140-6736(02)08160-6	http://dx.doi.org/10.1016/S0140-6736(02)08160-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943264				2022-12-24	WOS:000174729200015
J	Hakeda-Suzuki, S; Ng, J; Tzu, J; Dietzl, G; Sun, Y; Harms, M; Nardine, T; Luo, LQ; Dickson, BJ				Hakeda-Suzuki, S; Ng, J; Tzu, J; Dietzl, G; Sun, Y; Harms, M; Nardine, T; Luo, LQ; Dickson, BJ			Rac function and regulation during Drosophila development	NATURE			English	Article							CELL-SHAPE CHANGES; ACTIN CYTOSKELETON; MYOBLAST FUSION; AXON GUIDANCE; RHO GTPASES; MORPHOGENESIS; MELANOGASTER; OUTGROWTH; POLARITY; PROTEIN	Rac GTPases regulate the actin cytoskeleton to control changes in cell shape(1,2). To date, the analysis of Rac function during development has relied heavily on the use of dominant mutant isoforms. Here, we use loss-of-function mutations to show that the three Drosophila Rac genes, Rac1, Rac2 and Mtl, have overlapping functions in the control of epithelial morphogenesis, myoblast fusion, and axon growth and guidance. They are not required for the establishment of planar cell polarity, as had been suggested on the basis of studies using dominant mutant isoforms(3,4). The guanine nucleotide exchange factor, Trio, is essential for Rac function in axon growth and guidance, but not for epithelial morphogenesis or myoblast fusion. Different Rac activators thus act in different developmental processes. The specific cellular response to Rac activation may be determined more by the upstream activator than the specific Rac protein involved.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Stanford Univ, Dept Biol Sci, Stanford, CA 94035 USA; Stanford Univ, Program Neurosci, Stanford, CA 94035 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Stanford University; Stanford University	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@nt.imp.univie.ac.at	Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Hakeda-Suzuki, Satoko/0000-0001-8749-1479; Ng, Julian/0000-0002-1908-4414; Luo, Liqun/0000-0001-5467-9264				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Chang HY, 2000, SCIENCE, V290, P1978, DOI 10.1126/science.290.5498.1978; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; WAKELAM MJO, 1985, BIOCHEM J, V228, P1; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29	30	292	295	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 28	2002	416	6879					438	442		10.1038/416438a	http://dx.doi.org/10.1038/416438a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919634				2022-12-24	WOS:000174607800049
J	Bachtrog, D; Charlesworth, B				Bachtrog, D; Charlesworth, B			Reduced adaptation of a non-recombining neo-Y chromosome	NATURE			English	Article							MOLECULAR EVOLUTION; DROSOPHILA-MIRANDA; DOSAGE-COMPENSATION; SEX; PSEUDOOBSCURA; VARIABILITY; LIKELIHOOD; PROTEIN; HISTORY; GENES	Sex chromosomes are generally believed to have descended from a pair of homologous autosomes. Suppression of recombination between the ancestral sex chromosomes led to the genetic degeneration of the Y chromosome(1). In response, the X chromosome may become dosage-compensated(1,2). Most proposed mechanisms for the degeneration of Y chromosomes involve the rapid fixation of deleterious mutations on the Y-1. Alternatively, Y-chromosome degeneration might be a response to a slower rate of adaptive evolution, caused by its lack of recombination(3). Here we report patterns of DNA polymorphism and divergence at four genes located on the neo-sex chromosomes of Drosophila miranda. We show that a higher rate of protein sequence evolution of the neo-X-linked copy of Cyclin B relative to the neo-Y copy is driven by positive selection, which is consistent with the adaptive hypothesis for the evolution of the Y chromosome(3). In contrast, the neo-Y-linked copies of even-skipped and roundabout show an elevated rate of protein evolution relative to their neo-X homologues, probably reflecting the reduced effectiveness of selection against deleterious mutations in a non-recombining genome(1). Our results provide evidence for the importance of sexual recombination for increasing and maintaining the level of adaptation of a population.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Bachtrog, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.							Bachtrog D, 2000, CURR BIOL, V10, P1025, DOI 10.1016/S0960-9822(00)00656-4; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bell G., 1982, MASTERPIECE NATURE; Carvalho AB, 2000, P NATL ACAD SCI USA, V97, P13239, DOI 10.1073/pnas.230438397; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; DAS M, 1982, CHROMOSOMA, V87, P373, DOI 10.1007/BF00327180; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Fridolfsson AK, 2000, GENETICS, V155, P1903; GETHMANN RC, 1988, J HERED, V79, P344, DOI 10.1093/oxfordjournals.jhered.a110526; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENETICS, V116, P153; KIMURA M, 1986, NEUTRAL THEORY MOL E; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Li W-H, 1997, MOL EVOLUTION; Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486; Marin I, 2000, BIOESSAYS, V22, P1106, DOI 10.1002/1521-1878(200012)22:12&lt;1106::AID-BIES8&gt;3.0.CO;2-W; Maynard Smith J., 1978, EVOLUTION SEX; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Orr HA, 1998, GENETICS, V150, P1693; Powell J.R., 1997, PROGR PROSPECTS EVOL; SCHAEFFER SW, 1992, GENETICS, V132, P163; Steinemann M, 1998, GENETICA, V102-3, P409, DOI 10.1023/A:1017058119760; TAJIMA F, 1993, JPN J GENET, V68, P567, DOI 10.1266/jjg.68.567; Wang RL, 1996, GENETICS, V144, P1113; Waters PD, 2001, CYTOGENET CELL GENET, V92, P74, DOI 10.1159/000056872; Weiss G, 1998, GENETICS, V149, P1539; Wright S., 1969, EVOLUTION GENETICS P; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yi SJ, 2000, MOL BIOL EVOL, V17, P703, DOI 10.1093/oxfordjournals.molbev.a026349	30	157	160	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					323	326		10.1038/416323a	http://dx.doi.org/10.1038/416323a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907578	Green Published			2022-12-24	WOS:000174482200043
J	Li, XM; Yang, YL; Ashwell, JD				Li, XM; Yang, YL; Ashwell, JD			TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CELL-DEATH; SIGNALING COMPLEX; PROTEIN LIGASE; APOPTOSIS; ACTIVATION; RECEPTOR; MICE; SENSITIVITY	Tumour necrosis factor-alpha (TNF-alpha) is a proinflammatory mediator that exerts its biological functions by binding two TNF receptors (TNF-RI and TNF-RII), which initiate biological responses by interacting with adaptor and signalling proteins. Among the signalling components that associate with TNF receptors are members of the TNF-R-associated factor (TRAF) family(1,2). TRAF2 is required for TNF-alpha-mediated activation of c-Jun N-terminal kinase (JNK), contributes to activation of NF-kappaB, and mediates anti- apoptotic signals(3,4). TNF-RI and TNF-RII signalling complexes also contain the anti- apoptotic ('inhibitor of apoptosis') molecules c-IAP1 and c-IAP2 (refs 5, 6), which also have RING domain-dependent ubiquitin protein ligase (E3) activity(7). The function of IAPs in TNF-R signalling is unknown. Here we show that binding of TNF-alpha to TNF-RII induces ubiquitination and proteasomal degradation of TRAF2. Although c-IAP1 bound TRAF2 and TRAF1 in vitro, it ubiquitinated only TRAF2. Expression of wild-type c-IAP1, but not an E3-defective mutant, resulted in TRAF2 ubiquitination and degradation. Moreover, E3-defective c-IAP1 prevented TNF-alpha-induced TRAF2 degradation and inhibited apoptosis. These findings identify a physiologic role for c-IAP1 and define a mechanism by which TNF-RII-regulated ubiquitin protein ligase activity can potentiate TNF-induced apoptosis.	NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA.							Arch RH, 2000, BIOCHEM BIOPH RES CO, V272, P936, DOI 10.1006/bbrc.2000.2873; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; Chan FKM, 2000, IMMUNITY, V13, P419, DOI 10.1016/S1074-7613(00)00041-8; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Clem RJ, 2001, J BIOL CHEM, V276, P7602, DOI 10.1074/jbc.M010259200; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Huang HK, 2000, J BIOL CHEM, V275, P26661; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; MEMON SA, 1995, J IMMUNOL METHODS, V180, P15, DOI 10.1016/0022-1759(94)00294-7; Peschon JJ, 1998, J IMMUNOL, V160, P943; Reinhard C, 1997, EMBO J, V16, P1080, DOI 10.1093/emboj/16.5.1080; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SARIN A, 1995, J IMMUNOL, V155, P3716; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Tschopp J, 1999, CURR BIOL, V9, pR381, DOI 10.1016/S0960-9822(99)80233-4; VAN AD, 1996, SCIENCE, V274, P787; Weiss T, 1998, J IMMUNOL, V161, P3136; Weiss T, 1997, J IMMUNOL, V158, P2398; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	30	387	402	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					345	349		10.1038/416345a	http://dx.doi.org/10.1038/416345a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907583	Green Published			2022-12-24	WOS:000174482200049
J	Pearson, H				Pearson, H			Breast-cancer survey sets screening age for women	NATURE			English	News Item																		2002, NATURE, V415, P950	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					251	251		10.1038/416251b	http://dx.doi.org/10.1038/416251b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907539	Bronze			2022-12-24	WOS:000174482200008
J	Korbling, M; Katz, RL; Khanna, A; Ruifrok, AC; Rondon, G; Albitar, M; Champlin, RE; Estrov, Z				Korbling, M; Katz, RL; Khanna, A; Ruifrok, AC; Rondon, G; Albitar, M; Champlin, RE; Estrov, Z			Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; BONE-MARROW; STROMAL CELLS; TRANSPLANTATION; DIFFERENTIATE; COLLECTIONS; LEUKEMIA	Background: Bone marrow contains stem cells with the potential to differentiate into mature cells of various organs. We determined whether circulating stem cells have a similar potential. Methods: Biopsy specimens from the liver, gastrointestinal tract, and skin were obtained from 12 patients who had undergone transplantation of hematopoietic stem cells from peripheral blood (11 patients) or bone marrow (1 patient). Six female patients had received transplants from a male donor. Five had received a sex-matched transplant, and one had received an autologous transplant. Hematopoietic stem-cell engraftment was verified by cytogenetic analysis or restriction-fragment-length polymorphism analysis. The biopsies were studied for the presence of donor-derived epithelial cells or hepatocytes with the use of fluorescence in situ hybridization of interphase nuclei and immunohistochemical staining for cytokeratin, CD45 (leukocyte common antigen), and a hepatocyte-specific antigen. Results: All six recipients of sex-mismatched transplants showed evidence of complete hematopoietic donor chimerism. XY-positive epithelial cells or hepatocytes accounted for 0 to 7 percent of the cells in histologic sections of the biopsy specimens. These cells were detected in liver tissue as early as day 13 and in skin tissue as late as day 354 after the transplantation of peripheral-blood stem cells. The presence of donor cells in the biopsy specimens did not seem to depend on the intensity of tissue damage induced by graft-versus-host disease. Conclusions: Circulating stem cells can differentiate into mature hepatocytes and epithelial cells of the skin and gastrointestinal tract.	Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Korbling, M (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Box 423,1515 Holcombe Blvd, Houston, TX 77030 USA.							Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Almeida-Porada G, 2000, BLOOD, V96, p494A; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bensinger WI, 2001, NEW ENGL J MED, V344, P175, DOI 10.1056/NEJM200101183440303; BRUGGER W, 1994, BLOOD, V83, P636; Farace F, 2000, BLOOD, V96, p494A; Fernandez M, 1997, BONE MARROW TRANSPL, V20, P265, DOI 10.1038/sj.bmt.1700890; Ferrari G, 1998, SCIENCE, V281, P923; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Giralt S, 1997, BLOOD, V89, P4531, DOI 10.1182/blood.V89.12.4531; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252; KNOWLTON RG, 1986, BLOOD, V68, P378; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; KORBLING M, 1995, BLOOD, V85, P1659, DOI 10.1182/blood.V85.6.1659.bloodjournal8561659; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lazarus HM, 1997, J HEMATOTHER, V6, P447, DOI 10.1089/scd.1.1997.6.447; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Zanjani ED, 2000, BLOOD, V96, p494A	25	620	709	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 7	2002	346	10					738	746		10.1056/NEJMoa3461002	http://dx.doi.org/10.1056/NEJMoa3461002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527UA	11882729				2022-12-24	WOS:000174205000004
J	Ostendorff, HP; Peirano, RI; Peters, MA; Schluter, A; Bossenz, M; Scheffner, M; Bach, I				Ostendorff, HP; Peirano, RI; Peters, MA; Schluter, A; Bossenz, M; Scheffner, M; Bach, I			Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors	NATURE			English	Article							DROSOPHILA; DOMAIN; CHIP; COREGULATOR; RECEPTORS; PROTEINS; BINDING; COMPLEX; HORMONE; FAMILY	The interactions of distinct cofactor complexes with transcription factors are decisive determinants for the regulation of gene expression. Depending on the bound cofactor, transcription factors can have either repressing or transactivating activities(1). To allow a switch between these different states, regulated cofactor exchange has been proposed(2,3); however, little is known about the molecular mechanisms that are involved in this process. LIM homeodomain (LIM-HD) transcription factors associate with RLIM (RING finger LIM domain-binding protein) and with CLIM (cofactor of LIM-HD proteins; also known as NLI, Ldb and Chip) cofactors. The co-repressor RLIM inhibits the function of LIM-HD transcription factors, whereas interaction with CLIM proteins is important for the exertion of the biological activity conferred by LIM-HD transcription-factors(4,5). Here we identify RLIM as a ubiquitin protein ligase that is able to target CLIM cofactors for degradation through the 26S proteasome pathway. Furthermore, we demonstrate a ubiquitination-dependent association of RLIM with LIM-HD proteins in the presence of CLIM cofactors. Our data provide a mechanistic basis for cofactor exchange on DNA-bound transcription factors, and probably represent a general mechanism of transcriptional regulation.	Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; Univ Cologne, Fak Med, Inst Biochem 1, D-50931 Cologne, Germany	University of Hamburg; University of Cologne	Bach, I (corresponding author), Univ Hamburg, ZMNH, Martinistr 85, D-20251 Hamburg, Germany.		Scheffner, Martin/K-2940-2012	Scheffner, Martin/0000-0003-2229-0128; Ostendorff, Heather/0000-0002-1481-8263				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; BACH I, 1995, P NATL ACAD SCI USA, V92, P2720, DOI 10.1073/pnas.92.7.2720; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glass CK, 2000, GENE DEV, V14, P121; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Ostendorff HP, 2000, GENOMICS, V69, P120, DOI 10.1006/geno.2000.6311; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Tiedt R, 2001, EMBO J, V20, P4143, DOI 10.1093/emboj/20.15.4143; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	27	131	147	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					99	103		10.1038/416099a	http://dx.doi.org/10.1038/416099a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882901				2022-12-24	WOS:000174211600047
J	Pfisterer, AB; Schmid, B				Pfisterer, AB; Schmid, B			Diversity-dependent production can decrease the stability of ecosystem functioning	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; COMMUNITIES	There is concern that species loss may adversely affect ecosystem functioning and stability. But although there is evidence that biodiversity loss can lead to reductions in biomass production(1-4), there is no direct evidence that biodiversity loss affects ecosystem resistance (ability to withstand perturbation) or resilience (recovery from perturbation). Yet theory(5,6), laboratory experiments(7-11) and indirect experimental evidence(12-14) strongly suggest that diversity and stability are related. Here we report results from a field experiment with factorially crossed perturbation and diversity manipulations. We simulated drought perturbation on constructed grassland ecosystems containing 1, 2, 4, 8 or 32 plant species. Under unperturbed conditions, the species-poor systems achieved lower biomass production than the species-rich systems. However, the species-poor systems were more resistant to perturbation than the species-rich systems. The species-poor systems also showed a larger initial resilience following perturbation, although the original relationship between diversity and productivity was fully restored after 1 year. Our results confirm that biodiversity increases biomass production, but they also point to the fact that such diversity-production associations may lead to an inverse relationship between biodiversity and the stability of ecosystem functioning.	Univ Zurich, Inst Umweltwissensch, CH-8057 Zurich, Switzerland	University of Zurich	Schmid, B (corresponding author), Univ Zurich, Inst Umweltwissensch, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	bschmid@uwinst.unizh.ch	Schmid, Bernhard/C-8625-2009	Schmid, Bernhard/0000-0002-8430-3214				Burnham K.P., 1998, MODEL SELECTION INFE; Diemer Matthias, 1997, Bulletin of the Geobotanical Institute ETH, V63, P95; DODD ME, 1994, PHILOS T R SOC B, V346, P185, DOI 10.1098/rstb.1994.0140; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Herbert DA, 1999, ECOLOGY, V80, P908, DOI 10.1890/0012-9658(1999)080[0908:HDTAHF]2.0.CO;2; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; LAWTON JH, 1993, ECOL STU AN, V99, P255; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; May R. M., 1973, STABILITY COMPLEXITY; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PAYNE RW, 1993, GENSTAT 5 REFERENCE; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Sankaran M, 1999, NATURE, V401, P691, DOI 10.1038/44368; Stephan A, 2000, J ECOL, V88, P988, DOI 10.1046/j.1365-2745.2000.00510.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	21	302	330	18	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					84	86		10.1038/416084a	http://dx.doi.org/10.1038/416084a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882897				2022-12-24	WOS:000174211600043
J	Grech, V; Savona-Ventura, C; Vassallo-Agius, P				Grech, V; Savona-Ventura, C; Vassallo-Agius, P			Unexplained differences in sex ratios at birth in Europe and North America	BRITISH MEDICAL JOURNAL			English	Article									St Lukes Hosp, Dept Paediat, MSD-09 Guardamangia, Malta; St Lukes Hosp, Dept Obstet & Gynaecol, MSD-09 Guardamangia, Malta; Univ Malta, Sch Med, MSD-06 Msida, Malta	University of Malta	Grech, V (corresponding author), St Lukes Hosp, Dept Paediat, MSD-09 Guardamangia, Malta.		Savona-Ventura, Charles/W-2351-2019	Savona-Ventura, Charles/0000-0001-9143-4311				Grech V, 2000, J EPIDEMIOL COMMUN H, V54, P244, DOI 10.1136/jech.54.4.244	1	57	58	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 27	2002	324	7344					1010	1011		10.1136/bmj.324.7344.1010	http://dx.doi.org/10.1136/bmj.324.7344.1010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547UP	11976243	Green Published, Bronze			2022-12-24	WOS:000175350900021
J	Willett, WC				Willett, WC			Balancing life-style and genomics research for disease prevention	SCIENCE			English	Editorial Material							CORONARY HEART-DISEASE; RISK FACTOR; METHYLENETETRAHYDROFOLATE REDUCTASE; COLON-CANCER; WOMEN; DIET; MEN; POLYMORPHISMS; CHOLESTEROL; LIPIDS	Genetic and environmental factors, including diet and life-style, both contribute to cardiovascular disease, cancers, and other major causes of mortality, but various lines of evidence indicate that environmental factors are most important. Overly enthusiastic expectations regarding the benefits of genetic research for disease prevention have the potential to distort research priorities and spending for health. However, integration of new genetic information into epidemiologic studies can help clarify causal relations between both life-style and genetic factors and risks of disease. Thus, a balanced approach should provide the best data to make informed choices about the most effective means to prevent disease.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Willett, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.		Deschepper, Reginald/B-8103-2013	Deschepper, Reginald/0000-0002-4222-3945	NATIONAL CANCER INSTITUTE [P01CA055075] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA55075] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AOKI K, 1992, DEATH RATES MALIGNAN; ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Chen J, 1996, CANCER RES, V56, P4862; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ensrud KE, 1999, J BONE MINER RES, V14, P1637, DOI 10.1359/jbmr.1999.14.10.1637; Ferlay J, 2001, IARC CANCERBASE; Giovannucci E, 1998, ANN INTERN MED, V129, P517, DOI 10.7326/0003-4819-129-7-199810010-00002; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; KATO H, 1973, AM J EPIDEMIOL, V97, P372, DOI 10.1093/oxfordjournals.aje.a121518; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; London SJ, 2000, LANCET, V356, P724, DOI 10.1016/S0140-6736(00)02631-3; MILLER BA, 1996, NIH PUBL; Platz EA, 2000, CANCER CAUSE CONTROL, V11, P579, DOI 10.1023/A:1008999232442; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Winkelmann BR, 2000, AM HEART J, V140, pS11, DOI 10.1067/mhj.2000.109636	23	553	588	4	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 26	2002	296	5568					695	698		10.1126/science.1071055	http://dx.doi.org/10.1126/science.1071055			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546PD	11976443				2022-12-24	WOS:000175281700042
J	Crystal, E; Connolly, SJ				Crystal, E; Connolly, SJ			Evolution of the implantable cardioverter defibrillator	LANCET			English	Editorial Material							HEART-FAILURE		McMaster Univ, Div Cardiol, Hamilton, ON L8L 2X2, Canada	McMaster University	Connolly, SJ (corresponding author), McMaster Univ, Div Cardiol, Hamilton, ON L8L 2X2, Canada.	connostu@hhsc.ca						Boriani G, 1998, INT J CARDIOL, V66, P261, DOI 10.1016/S0167-5273(98)00239-3; Butter C, 2001, CIRCULATION, V104, P3026, DOI 10.1161/hc5001.102229; Butter C, 2001, CIRCULATION, V104, P2533, DOI 10.1161/hc4601.099463; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; Fotuhi PC, 1999, AM J CARDIOL, V83, p24D; Glikson M, 2001, LANCET, V357, P1107, DOI 10.1016/S0140-6736(00)04263-X; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Leclercq C, 2002, J AM COLL CARDIOL, V39, P194, DOI 10.1016/S0735-1097(01)01747-8; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474	10	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 20	2002	359	9315					1362	1363		10.1016/S0140-6736(02)08389-7	http://dx.doi.org/10.1016/S0140-6736(02)08389-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978329				2022-12-24	WOS:000175076200004
J	Clark, D				Clark, D			Between hope and acceptance: the medicalisation of dying	BRITISH MEDICAL JOURNAL			English	Article									Univ Sheffield, Trent Palliat Care Ctr, Acad Palliat Med Unit, Sheffield S11 9NE, S Yorkshire, England	University of Sheffield	Clark, D (corresponding author), Univ Sheffield, Trent Palliat Care Ctr, Acad Palliat Med Unit, Sykes House, Sheffield S11 9NE, S Yorkshire, England.		Clark, David/A-1645-2009					AHMEDZAI S, 1997, PROGR PALLIATIVE CAR, V5, P235; Ahronheim JC, 1996, ARCH INTERN MED, V156, P2094, DOI 10.1001/archinte.156.18.2094; Audit Commission, 1999, CRIT SUCC PLAC EFF E; Bauman Zygmunt, 1992, MORTALITY IMMORTALIT; Bion J, 1996, BRIT J ANAESTH, V77, P1; Biswas B., 1993, FUTURE PALLIATIVE CA, P135; Clark D, 1999, SOC SCI MED, V49, P727, DOI 10.1016/S0277-9536(99)00098-2; CLARK D, 1999, REFLECTIONS PALLIATI; Clark David, 1999, MORTALITY, V4, P225, DOI 10.1080/713685979; CLINCH JJ, 1998, OXFORD TXB PALLIATIV; Doyle D, 1993, Palliat Med, V7, P253, DOI 10.1177/026921639300700401; Good P, 2001, PALLIATIVE MED, V15, P493, DOI 10.1191/026921601682553987; Illich I., 1976, LIMITS MED MED NEMES; KEARNEY M, 1992, Palliative Medicine, V6, P39, DOI 10.1177/026921639200600107; Mathers N, 1997, BRIT J GEN PRACT, V47, P177; Moskowitz E, 1995, HASTINGS CENT REP  S, P53; Mount B, 1997, HOSPICE CARE INT SCE; Paci E, 2001, J PAIN SYMPTOM MANAG, V21, P179, DOI 10.1016/S0885-3924(01)00263-9; Seymour J., 2001, CRITICAL MOMENTS DEA; *SMAC SNMAC, 1992, PRINC PROV PALL CAR; [No title captured]	21	169	170	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 13	2002	324	7342					905	907		10.1136/bmj.324.7342.905	http://dx.doi.org/10.1136/bmj.324.7342.905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542PA	11950744	Green Published			2022-12-24	WOS:000175052200030
J	Bell, SD; Botting, CH; Wardleworth, BN; Jackson, SP; White, MF				Bell, SD; Botting, CH; Wardleworth, BN; Jackson, SP; White, MF			The interaction of Alba, a conserved archaeal, chromatin protein, with Sir2 and its regulation by acetylation	SCIENCE			English	Article								The conserved Sir2 family of proteins has protein deacetylase activity that is dependent on NAD (the oxidized form of nicotinamide adenine dinucleotide). Although histones are one likely target for the enzymatic activity of eukaryotic Sir2 proteins, little is known about the substrates and roles of prokaryotic Sir2 homologs. We reveal that an archaeal Sir2 homolog interacts specifically with the major archaeal chromatin protein, Alba, and that Alba exists in acetylated and nonacetylated forms. Furthermore, we show that Sir2 can deacetylate Alba and mediate transcriptional repression in a reconstituted in vitro transcription system. These data provide a paradigm for how Sir2 family proteins influence transcription and suggest that modulation of chromatin structure by acetylation arose before the divergence of the archaeal and eukaryotic lineages.	Hutchinson MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2QH, England; Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; Wellcome Trust Res Labs, Cambridge CB2 1QR, England; Canc Res Campaign, Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Zool, Cambridge, England	University of St Andrews; Wellcome Trust Sanger Institute; CRUK Cambridge Institute; University of Cambridge	Bell, SD (corresponding author), Hutchinson MRC Res Ctr, MRC, Canc Cell Unit, Hills Rd, Cambridge CB2 2QH, England.		White, Malcolm F/A-6055-2010; Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	White, Malcolm F/0000-0003-1543-9342; Jackson, Stephen Philip/0000-0001-9317-7937; Bell, Stephen/0000-0002-8474-6592				Bell SD, 1999, MOL CELL, V4, P971, DOI 10.1016/S1097-2765(00)80226-9; Bell SD, 2001, CURR OPIN MICROBIOL, V4, P208, DOI 10.1016/S1369-5274(00)00190-9; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guarente L, 2000, GENE DEV, V14, P1021; Magill CP, 2001, J BIOL CHEM, V276, P46693, DOI 10.1074/jbc.C100567200; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2	12	219	237	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 5	2002	296	5565					148	151		10.1126/science.1070506	http://dx.doi.org/10.1126/science.1070506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935028				2022-12-24	WOS:000174858800050
J	Yu, J; Hu, SN; Wang, J; Wong, GKS; Li, SG; Liu, B; Deng, YJ; Dai, L; Zhou, Y; Zhang, XQ; Cao, ML; Liu, J; Sun, JD; Tang, JB; Chen, YJ; Huang, XB; Lin, W; Ye, C; Tong, W; Cong, LJ; Geng, JN; Han, YJ; Li, L; Li, W; Hu, GQ; Huang, XG; Li, WJ; Li, J; Liu, ZW; Li, L; Liu, JP; Qi, QH; Liu, JS; Li, L; Li, T; Wang, XG; Lu, H; Wu, TT; Zhu, M; Ni, PX; Han, H; Dong, W; Ren, XY; Feng, XL; Cui, P; Li, XR; Wang, H; Xu, X; Zhai, WX; Xu, Z; Zhang, JS; He, SJ; Zhang, JG; Xu, JC; Zhang, KL; Zheng, XW; Dong, JH; Zeng, WY; Tao, L; Ye, J; Tan, J; Ren, XD; Chen, XW; He, J; Liu, DF; Tian, W; Tian, CG; Xia, HG; Bao, QY; Li, G; Gao, H; Cao, T; Wang, J; Zhao, WM; Li, P; Chen, W; Wang, XD; Zhang, Y; Hu, JF; Wang, J; Liu, S; Yang, J; Zhang, GY; Xiong, YQ; Li, ZJ; Mao, L; Zhou, CS; Zhu, Z; Chen, RS; Hao, BL; Zheng, WM; Chen, SY; Guo, W; Li, GJ; Liu, SQ; Tao, M; Wang, J; Zhu, LH; Yuan, LP; Yang, HM				Yu, J; Hu, SN; Wang, J; Wong, GKS; Li, SG; Liu, B; Deng, YJ; Dai, L; Zhou, Y; Zhang, XQ; Cao, ML; Liu, J; Sun, JD; Tang, JB; Chen, YJ; Huang, XB; Lin, W; Ye, C; Tong, W; Cong, LJ; Geng, JN; Han, YJ; Li, L; Li, W; Hu, GQ; Huang, XG; Li, WJ; Li, J; Liu, ZW; Li, L; Liu, JP; Qi, QH; Liu, JS; Li, L; Li, T; Wang, XG; Lu, H; Wu, TT; Zhu, M; Ni, PX; Han, H; Dong, W; Ren, XY; Feng, XL; Cui, P; Li, XR; Wang, H; Xu, X; Zhai, WX; Xu, Z; Zhang, JS; He, SJ; Zhang, JG; Xu, JC; Zhang, KL; Zheng, XW; Dong, JH; Zeng, WY; Tao, L; Ye, J; Tan, J; Ren, XD; Chen, XW; He, J; Liu, DF; Tian, W; Tian, CG; Xia, HG; Bao, QY; Li, G; Gao, H; Cao, T; Wang, J; Zhao, WM; Li, P; Chen, W; Wang, XD; Zhang, Y; Hu, JF; Wang, J; Liu, S; Yang, J; Zhang, GY; Xiong, YQ; Li, ZJ; Mao, L; Zhou, CS; Zhu, Z; Chen, RS; Hao, BL; Zheng, WM; Chen, SY; Guo, W; Li, GJ; Liu, SQ; Tao, M; Wang, J; Zhu, LH; Yuan, LP; Yang, HM			A draft sequence of the rice genome (Oryza sativa L. ssp indica)	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS; ARABIDOPSIS-THALIANA; HUMAN GENES; COMPARATIVE GENETICS; BIALLELIC MARKERS; GRASS GENOMES; CPG ISLANDS; DNA; PLANTS; IDENTIFICATION	We have produced a draft sequence of the rice genome for the most widely cultivated subspecies in China, Oryza sativa L. ssp. indica, by whole-genome shotgun sequencing. The genome was 466 megabases in size, with an estimated 46,022 to 55,615 genes. Functional coverage in the assembled sequences was 92.0%. About 42.2% of the genome was in exact 20-nucleotide oligomer repeats, and most of the transposons were in the intergenic regions between genes. Although 80.6% of predicted Arabidopsis thaliana genes had a homolog in rice, only 49.4% of predicted rice genes had a homolog in A. thaliana. The large proportion of rice genes with no recognizable homologs is due to a gradient in the GC-content of rice coding sequences.	Chinese Acad Sci, Inst Genet, Beijing 100101, Peoples R China; Chinese Acad Sci, Beijing Genom Inst, Ctr Genom & Bioinformat, Beijing 101300, Peoples R China; Zhejiang Univ, Hangzhou Genom Inst, Inst Bioinformat, Key Lab Bioinformat Zhejiang Prov, Hangzhou 310007, Peoples R China; Univ Washington, Dept Med, Genome Ctr, Seattle, WA 98195 USA; Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; Xi An Jiao Tong Univ, Coll Med, Xian 710061, Peoples R China; Fudan Univ, Shanghai 200433, Peoples R China; Natl Hybrid Rice R&D Ctr, Changsha 410125, Peoples R China; Chinese Acad Sci, Inst Biophys, Lab Bioinformat, Beijing 100101, Peoples R China; Digital China Ltd, Beijing 100080, Peoples R China; Chinese Acad Sci, Inst Comp Technol, Beijing 100080, Peoples R China; Chinese Acad Sci, Inst Theoret Phys, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Zhejiang University; University of Washington; University of Washington Seattle; Peking University; Xi'an Jiaotong University; Fudan University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Computing Technology, CAS; Chinese Academy of Sciences; Institute of Theoretical Physics, CAS	Yuan, LP (corresponding author), Chinese Acad Sci, Inst Genet, Beijing 100101, Peoples R China.	hyang@genomics.org.cn	Li, Wei/A-8544-2009; Li, Xianran/I-5651-2012; Li, Xianran/AAH-1070-2019; Xiong, Yuqing/D-5404-2009; WONG, Gane Ka-Shu/G-5784-2013; 郑, 征/C-8514-2011; Bao, Qiyu/AAH-6113-2020; Hong, LU/HDM-0673-2022; Lu, Hong/F-2744-2015; Chen, Runsheng/S-9834-2017; Hu, Jianfei/A-4949-2011; Hu, Songnian/C-6509-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Li, Xianran/0000-0002-4252-6911; Xiong, Yuqing/0000-0001-5826-3696; WONG, Gane Ka-Shu/0000-0001-6108-5560; Bao, Qiyu/0000-0001-6523-8763; Lu, Hong/0000-0002-4026-4292; Chen, Runsheng/0000-0001-6049-8347; Li, Wei/0000-0001-9931-5990; Liu, Jianping/0000-0002-7336-3895; Zhang, Jianguo/0000-0003-0723-1701; Hu, Songnian/0000-0003-3966-3111; Jianfei, Hu/0000-0001-8458-6683; Tao, Lin/0000-0001-7494-4758; Wang, Hao/0000-0001-7475-0136; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009909] Funding Source: NIH RePORTER; NIEHS NIH HHS [1 RO1 ES09909] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P44, DOI 10.1093/nar/29.1.44; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashikawa I, 2001, PLANT J, V26, P617, DOI 10.1046/j.1365-313x.2001.01062.x; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; BERNARDI G, 1985, SCIENCE, V228, P953, DOI 10.1126/science.4001930; Bernardi G, 2000, GENE, V259, P31, DOI 10.1016/S0378-1119(00)00441-8; Bevan M, 1999, TRENDS GENET, V15, P211, DOI 10.1016/S0168-9525(99)01744-8; Bevan M, 2001, CURR OPIN PLANT BIOL, V4, P105, DOI 10.1016/S1369-5266(00)00144-8; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Brendel V, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews1005; Brett D, 2000, FEBS LETT, V474, P83, DOI 10.1016/S0014-5793(00)01581-7; Breyne P, 2001, CURR OPIN PLANT BIOL, V4, P136, DOI 10.1016/S1369-5266(00)00149-7; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carels N, 2000, GENETICS, V154, P1819; CHARGAFF E, 1950, EXPERIENTIA, V6, P201, DOI 10.1007/BF02173653; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; Croft L, 2000, NAT GENET, V24, P340, DOI 10.1038/74153; Davenport RJ, 2001, SCIENCE, V291, P807, DOI 10.1126/science.291.5511.2071; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DEVAN M, 2001, CURR OPIN PLANT BIOL, V4, P105; Devos KM, 1999, GENOME RES, V9, P825, DOI 10.1101/gr.9.9.825; Dickson D, 2001, NATURE, V409, P551, DOI 10.1038/35054705; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Eckardt N A, 2000, Plant Cell, V12, P2011; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Feuillet C, 1999, P NATL ACAD SCI USA, V96, P8265, DOI 10.1073/pnas.96.14.8265; FILIPSKI J, 1973, J MOL BIOL, V80, P177, DOI 10.1016/0022-2836(73)90240-4; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Forsdyke DR, 2000, GENE, V261, P127, DOI 10.1016/S0378-1119(00)00472-8; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gautier C, 2000, CURR OPIN GENET DEV, V10, P656, DOI 10.1016/S0959-437X(00)00144-1; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Goff SA, 1999, CURR OPIN PLANT BIOL, V2, P86, DOI 10.1016/S1369-5266(99)80018-1; Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HATANO S, 1992, PLANT SCI, V83, P55, DOI 10.1016/0168-9452(92)90062-Q; ISLAM SA, 1995, PROTEIN ENG, V8, P513, DOI 10.1093/protein/8.6.513; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; LANDER E S, 1988, Genomics, V2, P231; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Liu H, 2001, GENOME RES, V11, P2020, DOI 10.1101/gr.194501; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Martienssen R, 2001, CELL, V105, P571, DOI 10.1016/S0092-8674(01)00382-8; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mayer K, 2001, GENOME RES, V11, P1167, DOI 10.1101/gr.GR-1617R; Messing J, 1998, P NATL ACAD SCI USA, V95, P2017, DOI 10.1073/pnas.95.5.2017; MESSING J, 2001, TRENDS GENET, V6, P196; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nekrutenko A, 2001, TRENDS GENET, V17, P619, DOI 10.1016/S0168-9525(01)02445-3; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rogic S, 2001, GENOME RES, V11, P817, DOI 10.1101/gr.147901; ROLFE R, 1959, P NATL ACAD SCI USA, V45, P1039, DOI 10.1073/pnas.45.7.1039; SAKATA K, 2000, 4 ANN C COMP GEN, P31; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sambrook J., 2001, MOL CLONING; Sanchez-Fernandez R, 2001, TRENDS PLANT SCI, V6, P347, DOI 10.1016/S1360-1385(01)02038-6; Sasaki T, 2000, CURR OPIN PLANT BIOL, V3, P138, DOI 10.1016/S1369-5266(99)00047-3; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schmidt R, 2000, CURR OPIN PLANT BIOL, V3, P97, DOI 10.1016/S1369-5266(99)00048-5; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Sowdhamini R, 1996, FOLD DES, V1, P209, DOI 10.1016/S1359-0278(96)00032-6; SUEOKA N, 1959, NATURE, V183, P1429, DOI 10.1038/1831429a0; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Tao Q.Z., 1994, CELL RES, V4, P127; Tarchini R, 2000, PLANT CELL, V12, P381, DOI 10.1105/tpc.12.3.381; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; TEMNYKH S, 1994, NAT GENET, V6, P114; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; UMEHARA Y, 1995, MOL BREEDING, V1, P79, DOI 10.1007/BF01682091; van Dodeweerd AM, 1999, GENOME, V42, P887, DOI 10.1139/gen-42-5-887; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vicient CM, 2001, PLANT PHYSIOL, V125, P1283, DOI 10.1104/pp.125.3.1283; WANG GL, 1995, PLANT J, V7, P525, DOI 10.1046/j.1365-313X.1995.7030525.x; WANG J, IN PRESS GENOME RES; Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613; Wong GKS, 2000, GENOME RES, V10, P1672, DOI 10.1101/gr.148900; Wong GKS, 2001, GENOME RES, V11, P1975, DOI 10.1101/gr.202401; WONG GKS, IN PRESS GENOME RES; Yu J, 2001, CHINESE SCI BULL, V46, P1937, DOI 10.1007/BF02901901; YUAN LP, 1997, HYBRID RICE, V1, P1; Zhang, 1997, JIANGSU AGR SCI, V4, P13; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	109	2456	2953	20	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2002	296	5565					79	92		10.1126/science.1068037	http://dx.doi.org/10.1126/science.1068037			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11935017				2022-12-24	WOS:000174858800038
J	Jia, JH; Amanal, K; Wang, GL; Tang, J; Wang, B; Jiang, J				Jia, JH; Amanal, K; Wang, GL; Tang, J; Wang, B; Jiang, J			Shaggy/GSK3 antagonizes Hedgehog signalling by regulating Cubitus interruptus	NATURE			English	Article							PROTEIN-KINASE-A; TRANSCRIPTIONAL ACTIVATOR; SUBCELLULAR-LOCALIZATION; LIMB DEVELOPMENT; GENE-EXPRESSION; REPRESSOR FORMS; DROSOPHILA; PROTEOLYSIS; SUPPRESSOR; COSTAL2	The Drosophila protein Shaggy (Sgg, also known as Zeste-white3, Zw3) and its vertebrate orthologue glycogen synthase kinase 3 (GSK3) are inhibitory components of the Wingless (Wg) and Wnt pathways(1). Here we show that Sgg is also a negative regulator in the Hedgehog (Hh) pathway. In Drosophila, Hh acts both by blocking the proteolytic processing of full-length Cubitus interruptus, Ci (Ci155), to generate a truncated repressor form( Ci75), and by stimulating the activity of accumulated Ci155 (refs 2-6). Loss of sgg gene function results in a cell-autonomous accumulation of high levels of Ci155 and the ectopic expression of Hh-responsive genes including decapentaplegic (dpp) and wg. Simultaneous removal of sgg and Suppressor of fused, Su(fu)(7), results in wing duplications similar to those caused by ectopic Hh signalling. Ci is phosphorylated by GSK3 after a primed phosphorylation by protein kinase A (PKA), and mutating GSK3-phosphorylation sites in Ci blocks its processing and prevents the production of the repressor form. We propose that Sgg/GSK3 acts in conjunction with PKA to cause hyperphosphorylation of Ci, which targets it for proteolytic processing, and that Hh opposes Ci proteolysis by promoting its dephosphorylation.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Div Cell & Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Jiang, J (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.			Jia, Jianhang/0000-0002-9313-3843	NIGMS NIH HHS [R01 GM061269] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1999, DEVELOPMENT, V126, P3607; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; PREAT T, 1992, GENETICS, V132, P725; Price MA, 1999, DEVELOPMENT, V126, P4331; Roelink H, 1996, CURR OPIN NEUROBIOL, V6, P33, DOI 10.1016/S0959-4388(96)80006-7; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wang QT, 1999, DEVELOPMENT, V126, P5097; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	30	234	243	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 4	2002	416	6880					548	552		10.1038/nature733	http://dx.doi.org/10.1038/nature733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537JY	11912487				2022-12-24	WOS:000174756500047
J	Higashi, MK; Veenstra, DL; Kondo, LML; Wittkowsky, AK; Srinouanprachanh, SL; Farin, FM; Rettie, AE				Higashi, MK; Veenstra, DL; Kondo, LML; Wittkowsky, AK; Srinouanprachanh, SL; Farin, FM; Rettie, AE			Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLEEDING COMPLICATIONS; CYTOCHROME-P450 CYP2C9; DOSE REQUIREMENT; RISK-FACTORS; POLYMORPHISM; SENSITIVITY; (S)-WARFARIN; ENANTIOMERS; METABOLISM	Context Warfarin is a commonly used anticoagulant that requires careful clinical management to balance the risks of overanticoagulation and bleeding with those of under-anticoagulation and clotting. The principal enzyme involved in warfarin metabolism is CYP2C9, and 2 relatively common variant forms with reduced activity have been identified, CYP2C9*2 and CYP2C93. Patients with these genetic variants have been shown to require lower maintenance doses of warfarin, but a direct association between CYP2C9 genotype and anticoagulation status or bleeding risk has not been established. Objective To determine if CYP2C9*2 and CYP2C9*3 variants are associated with overanticoagulation and bleeding events during warfarin therapy. Design and Setting Retrospective cohort study conducted at 2 anticoagulation clinics based in Seattle, Wash. Participants Two hundred patients receiving long-term warfarin therapy for various indications during April 3, 1990, to May 31, 2001. Only patients with a complete history of warfarin exposure were included, Main Outcome Measures Anticoagulation status, measured by time to therapeutic international normalized ratio (INR), rate of above-range INRs, and time to stable warfarin dosing; and time to serious or life-threatening bleeding events. Results Among 185 patients with analyzable data, 58 (31.4%) had at least 1 variant CYP2C9 allele and 127 (68.6%) had the wild-type (*1/*1) genotype. Mean maintenance dose varied significantly among the 6 genotype groups (*1/*1 [n = 127], *1/*2 [n =28], *1/*3 [n = 18], *2/*2 [n=4], *2/*3 [n=3], *3/*3 [n =5]) (by Kruskall-Wallis test, chi(5)(2) =37.348; P<.001). Compared with patients with the wild-type genotype, patients with at least 1 variant allele had an increased risk of above-range INRs (hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.03-1.90). The variant group also required more me to achieve stable dosing (HR, 0.65; 95% Cl, 0.45-0.94), with a median difference of 95 days (P=.004). In addition, although numbers were small for some genotypes, representing potentially unstable estimates, patients with a variant genotype had a significantly increased risk of a serious or life-threatening bleeding event (HR, 2.39; 95% Cl, 1.18-4.86). Conclusions The results of our study suggest that the CYP2C9*2 and CYP2C9*3 polymorphisms are associated with an increased risk of overanticoagulation and of bleeding events among patients in a warfarin anticoagulation clinic setting, although small numbers in some cases would suggest the need for caution in interpretation. Screening for CYP2C9 variants may allow clinicians to develop dosing protocols and surveillance techniques to reduce the risk of adverse drug reactions in patients receiving warfarin.	Univ Washington, Med Ctr, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Inst Publ Hlth Genet, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Pharm Serv, Seattle, WA 98195 USA; Univ Washington, Ctr Ecogenet & Environm Hlth, Mol Biomarkers Lab, Seattle, WA 98195 USA; Univ Washington, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Veenstra, DL (corresponding author), Univ Washington, Dept Pharm, Box 357630,Hlth Sci Bldg,Room H-375A, Seattle, WA 98195 USA.	veen-stra@u.washington.edu			NIEHS NIH HHS [P30 ES07033] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; CLAYTON D, 1998, OXFORD SCI PUBLICATI, P298; Crespi CL, 1997, PHARMACOGENETICS, V7, P203, DOI 10.1097/00008571-199706000-00005; Dickmann LJ, 2001, MOL PHARMACOL, V60, P382, DOI 10.1124/mol.60.2.382; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Haining RL, 1996, ARCH BIOCHEM BIOPHYS, V333, P447, DOI 10.1006/abbi.1996.0414; Harrison L, 1997, ANN INTERN MED, V126, P133, DOI 10.7326/0003-4819-126-2-199701150-00006; Henne KR, 1998, J CHROMATOGR B, V710, P143, DOI 10.1016/S0378-4347(98)00099-1; Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S; Hirsh J, 2001, AM HEART J, V142, pS3, DOI 10.1067/mhj.2001.117031; HOSMER DW, 1999, APPL SURVIVAL ANAL R, P308; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; INCIARDI JF, 1994, THER DRUG MONIT, V16, P425, DOI 10.1097/00007691-199408000-00015; KHOURY MJ, 1993, FUNDAMENTALS GENETIC, P49; Kimura M, 1998, THER DRUG MONIT, V20, P243, DOI 10.1097/00007691-199806000-00001; KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5; Leung AYH, 2001, BLOOD, V98, P2584, DOI 10.1182/blood.V98.8.2584; Loebstein R, 2001, CLIN PHARMACOL THER, V70, P159, DOI 10.1067/mcp.2001.117444; MCBRIDE R, 1994, LANCET, V343, P687; Nasu K, 1997, PHARMACOGENETICS, V7, P405, DOI 10.1097/00008571-199710000-00011; Phillips KA, 2001, JAMA-J AM MED ASSOC, V286, P2270, DOI 10.1001/jama.286.18.2270; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009; Rettie AE, 1999, EPILEPSY RES, V35, P253, DOI 10.1016/S0920-1211(99)00017-0; Stubbins MJ, 1996, PHARMACOGENETICS, V6, P429, DOI 10.1097/00008571-199610000-00007; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Takahashi H, 1998, CLIN PHARMACOL THER, V63, P519, DOI 10.1016/S0009-9236(98)90103-5; Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001; Takanashi K, 2000, PHARMACOGENETICS, V10, P95, DOI 10.1097/00008571-200003000-00001; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; Thompson E. A., 2000, NSF CBMS REGIONAL C, V6; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.; Weir B., 1996, GENETIC DATA ANAL; WITTKOWSKY AK, 2001, APPL THERAPEUTICS CL; Yasar U, 1999, BIOCHEM BIOPH RES CO, V254, P628, DOI 10.1006/bbrc.1998.9992	37	820	882	1	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1690	1698		10.1001/jama.287.13.1690	http://dx.doi.org/10.1001/jama.287.13.1690			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926893	Bronze			2022-12-24	WOS:000174730300023
J	Wiley, JS; Dao-Ung, LP; Gu, BJ; Sluyter, R; Shemon, AN; Li, CP; Taper, J; Gallo, J; Manoharan, A				Wiley, JS; Dao-Ung, LP; Gu, BJ; Sluyter, R; Shemon, AN; Li, CP; Taper, J; Gallo, J; Manoharan, A			A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study	LANCET			English	Article							CELL-DEATH; ATP; ACTIVATION; APOPTOSIS; LEUKEMIA; PERMEABILITY; EXPRESSION; INDUCTION; CHANNELS; P2X(7)	Background Chronic lymphocytic leukaemia (CLL) has a familial incidence nearly three times higher than expected for the general population and one predisposing factor might be an inherited failure of mechanisms involved in apoptosis of lymphocytes. Our aim was to ascertain whether or not a defect in a proapoptotic pathway, caused by a single nucleotide polymorphism that results in loss-of-function of P2X7 in healthy individuals, was present in leukaemic 6 lymphocytes of patients with CLL. Methods We extracted genomic DNA from the peripheral blood leucocytes of 36 unrelated individuals with CLL, four individuals with familial CLL, and 46 age-matched controls. We sequenced a PCR product to detect mutations in exon 13 of P2X7. In most patients with CLL, we measured expression and function of the P2X7 receptor by flow cytometry in B lymphocytes and T lymphocytes. Findings The prevalence of the polymorphic mutation and the frequency of the mutant allele were three-fold greater in individuals with CLL than in white, elderly controls. Individuals homozygous for the polymorphic allele had no P2X7 receptor function and heterozygotes had half the mean function of that seen in individuals homozygous for the wildtype allele; amounts of ATP-induced apoptosis varied accordingly. In two families, in which we studied a father-son pair and a sister-sister pair with CLL, loss of P2X7 function arose because of inheritance of one or two 1513A-->C alleles for P2X7. Interpretation Activation of the P2X7 receptor leads to apoptosis of lymphocytes in individuals with CLL, and reduced function of this receptor has an anti-apoptotic effect, resulting in an increase in B-cell numbers. Thus, inheritance of a loss-of-function polymorphic mutation at position 1513 in the P2X7 gene could contribute to the pathogenesis of CLL.	Univ Sydney, Dept Med, Nepean Hosp, Penrith, NSW 2751, Australia; Liverpool Hosp, Dept Haematol, Liverpool, Merseyside, England; Univ New S Wales, St George Hosp, Dept Clin Haematol, Kogarah, NSW, Australia	Nepean Hospital; University of Sydney; St George Hospital; University of New South Wales Sydney	Wiley, JS (corresponding author), Univ Sydney, Dept Med, Nepean Hosp, POB 63, Penrith, NSW 2751, Australia.		Sluyter, Ronald/B-5798-2009	Sluyter, Ronald/0000-0003-4909-686X; Gu, Ben/0000-0001-5500-4453; Wiley, James/0000-0001-9421-4154				Bevan S, 2000, BLOOD, V96, P3982; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; DAMASHEK W, 1967, BLOOD, V29, P219; Dameshek W, 1929, JAMA-J AM MED ASSOC, V92, P1348, DOI 10.1001/jama.1929.92700420002009b; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; DOHNER H, 1995, BLOOD, V85, P1580, DOI 10.1182/blood.V85.6.1580.bloodjournal8561580; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Fernando KC, 1999, ARCH BIOCHEM BIOPHYS, V362, P197, DOI 10.1006/abbi.1998.1045; Ferrari D, 1999, FEBS LETT, V447, P71, DOI 10.1016/S0014-5793(99)00270-7; GALTON DAG, 1966, CAN MED ASSOC J, V94, P1005; Gargett CE, 1997, BRIT J PHARMACOL, V122, P911, DOI 10.1038/sj.bjp.0701447; Gu B, 1998, BLOOD, V92, P946; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; GUNZ FW, 1975, SCAND J HAEMATOL, V15, P117; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nihei OK, 2000, BLOOD, V96, P996, DOI 10.1182/blood.V96.3.996.015k02_996_1005; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Sharma N, 2000, KIDNEY INT, V57, P803, DOI 10.1046/j.1523-1755.2000.00918.x; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Stankovic T, 1999, LANCET, V353, P26, DOI 10.1016/S0140-6736(98)10117-4; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Wickremasinghe RG, 1999, BLOOD, V93, P3587, DOI 10.1182/blood.V93.11.3587.411k46_3587_3600; Wiernik PH, 2001, BRIT J HAEMATOL, V113, P407, DOI 10.1046/j.1365-2141.2001.02773.x; WILEY JS, 1993, ARCH BIOCHEM BIOPHYS, V305, P54, DOI 10.1006/abbi.1993.1392; WILEY JS, 1989, BLOOD, V73, P1316; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	32	128	132	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 30	2002	359	9312					1114	1119		10.1016/S0140-6736(02)08156-4	http://dx.doi.org/10.1016/S0140-6736(02)08156-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YJ	11943260				2022-12-24	WOS:000174729200011
J	Clapham, DE				Clapham, DE			Signal transduction - Hot and cold TRP ion channels	SCIENCE			English	Editorial Material							CAPSAICIN-RECEPTOR; HEAT		Harvard Univ, Sch Med, Childrens Hosp,Howard Hughes Med Inst, Dept Neurobiol,Cardiovasc Div, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Childrens Hosp,Howard Hughes Med Inst, Dept Neurobiol,Cardiovasc Div, Boston, MA 02115 USA.		Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428				Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; MCKERNY DD, 2002, NATURE          0210; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; PEIER AM, 2002, CELL IMMEDIATE EARLY; Tsavaler L, 2001, CANCER RES, V61, P3760	9	30	38	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2228	2229		10.1126/science.1070766	http://dx.doi.org/10.1126/science.1070766			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910099				2022-12-24	WOS:000174561700032
J	Giles, J				Giles, J			Diplomats near pact in simmering debate over transgenic foods	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 21	2002	416	6878					252	252		10.1038/416252b	http://dx.doi.org/10.1038/416252b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532NP	11907542	Bronze			2022-12-24	WOS:000174482200010
J	Vandenkoornhuyse, P; Baldauf, SL; Leyval, C; Straczek, J; Young, JPW				Vandenkoornhuyse, P; Baldauf, SL; Leyval, C; Straczek, J; Young, JPW			Evolution - Extensive fungal diversity in plant roots	SCIENCE			English	Article									Univ York, Dept Biol, York YO10 5SW, N Yorkshire, England; Ctr Pedol Biol, F-54500 Vandoeuvre Les Nancy, France; Ctr Hosp Univ Nancy, F-54500 Nancy, France	University of York - UK; CHU de Nancy	Vandenkoornhuyse, P (corresponding author), Univ York, Dept Biol, POB 373, York YO10 5SW, N Yorkshire, England.		Young, Peter/C-1446-2012	Young, Peter/0000-0001-5259-4830; Baldauf, Sandra/0000-0003-4485-6671				Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Tehler A, 2000, MYCOLOGIA, V92, P459, DOI 10.2307/3761505	3	299	330	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2051	2051		10.1126/science.295.5562.2051	http://dx.doi.org/10.1126/science.295.5562.2051			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896270				2022-12-24	WOS:000174450500040
J	Wang, JW; Howson, JM; Ghansah, T; Desponts, C; Ninos, JM; May, SL; Nguyen, KHT; Toyama-Sorimachi, N; Kerr, WG				Wang, JW; Howson, JM; Ghansah, T; Desponts, C; Ninos, JM; May, SL; Nguyen, KHT; Toyama-Sorimachi, N; Kerr, WG			Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation	SCIENCE			English	Article							TRANSGENIC EXPRESSION; RECEPTOR; CELLS; LY49A; PHOSPHATASE; SHP-1; LEADS; LCK	Natural killer cell (NK) receptors for major histocompatibility complex (MHC) class I influence engraftment and graft-versus-tumor effects after allogeneic bone marrow transplantation. We find that SH2-containing inositol phosphatase (SHIP) influences the repertoire of NK receptors. In adult SHIP-/- mice, the NK compartment is dominated by cells that express two inhibitory receptors capable of binding either self or allogeneic MHC ligands. This promiscuous repertoire has significant functional consequences, because SHIP-/- mice fail to reject fully mismatched allogeneic marrow grafts and show enhanced survival after such transplants. Thus, SHIP plays an important role in two processes that limit the success of allogeneic marrow transplantation: graft rejection and graft-versus-host disease.	Univ S Florida, Program Immunol, H Lee Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; Univ S Florida, Dept Biochem, Tampa, FL 33612 USA; Tokyo Med & Dent Univ, Dept Immune Regulat, Tokyo 1138150, Japan	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Tokyo Medical & Dental University (TMDU)	Kerr, WG (corresponding author), Univ S Florida, Program Immunol, H Lee Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL 33612 USA.		Wang, Jia-Wang/I-4966-2012; Ghansah, Tomar/H-4566-2011; Kerr, William G/B-8616-2015	Kerr, William G/0000-0002-4720-7135	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS027405] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK54767] Funding Source: Medline; NINDS NIH HHS [P01 NS27405] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Binstadt BA, 1996, IMMUNITY, V5, P629, DOI 10.1016/S1074-7613(00)80276-9; Bolland S, 1999, ADV IMMUNOL, V72, P149, DOI 10.1016/S0065-2776(08)60019-X; Brawand P, 2000, J IMMUNOL, V165, P1871, DOI 10.4049/jimmunol.165.4.1871; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Daws MR, 1999, IMMUNOLOGY, V97, P656; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GHANSAH T, UNPUB; Held W, 1996, J EXP MED, V184, P2037, DOI 10.1084/jem.184.5.2037; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Lowin-Kropf B, 2000, J IMMUNOL, V165, P91, DOI 10.4049/jimmunol.165.1.91; Marti F, 1998, P NATL ACAD SCI USA, V95, P11810, DOI 10.1073/pnas.95.20.11810; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; Nakamura MC, 1997, J EXP MED, V185, P673, DOI 10.1084/jem.185.4.673; Nisitani S, 2000, P NATL ACAD SCI USA, V97, P2737, DOI 10.1073/pnas.050583597; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Raulet DH, 1999, CURR OPIN IMMUNOL, V11, P129, DOI 10.1016/S0952-7915(99)80023-5; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Zajac AJ, 1999, J IMMUNOL, V163, P5526	20	132	145	4	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 15	2002	295	5562					2094	2097		10.1126/science.1068438	http://dx.doi.org/10.1126/science.1068438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	532AY	11896280				2022-12-24	WOS:000174450500055
J	Soubeyran, P; Kowanetz, K; Szymkiewicz, I; Langdon, WY; Dikic, I				Soubeyran, P; Kowanetz, K; Szymkiewicz, I; Langdon, WY; Dikic, I			Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; C-CBL; ADAPTER PROTEIN; SH3 DOMAIN; TYROSINE PHOSPHORYLATION; VESICLE FORMATION; ENDOPHILIN; C-CBL/SLI-1; CIN85; PYK2	Cbl is a multi-adaptor protein involved in ligand-induced down-regulation of receptor tyrosine kinases. It is thought that Cbl-mediated ubiquitination of active receptors is essential for receptor degradation and cessation of receptor-induced signal transduction(1-5). Here we demonstrate that Cbl additionally regulates epidermal growth factor (EGF) receptor endocytosis. Cbl rapidly recruits CIN85 (Cbl-interacting protein of 85K; ref. 6) and endophilins (regulatory components of clathrin-coated vesicles(7-10)) to form a complex with activated EGF receptors, thus controlling receptor internalization. CIN85 was constitutively associated with endophilins, whereas CIN85 binding to the distal carboxy terminus of Cbl was increased on EGF stimulation. Inhibition of these interactions was sufficient to block EGF receptor internalization, delay receptor degradation and enhance EGF-induced gene transcription, without perturbing Cbl-directed receptor ubiquitination. Thus, the evolutionary divergent C terminus of Cbl uses a mechanism that is functionally separable from the ubiquitin ligase activity of Cbl to mediate ligand-dependent down-regulation of receptor tyrosine kinases.	Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; Univ Western Australia, Dept Pathol, Crawley, WA 6009, Australia	Ludwig Institute for Cancer Research; University of Western Australia	Dikic, I (corresponding author), Ludwig Inst Canc Res, Box 595,Husargatan 3, S-75124 Uppsala, Sweden.		Pilecka, Iwona/AAT-9114-2021; Dikic, Ivan/O-4650-2015; Soubeyran, Philippe/P-1758-2018	Pilecka, Iwona/0000-0002-5057-346X; Dikic, Ivan/0000-0001-8156-9511; Soubeyran, Philippe/0000-0002-5876-3217				Bogler O, 2000, NEURO-ONCOLOGY, V2, P6, DOI 10.1093/neuonc/2.1.6; Borinstein SC, 2000, CELL SIGNAL, V12, P769, DOI 10.1016/S0898-6568(00)00129-7; de Melker AA, 2001, J CELL SCI, V114, P2167; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; GALISTEO ML, 1995, J BIOL CHEM, V270, P20242, DOI 10.1074/jbc.270.35.20242; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Scaife RM, 2000, J CELL SCI, V113, P215; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Sorkin A, 1996, J BIOL CHEM, V271, P13377, DOI 10.1074/jbc.271.23.13377; Take H, 2000, BIOCHEM BIOPH RES CO, V268, P321, DOI 10.1006/bbrc.2000.2147; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Yoon CH, 2000, MOL BIOL CELL, V11, P4019, DOI 10.1091/mbc.11.11.4019	27	463	491	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 14	2002	416	6877					183	187		10.1038/416183a	http://dx.doi.org/10.1038/416183a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530FR	11894095				2022-12-24	WOS:000174348100039
J	McKemy, DD; Neuhausser, WM; Julius, D				McKemy, DD; Neuhausser, WM; Julius, D			Identification of a cold receptor reveals a general role for TRP channels in thermosensation	NATURE			English	Article							CULTURED SENSORY NEURONS; ROOT GANGLION NEURONS; CAPSAICIN-RECEPTOR; ION CHANNELS; NOXIOUS HEAT; MENTHOL; PAIN; NOCICEPTORS; INPUT	The cellular and molecular mechanisms that enable us to sense cold are not well understood. Insights into this process have come from the use of pharmacological agents, such as menthol, that elicit a cooling sensation. Here we have characterized and cloned a menthol receptor from trigeminal sensory neurons that is also activated by thermal stimuli in the cool to cold range. This cold- and menthol-sensitive receptor, CMR1, is a member of the TRP family of excitatory ion channels, and we propose that it functions as a transducer of cold stimuli in the somatosensory system. These findings, together with our previous identification of the heat-sensitive channels VR1 and VRL-1, demonstrate that TRP channels detect temperatures over a wide range and are the principal sensors of thermal stimuli in the mammalian peripheral nervous system.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.							Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BESSOU P, 1969, J NEUROPHYSIOL, V32, P1025, DOI 10.1152/jn.1969.32.6.1025; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Cain DM, 2001, J NEUROPHYSIOL, V85, P1561, DOI 10.1152/jn.2001.85.4.1561; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; DODT E, 1952, ACTA PHYSIOL SCAND, V26, P358, DOI 10.1111/j.1748-1716.1952.tb00917.x; Eccles R, 2000, APPETITE, V34, P29, DOI 10.1006/appe.1999.0291; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; Eckert SP, 1997, J NEUROSCI METH, V77, P183, DOI 10.1016/S0165-0270(97)00125-8; FIELDS HL, 1987, PAIN, P13; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Rainville P, 1999, EXP BRAIN RES, V125, P28, DOI 10.1007/s002210050654; RAJA SN, 1999, TXB PAIN, P00011; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Simone DA, 1996, NEUROSCI LETT, V213, P53, DOI 10.1016/0304-3940(96)12838-X; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9; SWANDULLA D, 1987, PFLUG ARCH EUR J PHY, V409, P52, DOI 10.1007/BF00584749; TAKEUCHI S, 1994, BIOCHEM BIOPH RES CO, V201, P1333, DOI 10.1006/bbrc.1994.1850; Tsavaler L, 2001, CANCER RES, V61, P3760; WAHREN LK, 1989, PAIN, V38, P313, DOI 10.1016/0304-3959(89)90218-2; WEI ET, 1983, J PHARM PHARMACOL, V35, P110, DOI 10.1111/j.2042-7158.1983.tb04279.x; WEI ET, 1981, FED PROC, V40, P1491; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	50	1760	1915	19	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					52	58		10.1038/nature719	http://dx.doi.org/10.1038/nature719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882888				2022-12-24	WOS:000174211600034
J	Reif, K; Ekland, EH; Ohl, L; Nakano, H; Lipp, M; Forster, R; Cyster, JG				Reif, K; Ekland, EH; Ohl, L; Nakano, H; Lipp, M; Forster, R; Cyster, JG			Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position	NATURE			English	Article							SECONDARY LYMPHOID ORGANS; DENDRITIC CELLS; HELPER-FREE; HIGH-TITER; CHEMOKINE; LOCALIZATION; EXPRESSION; FOLLICLES; MIGRATION; MICE	B lymphocytes re-circulate between B-cell-rich compartments (follicles or B zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells(1-3). Despite the importance of B-T-cell interactions for the induction of antibody responses, the mechanism causing B-cell movement to the T zone has not been defined. Here we show that antigen-engaged B cells have increased expression of CCR7, the receptor for the T-zone chemokines(4,5) CCL19 and CCL21, and that they exhibit increased responsiveness to both chemoattractants. In mice lacking lymphoid CCL19 and CCL21 chemokines, or with B cells that lack CCR7, antigen engagement fails to cause movement to the T zone. Using retroviral-mediated gene transfer we demonstrate that increased expression of CCR7 is sufficient to direct B cells to the T zone. Reciprocally, overexpression of CXCR5, the receptor for the B-zone chemokine CXCL13, is sufficient to overcome antigen-induced B-cell movement to the T zone. These findings define the mechanism of B-cell relocalization in response to antigen, and establish that cell position in vivo can be determined by the balance of responsiveness to chemoattractants made in separate but adjacent zones.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Erlangen Nurnberg, Surg Clin, D-91054 Erlangen, Germany; Toho Univ, Sch Med, Dept Immunol, Tokyo 1438540, Japan; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Erlangen Nuremberg; Toho University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Reif, Karin/AAD-4692-2020; Förster, Reinhold/D-6770-2011; Lipp, Martin/G-2235-2010	Reif, Karin/0000-0001-5490-8389; Forster, Reinhold/0000-0001-6190-7923; Lipp, Martin/0000-0002-0087-2672				Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; BASTEN A, 1991, IMMUNOL REV, V122, P5, DOI 10.1111/j.1600-065X.1991.tb00593.x; Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kellermann SA, 1999, J IMMUNOL, V162, P3859; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; MandikNayak L, 1997, J EXP MED, V186, P1257, DOI 10.1084/jem.186.8.1257; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Nakano H, 2001, J IMMUNOL, V166, P361, DOI 10.4049/jimmunol.166.1.361; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Schmidt KN, 1998, J EXP MED, V187, P929, DOI 10.1084/jem.187.6.929; Van Parijs L, 1999, IMMUNITY, V11, P763, DOI 10.1016/S1074-7613(00)80150-8; Vassileva G, 1999, J EXP MED, V190, P1183, DOI 10.1084/jem.190.8.1183; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	30	406	432	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 7	2002	416	6876					94	99		10.1038/416094a	http://dx.doi.org/10.1038/416094a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882900				2022-12-24	WOS:000174211600046
J	Maron, BJ; Gohman, TE; Kyle, SB; Estes, NAM; Link, MS				Maron, BJ; Gohman, TE; Kyle, SB; Estes, NAM; Link, MS			Clinical profile and spectrum of commotio cordis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN-DEATH; SPORTS ACTIVITIES; CARDIAC-ARREST; YOUNG; IMPACT	Context Although blunt, nonpenetrating chest blows causing sudden cardiac death (commotio cordis) are often associated with competitive sports, dangers implicit in such blows can extend into many other life activities. Objective To describe the comprehensive spectrum of commotio cordis events. Design and Setting Analysis of confirmed cases from the general community assembled in the US Commotio Cordis Registry occurring up to September 1, 2001. Main Outcome Measure Commotio cordis event. Results Of 128 confirmed cases, 122 (95%) were in males and the mean (SD) age was 13.6 (8.2) years (median, 14 years; range, 3 months to 45 years); only 28 (22%) cases were aged 18 years or older. Commotio cordis events occurred most commonly during organized sporting events (79 [62%]), such as baseball, but 49 (38%) occurred as part of daily routine and recreational activities. Fatal blows were inflicted with a wide range of velocities but often occurred inadvertently and under circumstances not usually associated with risk for sudden death in informal settings near the home or playground. Twenty-two (28%) participants were wearing commercially available chest barriers, including 7 in whom the projectile made direct contact with protective padding (baseball catchers and lacrosse/hockey goalies), and 2 in whom the projectile was a baseball specifically designed to reduce risk. Only 21 (16%) individuals survived their event, with particularly prompt cardiopulmonary resuscitation/defibrillation (most commonly reversing ventricular fibrillation) the only identifiable factor associated with a favorable outcome. Conclusions The expanded spectrum of commotio cordis illustrates the potential dangers implicit in striking the chest, regardless of the intent or force of the blow. These findings also suggest that the safety of young athletes will be enhanced by developing more effective preventive strategies (such as chest wall barriers) to achieve protection from ventricular fibrillation following precordial blows.	Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA; Tufts Univ New England Med Ctr, Cardiac Arrhythmia Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; US Consumer Prod Safety Commiss, Washington, DC USA	Minneapolis Heart Institute Foundation; Tufts Medical Center; Tufts University	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.							ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; Curfman GD, 1998, NEW ENGL J MED, V338, P1841, DOI 10.1056/NEJM199806183382511; ESTES NAM, 1995, NEW ENGL J MED, V333, P380, DOI 10.1056/NEJM199508103330611; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; KING AI, 1986, BASEBALL RELATED CHE; Link MS, 1999, CIRCULATION, V100, P413, DOI 10.1161/01.CIR.100.4.413; Link MS, 1998, NEW ENGL J MED, V338, P1805, DOI 10.1056/NEJM199806183382504; Link MS, 1998, CHEST, V114, P326, DOI 10.1378/chest.114.1.326; Link MS, 2001, J AM COLL CARDIOL, V37, P649, DOI 10.1016/S0735-1097(00)01142-6; Link MS, 2001, J AM COLL CARDIOL, V37, p135A; LINK MS, 2001, PACE, V24, P614; Maron BJ, 1997, AM J CARDIOL, V79, P840, DOI 10.1016/S0002-9149(96)00887-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 1999, J CARDIOVASC ELECTR, V10, P114, DOI 10.1111/j.1540-8167.1999.tb00648.x; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; Maron BJ, 2002, AM J CARDIOL, V89, P210, DOI 10.1016/S0002-9149(01)02202-0; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Nesbitt AD, 2001, LANCET, V357, P1195, DOI 10.1016/S0140-6736(00)04338-5; SWIFT EW, 1993, SPORTS ILLUSTRA 1206, P68; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Washington RL, 2001, PEDIATRICS, V107, P782, DOI 10.1542/peds.107.4.782	23	221	231	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2002	287	9					1142	1146		10.1001/jama.287.9.1142	http://dx.doi.org/10.1001/jama.287.9.1142			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	527KV	11879111	Bronze			2022-12-24	WOS:000174186000029
J	Shanafelt, TD; Bradley, KA; Wipf, JE; Back, AL				Shanafelt, TD; Bradley, KA; Wipf, JE; Back, AL			Burnout and self-reported patient care in an internal medicine residency program	ANNALS OF INTERNAL MEDICINE			English	Article							HOUSE STAFF; DEPRESSION; PHYSICIANS; STRESS; SATISFACTION; MANAGEMENT; DISORDERS; QUESTIONS; DISTRESS; VALIDITY	Background: Burnout is a syndrome of depersonalization, emotional exhaustion, and a sense of low personal accomplishment. Little is known about burnout in residents or its relationship to patient care. Objective: To determine the prevalence of burnout in medical residents and explore its relationship to self-reported patient care practices. Design: Cross-sectional study using an anonymous, mailed survey. Setting: University-based residency program in Seattle, Washington. Participants: 115 internal medicine residents. Measurements: Burnout was measured by using the Maslach Burnout Inventory and was defined as scores in the high range for medical professionals on the depersonalization or emotional exhaustion subscales. Five questions developed for this study assessed self-reported patient care practices that suggested suboptimal care (for example, "I did not fully discuss treatment options or answer a patient's questions" or "I made ... errors that were not due to a lack of knowledge or inexperience"). Depression and at-risk alcohol use were assessed by using validated screening questionnaires. Results: Of 115 (76%) responding residents, 87 (76%) met the criteria for burnout. Compared with non-burned-out residents, burned-out residents were significantly more likely to self-report providing at least one type of suboptimal patient care at least monthly (53% vs. 21%; P=0.004). In multivariate analyses, burnout-but not sex, depression, or at-risk alcohol use-was strongly associated with self-report of one or more suboptimal patient care practices at least monthly (odds ratio, 8.3 [95% Cl, 2.6 to 26.5]). When each domain of burnout was evaluated separately, only a high score for depersonalization was associated with self-reported suboptimal patient care practices (in a dose-response relationship). Conclusion: Burnout was common among resident physicians and was associated with self-reported suboptimal patient care practices.	Univ Washington, Vet Affairs NW Hlth Serv Res & Dev Ctr Excellence, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Back, AL (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way S-111, Seattle, WA 98108 USA.	tonyback@u.washington.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA000313] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], 1995, BURNOUT HELPING TEAC; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Burack JH, 1999, J GEN INTERN MED, V14, P49, DOI 10.1046/j.1525-1497.1999.00280.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; CLARK DC, 1987, JAMA-J AM MED ASSOC, V257, P2921, DOI 10.1001/jama.257.21.2921; COLFORD JM, 1989, JAMA-J AM MED ASSOC, V261, P889, DOI 10.1001/jama.261.6.889; DECKARD GJ, 1992, J INFECT DIS, V165, P224, DOI 10.1093/infdis/165.2.224; EISENBERG J, 1986, DOCTORS DECISIONS CO; FIRTHCOZENS J, 1987, BRIT MED J, V295, P533, DOI 10.1136/bmj.295.6597.533; GALLERY ME, 1992, ANN EMERG MED, V21, P58, DOI 10.1016/S0196-0644(05)82238-3; GIRARD DE, 1986, WESTERN J MED, V144, P93; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; Grassi L, 2000, PSYCHOTHER PSYCHOSOM, V69, P329, DOI 10.1159/000012416; Gundersen L, 2001, ANN INTERN MED, V135, P145, DOI 10.7326/0003-4819-135-2-200107170-00023; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; HSU K, 1987, AM J PSYCHIAT, V144, P1561; HUGHES PH, 1991, JAMA-J AM MED ASSOC, V265, P2069, DOI 10.1001/jama.265.16.2069; KELLER KL, 1989, ANN EMERG MED, V18, P42; Kenagy JW, 1999, JAMA-J AM MED ASSOC, V281, P661, DOI 10.1001/jama.281.7.661; Kilfedder CJ, 2001, J ADV NURS, V34, P383, DOI 10.1046/j.1365-2648.2001.01769.x; Kohn LT, 2000, ERR IS HUMAN BUILDIN; KORAN LM, 1988, WESTERN J MED, V148, P97; Lee RT, 1996, J APPL PSYCHOL, V81, P123, DOI 10.1037/0021-9010.81.2.123; Leiter MP, 1998, SOC SCI MED, V47, P1611, DOI 10.1016/S0277-9536(98)00207-X; LEITER MP, 1994, ANXIETY STRESS COPIN, V7, P357, DOI 10.1080/10615809408249357; Lemkau J, 1994, Fam Pract Res J, V14, P213; Levey RE, 2001, ACAD MED, V76, P142, DOI 10.1097/00001888-200102000-00010; LICHTENSTEIN R, 1984, MED CARE, V22, P56, DOI 10.1097/00005650-198401000-00005; Lichtenstein R L, 1984, Med Care Rev, V41, P139, DOI 10.1177/107755878404100301; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1986, MASLACH BURNOUT INVE; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; MCCUE JD, 1991, ARCH INTERN MED, V151, P2273, DOI 10.1001/archinte.151.11.2273; NESBITT D, 1988, ANN INTERN MED, V109, P154, DOI 10.7326/0003-4819-109-2-154; Parker PA, 1995, J BEHAV MED, V18, P581, DOI 10.1007/BF01857897; Purdy R R, 1987, Fam Med, V19, P203; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; RAMIREZ AJ, 1995, BRIT J CANCER, V71, P1263, DOI 10.1038/bjc.1995.244; REUBEN DB, 1985, ARCH INTERN MED, V145, P286, DOI 10.1001/archinte.145.2.286; REUBEN DB, 1984, PSYCHOSOMATICS, V25, P815, DOI 10.1016/S0033-3182(84)72942-2; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SMITH JW, 1986, JAMA-J AM MED ASSOC, V255, P1155, DOI 10.1001/jama.255.9.1155; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Yao DC, 2000, JAMA-J AM MED ASSOC, V284, P1099, DOI 10.1001/jama.284.9.1099	45	1325	1361	3	153	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 5	2002	136	5					358	367		10.7326/0003-4819-136-5-200203050-00008	http://dx.doi.org/10.7326/0003-4819-136-5-200203050-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525VT	11874308				2022-12-24	WOS:000174095300003
J	Quere, I; Perneger, TV; Zittoun, J; Bellet, H; Gris, JC; Daures, JP; Schved, JF; Mercier, E; Laroche, JP; Dauzat, M; Bounameaux, H; Janbon, C; de Moerloose, P				Quere, I; Perneger, TV; Zittoun, J; Bellet, H; Gris, JC; Daures, JP; Schved, JF; Mercier, E; Laroche, JP; Dauzat, M; Bounameaux, H; Janbon, C; de Moerloose, P			Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study	LANCET			English	Article							FACTOR-V-LEIDEN; THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE; FOLIC-ACID; ENDOTHELIAL DYSFUNCTION; FATTY-ACIDS; FOLATE; HYPERHOMOCYSTEINEMIA; PROTHROMBIN; C677T; POLYMORPHISM	Background Moderate hyperhomocysteinaemia is a risk factor for venous thromboembolism. We do not know whether this risk depends on homocysteine itself or on components of the homocysteine remethylation pathway, such as methylfolate. We did a case-control study to analyse the relation between the major components of the homocysteine remethylation pathway and risk of venous thromboembolism. Methods We measured concentrations of homocysteine, methionine, and folate in plasma, total folate and methylfolate in red-blood cells, and 5, 10-methylenetetrahydrofolate reductase (MTHFR) C677T genotype and other known risk factors for venous thromboembolic, disease in 243 patients with deep vein thrombosis or pulmonary embolism and controls matched for sex and age. Findings Concentrations in plasma of homocysteine differed significantly between cases and controls. We noted a strong concentration-dependent association between concentrations of methylfolate in red-blood cells and risk of venous thromboembolism. The adjusted conditional odds ratio ranged from 1.0 for methylfoate 249 mug/L or greater to 7.1 (3.2-15.8) for methylfolate 141 mug/L or less. Methionine concentrations below the median were also independently associated with raised risk of venous thromboembolic disease, as were established risk factors such as high body-mass index, history of cancer, family history of thromboembolism, oral contraceptive use, and factor V Leiden mutation. Furthermore, the association between concentrations of methylfolate in red-blood cells and risk of thromboembolism varied according to MTHFR C677T genotype. Interpretation Measurement of methylfolate concentrations in red-blood cells might help to identify people at risk of venous thromboembolism.	Univ Hosp St Eloi, Dept Internal Med, Montpellier, France; Univ Hosp St Eloi, Haematol Lab, Montpellier, France; Univ Hosp St Eloi, Biochem Lab, Montpellier, France; Univ Hosp Henri Mondor, Haematol Lab, Creteil, France; Univ Hosp, Physiol Lab, Nimes, France; Univ Hosp, Haematol Lab, Nimes, France; Univ Clin Res Inst, Montpellier, France; Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland; Univ Hosp Geneva, Div Angiol & Haemostasis, Geneva, Switzerland	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Montpellier; CHU de Nimes; Universite de Montpellier; CHU de Nimes; University of Geneva; University of Geneva	Quere, I (corresponding author), Hop St Eloi, Serv Med Interne B, 2 Av Bertin Sans, F-34295 Montpellier, France.	i-quere@chu-montpellier.fr	Dauzat, Michel/Q-7200-2019; Quere, Isabelle/AAB-8519-2020; GRIS, Jean-Christophe/AAA-2923-2019	Dauzat, Michel/0000-0002-9496-3857; Quere, Isabelle/0000-0002-1492-9764; GRIS, Jean-Christophe/0000-0002-9899-9910; Schved, Jean-Francois/0000-0003-0332-3254; Mercier, Eric/0000-0001-7917-1918				Alhenc-Gelas M, 1999, THROMB HAEMOSTASIS, V81, P506; AMUNDSEN T, 1995, ARTERIOSCL THROM VAS, V15, P1321, DOI 10.1161/01.ATV.15.9.1321; Andriamampandry M, 1998, CR ACAD SCI III-VIE, V321, P415, DOI 10.1016/S0764-4469(98)80306-5; Bolton-Smith C, 2000, BRIT J NUTR, V83, P389; BRATTSTROM LE, 1988, SCAND J CLIN LAB INV, V48, P215, DOI 10.3109/00365518809167487; Cattaneo M, 1999, THROMB RES, V93, P1, DOI 10.1016/S0049-3848(98)00136-4; D'Angelo A, 2000, THROMB HAEMOSTASIS, V83, P563; Dauzat M, 1997, J CLIN ULTRASOUND, V25, P343, DOI 10.1002/(SICI)1097-0096(199709)25:7<343::AID-JCU1>3.0.CO;2-A; de Moerloose P, 2000, BRIT J HAEMATOL, V110, P125, DOI 10.1046/j.1365-2141.2000.02039.x; De Stefano V, 2000, SEMIN THROMB HEMOST, V26, P305, DOI 10.1055/s-2000-8473; Den Heijer M, 2000, DEV CARDIOVASC MED, V230, P239; DENHEIJER M, 1995, LANCET, V345, P882, DOI 10.1016/S0140-6736(95)90008-X; Durand P, 1997, ARTERIOSCL THROM VAS, V17, P1939, DOI 10.1161/01.ATV.17.10.1939; Durand P, 1996, ATHEROSCLEROSIS, V121, P231, DOI 10.1016/0021-9150(95)06724-8; Egerton W, 1996, AM J CARDIOL, V77, P759, DOI 10.1016/S0002-9149(97)89213-2; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Gemmati D, 1999, ARTERIOSCL THROM VAS, V19, P1761, DOI 10.1161/01.ATV.19.7.1761; HOFFBRAND AV, 1966, J CLIN PATHOL, V19, P17, DOI 10.1136/jcp.19.1.17; Kluijtmans LAJ, 1998, THROMB HAEMOSTASIS, V79, P254, DOI 10.1055/s-0037-1614974; Kraaijenhagen RA, 1998, BAILLIERE CLIN HAEM, V11, P541, DOI 10.1016/S0950-3536(98)80083-8; LINDGREN A, 1995, STROKE, V26, P795, DOI 10.1161/01.STR.26.5.795; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; Meiklejohn DJ, 2001, STROKE, V32, P57, DOI 10.1161/01.STR.32.1.57; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Pita ML, 2000, THROMB HAEMOSTASIS, V84, P420; Quere I, 1998, THROMB HAEMOSTASIS, V80, P707; Ridker PM, 1997, CIRCULATION, V95, P1777; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Usui M, 1999, CLIN SCI, V96, P235, DOI 10.1042/CS19980382; Zittoun J, 1998, METABOLISM, V47, P1413, DOI 10.1016/S0026-0495(98)90315-8; ZITTOUN J, 1993, EUR J CLIN PHARMACOL, V44, P569, DOI 10.1007/BF02440861	33	82	86	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					747	752		10.1016/S0140-6736(02)07876-5	http://dx.doi.org/10.1016/S0140-6736(02)07876-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888585				2022-12-24	WOS:000174115200009
J	Senior, K				Senior, K			Microbleeds may predict cerebral bleeding after stroke	LANCET			English	News Item																		Nighoghossian N, 2002, STROKE, V33, P735, DOI 10.1161/hs0302.104615	1	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					769	769		10.1016/S0140-6736(02)07911-4	http://dx.doi.org/10.1016/S0140-6736(02)07911-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888596				2022-12-24	WOS:000174115200019
J	Ferguson, AD; Chakraborty, R; Smith, BS; Esser, L; van der Helm, D; Deisenhofer, J				Ferguson, AD; Chakraborty, R; Smith, BS; Esser, L; van der Helm, D; Deisenhofer, J			Structural basis of gating by the outer membrane transporter FecA	SCIENCE			English	Article							INDUCED CONFORMATIONAL CHANGE; ENTEROBACTIN RECEPTOR FEPA; FERRIC CITRATE TRANSPORT; ELECTRON-DENSITY MAPS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ANOMALOUS DIFFRACTION; IRON TRANSPORT; PROTEIN TONB; FHUA	Siderophore-mediated acquisition systems facilitate iron uptake. We present the crystallographic structure of the integral outer membrane receptor FecA from Escherichia coli with and without ferric citrate at 2.5 and 2.0 angstrom resolution. FecA is composed of three distinct domains: the barrel, plug, and NH2-terminal extension. Binding of ferric citrate triggers a conformational change of the extracellular loops that close the external pocket of FecA. Ligand-induced allosteric transitions are propagated through the outer membrane by the plug domain, signaling the occupancy of the receptor in the periplasm. These data establish the structural basis of gating for receptors dependent on the cytoplasmic membrane protein TonB. By compiling available data for this family of receptors, we propose a mechanism for the energy-dependent transport of siderophores.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; E Tennessee State Univ, Coll Publ & Allied Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Oklahoma System; University of Oklahoma - Norman; East Tennessee State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Victoria	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	johann.deisenhofer@utsouthwestern.edu						ANGERER A, 1995, MOL MICROBIOL, V18, P163, DOI 10.1111/j.1365-2958.1995.mmi_18010163.x; Bonhivers M, 1996, EMBO J, V15, P1850, DOI 10.1002/j.1460-2075.1996.tb00535.x; Bos C, 1998, J BACTERIOL, V180, P605; Braun M, 1999, MOL MICROBIOL, V33, P1037, DOI 10.1046/j.1365-2958.1999.01546.x; Braun V, 1998, MET IONS BIOL SYST, V35, P67; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DOUBLIE S, 1997, METHOD ENZYMOL, V276, P532; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSER L, COMMUNICATION; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2001, STRUCTURE, V9, P707, DOI 10.1016/S0969-2126(01)00631-1; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Jiang XQ, 1997, SCIENCE, V276, P1261, DOI 10.1126/science.276.5316.1261; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; Kim I, 1997, MOL MICROBIOL, V23, P333, DOI 10.1046/j.1365-2958.1997.2401593.x; KIM WY, 1995, IEEE T CIRC SYST VID, V5, P1, DOI 10.1109/76.350773; Klug CS, 1998, BIOCHEMISTRY-US, V37, P9016, DOI 10.1021/bi980144e; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Larsen RA, 1999, MOL MICROBIOL, V31, P1809, DOI 10.1046/j.1365-2958.1999.01317.x; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Locher KP, 1997, J BIOL CHEM, V272, P1448, DOI 10.1074/jbc.272.3.1448; Moeck GS, 1997, J BIOL CHEM, V272, P28391, DOI 10.1074/jbc.272.45.28391; Moeck GS, 2001, J BACTERIOL, V183, P2755, DOI 10.1128/JB.183.9.2755-2764.2001; NICHOLLS A, 1991, PROTEIN-STRUCT FUNCT, V11, P282; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roosenberg JM, 2000, CURR MED CHEM, V7, P159, DOI 10.2174/0929867003375353; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; SHWEKY I, 1994, INORG CHEM, V33, P5161, DOI 10.1021/ic00101a001; Smith BS, 1998, ACTA CRYSTALLOGR D, V54, P697, DOI 10.1107/S0907444997020222; Usher KC, 2001, P NATL ACAD SCI USA, V98, P10676, DOI 10.1073/pnas.181353398; Weeks CM, 1999, ACTA CRYSTALLOGR D, V55, P492, DOI 10.1107/S0907444998012633	40	289	297	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1715	1719		10.1126/science.1067313	http://dx.doi.org/10.1126/science.1067313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872840				2022-12-24	WOS:000174212900047
J	Guttman, DS; Vinatzer, BA; Sarkar, SF; Ranall, MV; Kettler, G; Greenberg, JT				Guttman, DS; Vinatzer, BA; Sarkar, SF; Ranall, MV; Kettler, G; Greenberg, JT			A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae	SCIENCE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PROGRAMMED CELL-DEATH; AVIRULENCE; PROTEIN; GENE; IDENTIFICATION; EFFECTOR; AVRRPT2; ARABIDOPSIS; YOPE	Type III secreted "effector" proteins of bacterial, pathogens play central roles in virulence, yet are notoriously difficult to identify. We used an in vivo genetic screen to identify 13 effectors secreted by the type III apparatus (called Hrp, for "hypersensitive response and pathogenicity") of the plant pathogen Pseudomonas syringae. Although sharing little overall homology, the amino-terminal regions of these effectors had strikingly similar amino acid compositions. This feature facilitated the bioinformatic prediction of 38 P. syringae effectors, including 15 previously unknown proteins, The secretion of two of these putative effectors was shown to be type III-dependent. Effectors showed high interstrain variation, supporting a rote for some effectors in adaptation to different hosts.	Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Toronto; University of Chicago	Guttman, DS (corresponding author), Univ Toronto, Dept Bot, 25 Willcocks St, Toronto, ON M5S 3B2, Canada.	guttman@botany.utoronto.ca		Greenberg, Jean/0000-0002-7213-7618				Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Axtell MJ, 2001, MOL PLANT MICROBE IN, V14, P181, DOI 10.1094/MPMI.2001.14.2.181; Barbieri AM, 2001, INFECT IMMUN, V69, P5329, DOI 10.1128/IAI.69.9.5329-5334.2001; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Collmer A, 1998, CURR OPIN PLANT BIOL, V1, P329, DOI 10.1016/1369-5266(88)80055-4; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gabriel DW, 1999, PHYSIOL MOL PLANT P, V55, P205, DOI 10.1006/pmpp.1999.0230; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; Glazebrook J, 1997, ANNU REV GENET, V31, P547, DOI 10.1146/annurev.genet.31.1.547; Glazebrook J, 1996, GENETICS, V143, P973; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; GREENBERG JT, 1994, CELL, V77, P551, DOI 10.1016/0092-8674(94)90217-8; Guttman DS, 1998, NATURE, V393, P263, DOI 10.1038/30492; Guttman DS, 2001, MOL PLANT MICROBE IN, V14, P145, DOI 10.1094/MPMI.2001.14.2.145; HERBERS K, 1992, NATURE, V356, P172, DOI 10.1038/356172a0; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; INNES RW, 1993, J BACTERIOL, V175, P4859, DOI 10.1128/JB.175.15.4859-4869.1993; Jackson RW, 1999, P NATL ACAD SCI USA, V96, P10875, DOI 10.1073/pnas.96.19.10875; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kenny B, 2000, CELL MICROBIOL, V2, P579, DOI 10.1046/j.1462-5822.2000.00082.x; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; Liao CH, 1997, CAN J MICROBIOL, V43, P425, DOI 10.1139/m97-060; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; MANSFIELD J, 1994, MOL PLANT MICROBE IN, V7, P726, DOI 10.1094/MPMI-7-0726; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Nambu T, 1999, J BACTERIOL, V181, P1555, DOI 10.1128/JB.181.5.1555-1561.1999; OCHMAN H, 1993, METHOD ENZYMOL, V218, P309; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; RAHME LG, 1992, J BACTERIOL, V174, P3499, DOI 10.1128/JB.174.11.3499-3507.1992; SALMERON JM, 1993, MOL GEN GENET, V239, P6, DOI 10.1007/BF00281595; Sambrook JFE, 1989, MOL CLONING LAB MANU; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; van Dijk K, 1999, J BACTERIOL, V181, P4790, DOI 10.1128/JB.181.16.4790-4797.1999; Yokoyama K, 2000, GENE, V258, P127, DOI 10.1016/S0378-1119(00)00416-9	43	299	326	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2002	295	5560					1722	1726		10.1126/science.295.5560.1722	http://dx.doi.org/10.1126/science.295.5560.1722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527XH	11872842				2022-12-24	WOS:000174212900049
J	Yakir, D				Yakir, D			Global enzymes - Sphere of influence	NATURE			English	Editorial Material									Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yakir, D (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.		Yakir, Dan/K-1500-2012					BERRY J, 1992, PRIMARY PRODUCTIVITY, P411; BIGELEISEN J, 1965, SCIENCE, V147, P463, DOI 10.1126/science.147.3657.463; GRIFFITH H, 1998, STABLE ISOTOPES INTE	3	10	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2002	416	6883					795	795		10.1038/416795a	http://dx.doi.org/10.1038/416795a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544MH	11976659	Bronze			2022-12-24	WOS:000175163800029
J	Walker, NJ				Walker, NJ			A technique whose time has come	SCIENCE			English	Article							POLYMERASE CHAIN-REACTION; PCR; AMPLIFICATION		NIEHS, Environm Toxicol Program, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Walker, NJ (corresponding author), NIEHS, Environm Toxicol Program, POB 12233, Res Triangle Pk, NC 27709 USA.		Walker, Nigel J/D-6583-2012	Walker, Nigel J/0000-0002-9111-6855				Gibbs WW, 2001, SCI AM, V285, P52, DOI 10.1038/scientificamerican0801-52; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GUYER RL, 1989, SCIENCE, V246, P1543, DOI 10.1126/science.2688087; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Lobenhofer EK, 2001, ENVIRON HEALTH PERSP, V109, P881, DOI 10.2307/3454988; Mitchell P, 2001, NAT BIOTECHNOL, V19, P717, DOI 10.1038/90754; MULLIS KB, 1990, SCI AM, V262, P56, DOI 10.1038/scientificamerican0490-56; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Walker NJ, 2001, J BIOCHEM MOL TOXIC, V15, P121, DOI 10.1002/jbt.8; White B. A., 1993, PCR PROTOCOLS CURREN, V15	16	246	259	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 19	2002	296	5567					557	+		10.1126/science.296.5567.557	http://dx.doi.org/10.1126/science.296.5567.557			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11964485				2022-12-24	WOS:000175179400054
J	Schnitzer, MJ				Schnitzer, MJ			Biological computation: Amazing algorithms	NATURE			English	Editorial Material									Bell Labs, Lucent Technol, Dept Biol Computat & Theoret Phys, Murray Hill, NJ 07974 USA	Alcatel-Lucent; Lucent Technologies; AT&T	Schnitzer, MJ (corresponding author), Bell Labs, Lucent Technol, Dept Biol Computat & Theoret Phys, 600 Mt Ave, Murray Hill, NJ 07974 USA.							[Anonymous], [No title captured]; Carew T., 2000, BEHAV NEUROBIOLOGY; Von Neumann J., 2012, COMPUTER BRAIN; Wandell B., 1995, FDN VISION; WEINER N, 1961, CYBERNETICS	5	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 18	2002	416	6882					683	683		10.1038/416683a	http://dx.doi.org/10.1038/416683a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961533	Bronze			2022-12-24	WOS:000175033500022
J	Shinohara, M; Terada, Y; Iwamatsu, A; Shinohara, A; Mochizuki, N; Higuchi, M; Gotoh, Y; Ihara, S; Nagata, S; Itoh, H; Fukui, Y; Jessberger, R				Shinohara, M; Terada, Y; Iwamatsu, A; Shinohara, A; Mochizuki, N; Higuchi, M; Gotoh, Y; Ihara, S; Nagata, S; Itoh, H; Fukui, Y; Jessberger, R			SWAP-70 is a guanine-nucleotide-exchange factor that mediates signalling of membrane ruffling	NATURE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHOINOSITIDE 3-KINASE; LIPID PRODUCTS; PHOSPHATIDYLINOSITOL-3 KINASE; PLECKSTRIN HOMOLOGY; RAS; BINDING; TRANSDUCTION; CELLS	Phosphoinositide-3-OH kinase (PI(3) K), activated through growth factor stimulation, generates a lipid second messenger, phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5) P-3)(1-5). PtdIns(3,4,5) P-3 is instrumantal in signalling pathways that trigger cell activation, cytoskeletal rearrangement, survival and other reactions. However, some targets of PtdIns( 3,4,5) P3 are yet to be discovered(1-7). We demonstrate that SWAP-70, a unique signalling protein(8-10), specifically binds PtdIns(3,4,5) P-3.On stimulation by growth factors, cytoplasmic SWAP-70, which is dependent on PI(3) K but independent of Ras, moved to cell membrane rearrangements known as ruffles. However, mutant SWAP-70 lacking the ability to bind PtdIns(3, 4, 5) P-3 blocked membrane ruffling induced by epidermal growth factor or platelet-derived growth factor. SWAP-70 shows low homology with Rac-guanine nucleotide exchange factors (GEFs), and catalyses PtdIns( 3,4,5) P-3-dependent guanine nucleotide exchange to Rac. SWAP-70-deficient fibroblasts showed impaired membrane ruffling after stimulation with epidermal growth factor, and failed to activate Rac fully. We conclude that SWAP-70 is a new type of Rac-GEF which, independently of Ras, transduces signals from tyrosine kinase receptors to Rac.	Univ Tokyo, Fac Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; Int Med Ctr Japan, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Mt Sinai Sch Med, Carl C Icahn Inst Gene Therapy & Mol Med, New York, NY 10029 USA	University of Tokyo; Kirin Brewery Company Limited; National Center for Global Health & Medicine - Japan; University of Tokyo; Icahn School of Medicine at Mount Sinai	Fukui, Y (corresponding author), Univ Tokyo, Fac Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	ayfukui@mail.ecc.u-tokyo.ac.jp	Nagata, Satoshi/B-5781-2008; Fukui, Yasuhisa/E-8806-2010	Shinohara, Masahiro/0000-0002-5532-1042; Nagata, Satoshi/0000-0001-9156-5215				Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Borggrefe T, 1999, EUR J IMMUNOL, V29, P1812, DOI 10.1002/(SICI)1521-4141(199906)29:06<1812::AID-IMMU1812>3.0.CO;2-J; Borggrefe T, 2001, EUR J IMMUNOL, V31, P2467, DOI 10.1002/1521-4141(200108)31:8<2467::AID-IMMU2467>3.0.CO;2-P; CAMPBELL DJ, 1966, NATURE, V210, P756, DOI 10.1038/210756b0; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Downward J, 1997, ADV SEC MESS PHOSPH, V31, P1; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; GROSS B, IN PRESS EUR J IMMUN; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kita Y, 1998, J CELL SCI, V111, P907; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; MAEKAWA M, 1994, MOL CELL BIOL, V14, P6879, DOI 10.1128/MCB.14.10.6879; Martin SS, 1996, ENDOCRINOLOGY, V137, P5045, DOI 10.1210/en.137.11.5045; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Masat L, 2000, P NATL ACAD SCI USA, V97, P2180, DOI 10.1073/pnas.040374497; Missy K, 1998, J BIOL CHEM, V273, P30279, DOI 10.1074/jbc.273.46.30279; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Shirai R, 1998, TETRAHEDRON LETT, V39, P9485, DOI 10.1016/S0040-4039(98)02151-0; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Tanaka K, 1999, J BIOL CHEM, V274, P3919, DOI 10.1074/jbc.274.7.3919; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	31	176	179	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 18	2002	416	6882					759	763		10.1038/416759a	http://dx.doi.org/10.1038/416759a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	542FU	11961559				2022-12-24	WOS:000175033500047
J	Metz, M; Futterer, J				Metz, M; Futterer, J			Biodiversity (communications arising) - Suspect evidence of transgenic contamination	NATURE			English	Article									Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; ETH Zurich, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of Washington; University of Washington Seattle; Swiss Federal Institutes of Technology Domain; ETH Zurich	Metz, M (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.							Jayaraman KS, 2001, NATURE, V413, P555, DOI 10.1038/35098210; Neto RB, 1999, NATURE, V402, P344, DOI 10.1038/46400; Pawlowski WP, 1998, P NATL ACAD SCI USA, V95, P12106, DOI 10.1073/pnas.95.21.12106; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068	4	61	71	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 11	2002	416	6881					600	601		10.1038/nature738	http://dx.doi.org/10.1038/nature738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539YV	11935144				2022-12-24	WOS:000174901900030
J	Seki, M; Narusaka, M; Kamiya, A; Ishida, J; Satou, M; Sakurai, T; Nakajima, M; Enju, A; Akiyama, K; Oono, Y; Muramatsu, M; Hayashizaki, Y; Kawai, J; Carninci, P; Itoh, M; Ishii, Y; Arakawa, T; Shibata, K; Shinagawa, A; Shinozaki, K				Seki, M; Narusaka, M; Kamiya, A; Ishida, J; Satou, M; Sakurai, T; Nakajima, M; Enju, A; Akiyama, K; Oono, Y; Muramatsu, M; Hayashizaki, Y; Kawai, J; Carninci, P; Itoh, M; Ishii, Y; Arakawa, T; Shibata, K; Shinagawa, A; Shinozaki, K			Functional annotation of a full-length Arabidopsis cDNA collection	SCIENCE			English	Article							EXPRESSED SEQUENCE TAGS; TRAPPER-SELECTED CDNAS; CLONING; PLANT; DISCOVERY; THALIANA; SIZE	Full-length complementary DNAs (cDNAs) are essential for the correct annotation of genomic sequences and for the functional analysis of genes and their products. We isolated 155,144 RIKEN Arabidopsis full-length (RAFL) cDNA clones. The 3'-end expressed sequence tags (ESTs) of 155,144 RAFL cDNAs were clustered into 14,668 nonredundant cDNA groups, about 60% of predicted genes. We also obtained 5' ESTs from 14,034 nonredundant cDNA groups and constructed a promoter database. The sequence database of the RAFL cDNAs is useful for promoter analysis and correct annotation of predicted transcription units and gene products. Furthermore, the full-length cDNAs are useful resources for analyses of the expression profiles, functions, and structures of plant proteins.	RIKEN, Tsukuba Inst, Plant Mol Biol Lab, Tsukuba, Ibaraki 3050074, Japan; RIKEN, Genom Sci Ctr, Plant Funct Genom Res Grp, Plant Mutat Explorat Team, Tsukuba, Ibaraki 3050074, Japan; Univ Tsukuba, Masters Program Biosyst Studies, Tsukuba, Ibaraki 3050074, Japan; RIKEN GSC, Yokohama Inst, Lab Genome Explorat Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, Genome Sci Lab, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; University of Tsukuba; RIKEN; RIKEN	Shinozaki, K (corresponding author), RIKEN, Tsukuba Inst, Plant Mol Biol Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sinozaki@rtc.riken.go.jp	shibata, kazuhiro/A-9527-2008; Kawai, Jun/A-6451-2016; Sakurai, Tetsuya/B-2690-2010; Itoh, Masayoshi/N-5363-2015; Hayashizaki, Yoshihide/N-6590-2015; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/G-4202-2013; Carninci, Piero/K-1568-2014	Sakurai, Tetsuya/0000-0003-2046-8973; Itoh, Masayoshi/0000-0002-1772-318X; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Carninci, Piero/0000-0001-7202-7243				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Asamizu E, 2000, DNA RES, V7, P175, DOI 10.1093/dnares/7.3.175; Bevan M, 1997, PLANT CELL, V9, P476, DOI 10.1105/tpc.9.4.476; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Carninci P, 1998, P NATL ACAD SCI USA, V95, P520, DOI 10.1073/pnas.95.2.520; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2001, GENOMICS, V77, P79, DOI 10.1006/geno.2001.6601; Carninci P, 1997, DNA Res, V4, P61, DOI 10.1093/dnares/4.1.61; Cooke R, 1996, PLANT J, V9, P101, DOI 10.1046/j.1365-313X.1996.09010101.x; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HOFTE H, 1993, PLANT J, V4, P1051, DOI 10.1046/j.1365-313X.1993.04061051.x; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; NEWMAN T, 1994, PLANT PHYSIOL, V106, P1241, DOI 10.1104/pp.106.4.1241; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2001, PLANT PHYSIOL BIOCH, V39, P211, DOI 10.1016/S0981-9428(01)01244-X; Shibata Y, 2001, BIOTECHNIQUES, V30, P1250, DOI 10.2144/01306st01; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582	20	524	1720	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 5	2002	296	5565					141	145		10.1126/science.1071006	http://dx.doi.org/10.1126/science.1071006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539FA	11910074				2022-12-24	WOS:000174858800048
J	Woods, WG; Gao, RN; Shuster, JJ; Robison, LL; Bernstein, M; Weitzman, S; Bunin, G; Levy, I; Brossard, J; Dougherty, G; Tuchman, M; Lemieux, B				Woods, WG; Gao, RN; Shuster, JJ; Robison, LL; Bernstein, M; Weitzman, S; Bunin, G; Levy, I; Brossard, J; Dougherty, G; Tuchman, M; Lemieux, B			Screening of infants and mortality due to neuroblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AGE-SPECIFIC INCIDENCE; CHILDHOOD-CANCER; NEURO-BLASTOMA; UNITED-STATES; NORTH-AMERICA; PROJECT; JAPAN; CHILDREN; TRIALS	Background: Neuroblastoma, the most common extracranial solid tumor that occurs in early childhood, can be identified in the preclinical stages by the detection of catecholamines in the urine. However, it is unknown whether routine screening for neuroblastoma reduces mortality due to this disease. Methods: Through their parents, we offered screening for neuroblastoma at three weeks and six months of age to all 476,654 children born in the province of Quebec, Canada, during a five-year period (May 1, 1989, through April 30, 1994). The participation rate was 92 percent. The rate of death due to neuroblastoma was determined and compared with the rates in several unscreened control populations born during the same period. Results: Among children younger than eight years of age in the Quebec cohort, there were 22 deaths due to neuroblastoma; the cumulative (+/-SE) mortality rate due to neuroblastoma was 4.78+/-1.14 per 100,000 children over a period of nine years. The standardized incidence ratios for death due to neuroblastoma for the Quebec cohort were 1.11 (95 percent confidence interval, 0.64 to 1.92) as compared with a control group in Ontario, Canada; 0.90 (95 percent confidence interval, 0.48 to 1.70) as compared with a control group in Minnesota; 1.40 (95 percent confidence interval, 0.81 to 2.41) as compared with a control group in Florida; and 0.96 (95 percent confidence interval, 0.56 to 1.66) as compared with a control group in the Greater Delaware Valley. The standardized mortality ratio for the Quebec cohort as compared with the rest of Canada was 1.39 (95 percent confidence interval, 0.85 to 2.30); the odds ratio for the comparison with a cohort born in Quebec before the screening program began was 0.98 (95 percent confidence interval, 0.54 to 1.77). Conclusions: Screening infants for neuroblastoma does not appear to reduce mortality due to this disease.	Emory Univ, AFLAC Canc Ctr, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; Stat Canada, Ottawa, ON, Canada; Univ Florida, Gainesville, FL USA; Univ Minnesota, Minneapolis, MN USA; Hop St Justine, Montreal, PQ H3T 1C5, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Canadian Med Assoc, Ottawa, ON, Canada; Ctr Univ Sante Estrie, Sherbrooke, PQ, Canada; Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; Childrens Natl Med Ctr, Washington, DC 20010 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Statistics Canada; State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; Children's National Health System	Woods, WG (corresponding author), Emory Univ, AFLAC Canc Ctr, 1405 Clifton Rd NE,Rm 319, Atlanta, GA 30322 USA.		Shuster, Jonathan/ABB-5773-2021; Robison, Leslie/N-8122-2018	Shuster, Jonathan/0000-0001-9499-5616; 	NATIONAL CANCER INSTITUTE [R01CA046907] Funding Source: NIH RePORTER; NCI NIH HHS [CA46907] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ater JL, 1998, CANCER, V82, P1593, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1593::AID-CNCR23>3.0.CO;2-Z; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P323, DOI 10.1200/JCO.1992.10.2.323; BERNSTEIN ML, 1992, J CLIN ONCOL, V10, P1202; BESSHO F, 1991, J PEDIATR-US, V119, P237, DOI 10.1016/S0022-3476(05)80733-4; Bessho F, 1996, INT J CANCER, V67, P520, DOI 10.1002/(SICI)1097-0215(19960807)67:4<520::AID-IJC10>3.0.CO;2-B; BRESLOW NE, 1987, IARC SCI PUBL, V82, P8; BRODEUR GM, 1992, AM J PEDIAT HEMATOL, V14, P111; Brodeur GM, 2001, MED PEDIATR ONCOL, V36, P157, DOI 10.1002/1096-911X(20010101)36:1<157::AID-MPO1038>3.0.CO;2-F; Castleberry RP, 1997, PEDIATR CLIN N AM, V44, P919, DOI 10.1016/S0031-3955(05)70537-X; Gao RN, 1997, CANCER CAUSE CONTROL, V8, P745, DOI 10.1023/A:1018483405637; KANEKO Y, 1990, J CLIN ONCOL, V8, P2005, DOI 10.1200/JCO.1990.8.12.2005; KRAMER S, 1983, J NATL CANCER I, V70, P49; Lemieux B, 1987, ADV NEONATAL SCREENI, P209; MURPHY SB, 1991, LANCET, V337, P344, DOI 10.1016/0140-6736(91)90957-Q; NISHI M, 1987, CANCER, V60, P433, DOI 10.1002/1097-0142(19870801)60:3<433::AID-CNCR2820600326>3.0.CO;2-H; Ries L.A.G., 1999, CANC INCIDENCE SURVI; Ross JA, 1996, CANCER, V77, P201, DOI 10.1002/(SICI)1097-0142(19960101)77:1<201::AID-CNCR32>3.0.CO;2-7; SAWADA T, 1984, LANCET, V2, P271; Schilling FH, 2002, NEW ENGL J MED, V346, P1047, DOI 10.1056/NEJMoa012277; Suita S, 1998, J PEDIATR SURG, V33, P1674, DOI 10.1016/S0022-3468(98)90607-8; TUCHMAN M, 1990, PEDIATRICS, V86, P765; VOORHESS ML, 1962, J CLIN ENDOCR METAB, V22, P126, DOI 10.1210/jcem-22-2-126; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; WOODS WG, 1992, PEDIATRICS, V89, P114; WOODS WG, 1992, AM J PEDIAT HEMATOL, V14, P312; Woods WG, 1999, MED PEDIATR ONCOL, V33, P360; WOODS WG, 1992, SCREENING, V1, P273; YAMAMOTO K, 1995, J CLIN ONCOL, V13, P2033, DOI 10.1200/JCO.1995.13.8.2033; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; 1999, MED PEDIAT ONCOL, V33, P357	30	233	239	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 4	2002	346	14					1041	1046		10.1056/NEJMoa012387	http://dx.doi.org/10.1056/NEJMoa012387			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YL	11932470				2022-12-24	WOS:000174729400002
J	Ehrlich, GD; Veeh, R; Wang, X; Costerton, JW; Hayes, JD; Hu, FZ; Daigle, BJ; Ehrlich, MD; Post, JC				Ehrlich, GD; Veeh, R; Wang, X; Costerton, JW; Hayes, JD; Hu, FZ; Daigle, BJ; Ehrlich, MD; Post, JC			Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUORUM-SENSING SIGNALS; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILMS; VIABLE BACTERIA; EFFUSION; CULTURE; ADENOIDECTOMY; MICROSCOPY; PERSISTENT; ENDOTOXIN	Context Chronic otitis media with effusion (OME) has long been considered to be a sterile inflammatory process, The previous application of molecular diagnostic technologies to OME suggests that viable bacteria are present in complex communities known as mucosal biofilms; however, direct imaging evidence of mucosal biofilms associated with OM is lacking. Objective To determine whether biofilm formation occurs in middle-ear mucosa in an experimental model of otitis media. Design and Materials A total of 48 research-grade, young adult chinchillas weighing 500 g were used for 2 series of animal experiments: one to obtain specimens for scanning electron microscopy and the other to obtain specimens for confocal laser scanning microscopy using vital dyes. In each series, 21 animals were bilaterally injected with viable Haemophilus influenzae bacteria and 1 was inoculated to account for expected mortality, Three served as negative controls. Effusions and mucosal specimens were collected from 2 infected animals that were euthanized at 3, 6, 12, and 24 hours and at days 2, 4, 5, 10, 16, and 22 after inoculation. Main Outcome Measures Images were analyzed for biofilm morphology, including presence of microcolony formation and for presence of bacteria on tissue surfaces. Results Scanning electron microscopy demonstrated that biofilm formation was evident in all specimens from animals beginning 1 day after infection and was present through 21 days, Confocal laser scanning microscopy indicated that bacteria within the biofilms are viable. Conclusion These preliminary findings provide evidence that mucosal biofilms form in an experimental model of otitis media and suggest that biofilm formation may be an important factor in the pathogenesis of chronic otitis media with effusion.	Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; MCP Hahnemann Sch Med, Dept Microbiol & Immunol, Philadelphia, PA USA; Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	Drexel University; Montana State University System; Montana State University Bozeman	Ehrlich, GD (corresponding author), Allegheny Singer Res Inst, Ctr Genom Sci, 320 E N Ave, Pittsburgh, PA 15212 USA.		Daigle, Bernie/AAO-5462-2021	Ehrlich, Garth/0000-0003-1140-6594	NIDCD NIH HHS [DC04173, DC02148] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004173, R01DC002148] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aul JJ, 1998, ANN OTO RHINOL LARYN, V107, P508; Becker P, 2001, APPL ENVIRON MICROB, V67, P2958, DOI 10.1128/AEM.67.7.2958-2965.2001; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Cook G, 2000, INT J ANTIMICROB AG, V13, P169, DOI 10.1016/S0924-8579(99)00120-X; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86; Costerton JW, 2001, SCI AM, V285, P74, DOI 10.1038/scientificamerican0701-74; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; DEMARIA TF, 1984, J CLIN MICROBIOL, V20, P15, DOI 10.1128/JCM.20.1.15-17.1984; Dingman JR, 1998, J CLIN MICROBIOL, V36, P3417, DOI 10.1128/JCM.36.11.3417-3419.1998; DONOGHUE HD, 1991, CARIES RES, V25, P108, DOI 10.1159/000261352; Ehrlich GD, 1999, JAMA-J AM MED ASSOC, V282, P2167, DOI 10.1001/jama.282.22.2167; FITZGERALD G, 1975, J BACTERIOL, V122, P345, DOI 10.1128/JB.122.1.345-346.1975; GATES GA, 1987, NEW ENGL J MED, V317, P1444, DOI 10.1056/NEJM198712033172305; GEESEY GG, 1978, LIMNOL OCEANOGR, V23, P1214, DOI 10.4319/lo.1978.23.6.1214; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; HOYLE BD, 1990, J ANTIMICROB CHEMOTH, V26, P1, DOI 10.1093/jac/26.1.1; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Leung JW, 1998, GASTROINTEST ENDOSC, V48, P250, DOI 10.1016/S0016-5107(98)70186-5; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MAW R, 1993, BMJ-BRIT MED J, V306, P756, DOI 10.1136/bmj.306.6880.756; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Parsek MR, 1999, METHOD ENZYMOL, V310, P43; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Post JC, 2000, JAMA-J AM MED ASSOC, V283, P1544, DOI 10.1001/jama.283.12.1544; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Post JC, 1996, AM J OTOLARYNG, V17, P106, DOI 10.1016/S0196-0709(96)90005-8; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Rayner MG, 1998, JAMA-J AM MED ASSOC, V279, P296, DOI 10.1001/jama.279.4.296; ROSENFELD RM, 1992, OTOLARYNG HEAD NECK, V106, P378, DOI 10.1177/019459989210600411; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SIRAKOVA T, 1994, INFECT IMMUN, V62, P2002, DOI 10.1128/IAI.62.5.2002-2020.1994; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Williams I, 1999, MICROBIOL-UK, V145, P1325, DOI 10.1099/13500872-145-6-1325; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x	43	258	286	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1710	1715		10.1001/jama.287.13.1710	http://dx.doi.org/10.1001/jama.287.13.1710			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926896	Green Published, Bronze			2022-12-24	WOS:000174730300026
J	Kim, JH; Skates, SJ; Uede, T; Wong, KK; Schorge, JO; Feltmate, CM; Berkowitz, RS; Cramer, DW; Mok, SC				Kim, JH; Skates, SJ; Uede, T; Wong, KK; Schorge, JO; Feltmate, CM; Berkowitz, RS; Cramer, DW; Mok, SC			Osteopontin as a potential diagnostic biomarker for ovarian cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SECRETED PHOSPHOPROTEIN-I; MESSENGER-RNA; MOLECULAR-CLONING; PROSTATE-CANCER; GENE-EXPRESSION; IDENTIFICATION; MACROPHAGES; BREAST; CELLS; SERUM	Context Development of new biomarkers for ovarian cancer is needed for early detection and disease monitoring. Analyses involving complementary DNA (cDNA) microarray data can be used to identify up-regulated genes in cancer cells, whose products may then be further validated as potential biomarkers. Objective To describe validation studies of an up-regulated gene known as osteopontin, previously identified using a cDNA microarray system. Design, Setting, and Participants Experimental and cross-sectional studies were conducted involving ovarian cancer and healthy human ovarian surface epithelial cell lines and cultures, archival paraffin-embedded ovarian tissue collected between June 1992 and June 2001, and fresh tissue and preoperative plasma from 144 patients evaluated for a pelvic mass between June 1992 and June 2001 in gynecologic oncology services at 2 US academic institutions. Plasma samples from 107 women selected from an epidemiologic study of ovarian cancer initiated between May 1992 and March 1997 were used as healthy controls. Main Outcome Measures Relative messenger RNA expression in cancer cells and fresh ovarian tissue, measured by real-time polymerase chain reaction as 2(-DeltaDeltaCT) (a quantitative value representing the amount of osteopontin expression); osteopontin production, localized and scored in ovarian healthy and tumor tissue with immunohistochemical studies; and amount of osteopontin in patient vs control plasma, measured using an enzyme-linked immunoassay. Results The geometric mean for 2(-DeltaDeltaCT) for osteopontin expression in 5 healthy ovarian epithelial cell cultures was 4.1 compared with 270.4 in 14 ovarian cancer cell lines (P=.03). The geometric mean 2(-DeltaDeltaCT) for osteopontin expression in tissue from 2 healthy ovarian epithelial samples was 9.0 compared with 164.0 in 27 microdissected ovarian tumor tissue samples (P=.06). Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P=.03). Osteopontin levels in plasma were significantly higher (P<.001) in 51 patients with epithelial ovarian cancer (486.5 ng/mL) compared with those of 107 healthy controls (147.1 ng/mL), 46 patients with benign ovarian disease (254.4 ng/mL), and 47 patients with other gynecologic cancers (260.9 ng/mL). Conclusions Our findings provide evidence for an association between levels of a biomarker, osteopontin, and ovarian cancer and suggest that future research assessing its clinical usefulness would be worthwhile.	Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Gynecol Oncol, Lab Gynecol Oncol, Boston, MA 02115 USA; St Vincent Hosp, Dept Obstet & Gynecol, Suwon, Kyong Ki Do, South Korea; Catholic Univ Korea, Suwon, Kyong Ki Do, South Korea; Harvard Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Ctr Biostat, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Dana Farber Harvard Canc Ctr, Boston, MA USA; Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido, Japan; Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Obstet & Gynecol, Dallas, TX USA	Harvard University; Brigham & Women's Hospital; Catholic University of Korea; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Hokkaido University; Baylor College of Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mok, SC (corresponding author), Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Div Gynecol Oncol, Lab Gynecol Oncol, BL1-447,221 Longwood Ave, Boston, MA 02115 USA.	scmok@rics.bwh.harvard.edu	Wong, K.-k./AAA-6589-2020	Wong, K.-k./0000-0002-0375-6669; Feltmate, Colleen/0000-0002-7700-8575; Jae-Hoon, Kim/0000-0001-6599-7065	NATIONAL CANCER INSTITUTE [U01CA086381] Funding Source: NIH RePORTER; NCI NIH HHS [CA86381] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bull JH, 2001, BRIT J CANCER, V84, P1512, DOI 10.1054/bjoc.2001.1816; Casson AG, 1997, INT J CANCER, V72, P739, DOI 10.1002/(SICI)1097-0215(19970904)72:5<739::AID-IJC6>3.0.CO;2-T; CHACKALAPARAMPIL I, 1985, J VIROL, V53, P841, DOI 10.1128/JVI.53.3.841-850.1985; Chan WY, 2000, AM J PATHOL, V156, P409, DOI 10.1016/S0002-9440(10)64744-X; Cramer DW, 2001, INT J CANCER, V94, P128, DOI 10.1002/ijc.1435; Cramer DW, 2000, CANCER EPIDEM BIOMAR, V9, P95; Crawford HC, 1998, CANCER RES, V58, P5206; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; GIACHELLI C, 1991, BIOCHEM BIOPH RES CO, V177, P867, DOI 10.1016/0006-291X(91)91870-I; Giachelli CM, 1998, AM J PATHOL, V152, P353; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOGDALL CK, 1995, GYNECOL ONCOL, V56, P22, DOI 10.1006/gyno.1995.1004; HWANG S, 1994, J BIOL CHEM, V269, P711; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Kim Youn Wha, 1998, Journal of Korean Medical Science, V13, P652; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Maki M, 2000, PATHOL INT, V50, P531, DOI 10.1046/j.1440-1827.2000.01075.x; McKee MD, 1996, ANAT RECORD, V245, P394, DOI 10.1002/(SICI)1097-0185(199606)245:2<394::AID-AR19>3.0.CO;2-K; Mok SC, 2001, J NATL CANCER I, V93, P1458, DOI 10.1093/jnci/93.19.1458; Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414; NEGISHI Y, 1993, GYNECOL ONCOL, V48, P148, DOI 10.1006/gyno.1993.1026; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; *PE APPL BIOS, 1998, GEN AMP 5700 US MAN, pA9; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; REIS LA, 1998, SEER CANC STAT REV 1; Sandmaier BM, 1999, J IMMUNOTHER, V22, P54, DOI 10.1097/00002371-199901000-00008; SENGER DR, 1989, ANTICANCER RES, V9, P1291; Sgroi DC, 1999, CANCER RES, V59, P5656; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P1269, DOI 10.1164/ajrccm.160.4.9807094; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; SMITH JH, 1987, J CELL BIOCHEM, V34, P13, DOI 10.1002/jcb.240340103; Thalmann GN, 1999, CLIN CANCER RES, V5, P2271; Tiniakos DG, 1998, HUM PATHOL, V29, P1250, DOI 10.1016/S0046-8177(98)90253-2; TSAO SW, 1995, EXP CELL RES, V218, P499, DOI 10.1006/excr.1995.1184; Tuck AB, 1998, INT J CANCER, V79, P502, DOI 10.1002/(SICI)1097-0215(19981023)79:5<502::AID-IJC10>3.0.CO;2-3; Tunio GM, 1998, ARCH PATHOL LAB MED, V122, P1087; Tuxen MK, 1999, GYNECOL ONCOL, V74, P12, DOI 10.1006/gyno.1999.5414; Ue T, 1998, INT J CANCER, V79, P127, DOI 10.1002/(SICI)1097-0215(19980417)79:2<127::AID-IJC5>3.0.CO;2-V; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wong KK, 2001, BIOTECHNIQUES, V30, P670, DOI 10.2144/01303dd05; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Zhang J, 2001, CANCER LETT, V171, P215, DOI 10.1016/S0304-3835(01)00607-3	48	368	399	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 3	2002	287	13					1671	1679		10.1001/jama.287.13.1671	http://dx.doi.org/10.1001/jama.287.13.1671			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536YW	11926891	Bronze			2022-12-24	WOS:000174730300021
J	Dittmar, GAG; Wilkinson, CRM; Jedrzejewski, PT; Finley, D				Dittmar, GAG; Wilkinson, CRM; Jedrzejewski, PT; Finley, D			Role of a ubiquitin-like modification in polarized morphogenesis	SCIENCE			English	Article							PROTEIN CONJUGATION SYSTEM; YEAST	Type I ubiquitin-like proteins constitute a family of protein modifiers. Here we report the identification of a posttranslational protein modifier from Saccharomyces cerevisiae, Hub1. Overexpression of Hub1 resulted in enhanced conjugate formation when its carboxyl-terminal residue was deleted, suggesting that mature Hub1 may be produced by proteolytic processing. In vivo targets of Hub1 conjugation included cell polarity factors Sph1 and Hbt1. In the hub1Delta mutant, the subcellular localization of both Hbt1 and Sph1 was disrupted, and cell polarization during the formation of mating projections was defective. Consistent with these polarization defects, the hub1Delta mutant was deficient in mating.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Northeastern Univ, Barnett Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Northeastern University	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	daniel_finley@hms.harvard.edu	Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623	NIGMS NIH HHS [GM58223, GM62663] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058223, R01GM062663] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkowitz RA, 1997, J CELL BIOL, V138, P17, DOI 10.1083/jcb.138.1.17; DOOLITTLE RF, 1987, URFS ORFS PRIMER ANA; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Friedmann JS, 2001, GENOMICS, V71, P252, DOI 10.1006/geno.2000.6439; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P732; Roemer T, 1998, J CELL SCI, V111, P479; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	23	68	74	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 29	2002	295	5564					2442	2446		10.1126/science.1069989	http://dx.doi.org/10.1126/science.1069989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	536QD	11923536				2022-12-24	WOS:000174712600053
J	Ng, J; Nardine, T; Harms, M; Tzu, J; Goldstein, A; Sun, Y; Dietzl, G; Dickson, BJ; Luo, LQ				Ng, J; Nardine, T; Harms, M; Tzu, J; Goldstein, A; Sun, Y; Dietzl, G; Dickson, BJ; Luo, LQ			Rac GTPases control axon growth, guidance and branching	NATURE			English	Article							GTP-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; NEURONAL MORPHOGENESIS; ACTIN POLYMERIZATION; RHO GTPASES; DISTINCT; CDC42; PAK; PROLIFERATION; PURIFICATION	Growth, guidance and branching of axons are all essential processes for the precise wiring of the nervous system. Rho family GTPases transduce extracellular signals to regulate the actin cytoskeleton(1). In particular, Rac has been implicated in axon growth and guidance(2-8). Here we analyse the loss-of-function phenotypes of three Rac GTPases in Drosophila mushroom body neurons. We show that progressive loss of combined Rac1, Rac2 and Mtl activity leads first to defects in axon branching, then guidance, and finally growth. Expression of a Rac1 effector domain mutant that does not bind Pak rescues growth, partially rescues guidance, but does not rescue branching defects of Rac mutant neurons. Mosaic analysis reveals both cell autonomous and non-autonomous functions for Rac GTPases, the latter manifesting itself as a strong community effect in axon guidance and branching. These results demonstrate the central role of Rac GTPases in multiple aspects of axon development in vivo, and suggest that axon growth, guidance and branching could be controlled by differential activation of Rac signalling pathways.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Ng, Julian/C-5747-2009; Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Luo, Liqun/0000-0001-5467-9264; Ng, Julian/0000-0002-1908-4414				BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kaufmann N, 1998, DEVELOPMENT, V125, P453; KNAUS UG, 1992, J BIOL CHEM, V267, P23575; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MARSH L, 1984, J CELL BIOL, V99, P2041, DOI 10.1083/jcb.99.6.2041; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; YAMADA KM, 1970, P NATL ACAD SCI USA, V66, P1206, DOI 10.1073/pnas.66.4.1206; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	30	266	271	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 28	2002	416	6879					442	447		10.1038/416442a	http://dx.doi.org/10.1038/416442a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534UX	11919635				2022-12-24	WOS:000174607800050
J	Carbone, C; Gittleman, JL				Carbone, C; Gittleman, JL			A common rule for the scaling of carnivore density	SCIENCE			English	Article							POPULATION-DENSITY; PLANT ENERGETICS; BODY SIZE; PREY; TERRESTRIAL; ECOLOGY; CONSERVATION; EXTINCTION; PREDATOR; MAMMALS	Population density in plants and animals is thought to scale with size as a result of mass-related energy requirements. Variation in resources, however, naturally limits population density and may alter expected scaling patterns. We develop and test a general model for variation within and between species in population density across the order Carnivora. We find that 10,000 kilograms of prey supports about 90 kilograms of a given species of carnivore, irrespective of body mass, and that the ratio of carnivore number to prey biomass scales to the reciprocal of carnivore mass. Using mass-specific equations of prey productivity, we show that carnivore number per unit prey productivity scales to carnivore mass near -0.75, and that the scaling rule can predict population density across more than three orders of magnitude. The relationship provides a basis for identifying declining carnivore species that require conservation measures.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	Zoological Society of London; University of Virginia	Carbone, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	chris.carbone@ioz.ac.uk						Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; [Anonymous], PATTERNS PROCESSES M; Bailey, 1993, AFRICAN LEOPARD ECOL; BANSE K, 1980, ECOL MONOGR, V50, P355, DOI 10.2307/2937256; Berger J, 2001, SCIENCE, V291, P1036, DOI 10.1126/science.1056466; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Blackburn TM, 1996, OIKOS, V75, P303, DOI 10.2307/3546254; Brown JH, 2000, SFI S SCI C, P1; Brown JH, 1995, MACROECOLOGY; Calder WA, 2000, SFI S SCI C, P297; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Damuth JD, 1998, NATURE, V395, P115, DOI 10.1038/25843; Dewar RC, 1999, NATURE, V398, P572, DOI 10.1038/19215; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V398, P573, DOI 10.1038/19219; FARLOW JO, 1976, ECOLOGY, V57, P841, DOI 10.2307/1941052; Fuller TK, 1998, ANIM CONSERV, V1, P153, DOI 10.1111/j.1469-1795.1998.tb00023.x; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; Gittleman JL, 2001, SCIENCE, V291, P997, DOI 10.1126/science.291.5506.997; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Hubbell Stephen P., 2001, V32, pi; JEDRZEJEWSKI B, 1998, PREDATION VERTEBRATE; Jobin A, 2000, ACTA THERIOL, V45, P243, DOI 10.4098/AT.arch.00-26; KRUUK H, 1982, J ZOOL, V196, P31; LAURENSON MK, 1995, CONSERV BIOL, V9, P1329, DOI 10.1046/j.1523-1739.1995.9051327.x-i1; Magnani F, 1999, NATURE, V398, P572, DOI 10.1038/19217; Marquet PA, 2000, SCIENCE, V289, P1487, DOI 10.1126/science.289.5484.1487; Mills MGL, 1997, CONSERV BIOL, V11, P1397, DOI 10.1046/j.1523-1739.1997.96252.x; MOLINARIJOBIN A, IN PRESS WILDLIFE BI; ODonoghue M, 1997, OIKOS, V80, P150, DOI 10.2307/3546526; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; Smallwood KS, 1996, OECOLOGIA, V105, P329, DOI 10.1007/BF00328735; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; VEZINA AF, 1985, OECOLOGIA, V67, P555, DOI 10.1007/BF00790027	38	430	441	3	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 22	2002	295	5563					2273	2276		10.1126/science.1067994	http://dx.doi.org/10.1126/science.1067994			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910114				2022-12-24	WOS:000174561700048
J	Marchetti, O; Calandra, T				Marchetti, O; Calandra, T			Infections in neutropenic cancer patients	LANCET			English	Editorial Material							FEBRILE PATIENTS; THERAPY; GRANULOCYTOPENIA; CHEMOTHERAPY; PROPHYLAXIS; FEVER		CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Calandra, T (corresponding author), CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland.		Calandra, Thierry/D-9017-2015	Calandra, Thierry/0000-0003-3051-1285				BOCHUD PY, 1994, AM J MED, V97, P256, DOI 10.1016/0002-9343(94)90009-4; CALANDRA T, 1991, J INFECT DIS, V163, P951; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; COMETTA A, 1994, NEW ENGL J MED, V330, P1240, DOI 10.1056/NEJM199404283301717; COMETTA A, 2001, 4 ICAAC CHIC 2001; DEBOCK R, 2001, 4 ICAAC CHIC 2001; Del Favero A, 2001, CLIN INFECT DIS, V33, P1295, DOI 10.1086/322646; Engels EA, 1998, J CLIN ONCOL, V16, P1179, DOI 10.1200/JCO.1998.16.3.1179; *EORTC INT ANT THE, 1978, J INFECT DIS, V137, P14; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; Kern WV, 1999, NEW ENGL J MED, V341, P312, DOI 10.1056/NEJM199907293410502; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Murphy M, 1997, CLIN INFECT DIS, V25, P346, DOI 10.1086/516925; SCHIMPFF S, 1971, NEW ENGL J MED, V284, P1061, DOI 10.1056/NEJM197105132841904; TALCOTT JA, 1992, J CLIN ONCOL, V10, P316, DOI 10.1200/JCO.1992.10.2.316; ZINNER SH, 1994, JAMA-J AM MED ASSOC, V272, P1183, DOI 10.1001/jama.1994.03520150051036	16	25	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 2	2002	359	9308					723	725		10.1016/S0140-6736(02)07900-X	http://dx.doi.org/10.1016/S0140-6736(02)07900-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888579				2022-12-24	WOS:000174115200003
J	Cunliffe, NA; Bresee, JS; Gentsch, JR; Glass, RI; Hart, CA				Cunliffe, NA; Bresee, JS; Gentsch, JR; Glass, RI; Hart, CA			The expanding diversity of rotaviruses	LANCET			English	Editorial Material							RNA-RNA HYBRIDIZATION; VACCINE DEVELOPMENT; GENOGROUPS; SEROTYPES; DIARRHEA; CHILDREN; INFANTS; STRAINS		Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England; Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA USA	University of Liverpool; Centers for Disease Control & Prevention - USA	Cunliffe, NA (corresponding author), Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3GA, Merseyside, England.			Cunliffe, Nigel/0000-0002-5449-4988				Bernstein DI, 1999, LANCET, V354, P287, DOI 10.1016/S0140-6736(98)12106-2; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001; DUNN SJ, 1993, J CLIN MICROBIOL, V31, P165, DOI 10.1128/JCM.31.1.165-169.1993; FLORES J, 1985, J MED VIROL, V17, P135, DOI 10.1002/jmv.1890170206; Gentsch JR, 1996, J INFECT DIS, V174, pS30, DOI 10.1093/infdis/174.Supplement_1.S30; GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1408, DOI 10.1128/JCM.32.5.1408-1409.1994; Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5; Iturriza-Gomara M, 2001, J VIROL, V75, P3696, DOI 10.1128/JVI.75.8.3696-3705.2001; Koshimura Y, 2000, MICROBIOL IMMUNOL, V44, P499, DOI 10.1111/j.1348-0421.2000.tb02525.x; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; NAKAGOMI T, 1989, J VIROL, V63, P1431, DOI 10.1128/JVI.63.3.1431-1434.1989; Palombo EA, 1999, FEMS MICROBIOL LETT, V181, P1; Ramachandran M, 2000, VIROLOGY, V278, P436, DOI 10.1006/viro.2000.0682; TANIGUCHI K, 1995, SEMIN VIROL, V6, P123, DOI 10.1006/smvy.1995.0016; Unicomb LE, 1999, J CLIN MICROBIOL, V37, P1885, DOI 10.1128/JCM.37.6.1885-1891.1999; WARD RL, 1990, J VIROL, V64, P3219, DOI 10.1128/JVI.64.7.3219-3225.1990; Watanabe M, 2001, ARCH VIROL, V146, P557, DOI 10.1007/s007050170162; 1990, LANCET, V335, P573	21	49	54	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					640	642		10.1016/S0140-6736(02)07781-4	http://dx.doi.org/10.1016/S0140-6736(02)07781-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879856				2022-12-24	WOS:000174107400004
J	Haissaguerre, M; Shah, DC; Jais, P; Shoda, M; Kautzner, J; Arentz, T; Kalushe, D; Kadish, A; Griffith, M; Gaita, F; Yamane, T; Garrigue, S; Hocini, M; Clementy, J				Haissaguerre, M; Shah, DC; Jais, P; Shoda, M; Kautzner, J; Arentz, T; Kalushe, D; Kadish, A; Griffith, M; Gaita, F; Yamane, T; Garrigue, S; Hocini, M; Clementy, J			Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation	LANCET			English	Article								Ventricular fibrillation Is the main mechanism of sudden cardiac death, but the source of its spontaneous initiation has not been mapped. 16 patients were Investigated by electrography and radiofrequency ablation after resuscitation from recurrent idiopathic ventricular fibrillation. Triggers of ventricular fibrillation originated from various locations within the Purkinje system in :12 patients and from the ordinary myocardial muscle in four. The accuracy of mapping was confirmed by acute elimination of triggers by radiofrequency delivery, and there was no recurrence of ventricular fibrillation in 14 patients. Long-term follow-up Is necessary to establish that ablation is curative and avoids use of a defibrillator.	Hop Cardiol Haut Leveque, F-33604 Bordeaux, France; Tokyo Womens Med Coll, Tokyo 162, Japan; Inst Clin Med, Prague, Czech Republic; Herz Zentrum, Bad Krozingen, Germany; Northwestern Med Fac, Chicago, IL USA; Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England	CHU Bordeaux; Tokyo Women's Medical University; University of Birmingham	Haissaguerre, M (corresponding author), Hop Cardiol Haut Leveque, Ave Magellan, F-33604 Bordeaux, France.			Gaita, Fiorenzo/0000-0003-3178-6205				BELHASSEN B, 1993, J CARDIOVASC ELECTR, V4, P356, DOI 10.1111/j.1540-8167.1993.tb01236.x; FRIEDMAN PL, 1973, CIRC RES, V33, P612, DOI 10.1161/01.RES.33.5.612; *JOINT COMM UN CAR, 1996, CIRCULATION, V95, P265; MYERBURG RJ, 1970, CIRC RES, V26, P361, DOI 10.1161/01.RES.26.3.361	4	204	210	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 23	2002	359	9307					677	678		10.1016/S0140-6736(02)07807-8	http://dx.doi.org/10.1016/S0140-6736(02)07807-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526AZ	11879868				2022-12-24	WOS:000174107400016
J	Fukuda, M; Fukuda, K; Shimizu, T; Andersen, CY; Byskov, AG				Fukuda, M; Fukuda, K; Shimizu, T; Andersen, CY; Byskov, AG			Parental periconceptional smoking and male : female ratio of newborn infants	LANCET			English	Article							SEX-RATIO	We assessed whether the smoking habits of parents around the time of conception affects the likelihood of the offspring being male or female. We found that the offspring sex ratio (male to female) was lower when either one or both of the parents smoked more than 20 cigarettes per day compared with couples in which neither of the parents smoked. We found the lowest sex ratio among children whose mothers and fathers both smoked more than 20 cigarettes per day (p<0.0001). Parental periconceptional smoking might be a contributing factor to a lower male to female sex ratio of offspring.	Fukuda Ladies Clin, Ako, Hyogo 6780239, Japan; Shimizu Womens Clin, Takarazuka, Hyogo 6650011, Japan; Univ Copenhagen Hosp, Reprod Biol Lab, Sect 5712, DK-2100 Copenhagen, Denmark	University of Copenhagen	Fukuda, M (corresponding author), Fukuda Ladies Clin, 30-9 Kariya, Ako, Hyogo 6780239, Japan.			Andersen, Claus Yding/0000-0001-7681-253X				BUTLER NR, 1969, PERINATAL PROBLEMS, P339; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Mocarelli P, 2000, LANCET, V355, P1858, DOI 10.1016/S0140-6736(00)02290-X; Moller H, 1996, LANCET, V348, P828, DOI 10.1016/S0140-6736(05)65253-1; Sakamoto M, 2001, ENVIRON RES, V87, P92, DOI 10.1006/enrs.2001.4293	5	118	120	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 20	2002	359	9315					1407	1408		10.1016/S0140-6736(02)08362-9	http://dx.doi.org/10.1016/S0140-6736(02)08362-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542ZQ	11978342				2022-12-24	WOS:000175076200017
J	Braich, RS; Chelyapov, N; Johnson, C; Rothemund, PWK; Adleman, L				Braich, RS; Chelyapov, N; Johnson, C; Rothemund, PWK; Adleman, L			Solution of a 20-variable 3-SAT problem on a DNA computer	SCIENCE			English	Article							MOLECULAR COMPUTATION; MACHINE	A 20-variable instance of the NP-complete three-satisfiability (3-SAT) problem was solved on a simple DNA computer. The unique answer was found after an exhaustive search of more than 1 million (2(20)) possibilities. This computational problem may be the largest yet solved by nonelectronic means. Problems of this size appear to be beyond the normal range of unaided human computation.	Univ So Calif, Lab Mol Sci, Los Angeles, CA 90089 USA; CALTECH, Pasadena, CA 91125 USA	University of Southern California; California Institute of Technology	Adleman, L (corresponding author), Univ So Calif, Lab Mol Sci, Los Angeles, CA 90089 USA.	Adleman@USC.edu						ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Braich R.S., 2001, LECT NOTES COMPUTER, V2054, P27; BRAICH RS, UNPUB; CORMEN TH, 1990, INTRO ALGORITHMS, P916; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; HEAD T, 1987, B MATH BIOL, V49, P737, DOI 10.1016/S0092-8240(87)90018-8; Kenney M, 1998, BIOTECHNIQUES, V25, P516, DOI 10.2144/98253pf01; Landweber LF, 1999, BIOSYSTEMS, V52, P3, DOI 10.1016/S0303-2647(99)00027-1; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; MORIMOTO N, 1999, DIMACS SERIES DISCRE, V48, P193; ROTHEMUND PWK, 1996, DIMACS SERIES DISCRE, V27, P75; Roweis S, 1998, J COMPUT BIOL, V5, P615, DOI 10.1089/cmb.1998.5.615; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; SMITH WD, 1996, DIMACS SERIES DISCRE, V27, P121; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; [No title captured]; [No title captured]	24	362	437	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 19	2002	296	5567					499	502		10.1126/science.1069528	http://dx.doi.org/10.1126/science.1069528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544UE	11896237				2022-12-24	WOS:000175179400037
J	Cohen, AL; Owens, KE; Layne, GD; Shimizu, N				Cohen, AL; Owens, KE; Layne, GD; Shimizu, N			The effect of algal symbionts on the accuracy of Sr/Ca paleotemperatures from coral	SCIENCE			English	Article							SEA-SURFACE TEMPERATURE; ASTRANGIA-DANAE; EXPERIMENTAL ECOLOGY; PORITES CORALS; STRONTIUM; RATIOS; RECONSTRUCTIONS; CALCIFICATION; CALIBRATION; THERMOMETRY	The strontium-to-calcium ratio (Sr/Ca) of reef coral skeleton is commonly used as a paleothermometer to estimate sea surface temperatures (SSTs) at crucial times in Earth's climate history. However, these estimates are disputed, because uptake of Sr into coral skeleton is thought to be affected by algal symbionts (zooxanthellae) living in the host tissue. Here, we show that significant distortion of the Sr/Ca temperature record in coral skeleton occurs in the presence of algal symbionts. Seasonally resolved Sr/Ca in coral without symbionts reflects local SSTs with a temperature sensitivity equivalent to that of laboratory aragonite precipitated at equilibrium and the nighttime skeletal deposits of symbiotic reef corals. However, up to 65% of the Sr/Ca variability in symbiotic skeleton is related to symbiont activity and does not reflect water temperature.	Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Cohen, AL (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.		Facility, NENIMF/B-8811-2015					Alibert C, 1997, PALEOCEANOGRAPHY, V12, P345, DOI 10.1029/97PA00318; BARD E, 2001, GEOCHEM GEOPHYS GEOS, V2; BECK JW, 1992, SCIENCE, V257, P644, DOI 10.1126/science.257.5070.644; Charles CD, 2001, CLIM DYNAM, V17, P489, DOI 10.1007/s003820000126; Cohen AL, 2001, PALEOCEANOGRAPHY, V16, P20, DOI 10.1029/1999PA000478; CROWLEY TJ, 1994, NATURE, V371, P664, DOI 10.1038/371664a0; Crowley TJ, 1999, PALEOCEANOGRAPHY, V14, P605, DOI 10.1029/1999PA900032; Crowley TJ, 2000, CLIM DYNAM, V16, P241, DOI 10.1007/s003820050325; DEVILLIERS S, 1994, GEOCHIM COSMOCHIM AC, V58, P197, DOI 10.1016/0016-7037(94)90457-X; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; HOEGHGUILDBERG O, 2001, COMMUNICATION    NOV; HOFFERT MI, 1992, NATURE, V360, P573, DOI 10.1038/360573a0; Hughen KA, 1999, GEOPHYS RES LETT, V26, P3129, DOI 10.1029/1999GL006062; IP YK, 1991, J EXP ZOOL, V258, P273, DOI 10.1002/jez.1402580219; JACQUES TG, 1980, MAR BIOL, V60, P167, DOI 10.1007/BF00389160; JACQUES TG, 1983, MAR BIOL, V76, P135, DOI 10.1007/BF00392730; KINSMAN DJJ, 1969, GEOCHIM COSMOCHIM AC, V33, P1, DOI 10.1016/0016-7037(69)90089-1; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; Mitsuguchi T, 1996, SCIENCE, V274, P961, DOI 10.1126/science.274.5289.961; PETERS EC, 1985, J EXP MAR BIOL ECOL, V92, P215, DOI 10.1016/0022-0981(85)90096-6; PETERS EC, 1988, P BIOL SOC WASH, V101, P234; Schrag DP, 1999, PALEOCEANOGRAPHY, V14, P97, DOI 10.1029/1998PA900025; Shen CC, 1996, GEOCHIM COSMOCHIM AC, V60, P3849, DOI 10.1016/0016-7037(96)00205-0; Sinclair DJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1889, DOI 10.1016/S0016-7037(98)00112-4; SMITH SV, 1979, SCIENCE, V204, P404, DOI 10.1126/science.204.4391.404; SZMANTFROELICH A, 1980, BIOL BULL, V158, P257, DOI 10.2307/1540935; THOMPSON G, 1970, EARTH PLANET SC LETT, V8, P439, DOI 10.1016/0012-821X(70)90148-2; WEBER JN, 1973, GEOCHIM COSMOCHIM AC, V37, P2173, DOI 10.1016/0016-7037(73)90015-X; WOOD EM, 1983, CORALS WORLD	30	118	131	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 12	2002	296	5566					331	333		10.1126/science.1069330	http://dx.doi.org/10.1126/science.1069330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541TJ	11884719				2022-12-24	WOS:000175000300053
J	Vaessen, N; Janssen, JA; Heutink, P; Hofman, A; Lamberts, SWJ; Oostra, BA; Pols, HAP; van Duijn, CM				Vaessen, N; Janssen, JA; Heutink, P; Hofman, A; Lamberts, SWJ; Oostra, BA; Pols, HAP; van Duijn, CM			Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight	LANCET			English	Article							DISEASE	Low birthweight Is associated with later risk of type 2 diabetes and related disorders. We aimed to show that a polymorphism In the gone for Insulin-like growth factor-I, which has proved to raise risk of type 2 diabetes and myocardial Infarction, Is associated with low birthweight. We recorded birthweight and obtained DNA for 463 adults. Individuals who did not have the wild-type allele of the polymorphism had a 215 g lower birthweight than those homozygous for this allele (95% CI -4.11 to -10). Our data lend support to the hypothesis that genetic variation affecting fetal growth could account for the association between low birthweight and susceptibility to diabetes and cardiovascular disease In later life.	Erasmus Med Ctr Rotterdam, Ctr Biomed Genet, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Duijn, CM (corresponding author), Erasmus Med Ctr Rotterdam, Ctr Biomed Genet, Dept Epidemiol & Biostat, Genet Epidemiol Unit, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Janssen, Joseph A.M.J.L./AAU-5133-2021	Janssen, Joseph A.M.J.L./0000-0002-9363-6408; Heutink, Peter/0000-0001-5218-1737; Van Duijn, Cornelia/0000-0002-2374-9204				BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Hill DJ, 1998, DIABETES CARE, V21, pB60; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Vaessen N, 2001, DIABETES, V50, P637, DOI 10.2337/diabetes.50.3.637	5	169	178	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 23	2002	359	9311					1036	1037		10.1016/S0140-6736(02)08067-4	http://dx.doi.org/10.1016/S0140-6736(02)08067-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534KP	11937187				2022-12-24	WOS:000174585800014
J	Shen, Y; Zhou, DJ; Qiu, LY; Lai, XM; Simon, M; Shen, L; Kou, ZC; Wang, QF; Jiang, JM; Estep, J; Hunt, R; Clagett, M; Sehgal, PK; Li, YY; Zeng, XJ; Morita, CT; Brenner, MB; Letvin, NL; Chen, ZW				Shen, Y; Zhou, DJ; Qiu, LY; Lai, XM; Simon, M; Shen, L; Kou, ZC; Wang, QF; Jiang, JM; Estep, J; Hunt, R; Clagett, M; Sehgal, PK; Li, YY; Zeng, XJ; Morita, CT; Brenner, MB; Letvin, NL; Chen, ZW			Adaptive immune response of V gamma 2V delta 2(+) T cells during mycobacterial infections	SCIENCE			English	Article							BACILLUS-CALMETTE-GUERIN; AIRBORNE TUBERCULOSIS; PUBLISHED LITERATURE; EFFICACY; LIGANDS; MICE; METAANALYSIS; VACCINATION; STIMULATION; LYMPHOCYTES	To examine the role of T cell receptor (TCR) in gammadelta T cells in adaptive immunity, a macaque model was used to follow Vgamma2Vdelta2(+) T cell responses to mycobacterial infections. These phosphoantigen-specific gammadelta T cells displayed major expansion during Mycobacterium bovis Bacille Calmette-Guerin (BCG) infection and a clear memory-type response after BCG reinfection. Primary and recall expansions of Vgamma2Vdelta2(+) T cells were also seen during Mycobacterium tuberculosis infection of naive and BCG-vaccinated macaques, respectively. This capacity to rapidly expand coincided with a clearance of BCG bacteremia and immunity to fatal tuberculosis in BCG-vaccinated macaques. Thus, Vgamma2Vdelta2(+) T cells may contribute to adaptive immunity to mycobacterial infections.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, TB Res Unit, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02115 USA; New England Reg Primate Res Ctr, Southborough, MA 01772 USA; Battelle Mem Inst, Battelle Med Res & Evaluat Facil, Columbus, OH 43201 USA; Univ Iowa, Dept Internal Med, Div Rheumatol, Iowa City, IA 52242 USA; Univ Iowa, Interdisciplinary Grp Immunol, Iowa City, IA 52242 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Battelle Memorial Institute; University of Iowa; University of Iowa; Harvard University; Brigham & Women's Hospital	Chen, ZW (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, TB Res Unit, Boston, MA 02115 USA.		Morita, Craig T/C-1365-2011	Morita, Craig T/0000-0001-8496-8294	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR013601, RR13601, R01 RR013601-04] Funding Source: Medline; NHLBI NIH HHS [R01 HL064560, HL64560, R01 HL064560-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARCLAY WR, 1973, AM REV RESPIR DIS, V107, P351; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; BURK MR, 1995, EUR J IMMUNOL, V25, P2052, DOI 10.1002/eji.1830250737; Chen ZW, 2000, J MED PRIMATOL, V29, P143, DOI 10.1034/j.1600-0684.2000.290307.x; COLDITZ GA, 1995, PEDIATRICS, V96, P29; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; DSouza CD, 1997, J IMMUNOL, V158, P1217; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; JANICKI BW, 1973, AM REV RESPIR DIS, V107, P359; Kunzmann V, 1999, NEW ENGL J MED, V340, P737, DOI 10.1056/NEJM199903043400914; LADEL CH, 1995, EUR J IMMUNOL, V25, P838, DOI 10.1002/eji.1830250331; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; McMurray DN, 2000, CLIN INFECT DIS, V30, pS210, DOI 10.1086/313885; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Morita CT, 2000, SPRINGER SEMIN IMMUN, V22, P191, DOI 10.1007/s002810000042; MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7; Mukasa A, 1999, J IMMUNOL, V162, P4910; PFEFFER K, 1990, EUR J IMMUNOL, V20, P1175, DOI 10.1002/eji.1830200534; Poquet Y, 1996, RES IMMUNOL, V147, P542, DOI 10.1016/S0923-2494(97)85220-0; RIBI E, 1971, J INFECT DIS, V123, P527, DOI 10.1093/infdis/123.5.527; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Sciammas R, 1997, J EXP MED, V185, P1969, DOI 10.1084/jem.185.11.1969; Shen Y, 2002, INFECT IMMUN, V70, P869, DOI 10.1128/IAI.70.2.869-877.2002; Shen Y, 2001, J VIROL, V75, P8690, DOI 10.1128/JVI.75.18.8690-8696.2001; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175; Zhou DJ, 1999, J IMMUNOL, V162, P2204	30	299	314	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 22	2002	295	5563					2255	2258		10.1126/science.1068819	http://dx.doi.org/10.1126/science.1068819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	534AD	11910108	Green Accepted			2022-12-24	WOS:000174561700042
J	Jormakka, M; Tornroth, S; Byrne, B; Iwata, S				Jormakka, M; Tornroth, S; Byrne, B; Iwata, S			Molecular basis of proton motive force generation: Structure of formate dehydrogenase-N	SCIENCE			English	Article							ESCHERICHIA-COLI; WOLINELLA-SUCCINOGENES; MOLYBDENUM-COFACTOR; NITRATE REDUCTASE; CRYSTAL-STRUCTURE; MOLYBDOPTERIN; OXIDATION; SELENOCYSTEINE; HYDROGENASE; MECHANISM	The structure of the membrane protein formate dehydrogenase-N (Fdn-N), a major component of Escherichia coli nitrate respiration, has been determined at 1.6 angstroms. The structure demonstrates 11 redox centers, including molybdopterin-guanine dinucleotides, five [4Fe-4S] clusters, two heme b groups, and a menaquinone analog. These redox centers are aligned in a single chain, which extends almost 90 angstroms through the enzyme. The menaquinone reduction site associated with a possible proton pathway was also characterized. This structure provides critical insights into the proton motive force generation by redox loop, a common mechanism among a wide range of respiratory enzymes.	Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; Univ Uppsala, BMC, Dept Biochem, S-75123 Uppsala, Sweden	Imperial College London; Imperial College London; Uppsala University	Iwata, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England.		Törnroth-Horsefield, Susanna/B-2702-2010	Byrne, Bernadette/0000-0001-9598-9832; Tornroth-Horsefield, Susanna/0000-0002-9435-8243				Benoit S, 1998, J BACTERIOL, V180, P6625, DOI 10.1128/JB.180.24.6625-6634.1998; BERG BL, 1991, J BIOL CHEM, V266, P22380; BERKS BC, 1995, MOL MICROBIOL, V15, P319, DOI 10.1111/j.1365-2958.1995.tb02246.x; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; BIEL S, IN PRESS EUR J BIOCH; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Dias JM, 1999, STRUCTURE, V7, P65, DOI 10.1016/S0969-2126(99)80010-0; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; Gross R, 1998, MOL MICROBIOL, V30, P639, DOI 10.1046/j.1365-2958.1998.01100.x; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES RW, 1980, FEMS MICROBIOL LETT, V8, P167, DOI 10.1111/j.1574-6968.1980.tb05072.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Khangulov SV, 1998, BIOCHEMISTRY-US, V37, P3518, DOI 10.1021/bi972177k; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KROGER A, 1979, EUR J BIOCHEM, V94, P465, DOI 10.1111/j.1432-1033.1979.tb12914.x; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Meek L, 2000, J BACTERIOL, V182, P3429, DOI 10.1128/JB.182.12.3429-3436.2000; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; SIEKER LC, 1972, NATURE, V235, P40, DOI 10.1038/235040a0	28	372	383	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2002	295	5561					1863	1868		10.1126/science.1068186	http://dx.doi.org/10.1126/science.1068186			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529KW	11884747				2022-12-24	WOS:000174299500030
J	Brasier, MD; Green, OR; Jephcoat, AP; Kleppe, AK; Van Kranendonk, MJ; Lindsay, JF; Steele, A; Grassineau, NV				Brasier, MD; Green, OR; Jephcoat, AP; Kleppe, AK; Van Kranendonk, MJ; Lindsay, JF; Steele, A; Grassineau, NV			Questioning the evidence for Earth's oldest fossils	NATURE			English	Article							NORTH-POLE; CHERT; MICROFOSSILS; GRAPHITE; CARBON; OXYGEN	Structures resembling remarkably preserved bacterial and cyanobacterial microfossils from similar to3,465-million-year-old Apex cherts of the Warrawoona Group in Western Australia(1-4) currently provide the oldest morphological evidence for life on Earth and have been taken to support an early beginning for oxygen-producing photosynthesis(5). Eleven species of filamentous prokaryote, distinguished by shape and geometry, have been put forward as meeting the criteria required of authentic Archaean microfossils(1-5), and contrast with other microfossils dismissed as either unreliable or unreproducible(1,3,6,7). These structures are nearly a billion years older than putative cyanobacterial biomarkers(8), genomic arguments for cyanobacteria(9), an oxygenic atmosphere(10) and any comparably diverse suite of microfossils(5). Here we report new research on the type and re-collected material, involving mapping, optical and electron microscopy, digital image analysis, micro-Raman spectroscopy and other geochemical techniques. We reinterpret the purported microfossil-like structure as secondary artefacts formed from amorphous graphite within multiple generations of metalliferous hydrothermal vein chert and volcanic glass. Although there is no support for primary biological morphology, a Fischer-Tropsch-type synthesis of carbon compounds and carbon isotopic fractionation is inferred for one of the oldest known hydrothermal systems on Earth.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Geol Survey Western Australia, Perth, WA 6004, Australia; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Portsmouth, Sch Earth Environm & Phys Sci, Portsmouth PO1 3QL, Hants, England; Royal Holloway Univ London, Dept Geol, Egham TW20 0EX, Surrey, England	University of Oxford; Geological Survey of Western Australia; Australian National University; University of Portsmouth; University of London; Royal Holloway University London	Brasier, MD (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	martinb@earth.ox.ac.uk	Steele, Andrew/A-3573-2013	Steele, Andrew/0000-0001-9643-2841; Grassineau, Nathalie/0000-0001-7958-7104; Van Kranendonk, Martin/0000-0002-0611-2703				[Anonymous], 1992, PROTEROZOIC BIOSPHER; [Anonymous], CRADLE LIFE; AWRAMIK SM, 1979, CAN J EARTH SCI, V16, P484, DOI 10.1139/e79-044; BAKER RTK, 1978, CHEM PHYS CARBON, P2; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; CLAYTON RN, 1963, GEOCHIM COSMOCHIM AC, V27, P43, DOI 10.1016/0016-7037(63)90071-1; deRonde CEJ, 1996, GEOLOGY, V24, P791, DOI 10.1130/0091-7613(1996)024<0791:BYOOCF>2.3.CO;2; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; Hedges SB, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-4; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; KAGI H, 1994, GEOCHIM COSMOCHIM AC, V58, P3527, DOI 10.1016/0016-7037(94)90104-X; Kudryavtsev AB, 2001, P NATL ACAD SCI USA, V98, P823, DOI 10.1073/pnas.98.3.823; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; MATTHEWS DE, 1978, ANAL CHEM, V50, P1465, DOI 10.1021/ac50033a022; Mendelson C.V., 1992, P867; Nijman W, 1998, PRECAMBRIAN RES, V88, P25, DOI 10.1016/S0301-9268(97)00062-4; OEHLER JH, 1976, GEOL SOC AM BULL, V87, P1143, DOI 10.1130/0016-7606(1976)87<1143:HCOSG>2.0.CO;2; ROBERT F, 1988, GEOCHIM COSMOCHIM AC, V52, P1473, DOI 10.1016/0016-7037(88)90218-9; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; Schopf JW, 1994, EARLY LIFE EARTH, P193; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; VANKRANENDONK MJ, IN PRESS PRECAMBRIAN; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; WOPENKA B, 1993, AM MINERAL, V78, P533	30	593	632	0	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 7	2002	416	6876					76	81		10.1038/416076a	http://dx.doi.org/10.1038/416076a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527WU	11882895				2022-12-24	WOS:000174211600041
J	Mallal, S; Nolan, D; Witt, C; Masel, G; Martin, AM; Moore, C; Sayer, D; Castley, A; Mamotte, C; Maxwell, D; James, I; Christiansen, FT				Mallal, S; Nolan, D; Witt, C; Masel, G; Martin, AM; Moore, C; Sayer, D; Castley, A; Mamotte, C; Maxwell, D; James, I; Christiansen, FT			Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir	LANCET			English	Article							HEAT-SHOCK PROTEINS; DISEASE ASSOCIATIONS; ACTIVATION; POLYMORPHISM; RECOGNITION; GENE; HLA	Background The use of abacavir-a potent HIV-1 nucleoside-analogue reverse-transcriptase inhibitor-is complicated by a potentially life-threatening hypersensitivity syndrome in about 5% of cases. Genetic factors influencing the immune response to abacavir might confer susceptibility. We aimed to find associations between MHC alleles and abacavir hypersensitivity in HIV-1-positive individuals treated with abacavir. Methods MHC region typing was done in the first 200 Western Australian HIV Cohort Study participants exposed to abacavir. Definite abacavir hypersensitivity was identified in 18 cases, and was excluded in 167 individuals with more than 6 weeks' exposure to the drug (abacavir tolerant). 15 individuals experienced some symptoms but did not meet criteria for abacavir hypersensitivity. p values were corrected for comparisons of multiple HLA alleles (p.) by multiplication of the raw p value by the estimated number of HLA alleles present within the loci examined. Findings HLA-B*5701 was present in 14 (78%) of the 18 Patients with abacavir hypersensitivity, and in four (2%) of the 167 abacavir tolerant patients (odds ratio 117 [95% CI 29-481], p(c)<0.0001), and the HLA-DR7 and HLA-DQ3 combination was found in 13 (72%) of hypersensitive and five (3%) of tolerant patients (73 [20-268], p <0.0001). HLAB*5701, HLA-DR7, and HLA-DQ3 were present in combination in 13 (72%) hypersensitive patients and none of the tolerant patients (822 [43-15 675], p,<0.0001). Other MHC markers also present on the 57.1 ancestral haplotype to which the three markers above belong confirmed the presence of haplotype-specific linkage disequilibrium, and mapped potential susceptibility loci to a region bounded by C4A6 and HLA-C. Within the entire abacavir-exposed cohort (n=200), presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 had a positive predictive value for hypersensitivity of 100%, and a negative predictive value of 97%. Interpretation Genetic susceptibility to abacavir hypersensitivity is carried on the 57.1 ancestral haplotype. in our population, withholding abacavir In those with HLA-B*5701, HLA-DR7, and HLA-DQ3 should reduce the prevalence of hypersensitivity from 9% to 2.5% without inappropriately denying abacavir to any patient.	Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Perth, WA, Australia; Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA 6000, Australia; Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; University of Western Australia	Mallal, S (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, 2nd Floor,N Block, Perth, WA 6000, Australia.	mallal@prodigal.murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022; Mamotte, Cyril/AAF-9603-2020	Mallal, Simon Alexander/0000-0002-7036-1309; Mamotte, Cyril/0000-0003-1831-3921				BREWERTON DA, 1973, LANCET, V1, P904; Cheong KY, 2001, HUM IMMUNOL, V62, P1363, DOI 10.1016/S0198-8859(01)00351-2; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; DAWKINS RL, 1991, BAILLIERE CLIN ENDOC, V5, P285, DOI 10.1016/S0950-351X(05)80128-4; Escaut L, 1999, AIDS, V13, P1419, DOI 10.1097/00002030-199907300-00026; Faletto MB, 1997, ANTIMICROB AGENTS CH, V41, P1099, DOI 10.1128/AAC.41.5.1099; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; HETHERINGTON S, 2001, 1 IAS C HIV PATH TRE; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; More SH, 2001, INT IMMUNOL, V13, P1121, DOI 10.1093/intimm/13.9.1121; Multhoff G, 1998, BIOL CHEM, V379, P295; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Park BK, 2001, TOXICOLOGY, V158, P11, DOI 10.1016/S0300-483X(00)00397-8; Peyriere H, 2001, ANN PHARMACOTHER, V35, P1291; Pirmohamed M, 2001, NEUROLOGY, V56, P890, DOI 10.1212/WNL.56.7.890; Schnyder B, 2000, J IMMUNOL, V164, P6647, DOI 10.4049/jimmunol.164.12.6647; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; White AJ, 2001, SEX TRANSM INFECT, V77, P158, DOI 10.1136/sti.77.3.158; Wilson A. G., 1992, Human Molecular Genetics, V1, P353, DOI 10.1093/hmg/1.5.353; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544	22	1001	1060	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2002	359	9308					727	732		10.1016/S0140-6736(02)07873-X	http://dx.doi.org/10.1016/S0140-6736(02)07873-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	526DZ	11888582				2022-12-24	WOS:000174115200006
J	Aitken, RJ; Graves, JAM				Aitken, RJ; Graves, JAM			Human spermatozoa: The future of sex	NATURE			English	Editorial Material									Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia; Univ Newcastle, Discipline Biol Sci, Callaghan, NSW 2308, Australia; Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Australian National University	Aitken, RJ (corresponding author), Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia.		Aitken, Robert John/AAY-8238-2020; Graves, Jennifer A.M./A-1387-2008	Aitken, Robert John/0000-0002-9152-156X; Graves, Jennifer/0000-0001-6480-7856				Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Graves JAM, 2000, BIOL REPROD, V63, P667, DOI 10.1095/biolreprod63.3.667b; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Kamp C, 2001, MOL HUM REPROD, V7, P987, DOI 10.1093/molehr/7.10.987; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757	5	83	90	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 28	2002	415	6875					963	963		10.1038/415963a	http://dx.doi.org/10.1038/415963a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875544				2022-12-24	WOS:000174075000022
J	Fay, JC; Wyckoff, GJ; Wu, CI				Fay, JC; Wyckoff, GJ; Wu, CI			Testing the neutral theory of molecular evolution with genomic data from Drosophila	NATURE			English	Article							POPULATION-GENETICS; ADAPTIVE EVOLUTION; SUBSTITUTIONS; MELANOGASTER; DIVERGENCE; PROTEIN; NUCLEAR; GENES	Although positive selection has been detected in many genes, its overall contribution to protein evolution is debatable(1). If the bulk of molecular evolution is neutral, then the ratio of amino-acid (A) to synonymous (S) polymorphism should, on average, equal that of divergence(2). A comparison of the A/S ratio of polymorphism in Drosophila melanogaster with that of divergence from Drosophila simulans shows that the A/S ratio of divergence is twice as high-a difference that is often attributed to positive selection. But an increase in selective constraint owing to an increase in effective population size could also explain this observation, and, if so, all genes should be affected similarly. Here we show that the difference between polymorphism and divergence is limited to only a fraction of the genes, which are also evolving more rapidly, and this implies that positive selection is responsible. A higher A/S ratio of divergence than of polymorphism is also observed in other species, which suggests a rate of adaptive evolution that is far higher than permitted by the neutral theory of molecular evolution.	Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Fay, JC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Genome Sci, Berkeley, CA 94720 USA.			Wyckoff, Gerald/0000-0003-2604-2666; Fay, Justin/0000-0003-1893-877X				Akashi H, 1997, GENE, V205, P269, DOI 10.1016/S0378-1119(97)00400-9; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Begun DJ, 2000, GENETICS, V154, P1231; Begun DJ, 2001, MOL BIOL EVOL, V18, P1343, DOI 10.1093/oxfordjournals.molbev.a003918; EANES WF, 1993, P NATL ACAD SCI USA, V90, P7475, DOI 10.1073/pnas.90.16.7475; Fay JC, 2001, GENETICS, V158, P1227; Hey J, 1997, GENETICS, V145, P833; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kimura M, 1985, NEUTRAL THEORY MOL E; Kliman RM, 2000, GENETICS, V156, P1913; LACHAISE D, 1988, EVOL BIOL, V22, P159; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2001, GENETICS, V157, P245; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nei M, 1987, MOL EVOLUTIONARY GEN; OHTA T, 1995, J MOL EVOL, V40, P56, DOI 10.1007/BF00166595; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Tsaur SC, 1998, MOL BIOL EVOL, V15, P1040, DOI 10.1093/oxfordjournals.molbev.a026002; Weinreich DM, 2000, GENETICS, V156, P385; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	23	264	271	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 28	2002	415	6875					1024	1026		10.1038/4151024a	http://dx.doi.org/10.1038/4151024a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	525MF	11875569				2022-12-24	WOS:000174075000045
